<SEC-DOCUMENT>0001731122-25-001281.txt : 20250922
<SEC-HEADER>0001731122-25-001281.hdr.sgml : 20250922
<ACCEPTANCE-DATETIME>20250922164518
ACCESSION NUMBER:		0001731122-25-001281
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		93
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250922
DATE AS OF CHANGE:		20250922

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		251330602

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>e6836_10k.htm
<DESCRIPTION>FONAR CORPORATION FORM 10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:FONR="http://fonar.com/20250630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2025%2D(with%2DECD%2Dand%2DCYD) -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_FONR_fonar.com_20250630 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20240701_20250630 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DDocumentFiscalYearFocus_2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<body style="font: 11pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000004" name="dei:DocumentFiscalYearFocus">2025</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000005" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000006" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonFraction name="FONR:PrepaidExpensesAndOtherCurrentAssetsRelatedParty" contextRef="AsOf2024-06-30" id="xdx2ixbrl0104" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2025-06-30" id="xdx2ixbrl0145" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2025-06-30" id="xdx2ixbrl0187" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0471" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0474" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0482" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0484" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0485" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0497" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0499" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterest" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0507" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterest" contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0510" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember" id="xdx2ixbrl0514" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0531" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0532" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0533" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0535" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0536" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0541" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0547" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0548" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0549" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0551" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0552" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0553" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0561" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0562" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0563" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0571" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterest" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0577" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterest" contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0579" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0581" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0582" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0583" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0586" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0587" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0600" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0603" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0604" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0607" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0608" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0609" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0611" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0615" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0624" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0627" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0628" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0631" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0632" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleNonControllingInterest" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0635" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0639" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0643" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:GainOnSaleOfEquipmentRelatedParty" contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0672" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:GainlossOnDispositionOfFixedAssets" contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0675" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivable" contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0687" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInNotesReceivableRelatedParties" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SaleOfNoncontrollingInterest" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0745" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2025-06-30_us-gaap_NotesReceivableMember" id="xdx2ixbrl1152" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember" id="xdx2ixbrl1154" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember" id="xdx2ixbrl1159" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="xdx2ixbrl1163" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl1191" unitRef="Integer" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember" id="xdx2ixbrl1288" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="xdx2ixbrl1388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl1412" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="xdx2ixbrl1434" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl1450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="xdx2ixbrl1496" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="xdx2ixbrl1504" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="xdx2ixbrl1512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="xdx2ixbrl1520" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CorrectionOfError" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl1552" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2025-06-30" id="xdx2ixbrl1868" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2025-06-30" id="xdx2ixbrl1920" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdvancePaymentsByBorrowersForTaxesAndInsurance" contextRef="AsOf2024-06-30" id="xdx2ixbrl1927" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedUtilitiesCurrent" contextRef="AsOf2024-06-30" id="xdx2ixbrl1930" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:SoftwareLicenses" contextRef="AsOf2024-06-30" id="xdx2ixbrl1936" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:RecruitingFees" contextRef="AsOf2024-06-30" id="xdx2ixbrl1939" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:RentExpenses" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="xdx2ixbrl2037" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="xdx2ixbrl2050" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="xdx2ixbrl2054" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="xdx2ixbrl2058" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="xdx2ixbrl2110" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:RentExpenses" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="xdx2ixbrl2133" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="xdx2ixbrl2146" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="xdx2ixbrl2150" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="xdx2ixbrl2154" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="xdx2ixbrl2206" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2024-07-012025-06-30_country_CA" id="xdx2ixbrl2238" unitRef="Ratio" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2023-07-012024-06-30_custom_TwoMember" id="xdx2ixbrl2244" unitRef="Ratio" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_CA" id="xdx2ixbrl2282" unitRef="Ratio" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-012025-06-30_country_AU" id="xdx2ixbrl2288" unitRef="Ratio" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20250630.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-07-01to2025-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-09-08_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-09-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-09-08_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-09-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-09-08_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-09-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-09-08_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-09-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_CommonStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ClassANonVotingPreferredStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember516945625">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ClassAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ClassAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ClassAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_CommonStockMember516945765">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ClassAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ClassCCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_DiagnosticImagingFacilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-07-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-07-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:TwoVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoVendorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:TwoVendorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_BuildingMember_srt_WeightedAverageMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ClassAPreferredStockMember516949718">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ClassAPreferredStockMember516949796">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_NotesReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_DiagnosticEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDevelopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDevelopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MachineryAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_OperatingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_FinancingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_SoftwareLicenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:SoftwareLicenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_SoftwareLicenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:SoftwareLicenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_CostomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:CostomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_SoftwareLicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:SoftwareLicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_SoftwareLicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:SoftwareLicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-04-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_N2010StockBonusPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-252023-09-26_srt_BoardOfDirectorsChairmanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-25</xbrli:startDate>
        <xbrli:endDate>2023-09-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-12</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-12</xbrli:startDate>
        <xbrli:endDate>2013-02-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-03-05_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-03-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-072015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-07</xbrli:startDate>
        <xbrli:endDate>2015-01-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_MagneticResonanceManagementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_BensonhurstMRILimitedPartnershipMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_RadianHealthcareManagementLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:RadianHealthcareManagementLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingandServicingofMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManagementofDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_TotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:TotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingandServicingofMedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManagementofDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_TotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:TotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_TwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FONR:TwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_TwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FONR:TwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_PR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_CH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_DE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_AE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_AE">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_DO">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_GR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_AU">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>FONR:Integer</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 10pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt">SECURITIES
    AND EXCHANGE COMMISSION</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">WASHINGTON,
    D.C. 20549</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 10%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; width: 80%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
    <span id="xdx_909_edei--DocumentType_c20240701__20250630_zndHp8tbwiZk"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000013" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></td>
    <td style="width: 10%">&#160;</td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 12pt"><span id="xdx_905_edei--DocumentAnnualReport_c20240701__20250630_zApDUO2q0Xmc"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the fiscal year ended <span id="xdx_909_edei--DocumentPeriodEndDate_c20240701__20250630_z6uBBvwQ5fli"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:datemonthdayyearen" id="Fact000015" name="dei:DocumentPeriodEndDate"><span id="xdx_90A_edei--CurrentFiscalYearEndDate_c20240701__20250630_z7eTafc1GFN7"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:datemonthdayen" id="Fact000016" name="dei:CurrentFiscalYearEndDate">June 30</ix:nonNumeric></span>, 2025</ix:nonNumeric></span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">OR</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 12pt"><span id="xdx_908_edei--DocumentTransitionReport_c20240701__20250630_zL8Lstogiywg"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000017" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">&#160;TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the transition period from _____________ to _____________</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Commission File No. <span id="xdx_90F_edei--EntityFileNumber_c20240701__20250630_zoUIwnZCiR0l"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000018" name="dei:EntityFileNumber">0-10248</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><img src="fonar_logo.jpg" alt="" style="height: 21.75pt; width: 144.75pt"/></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; vertical-align: bottom; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 24pt"><b><span id="xdx_90E_edei--EntityRegistrantName_c20240701__20250630_zg6d7zscXmE5"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000019" name="dei:EntityRegistrantName">FONAR CORPORATION</ix:nonNumeric></span></b></span></td>
    </tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(Exact name of registrant as specified in its charter)</span></td>
    </tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt; text-transform: uppercase"><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20240701__20250630_zqtSo08SwH2"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt-sec:stateprovnameen" id="Fact000020" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></span></td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20240701__20250630_zI0FuyQ1GFHa"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000021" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(State of incorporation)</span></td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(IRS Employer Identification Number)</span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding: 0pt; width: 49%; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_906_edei--EntityAddressAddressLine1_c20240701__20250630_zQRatxzPrwWf"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000022" name="dei:EntityAddressAddressLine1">110 Marcus Drive</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressCityOrTown_c20240701__20250630_zpdDdUBGrF6d"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000023" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20240701__20250630_zrJ7xi2GJA5k"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt-sec:stateprovnameen" id="Fact000024" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td>
    <td style="padding: 0pt; width: 2%; text-indent: 0pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding: 0pt; width: 49%; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20240701__20250630_zURaOq9ZWSp6"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000025" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(Address of principal executive offices)</span></td>
    <td style="padding: 0pt; text-indent: 0pt">&#160;</td>
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(Zip Code)</span></td>
    </tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 20%"><span style="font-size: 11pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: center; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(<span id="xdx_90B_edei--CityAreaCode_c20240701__20250630_zjg5Y99aW0Fl" title="City Area Code"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000027" name="dei:CityAreaCode">631</ix:nonNumeric></span>)
    <span id="xdx_90B_edei--LocalPhoneNumber_c20240701__20250630_zrhrIoKRBUdj"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000028" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></span></td>
    <td style="width: 20%"><span style="font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(Registrant's
    Telephone Number, including area code)</span></td>
    <td><span style="font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td><span style="font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 11pt">&#160;</span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Securities
    Registered pursuant to Section 12(b) of the Act</span></td>
    <td><span style="font-size: 11pt">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Title
    of Each Class</span></span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Trading
    Symbol(s)</span></span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="text-decoration: underline">Exchange
    Registered</span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_edei--Security12bTitle_c20240701__20250630_zkj69Qfd69c9"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000029" name="dei:Security12bTitle">Common
    Stock, $.0001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_907_edei--TradingSymbol_c20240701__20250630_zehK7brVsJ5c"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000030" name="dei:TradingSymbol">FONR</ix:nonNumeric></span></span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90A_edei--SecurityExchangeName_c20240701__20250630_zLyWAkUpJKWd"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center; white-space: nowrap; text-indent: 0pt"><span style="font-size: 11pt">&#160;</span></td>
    <td style="padding: 0pt; text-align: center; white-space: nowrap; text-indent: 0pt"><span style="font-size: 11pt">&#160;</span></td>
    <td style="padding: 0pt; text-align: center; white-space: nowrap; text-indent: 0pt"><span style="font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Securities
    Registered pursuant to Section 12(g) of the Act</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-align: center; white-space: nowrap; text-indent: 0pt"><span style="font-size: 11pt">&#160;</span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">None</span></td>
    <td style="padding: 0pt; text-align: center; white-space: nowrap; text-indent: 0pt"><span style="font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; white-space: nowrap; text-indent: 0pt"><span style="font-size: 11pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding: 0pt; white-space: nowrap; text-align: center; text-indent: 0pt"><span style="font-size: 11pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; white-space: nowrap; text-indent: 0pt"><span style="font-size: 11pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_90C_edei--EntityWellKnownSeasonedIssuer_c20240701__20250630_zlAutlSgAYKc" title="Entity Well-known Seasoned Issuer"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000033" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>
</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span> <span style="font-family: Times New Roman, Times, Serif">.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_90E_edei--EntityVoluntaryFilers_c20240701__20250630_zK0W61Tao3J" title="Entity Voluntary Filers"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000035" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span> <span style="font-family: Times New Roman, Times, Serif">.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_90C_edei--EntityCurrentReportingStatus_c20240701__20250630_zhNUcnOFGAw"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000036" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span>
<span style="font-family: Times New Roman, Times, Serif">No </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span>
<span style="font-family: Times New Roman, Times, Serif">.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has submitted electronically and posted on its corporate website, if any, every Interactive Data
File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant was required to submit and post such files). <span id="xdx_900_edei--EntityInteractiveDataCurrent_c20240701__20250630_zb7LaSiZwHQh"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000037" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span>
<span style="font-family: Times New Roman, Times, Serif">No </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant is a
large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of &#8220;large
accelerated filer&#8221;, &#8220;accelerated filer and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check
one):</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 11pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Large
    accelerated filer&#160;&#9744;</span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; width: 34%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90C_edei--EntityFilerCategory_c20240701__20250630_zKtX8rHtotAa"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt-sec:entityfilercategoryen" id="Fact000038" name="dei:EntityFilerCategory">Accelerated filer</ix:nonNumeric> </span>&#9746;</span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Non-accelerated filer &#9744;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Smaller
    reporting company <span id="xdx_907_edei--EntitySmallBusiness_c20240701__20250630_zmnx0s1ziIPi"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000039" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Emerging
    Growth Company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20240701__20250630_zHYYB5fcxUtj"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000040" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
securities are registers pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. Yes&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span>
<span style="font-family: Times New Roman, Times, Serif">No </span><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_909_edei--DocumentFinStmtErrorCorrectionFlag_dbF_c20240701__20250630_zT2Kjk2rB7V6"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000041" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9746;</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif">&#160;.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). Yes&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span>
<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--IcfrAuditorAttestationFlag_c20240701__20250630_zQXryPxgajQ2"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000042" name="dei:IcfrAuditorAttestationFlag">No</ix:nonNumeric></span> </span><span style="font-family: Segoe UI Symbol,sans-serif">&#9746;</span><span style="font-family: Times New Roman, Times, Serif">&#160;.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes&#160;</span><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span>
<span style="font-family: Times New Roman, Times, Serif">No </span><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_909_edei--EntityShellCompany_dbF_c20240701__20250630_zl61IkISR812"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000043" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif">&#160;.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate market value of the shares of Common
Stock held by non-affiliates as of December 31, 2024 based on the closing price of $15.14 per share on such date as reported on the NASDAQ
System, was approximately $<span id="xdx_901_edei--EntityPublicFloat_iI_pn5n6_c20241231_zMZ0EoLaoqrc" title="Entity Public Float"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2024-12-31" id="Fact000045" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">91.8</ix:nonFraction></span> million. The other outstanding classes do not have a readily determinable market value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 8, 2025, <span id="xdx_903_edei--EntityCommonStockSharesOutstanding_iI_c20250908__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zRTmLWVooDyd" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-09-08_us-gaap_CommonStockMember" id="Fact000047" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,203,465</ix:nonFraction></span> shares of Common
Stock, <span id="xdx_900_edei--EntityCommonStockSharesOutstanding_iI_c20250908__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zrF9NRUYzJkj" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-09-08_us-gaap_CommonClassBMember" id="Fact000049" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></span> shares of Class B Common Stock, <span id="xdx_90F_edei--EntityCommonStockSharesOutstanding_iI_c20250908__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEkS6fIZwDGi" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-09-08_us-gaap_CommonClassCMember" id="Fact000051" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span> shares of Class C Common Stock and <span id="xdx_90B_edei--EntityCommonStockSharesOutstanding_iI_c20250908__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zsnszpDSLlL5" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-09-08_custom_ClassANonVotingPreferredStockMember" id="Fact000053" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span> shares of Class A Non-voting Preferred Stock
of the registrant were outstanding.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">DOCUMENTS INCORPORATED BY REFERENCE</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">NONE</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">TABLE OF CONTENTS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 10%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 10%">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">FORM 10-K ITEMS</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: top; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PAGE</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PART I</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 1.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Business</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">4</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 1A.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Risk Factors</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">22</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 1B.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Unresolved Staff Comments</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">24</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 1C.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Cybersecurity </span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">25</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 2.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Properties</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">26</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 3.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Legal Proceedings</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">26</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 4.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Mine Safety Disclosures</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">26</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PART II</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 5.</span></td>
    <td>&#160;</td>
    <td><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">26</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 6.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">[Reserved[</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">28</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 7.</span></td>
    <td>&#160;</td>
    <td><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">28</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 7A.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Quantitative and Qualitative Disclosures About Market Risk.</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">34</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 8.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Financial Statements and Supplementary Data</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">35</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 9.</span></td>
    <td>&#160;</td>
    <td><a href="#a_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">83</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 9A.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">83</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 9B.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Other Information</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">85</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 9C.</span></td>
    <td>&#160;</td>
    <td><a href="#a_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Disclosures Regarding Foreign Jurisdictions that Prevent Inspections</span></a></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">85</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PART III</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 10.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Directors, Executive Officers and Corporate Governance</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">85</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 11.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Executive Compensation</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">88</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 12.</span></td>
    <td>&#160;</td>
    <td><a href="#a_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">90</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 13.</span></td>
    <td>&#160;</td>
    <td><a href="#a_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Certain Relationships and Related Transactions, and Director Independence</span></a></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">92</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 14.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Principal Accountant Fees and Services</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">93</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PART IV</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Item 15.</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="#a_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibits and Financial Statement Schedules</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">94</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>PART I</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_001"></span>ITEM 1. BUSINESS	</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>GENERAL</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR Corporation, sometimes referred to as the &#8220;Company&#8221;
or &#8220;FONAR&#8221;, is a Delaware corporation which was incorporated on July 17, 1978. Our address is 110 Marcus Drive, Melville,
New York 11747 and our telephone number is 631-694-2929. FONAR also maintains a website at www.fonar.com. FONAR provides copies of its
filings with the Securities and Exchange Commission on Forms 10-K, 10-Q and 8-K and amendments to these reports to stockholders on request.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conduct our business in two segments. Our medical
equipment segment is conducted directly through FONAR. Our physician management and diagnostic services segment is conducted through our
subsidiary Health Management Corporation of America (&#8220;HMCA&#8221;). HMCA provides management services, administrative services,
billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing, IT services, hiring,
conducting interviews and managing personnel, storage of medical records, office space, equipment, repair, maintenance service, and clerical
and other non-medical personnel to medical providers engaged in diagnostic imaging. In addition to acting as a management company, HMCA
owns and operates six diagnostic imaging facilities in Florida. See Note 15 for a more detailed analysis.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR is engaged in the business of designing, manufacturing,
selling and servicing magnetic resonance imaging scanners, also referred to as &#8220;MRI&#8221; or &#8220;MR&#8221; scanners, which utilize
MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. FONAR&#8217;s founders
built the first MRI scanner in 1977 and FONAR introduced the first commercial MRI scanner in 1980. FONAR is also the originator of the
iron-core non-superconductive and permanent magnet MRI technology.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s iron frame technology made FONAR the
originator of &#8220;open&#8221; MRI scanners. We introduced the first &#8220;open&#8221; MRI in 1980. Since that time we have concentrated
on further application of our &#8220;open&#8221; MRI, introducing most recently the Upright&#174; Multi-Position&#8482;&#8221; MRI scanner
(also referred to as the &#8220;Upright&#174;&#8221; or &#8220;Stand-Up&#174;&#8221; MRI scanner) and the FONAR 360&#8482; MRI scanner.
The FONAR 360&#8482; MRI is not presently being marketed.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 15 to the Consolidated Financial Statements
for separate financial information regarding our medical equipment and physician and diagnostic management services segments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 7, 2025, the board of directors received a
non-binding proposal from a group led by Timothy Damadian, the Company&#8217;s Chief Executive Officer, and Luciano Bonanni, the Company&#8217;s
Chief Operating Officer, pursuant to which proposal the group would acquire all of the outstanding common stock and other securities of
the Company not currently owned by the members of the group. &#160; Members of the group have voting control of the Company&#8217;s equity
securities and the group advised the Company that it was unwilling to support any alternative transaction. &#160;As proposed, the transaction,
if completed, would result in the Company no longer being a publicly held company, and its Common Stock would be de-listed from the NASDAQ
Stock Market. &#160;The Board of Directors has established a Special Committee of independent and disinterested directors to consider
the proposal and negotiate on behalf of the Company and its stockholders. &#160;The Special Committee has retained its own independent
financial and legal advisors to assist it in this process. The group and the Special Committee are engaged in negotiations related to
the proposed going private transaction. &#160;No definitive agreements or terms have been executed by the parties and there is no assurance
that the transaction will be completed. &#160;Any definitive agreement and transaction will require approval by the Company&#8217;s common
stock holders and will require the filing of definitive proxy materials in accordance with the SEC&#8217;s proxy rules to obtain such
approval.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS</b>.&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We make certain statements in this Annual Report on
Form 10-K regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events. All statements, other
than statements of historical facts, included or incorporated by reference herein relating to management&#8217;s current expectations
of future financial performance, continued growth and changes in economic conditions or capital markets are forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Forward-looking statements involve risks and uncertainties
which may cause actual results or outcomes to differ materially from those expressed herein. While we make such statements in good faith
and we believe such statements are based on reasonable assumptions, including without limitation, management&#8217;s examination of historical
operating trends, data contained in records and other data available from third parties, we cannot assure you that our projections will
be achieved. These assumptions involve judgments with respect to future economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Factors that may cause
such differences include: economic conditions generally and in each of the markets in which we are located, the amount of sales contributed
by new and existing locations, labor costs for our personnel, and the level of competition from existing or new competitors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While we believe that our assumptions are reasonable,
it is very difficult to predict the impact of unknown factors, and it is impossible for us to anticipate all factors that could affect
our actual results. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. You should
evaluate all forward-looking statements made in this report in the context of the factors that could cause outcomes to differ materially
from our expectations. These statements are not guarantees of future performance and undue reliance should not be placed on them.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The forward-looking statements included in this report are made only as
of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information,
future events or otherwise, except as required by law.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>PHYSICIAN AND DIAGNOSTIC SERVICES MANAGEMENT SEGMENT</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Health Diagnostics Management, LLC (HDM) is owned
by Health Management Corporation of America (70.6%) and investors (29.4%). Health Management Corporation of America is owned 100% by FONAR
Corporation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HDM operates under the assumed name &#8220;Health
Management Company of America&#8221; (&#8220;HMCA&#8221;).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The combined business (HDM and Health Management Corporation
of America) will be referred to as &#8220;HMCA&#8221; for all periods before and after July 1, 2015, unless otherwise indicated.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA provides comprehensive non-medical management
services to diagnostic imaging facilities. These services include administrative services, billing and collection services, credentialing
services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and
management of non-medical personnel, storage of medical records, office space, equipment, repair &amp; maintenance services, accounting,
assistance with legal and regulatory matters, and the development and implementation of practice growth and marketing strategies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2025, HMCA managed a total of 44 MRI
scanners. Twenty-six (26) scanners are located in New York and eighteen (18) scanners are located in Florida. For the 2025 fiscal year,
the revenues HMCA recognized from the MRI facilities has increased to $95.4 million from $94.6 million in fiscal 2024. Six of the facilities
in Florida are owned and operated by HMCA subsidiaries.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe the utilization of FONAR Upright&#174; MRI
scanning systems, which are produced under the protection of our patents, accounts for the historically robust patient volume at the scanning
facilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During fiscal 2025, two additional high field magnets
were installed at our existing facilities in Naples, FL and Melville, NY, respectively. During fiscal year 2026, we expect to complete
installation of an additional high field magnet in Lynbrook, NY, to supplement the existing FONAR Upright&#174; MRI scanning systems at
that facility along with a new location in Nassau County, NY.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>HMCA GROWTH STRATEGY</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s growth strategy focuses on upgrading
and expanding the existing facilities it manages and expanding the number of facilities it either owns or manages for its clients, including
new sites. In connection with improving the performance of the facilities, we have added high field MRI scanners, extremity scanners and
x-ray machines to the Upright&#174; MRI scanners at certain of the sites where such additional diagnostic imaging modalities are expected
to produce the greatest return.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>PHYSICIAN AND DIAGNOSTIC MANAGEMENT SERVICES</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s services to the facilities it manages
encompass substantially all of their business operations. Each facility is controlled, however, not by HMCA, but by the physician owner,
or in the case of the six Florida sites owned by HMCA subsidiaries, by the medical director. All medical services are performed by physicians
and other medical personnel under the physician-owner&#8217;s supervision. HMCA is the management company and performs services of a non-medical
nature. These services include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. Offices and Equipment. HMCA identifies, negotiates
leases for and/or provides office space and equipment to its clients. This includes technologically sophisticated medical equipment. HMCA
also provides improvements to leaseholds, assistance in site selection and advice on improving, updating, expanding and adapting to new
technology.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. Personnel. HMCA staffs all the non-medical positions
of its clients with its own employees, eliminating the client&#8217;s need to interview, train and manage non-medical employees. HMCA
processes the necessary tax, insurance and other documentation relating to employees.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. Administrative. HMCA assists in scheduling patient
appointments, purchasing medical supplies and equipment, and handles the reporting, accounting, processing and filing systems. It prepares
and files the complex applications which enables our clients to participate in managed care programs and to qualify for insurance reimbursement.
HMCA assists the clients to implement programs and procedures to ensure full and timely regulatory compliance and appropriate cost reimbursement
under no-fault insurance and Workers&#8217; Compensation guidelines, as well as compliance with other applicable governmental requirements
and regulations, including HIPAA and other privacy requirements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;4. Billing and Collections. HMCA is responsible
for the billing and collection of revenues from third-party payors including those governed by No-Fault and Workers&#8217; Compensation
statutes.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5. Cost Saving Programs. Based on available volume
discounts, HMCA seeks to assist in obtaining favorable pricing for office and medical supplies, equipment, contrast agents, and other
inventory for its clients.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">6. Diagnostic Imaging and Ancillary Services. HMCA
can offer access to diagnostic imaging equipment through diagnostic imaging facilities it manages. The Company is expanding the ancillary
services offered in its network to include x-rays, and other MRI equipment such as high-field (1.5 or 3.0 Tesla magnet strength) MRI scanners
and extremity MRI scanners.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">7. Marketing Strategies. HMCA is responsible for developing
and proposing marketing plans for its clients.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">8. Expansion Plans. HMCA assists the clients in developing
expansion plans including the opening of new or replacement facilities where appropriate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s objective is to free physicians from
as many non-medical duties as is practicable, allowing physicians to spend less time on business and administrative matters and more time
practicing medicine.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The exceptions to this general model of operation
are six of the facilities located in Florida. These Florida facilities are owned by limited liability companies which, as our subsidiaries,
conduct their operations directly and bill and collect their fees from the patients and third-party payors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The facilities enter into contracts with third-party
payors, including managed care companies. None of HMCA&#8217;s clients participate in any capitated plans or other risk-sharing arrangements.
Capitated plans are those Health Maintenance Organization programs where the provider is paid a flat monthly fee per patient.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The management fees payable by the facilities to HMCA
are flat monthly fees. In fiscal 2025, the aggregate amount of active management fees was $5,160,735 per month. In fiscal 2024, the aggregate
amount of active management fees was $4,960,733 per month. Fees under the management agreements are subject to adjustment by mutual agreement
on an annual basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Timothy Damadian currently owns three HMCA-managed
MRI facilities in Florida. The facilities were owned by the Company&#8217;s founder and former CEO, Dr. Raymond Damadian until his passing
in August of 2022. The fees for these three sites are flat monthly fees which are subject to adjustment by mutual agreement on an annual
basis. In fiscal 2025 and fiscal 2024, the aggregate monthly amount of management fees payable to HMCA by these sites was $995,825.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The six Florida facilities owned by HMCA subsidiaries
directly bill their patients or the patients&#8217; insurance carriers. Patient fees net of contractual allowances and discounts were
$33,179,446 in fiscal 2025 as compared to $33,815,796 in fiscal 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>HMCA MARKETING</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s marketing strategy is to expand the business
and improve the facilities which it manages. HMCA is seeking to increase the number of locations of those facilities where market conditions
are promising and to promote growth of our clients&#8217; and Florida subsidiaries&#8217; patient volume and revenue.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>DIAGNOSTIC IMAGING FACILITIES</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Diagnostic imaging facilities managed by HMCA provide
diagnostic imaging services to patients referred by physicians. The facilities are operated in a manner which eliminates the admission
and other administrative inconveniences of in-hospital diagnostic imaging services. Imaging services are performed in an outpatient setting
by trained medical technologists under the direction of physicians. Following diagnostic procedures, the images are reviewed by the interpreting
physicians who prepare reports of these tests and their findings. The vast majority of reports for the New York facilities are transcribed
by HMCA personnel and the remainder are outsourced to professional transcription services. Reports for the Florida facilities are outsourced
to professional transcription services.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA develops marketing programs and educational programs
in an effort to establish and maintain referring physician relationships for our clients and Florida subsidiaries.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To further its position, HMCA is seeking to expand
the imaging modalities offered at its managed and owned diagnostic imaging facilities. Six facilities in New York and nine facilities
in Florida have two or more MRI scanners. One facility in New York and three in Florida also perform X-rays.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>REIMBURSEMENT</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s clients receive reimbursements for their
services through Medicare, Medicaid, managed care, private commercial insurance, third-party administrators, Workers&#8217; Compensation,
No-Fault and other insurance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Medicare</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Medicare program provides reimbursement for hospitalization,
physician, diagnostic and certain other services to eligible persons 65 years of age and over and certain other individuals. Providers
are paid by the federal government in accordance with regulations promulgated by the Department of Health and Human Services, HSS, and
generally accept the payment with nominal deductible and co-insurance amounts required to be paid by the service recipient, as payment
in full. Hospital inpatient services are reimbursed under a prospective payment system. Hospitals receive a specific prospective payment
for inpatient treatment services based upon the diagnosis of the patient.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under Medicare&#8217;s prospective payment system
for hospital outpatient services, or OPPS, a hospital is paid for outpatient services on a rate per service basis that varies according
to the ambulatory payment classification group, or APC, to which the service is assigned rather than on a hospital&#8217;s costs. Each
year the Centers for Medicare and Medicaid Services, or CMS, publishes new APC rates that are determined in accordance with the promulgated
methodology.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Services provided in non-hospital based freestanding
facilities are paid under the Medicare Physician Fee Schedule, or MPFS. All of HMCA&#8217;s clients are presently in this category. The
MPFS is updated on an annual basis and sometimes modified more frequently.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have experienced reimbursement reductions for radiology
services provided to Medicare beneficiaries. In calendar year 2025, changes to the MPFS included a reduction in the conversion factor.
For our fiscal year ended June 30, 2025, Medicare revenues represented approximately 2.6% of the revenues for HMCA&#8217;s clients and
subsidiaries as compared to 2.7% for the fiscal year ended June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Medicaid</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Medicaid program is a jointly-funded federal and
state program providing coverage for low-income persons. In addition to federally-mandated basic services, the services offered and reimbursement
methods vary from state to state. In many states, Medicaid reimbursement is patterned after the Medicare program; however, an increasing
number of states have established or are establishing payment methodologies intended to provide healthcare services to Medicaid patients
through managed care arrangements. In fiscal 2025, approximately .05% of the revenues of HMCA&#8217;s clients and subsidiaries were attributable
to Medicaid, as compared to 0.06% in fiscal 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Managed Care and Private Insurance</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Health Maintenance Organizations, or HMOs, Preferred
Provider Organizations, or PPOs, and other managed care organizations attempt to control the cost of healthcare services by a variety
of measures, including imposing lower payment rates, preauthorization requirements, limiting services and mandating less costly treatment
alternatives. Managed care contracting is competitive and reimbursement schedules in many cases can be at or below Medicare reimbursement
levels. Some managed care organizations have reduced or otherwise limited, and other managed care organizations may reduce or otherwise
limit, reimbursement in response to reductions in government reimbursement. These reductions could have an adverse impact on our financial
condition and results of operations. These reductions have been, and any future reductions may be, similar to the reimbursement reductions
previously proposed.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">HMCA COMPETITION</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The physician and diagnostic management services field
is highly competitive. A number of large health systems have acquired medical practices, and this trend is expected to continue. HMCA
anticipates that more competition will develop. Many competitors have greater financial and other resources than HMCA.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With respect to the diagnostic imaging facilities
managed by HMCA, the outpatient diagnostic imaging industry is highly competitive. Competition focuses primarily on attracting physician
referrals at the local market level and increasing referrals through relationships with managed care organizations, as well as emphasizing
to potential referral sources the advantages of Upright&#174; MRI scanning. HMCA believes that principal competitors for the diagnostic
imaging centers are hospitals and independent or management company-owned imaging centers. Competitive factors include quality and timeliness
of test results, ability to develop and maintain relationships with managed care organizations and referring physicians, type and quality
of equipment, facility location, convenience of scheduling and availability of patient appointment times. HMCA believes that it will be
able to effectively meet the competition in the outpatient diagnostic imaging industry with the FONAR Upright&#174; MRI scanners and strategically
placed high field MRI scanners at its facilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">GOVERNMENT REGULATION APPLICABLE TO HMCA</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>FEDERAL REGULATION</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The healthcare industry is highly regulated and changes
in laws and regulations can be significant. Changes in the law or new interpretation of existing laws can have a material effect on our
permissible activities, the relative costs associated with doing business and the amount of reimbursement by government and other third-party
payors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Federal False Claims Act</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The federal False Claims Act and, in particular, the
False Claims Act&#8217;s &#8220;qui tam&#8221; or &#8220;whistleblower&#8221; provisions allow a private individual to bring actions in
the name of the government alleging that a defendant has made false claims for payment from federal funds. After the individual has initiated
the lawsuit the government must decide whether to intervene in the lawsuit and to become the primary prosecutor. If the government declines
to join the lawsuit, the individual may choose to pursue the case alone, although the government must be kept apprised of the progress
of the lawsuit, and may intervene later. Whether or not the federal government intervenes in the case, it will receive the majority of
any recovery.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When an entity is determined to have violated the
federal False Claims Act, it must pay three times the actual damages sustained by the government, plus mandatory civil penalties for each
separate false claim and the government&#8217;s attorneys&#8217; fees. Liability arises when an entity knowingly submits, or causes someone
else to submit, a false claim for reimbursement to the federal government. The False Claims Act defines the term &#8220;knowingly&#8221;
broadly, though simple negligence will not give rise to liability under the False Claims Act. Examples of the other actions which may
lead to liability under the False Claims Act are set forth below:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Failure to comply with the many technical
billing requirements applicable to our Medicare and Medicaid business;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Failure to comply with the prohibition against
billing for services ordered or supervised by a physician who is excluded from any federal healthcare program, or the prohibition against
employing or contracting with any person or entity excluded from any federal healthcare program;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Failure to comply with the Medicare physician
supervision requirements for the services we provide, or the Medicare documentation requirements concerning physician supervision.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Fraud Enforcement and Recovery Act of 2009 expanded
the scope of the False Claims Act by, among other things, broadening protections for whistleblowers and creating liability for knowingly
retaining a government overpayment, acting in deliberate ignorance of a government overpayment or acting in reckless disregard of a government
overpayment. The healthcare reform bills in the form of the Patient Protection and Affordable Care Act, as amended by the Health Care
and Education Reconciliation Act of 2010 (collectively, &#8220;PPACA&#8221;) expanded on changes made by the 2009 Fraud Enforcement and
Recovery Act with regard to such &#8220;reverse false claims.&#8221; Under PPACA, the knowing failure to report and return an overpayment
within 60 days of identifying the overpayment or by the date a corresponding cost report is due, whichever is later, constitutes a violation
of the False Claims Act. HMCA and its clients have never been sued under the False Claims Act and believe we are in compliance with the
law.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stark Law</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the federal Self-Referral Law, also referred
to as the &#8220;Stark Law&#8221;, which is applicable to Medicare and Medicaid patients, and the self-referral laws of various States,
certain health practitioners, including physicians, chiropractors and podiatrists, are prohibited from referring their patients for the
provision of designated health services, including diagnostic imaging services, to any entity with which they or their immediate family
members have a financial relationship, unless the referral fits within one of the specific exceptions in the statutes or regulations.
The federal government has taken the position that a violation of the federal Stark Law is also a violation of the Federal False Claims
Act. Statutory exceptions under the Stark Law include, among others, direct physician services, in-office ancillary services rendered
within a group practice, space and equipment rental and services rendered to enrollees of certain prepaid health plans. Some of these
exceptions are also available under the State self-referral laws. HMCA believes that it and its clients are in compliance with these laws.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Anti-Kickback Regulation</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are subject to federal and state laws which govern
financial and other arrangements between healthcare providers. These include the federal anti-kickback statute which, among other things,
prohibits the knowing and willful solicitation, offer, payment or receipt of any remuneration, direct or indirect, in cash or in kind,
in return for or to induce the referral of patients for items or services covered by Medicare, Medicaid and certain other governmental
health programs. Under PPACA, knowledge of the anti-kickback statute or the specific intent to violate the law is not required. Violation
of the anti-kickback statute may result in civil or criminal penalties and exclusion from the Medicare, Medicaid and other federal healthcare
programs, and according to PPACA, now provides a basis for liability under the False Claims Act. In addition, it is possible that private
parties may file &#8220;qui tam&#8221; actions based on claims resulting from relationships that violate the anti-kickback statute, seeking
significant financial rewards. Many states have enacted similar statutes, which are not limited to items and services paid for under Medicare
or a federally funded healthcare program. Neither HMCA nor its clients engage in this practice.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Health Insurance Portability and Accountability Act</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Congress enacted the Health Insurance Portability
and Accountability Act of 1996, or HIPAA, in part, to combat healthcare fraud and to protect the privacy and security of patients&#8217;
individually identifiable healthcare information. HIPAA, among other things, amends existing crimes and criminal penalties for Medicare
fraud and enacts new federal healthcare fraud crimes, including actions affecting non-governmental healthcare benefit programs by means
of false or fraudulent representations in connection with the delivery of healthcare services is subject to a fine or imprisonment, or
potentially both. In addition, HIPAA authorizes the imposition of civil money penalties against entities that employ or enter into contracts
with excluded Medicare or Medicaid program participants if such entities provide services to federal health program beneficiaries. A finding
of liability under HIPAA could have a material adverse effect on our business, financial condition and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Further, HIPAA requires healthcare providers and their
business associates to maintain the privacy and security of individually identifiable protected health information (&#8220;PHI&#8221;).
HIPAA imposes federal standards for electronic transactions, for the security of electronic health information and for protecting the
privacy of PHI. The Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), signed into law
on February 17, 2009, dramatically expanded, among other things, (1) the scope of HIPAA to now apply directly to &#8220;business associates,&#8221;
or independent contractors who receive or obtain PHI in connection with providing a service to a covered entity, (2) substantive security
and privacy obligations, including new federal security breach notification requirements to affected individuals, HHS and prominent media
outlets, of certain breaches of unsecured PHI, (3) restrictions on marketing communications and a prohibition on covered entities or business
associates from receiving remuneration in exchange for PHI, and (4) the civil and criminal penalties that may be imposed for HIPAA violations,
increasing the annual cap in penalties from $25,000 to $1.5 million per occurrence. In 2013 additional legal requirements were adopted
to provide further protection for PHI.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, many states have enacted comparable privacy
and security statues or regulations that, in some cases, are more stringent than HIPAA requirements. It may be necessary to modify our
operations and procedures to comply with the more stringent state laws, which may entail significant and costly changes for us. We believe
that we are in compliance with such state laws and regulations. However, if we fail to comply with applicable state laws and regulations,
we could be subject to sanctions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe that we are in compliance with the current
HIPAA requirements, as amended by HITECH, together with other legislation and regulations, and comparable state laws, but we anticipate
that we may encounter certain costs associated with future compliance. Moreover, we cannot guarantee that enforcement agencies or courts
will not make interpretations of the HIPAA standards that are inconsistent with our own interpretation, or the interpretations of our
contracted radiology practices or their affiliated physicians. A finding of liability under the HIPAA standards may result in significant
criminal and civil penalties. Noncompliance also may result in exclusion from participation in government programs, including Medicare
and Medicaid. These actions could have a material adverse effect on our business, financial condition, and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Civil Money Penalty Law and Other Federal Statutes</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Civil Money Penalty, or CMP, law covers a variety
of practices. It provides a means of administrative enforcement of the anti-kickback statute, and prohibits false claims, claims for medically
unnecessary services, violations of Medicare participating provider or assignment agreements and other practices. The statute gives the
Office of Inspector General of the HHS the power to seek substantial civil fines, exclusion and other sanctions against providers or others
who violate the CMP prohibitions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, in 1996, Congress created a new federal
crime: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully
executing a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may
result in fines, imprisonment or exclusion from government sponsored programs such as the Medicare and Medicaid programs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certificates of Need</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Some states require hospitals and certain other healthcare
facilities and providers to obtain a certificate of need, or CON, or similar regulatory approval prior to establishing certain healthcare
operations or services, incurring certain capital projects and/or the acquisition of major medical equipment including MRI and PET/CT
systems. We are not currently operating in any such states.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">State Regulation</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to the federal self-referral law and federal
Anti-kickback statute, many States, including those in which HMCA and its clients operate, have their own versions of self-referral and
anti-kickback laws. These laws are not limited in their applicability, as are the federal laws, to specific programs. HMCA believes that
it and its clients are in compliance with these laws.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Various States prohibit business corporations from
practicing medicine. Various States, including New York, also prohibit the sharing of professional fees or fee splitting. Consequently,
in New York HMCA leases space and equipment to clients and provides clients with a range of non-medical administrative and managerial
services for agreed upon fees. Under Florida law a business entity can bill patients and third-party payors directly if that entity is
properly licensed through AHCA. All of the nine facilities in Florida are licensed healthcare clinics through AHCA.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA&#8217;s clients and subsidiaries generate revenue
from patients covered by no-fault insurance and workers&#8217; compensation programs. For the fiscal year ended June 30, 2025 approximately
58.0% of our clients&#8217; receipts were from patients covered by no-fault insurance and approximately 9.1% of our client&#8217;s receipts
were from patients covered by workers&#8217; compensation programs. For the fiscal year ended June 30, 2024, approximately 58.0% of HMCA&#8217;s
clients&#8217; receipts were from patients covered by no-fault insurance and approximately 8.8% of HMCA&#8217;s clients&#8217; receipts
were from patients covered by workers&#8217; compensation programs. The foregoing numbers do not include payments from third-party administrators.
In the event that changes in these laws alter the fee structures or methods of providing service, or impose additional or different requirements,
HMCA could be required to modify its business practices and services in ways that could be more costly to HMCA or in ways that decrease
the revenues which HMCA receives from its clients.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Compliance Program</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain a program to monitor compliance with federal
and state laws and regulations applicable to the healthcare entities. The compliance program includes the adoption of (i) Standards of
Conduct for our employees and affiliates and (ii) a process that specifies how employees, affiliates and others may report regulatory
or ethical concerns. We believe that our compliance program meets the relevant standards provided by the Office of Inspector General of
the Department of Health and Human Services.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An important part of our compliance program consists
of conducting periodic audits of various aspects of our operations and that of the contracted radiology practices. We also assist our
clients with educational programs designed to familiarize them with the regulatory requirements and specific elements of our compliance
program.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HMCA believes that it and its clients are in compliance
with applicable Federal, State and local laws. HMCA does not believe that such laws will have any adverse material effect on its business.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>MEDICAL EQUIPMENT SEGMENT</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline">PRODUCTS</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The Upright&#174; MRI scanner is our primary product.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI is a &#8220;whole-body&#8221;
MRI, meaning that it can be used to scan virtually any part of the body. The Upright&#174; MRI differs from conventional MRI scanners in
that it is not limited to scanning patients in the recumbent posture. For example, patients can be scanned while sitting, standing, bending,
or lying down.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fact that the patient space is unobstructed permits
scanning in a variety of postures that cannot be duplicated in conventional MRI scanners. Most conventional MRI scanners in use today
employ solenoidal super-conducting magnets whose magnetic field orientation is along the axis of the patient&#8217;s body, which must
be placed into the bore of the scanner in either a supine or prone posture. Our experience is that when presented with a choice between
being scanned lying down in a tunnel-like enclosure or seated in an open MRI, most patients will choose the latter.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI is also, by design, a non-claustrophobic
MRI scanner. The Upright&#174; MRI employs a dipole magnet whose magnetic field orientation is transverse to the axis of the patient&#8217;s
body. The gap between the poles of the magnet is the space into which the patient is placed. Because the magnetic field direction is horizontal
and transverse to the body, a patient who is scanned seated or standing has an unobstructed view out of the gap of the magnet. In typical
installations, patients watch television while being scanned, without the aid of special glasses with mirrors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI facilitates patient scanning
in a variety of postures thanks to a unique, three-axis patient handling system. The motorized patient table, or bed, can be rotated to
any angle between 0 (horizontal) and 84 degrees (nearly vertical). Unlike a conventional recumbent MRI patient table, which can only move
into or out of the scanner&#8217;s bore, the Upright&#174; MRI bed can be translated with two degrees of freedom, in/out and up/down. User-friendly
software allows the scanner operator to move the anatomical region of interest precisely to the center of the magnet using a cursor placed
on a localizer image. Anatomically true image orientation is assured, regardless of the rotation angle of the bed, via computer read-back
of the table&#8217;s position. A seat can be hooked onto the bed in a variety of locations, or removed, as needed. Transpolar VersaRests&#8482;
and other devices can be used to keep the patient comfortable and motionless throughout the scanning process.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>IMAGE QUALITY AND FIELD STRENGTH</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Most commercially available MRI scanners range in
magnetic field strength from about 0.2 T (Tesla) to 7.0 T, and open MRI scanners range from about 0.2 T to 1.2 T.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Field strength is an important characteristic of MRI
scanners, but not the only one. Higher field strengths generally provide higher signal-to-noise ratios (SNR) on account of the Boltzmann
distribution, but SNR is not the only determinant of image quality. For example, the spin-lattice relaxation time T<sub>1</sub> that characterizes
the nuclear magnetic resonance (NMR) signal increases with field strength, decreasing the difference in T<sub>1</sub> values between tissues
that is an essential contributor to contrast in images. For example, grey/white matter contrast in the brain falls off rapidly above about
1.0 T, and some studies have shown that optimal tissue contrast occurs in the mid-field region, down to 0.2 T. Imaging bandwidth, receiver
coil design, pulse sequence design, and scan parameters significantly affect image quality. Indeed, researchers and MRI vendors are pushing
the boundaries of MRI technology in both directions, that is, to very low (1 &#8211; 199 mT) and very high (7.0 T and above) field strengths
for a variety of technical and diagnostic reasons. For instance, one advantage of lower field strengths is that image artifacts arising
from metallic implants such as surgical screws diminish as field strength decreases. This is particularly important for surgeons referring
their postoperative patients for diagnostic imaging studies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI operates at a mid-field strength
of 0.6 T and enjoys wide acceptance in the radiological community. The scanner is diagnostically versatile and equipped with a broad range
of clinically proven imaging protocols that produce images of exceptional quality, and a fully-featured, robust, and user-friendly software
interface.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>DIAGNOSTIC ADVANTAGES OF POSITIONAL MRI</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Apart from its attractiveness as an open, non-claustrophobic,
general-purpose MRI, the Upright&#174; MRI can deliver diagnostically relevant information that correlates with patient posture.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For example, a variety of injuries to and pathologies
of the spine, such as spondylolisthesis (&#8220;slipped disc&#8221;), may go undetected in the recumbent posture, but manifest themselves
when the patient is scanned in a normal, weight-bearing (&#8220;physiological&#8221;) position, such as seated, or seated in forward flexion,
extension, or standing.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Upright&#174; MRI has demonstrated its value for
patients suffering from scoliosis, who typically undergo regular x-ray exams over a course of years. A study by the National Cancer Institute
(2000) of 5,466 women with scoliosis reported a 70% increase in breast cancer resulting from 24.7 chest x-rays received on average over
the course of their treatment. Prior to the advent of the Upright&#174; MRI, the x-ray machine was the only imaging modality that could
evaluate the condition because the patient must be imaged standing. FONAR has developed an RF receiver coil and a 3D scanning protocol
that for the first time allows scoliosis patients to obtain diagnostic, multi-slice images of their spines while standing, without the
risks associated with radiation, and with the soft-tissue-contrast benefits of MRI over x-ray.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The utility of upright, weight-bearing MRI is not
limited to the spine. For example, approximately one in a thousand people (some 200,000 to 500,000 in the US) have a congenital condition
known as Chiari malformation, an abnormality of the brain at the junction with the spine at the base of the skull. In people with Chiari
malformation, the lowest lying structures of the brain, the tonsils of the cerebellum, descend into and become entrapped by the foramen
magnum, the circular bony opening at the base of the skull</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><br/>
 where the spinal cord exits. While most of these individuals are asymptomatic,
many suffer from more severe forms of the syndrome (e.g., type II or Arnold-Chiari syndrome), in which brain stem compression results
in severe neurological symptoms. The Chiari syndrome is also called Cerebellar Tonsillar Ectopia (CTE) because of the displacement (ectopia)
of the cerebellar tonsils. Classic symptoms of Chiari syndrome include the &#8220;drop attack,&#8221; in which the afflicted individual
unexpectedly experiences an explosive rush at the base of the brain that runs down the body to the extremities, causing the patient to
collapse in a temporary neuromuscular paralysis. These symptoms subside when the patient is lying down. Conventional lie-down MRI scanners
cannot make an adequate evaluation of the pathology since this pathology is most visible and the symptoms are most acute when the patient
is scanned in the upright, weight-bearing position (Brain Injury 2010, 24 (7-8) 988-994).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the body, the Upright&#174; MRI is being utilized
in a variety of ways, for example to image pelvic organ prolapse in the standing posture, inguinal hernias, defecation in the sitting
posture (utilizing cine MRI), and the prostate in the sitting posture (utilizing a flat, multi-channel receiver coil on top of which the
patient simply sits).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">PRODUCT MARKETING</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s principal marketing efforts in the medical
equipment segment have been focused on the Upright&#174; MRI, which we believe is a unique product. We expect to focus on the Upright&#174;
MRI going forward.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The principal markets for the Company&#8217;s scanners
are private diagnostic imaging centers and hospital outpatient imaging facilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s marketing strategy has been designed
to reach key purchasing decision makers with information concerning the Upright&#174; MRI. This has led to many inquiries and some sales
of the Upright&#174; MRI scanner and is intended to increase FONAR&#8217;s presence in the medical equipment market. FONAR focuses primarily
on four target audiences: neurosurgeons, orthopedic surgeons, radiologists, and general physicians.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our advertising for FONAR and HMCA reinforces the
unique value provided by the FONAR Upright&#174; MRI scanner. We have increased internet awareness of our product by driving patient traffic
to the HMCA scanning centers we manage via the FONAR website as well as through websites for each HMCA location. These websites give prospective
customers of Upright&#174; MRI scanners a view of operating Upright&#174; MRI centers and highlight the benefits of using the Upright&#174;
MRI scanner.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">SERVICE AND UPGRADES FOR MRI SCANNERS</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income is generated from the installed base in two
principal areas, namely, service and upgrades. Service and maintenance revenues from our external installed base were approximately $8.4
million in fiscal 2025 and $7.6 million in fiscal 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We hope to maintain service revenues at present levels,
based on the demonstrated longevity of the Upright&#174; MRI scanner and continued customer satisfaction with the product. Critical to
this longevity and customer satisfaction is the stream of software improvements and hardware upgrades that FONAR has delivered over the
years to keep the scanners competitive with the latest technology in the marketplace. We also anticipate that our installed base of scanners
will generate income from upgrades in future fiscal years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have engaged with AIRS Medical USA, Inc., to distribute
their SwiftMR<sup>TM</sup> product to our installed base of customers. We believe that the SwiftMR<sup>TM </sup>product significantly
improves the image quality and efficiency of both the Upright&#174; MRI and the outside manufacturer equipment that is operated by our
installed base. Revenues from the sale of SwiftMR<sup>TM </sup>are included in the service and maintenance revenues described above.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2024, we formed a new subsidiary, Opus Diagnostic
Management, LLC, which is focused on providing service for MRI scanners sold by other manufacturers. We hope to control the cost of maintaining
and repairing the outside manufacturer equipment operated by HMCA, and to expand into providing maintenance and repair services to other
third party operators of outside manufacturer equipment. Revenues from Opus are included in the service and maintenance revenues described
above.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">RESEARCH AND DEVELOPMENT</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the fiscal year ended June 30, 2025, we incurred
expenditures of $1,576,086, none of which were capitalized, on research and development, as compared to $1,735,949, none of which were
capitalized, during the fiscal year ended June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development activities have focused principally
on software improvements to the user interface of the MRI scanner. The Windows-based Sympulse&#8482; platform controls all of the functions
of the Upright&#174; scanner except those of the versatile, multi-position patient table. Separate, dedicated, motion-control software
is used to maneuver the Upright&#174; bed, and development of this software is ongoing as well.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While software improvements to the user interface
are important in their own right, significant value is added to the MRI scanner by the modification of existing protocols for examining
various parts of the body, and the development of new protocols that utilize new underlying capabilities of the pulse sequence software.
Over time, FONAR users have become accustomed to the steady improvement in the recommended clinical protocols that accompany new software
releases. More significantly, in recent years we have seen increasing adoption of FONAR-recommended clinical protocols over those developed
on site. This is a testament to the superior image quality they produce in attractively short scan times.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The development of clinically practical scan protocols
and software depends on close contact between research and development scientists and engineers, and end users. That close contact is
facilitated in part by the relationship with HMCA and the scanning centers. In addition to that collaboration, R&amp;D staff have pursued
a variety of novel and Upright&#174; MRI-specific research projects. It is anticipated that these will ultimately lead to new applications
that are made available to existing customers as upgrade add-ons to their machines. For example, phase-contrast imaging techniques originally
developed for angiography have recently been applied to cerebrospinal fluid (CSF) flow. Analysis of CSF flow in upright and recumbent
postures may prove to be of significant value in the evaluation of a variety of disorders and lead to a better understanding of human
physiology.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">PATENTS AND LICENSES</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red"><b><i>&#160;</i></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently have numerous patents in effect which
relate to the technology and components of our MRI scanners. We believe that these patents, and the know-how we have developed, are material
to our business.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our seminal patent, issued in the name of Dr. Damadian
and licensed to FONAR, was United States patent No. 3,789,832, Apparatus and Method for Detecting Cancer in Tissue, also referred to in
this report as the &#8220;1974 Patent&#8221;. The 1974 Patent was the first MRI patent issued by the United States Patent Office. The
development of our MRI scanners has been based upon the 1974 Patent, and we believe that the 1974 Patent was the first of its kind to
utilize MR to scan the human body and to detect cancer. The 1974 Patent was extended beyond its original 17-year term and expired in February,
1992. A number of FONAR&#8217;s existing patents specifically relate to protecting FONAR&#8217;s position in the Upright MRI market. The
patents further enhance Dr. Damadian&#8217;s pioneer patent that initiated the MRI industry and provided the original invention of MRI
scanning.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain a robust patent portfolio that provides
us, under the aegis of United States patent law, &#8220;the exclusive right to make, use and sell&#8221; many of the scanner features
which FONAR pioneered and which are now incorporated in most MRI scanners sold by the industry. As of June 30, 2025, a total of 245 patents
have been issued to FONAR. In fiscal year 2025, we obtained four new patents. Most significantly, we obtained approval for a patent related
to the development of our next generation patient positioning system. Other patents issued in fiscal 2025 include a system for monitoring
the effectiveness of a treatment regimen, and a method for assessing risk of cerebral palsy based on cerebrospinal fluid flow.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">PRODUCT COMPETITION</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>MRI SCANNERS</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR faces competition for MRI product sales from
companies such as Siemens, General Electric, Philips, Fujifilm, Canon, and United Imaging. Each of these is primarily focused on the high-field
(1.0 T and above) marketplace, though some have produced open MRI scanners for imaging in the recumbent posture. None of these firms has
so far introduced an open, upright MRI.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In recent years, other companies have introduced MRI
scanners aimed at the upright, weight-bearing MRI market. Their success in the US has so far been limited. We believe that the higher
field strength and larger dimensions of the FONAR Upright&#174; MRI magnet, together with the greater variety of patient positioning possibilities
afforded by the FONAR Upright&#174; MRI bed, give us a competitive advantage over the products introduced by these companies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Most of our competitors have marketing and financial
resources more substantial than those available to us. They have in the past, and may in the future, heavily discount the sales price
of their scanners.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>OTHER IMAGING MODALITIES</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s MRI scanners also compete with other
diagnostic imaging systems, all of which are based upon the ability of some form of energetic wave to penetrate human tissue and be detected
by either photographic film or electronic devices for presentation on a display monitor. Three different kinds of energy waves &#8211;
x-ray, gamma, and sound &#8211; are used in medical imaging techniques that compete with MRI, the first two of which involve exposing
the patient to potentially harmful radiation. These other imaging modalities compete with MRI products on the basis of cost, space requirements,
and specific clinical applications.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">X-rays are the most common energy source used in imaging
the body and are employed in three imaging modalities: conventional x-ray systems, computerized tomography (CT), and digital radiography.
None of these enjoy the exquisite soft-tissue contrast of MRI, but they do offer high resolution imaging in certain applications and high
speed of image acquisition.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Nuclear medicine systems, which are based upon the
detection of photons (gamma radiation) generated by radioactive pharmaceuticals introduced into the body, are used to provide information
concerning soft tissue and internal body organs and particularly to examine organ function over time.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ultrasound systems emit, detect, and process high
frequency sound waves reflected from organ boundaries and tissue interfaces to generate images of soft tissue and internal body organs.
Although the images are substantially less detailed than those obtainable with x-rays or MRI, ultrasound is generally considered harmless
and therefore has found applications in imaging the pregnant uterus and the breast, to name two.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">X-ray (including CT), nuclear medicine, and ultrasound
compete with the MRI scanners by offering significantly lower price and space requirements. However, history has shown that the superior
tissue contrast characteristics of MRI have secured its place as the diagnostic imaging modality of choice for a wide variety of pathologies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">GOVERNMENT REGULATION</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>FDA Regulation</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Food and Drug Administration in accordance with
Title 21 of the Code of Federal Regulations regulates the manufacturing and marketing of FONAR&#8217;s MRI scanners. The regulations can
be classified as either pre-market or post-market. The pre-market requirements include obtaining marketing clearance, proper device labeling,
establishment registration and device listing. Once the products are on the market, FONAR must comply with post-market surveillance controls.
These requirements include the Quality Systems Regulation, or &#8220;QSR&#8221;, also known as Current Good Manufacturing Practices or
CGMPs, and Medical Device Reporting, also referred to as MDR regulations. The QSR is a quality assurance requirement that covers the design,
packaging, labeling and manufacturing of a medical device. The MDR regulation is an adverse event-reporting program.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Classes of Products</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the Medical Device Amendments of 1976 to the
Federal Food, Drug and Cosmetic Act, all medical devices are classified by the FDA into one of three classes. A Class I device is subject
only to general controls, such as labeling requirements and manufacturing practices; a Class II device must comply with certain performance
standards established by the FDA; and a Class III device must obtain pre-market approval from the FDA prior to commercial marketing. FONAR&#8217;s
products are Class II devices. Class II devices are subject to &#8220;General Controls&#8221;; General Controls include:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">1.</td><td style="text-align: justify">Establishment registration of companies which are required to register under 21 CFR Part 807.20, such
as manufacturers, distributors, re-packagers and re-labelers.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">2.</td><td style="text-align: justify">Medical device listing with FDA of devices to be marketed.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">3.</td><td style="text-align: justify">Manufacturing devices in accordance with the Current Good Manufacturing Practices Quality System Regulation
in 21 CFR Part 820.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">4.</td><td style="text-align: justify">Labeling devices in accordance with labeling regulations in 21 CFR Part 801 or 809.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">5.</td><td style="text-align: justify">Submission of a Premarket Notification, pursuant to 510(k), before marketing a device.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to complying with general controls, Class
II devices are also subject to special controls. Special controls may include special labeling requirements, guidance documents, mandatory
performance standards and post-market surveillance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 3, 2000 FONAR received FDA clearance for
the Upright&#174; MRI under the name &#8220;Indomitable&#8221;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Premarketing Submission</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Each person who wants to market Class I, II and some
III devices intended for human use in the U.S. must submit a 510(k) to FDA at least 90 days before marketing unless the device is exempt
from 510(k) requirements. A 510(k) is a pre-marketing submission made to FDA to demonstrate that the device to be marketed is as safe
and effective, that is, substantially equivalent, SE, to a legally marketed device that is not subject to pre-market approval, PMA. Applicants
must compare their 510(k) device to one or more similar devices currently on the U.S. market and make and support their substantial equivalency
claims.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The FDA is committed to a 90-day clearance after submission
of a 510(k), provided the 510(k) is complete and there is no need to submit additional information or data.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The 510(k) is essentially a brief statement and description
of the product. As FONAR&#8217;s scanner products are Class II products, there are no pre-market data requirements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An investigational device exemption, also referred
to as IDE, allows the investigational device to be used in a clinical study pending FDA clearance in order to collect safety and effectiveness
data required to support the Premarket Approval, also referred to as PMA, application or a Premarket Notification pursuant to 510(k),
submission to the FDA. Clinical studies are most often conducted to support a PMA.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the most part, however, we have not found it necessary
to utilize IDE&#8217;s. The standard 90 day clearance for our new MRI scanner products classified as Class II products makes the IDE unnecessary,
particularly in view of the time and effort involved in compiling the information necessary to support an IDE.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Quality System Regulation</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Quality Management System is applicable to the
design, manufacture, administration of installation and servicing of magnetic resonance imaging scanner systems. The FDA has authority
to conduct detailed inspections of manufacturing plants, to establish Good Manufacturing Practices which must be followed in the manufacture
of medical devices, to require periodic reporting of product defects and to prohibit the exportation of medical devices that do not comply
with the law.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Medical Device Reporting Regulation</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Manufacturers must report all MDR reportable events
to the FDA. Each manufacturer must review and evaluate all complaints to determine whether the complaint represents an event which is
required to be reported to FDA. Section 820.3(b) of the Quality Systems regulation defines a complaint as, &#8220;any written, electronic
or oral communication that alleges deficiencies related to the identity, quality, durability, reliability, safety, effectiveness, or performance
of a device after it is released for distribution.&#8221;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A report is required when a manufacturer becomes aware
of information that reasonably suggests that one of their marketed devices has or may have caused or contributed to a death, serious injury,
or has malfunctioned and that the device or a similar device marketed by the manufacturer would be likely to cause or contribute to a
death or serious injury if the malfunction were to recur.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Malfunctions are not reportable if they are not likely
to result in a death, serious injury or other significant adverse event experience.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A malfunction which is or can be corrected during
routine service or device maintenance still must be reported if the recurrence of the malfunction is likely to cause or contribute to
a death or serious injury if it were to recur.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have established and maintained written procedures
for implementation of the MDR regulation. These procedures include internal systems that:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in">-</td>
    <td style="text-align: justify">provide for timely
and effective identification, communication and evaluation of adverseevents;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in">-</td>
    <td style="text-align: justify">provide a standardized review process and procedures for determining whether
or not an event is reportable; and</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">provide procedures to insure the timely transmission of complete reports.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These procedures also include documentation and record
keeping requirements for information that was evaluated to determine if an event was reportable; all medical device reports and information
submitted to the FDA; any information that was evaluated during preparation of annual certification reports; and systems that ensure access
to information that facilitates timely follow up and inspection by the FDA.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>FDA Enforcement</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FDA may take the following actions to enforce the
MDR regulation:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FDA-Initiated or Voluntary Recalls</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Recalls are regulatory actions that remove a hazardous,
potentially hazardous, or a misbranded product from the marketplace. Recalls are also used to convey additional information to the user
concerning the safe use of the product. Either FDA or the manufacturer can initiate recalls.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are three classifications, i.e., I, II, or III,
assigned by the Food and Drug Administration to a particular product recall to indicate the relative degree of health hazard presented
by the product being recalled.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class I</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Is a situation in which there is a reasonable probability
that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class II</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Is a situation in which use of, or exposure to, a
violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse
health consequences is remote.&#8195;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class III</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Is a situation in which use of, or exposure to, a
violative product is not likely to cause adverse health consequences.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR has initiated six voluntary recalls which occurred
between 1987 and 2016. Five of the recalls were Class II and one was Class III. The recalls involved making minor corrections to the product
in the field. Frequently, corrections which are made at the site of the device are called field corrections as opposed to recalls.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Civil Money Penalties</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The FDA, after an appropriate hearing, may impose
civil money penalties for violations of the Food Drug &amp; Cosmetic Act that relate to medical devices. In determining the amount of
a civil penalty, FDA will take into account the nature, circumstances, extent, and gravity of the violations, the violator&#8217;s ability
to pay, the effect on the violator&#8217;s ability to continue to do business, and any history of prior violations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warning Letters</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FDA issues written communications to a firm, indicating
that the firm may incur more severe sanctions if the violations described in the letter are not corrected. Warning letters are issued
to cause prompt correction of violations that pose a hazard to health or that involve economic deception. The FDA generally issues the
letters before pursuing more severe sanctions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Seizure</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A seizure is a civil court action against a specific
quantity of goods which enables the FDA to remove these goods from commercial channels. After seizure, no one may tamper with the goods
except by permission of the court. The court usually gives the owner or claimant of the seized merchandise approximately 30 days to decide
a course of action. If they take no action, the court will recommend disposal of the goods. If the owner decides to contest the government&#8217;s
charges, the court will schedule the case for trial. A third option allows the owner of the goods to request permission of the court to
bring the goods into compliance with the law. The owner of the goods is required to provide a bond or, security deposit, to assure that
they will perform the orders of the court, and the owner must pay for FDA supervision of any activities by the company to bring the goods
into compliance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Citation</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A citation is a formal warning to a firm of intent
to prosecute the firm if violations of the FD&amp;C Act are not corrected. It provides the firm an opportunity to convince FDA not to
prosecute.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Injunction</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An injunction is a civil action filed by FDA against
an individual or company. Usually, FDA files an injunction to stop a company from continuing to manufacture, package or distribute products
that are in violation of the law.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prosecution</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prosecution is a criminal action filed by FDA against
a company or individual charging violation of the law for past practices.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Foreign and Export Regulation</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We obtain approvals as necessary in connection with
the sales of our products in foreign countries. In some cases, FDA approval has been sufficient for foreign sales as well. Our standard
practice has been to require either the distributor or the customer to obtain any such foreign approvals or licenses which may be required.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Legally marketed devices that comply with the requirements
of the FD&amp;C Act require a Certificate to Foreign Government issued by the FDA for export. Other devices that do not meet the requirements
of the FD&amp;C Act but comply with the laws of a foreign government require a Certificate of Exportability issued by the FDA. All products
which we sell have FDA clearance and would fall into the first category.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Foreign governments have differing requirements concerning
the import of medical devices into their respective jurisdictions. The European Union&#8217;s new medical device regulation, EU 2017/745
went into effect on May 25, 2021, and contains significant changes from the prior European regulatory scheme. We have applied to the Notified
Body, TUV-SUD, to perform a Conformity Assessment of our technical documentation and our Quality Management System.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other countries require that their own testing laboratories
perform an evaluation of our devices. This requires that we must bring the foreign agency&#8217;s personnel to the USA to perform the
evaluation at our expense before exporting.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Some countries, including many in Latin America and
Africa, have very few regulatory requirements, beyond FDA clearance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To date, FONAR has been able to comply with all foreign
regulatory requirements applicable to its export sales.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline">EMPLOYEES</span></i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR and HMCA had approximately 535 employees as
of August 7, 2025. This total number included employees engaged in production, customer support, research and development, information
technology, employees engaged in marketing and sales, billing and collection, legal and compliance matters, as well as transcriptionists,
Florida technologists, field service technicians and individuals in various administrative positions. A significant number of employees
were employed at the MRI facilities managed or owned by HMCA, primarily in administrative positions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_002"></span>ITEM 1A. RISK FACTORS</b>&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. Reduced Reimbursement Rates. Most of our revenues
are derived from our scanning center business conducted by HMCA. Our scanning center clients and the Florida facilities owned by HMCA
are experiencing lower reimbursement rates from Medicare, other government programs and private insurance companies. To the extent possible,
we counter these reductions by increasing scanning volume and controlling operating expenses. Inflation in the cost of both materials
and labor have limited our ability to control our costs, negatively impacting our ability to maintain profitability in this business segment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. Inflation. Inflation has drastically increased
our costs for both materials and labor. Diagnostic imaging facilities require significant amounts of capital to operate, particularly
in the context of opening new diagnostic imaging centers. These increased costs make it more difficult to achieve organic growth and extend
the time that a new center takes to achieve profitability. Continued cost increases, coupled with reduced reimbursement rates may threaten
the profitability of our current operations and cause the cost of expansion to become prohibitively high.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. Cybersecurity threats. Diagnostic imaging
centers have increasingly become a target for threat actors. Our organization relies on information technology systems and computer
networks to operate. Our partners, vendors, and business associates are equally reliant on their own computer systems to provide the
services that we depend on to perform core functions. Data incidents in the form of breaches, ransomware attacks, denial-of-service
attacks, and a variety of other hazards could materially disrupt our operations, or the operations of our partners. In addition, the
costs to respond to such incidents related to rebuilding internal systems, restoring data, responding to regulatory investigations
and/or litigation could be significant. Our cybersecurity liability insurance may be inadequate to cover these losses. Management
has identified a material weakness in our internal controls over our information technology systems during the fiscal year ending
June 30, 2025. While management has enacted a plan for remediation by improving these internal controls and implementing additional
controls, there is no guarantee these remediation efforts will be adequate. Further, there is no guarantee that other, unidentified
risks could negatively impact our operations in the future. The cost of maintaining and improving our security technologies to
protect ourselves from these threats, and to comply with associated regulatory requirements related to cybersecurity, has increased
substantially in the most recent fiscal year and will continue to increase in the future. Previous cybersecurity incidents have not
materially affected our results of operations or financial condition. However, cybersecurity threats have the potential to
significantly impair our operations and the operations of the various third parties upon whom we rely. Risks outside of our control,
such as cybersecurity attacks to our partners, vendors and business associates could threaten our ability to operate and reduce
operating margins.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4. Dependence on Referrals. HMCA derives substantially
all of its revenue, directly or indirectly, from fees charged for the diagnostic imaging services performed at the facilities. We depend
on referrals of patients from unaffiliated physicians and other third parties to the facilities we manage or own for the services we perform.
If these physicians and other third parties were to reduce the number of patients they refer or discontinue referring patients, scan volumes
could decrease, which would reduce our net revenue and operating margins.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5. Current and future changes in Florida Insurance
Law. On March 24, 2023, Florida enacted House Bill 837. Dubbed the Tort Reform Act, the bill made sweeping changes to Florida&#8217;s
negligence laws that negatively impact our Florida diagnostic imaging facilities (both those we own and those we manage) with more unpaid
bills, higher administrative costs, and lower reimbursement rates. Florida legislators continue to propose significant changes to the
current structure of Florida&#8217;s insurance industry, including an annual proposal to repeal of Florida&#8217;s no-fault insurance
law and replace it with a fault-based system. This proposal was vetoed by Governor Ron DeSantis after passing both houses in 2021, but
similar legislation was proposed in 2022, 2023, and again in 2025. The 2025 proposal died unheard in the Florida Senate&#8217;s Banking
and Insurance committee. A repeal of the no-fault law will result in significant delays in payment for the services we render and will
have a negative effect on our operations. The full impact of these proposed changes, including their impact on scan volume, are impossible
to estimate at this time. We will continue to monitor this bill as it continues through the legislative process.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">6. Scanning Facility Competition. The market for diagnostic
imaging services is highly competitive. The facilities we manage or own compete for patients on the basis of reputation, location and
the quality of diagnostic imaging services. Groups of radiologists, established hospitals, clinics and other independent organizations
that own and operate imaging equipment are the principal competitors. The Florida market in particular is experiencing a high level of
competition, which, coupled with recent Tort Reform, has created a challenging landscape for the centers we own and manage in that state,
and may deter future expansion.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">7. Pressure to Control Healthcare Costs. One of the
principal objectives of health maintenance organizations and preferred provider organizations is to control the cost of healthcare services.
Healthcare providers participating in managed care plans may be required to refer diagnostic imaging tests to certain providers depending
on the plan in which a covered patient is enrolled. In addition, managed care contracting has become very competitive. The expansion of
health maintenance organizations, preferred provider organizations and other managed care organizations in New York or Florida could have
a negative impact on the utilization and pricing of services performed at the facilities HMCA manages or owns to the extent these organizations
exert control over patients&#8217; access to diagnostic imaging services, selections of the provider of such services and reimbursement
rates for those services.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">8. Eligibility Changes to Insurance Programs. Due
to potential decreased availability of healthcare through private employers, the number of patients who are uninsured or participate in
governmental programs may increase. Healthcare reform legislation will continue to increase the participation of individuals in the Medicaid
program in states that elect to participate in the expanded Medicaid coverage. A shift in payor mix from managed care and other private
payors to government payors or an increase in the number of uninsured patients may result in a reduction in the rates of reimbursement
or an increase in uncollectible receivables or uncompensated care, with a corresponding decrease in net revenue. Policies now being offered
under various insurance plans are expected to reduce demand for MRI scans as they become less affordable. Changes in the eligibility requirements
for governmental programs such as the Medicaid program and state decisions on whether to participate in the expansion of such programs
also could increase the number of patients who participate in such programs and the number of uninsured patients. Even for those patients
who remain in private insurance plans, changes to those plans could increase patient financial responsibility, resulting in a greater
risk of uncollectible receivables. These factors and events could have a material adverse effect on our business, financial condition,
and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9. Federal and state privacy and information security
laws. We must comply with numerous federal and state laws and regulations governing the collection, dissemination, access, use, security
and privacy of PHI, including HIPAA and its implementing privacy and security regulations, as amended by the federal HITECH Act. If we
fail to comply with applicable privacy and security laws, regulations and standards, properly maintain the integrity of our data, or protect
our proprietary rights to our systems, our business, reputation, results of operations, financial position and cash flows could be materially
and adversely affected.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">10. Demand for MRI Scanners. The reduced reimbursement
rates have a negative effect on our sales of MRI scanners. With lower revenue projections, prospective customers would demand lower prices
for scanners. Although the reduced reimbursements may not affect foreign demand, a lower number of sales in the aggregate could reduce
economies of scale and consequently, profit margins.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">11. Manufacturing Competition. Many if not most of
our competing scanner manufacturers have significantly greater financial resources, production capacity, and other resources than we do.
Such competitors would include General Electric, Siemens, Hitachi and Phillips. Although FONAR is the only company which can manufacture
and sell the unique Stand-Up&#174; (Upright&#174;) MRI scanner, potential customers must be convinced that the purchase of a FONAR scanner
is their best choice. We believe that with time, that objective will be reached, particularly with customers scanning patients having
neck, back, knee and various orthopedic issues who would benefit from being scanned in weight-bearing positions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">12. Other changes in Domestic and Worldwide Economic
Conditions. We are subject to risk arising from adverse changes in general domestic and global economic and other conditions, including
tariffs, recessions or economic slowdowns, disruptions of credit markets and military conflicts. Turbulence and uncertainty in the United
States and international markets and economies may adversely affect our workforce, liquidity, financial condition, revenues, profitability
and business operations generally.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_003"></span>ITEM 1B. UNRESOLVED STAFF COMMENTS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">None.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_004"></span>ITEM 1C. CYBERSECURITY </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<div id="xdx_98D_ecyd--CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_iB_c20240701__20250630_zU6Vrg2Qb9sf" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000054" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Risk Management and Strategy</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Cybersecurity Risk Management Strategy includes
a myriad of tools and resources that are designed to ensure the integrity of our information systems. We place particular emphasis on
protecting the privacy of our patient data pursuant to the HIPAA Security Rule. Our cybersecurity risk management process is integrated
with our larger risk <span id="xdx_90C_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240701__20250630_zQUvRfWfjMji" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000055" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">management</ix:nonNumeric></span> system and is considered a core function of our overall risk management strategy.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our strategy is based around identification,
mitigation, avoidance and response to material cybersecurity risks. We employ physical and electronic safeguards to control access
to our systems. We employ additional electronic safeguards to control/limit access to the data contained in those systems. We review
and re-assess these processes on a rolling basis with the assistance of both internal staff and outside vendors, including
assessors, consultants, auditors, and other third parties. Some steps we take include the use of standard security protocols such as
password maintenance, multi-factor identification, and penetration testing. We take other steps as may be situationally appropriate
for the specific risk presented.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the fiscal year ended June 30, 2025, management has identified
a material weakness in our internal controls over our information technology systems, as described in greater detail in Item 9A. In response,
we have taken several steps to enhance our cybersecurity efforts. Those steps include increasing the scope of our Multi-Factor Authentication
requirement to include additional tertiary information systems, improving password security, upgrading our anti-virus software, upgrading
our threat detection tools, implementing additional threat detection tools, and replacing and/or decommissioning hardware that has known
vulnerabilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We require all of our employees to receive cybersecurity
training as part of their initial onboarding process, and employees are required to complete additional training throughout the year.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate all of our vendors and <span id="xdx_90D_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240701__20250630_z7T4jZ4Td6Yh" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000056" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag">third-party</ix:nonNumeric> </span>partners
for material cybersecurity risks and take steps to mitigate risk through insurance and contractual risk transfer provisions when appropriate.
Our Information Technology department works collaboratively with our third-party vendors to coordinate a mutually beneficial approach
to cybersecurity in the specific context in which risk is presented. These collaborations sometimes take place on a rolling basis, and
sometimes take place on a semi-annual or annual basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_90A_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240701__20250630_zhCcuDSrPii7" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000057" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">Cybersecurity threats, including previous cybersecurity incidents, have
not materially affected our results of operations or financial condition. However, cybersecurity threats have the potential to significantly
impair our operations and the operations of the various third parties upon whom we rely.</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<div id="xdx_98B_ecyd--CybersecurityRiskBoardOfDirectorsOversightTextBlock_c20240701__20250630_zMgqBzIaTeUj" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000058" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Governance</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_903_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240701__20250630_zcKQXoyHGSSl" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000059" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">The audit committee of our Board of Directors provides
oversight of cybersecurity risks.</ix:nonNumeric></span> It receives regular reports from management, including our General Counsel, on various cybersecurity
matters during each board meeting. Such reports include information on current cybersecurity risks facing the organization, cybersecurity
incidents involving our partners and/or other participants in our industry, and routine updates on the status of our internal cybersecurity
risk management plan.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our General Counsel oversees and manages our cybersecurity
program. Our General Counsel acts as the coordinator of our cybersecurity team, which includes representatives from our Information Technology
department and Compliance department. In addition, he regularly interacts with various department heads from both our New York and Florida
regions regarding the prevention, detection, mitigation and remediation of cybersecurity risks. Our General Counsel has an educational
background in computer science and has relevant work experience in cybersecurity insurance and risk management.</p>

</ix:nonNumeric></div>

</ix:nonNumeric></div>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_005"></span>ITEM 2. PROPERTIES</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR and HMCA currently lease approximately 78,000
square feet of office and plant space at its principal offices in Melville, New York. The term of the lease runs through November, 2033.
Management believes that the premises will be adequate for its current needs. HMCA also maintains office space for the Facilities owned
by its subsidiaries in Florida and for its clients at the clients&#8217; sites in New York and Florida under leases having various terms.
HMCA owns the building for the client&#8217;s premises in Tallahassee, Florida.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_006"></span>ITEM 3. LEGAL PROCEEDINGS.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">From time to time we are involved in various litigation matters arising
in the ordinary course of our business. We do not believe the disposition of any current matter will have a material adverse effect on
our consolidated financial position or results of operations. There are no material legal proceedings threatened or pending against the
Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_007"></span>ITEM 4. MINE SAFETY DISCLOSURES.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b><br/>
Not Applicable</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>PART II</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_008"></span>ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Common Stock is traded on NASDAQ Capital Markets
under the symbol FONR.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 8, 2025 we had approximately 922 stockholders
of record of our Common Stock, 12 stockholders of record of our Class B Common Stock, 3 stockholders of record of our Class C Common Stock
and 992 stockholders of record of our Class A Non-voting Preferred Stock<span>.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The only class of our securities for which there is
a market is the Common Stock.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We currently have a policy of retaining earnings to
finance the development and expansion of our business. We expect to continue this policy for the foreseeable future.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Performance Graph</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The following graph compares
the Company&#8217;s cumulative total stockholder return on its Common Stock against industry and broad-market indexes which have been
compiled by the Nasdaq Global Index Group. The periods commence on June 30, 2021 for five years and end on June 30, 2025. The graph assumes
$100 is invested in FONAR Common Stock (NASDAQ: FONR), the Nasdaq Composite Total Return (Nasdaq Composite), Nasdaq Health Care Management
Services (Nasdaq Health), and Nasdaq Medical Equipment (Nasdaq Equipment). The comparisons in the graph below are based on historical
data and are not intended to forecast the possible future performance of the common stock.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Relative Dollar Values</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 1pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">June 30, <span style="text-decoration: none">2021</span></span></td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">June 30, <span style="text-decoration: none">2022</span></span></td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">June 30, <span style="text-decoration: none">2023</span></span></td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">June 30, <span style="text-decoration: none">2024</span></span></td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">June 30, <span style="text-decoration: none">2025</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 35%; text-align: left; text-indent: -10pt">FONR Common Stock</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 9%; text-align: right">100</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 9%; text-align: right">86</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 9%; text-align: right">97</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 9%; text-align: right">90</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 9%; text-align: right">85</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">NASDAQ Composite</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">100</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">77</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">97</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">125</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">145</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Health Care Management Services</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">100</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">122</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">117</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">127</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">91</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Medical Equipment</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">100</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">83</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">94</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">98</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">104</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><img src="image_002.jpg" alt="" style="height: 240pt; width: 468pt"/></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Share Repurchase Program</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="background-color: white">In
September 2022, our Board of Directors authorized a program to repurchase up to $9 million of our common stock. Under this program, we
may purchase stock in the open market or through privately negotiated transactions in accordance with applicable securities laws, including
pursuant to pre-arranged stock trading plans. The timing and actual amount of the stock repurchases will depend on several factors including
price, capital availability, regulatory requirements, and other market conditions. We are not obligated to repurchase a specific number
of shares under this program and it may be modified, suspended or discontinued at any time. </span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The following table summarizes
the number of shares repurchased during the three months ended June 30, 2025:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td colspan="2" style="text-align: center">Fiscal Month</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Total Number of Shares Purchased</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Average Price Paid per Share</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Total Number of Shares Purchased as Part of Publicly Announced Programs</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Maximum Dollar Value that May Still Be Purchased Under the Program (In Thousands)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">April 1, 2025 &#8211; April 30, 2025</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 14%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 14%; text-align: right">&#8212;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 14%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 14%; text-align: right">2,928</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">May 1, 2025 &#8211; May 31, 2025</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">2,928</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">June 1, 2025 &#8211; June 30, 2025</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">2,928</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; font-weight: bold; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>Total</b></span></td>
<td style="font-weight: bold; text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_009"></span>ITEM 6. [Reserved]</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Not applicable.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_010"></span>ITEM 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>INTRODUCTION.</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR was formed in 1978 to engage in the business
of designing, manufacturing and selling MRI scanners. HMCA, a subsidiary of FONAR, provides management services to diagnostic imaging
facilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR&#8217;s principal MRI product is its Upright&#174;
MRI (also called Stand-Up&#174; MRI) scanner. The Upright&#174; MRI allows patients to be scanned for the first time under weight-bearing
conditions. The Stand-Up&#174; MRI is the only MRI capable of producing images in the weight-bearing state.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At 0.6 Tesla field strength, the Upright&#174; MRI
is among the highest field open MRI scanners in the industry, offering non-claustrophobic MRI together with high-field image quality.
FONAR&#8217;s open MRI scanners were the first high field strength open MRI scanners in the industry.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">FONAR&#8217;s
wholly owned subsidiary, Health Management Corporation of America (&#8220;HMCA&#8221;), has the controlling interest in Health Diagnostics
Management, LLC (&#8220;HDM&#8221;). HMCA presently has a direct ownership interest of 70.6% in HDM, and the investors in HDM have a
29.4% ownership interest. During the fiscal year ended June 30, 2025, the Company sold non-controlling interests to a minority shareholder
for $132,000. The management of the diagnostic imaging centers business segment is being conducted by HDM, operating under the name &#8220;Health
Management Company of America&#8221;. For the sake of simplicity, HMCA, and HDM are referred to as &#8220;HMCA&#8221;, unless otherwise
indicated .HMCA generates revenues from providing comprehensive management services, including development, administration, accounting,
billing and collection services, together with office space, medical equipment, supplies and non-medical personnel to its clients. Revenues
are in the form of fees which are earned under contracts with HMCA&#8217;s clients, except for its six Florida subsidiaries which bill
and collect fees from patients, insurers and other third-party payors directly.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2024, FONAR formed a wholly-owned subsidiary,
Opus Diagnostic Management, LLC, to provide repair and maintenance of third party manufactured MRI equipment that HMCA operates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our discussion and analysis of financial condition
and results of operations are based on our consolidated financial statements that were prepared in accordance with U.S. generally accepted
accounting principles, or GAAP. Management makes estimates and assumptions when preparing financial statements. These estimates and assumptions
affect various matters, including:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our reported amounts of assets and liabilities in
our consolidated balance sheets at the dates of the financial statements;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our disclosure of contingent assets and liabilities
at the dates of the financial statements; and</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our reported amounts of net revenue and expenses in
our consolidated statements of operations during the reporting periods</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These estimates involve judgments with respect to
numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could differ materially
from these estimates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We believe our critical accounting estimates in the
following areas affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue Recognition and Receivable Allowances</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s receivables from the related and
non-related professional corporations, as well as those receivables due under fee-for-service contracts at the Florida subsidiaries, are
largely dependent on collection of fees from various third-party payers. As described in greater detail in Note 2 to the Consolidated
Financial Statements, we recognize revenue in accordance with Accounting Standards Codification 606, as the services are provided.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Medical receivables are due under fee-for-service
contracts with third-party payors, such as hospitals, government sponsored healthcare programs, patients&#8217; legal counsel and directly
from patients. The carrying amount of the medical receivable is reduced by contractual allowances and discounts based on the historical
experience with each payor class on a per location basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fee receivable is related to the management
fees outstanding from the related and non-related professional corporations (&#8220;PCs&#8221;) under management agreements. The Company
establishes a current expected credit loss (&#8220;CECL&#8221;) to address the risk that a portion of the contractually obligated management
fees receivable from the PCs may not be paid. The PCs may be limited in their ability to pay the full management fees receivable if they
do not collect sufficient expected fees from third-party payers and patients. The Company&#8217;s management fees are collateralized,
individually and collectively, by the assets of the PCs. The CECL is determined based upon the difference between the management fee receivable
and the current amount of outstanding fees estimated to be collected by the PCs. The Company&#8217;s considerations into the estimate
of the PCs fee collection included historical loss rates to pools of receivables with similar risks and characteristics, current and forward
looking economic conditions, and the financial condition of each PC.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize revenue and related costs of revenue
from sales contracts for our MRI scanners and major upgrades, under the percentage-of-completion method. Under this method, we recognize
revenue and related costs of revenue, as each sub-assembly is completed. Amounts received in advance of our commencement of production
are recorded as customer advances.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>RESULTS OF OPERATIONS. FISCAL 2025 COMPARED TO
FISCAL 2024</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In fiscal 2025, we recognized net income of $10.7
million on revenues of $104.4 million, as compared to net income of $14.1 million on revenues of $102.9 million for fiscal 2024. This
represents an increase in revenues of 1.4%. Total costs and expenses increased by 7.4%. Our consolidated operating results decreased by
29.7% to an operating income of $11.6 million for fiscal 2025 as compared to operating income of $16.5 million for fiscal 2024.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Discussion of Consolidated Results of Operations</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fiscal 2025 Compared to Fiscal 2024</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While revenue increased by 1.4% selling, general and
administrative expenses increased by 10.7% to $29.7 million in fiscal 2025 from $26.9 million in fiscal 2024. This difference in selling,
general and administrative expenses was largely due to a $2,300,000 increase on reserves for credit loses for a single payer &#8211; American
Transit Insurance Company. American Transit Insurance Company (ATIC) is a New York based motor vehicle insurer primarily focused on for-hire
automobile insurance. During Fiscal 2025, ATIC posted over $750 million in net losses and has indicated that they are approaching insolvency.
ATIC continues to operate and is working with the New York Department of Financial Services to resolve its issues. We are monitoring the
situation for new developments. If ATIC enters receivership or suffers additional adverse consequences, we may need to take additional
reserves in the future.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interest and investment income remained constant in
2025 compared to 2024. We recognized investment income of $2.1 million in fiscal 2025 and 2024. This is due to the Company placing cash
in interest bearing accounts and purchasing short term treasury bills.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interest expense of $25,611 was recognized in fiscal
2025, as compared to interest expense of $76,997 in fiscal 2024. The Company repaid the outstanding debt for a building located in Florida
during fiscal 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The 29.4% non-controlling interest allocations of
$2,339,000 and $3,530,000 for fiscal 2025 and fiscal 2024, respectively, have been calculated by Income from operations, and adding depreciation
and amortization net of miscellaneous losses and other income from the Physician and Diagnostic Service Management segment (See Note 15).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We incurred some unusual one-time expenses during
Fiscal Year 2025. We settled an outstanding tax debt related to New York City Commercial Rent Tax in the amount of $172,000. We also incurred
a significant expense from Consolidated Edison Company in the amount of $206,000 for unreported electricity bills at our Midtown Manhattan
location, due to faulty meter reading over a period of years. These one-time expenses have been resolved.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Continuing our tradition as the originator of MRI,
we remain committed to maintaining our position as the leading innovator of the industry through investing in research and development.
In fiscal 2025 we continued our investment in the development of various upgrades for the UPRIGHT&#174; MRI, with an investment of $1,576,086
in research and development, none of which was capitalized, as compared to $1,735,949, none of which was capitalized, in fiscal 2024.
The research and development expenditures were approximately 17.6% of revenues attributable to our medical equipment segment and 1.5%
of total revenues in 2025, and 20.8% of medical equipment segment revenues and 1.7% of total revenues in fiscal 2024. This represented
a 9.2% decrease in research and development expenditures in fiscal 2025 as compared to fiscal 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the fiscal year 2025 the Company recorded an income
tax expense of $3.1 million compared with an income tax expense of $5.2 million for 2024. The Company has recorded a deferred tax asset
of $6.3 million as of June 30, 2025, primarily relating to the tax benefits from the net allowance for credit losses and tax credits available
to offset future taxable income. The income tax benefits are attributable to the expected tax benefits associated with the projected realization
and utilization of our net state operating losses in future periods. The utilization of these tax benefits is dependent on the Company
generating future taxable income and other factors. A partial valuation allowance will be maintained until evidence exists to support
that it is no longer needed, (principally related to unrealizable state operating losses). Although the Company is expecting to generate
taxable income in future periods, we cannot accurately measure the full impact of the adoption of healthcare regulations, including the
impact of continuing changes in MRI scanning reimbursement rates, which could materially impact operations. A partial valuation allowance
will be maintained until evidence exists to support that it is no longer needed. As of June 30, 2025, the valuation allowance was $252,000.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have been taking steps to improve HMCA revenues
by our marketing efforts, which focus on the unique capability of our Upright&#174; MRI scanners to scan patients in different positions.
We have also been increasing the number of health insurance plans in which our clients participate. Operationally, we have invested in
technology that we believe will reduce scan times and improve operational efficiency in the centers that we manage.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our management fees are dependent on collection by
our clients of fees from reimbursements from Medicare, Medicaid, private insurance, no fault and workers&#8217; compensation carriers,
self&#8211;pay and other third-party payers. The health care industry is experiencing the effects of the federal and state governments&#8217;
trend toward cost containment, as governments and other third-party payers seek to impose lower reimbursement and utilization rates and
negotiate reduced payment schedules with providers. The cost-containment measures, consolidated with the increasing influence of managed-care
payers and competition for patients, have resulted in reduced rates of reimbursement for services provided by our clients from time to
time. Our future revenues and results of operations may be adversely impacted by future reductions in reimbursement rates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain third-party payers have proposed and implemented
changes in the methods and rates of reimbursement that have had the effect of substantially decreasing reimbursement for diagnostic imaging
services that HMCA&#8217;s clients provide. To the extent reimbursement from third-party payers is reduced, it will likely have an adverse
impact on the rates they pay us, as they would need to reduce the management fees they pay HMCA to offset such decreased reimbursement
rates. Furthermore, many commercial health care insurance arrangements are changing, so that individuals bear greater financial responsibility
through high deductible plans, co-insurance and higher co-payments, which may result in patients delaying or foregoing medical procedures.
More frequently, however, patients are scanned and we experience difficulty in collecting deductibles and co-payments. We expect recent
changes to the Florida insurance laws to result in less patients being reimbursed through no-fault auto insurance, resulting in both lower
reimbursement rates and a higher rate of uncollectible billings. Further, we believe that the passage of New York Public Health Law Article
49A will have a significant negative impact on our collection rates. We expect that any further changes to the rates or methods of reimbursement
for services, which reduce the reimbursement per scan of our clients may partially offset the increases in scan volume we are working
to achieve for our clients, and indirectly will result in a decline in our revenues.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, the use of radiology benefit managers,
or RBM&#8217;s has increased in recent years. It is common practice for health insurance carriers to contract with RBMs to manage utilization
of diagnostic imaging procedures for their insureds. In many cases, this leads to lower utilization of imaging procedures based on a determination
of medical necessity. The efficacy of RBMs is still a highly controversial topic. We cannot predict whether the use of RBMs will negatively
impact our business, but it is possible that our financial position and results of operations could be negatively affected.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>Discussion of Operating Results of Management of Diagnostic Imaging
Centers</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Fiscal 2025 Compared to Fiscal 2024</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues attributable to the Company&#8217;s physician
and diagnostic services management segment, HMCA, increased to $95.4 million in fiscal 2025 as compared to $94.6 million in fiscal 2024.
The increase in revenues was due to an increase of $1.5 million of management and other fees which was offset from a decrease of patient
fees (net of contractual allowances and discounts) from patient and third-party payers recognized by six of the facilities in Florida
of approximately $636,000. The decrease in patient fees at our Florida locations is a consequence of Florida&#8217;s 2023 Tort Reform
Act. We have seen a decrease in both volume and average reimbursement rate since the act took effect, and we expect that trend to continue
for the immediate future.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of revenues as a percentage of the related revenues
for our physician and diagnostic services management segment increased from $53.0 million or 56.0% of related revenues for the year ended
June 30, 2024 to $55.6 million, or 58.3% of related revenues for the year ended June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Operating results of this segment decreased from operating
income of $23.5 million in fiscal 2024 to operating income of $19.2 million in fiscal 2025. The decrease is due mainly to taking a large
reserve for the American Transit Insurance Company business along with increased expenses in the form of staffing costs, equipment repair
costs and helium replacement costs. We believe that our efforts to expand and improve the operation of our physician and diagnostic services
management segment are directly responsible for the profitability of this segment and our company as a whole.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the fiscal year ended June 30, 2025, 11.5% of
total revenues were derived from contracts with facilities that are currently owned by Timothy Damadian, the Chief Executive Officer of
FONAR as compared to 11.6% of total revenues were derived from these contracts for the 2024 fiscal year. The agreements with these MRI
facilities are for one-year terms which renew automatically on an annual basis, unless terminated. The fees for these sites, which are
located in Florida, are flat monthly fees.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Discussion of Operating Results of Medical Equipment
- Manufacturing and Service of MRI Equipment</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fiscal 2025 Compared to Fiscal 2024</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues attributable to our medical equipment segment
increased to $9.0 million in fiscal 2025 as compared to $8.4 million in fiscal 2024, with product sales revenues decreasing by 23.6% from
$738,000 in fiscal 2024 to $563,000 in fiscal 2025. Service revenue increased by 10.8% from $7.6 million in fiscal 2024 to $8.4 million
in fiscal 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lower reimbursement rates have reduced the demand
for our MRI products, resulting in lower sales volumes. As a result of fewer sales, service revenues have decreased since as older scanners
are taken out of service, there are fewer new scanners available to sign service contracts.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The operating loss for the medical equipment segment
increased from an operating loss of $7.0 million in fiscal 2024 to an operating loss of $7.6 million in fiscal 2025. The losses are attributable
most significantly to the fact that costs increased by a greater amount than revenues.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The increase in costs was the result of several factors.
We made a significant investment into developing the capacity to service MRI equipment manufactured by third manufacturers through our
Opus Diagnostic Services, LLC subsidiary. We made additional investments into sales and marketing of image enhancement software SwiftMR<sup>TM</sup>
pursuant to our distribution agreement with AIRS Medical USA, Inc. We hope these ventures will develop into a viable source of new revenue
in the future.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development expenses decreased to $1.6
million in fiscal 2025 from $1.7 million in fiscal 2024. Our expenses for fiscal 2025 represented continued research and development of
various upgrades for the Upright&#174; MRI scanner.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>LIQUIDITY AND CAPITAL RESOURCES</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash, and cash equivalents remained constant at $56.3
million at June 30, 2025 and June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash provided by operating activities for fiscal 2025
was approximately $11.3 million. Cash provided by operating activities was attributable to the consolidated net income of $10.7 million,
adjusted primarily for depreciation and amortization of $4.7 million, provision for credit losses of $3.2 million, and an increase in
other current liabilities of $2.7 million which was offset by the increase in accounts, and medical and management fee receivables of
$9.0 million and an increase in prepaid expenses and other current assets of $1.2 million.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash used in investing activities for fiscal 2025
was approximately $3.8 million. The cash used in investing activities was attributable to purchases of property and equipment of $3.8
million, costs of patents of $25,325, offset by proceeds from short term investments of $15,608. The majority of the purchases of property
and equipment was due to the addition of an additional high field scanners at two existing centers.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash used in financing activities for fiscal 2025
approximated $7.5 million. The principal uses of cash used in financing activities included the repayment of borrowings and capital lease
obligations of $113,940, purchase of treasury stock of $1.8 million and distributions to non-controlling interests of $5.7 million which
was offset by the sale of noncontrolling interests of $132,000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Total liabilities decreased by 1.2% during fiscal
2025 from approximately $57.5 million at June 30, 2024 to approximately $56.8 million at June 30, 2025.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At June 30, 2025, we had working capital of approximately
$127.5 million as compared to working capital of $122.5 million at June 30, 2024, and equity of $160.1 million at June 30, 2025 as compared
to equity of $156.8 million at June 30, 2024. This resulted from an increase in current assets ($140.3 million at June 30, 2024 as compared
to $144.7 million at June 30, 2025), and a decrease in current liabilities from $17.9 million at June 30, 2024 to $17.1 million at June
30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our principal sources of liquidity are derived from
revenues.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our business plan includes a program for manufacturing,
selling, maintaining and repairing our Upright&#174; MRI scanners. In addition, we generate the majority of our revenue by participating
in the physician and diagnostic services management business through our subsidiary, HMCA. As of June 30, 2025, HMCA manages a total of
44 MRI scanners of which 26 MRI scanners are located in New York and 18 are located in Florida.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our business plan also calls for a continuing emphasis
on providing our customers with enhanced equipment service and maintenance capabilities and delivering state-of-the-art, innovative and
high quality equipment upgrades at competitive prices. Fees for on-going service and maintenance from our installed base of scanners were
$7.6 million for the year ended June 30, 2024 and $8.4 million for the year ended June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to promote profitability and to reduce demands
on our cash and other liquid reserves, we maintain an aggressive program of cost containment. Previously, these measures included consolidating
HMCA&#8217;s office space with FONAR&#8217;s office space and reducing the size of our workforce, compensation and benefits. We continue
to attempt to contain expenses across the board, despite significant increases in the cost of labor and materials as the result of inflation.
The cost control efforts are intended to keep expenditures at levels which can be supported by service revenues and HMCA revenues. To
this end, in February 2024, we have formed a subsidiary, Opus Diagnostic Management, LLC, to provide in-house repair and maintenance of
third party manufactured MRI equipment that we operate. We hope this entity will contain the maintenance and repair costs of our equipment
fleet, and eventually expand into providing service to outside entities, including third party equipment operated by FONAR&#8217;s existing
installed base.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Current economic credit conditions have contributed
to a slower than optimal business environment. As a result our business may suffer, should the credit markets not improve in the near
future. The direct impact of these conditions is not fully known.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues from HMCA have been the principal reason
for our profitability, and we have so far been able to maintain such revenues by increasing the number of scans being performed by the
sites we manage and those we own, notwithstanding reductions in reimbursement rates and increases in operating costs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Capital expenditures for fiscal 2025 approximated
$3.8 million and capitalized patent costs were approximately $25,000. Purchases of property and equipment were approximately $3.8 million.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have committed to making material capital expenditures
in the 2026 fiscal year. We expect to complete the installation of an additional high field scanner in Lynbrook, New York in the first
quarter of fiscal 2026.The capital expenditures for this project will approximate $1.5 million for the purchase of a new scanner. We also
intend to open an additional location in New York, and we hope to have that center operational before the end of the fiscal year. The
expected cost of this project will approximate $400,000 for the purchase of a new scanner and related buildout costs to be approximately
$500,000.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believes that its business plan has been
responsible for the past five consecutive fiscal years of profitability (fiscal 2025, fiscal 2024, fiscal 2023, fiscal 2022 and fiscal
2021), our current cash balance of $56. 3 million, along with a working capital of $127. 5 million and its capital resources will be adequate
to support operations at current levels through September 30, 2026.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a stock
repurchase plan. On September 26, 2022, the Board of Directors has approved up to $9 million to be repurchased under the plan which will
be purchased on the open market at prevailing prices. During fiscal 2025, we repurchased 114,588 shares for $1.8 million. Since the adoption
of the repurchase plan, the Company has repurchased 373,942 shares for $6.1 million.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_011"></span>ITEM 7A. QUALITATIVE AND QUANTITATIVE DISCLOSURES
ABOUT MARKET RISK</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have any significant investments
in marketable securities, foreign currencies, mutual funds, certificates of deposit or other fixed rate instruments. The Company currently
has 2 certificates of deposits totaling approximately $120,000 with maturities under 1 year. Most of our funds are in cash accounts or
money market accounts which are liquid. The Company has been investing in short term Treasury bills with a maturity date of 90 days or
less.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of our revenue, expense and capital purchasing
activities are transacted in United States dollars.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_012"></span>ITEM 8. &#8211; FINANCIAL STATEMENTS AND FOOTNOTES</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">PAGE</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="#b_001">REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</a></span></td>
<td style="text-align: right; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">36</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><a href="#b_002">CONSOLIDATED BALANCE SHEETS As of June 30, 2025 and 2024</a></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">43</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td><a href="#b_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">CONSOLIDATED STATEMENTS OF OPERATIONS For the Years Ended June 30, 2025 and 2024</span></a></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">46</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td><a href="#b_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">CONSOLIDATED STATEMENTS OF EQUITY For the Years Ended June 30, 2025 and 2024</span></a></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">48</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td><a href="#b_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">CONSOLIDATED STATEMENTS OF CASH FLOWS For the Years Ended June 30, 2025 and 2024</span></a></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">51</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td><a href="#b_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></a></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">53</span></td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b><span id="b_001"></span>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To the Shareholders and Board of Directors of</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR Corporation and Subsidiaries</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Opinion on the Financial Statements</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have audited the accompanying consolidated balance
sheet of FONAR Corporation and Subsidiaries (the &#8220;Company&#8221;) as of June 30, 2025 and the related consolidated statements of
income, stockholders&#8217; equity and cash flows for the year then ended, and the related notes (collectively referred to as the &#8220;financial
statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company
as of June 30, 2025, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles
generally accepted in the United States of America.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We also have audited, in accordance with the standards
of the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;), the Company&#8217;s internal control over financial
reporting as of June 30, 2025, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee
of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;), and our report dated September 19, 2025 expressed an adverse
opinion.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis for Opinion</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our
audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conducted our audit in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation
of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Critical Audit Matters</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The critical audit matters communicated below are
matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the
audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially
challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the
financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions
on the critical audit matters or on the accounts or disclosures to which they relate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Medical Receivable &#8211; Refer to Note 2 to the
financial statements</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><i>Critical
Audit Matter Description</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net realizable value of patient fee revenue and medical
receivables are due under fee-for-service contracts from third-party payors, such as hospitals, government sponsored healthcare programs,
patients legal counsel, and directly from patients. Medical receivables are recorded at net realizable value based on the estimated amounts
the Company expects to receive from patients and third-party payors. The medical receivable is reduced by contractual adjustments estimated
by management based on historical experience with each payor class at each location. Given these factors, the related audit effort in
evaluating management&#8217;s judgments in determining the medical receivables was challenging, subjective, and complex and required a
high degree of auditor judgment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><i>How the
Critical Audit Matter Was Addressed in the Audit</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit procedures related to the net realizable
value of patient fee revenues and medical receivables included the following:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We tested the effectiveness of internal controls related to the measurement of patient fee revenue and
medical receivables.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We evaluated management&#8217;s significant accounting policies related to patient fee revenue for reasonableness.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We tested information technology general controls around the Company&#8217;s billing system and associated
database.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We tested the underlying data related to the recognition of patient level charges and the subsequent activities,
including cash collections and non-cash adjustments.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We tested the estimated contractual adjustments set forth by the third-party payors.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We tested the mathematical accuracy of the estimates applied to patient fee revenue and medical receivables.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Management Fees Receivable &#8211; Refer to Note
2 to the financial statements.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management
fees outstanding from the related and non-related professional corporations (&#8220;PCs&#8221;) under management agreements. The Company
has established a current expected credit loss (&#8220;CECL&#8221;) to address the risk that a portion of the contractually obligated
management fees receivable from the PCs may not be paid. The PCs may be limited in their ability to pay the full management fee receivable
if they do not collect sufficient expected fees from third-party payors and patients. The Company&#8217;s management fees are collateralized,
individually and collectively, by the assets of the PCs. The CECL is determined based on the difference between the management fee receivable
and the current amount of outstanding fees estimated to be collected by the PCs. The Company&#8217;s considerations into the estimate
of the PCs&#8217; fee collection include historical loss rates to pools of receivables with similar risks characteristics, current and
forward-looking economic conditions, and the financial condition of each PC. Given these factors, the related audit effort in evaluating
management&#8217;s judgments in determining CECL was challenging, subjective, and complex and required a high degree of auditor judgment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><i>How the
Critical Audit Matter Was Addressed in the Audit</i></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit procedures related to the CECL estimate
of management fees receivable included the following:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We tested the effectiveness of internal controls that address the risk of material misstatement related
to the measurement of the CECL estimate.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We evaluated management&#8217;s significant accounting policies related to CECL for reasonableness.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We tested that management fees for the year agreed with the executed management fee contracts with each
PC.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We tested information technology general controls surrounding the billing system utilized by the PCs.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">-</td><td style="text-align: justify">We tested the mathematical accuracy of the calculations used to determine the CECL estimate.</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have served as the auditors since 2025</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">/s/ <span id="xdx_90E_edei--AuditorName_c20240701__20250630_ztApHAMD0OQb"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000060" name="dei:AuditorName">CohnReznick LLP</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_904_edei--AuditorLocation_c20240701__20250630_zV7LjqUG4Wkg"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000061" name="dei:AuditorLocation">Melville, NY</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">September 22, 2025</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<span id="xdx_908_edei--AuditorFirmId_c20240701__20250630_zls59V1c2lp7" style="display: none"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000062" name="dei:AuditorFirmId">596</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">To the Board of Directors and<br/>
Stockholders of FONAR Corporation and Subsidiaries</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Adverse Opinion on Internal Control over Financial
Reporting</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have audited FONAR Corporation and Subsidiaries&#8217;
(the Company&#8217;s) internal control over financial reporting as of June 30, 2025, based on criteria established in <i>Internal Control&#8212;Integrated
Framework (2013)</i> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, because of
the effect of the material weakness described in the following paragraph on the achievement of the objectives of the control criteria,
the Company has not maintained effective internal control over financial reporting as of June 30, 2025, based on criteria established
in <i>Internal Control&#8212;Integrated Framework (2013)</i> issued by COSO.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A material weakness is a control deficiency, or a
combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material
misstatement of the Company&#8217;s annual or interim consolidated financial statements will not be prevented or detected on a timely
basis. The following material weakness has been identified and included in management&#8217;s assessment. Management has identified a
material weakness in logical access within its systems supporting the Company&#8217;s accounting and reporting processes.&#160;This material
weakness was considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2025 consolidated financial
statements, and this report does not affect our report dated September 19, 2025, on those consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We also have audited, in accordance with the standards
of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet and the related consolidated
statements of income, stockholders&#8217; equity, and cash flows of the Company as of and for the year ended June 30, 2025, and our report
dated September 19, 2025 expressed an unqualified opinion.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis for Opinion</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s management is responsible for
maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over
financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility
is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting
firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conducted our audit in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal
control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included
obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing
and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing
such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Definition and Limitations of Internal Control
over Financial Reporting</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A company&#8217;s internal control over financial
reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control
over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and
that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the
company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition
of the company&#8217;s assets that could have a material effect on the consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because of its inherent limitations, internal control
over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">/s/
CohnReznick LLP</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">Melville, NY</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">September 22,
2025&#160;</p>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Report of Independent Registered Public Accounting
Firm</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To the Stockholders and Board of Directors of&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fonar Corporation and Subsidiaries</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Opinion on the Financial Statements</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have audited, before the effects of the retrospective
adjustments to the disclosures for the adoption of ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures
(&#8220;ASU 2023-07&#8221;) discussed in Notes 2 and 15 and before the effects of the retrospective adjustments to the disclosures for
the adoption of ASU 2023-09, Improvements to Income Tax Disclosures discussed in Notes 2 and 10 to the consolidated financial statements,
the accompanying consolidated balance sheet of Fonar Corporation and Subsidiaries (the &#8220;Company&#8221;) as of June 30, 2024, the
related consolidated statements of income, stockholders&#8217; equity and cash flows for the year ended June 30, 2024, and the related
notes (collectively referred to as the &#8220;financial statements&#8221;) (the 2024 financial statements before the effects of the adjustments
discussed in Notes 2 and 10 and 15 to the financial statements are not presented herein). In our opinion, the June 30, 2024 financial
statements before the effects of the retrospective adjustments to the disclosures for the adoption of ASU 2023-07 discussed in Notes 2
and 15 to the financial statements and before the effects of the retrospective adjustments to the disclosures for the adoption of ASU
2023-09 discussed in Notes 2 and 10 to the financial statements, the financial statements present fairly, in all material respects, the
financial position of the Company as of June 30, 2024, and the results of its operations and its cash flows for the year ended June 30,
2024, in conformity with accounting principles generally accepted in the United States of America.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We were not engaged to audit, review, or apply any
procedures to the retrospective adjustments to the disclosures for the adoption of ASU 2023-07 discussed in Notes 2 and 15 and we were
not engaged to audit, review, or apply any procedures to the retrospective adjustments to the disclosures for the adoption of ASU 2023-09
discussed in Notes 2 and 10.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Basis for Opinion</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our
audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We conducted our audit in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal
control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal
control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. we believe that our audit provides a reasonable basis for our opinion.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">/s/Marcum LLP</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-variant: small-caps">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_902_edei--AuditorName_c20230701__20240630_zS6mCjtzKOX7"><ix:nonNumeric contextRef="From2023-07-012024-06-30" id="Fact000063" name="dei:AuditorName">Marcum LLP</ix:nonNumeric></span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-variant: small-caps">&#160;</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We served as the Company&#8217;s auditor from 1990, such date takes into
account the merger of Tabb, Conigliaro, McGann, P.C. (&#8220;Tabb&#8221;) into another firm in approximately 2001 and the former partners
of Tabb joining Marcum LLP in 2002 to 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_90E_edei--AuditorLocation_c20230701__20240630_zOjZkyTmRXr4"><ix:nonNumeric contextRef="From2023-07-012024-06-30" id="Fact000064" name="dei:AuditorLocation">New York, NY</ix:nonNumeric></span><br/>
September 27, 2024</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;<span id="xdx_90B_edei--AuditorFirmId_c20230701__20240630_znpqiTeVZpAj" style="display: none"><ix:nonNumeric contextRef="From2023-07-012024-06-30" id="Fact000065" name="dei:AuditorFirmId">688</ix:nonNumeric></span><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_002"></span>CONSOLIDATED BALANCE SHEETS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">ASSETS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_111_zTZlkmepPj7a" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49E_20250630_zELqdYZTEwLf" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_492_20240630" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_iB_zuf70lUorLf3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Current Assets:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_maACzhK1_z6okRh6sedti" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt">Cash and cash equivalents</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2025-06-30" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,333,636</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-06-30" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,341,193</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ShortTermInvestments_i01I_maACzhK1_zh2ZhtFUsMWb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Short-term investments</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2025-06-30" id="Fact000073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">120,494</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2024-06-30" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">136,102</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--AccountsReceivableNetCurrent_i01I_maACzhK1_zJHknfbRqEH" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Accounts receivable &#8211; net of allowances for credit losses of $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20250630_z72nQ7pBW0C7" title="Accounts receivable - net of allowances for credit losses"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2025-06-30" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">264,212</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20240630_zn6dvxC86hIb" title="Accounts receivable - net of allowances for credit losses"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" contextRef="AsOf2024-06-30" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">166,049</ix:nonFraction></span> at June 30, 2025 and 2024, respectively</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2025-06-30" id="Fact000076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,304,698</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-06-30" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,035,336</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--MedicalReceivable_i01I_maACzhK1_zWOIRsnLLJKb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Medical receivables</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2025-06-30" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,489,808</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2024-06-30" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,991,533</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AccruedFeesAndOtherRevenueReceivable_i01I_maACzhK1_zMhM2JoQ01m7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Management and other fees receivable &#8211; net of allowances for credit losses of $<span id="xdx_90F_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_c20250630_zGkA2Q7yHpy3" title="Management and other fees receivable - net of allowances for credit losses"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2025-06-30" id="Fact000089" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,295,988</ix:nonFraction></span> and $<span id="xdx_90B_ecustom--ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_iI_c20240630_zJViHCPh7Ji9" title="Management and other fees receivable - net of allowances for credit losses"><ix:nonFraction name="FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2024-06-30" id="Fact000091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,369,921</ix:nonFraction></span> at June 30, 2025 and 2024, respectively</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedFeesAndOtherRevenueReceivable" contextRef="AsOf2025-06-30" id="Fact000086" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,401,252</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedFeesAndOtherRevenueReceivable" contextRef="AsOf2024-06-30" id="Fact000087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,953,657</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_maACzhK1_zA5TFoX8CLje" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for credit losses of $<span id="xdx_904_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_c20250630_ziXItdF5N7ql" title="Management and other fees receivable - related party medical practices - net of allowances for credit losses"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2025-06-30" id="Fact000096" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,136,836</ix:nonFraction></span> and $<span id="xdx_90B_ecustom--RelatedPartyReceivableAllowancesForDoubtfulAccounts_iI_c20240630_zEoDwZMPFnQ8" title="Management and other fees receivable - related party medical practices - net of allowances for credit losses"><ix:nonFraction name="FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts" contextRef="AsOf2024-06-30" id="Fact000098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,110,399</ix:nonFraction></span> at June 30, 2025 and 2024, respectively</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2025-06-30" id="Fact000093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,748,521</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2024-06-30" id="Fact000094" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,865,061</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--InventoryNet_i01I_maACzhK1_z9OOGbgClc87" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Inventories - net</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2025-06-30" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,812,682</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-06-30" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,715,441</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--PrepaidExpensesAndOtherCurrentAssetsRelatedParty_i01I_maACzhK1_zXJxZa8ubTD3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Prepaid expenses and other current assets &#8211; related party</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:PrepaidExpensesAndOtherCurrentAssetsRelatedParty" contextRef="AsOf2025-06-30" id="Fact000103" format="ixt:numdotdecimal" decimals="0" unitRef="USD">410,659</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0104">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maACzhK1_zJtSwIPLBN0k" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Prepaid expenses and other current assets</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2025-06-30" id="Fact000106" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,050,060</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,285,962</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--AssetsCurrent_i01TI_mtACzhK1_maAzsfb_z0z3l1onk3Z" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Current Assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2025-06-30" id="Fact000109" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,671,810</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,324,285</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--AccountsReceivableNetLongTerm_i01I_maAzsfb_zXsJ6xXJNsDl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Accounts receivable &#8211; long term</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2025-06-30" id="Fact000112" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,549,956</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2024-06-30" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">829,473</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--NoteReceivableRelatedParty_i01I_d0_maAzsfb_zx3KLejJR4fg" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Note receivable &#8211; related party</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:NoteReceivableRelatedParty" contextRef="AsOf2025-06-30" id="Fact000115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">554,857</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:NoteReceivableRelatedParty" contextRef="AsOf2024-06-30" id="Fact000116" format="ixt:numdotdecimal" decimals="0" unitRef="USD">581,183</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_maAzsfb_zvasPR4ICJR1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Deferred income tax asset</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2025-06-30" id="Fact000118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,349,194</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2024-06-30" id="Fact000119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,223,255</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maAzsfb_z2nQlITvBpkh" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Property and equipment &#8211; net</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2025-06-30" id="Fact000121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,531,919</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30" id="Fact000122" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,708,920</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maAzsfb_zfB9Nmd8PiEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Right-of-use-asset &#8211; operating leases</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2025-06-30" id="Fact000124" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,136,412</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,427,757</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_maAzsfb_zipL7GpgwnMi" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Right-of-use-asset &#8211; finance lease</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2025-06-30" id="Fact000127" format="ixt:numdotdecimal" decimals="0" unitRef="USD">376,569</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">530,348</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--Goodwill_i01I_maAzsfb_zZk1ISC9pSN6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-indent: -10pt">Goodwill</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2025-06-30" id="Fact000130" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,269,277</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-06-30" id="Fact000131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,269,277</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maAzsfb_za4jERywBj95" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Other intangible assets &#8211; net</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2025-06-30" id="Fact000133" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,992,203</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-06-30" id="Fact000134" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,870,324</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OtherAssets_i01I_maAzsfb_znbPJeQ9BK54" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Other assets</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2025-06-30" id="Fact000136" format="ixt:numdotdecimal" decimals="0" unitRef="USD">475,680</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2024-06-30" id="Fact000137" format="ixt:numdotdecimal" decimals="0" unitRef="USD">481,147</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--Assets_i01TI_mtAzsfb_zNw7awgMxrLb" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Assets</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2025-06-30" id="Fact000139" format="ixt:numdotdecimal" decimals="0" unitRef="USD">216,907,877</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-06-30" id="Fact000140" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,245,969</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED BALANCE SHEETS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">LIABILITIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_iB_ziJPJQBZEqih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Current Liabilities:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--LongTermDebtCurrent_i01I_maLCzeS8_zKD5skYyKYAk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt">Current portion of long-term debt</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0145">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2024-06-30" id="Fact000146" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,002</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--AccountsPayableCurrent_i01I_maLCzeS8_zWQ3K8V4hAe4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Accounts payable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2025-06-30" id="Fact000148" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,302,317</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-06-30" id="Fact000149" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,855,879</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i01I_maLCzeS8_zUAEXYHdGATc" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Other current liabilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2025-06-30" id="Fact000151" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,974,997</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000152" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,941,039</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_maLCzeS8_zc03I9MPL9Nb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Operating lease liabilities &#8211; current portion</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2025-06-30" id="Fact000154" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,382,675</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000155" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,473,674</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityCurrent_i01I_maLCzeS8_zl6Ekr0eGxe" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Finance lease liability &#8211; current portion</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2025-06-30" id="Fact000157" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,237</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000158" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,786</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredRevenueCurrent_i01I_maLCzeS8_z7y5Vje6jqC6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Unearned revenue on service contracts</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2025-06-30" id="Fact000160" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,865,936</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-06-30" id="Fact000161" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,870,229</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--CustomerDeposits_i01I_maLCzeS8_z5bqjupOC43d" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Customer deposits</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2025-06-30" id="Fact000163" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,244</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2024-06-30" id="Fact000164" format="ixt:numdotdecimal" decimals="0" unitRef="USD">443,471</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzeS8_maLzwsF_zPgsVRgJpLEh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Current Liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2025-06-30" id="Fact000166" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,124,406</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000167" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,857,080</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zNLrFC4RlzS1" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Long-Term Liabilities:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredRevenueNoncurrent_i01I_maLNz0h3_zCx1to3223Ac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Unearned revenue on service contracts</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2025-06-30" id="Fact000172" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,800,746</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2024-06-30" id="Fact000173" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,174,844</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_maLNz0h3_zg5QunyOf59b" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Deferred income tax liability</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2025-06-30" id="Fact000175" format="ixt:numdotdecimal" decimals="0" unitRef="USD">321,159</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact000176" format="ixt:numdotdecimal" decimals="0" unitRef="USD">371,560</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--AccountsPayableRelatedPartyNoncurrent_i01I_maLNz0h3_zbmgiGMa2wg7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Due to related party medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2025-06-30" id="Fact000178" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,663</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2024-06-30" id="Fact000179" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,663</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLNz0h3_zXRPg9CQMPs4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Operating lease liabilities &#8211; net of current portion</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2025-06-30" id="Fact000181" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,148,907</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000182" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,467,746</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_maLNz0h3_zEqcxoRmaJe4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Finance lease liability &#8211; net of current portion</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2025-06-30" id="Fact000184" format="ixt:numdotdecimal" decimals="0" unitRef="USD">142,523</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000185" format="ixt:numdotdecimal" decimals="0" unitRef="USD">394,723</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--LongTermDebtNoncurrent_i01I_maLNz0h3_zYFtakxMfPMf" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Long-term debt, less current portion</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0187">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2024-06-30" id="Fact000188" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,938</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OtherLiabilities_i01I_maLNz0h3_zlioEbEpabHc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Other liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2025-06-30" id="Fact000190" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,853</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2024-06-30" id="Fact000191" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,026</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--LiabilitiesNoncurrent_i01TI_mtLNz0h3_maLzwsF_zXmyXu5Kz6Fh" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Long-Term Liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2025-06-30" id="Fact000193" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,678,851</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact000194" format="ixt:numdotdecimal" decimals="0" unitRef="USD">39,600,500</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--Liabilities_i01TI_mtLzwsF_maLASEzyw7_z23CGybEiyP9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">$</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2025-06-30" id="Fact000196" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,803,257</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">$</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-06-30" id="Fact000197" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,457,580</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Commitments and Contingencies</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED BALANCE SHEETS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">EQUITY</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Equity:</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt">Class A non-voting preferred stock $<span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z0CMjtcAkYTe" title="Preferred stock, par value"><span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zpX0eFIwF4wc" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000202" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000204" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_c20250630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zarzXFSmFkB2" title="Preferred stock, shares authorized"><span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z6Irfdnjv3i1" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000206" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000208" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">453,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2025 and 2024, <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20250630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zkNJYGeX49Q2" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20250630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zPvcSRLbmMyi" title="Preferred stock, shares outstanding"><span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zwjVcjZWsaI1" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zNEhRrP1l023" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000210" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000212" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000214" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000216" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding at June 30, 2025 and 2024</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--PreferredStockValue_i01I_maSEzM9Y_c20250630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zbLL2maY63r2" title="Preferred stock value" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000218" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--PreferredStockValue_i01I_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zVfQRw9HCeXl" title="Preferred stock value" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember" id="Fact000220" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">&#160;Preferred stock $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zSRQCxkZNpr5" title="Preferred stock, par value"><span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zkyqZYZrcWyg" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember" id="Fact000222" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000224" decimals="INF" unitRef="USDPShares">.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zRMPlh09Lexb" title="Preferred stock, shares authorized"><span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zpvVMHO4iPHf" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember" id="Fact000226" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000228" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2025 and 2024, issued and outstanding &#8211; <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_dn_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zwIyDJXXtET4" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zN5LHxwFYsW8" title="Preferred stock, shares outstanding"><span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_dn_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zN7Nu9YaSQY2" title="Preferred stock, shares issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_dn_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zvfFzVRSstP3" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember" id="Fact000230" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember" id="Fact000232" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000234" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000236" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--PreferredStockValue_i01I_d0_maSEzM9Y_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z9R53cBCTqA8" title="Preferred stock value" style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember" id="Fact000238" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--PreferredStockValue_i01I_d0_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zNfUIfJ3Kmv7" title="Preferred stock value" style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember" id="Fact000240" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Common stock $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgSDrD1uxGpa" title="Common stock, par value"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zvaFKiKxQZ36" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" id="Fact000242" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000244" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbXW7b0pwB0j" title="Common stock, shares authorized"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLzGvqGJAmi5" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" id="Fact000246" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000248" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,500,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2025 and 2024, <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcnURcFCtmA" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" id="Fact000250" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,203,465</ix:nonFraction></span> and <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0ab318MQ4V1" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000252" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,328,494</ix:nonFraction></span> issued at June 30, 2025 and 2024, respectively <span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdTBmppcwhi8" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" id="Fact000254" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,168,625</ix:nonFraction></span> and <span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3vlMHpgptBe" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000256" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,283,213</ix:nonFraction></span> outstanding at June 30, 2025 and 2024, respectively</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--CommonStockValue_i01I_maSEzM9Y_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zquDtyzZvcl5" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" id="Fact000258" format="ixt:numdotdecimal" decimals="0" unitRef="USD">622</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--CommonStockValue_i01I_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgCqQU69wxt3" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000260" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Class B convertible common stock (10 votes per share) $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zvuth1DS4P81" title="Common stock, par value"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z3PDojPwhHi3" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember" id="Fact000262" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000264" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zj7LtXjuehFi" title="Common stock, shares authorized"><span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKNLkn7OBMW3" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember" id="Fact000266" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000268" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">227,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2025 and 2024, <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zQhGbThasaRa" title="Common stock, shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zG5bRsCu7we6" title="Common stock, shares outstanding"><span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9pti7rgRks2" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zDkyuIsbTRyb" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember" id="Fact000270" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember" id="Fact000272" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000274" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000276" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding at June 30, 2025 and 2024</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--CommonStockValue_i01I_d0_maSEzM9Y_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z31aZKNvbtsf" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember" id="Fact000278" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--CommonStockValue_i01I_d0_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzmmBzS5169l" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact000280" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Class C common stock (25 votes per share) $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3U2EskNC0w2" title="Common stock, par value"><span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zGQvCQlQk0Oc" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember" id="Fact000282" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000284" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxjn3inBFzhl" title="Common stock, shares authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zGJeOyUM7tsd" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember" id="Fact000286" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000288" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">567,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at June 30, 2025 and 2024, <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEKlm1qgI158" title="Common stock, shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4qOylUd39t5" title="Common stock, shares outstanding"><span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2WouVCI1Xuj" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zS2Qn7Zj2qPb" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember" id="Fact000290" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember" id="Fact000292" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000294" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000296" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding at June 30, 2025 and 2024</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--CommonStockValue_i01I_maSEzM9Y_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1xEysAJs8Df" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember" id="Fact000298" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--CommonStockValue_i01I_maSEzM9Y_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYHpLd5Sd1D3" title="Common stock value" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember" id="Fact000300" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_i01I_maSEzM9Y_z4cm58WLoy55" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Paid-in capital in excess of par value</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2025-06-30" id="Fact000302" format="ixt:numdotdecimal" decimals="0" unitRef="USD">178,756,712</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-06-30" id="Fact000303" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,607,510</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maSEzM9Y_zNMl4fgn6e58" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Accumulated deficit</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2025-06-30" id="Fact000305" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,289,324</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-06-30" id="Fact000306" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,623,585</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--TreasuryStockValue_i01NI_di_msSEzM9Y_zGgKALsK1rW4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Treasury stock, at cost &#8211; <span id="xdx_90C_eus-gaap--TreasuryStockCommonShares_iI_c20250630_zhPo4Zi2FsW" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2025-06-30" id="Fact000311" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,840</ix:nonFraction></span> and <span id="xdx_90A_eus-gaap--TreasuryStockCommonShares_c20240630_zmGM8q4cDzy2" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2024-06-30" id="Fact000313" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,081</ix:nonFraction></span> shares of common stock at June 30, 2025 and 2024, respectively</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2025-06-30" id="Fact000308" format="ixt:numdotdecimal" decimals="0" unitRef="USD">859,893</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2024-06-30" id="Fact000309" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,632</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--StockholdersEquity_i01TI_mtSEzM9Y_maSEIPAzuBL_zfqqX4NOgzEg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30" id="Fact000315" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,608,186</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000316" format="ixt:numdotdecimal" decimals="0" unitRef="USD">165,967,997</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--MinorityInterest_i01I_maSEIPAzuBL_zHJmghAdKiVe" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Noncontrolling interests</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2025-06-30" id="Fact000318" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,503,566</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2024-06-30" id="Fact000319" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,179,608</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_409_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_mtSEIPAzuBL_maLASEzyw7_zyP7naL7k4Xh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Equity</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30" id="Fact000321" format="ixt:numdotdecimal" decimals="0" unitRef="USD">160,104,620</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000322" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,788,389</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzyw7_zeghYAZVfaBl" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Liabilities and Equity</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2025-06-30" id="Fact000324" format="ixt:numdotdecimal" decimals="0" unitRef="USD">216,907,877</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000325" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,245,969</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_003"></span>CONSOLIDATED STATEMENTS OF OPERATIONS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_113_zkkVigQFnMY3" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_493_20240701__20250630_zXciZWdfGbmf" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_495_20230701__20240630_zjy2gnYrI8Ni" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_407_eus-gaap--RevenuesAbstract_iB_zOUMx6qONdY5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Revenues</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maRz6Rf_zTp1k0EBKuqk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; width: 56%; text-align: left; text-indent: -10pt">Patient fee revenue &#8211; net of contractual allowances and discounts</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2024-07-01to2025-06-30" id="Fact000330" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,179,446</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2023-07-012024-06-30" id="Fact000331" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,815,796</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--ProductSalesNet_i01_maRz6Rf_zfguNAHZpB5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Product sales</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2024-07-01to2025-06-30" id="Fact000333" format="ixt:numdotdecimal" decimals="0" unitRef="USD">563,296</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2023-07-012024-06-30" id="Fact000334" format="ixt:numdotdecimal" decimals="0" unitRef="USD">737,727</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ServiceAndRepairFeesNet_i01_maRz6Rf_zXfNSDqaK0if" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Service and repair fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2024-07-01to2025-06-30" id="Fact000336" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,234,053</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2023-07-012024-06-30" id="Fact000337" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,452,212</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maRz6Rf_zkH8FG6KDTY7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Service and repair fees &#8211; related parties</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2024-07-01to2025-06-30" id="Fact000339" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2023-07-012024-06-30" id="Fact000340" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,167</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--ManagementAndOtherFeesNet_i01_maRz6Rf_z0L2D7Nl2Yag" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Management and other fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2024-07-01to2025-06-30" id="Fact000342" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,900,555</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2023-07-012024-06-30" id="Fact000343" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,789,287</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maRz6Rf_zTslYmCerkAd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Management and other fees &#8211; related medical practices</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2024-07-01to2025-06-30" id="Fact000345" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,293,968</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2023-07-012024-06-30" id="Fact000346" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,949,900</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--Revenues_iT_mtRz6Rf_maILFCOzRn5_zwvLB06wlev8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Total Revenues &#8211; Net</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-01to2025-06-30" id="Fact000348" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,351,318</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012024-06-30" id="Fact000349" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,884,089</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CostsAndExpensesAbstract_iB_zjjt2IQ33Izl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Costs and Expenses</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--CostsRelatedToProductSales_i01_maCAEzSDb_zH8mmpPRgXGk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Costs related to product sales</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2024-07-01to2025-06-30" id="Fact000354" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,018,029</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2023-07-012024-06-30" id="Fact000355" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,052,159</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCAEzSDb_z70Rh4X6WOc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Costs related to service and repair fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2024-07-01to2025-06-30" id="Fact000357" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,508,518</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2023-07-012024-06-30" id="Fact000358" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,577,570</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCAEzSDb_zUDD5uAzvSr" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Costs related to service and repair fees &#8211; related parties</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2024-07-01to2025-06-30" id="Fact000360" format="ixt:numdotdecimal" decimals="0" unitRef="USD">323,504</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2023-07-012024-06-30" id="Fact000361" format="ixt:numdotdecimal" decimals="0" unitRef="USD">144,413</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OtherCostOfOperatingRevenue_i01_maCAEzSDb_znKLbwmvMILd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Costs related to patient fee revenue</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2024-07-01to2025-06-30" id="Fact000363" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,130,935</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2023-07-012024-06-30" id="Fact000364" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,199,579</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCAEzSDb_zRKb0G8XR78k" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Costs related to management and other fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2024-07-01to2025-06-30" id="Fact000366" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,073,045</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2023-07-012024-06-30" id="Fact000367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,626,595</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_maCAEzSDb_zKF3U5sFMI9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Costs related to management and other fees &#8211; related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2024-07-01to2025-06-30" id="Fact000369" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,388,281</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2023-07-012024-06-30" id="Fact000370" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,143,728</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ResearchAndDevelopmentExpense_i01_maCAEzSDb_zixiOr2hxmW1" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Research and development</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000372" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,576,086</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-012024-06-30" id="Fact000373" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,735,949</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zTOiqPSROTG4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Selling, general and administrative expenses</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,734,163</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2023-07-012024-06-30" id="Fact000376" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,868,732</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CostsAndExpenses_i01T_mtCAEzSDb_msILFCOzRn5_zQsxtzWmUFDd" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Total Costs and Expenses</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2024-07-01to2025-06-30" id="Fact000378" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,752,561</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2023-07-012024-06-30" id="Fact000379" format="ixt:numdotdecimal" decimals="0" unitRef="USD">86,348,725</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtILFCOzRn5_maONIEzqND_zP1dVkoheZP2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Income from Operations</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2024-07-01to2025-06-30" id="Fact000381" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,598,757</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2023-07-012024-06-30" id="Fact000382" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,535,364</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB_z3ks7Hd9nvj1" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Other Income and (Expenses):</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--InterestExpenseNonoperating_iN_di_msONIEzqND_ztdgUawIPbs1" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Interest expense</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2024-07-01to2025-06-30" id="Fact000387" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,611</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-07-012024-06-30" id="Fact000388" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,997</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_408_ecustom--InvestmentIncomeRelatedParty_d0_maONIEzqND_zANr2Dwq7YT9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Interest income &#8211; related party</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:InvestmentIncomeRelatedParty" contextRef="From2024-07-01to2025-06-30" id="Fact000390" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,917</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:InvestmentIncomeRelatedParty" contextRef="From2023-07-012024-06-30" id="Fact000391" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,959</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--InvestmentIncomeNet_maONIEzqND_zzJaOKMx8Nyb" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Investment income</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2024-07-01to2025-06-30" id="Fact000393" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,118,980</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-07-012024-06-30" id="Fact000394" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,126,439</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--OtherIncomeRelatedParty_d0_maONIEzqND_zgKibI1feXg5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Other income &#8211; related party</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:OtherIncomeRelatedParty" contextRef="From2024-07-01to2025-06-30" id="Fact000396" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:OtherIncomeRelatedParty" contextRef="From2023-07-012024-06-30" id="Fact000397" format="ixt:numdotdecimal" decimals="0" unitRef="USD">576,857</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OtherNonoperatingIncomeExpense_maONIEzqND_zPOopPb0iNCk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Other income</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000399" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,195</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-07-012024-06-30" id="Fact000400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,763</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtONIEzqND_maPLzOwn_zpX7o74VIWS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Income before Provision for Income Taxes and Noncontrolling Interests</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000402" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,780,238</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-012024-06-30" id="Fact000403" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,266,385</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msPLzOwn_zMR3vjBlCTia" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Provision for Income Taxes</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact000405" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,106,805</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact000406" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,168,968</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_401_ecustom--ConsolidatedNetIncome_iT_mtPLzOwn_maNILzt1K_zOcqFtJEsDRl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Consolidated Net Income</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ConsolidatedNetIncome" contextRef="From2024-07-01to2025-06-30" id="Fact000408" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,673,433</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ConsolidatedNetIncome" contextRef="From2023-07-012024-06-30" id="Fact000409" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,097,417</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_msNILzt1K_zll5SjyureZ6" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income &#8211; Noncontrolling Interests</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000411" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,339,172</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30" id="Fact000412" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,530,021</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--NetIncomeLoss_iT_mtNILzt1K_zakvphCxhmK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income &#8211; Attributable to FONAR</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2025-06-30" id="Fact000414" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,334,261</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30" id="Fact000415" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,567,396</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED STATEMENTS OF OPERATIONS (Continued)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Net Income Available to Common&#160;Stockholders</td>
<td style="width: 8%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zOuYhiSZOVS2" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember" id="Fact000417" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,802,351</ix:nonFraction></td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 8%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_983_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zGz630UDhkf" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000419" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,908,920</ix:nonFraction></td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income Available to Class A Non &#8211;Voting Preferred Stockholders</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_980_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_zGtiTZ5vuAqa" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012025-06-30_custom_ClassANonVotingPreferredStockholdersMember" id="Fact000421" format="ixt:numdotdecimal" decimals="0" unitRef="USD">396,443</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_986_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockholdersMember_zVc3Av3VklV5" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredStockholdersMember" id="Fact000423" format="ixt:numdotdecimal" decimals="0" unitRef="USD">490,776</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income Available to Class C Common&#160;Stockholders</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgUNCEOfS3db" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember" id="Fact000425" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,467</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zmr3En1VBf78" title="Net Income Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000427" format="ixt:numdotdecimal" decimals="0" unitRef="USD">167,700</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic Net Income Per Common Share Available to Common Stockholders</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_988_eus-gaap--EarningsPerShareBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zmXk6XP6PtW1" title="Basic Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember" id="Fact000429" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.26</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--EarningsPerShareBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zP7PK6BgyE65" title="Basic Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000431" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.56</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Diluted Net Income Per Common Share Available to Common Stockholders</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z1wiZmXArVF3" title="Diluted Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember" id="Fact000433" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.23</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_984_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z96FTN4W4eKe" title="Diluted Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000435" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.53</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic and Diluted Income Per Share &#8211;&#160;Class C Common</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zKb5d4RiTxAg" title="Basic Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLzwIrhZ5lI6" title="Diluted Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember" id="Fact000437" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember" id="Fact000439" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></ix:nonFraction></span></span></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcO9vBPjqgo6" title="Basic Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zVRCil3TBaLe" title="Diluted Net Income Per Common Share Available to Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000441" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000443" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></ix:nonFraction></span></span></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted Average Basic Shares Outstanding &#8211; Common Stockholders</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zEmIoV4lqeP6" title="Weighted Average Basic Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember" id="Fact000445" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,210,852</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zOFJpU3mnJNh" title="Weighted Average Number of Shares Outstanding, Basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000447" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,351,008</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted Average Diluted Shares Outstanding &#8211; Common Stockholders</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_z1fXhE8kRzx4" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember" id="Fact000449" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,338,356</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--CommonStockholdersMember_zqTf6JR1c1vd" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember" id="Fact000451" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,478,512</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted Average Basic and Diluted Shares Outstanding &#8211; Class C Common</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zsD4JxvFkWji" title="Weighted Average Basic Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zwZgDEcA7VGg" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember" id="Fact000453" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember" id="Fact000455" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></ix:nonFraction></span></span></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbg0gNrJd2d" title="Weighted Average Basic Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zqp0kjVYtyFe" title="Weighted Average Diluted Shares Outstanding - Common Stockholders" class="xdx_phnt_U3RhdGVtZW50IC0gQ09OU09MSURBVEVEIFNUQVRFTUVOVFMgT0YgT1BFUkFUSU9OUwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000457" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember" id="Fact000459" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></ix:nonFraction></span></span></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_004"></span>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FOR THE YEARS ENDED JUNE 30, 2025 AND 2024</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_307_114_zfAVYxLMZOrg" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z7tf8Wm7UpPl" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_custom--ClassAPreferredStockMember_zifBozYTGaW5" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Common Stock</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Common Stock Issued (Shares)</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Class A Preferred Stock (Shares)</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Class A Preferred Stock</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Class C Common Stock (Shares)</span></td></tr>
<tr id="xdx_43A_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zkzo3ULvLV6l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 35%; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Balance &#8211; July 1,2023</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">$</span></td>
<td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000461" format="ixt:numdotdecimal" decimals="0" unitRef="USD">647</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_984_eus-gaap--SharesOutstanding_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZ8KTU3jLQjc" title="Beginning balance, shares" style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000464" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,450,882</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--ClassAPreferredStockMember_z3EvpI3ikmrb" title="Beginning balance, shares" style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_ClassAPreferredStockMember" id="Fact000466" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">$</span></td>
<td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_ClassAPreferredStockMember" id="Fact000462" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_989_eus-gaap--SharesOutstanding_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__custom--ClassCCommonStockMember_zsm1g0EWTdwj" title="Beginning balance, shares" style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_ClassCCommonStockMember" id="Fact000468" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--ProfitLoss_zVtF714uxvok" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Net Income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0470">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0471">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zK3KdGTa4eY5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Purchase of Treasury Stock</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0474">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_iN_di_zTK8K7UooB5k" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Cancellation of Treasury Stock</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000476" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9G0U4gpKxhi" title="Cancellation of shares, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000479" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">122,588</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0477">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zyT1UpJi5ihe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Distributions &#8211; Non controlling interest</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0481">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0482">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zdH3pL2cPJXj" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Net Income &#8211; Non controlling interests</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0484">&#8212;</span></span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0485">&#8212;</span></span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20240701__20250630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z3mEAMDBlrzj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Balance &#8211; June 30, 2024</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember516945625" id="Fact000487" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zj9i1ERe06u4" title="Beginning balance, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember516945625" id="Fact000490" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,328,294</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--ClassAPreferredStockMember_z17bvIcti2Fl" title="Beginning balance, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_custom_ClassAPreferredStockMember" id="Fact000492" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_custom_ClassAPreferredStockMember" id="Fact000488" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_982_eus-gaap--SharesOutstanding_iS_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--ClassCCommonStockMember_zFVRT2tyQtC2" title="Beginning balance, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_custom_ClassCCommonStockMember" id="Fact000494" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--ProfitLoss_zwkGSEQBBHQ4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Net Income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0496">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0497">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_z12XUUYV3gu7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Purchase of Treasury Stock</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0499">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0500">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_iN_di_zkuOV6Hvcdq4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Cancellation of Treasury Stock</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000502" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeL8DpoG1Sml" title="Cancellation of shares, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000505" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">124,829</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0503">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--SaleNonControllingInterest_zfTydvf793Z" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Sale &#8211; Non controlling interest</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0507">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0508">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zpXPFK2J5pK1" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Distributions &#8211; Non controlling interest</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0510">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0511">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zpAjDWu0EME9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Net Income &#8211; Non controlling interests</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0513">&#8212;</span></span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl0514">&#8212;</span></span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
<tr id="xdx_434_c20240701__20250630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zyAXIaxatLia" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Balance &#8211; June 30, 2025</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember516945765" id="Fact000516" format="ixt:numdotdecimal" decimals="0" unitRef="USD">622</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zU890NRBksW3" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember516945765" id="Fact000519" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,203,465</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_985_eus-gaap--SharesOutstanding_iE_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--ClassAPreferredStockMember_zNxXwpVtWxC1" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-06-30_custom_ClassAPreferredStockMember" id="Fact000521" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">$</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_custom_ClassAPreferredStockMember" id="Fact000517" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td id="xdx_988_eus-gaap--SharesOutstanding_iE_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--ClassCCommonStockMember_zQV33HzufGFl" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-06-30_custom_ClassCCommonStockMember" id="Fact000523" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FOR THE YEARS ENDED JUNE 30, 2025 AND 2024</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--ClassCCommonStockMember_zMAs3qS8A7i3" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z5xUo8kTGKb" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockCommonMember_zQCkoiNo3Wv9" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Paid-in Capital in Excess of Par Value</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Treasury Stock (Shares)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Treasury Stock</td></tr>
<tr id="xdx_43A_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zuWjmh6OQq48" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-indent: -10pt">Balance &#8211; July 1, 2023</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_ClassCCommonStockMember" id="Fact000525" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000526" format="ixt:numdotdecimal" decimals="0" unitRef="USD">182,612,518</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zIC0sXNaotZa" title="Beginning balance, shares" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000529" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,463</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000527" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">515,820</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--ProfitLoss_znBIlGs0qU79" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0531">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0532">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0533">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zhMznJQSP7qe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Purchase of Treasury Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0535">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0536">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--StockRepurchasedDuringPeriodShares_iP3us-gaap--StockRepurchasedDuringPeriodValue_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_z6fUKPbJLVy" title="Purchase of Treasury Stock, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000539" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,206</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000537" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505,832</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_iN_di_zreKkHRbVmG7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Cancellation of Treasury Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0541">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000542" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,005,008</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zNnZNNgwAUik" title="Cancellation of Treasury Stock, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000545" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">122,588</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000543" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,005,020</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zsjODL9V8oT3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Distributions &#8211; Non controlling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0547">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0548">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0549">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zlSBeKr1qvi2" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income &#8211; Non controlling interests</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0551">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0552">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0553">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_435_c20240701__20250630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z4xumzhJKcO9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Balance &#8211; June 30, 2024</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_custom_ClassCCommonStockMember" id="Fact000555" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000556" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,607,510</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zpFmS5I3Cv3i" title="Beginning balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000559" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,081</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000557" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,016,632</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--ProfitLoss_z7Sgh08AJKtj" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0561">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0562">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0563">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zCvzstUvczi7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Purchase of Treasury Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0565">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0566">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--StockRepurchasedDuringPeriodShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zKpWcxAotSe4" title="Purchase of Treasury Stock, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000569" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">114,588</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000567" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,806,646</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_iN_di_zk3rhdr4YxN8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Cancellation of Treasury Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0571">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000572" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,963,373</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zGuUqAE1nRpc" title="Cancellation of Treasury Stock, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000575" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">124,829</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000573" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,963,385</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--SaleNonControllingInterest_z6jyWqomWCU3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Sale &#8211; Non controlling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0577">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:SaleNonControllingInterest" contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000578" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112,575</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0579">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zrFIqOgbKygl" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Distributions &#8211; Non controlling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0581">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0582">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0583">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zUPwpUn5FMp1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income &#8211; Non controlling interests</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0585">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0586">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_43C_c20240701__20250630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zfi8XR0TA5H7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Balance &#8211; June 30, 2025</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_custom_ClassCCommonStockMember" id="Fact000589" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000590" format="ixt:numdotdecimal" decimals="0" unitRef="USD">178,756,712</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_ziy8JbUdvYqe" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000593" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,840</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000591" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">859,893</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FOR THE YEARS ENDED JUNE 30, 2025 AND 2024</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zvi0TLwy5Xj" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zNwcFFtg8L5j" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_4B6_zhkOVJw6Ll52" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Deficit</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Non Controlling Interests</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td></tr>
<tr id="xdx_430_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zcNeY64yBwNb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 46%; text-indent: -10pt">Balance &#8211; July 1, 2023</td>
<td style="width: 5%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000595" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,190,981</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 5%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000596" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,079,293</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 5%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" id="Fact000597" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,827,140</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ProfitLoss_ze0Q8D2xi2b" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000599" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,567,396</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0600">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30" id="Fact000601" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,567,396</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zSgiHbVSPWw7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Purchase of Treasury Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0603">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0604">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30" id="Fact000605" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505,832</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_iN_di_zPZYfFqzNFEc" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Cancellation of Treasury Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0607">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0608">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0609">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zHQCIuHXrmBh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Distributions &#8211; Non controlling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0611">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000612" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,630,336</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-07-012024-06-30" id="Fact000613" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,630,336</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_z32I4b6Y2yj5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income &#8211; Non controlling interests</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0615">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000616" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,530,021</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30" id="Fact000617" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,530,021</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_433_c20240701__20250630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zZtRNQIVVfuj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Balance &#8211; June 30, 2024</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000619" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,623,585</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000620" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,179,608</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000621" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,788,389</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ProfitLoss_zx83hMuMcIVk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="Fact000623" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,334,261</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0624">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-01to2025-06-30" id="Fact000625" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,334,261</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_z0CLlsvGAwRe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Purchase of Treasury Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0627">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-01to2025-06-30" id="Fact000629" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,806,646</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensationForfeited_iN_di_zazp2bAOsac5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Cancellation of Treasury Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0631">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0632">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="From2024-07-01to2025-06-30" id="Fact000633" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--SaleNonControllingInterest_ziJTEF7fPPj9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Sale &#8211; Non controlling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0635">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:SaleNonControllingInterest" contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000636" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,425</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:SaleNonControllingInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000637" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zHzsqMhyT1S7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Distributions &#8211; Non controlling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0639">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000640" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,682,555</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2024-07-01to2025-06-30" id="Fact000641" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,682,555</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_za3Wkdeptdec" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Income &#8211; Non controlling interests</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0643">&#8212;</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000644" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,339,172</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000645" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,339,172</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_439_c20240701__20250630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zXjI37rgZHfh" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Balance &#8211; June 30, 2025</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_us-gaap_RetainedEarningsMember" id="Fact000647" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,289,324</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_us-gaap_NoncontrollingInterestMember" id="Fact000648" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">12,503,566</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30" id="Fact000649" format="ixt:numdotdecimal" decimals="0" unitRef="USD">160,104,620</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><br/></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_005"></span>CONSOLIDATED STATEMENTS OF CASH FLOWS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_112_zmsTsk9b65Ah" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49E_20240701__20250630_zihWpyPp551" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_491_20230701__20240630_zr2HxvLQYh57" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
<tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zAMJmkXX9os4" style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">CASH FLOWS FROM OPERATING ACTIVITIES</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_402_ecustom--ConsolidatedNetIncomeLoss_maNCPBUzS6D_z8rrRCJNKaxi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Consolidated Net Income</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:ConsolidatedNetIncomeLoss" contextRef="From2024-07-01to2025-06-30" id="Fact000654" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,673,433</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:ConsolidatedNetIncomeLoss" contextRef="From2023-07-012024-06-30" id="Fact000655" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,097,417</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zS0NOPCF8aq8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Adjustments to reconcile consolidated net income to net cash provided by operating activities:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DepreciationAndAmortization_i01_maNCPBUzS6D_zd6kmfbzj8c7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Depreciation and amortization</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-07-01to2025-06-30" id="Fact000660" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,698,321</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-07-012024-06-30" id="Fact000661" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,596,421</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--ProvisionForBadDebts_i01_maNCPBUzS6D_zWdjfkxyUS01" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Provision for credit losses</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2024-07-01to2025-06-30" id="Fact000663" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,206,756</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2023-07-012024-06-30" id="Fact000664" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,882,061</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_maNCPBUzS6D_z0T3IZTG4YH2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Deferred income tax - net</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact000666" format="ixt:numdotdecimal" decimals="0" unitRef="USD">823,660</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact000667" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,795,507</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities_i01N_di_msNCPBUzS6D_z0eynMDqWBb2" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Net change in operating right-of-use assets and lease liabilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="FONR:NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" contextRef="From2024-07-01to2025-06-30" id="Fact000669" format="ixt:numdotdecimal" decimals="0" unitRef="USD">493</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="FONR:NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" contextRef="From2023-07-012024-06-30" id="Fact000670" format="ixt:numdotdecimal" decimals="0" unitRef="USD">229,590</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_403_ecustom--GainOnSaleOfEquipmentRelatedParty_i01N_di_msNCPBUzS6D_zuR0rFlQ7Ivd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Gain on sale of equipment &#8211; related party</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0672">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="FONR:GainOnSaleOfEquipmentRelatedParty" contextRef="From2023-07-012024-06-30" id="Fact000673" format="ixt:numdotdecimal" decimals="0" unitRef="USD">581,183</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_40B_ecustom--GainlossOnDispositionOfFixedAssets_iN_di_msNCPBUzS6D_zmrDVdewVroc" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Gain on disposition of fixed assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0675">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="FONR:GainlossOnDispositionOfFixedAssets" contextRef="From2023-07-012024-06-30" id="Fact000676" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,411</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_40C_ecustom--AbandonedPatents_d0_maNCPBUzS6D_zGmJU0yAZfde" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Abandoned patents</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:AbandonedPatents" contextRef="From2024-07-01to2025-06-30" id="Fact000678" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,707</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:AbandonedPatents" contextRef="From2023-07-012024-06-30" id="Fact000679" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,419</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_zzduuPQHpIM1" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;Changes in operating assets and liabilities, net:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msNCPBUzS6D_zb4AAlS92Vhg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Accounts, medical and management fee receivable(s)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2024-07-01to2025-06-30" id="Fact000684" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,005,766</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-07-012024-06-30" id="Fact000685" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,676,139</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_405_ecustom--IncreaseDecreaseInNotesReceivable_i01_maNCPBUzS6D_zwzeuyVRgnz4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0687">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:IncreaseDecreaseInNotesReceivable" contextRef="From2023-07-012024-06-30" id="Fact000688" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,200</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInNotesReceivableRelatedParties_i01N_di_msNCPBUzS6D_zj591UDNrQkd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Notes receivable &#8211; related party</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInNotesReceivableRelatedParties" contextRef="From2024-07-01to2025-06-30" id="Fact000690" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">26,326</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0691">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msNCPBUzS6D_zCWkE6pnBlO" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Inventories</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2024-07-01to2025-06-30" id="Fact000693" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,241</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-07-012024-06-30" id="Fact000694" format="ixt:numdotdecimal" decimals="0" unitRef="USD">145,775</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i01N_di_msNCPBUzS6D_zhV737RncqTi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Prepaid expenses and other current assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2024-07-01to2025-06-30" id="Fact000696" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,194,922</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-07-012024-06-30" id="Fact000697" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">266,606</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_di_msNCPBUzS6D_zurDDDZRrPo4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Other assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2024-07-01to2025-06-30" id="Fact000699" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,467</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2023-07-012024-06-30" id="Fact000700" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">42,359</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maNCPBUzS6D_zUVwhu3BOiQh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Accounts payable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2024-07-01to2025-06-30" id="Fact000702" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">553,562</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-07-012024-06-30" id="Fact000703" format="ixt:numdotdecimal" decimals="0" unitRef="USD">276,669</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_maNCPBUzS6D_zDq0eHzM1y7b" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Other current liabilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2024-07-01to2025-06-30" id="Fact000705" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,655,567</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2023-07-012024-06-30" id="Fact000706" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,949,962</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--IncreaseDecreaseInCustomerAdvance_i01_maNCPBUzS6D_zLqeb86r6ZVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Customer advances</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2024-07-01to2025-06-30" id="Fact000708" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">89,227</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2023-07-012024-06-30" id="Fact000709" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">158,906</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--IncreaseDecreaseInTradingLiabilities_i01_maNCPBUzS6D_z8hY6W1tPvN1" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt">Finance lease liabilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInTradingLiabilities" contextRef="From2024-07-01to2025-06-30" id="Fact000711" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">79,970</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInTradingLiabilities" contextRef="From2023-07-012024-06-30" id="Fact000712" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">217,569</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_409_eus-gaap--IncreaseDecreaseInOtherAccruedLiabilities_i01_maNCPBUzS6D_zEOSbrR3t0zg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" contextRef="From2024-07-01to2025-06-30" id="Fact000714" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,826</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" contextRef="From2023-07-012024-06-30" id="Fact000715" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,724</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzS6D_maCCERCzgW3_zzyX264FJsO" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">NET CASH PROVIDED BY OPERATING ACTIVITIES</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-07-01to2025-06-30" id="Fact000717" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,264,882</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-012024-06-30" id="Fact000718" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,093,294</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zhOmcYA9AGq2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">CASH FLOWS FROM INVESTING ACTIVITIES</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUzoxO_zQw9UX4fQZB7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Purchases of property and equipment</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2024-07-01to2025-06-30" id="Fact000723" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,791,581</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30" id="Fact000724" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,961</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--PaymentsForProceedsFromShortTermInvestments_i01N_di_msNCPBUzoxO_zMQIjgZWXpfi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Proceeds (Purchase) from short-term investment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2024-07-01to2025-06-30" id="Fact000726" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">15,608</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromShortTermInvestments" contextRef="From2023-07-012024-06-30" id="Fact000727" format="ixt:numdotdecimal" decimals="0" unitRef="USD">103,303</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--ProceedsFromSaleOfPropertyPlantAndEquipment_i01_d0_maNCPBUzoxO_zHyTIPYhiL34" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Proceeds from sale of equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2024-07-01to2025-06-30" id="Fact000729" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" contextRef="From2023-07-012024-06-30" id="Fact000730" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,411</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--PaymentsToAcquireIntangibleAssets_iN_di_msNCPBUzoxO_zqpEmdrJPqP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Cost of patents</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2024-07-01to2025-06-30" id="Fact000732" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,325</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-07-012024-06-30" id="Fact000733" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,885</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtNCPBUzoxO_maCCERCzgW3_zV8XhafgcASh" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">NET CASH USED IN INVESTING ACTIVITIES</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-07-01to2025-06-30" id="Fact000735" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,801,298</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-07-012024-06-30" id="Fact000736" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">850,738</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zP5iFB94NK13" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;&#160;CASH FLOWS FROM FINANCING ACTIVITIES:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msNCPBUzOn6_z4GxMZdzkBIc" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Repayment of borrowings and finance obligations</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2024-07-01to2025-06-30" id="Fact000741" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,940</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2023-07-012024-06-30" id="Fact000742" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,902</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_402_ecustom--SaleOfNoncontrollingInterest_i01_maNCPBUzOn6_zCp71N4BAND1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Sale of noncontrolling interest</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:SaleOfNoncontrollingInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000744" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--PaymentsForRepurchaseOfEquity_i01N_di_msNCPBUzOn6_z1WMKiZN7CLd" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Purchase of treasury stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfEquity" contextRef="From2024-07-01to2025-06-30" id="Fact000747" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,806,646</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfEquity" contextRef="From2023-07-012024-06-30" id="Fact000748" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,505,832</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msNCPBUzOn6_zT3Gwjj0eTL8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Distributions to noncontrolling interests</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000750" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,682,555</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2023-07-012024-06-30" id="Fact000751" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,630,336</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzOn6_maCCERCzgW3_z1dMaGudGci8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">NET CASH USED IN FINANCING ACTIVITIES</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-07-01to2025-06-30" id="Fact000753" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,471,141</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-07-012024-06-30" id="Fact000754" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,181,070</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_mtCCERCzgW3_z9TFO5r6qqQl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;&#160;NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2024-07-01to2025-06-30" id="Fact000756" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,557</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2023-07-012024-06-30" id="Fact000757" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,061,486</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_zF9SlY1XIif4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000759" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,341,193</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000760" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,279,707</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_z7RA1NYYxSma" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">CASH AND CASH EQUIVALENTS - END OF YEAR</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2025-06-30" id="Fact000762" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,333,636</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000763" format="ixt:numdotdecimal" decimals="0" unitRef="USD">56,341,193</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">See accompanying notes to consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="b_006"></span>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000765" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock"><p id="xdx_806_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zm6bDqPEpSSl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1 - <span id="xdx_82F_zAAccN59coej">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Description of Business</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR is a Delaware corporation, which was incorporated
on July 17, 1978. FONAR is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles
of MRI for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue
is also generated from our installed-base of customers through our service and upgrade programs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR, through its wholly-owned subsidiary Health
Management Company of America (&#8220;HMCA&#8221;) provides comprehensive management services to diagnostic imaging facilities. The services
provided by the Company include development, administration, leasing of office space, facilities and medical equipment, provision of supplies,
staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and the development and implementation
of practice growth and marketing strategies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 1, 2015, the Company restructured the corporate
organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely
integrate the operations of Health Management Corporation of America and Health Diagnostics Management (&#8220;HDM&#8221;). Imperial contributed
all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a <span id="xdx_900_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zf3RUtwHRPbg"><ix:nonFraction name="us-gaap:InvestmentOwnedPercentOfNetAssets" contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember" id="Fact000766" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">24.2</ix:nonFraction></span>% interest
in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zpWk0QeY0j8c"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember" id="Fact000767" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">45.8</ix:nonFraction></span>% in HDM, and the original investors in HDM
retained a <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zV44CmBINwsg"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember" id="Fact000768" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">30.0</ix:nonFraction></span>% ownership interest in the newly expanded HDM. As of June 30, 2024 the Company had direct ownership interest of <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zDxMTYcBgfW7"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-06-30_us-gaap_OtherInvesteesMember" id="Fact000769" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">70.8</ix:nonFraction></span>%
and the investors&#8217; a <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zSeUsG2lI1e2"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember" id="Fact000770" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">29.2</ix:nonFraction></span>% ownership interest. During the year ended June 30, 2025, the Company sold non-controlling interests to
a minority shareholder for $<span id="xdx_902_eus-gaap--ProceedsFromPaymentsToMinorityShareholders_c20240701__20250630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zxD6sSrLwat"><ix:nonFraction name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" contextRef="From2024-07-012025-06-30_us-gaap_OtherInvesteesMember" id="Fact000771" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,000</ix:nonFraction></span>. Currently, the Company has a direct ownership interest of <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20250630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zzboe7iRzJn7"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2025-06-30_us-gaap_OtherInvesteesMember" id="Fact000772" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">70.63</ix:nonFraction></span>% and the investors have a <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zRwGl26FSXrd"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2025-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember" id="Fact000773" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">29.37</ix:nonFraction></span>%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under
the name &#8220;Health Management Company of America&#8221;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000775" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zyqDtpRlFKlk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - <span id="xdx_829_zR0YgLo1capg">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000777" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_z5xPkgHj8hYa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_zx6kXp4uZd52">Principles of Consolidation</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zDl4MHGuyLUj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zx4gdJV4lT86" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zonAR6PTOMI3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zEvy670plx0d" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_232_zyBwcIS0uiyf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_231_zs6HS3ZTNlVb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zwNDzTOjDn61" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zjFlJD0pC6Ki" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zRQKt3R4HBu8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000788" name="us-gaap:UseOfEstimates"><p id="xdx_84F_eus-gaap--UseOfEstimates_zYc49DEOlEDc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zYgLacFU6f57">Use of Estimates</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, and revenue recognition. In addition,
healthcare industry reforms and reimbursement practices will continue to impact the Company&#8217;s operations and the determination of
contractual and other allowance estimates. Actual results could differ from those estimates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000790" name="us-gaap:InventoryWorkInProcessPolicy"><p id="xdx_841_eus-gaap--InventoryWorkInProcessPolicy_zOx1Y181YsB9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_zFZ9ThetLNwd">Inventories</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000792" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_847_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zFYfUM6zwBbf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zRC1ApUdAOxc">Property and Equipment</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment is stated at cost less accumulated
depreciation. Property and equipment purchased in connection with an acquisition is stated at its estimated fair value, generally based
on an appraisal. Property and equipment is being depreciated for financial accounting purposes using the straight-line method over their
estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon
retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts
and the resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to operations.
Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $<span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20240701__20250630_zPvUEDSVTEd3" title="Maintenance and repair expenses"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2024-07-01to2025-06-30" id="Fact000794" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,751,000</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zSW98m5gQHsi" title="Maintenance and repair expenses"><ix:nonFraction name="us-gaap:CostOfPropertyRepairsAndMaintenance" contextRef="From2023-07-012024-06-30" id="Fact000796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,948,000</ix:nonFraction></span> for the years
ended June 30, 2025 and 2024 respectively. The estimated useful lives in years are generally as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000798" name="FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zzRfNYFNcoyh" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_z6ny7nwymeeb" style="display: none">Schedule of Estimated Useful Life in Years for Property and Equipment</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Estimated Useful Life in Years for Property and Equipment</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Diagnostic equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLUOWqTLUb0a"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember" format="ixt-sec:duryear" id="Fact000799" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>&#8211;<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z25tJH8zhlvh"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember" format="ixt-sec:duryear" id="Fact000800" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">13</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6nTPQReSsH2"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember" format="ixt-sec:duryear" id="Fact000801" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zNHPd6S4KXHa"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember" format="ixt-sec:duryear" id="Fact000802" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zXdHeCgwiGP9"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" id="Fact000803" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">2</ix:nonNumeric></span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z6qnagveRi84"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember" format="ixt-sec:duryear" id="Fact000804" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">7</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zksgPFS2gqC"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" id="Fact000805" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zCr1cYtEgT25"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" id="Fact000806" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">9</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgT9VqsgYLc4"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember" format="ixt-sec:duryear" id="Fact000807" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>&#8211;<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaYdZEw4QjCi"><ix:nonNumeric contextRef="AsOf2025-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember" format="ixt-sec:duryear" id="Fact000808" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">10</ix:nonNumeric></span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt">Building</td>
<td style="width: 10%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 18%; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zD9A92kl2CT6"><ix:nonNumeric contextRef="AsOf2025-06-30_us-gaap_BuildingMember_srt_WeightedAverageMember" format="ixt-sec:duryear" id="Fact000809" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">28</ix:nonNumeric></span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A6_zUTC8Bz6IHGl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zlxfsbrqDj6k" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zKNjcrcTUWL6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_238_zqDwP8NCt0h1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_237_zoTHd18vswF5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zXnPFtE13xsk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_237_zElTqNXgSrk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z0gO06y5Np57" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zeTFt5m5tNkg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_z8frqppQqNEc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zc4blPCtJR4l" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000821" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z9eSjjxYZdtf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_zxgC1avudAai">Other Intangible Assets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1) Patents and Copyrights</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Patent and copyrights are professional costs
incurred to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zJmhvKVVPtM" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2025-06-30_us-gaap_IntellectualPropertyMember" format="ixt-sec:duryear" id="Fact000823" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">15</ix:nonNumeric> </span>years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2) Non-Competition Agreements</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (<span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPBsjlpky802" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear" id="Fact000825" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">7</ix:nonNumeric></span> years).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3) Customer Relationships</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zcjurrsJnO4" title="Finite-lived intangible asset, useful life"><ix:nonNumeric contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" id="Fact000827" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">20</ix:nonNumeric></span> years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4) Software License</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Software license represents a license to improve the
image quality and efficiency of the MRI scanners. Amortization is calculated on the straight-line basis over 3 years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000829" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy"><p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_z0gpOauwkL85" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zbHeehKjQ3k9">Goodwill</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.<br/></p>

<ix:exclude><p id="xdx_239_zVPMUhVnVbZf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zAhi7AeKgUze" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zpRBFukVlOT4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_233_zjoslFiDxBvd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zeQS7O20wMkc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_234_zGDL1lCeqvMb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_234_zfDKqmwkhpwk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zAvkcsnVUgya" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zr3kAlADqtIi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zB3iUEPZpd29" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zu3jj8HGWii3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_ztEOQortyFXg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000843" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zw2Kb9FZsoO2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_863_zxgdpit5utq1">Revenue Recognition</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included
in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type
and Production-Type Contracts&#8221;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2024, the Company had unearned revenue
on service contracts of $3,870,229 of which all was recognized as revenue in the fiscal year ending June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales (upgrades and supplies)
is recognized upon shipment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized based
upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various
medical providers (the &#8220;PCs&#8221;). As of June 30, 2025, the Company has <span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20250630_ztnifEM7T7Y8" title="Management agreements with company total medical practices"><ix:nonFraction name="FONR:ManagementAgreementsWithCompanyTotalMedicalPractices" contextRef="AsOf2025-06-30" id="Fact000845" format="ixt:numdotdecimal" decimals="INF" unitRef="Ratio">22</ix:nonFraction></span> management agreements of which <span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20250630_z0JA4I1I8wD2" title="Scanners with management agreements with company owned by related party"><ix:nonFraction name="FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" contextRef="AsOf2025-06-30" id="Fact000847" format="ixt:numdotdecimal" decimals="INF" unitRef="Ratio">3</ix:nonFraction></span> were with PC&#8217;s
owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned by Raymond V. Damadian,
M.D., Chairman of the Board of FONAR until his unexpected death in August 2022) (&#8220;the Related medical practices&#8221;) and <span id="xdx_907_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20250630_zzPqbePjCJfh" title="Scanners with management with company located in new york state"><ix:nonFraction name="FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState" contextRef="AsOf2025-06-30" id="Fact000849" format="ixt:numdotdecimal" decimals="INF" unitRef="Ratio">19</ix:nonFraction></span> are
with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by four unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$<span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMinimum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zFaBwBpE3p8g" title="Contractual fees for services rendered minimum"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMinimum" contextRef="AsOf2025-06-30_custom_DiagnosticImagingFacilityMember" id="Fact000851" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,000</ix:nonFraction></span> to $<span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zOAiTymX0tk2" title="Contractual fees for services rendered Maximum"><ix:nonFraction name="FONR:ContractualFeesForServicesRenderedMaximum" contextRef="AsOf2025-06-30_custom_DiagnosticImagingFacilityMember" id="Fact000853" format="ixt:numdotdecimal" decimals="0" unitRef="USD">460,000</ix:nonFraction></span>. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit
loss expense for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the FASB and codified in the ASC 606. The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#8217;s revenue recognition policies and significant judgments employed in the determination of revenue.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zn1e3VaOd6bd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zc8Df7FfKQ5b" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_238_zbifsApDYNE9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zlQ6YR2dUZ05" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z3ACFL6xyK3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zkGeD4L1Zzfd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_236_zfHtq3JzxMNj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zp8OWVCWAZK1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zsrG95eNspUj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zvAi7iKjH1Rc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zGb77POwySgk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zIccZmRRKhya" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue Recognition (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zacJ4uBHXl3c" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2025 and 2024 are summarized in the following table.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000868" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zapBwZWhb56k" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_zmol8u26VQ13" style="display: none">Schedule of patient fee
    revenue - net</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patient Fee Revenue - Net</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Commercial Insurance/ Managed Care</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zZud5cYCZia5" title="Net Patient Fee Revenue" style="width: 12%; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-012025-06-30_custom_CommercialInsuranceManagedCareMember" id="Fact000870" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,957,159</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z6IYnDScgTRf" title="Net Patient Fee Revenue" style="width: 12%; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012024-06-30_custom_CommercialInsuranceManagedCareMember" id="Fact000872" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,952,712</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Medicare/Medicaid</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_z30m7YEAmVl1" title="Net Patient Fee Revenue" style="text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-012025-06-30_custom_MedicareMedicaidMember" id="Fact000874" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,160,839</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zszHemWRubW7" title="Net Patient Fee Revenue" style="text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012024-06-30_custom_MedicareMedicaidMember" id="Fact000876" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,138,176</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Workers&#8217; Compensation/Personal Injury</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zcAZ74TLZso3" title="Net Patient Fee Revenue" style="text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-012025-06-30_custom_WorkersCompensationPersonalInjuryMember" id="Fact000878" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,876,923</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zSnjmVbFtc7" title="Net Patient Fee Revenue" style="text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012024-06-30_custom_WorkersCompensationPersonalInjuryMember" id="Fact000880" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,673,483</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zUbUYJK57Pkk" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-012025-06-30_custom_OtherRevenueSourceMember" id="Fact000882" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,184,525</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVrbYwT44pae" title="Net Patient Fee Revenue" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012024-06-30_custom_OtherRevenueSourceMember" id="Fact000884" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,051,425</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Patient Fee Revenue</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630_zNAPiF0XqZ47" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2024-07-01to2025-06-30" id="Fact000886" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,179,446</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zjGCwrRjABoc" title="Net Patient Fee Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:NetPatientFeeRevenue" contextRef="From2023-07-012024-06-30" id="Fact000888" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,815,796</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8AE_z5b9wb4amYcc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000890" name="FONR:MedicalReceivablePolicyTextBlock"><p id="xdx_848_ecustom--MedicalReceivablePolicyTextBlock_zPIMLd4tJ5lb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86F_zazxmUxsiWZ2">Medical Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Medical receivables are due under fee-for-service
contracts from third-party payors, such as hospitals, government sponsored healthcare programs, patient&#8217;s legal counsel and directly
from patients. Substantially all the revenue relates to patients residing in Florida. Medical receivables are recorded at net realizable
value based on the estimated amounts the Company expects to receive from patients and third-party payers. The medical receivable is reduced
by an allowance for contractual adjustments based on the historical experience with each payor class at each location. The medical fee
receivable as of July 1, 2023 was $<span id="xdx_908_ecustom--MedicalFeeReceivable_iI_c20230702_zaZAh3y9yVR8" title="Medical fee receivable"><ix:nonFraction name="FONR:MedicalFeeReceivable" contextRef="AsOf2023-07-02" id="Fact000892" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,259,262</ix:nonFraction></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For LLCs owned by the Company, approximately <span id="xdx_90D_ecustom--RevenuePercentage_iI_dp_c20250630_zh33LI9cxjEf" title="revenue percentage"><ix:nonFraction name="FONR:RevenuePercentage" contextRef="AsOf2025-06-30" id="Fact000894" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">57</ix:nonFraction></span>%
and <span id="xdx_90F_ecustom--RevenuePercentage_iI_dp_c20240630_z4l7dDmxJqp" title="revenue percentage"><ix:nonFraction name="FONR:RevenuePercentage" contextRef="AsOf2024-06-30" id="Fact000896" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">67</ix:nonFraction>%</span> of net revenues were derived from no-fault and personal injury protection for the years end June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zxoue1acV6S6" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zLEZhBGmZ4e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_230_za44C8jnAtVc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zg5PkMVZyiR4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_zV9hRBIe4mOd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zgas4yZmIozj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23B_ztSwLT6FGse5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zhC24A9j3wqf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zNUvB6QgPZb4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management and Other Fees Receivable</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#8220;CECL&#8221;) reserve to address the risk that a portion of the contractually obligated management fees receivable from the
PCs may not be collectible. The PC&#8217;s may be limited in their ability to pay the full management fee receivable if they do not collect
sufficient expected fees from third-party payors and patients. The Company&#8217;s management fees are collateralized, individually and
collectively, by the assets of the PCs. The CECL reserve is determined based on the difference between the management fee receivable and
the current amount of outstanding fees estimated to be collected by the PCs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s considerations into the estimate
of the PC&#8217;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#8217;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. Specifically, insurance carriers covering automobile
no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other disallowed
claims.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company combines an objective
and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves objectively
using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and then subjectively
adjusting for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for credit losses for the year ended June 30, 2025 was
$3,079,261. The provision for credit losses is attributable to scan volume at all the PC&#8217;s and the nature of the payor classes,
where there can be longer expected payment terms. Also, during the year ended June 30, 2025, the Company recorded an additional reserve
of approximately $2,300,000 for a specific receivable that is attributable to a American Transit Insurance Company (ATIC). This reserve
for credit losses relates specifically to ATIC, which owes no-fault insurance claims by the PCs to the PCs, which are collateral for the
Company&#8217;s management and other fees receivable. ATIC is a New York based motor vehicle insurer primarily focused on for-hire automobile
insurance. During Fiscal 2025, ATIC posted over $750 million in net losses and has indicated that they are approaching insolvency. ATIC
continues to operate and is working with the New York Department of Financial Services (DFS) to resolve its issues. We continue to monitor
the situation for new developments. However, at the time of this filing, DFS has not publicly announced approval of any plans for ATIC
to resolve its financial situation. In addition, Uber has filed a lawsuit against ATIC alleging they are not properly paying claims. Additional
legislation in New York City to reduce coverage minimums and increase premiums may help to resolve the crisis, but there is no certainty
these efforts will be successful. If ATIC enters receivership or suffers additional adverse consequences, we may need to take additional
reserves in the future. The management fee receivable
for unrelated and related parties as of July 1, 2023 was $<span id="xdx_908_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20230702_z3epp298HNv7" title="Management fee receivable for unrelated parties"><ix:nonFraction name="FONR:ManagementFeeReceivableForUnrelatedParties" contextRef="AsOf2023-07-02" id="Fact000907" format="ixt:numdotdecimal" decimals="0" unitRef="USD">35,888,253</ix:nonFraction></span> and $<span id="xdx_902_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20230702_zcVLCbWvau8k" title="Management Fee Receivable For Related Parties"><ix:nonFraction name="FONR:ManagementFeeReceivableForRelatedParties" contextRef="AsOf2023-07-02" id="Fact000909" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,161,870</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zd6WVBNxPww1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zvbW0AOlSF9c" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_236_zRIKpazexl74" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_231_zEMn6ebyrbb8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_239_z61MfvIcI7Q8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_231_zDMfNvRk0i9k" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zjVpjdYwBrJk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zNyTJsPSl8Vl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z9lfxw2aPU65" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000920" name="us-gaap:ReceivablesPolicyTextBlock"><p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_z2dAUxER9VI6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_864_z9QMwu03zeo5">Accounts Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Credit risk with respect to the Company&#8217;s accounts
receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the commencement
of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed on a monthly
or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The Company controls
credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process, credit limits, monitoring
procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before a product sales contract is
entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service contracts as of July 1,
2023 was $<span id="xdx_90B_ecustom--AccountsReceivableServiceContractsNet_iI_c20230702_zP1nChfqcFzc" title="Account receivable"><ix:nonFraction name="FONR:AccountsReceivableServiceContractsNet" contextRef="AsOf2023-07-02" id="Fact000922" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,571,597</ix:nonFraction></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000924" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zHtlUHAE0r19" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_z41yjjbXl4fj">Research and Development Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000926" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_846_eus-gaap--AdvertisingCostsPolicyTextBlock_zx0hhJU3GzG5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86E_z8yGLCjM6W79">Advertising Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred. Advertising
expense approximated $ <span id="xdx_900_eus-gaap--AdvertisingExpense_c20240701__20250630_zy07m58XFKWj"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000927" format="ixt:numdotdecimal" decimals="0" unitRef="USD">773,000</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20230701__20240630_zm5LK0BUGRx6"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2023-07-012024-06-30" id="Fact000928" format="ixt:numdotdecimal" decimals="0" unitRef="USD">731,000</ix:nonFraction></span> and for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000930" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zJjWVKExln06" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86C_zOGPd9JGMpb9">Income Taxes</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zKDx7YVpKN66" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zYZn0C0fSQKl" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_z5BQ52qWrApc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_238_zJTKo6KIc6d4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_234_zI8M7Pcod9yf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zq90IaeIUQY4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zm2fGomkdfqe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_236_zyM60cLesM68" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zshGHDtDWXAf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zeYxhZmbTXej" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zbU4PGDxgXyh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zxAKC6h8HIk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income Taxes (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zMT3LLlOIXu8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 740, &#8220;Accounting for Income Taxes&#8221;,
prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#8217;s tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#8220;Interest expense, net. Penalties
if incurred would be recognized as a component of &#8220;Selling, general and administrative&#8221; expenses. Penalties for the years
ended June 30, 2025 and June 30, 2024 were $<span id="xdx_90A_ecustom--Penalties_c20240701__20250630_zz9AvmFTMGk6" title="Penalties"><ix:nonFraction name="FONR:Penalties" contextRef="From2024-07-01to2025-06-30" id="Fact000945" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_907_ecustom--Penalties_c20230701__20240630_z7nnh1DiSjA" title="Penalties"><ix:nonFraction name="FONR:Penalties" contextRef="From2023-07-012024-06-30" id="Fact000947" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,444</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000949" name="FONR:CustomerAdvancesPolicyTextBlock"><p id="xdx_84B_ecustom--CustomerAdvancesPolicyTextBlock_zt4hi9zatzA2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_z7gmUlKx0OXc">Customer Advances</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000951" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zQGycvRWLJ9e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_znvzMFwkxOI2">Earnings Per Share</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic earnings per share (&#8220;EPS&#8221;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class Method&#8221;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2025 and 2024, diluted EPS for common shareholders includes <span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20240701__20250630_zjNb4UsWTUV3" title="Conversion of Class C Common Stock"><span id="xdx_90A_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_z1OhV6G8wArg" title="Conversion of Class C Common Stock"><ix:nonFraction name="FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" contextRef="From2024-07-01to2025-06-30" id="Fact000953" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" contextRef="From2023-07-012024-06-30" id="Fact000955" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></ix:nonFraction></span></span> shares upon conversion of
Class C Common.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zSPn3PhMsdVh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zjwQmnTmFX61" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_238_zfSdqRJCXUxh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_238_zxrC4zPjnC2d" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_230_zZpQiDMrE1f5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_239_z4mOetiAnRe6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zI1zeWBvxUn7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zfgpVRdhqEeb" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zogN53glX176" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zFdWBSClRRHb" style="font: 11pt Times New Roman, Times, Serif; margin: 0">Earnings Per Share (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zlUmYbibpHth" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000968" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXgrVghbjdB7" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zrMYGGMVn0hh" style="display: none">Schedule of earnings per share</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Preferred <br/>&#160; <br/>Stock</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="text-decoration: underline">Numerator:</span></td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Net income available to common stockholders</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630_zwXbEOpHQRm" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-07-01to2025-06-30" id="Fact000970" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,334,261</ix:nonFraction></td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHQ0bwZGoRul" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718" id="Fact000972" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,802,352</ix:nonFraction></td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zTbMk0MKQADd" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718" id="Fact000974" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,467</ix:nonFraction></td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zOWRlysqdos5" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember516949718" id="Fact000976" format="ixt:numdotdecimal" decimals="0" unitRef="USD">396,443</ix:nonFraction></td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Denominator:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted average shares outstanding</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630_z4c3GDKwWT9b" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2024-07-01to2025-06-30" id="Fact000978" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,906,803</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7R8N2jl43U3" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718" id="Fact000980" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,210,852</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCw1jHBpm25h" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718" id="Fact000982" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zO7lozDT1tS2" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember516949718" id="Fact000984" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic income per common share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630_zYJDkImOYcv2" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-07-01to2025-06-30" id="Fact000986" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.21</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zK59KB7k5em4" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718" id="Fact000988" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.26</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zYUM1NLAtzjh" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718" id="Fact000990" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zo7FZ3bjowV3" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember516949718" id="Fact000992" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.26</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt">Diluted</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt">Denominator:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted average shares outstanding</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zI5vTOBCSz0j" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718" id="Fact000994" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,210,852</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zF2JaGEfpWe5" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718" id="Fact000996" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class C Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcPDQCeFugrf" title="Class C Common Stock" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718" id="Fact000998" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_z2aZ6uU4BtZ6" title="Class C Common Stock" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718" id="Fact001000" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8212;</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Denominator for diluted earnings per share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zj5GfCXGL8Hl" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718" id="Fact001002" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,338,356</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zgEFnhclg7m7" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718" id="Fact001004" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Diluted income per common share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5Dc9qQOYSRb" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718" id="Fact001006" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.23</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zX4OulzKmGXi" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718" id="Fact001008" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Preferred <br/>&#160; <br/>Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="text-decoration: underline">Numerator:</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Net income available to common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630_zxqVKlA1jCY9" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012024-06-30" id="Fact001010" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,567,396</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlznrJUeKC27" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781" id="Fact001012" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,908,920</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCg0idGNEmU1" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796" id="Fact001014" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">167,700</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zxCM8hZqgwFa" title="Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember516949796" id="Fact001016" format="ixt:numdotdecimal" decimals="0" unitRef="USD">490,776</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zI0FmbgqMxUg" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2023-07-012024-06-30" id="Fact001018" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,046,959</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuHuh97pIZ4" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781" id="Fact001020" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,351,008</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztvCZaYHkyU8" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796" id="Fact001022" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zjgiMv3bpst2" title="Weighted average shares outstanding basic" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageSharesOutstandingBasic" contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember516949796" id="Fact001024" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_z0Bwby6RQfU2" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012024-06-30" id="Fact001026" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.50</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVrQ7Azo2Gs7" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781" id="Fact001028" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.56</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztoADeqDrIP4" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796" id="Fact001030" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zCN37m1AK22f" title="Basic income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember516949796" id="Fact001032" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.57</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zruxKYiA6jC1" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781" id="Fact001034" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,351,008</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zXVyct5TGptj" title="Weighted average shares outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796" id="Fact001036" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsbWP3Ab8yRg" title="Class C Common Stock" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781" id="Fact001038" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">127,504</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zhcHa2K3gRM1" title="Class C Common Stock" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796" id="Fact001040" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8212;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQsK8CJDkgC7" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781" id="Fact001042" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,478,512</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zK9uAEAPE7O1" title="Total Denominator for diluted earnings per share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796" id="Fact001044" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYlkrMwYg6H" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781" id="Fact001046" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.53</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zUZzwVpni9qh" title="Diluted income per common share" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796" id="Fact001048" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.44</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><br/>
</span></p>

</ix:nonNumeric><p id="xdx_8AF_zWzuXeV2zvI8" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zAqoz3okyjyl" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_z9gFsgQWAwu4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zNWKEoyl1Psa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_236_zOOtByhyXyT4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zNUv3kNjlvYk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zHXr0XVPGSc9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zrD6hKQtJLu2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_237_zeceDWYLbFE7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zVyswUKgdgU7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zlPn9uz2vrCi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001060" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zksvfpjlvW22" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_864_zIURIV2GEw48">Cash and Cash Equivalents</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001062" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zJBdbK2KByyl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_861_z3MGEx6a1zh4">Short-Term Investments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001064" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z64eE4JWji8a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86F_zXte6nDBFVG1">Concentration of Credit Risk</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2025, the Company had cash
on deposit of approximately $<span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20250630_zQ3URKgZSaad" title="Cash deposit"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2025-06-30" id="Fact001066" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">53,676,000</ix:nonFraction></span> in excess of federally insured limits of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20250630_zzM4L0gibjxe" title="Federally insured limits"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2025-06-30" id="Fact001068" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">250,000</ix:nonFraction></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties
accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zb90mruYegCi" title="Concentration risk, percentage"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zkRDkTkOHw8" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember" id="Fact001070" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember" id="Fact001072" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">12</ix:nonFraction></ix:nonFraction></span></span>% of the consolidated net revenues for the years ended June 30, 2025 and 2024. Net management fee receivables
from the related party medical practices accounted for approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zTYTSQcAQ5" title="Concentration risk, percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zlOJ8OY6S8Le" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember" id="Fact001074" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember" id="Fact001076" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">12</ix:nonFraction></ix:nonFraction></span></span>% of the consolidated accounts receivable as of June 30, 2025 and
2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the years ended June 30, 2025 and June 30, 2024,
the Company made purchases from two vendors that accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zRVL8LyNfHm" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoVendorsMember" id="Fact001078" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">36</ix:nonFraction>%</span> and<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zoQXcPBtgjJ3" title="Concentration risk, percentage"> <ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoVendorsMember" id="Fact001080" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0</ix:nonFraction>%</span> of total purchases, respectively.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations
in the healthcare industry.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001082" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z06zC8G5lp3l" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86F_zRdQdhudXtik">Fair Value of Financial Instruments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures fair value in accordance with
ASC 820-10, &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_ztH5eWjzhYM8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_235_zyLAgYFilN2a" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zxyKY2GttGB6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_234_zIrEMsQXUS1a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zUzHyB9ubY6i" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zWcPfepKoWT6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_238_zECc559A6yFd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23C_z4B4ZSVUED05" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zn30NkW7Wmz4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_z30MmPjuZQie" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_z5gfr5QxWzWj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair Value of Financial Instruments (Continued)</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zx4OW334E352" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the Company&#8217;s financial instruments are
held for purposes other than trading.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>





<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zC2zpwctrYs7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zC6OQH1i9W14" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_237_zAbuwi3IMcFk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z5X86t6JUHAe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_231_zZZV58YaHq8g" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zqM1Hx3zubTf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z8hhHNaouSbh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zGmP9vcNf1W9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zUtyhj87iPok" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001105" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zkiejRFiZPTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_z6k5RBXXeNh3">Recently Adopted Accounting Standards</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, The Financial Accounting Standards Board (&#8220;FASB&#8221;)
issued ASU 2023-09, &#8220;Income Taxes (740) &#8220;Improvements to Income Tax Disclosures&#8221;, which requires the annual financial
statements to include consistent categories and great disaggregation of information in the rate reconciliation and income taxes paid disaggregated
by jurisdiction. ASU 2023-09 is effective for the Company&#8217;s annual reporting beginning after December 15, 2024, with early adoption
permitted, and should be applied on a prospective basis, with a retrospective option. The Company recently adopted this ASU retrospectively
for the year ended June 30, 2025 and 2024 and it impacts only our disclosures with no impacts to our financial condition and results of
operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, FASB issued ASU 2023-07, &#8220;Segment
Reporting (Topic 280)&#8221;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company adopted ASU for the year ended June 30,
2025 and it impacts only our disclosures with no impacts to our financial condition and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2024, the FASB issued ASU 2024-03, &#8220;Income
Statement &#8211; Reporting Comprehensive Income &#8211; Expense Disaggregation Disclosures&#8221; (Subtopic 220-40): Disaggregation of
Income Statement Expenses&#8221;. This ASU requires disaggregation of certain income statement expense captions into specified categories
to be disclosed within the notes to the financial statements, but does not change the expense captions on the income statement. The amendments
in this ASU are to be applied prospectively, although retrospective application is permitted, and is effective for annual financial statements
starting in fiscal 2028 and interim periods starting in fiscal 2029, with early adoption permitted. The Company is currently evaluating
the effect that the adoption of ASU 2024-03 will have on our disclosures.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2025 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#8217;s financial accounting
measures or disclosures had they been in effect during 2025 or 2024, and it does not believe that any of those standards will have a significant
impact on the Company&#8217;s consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zKml0PgRVz71" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zVtIOeoAEXr4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zr0k34khAU24" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_238_zIBsParw83j3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_232_zGhipDtIXDye" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_238_znikY4zTAiCa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_238_zBqDfzEq5mGf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001114" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_808_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zvM69ABmY3yf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;NOTE 3 &#8211; <span id="xdx_823_zGxO2fuc3EH9">ACCOUNTS RECEIVABLE, MEDICAL
RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long Term Accounts Receivable</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long term accounts receivable balances at June 30,
2025 and June 30, 2024 amounted to $<span id="xdx_900_ecustom--AccountsReceivableNetLongTerm_iI_c20250630_zJAsWv7AnoK3" title="Long term accounts receivable balances"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2025-06-30" id="Fact001116" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,549,956</ix:nonFraction></span> and $<span id="xdx_90A_ecustom--AccountsReceivableNetLongTerm_iI_c20240630_zGx0BKwHm0e1" title="Long term accounts receivable balances"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2024-06-30" id="Fact001118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">829,473</ix:nonFraction></span>, respectively. The Company will generate revenue from long-term, non-cancellable
contracts to provide service and repair services. Future revenue to be recognized over the following four years at June 30, 2025 is as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001120" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zXijzGO5ESQb" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B5_z0cZf7ccVUwa" style="display: none">Schedule of Long Term Accounts Receivable</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Receivables - Non Current - net</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: left; text-indent: -10pt">2027</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20250630_zY1nO0he1iA7" title="2026" style="width: 43%; text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2025-06-30" id="Fact001122" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,592,426</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20250630_zl2ff3MRTrt8" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueThreeToFourYears" contextRef="AsOf2025-06-30" id="Fact001124" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,031,910</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20250630_zk37cIAqVCyj" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueFourToFiveYears" contextRef="AsOf2025-06-30" id="Fact001126" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">831,660</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2030</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20250630_z5ycbIwXvoMk" title="2029" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractReceivableDueFiveYearsOrMore" contextRef="AsOf2025-06-30" id="Fact001128" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">344,750</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20250630_zSm0CQJJejm6" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2025-06-30" id="Fact001130" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,800,746</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zF7jlcHtEv2a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following represents a summary of allowance for
credit losses for the years ended June 30, 2025 and 2024, respectively:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001132" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zEJmGmLG4PJe" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zUYzCKeQzSsh" style="display: none">Schedule of Summary of Allowance For Credit Losses</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="17" style="text-align: center">Summary of Allowance For Credit Losses</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Description</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance<br/> June 30, 2024</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions (1)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance <br/> June 30, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Accounts receivable</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0ij1s42VJQd" title="Beginning Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember" id="Fact001134" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,049</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z4bTZ0RWGBEd" title="Additions (Included in provision for bad debts)" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember" id="Fact001136" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">107,330</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zR9jL8mRuUBc" title="Deductions" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember" id="Fact001138" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,167</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znv4xfD8zong" title="Ending Balance" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2025-06-30_us-gaap_AccountsReceivableMember" id="Fact001140" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">264,212</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zUTSyg7wxChi" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001141" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,369,921</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z1DWoU1Je85" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001142" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,052,824</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBPQGFy8jqg3" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001143" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,757</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zvqySRTABHDh" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2025-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001144" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,295,988</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable - related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztVQkHz0Nx7i" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001145" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,110,399</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z4UevtFf3qFg" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001146" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,026,437</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzYUj6zpTFf2" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001147" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zdaOks82DPNf" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001148" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,136,836</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zG80mJzulSue" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_us-gaap_NotesReceivableMember" id="Fact001149" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zhXdF15EnE15" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2024-07-012025-06-30_us-gaap_NotesReceivableMember" id="Fact001150" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zrQhCXjOSeF" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2024-07-012025-06-30_us-gaap_NotesReceivableMember" id="Fact001151" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zBgaNioATN1k" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1152">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Description</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions(Recovery)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Accounts receivable</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_za0anvkO7yyi" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember" id="Fact001153" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,593</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zTw9SA4YlWd6" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1154">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqc1aNYDTOK" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember" id="Fact001155" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,544</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqIYwzzax14" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember" id="Fact001156" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,049</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zgO2HKHEL1H2" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001157" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,608,567</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zLFpcnnnG5Rj" style="text-align: right">(<ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001158" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">238,646</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNp2SFKHPxX1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1159">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEUUIksXct8j" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember" id="Fact001160" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,369,921</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable - related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zq8rRjBmtWvk" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001161" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,989,692</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z99NIK7R5Al9" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001162" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,120,707</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zKWIlhQq0Uvg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1163">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzPXJe4kndel" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" id="Fact001164" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,110,399</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zNhNbhaSE1ma" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-06-30_us-gaap_NotesReceivableMember" id="Fact001165" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zA3FJdF8vJwb" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsAdditions" contextRef="From2023-07-012024-06-30_us-gaap_NotesReceivableMember" id="Fact001166" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zXwWgWj5i4Gl" style="text-align: right"><ix:nonFraction name="FONR:AllowanceForDoubtfulAccountsDeductions" contextRef="From2023-07-012024-06-30_us-gaap_NotesReceivableMember" id="Fact001167" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zsonrgb7xAri" style="text-align: right"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-06-30_us-gaap_NotesReceivableMember" id="Fact001168" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">777,354</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(1)</span></td>
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Included in provision for credit losses.</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AF_zYF2UHqoInNe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<ix:exclude><!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_z7sEk4kbmj87" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zr7z4oIw8Zhk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_zzECwKMYw7T" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zIEf27PKOL9l" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_237_zwi0qFeNVskk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_239_zgZq3QhxbqBl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_239_zipr2CrS3gi5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_234_zGsezmVCDay9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zdxvE47AELfk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE
AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_znN8qcn8BUvf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net revenues from management and other fees
charged to the related party medical practices accounted for approximately <span id="xdx_90A_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20240701__20250630_zBmZE50fBRM5" title="Percentage of consolidated net revenue from management fees"><span id="xdx_902_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20230701__20240630_zU9jx2CA3wy6" title="Percentage of consolidated net revenue from management fees"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2024-07-01to2025-06-30" id="Fact001180" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2023-07-012024-06-30" id="Fact001182" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">11</ix:nonFraction></ix:nonFraction></span></span>%
and <span id="xdx_903_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20220701__20230630_zdo5oDpHkHf8" title="Percentage of consolidated net revenue from management fees"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2022-07-012023-06-30" id="Fact001184" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">12</ix:nonFraction></span>% of the consolidated net revenues for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tallahassee Magnetic Resonance Imaging, Inc., Stand
Up MRI of Boca Raton, Inc. and Stand Up MRI &amp; Diagnostic Center, Inc. (all related party medical practices) entered into a guaranty
agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under each
individual management agreement.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the number of our facilities
for the years ended June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Total Facilities</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001186" name="FONR:TotalFacilitiesOwnedOrManagedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zOv85HqtP6ba" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B1_zQpHJjCYPWUi" style="display: none">Schedule of facilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_498_20240701__20250630_z126F3J4Yx3f" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_493_20230701__20240630_zIawC8tkkTwh" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zD376GVhfX8h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Total Facilities Owned or Managed (at Beginning of Year)</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2024-07-01to2025-06-30" id="Fact001188" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">28</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear" contextRef="From2023-07-012024-06-30" id="Fact001189" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">27</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Facilities Added by:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z99TkL8sA8S7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Internal development</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1191">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:ManagedFacilitiesAddedByInternalDevelopment" contextRef="From2023-07-012024-06-30" id="Fact001192" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zrsS1XQIBhVa" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Managed Facilities Closed</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2024-07-01to2025-06-30" id="Fact001194" format="ixt:zerodash" decimals="INF" unitRef="Integer">&#8212;</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:ManagedFacilitiesClosedDuringYear" contextRef="From2023-07-012024-06-30" id="Fact001195" format="ixt:zerodash" decimals="INF" unitRef="Integer">&#8212;</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_zjB1j5c3yxQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Facilities Owned or Managed (at End of Year)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2024-07-01to2025-06-30" id="Fact001197" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">28</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear" contextRef="From2023-07-012024-06-30" id="Fact001198" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">28</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A7_zVniYBQd1lb4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001200" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_808_eus-gaap--InventoryDisclosureTextBlock_zlxtrqpo5x8g" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 &#8211; <span id="xdx_822_z0qw8X0GKEMi">INVENTORIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories included in the accompanying consolidated
balance sheets consist of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001202" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zXfuasFLh8Y3" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zLeNHzBUWhj6" style="display: none">Schedule of inventories</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20250630_zpqQ2Y1skoLc" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_493_20240630_zkiufqQwbpMa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_z4C251s1UJ5f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Purchased parts and components</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2025-06-30" id="Fact001204" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,630,439</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2024-06-30" id="Fact001205" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,524,201</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zczgmYK1Nqy8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Work-in-process</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2025-06-30" id="Fact001207" format="ixt:numdotdecimal" decimals="0" unitRef="USD">182,243</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2024-06-30" id="Fact001208" format="ixt:numdotdecimal" decimals="0" unitRef="USD">191,240</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_z5v0Y3GQUwd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Inventories</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2025-06-30" id="Fact001210" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,812,682</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2024-06-30" id="Fact001211" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,715,441</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<ix:exclude><p id="xdx_23C_zBPj2KcTHjbg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zl0GfZLafJR" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zEBXM9BisHVj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_236_zwI5J7lt7WHf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_235_ztUGPSxl2d1d" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23E_za3dI2Atjspi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z1wyvAXfUWhd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_238_zPleEmstwtl4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001221" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_803_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNfR68MlYpfj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 - <span id="xdx_823_z8QBK0CLcYCg">PROPERTY AND EQUIPMENT</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment, at cost, less accumulated
depreciation and amortization, at June 30, 2025 and 2024, is comprised of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001223" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zhQrThtXHej6" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B2_zf0Yg3aSYLDj" style="display: none">Schedule of Property and equipment</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Diagnostic equipment</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zK9QK5pEKOR3" title="Property plant and equipment, gross" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-06-30_custom_DiagnosticEquipmentMember" id="Fact001225" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">35,276,823</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zYuokfAvcAS" title="Property plant and equipment, gross" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_custom_DiagnosticEquipmentMember" id="Fact001227" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,243,694</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zJSildhDTxqc" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember" id="Fact001229" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,490,872</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_z1qEXteKY4G" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember" id="Fact001231" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,199,941</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zMc7k7RwnCz9" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-06-30_us-gaap_MachineryAndEquipmentMember" id="Fact001233" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,128,398</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zfqYNyooTeNd" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_us-gaap_MachineryAndEquipmentMember" id="Fact001235" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,069,055</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzCw7Tco2Gtj" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-06-30_us-gaap_FurnitureAndFixturesMember" id="Fact001237" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,756,017</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ziy0RbjYTIaj" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_us-gaap_FurnitureAndFixturesMember" id="Fact001239" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,742,169</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zlZRvCL1gT26" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-06-30_us-gaap_LeaseholdImprovementsMember" id="Fact001241" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,707,234</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zDg71aaJXVU" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_us-gaap_LeaseholdImprovementsMember" id="Fact001243" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,312,904</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Building</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zXYkJLFbbe3c" title="Property plant and equipment, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-06-30_us-gaap_BuildingMember" id="Fact001245" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,614</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zethhpJzCrk5" title="Property plant and equipment, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30_us-gaap_BuildingMember" id="Fact001247" format="ixt:numdotdecimal" decimals="0" unitRef="USD">939,614</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630_zT6kwXaazpdf" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-06-30" id="Fact001249" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,298,958</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zUfqB06j7V33" title="Property plant and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30" id="Fact001251" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">62,507,377</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less: Accumulated depreciation and amortization</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20250630_zhRXJINJqTW7" title="Less: Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2025-06-30" id="Fact001253" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">47,767,039</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zCHOg3CwHw34" title="Less: Accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-06-30" id="Fact001255" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">43,798,457</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20250630_zYiilL7oZRu2" title="Property plant and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2025-06-30" id="Fact001257" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,531,919</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zP8Phe8iKCX1" title="Property plant and equipment, net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30" id="Fact001259" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,708,920</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation of property and equipment for the years
ended June 30, 2025 and 2024 was $<span id="xdx_909_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zYuCYFwKcBVf" title="Depreciation and amortization of property and equipment"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2024-07-012025-06-30_us-gaap_PropertyPlantAndEquipmentMember" id="Fact001261" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,968,582</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20230701__20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_z1F5RNfQ9Cle" title="Depreciation and amortization of property and equipment"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember" id="Fact001263" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,227,414</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001265" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zhRhpwUelLVl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; <span id="xdx_825_zvvZQ22xs477">OPERATING AND FINANCE LEASES</span> </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its various operating leases
in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211; Lease, as updated by ASU 2016-02. At the inception
of a lease, the Company recognizes right-of-use lease assets and related lease liabilities measured at present value of future lease payments
on its balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease. Our most common initial term varies
in length from 2 to 19 years. Including renewal options negotiated with the landlord, we have a total span of 2 to 16 years at the facilities
we lease. The Company reviewed its contracts with vendors and customers, determining that its right-to-use lease assets consisted of only
office space operating leases. In determining the right-to-use lease assets and liabilities, the Company did recognize lease extension
options which the Company feels would be reasonably exercised. Our incremental borrowing rate (&#8220;IBR&#8221;) used to discount the
stream of operating lease payments is closely related to the interest rates available to the Company. A reconciliation of operating and
finance lease payments undiscounted cash flows to lease liabilities recognized as of June 30, 2025 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_za06Naf8p0ic" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zsFt2ndF9Fd8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_232_z7J5vAOt6S04" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zfmzmTTYiHo8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z6ZqcQaKtWnc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_z6TiJz3ZBrlk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23E_ziKOj61pd7Ol" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zYy12HowLpI5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; OPERATING AND FINANCE LEASES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z0z8hv2V2vdf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001276" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDxsI4Y1txYj" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span id="xdx_8B1_zyWAFiHIlaTj" style="display: none">Schedule of Operating Lease and Finance Lease Payments</span></td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Year Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Operating Lease Payments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Finance Lease Payments</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: center; text-indent: -10pt">2026</td><td style="width: 1%; text-align: center">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zWDafO3P5Mpc" title="2025" style="width: 26%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember" id="Fact001278" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,753,674</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zdM46sjVWWO8" title="2025" style="width: 26%; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember" id="Fact001280" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,343</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2027</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpHOsA8i0Oxf" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember" id="Fact001282" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,718,999</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zz6FVYs7zQk9" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember" id="Fact001284" format="ixt:numdotdecimal" decimals="0" unitRef="USD">142,534</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2028</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z2pSmtSplgo4" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember" id="Fact001286" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,629,193</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zapwCpj5pNOh" title="2027" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1288">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2029</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zvxWe8aR5wXa" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember" id="Fact001290" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,240,019</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zgi9a6oLwg2d" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember" id="Fact001292" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2030</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zyOQhJ3L78I2" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember" id="Fact001294" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,120,717</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z4fS9Ud9lM6" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember" id="Fact001296" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziPkLtEvicAc" title="Thereafter" style="text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember" id="Fact001298" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,496,885</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpJoeYoMem4k" title="Thereafter" style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember" id="Fact001300" format="ixt:zerodash" decimals="0" unitRef="USD">&#8212;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Present value discount</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--PresentValueDiscount_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zwtqB5IIYRWk" title="Present value discount" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember" id="Fact001302" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,427,905</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBCRri7I40T7" title="Present value discount" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember" id="Fact001304" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">117</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zkj0dvleg71l" title="Total lease liability" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember" id="Fact001306" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,531,582</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--FinanceLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zEn4RLK9fS0l" title="Total lease liability" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseLiability" contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember" id="Fact001308" format="ixt:numdotdecimal" decimals="0" unitRef="USD">386,760</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zS6AbEg0VIfd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Weighted Average Remaining Lease Term</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001310" name="FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_z3eDopoWTWJj" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_zTgX3n0ZahDd" style="display: none">Schedule of Weighted Average Remaining Lease Term</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating leases - years</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zHlomr5OInP6" title="Operating leases - years"><ix:nonNumeric contextRef="AsOf2025-06-30" format="ixt-sec:duryear" id="Fact001312" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">10.2</ix:nonNumeric></span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zSLNi8IY6hMl" title="Operating leases - years"><ix:nonNumeric contextRef="AsOf2024-06-30" format="ixt-sec:duryear" id="Fact001314" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">11.0</ix:nonNumeric></span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Finance lease - years</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zi92dpfFY5si" title="Finance lease - years"><ix:nonNumeric contextRef="AsOf2025-06-30" format="ixt-sec:duryear" id="Fact001316" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1">1.6</ix:nonNumeric></span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zOCJPz0V9nag" title="Finance lease - years"><ix:nonNumeric contextRef="AsOf2024-06-30" format="ixt-sec:duryear" id="Fact001318" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1">2.6</ix:nonNumeric></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted Average Discount Rate</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Operating leases</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_zyFv1teZ9Irk" title="Weighted average discount rate, operating leases"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2025-06-30" id="Fact001320" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">6.5</ix:nonFraction></span></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zzJorkakxBe6" title="Weighted average discount rate, operating leases"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-06-30" id="Fact001322" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">6.4</ix:nonFraction></span></td>
<td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Finance lease</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_904_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_z4fe2RW4uQRb" title="Weighted average discount rate, finance leases"><ix:nonFraction name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2025-06-30" id="Fact001324" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.6</ix:nonFraction></span></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90F_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zhSBSeTbvqc8" title="Weighted average discount rate, finance leases"><ix:nonFraction name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2024-06-30" id="Fact001326" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.6</ix:nonFraction></span></td>
<td style="text-align: left">%</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A1_zrVdHwgD7SWf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">The components of lease expense were as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001328" name="us-gaap:LeaseCostTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zljEX1DG6Aqe" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt; width: 56%"><span id="xdx_8BE_zAgY4K5dylD1" style="display: none">Schedule of components of lease expense</span> </td>
<td style="width: 8%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td>
<td id="xdx_498_20240701__20250630_zwJTsmfnQdb" style="text-align: right; width: 12%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td>
<td id="xdx_498_20230701__20240630_zFFQzwnCo355" style="text-align: right; width: 12%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Components of lease expense</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating lease cost</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2024-07-01to2025-06-30" id="Fact001330" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,110,496</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2023-07-012024-06-30" id="Fact001331" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,685,008</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zNsu6kYYDVx5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Finance lease cost:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zC2enzvr4oii" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Depreciation of leased equipment</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2024-07-01to2025-06-30" id="Fact001336" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,881</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:DepreciationOfLeasedEquipment" contextRef="From2023-07-012024-06-30" id="Fact001337" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,881</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Interest on lease liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2024-07-01to2025-06-30" id="Fact001339" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,812</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseInterestExpense" contextRef="From2023-07-012024-06-30" id="Fact001340" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">26,534</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_zS5IjtXWMVfi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total finance lease cost</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2024-07-01to2025-06-30" id="Fact001342" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">215,693</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:FinanceLeaseCost" contextRef="From2023-07-012024-06-30" id="Fact001343" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">225,415</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zw8BjavZC4C6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zendG6pnzNmb" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zvXp3YRbOApi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_233_zGdASA1Z6Ajc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zH6h5URsMxcc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_239_zxBLGyhHELnf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_231_zle5gZg6X5zh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zyPDEjiIyVY6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_235_zB7S2elWTdlg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zRS7SFssdEGf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; OPERATING AND FINANCE LEASES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z9r6wDmCuwnf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Supplemental cash flow information related to leases
was as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001356" name="FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z2nLlQ5RQM4d" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BA_zYxWJuZ5EVlj" style="display: none">Schedule
    of supplemental cash flow information related to leases</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20240701__20250630_zFX1nnOT7YRi" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_495_20230701__20240630_zY41PWDBBtBa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Supplemental cash flow information related to leases</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Cash paid for amounts included in the measurement of lease liabilities:</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zo6hVNilhBz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating cash flows from operating leases</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2024-07-01to2025-06-30" id="Fact001358" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,729,571</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="FONR:OperatingCashFlowsFromOperatingLeases" contextRef="From2023-07-012024-06-30" id="Fact001359" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,363,561</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zUp3F5j14cah" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Financing cash flows from finance leases</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2024-07-01to2025-06-30" id="Fact001361" format="ixt:numdotdecimal" decimals="0" unitRef="USD">264,705</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:FinancingCashFlowsFromFinancingLeases" contextRef="From2023-07-012024-06-30" id="Fact001362" format="ixt:numdotdecimal" decimals="0" unitRef="USD">244,344</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zdnfXNxVLRrk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Right-of-use and equipment assets obtained in exchange for lease obligations:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zFx4RM1MNeek" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Operating leases</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2024-07-01to2025-06-30" id="Fact001367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,319,913</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right"><ix:nonFraction name="FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" contextRef="From2023-07-012024-06-30" id="Fact001368" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,715,138</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for operating leases approximated $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240701__20250630_zpkqqDqSdoMc" title="Operating leases"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2024-07-01to2025-06-30" id="Fact001370" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,110,000</ix:nonFraction></span>
and $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zXAIAMTZgLl3" title="Operating leases"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-07-012024-06-30" id="Fact001372" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,685,000</ix:nonFraction></span>, for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for the finance lease approximated
$<span id="xdx_901_eus-gaap--LeaseIncome_c20240701__20250630_z0t45OaNfeZ" title="financing lease"><ix:nonFraction name="us-gaap:LeaseIncome" contextRef="From2024-07-01to2025-06-30" id="Fact001374" format="ixt:numdotdecimal" decimals="0" unitRef="USD">216,000</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--LeaseIncome_c20230701__20240630_zWb0iyuHy9V6" title="financing lease"><ix:nonFraction name="us-gaap:LeaseIncome" contextRef="From2023-07-012024-06-30" id="Fact001376" format="ixt:numdotdecimal" decimals="0" unitRef="USD">225,000</ix:nonFraction></span> for the years ended June 30, 2025 and 2024, respectively.&#160;</p>

</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001378" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zD38rXrHOOs9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 - <span id="xdx_827_zXWJqVwtJ1O9">OTHER INTANGIBLE ASSETS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other intangible assets, net of accumulated amortization,
at June 30, 2025 and 2024, are comprised of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001380" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_ze6jecy5jy7l" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zjdKFLW30TPa" style="display: none">Schedule of other intangible assets, net of accumulated amortization</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted average useful lives</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Gross carrying amount &#8211; June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Accumulated amortization &#8211; June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Net carrying amount &#8211; June 30, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Capitalized software development costs</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 10%; text-align: right">&#160;&#160;<span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zcxLjNHjo9sb" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt-sec:duryear" id="Fact001382" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">5</ix:nonNumeric></span> years</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zccub73dIco1" title="Gross other intangible assets" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001384" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,004,847</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zenFCJDbiTWe" title="Accumulated amortization intangible assets" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001386" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,004,847</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zNf0GA3B27F1" title=" intangible assets net" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1388">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Software License</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zIdQ5TNLS9t7" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_SoftwareLicenseMember" format="ixt-sec:duryear" id="Fact001390" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">3</ix:nonNumeric></span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zs2WTzhFVN68" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="Fact001392" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,260,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z7gmBJxtnlga" title="Accumulated amortization intangible assets" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="Fact001394" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">756,000</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z9S58DXrYEbc" title=" intangible assets net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="Fact001396" format="ixt:numdotdecimal" decimals="0" unitRef="USD">504,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patents and copy rights</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zXsn4jzgsvt8" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_PatentsAndCopyrightsMember" format="ixt-sec:duryear" id="Fact001398" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">15</ix:nonNumeric></span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmqbV8MRz8t3" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-06-30_custom_PatentsAndCopyrightsMember" id="Fact001400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,229,429</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zoVolr2puTpb" title="Accumulated amortization intangible assets" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2025-06-30_custom_PatentsAndCopyrightsMember" id="Fact001402" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,255,393</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zDMJRimb7izl" title=" intangible assets net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2025-06-30_custom_PatentsAndCopyrightsMember" id="Fact001404" format="ixt:numdotdecimal" decimals="0" unitRef="USD">974,036</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Non-compete</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_904_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zUlA3pNL0DF8" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear" id="Fact001406" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">7</ix:nonNumeric></span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfwnnbDZAip7" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember" id="Fact001408" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,150,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zulGgrVw5Zol" title="Accumulated amortization intangible assets" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember" id="Fact001410" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,150,000</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zepyzPDKoKfd" title=" intangible assets net" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1412">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Customer relationships</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zh8vu5XvfQ22" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" id="Fact001414" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">20</ix:nonNumeric></span> years</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmU99ITjAMi3" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001416" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,900,000</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsNkcMF7qdAk" title="Accumulated amortization intangible assets" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001418" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,385,833</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKxPB3QSMXV6" title=" intangible assets net" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001420" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,514,167</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630_zFfyRNB2Xypi" title="Other intangible assets gross" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-06-30" id="Fact001422" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,544,276</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630_zaHDM4krr7wd" title="Accumulated amortization intangible assets" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2025-06-30" id="Fact001424" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,552,073</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630_zUDro6zeOWLi" title=" intangible assets net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2025-06-30" id="Fact001426" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,992,203</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted average useful lives</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Gross carrying amount &#8211; June 30, 2024</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Accumulated amortization &#8211; June 30, 2024</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Net carrying amount &#8211; June 30, 2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Capitalized software development costs</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 10%; text-align: right">&#160;&#160;<span id="xdx_909_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuHnLpF844F6" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt-sec:duryear" id="Fact001428" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">5</ix:nonNumeric></span> years</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zkdToiDAbXdi" title="Gross other intangible assets" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001430" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,004,847</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zwOYD4f6kkBl" title="Accumulated amortization intangible assets" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" id="Fact001432" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,004,847</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhwffGuiU8hg" title=" intangible assets net" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1434">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patents and copy rights</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zyn1e9LBAJt6" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_PatentsAndCopyrightsMember" format="ixt-sec:duryear" id="Fact001436" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">15</ix:nonNumeric></span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zPaBw6qvJiz8" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember" id="Fact001438" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,259,811</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zwKxMwYWS5C9" title="Accumulated amortization intangible assets" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember" id="Fact001440" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,103,654</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpryeG6JUIO9" title=" intangible assets net" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember" id="Fact001442" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,156,157</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Non-compete</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_907_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z23R4E4QgYL1" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt-sec:duryear" id="Fact001444" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">7</ix:nonNumeric></span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zS0aXBWjl8th" title="Gross other intangible assets" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember" id="Fact001446" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,150,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPx3nknpgai8" title="Accumulated amortization intangible assets" style="text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember" id="Fact001448" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,150,000</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWacoQ7pjq9b" title=" intangible assets net" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1450">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Customer relationships</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CostomerRelationshipsMember_zIr2O851xmgb" title="Weighted average useful lives"><ix:nonNumeric contextRef="From2023-07-012024-06-30_custom_CostomerRelationshipsMember" format="ixt-sec:duryear" id="Fact001452" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">20</ix:nonNumeric></span> years</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5jpHyQUy8o5" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001454" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,900,000</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXMVF3Q2PLof" title="Accumulated amortization intangible assets" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001456" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,185,833</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDUXS7F6ngUk" title=" intangible assets net" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001458" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,714,167</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zEeNu0QefyF7" title="Other intangible assets gross" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-06-30" id="Fact001460" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,314,658</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_ztndbXvjdv91" title="Accumulated amortization intangible assets" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-06-30" id="Fact001462" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,444,334</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zR5LdadD7Pbg" title=" intangible assets net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-06-30" id="Fact001464" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,870,324</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AA_ziCJEZp9ikx" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zgoRMKG5YSMf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zqVedLcVi1C7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_237_z8emak3ye0z" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zE3KEohvNDQ" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z6z4qfl9Eunh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zi5YWLDx1ffl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zZBvdjcahi4c" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zG9mJfZYi90b" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_z46PrXSJ9VE" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 - OTHER INTANGIBLE ASSETS (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_ztgHAAakwRZa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated amortization of other intangible assets
for the five years ending June 30, 2030 and thereafter is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001476" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zL4CB7bn6WA6" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span id="xdx_8B8_zXfFJHBEFVI" style="display: none">Schedule of estimated amortization of other intangible assets</span></td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Schedule Of Other Intangible Assets For the Years Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Software License</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Patents and Copyrights</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Customer Relationships</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 23%; text-align: center; text-indent: -10pt">2026</td><td style="width: 1%; text-align: center">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630_zCCOdsJlVbll" title="2025" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2025-06-30" id="Fact001478" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">756,880</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zdwFGC3NAu84" title="2025" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="Fact001480" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">420,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zr0THmwWgClg" title="2025" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2025-06-30_us-gaap_PatentsMember" id="Fact001482" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">136,880</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5ZEtCVj8JJd" title="2025" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001484" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2027</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630_zgLcCYoSisD3" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2025-06-30" id="Fact001486" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">402,426</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zsXJcdAqVhZc" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="Fact001488" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">84,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zCcqbtaWH4" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2025-06-30_us-gaap_PatentsMember" id="Fact001490" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">118,426</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zJDzhMS8sD2i" title="2026" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001492" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2028</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630_zp71AsATWC58" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2025-06-30" id="Fact001494" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">306,103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zqM2uyzgpzca" title="2027" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1496">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zJQ67hcmp083" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2025-06-30_us-gaap_PatentsMember" id="Fact001498" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z46a9Lcsf8Rf" title="2027" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001500" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2029</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630_zYTCc38ldubk" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2025-06-30" id="Fact001502" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">295,898</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zUHrCSjwdsOd" title="2028" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1504">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zExzTjdojVo4" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2025-06-30_us-gaap_PatentsMember" id="Fact001506" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">95,898</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvA4gKxrJVQ7" title="2028" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001508" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2030</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630_znyGkY0Rl8T7" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2025-06-30" id="Fact001510" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">291,464</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zU31l1ljdJgg" title="2029" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1512">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zDgEwO9Sn4pb" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2025-06-30_us-gaap_PatentsMember" id="Fact001514" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">91,464</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvSZI8HnqoM5" title="2029" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001516" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630_zDTUNpSSRAhd" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2025-06-30" id="Fact001518" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">939,432</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zduRQIijkgnb" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1520">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zeibptIFYaTd" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2025-06-30_us-gaap_PatentsMember" id="Fact001522" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">425,265</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zePM4ZpuYHK4" title="Thereafter" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001524" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">514,167</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Other intangible assets - net</span></td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630_zEj0yRJlnV37" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2025-06-30" id="Fact001526" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,992,203</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zylRkfbEs2ua" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember" id="Fact001528" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">504,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zTIbmCIdVqvf" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2025-06-30_us-gaap_PatentsMember" id="Fact001530" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">974,036</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyxLZ2YzBNZ6" title="Other intangible assets - net" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001532" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,514,167</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A0_zzFGz7Mz7Dr6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average amortization period for other
intangible assets is <span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630_z1fIAEwKl9N7" title="Weighted average amortization period for other intangible assets"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt-sec:duryear" id="Fact001534" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">9.0</ix:nonNumeric></span> years and they have no expected residual value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Information related to the above intangible assets
for the years ended June 30, 2025 and 2024 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001536" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zrN1IKH3zeIj" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zRoyqIjQvYx1" style="display: none">Schedule of other
    intangible assets</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other Intangible Assets</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year-ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Balance &#8211; Beginning of Year</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20240701__20250630_zPr8UzMW4XF6" title="Balance - Beginning of Year" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2024-06-30" id="Fact001538" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,870,324</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zThxwgeLT55b" title="Balance - Beginning of Year" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2023-06-30" id="Fact001540" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,431,865</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Amounts capitalized</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AmountsCapitalized_pp0p0_c20240701__20250630_zj02muTNgbPk" title="Amounts capitalized" style="text-align: right"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2024-07-01to2025-06-30" id="Fact001542" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,325</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zo9yVbNL1SA5" title="Amounts capitalized" style="text-align: right"><ix:nonFraction name="FONR:AmountsCapitalized" contextRef="From2023-07-012024-06-30" id="Fact001544" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">32,885</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patents written off</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20240701__20250630_zKST22nSdIVi" title="Patents written off" style="text-align: right">(<ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2024-07-01to2025-06-30" id="Fact001546" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">55,707</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20230701__20240630_zEDW1XF8MExa" title="Patents written off" style="text-align: right">(<ix:nonFraction name="FONR:SoftwareOrPatentsWrittenOff" contextRef="From2023-07-012024-06-30" id="Fact001548" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">225,419</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Correction of an error (Note 2)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--CorrectionOfError_pp0p0_c20240701__20250630_zJx9QIn2tu66" title="Correction of an error" style="text-align: right"><ix:nonFraction name="FONR:CorrectionOfError" contextRef="From2024-07-01to2025-06-30" id="Fact001550" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">882,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_ecustom--CorrectionOfError_pp0p0_c20230701__20240630_zUbBj2Bx5eC9" title="Correction of an error" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1552">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Amortization</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AdjustmentForAmortization_pp0p0_c20240701__20250630_zJWS5jv7WHnc" title="Amortization" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2024-07-01to2025-06-30" id="Fact001554" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">729,739</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zySzxFdKmeq9" title="Amortization" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2023-07-012024-06-30" id="Fact001556" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">369,007</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Balance &#8211; End of Year</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_981_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20240701__20250630_zCpYmqM2OMs" title="Balance - End of Year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2025-06-30" id="Fact001558" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,992,203</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zZh2Rb5CEhta" title="Balance - End of Year" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherIntangibleAssetsNet" contextRef="AsOf2024-06-30" id="Fact001560" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,870,324</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AF_zhoq1KTUX1i7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of patents and copyrights for the years
ended June 30, 2025 and 2024 amounted to $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zAFME4lTP5rc" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-07-012025-06-30_us-gaap_PatentsMember" id="Fact001562" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">151,739</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zalYfKXEXdqd" title="Amortization of patents and copyrights"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-07-012024-06-30_us-gaap_PatentsMember" id="Fact001564" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">169,007</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of customer relationships for the years
ended June 30, 2025 and 2024 amounted to $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zpzQG8QCvw84" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-07-012025-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001566" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyjCG4uFWuPk" title="Amortization of customer relationships"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember" id="Fact001568" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">200,000</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Amortization of software licenses for the years
ended June 30, 2025 and 2024 amounted to $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_ztuveKsPBA4i" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-07-012025-06-30_custom_SoftwareLicensesMember" id="Fact001570" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">378,000</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_zpqZDJfGWJk8" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-07-012024-06-30_custom_SoftwareLicensesMember" id="Fact001572" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23B_zFeJfizzKNq9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zNg2uQkzldj4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zWRM96FS02He" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zqmghPGa5lch" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zIggyFdXp642" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_236_zKGe54jHWkE3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zvlVLod2BKo5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23C_z4r3kmb5fC0e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001582" name="FONR:CapitalStockDisclosureTextblock"><p id="xdx_80C_ecustom--CapitalStockDisclosureTextblock_zHHv1W1A8TZ6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 - <span id="xdx_827_z4QSNReuWRng">CAPITAL STOCK</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90A_eus-gaap--DividendsPayableNature_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXSswjGHQ8Ie" title="Dividends payable, nature"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718" id="Fact001584" name="us-gaap:DividendsPayableNature">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock</ix:nonNumeric></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class B Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_905_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKQyhbPpBhL" title="Conversuion of shares into one-for-one basis"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_CommonClassBMember" id="Fact001586" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">Class B common stock is convertible into shares of
common stock on a one-for-one basis</ix:nonNumeric></span>. <span id="xdx_903_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zJol8IZHUJS4" title="Common stock, voting rights"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_CommonClassBMember" id="Fact001588" name="us-gaap:CommonStockVotingRights">Class B common stock has 10 votes per share</ix:nonNumeric></span>. There were <span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zdo5EDKZUmwi" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember" id="Fact001590" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">146</ix:nonFraction></span> of such shares outstanding at June 30,
2025and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class C Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_901_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3pQJwiLOxbd" title="Common stock, voting rights"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember" id="Fact001592" name="us-gaap:CommonStockVotingRights">The Class C common stock has 25 votes per share</ix:nonNumeric></span>, as
compared to 10 votes per share for the Class B common stock and <span id="xdx_903_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zS7ACJoeO16b" title="Common stock, voting rights"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718" id="Fact001594" name="us-gaap:CommonStockVotingRights">one vote per share for the common stock</ix:nonNumeric></span>. <span id="xdx_900_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zM2dDRgKwQia"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember" id="Fact001595" name="us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock</ix:nonNumeric></span>. Although having greater voting power, each share of Class
C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock
is convertible into shares of common stock on a three-for-one basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class A Non-Voting Preferred Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified a proposal
consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a
stock dividend on the Company&#8217;s common stock consisting of <span id="xdx_90B_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zJy7J9MEIbbg"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_PreferredClassAMember" id="Fact001596" name="us-gaap:CommonStockVotingRights">one share of Class A non-voting preferred stock for every five shares
of common stock</ix:nonNumeric></span>. <span id="xdx_903_eus-gaap--DividendsPayableNature_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zIo256cYieN1"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_PreferredClassAMember" id="Fact001597" name="us-gaap:DividendsPayableNature">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares</ix:nonNumeric></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock is entitled
to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next $20 million and 5-1/2% on amounts in excess of $30
million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company&#8217;s
patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company&#8217;s
patents.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock participates
on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights,
liquidation rights and other rights and preferences (other than the voting rights).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zJU4POp37tG2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zOv0zKmaT6Jc" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zz75cUoqXMB6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_230_zVhudcl61Yz4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_za1jk9h6OUm7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_235_zP2ERKPHPrcl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zk4JWrf0Pb0h" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_236_zWC2wkgjVOz8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zlafJJrnpQT6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 - CAPITAL STOCK (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zZdw4y13RUZ3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock Bonus Plans</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 23, 2010, the Board approved the 2010 Stock
Bonus Plan. The plan entitles the Company to reserve <span id="xdx_901_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zgOy0mSFNc3f" title="Common stock, capital shares reserved for future issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember" id="Fact001609" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares of common stock. On August 10, 2010, the Company filed Form S-8
to register the <span id="xdx_90E_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zfjS1k6B8Ydk" title="Shares registered"><ix:nonFraction name="FONR:SharesRegistered" contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember" id="Fact001611" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></span> shares. As of June 30, 2025, <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20250630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_z03zCl9loHLh" title="Number of shares available for future grant"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2025-06-30_custom_N2010StockBonusPlanMember" id="Fact001613" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">450,177</ix:nonFraction></span> shares of common stock of FONAR were available for future grant under this
plan. For the years ended June 30, 2025 and 2024, <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230701__20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zCU20jmQtUH8" title="Number of shares were issued"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20240701__20250630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zXE6TBaGNNp" title="Number of shares were issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2023-07-012024-06-30_custom_N2010StockBonusPlanMember" id="Fact001615" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2024-07-012025-06-30_custom_N2010StockBonusPlanMember" id="Fact001617" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></span></span> shares were issued.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Treasury Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a stock
repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On September 26,
2022, the Board of Directors has approved up to $<span id="xdx_90F_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20230925__20230926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zBELBrIsbBj" title="Payments for repurchase of equity"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfEquity" contextRef="From2023-09-252023-09-26_srt_BoardOfDirectorsChairmanMember" id="Fact001619" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">9</ix:nonFraction></span> million to be repurchased under the plan which will be purchased on the publicly traded
open market at prevailing prices.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes the cost method of accounting
to value the treasury stock when repurchasing stock. Under this method, the shares are valued at the price paid and recorded to treasury
stock. When the treasury stock is cancelled, the par value of the stock is reduced and the additional paid in capital is reduced for the
remaining value based upon the original stock sale. For the year ended June 30, 2025, the Company purchased <span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20240701__20250630_ziC7ZUk2DtMa" title="Purchase of treasury shares"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-07-01to2025-06-30" id="Fact001621" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">114,588</ix:nonFraction></span> shares at a cost of
$<span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20240701__20250630_zjNDndiUXsIe" title="Purchase of treasury stock"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-07-01to2025-06-30" id="Fact001623" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,806,646</ix:nonFraction></span> and cancelled <span id="xdx_906_ecustom--CancellationOfTreasuryShares_c20240701__20250630_zV3dOSUXvfC5" title="Cancellation of treasury shares"><ix:nonFraction name="FONR:CancellationOfTreasuryShares" contextRef="From2024-07-01to2025-06-30" id="Fact001625" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">124,829</ix:nonFraction></span> shares valued at $<span id="xdx_904_ecustom--CancellationOfTreasuryStock_c20240701__20250630_zd77AnbpJYRb" title="Cancellation of treasury stock"><ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2024-07-01to2025-06-30" id="Fact001627" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,963,385</ix:nonFraction></span>. For the year ended June 30, 2024, the Company purchased <span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_c20230701__20240630_z8tHhEUgsEV" title="Purchase of treasury shares"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-07-012024-06-30" id="Fact001629" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,206</ix:nonFraction></span> shares at
a cost of $<span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20230701__20240630_zSFoSXgGTX1d" title="Purchase of treasury stock"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-07-012024-06-30" id="Fact001631" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,505,832</ix:nonFraction></span> and cancelled <span id="xdx_904_ecustom--CancellationOfTreasuryShares_c20230701__20240630_z80tr1Ky5Noc" title="Cancellation of treasury shares"><ix:nonFraction name="FONR:CancellationOfTreasuryShares" contextRef="From2023-07-012024-06-30" id="Fact001633" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">122,588</ix:nonFraction></span> shares valued at $<span id="xdx_90B_ecustom--CancellationOfTreasuryStock_c20230701__20240630_z17TtO9LLUwl" title="Cancellation of treasury stock"><ix:nonFraction name="FONR:CancellationOfTreasuryStock" contextRef="From2023-07-012024-06-30" id="Fact001635" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,005,020</ix:nonFraction></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001637" name="us-gaap:MinorityInterestDisclosureTextBlock"><p id="xdx_808_eus-gaap--MinorityInterestDisclosureTextBlock_zOQRYD6kMSd8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>NOTE 9 &#8211; <span id="xdx_829_zvV9abneTIy6">CONTROLLING AND NONCONTROLLING
INTERESTS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 13, 2013, the Company entered into an
agreement with outside investors to acquire a 50.5% controlling interest in a newly formed limited liability company, Health Diagnostics
Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM there are two classes of members; Class A members
and one Class B member. The Class A members have an ownership interest of <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zJnzlOamuYy" title="Ownership interest"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember" id="Fact001639" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">49.5</ix:nonFraction></span>% of HDM. The Class B member (HMCA) has an ownership of
<span id="xdx_90B_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zCG94vL5D1oi" title="Ownership percenatge"><ix:nonFraction name="FONR:EquityMethodInvestmentOwnershipPercentages" contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember" id="Fact001641" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">50.5</ix:nonFraction></span>% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage
of ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be
allocated among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be allocated
solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions of
the operating agreement. The Company contributed $<span id="xdx_903_ecustom--ProceedsFromContributionsFromCompany_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zHaHjctPjc09" title="Company contribution"><ix:nonFraction name="FONR:ProceedsFromContributionsFromCompany" contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember" id="Fact001643" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,200,000</ix:nonFraction></span> to HDM and the group of outside investors contributed $<span id="xdx_90C_eus-gaap--ProceedsFromContributionsFromAffiliates_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zg0zi1EU0xe6" title="Investors contribution"><ix:nonFraction name="us-gaap:ProceedsFromContributionsFromAffiliates" contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember" id="Fact001645" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,800,000</ix:nonFraction></span> for its
non-controlling membership interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_z7hC27bImVO9" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zf5nJ8G2X2qg" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zSjxC2hK7xdk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_231_zWtg0Wwtaq59" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_237_zOjuYdnuRnc9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_237_zJhVlfqX7Q5d" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zJuCFEmP4gna" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_236_zmVGD84ZsKXh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zRQSoDbI88z9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>NOTE 9 &#8211; CONTROLLING AND NONCONTROLLING
INTERESTS (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zAUqgTtsjJLb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 5, 2013, HDM purchased from Health Diagnostics,
LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve (<span id="xdx_909_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zhJIGAIvrwqa" title="Purchase of stand up MRI centers"><ix:nonFraction name="FONR:PurchaseOfStandupMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001657" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">12</ix:nonFraction></span>) Stand-Up MRI Centers and two (<span id="xdx_906_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zkSu6U7LrsVg" title="Purchase of other MRI centers"><ix:nonFraction name="FONR:PurchaseOfOtherMriCenters" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001659" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">2</ix:nonFraction></span>) other scanning
centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_906_ecustom--ConsiderationToOutsideInvestors_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zRErML6KEiIj" title="HDM purchase price includes consideration to outside investors"><ix:nonFraction name="FONR:ConsiderationToOutsideInvestors" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001661" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million to outside investors)
aggregating $<span id="xdx_909_ecustom--TotalPurchasePrice_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zwN76PEMC0H7" title="HDM purchase from Health Diagnostics (HD) ($)"><ix:nonFraction name="FONR:TotalPurchasePrice" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001663" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">35.9</ix:nonFraction></span> million. Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a
consideration of $<span id="xdx_901_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zCjOqaWpT1ni" title="HDM entered agreement for consulting and non-competition agreement ($)"><ix:nonFraction name="FONR:ConsiderationForNoncompetitionAndConsultingAgreements" contextRef="AsOf2013-03-05_custom_HDMMember" id="Fact001665" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.1</ix:nonFraction></span> million. The acquisition was accounted for using the purchase method in accordance with ASC 805, &#8220;Business
Combinations&#8221;. The Company recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration
paid over the fair value of the identified net assets acquired.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 8, 2015, the Company purchased <span id="xdx_904_ecustom--EquityMethodInvestmentsOwnershipPercentage_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zddzxwihBdvg" title="Purchase of interests from Class A,  percentage"><ix:nonFraction name="FONR:EquityMethodInvestmentsOwnershipPercentage" contextRef="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001667" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">20</ix:nonFraction></span>% of the
Class A members ownership interest at a cost of $<span id="xdx_902_ecustom--DirectPurchaseOfNoncontrollingInterests_c20150107__20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zVSQSNLcO1bf" title="Purchase of interests from Class A"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2015-01-072015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001669" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,971,094</ix:nonFraction></span>. The Company has a <span id="xdx_902_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zEVBzxUQyT4e" title="Ownership interest in HDM"><ix:nonFraction name="FONR:EquityMethodInvestmentOwnershipPercentages" contextRef="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001671" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">60.4</ix:nonFraction></span>% ownership interest in HDM after this transaction.
During the year ended June 30, 2025, the Company sold non-controlling interests to a minority shareholder for $<span id="xdx_90E_ecustom--DirectPurchaseOfNoncontrollingInterests_c20240701__20250630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zWlzXP9AS6nk" title="Purchase of interests from Class A"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2024-07-012025-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001673" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,000</ix:nonFraction></span>. Currently, the
Company has a direct ownership interest of <span id="xdx_905_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20250630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z8XBiCfXtdI8" title="Ownership interest of company"><ix:nonFraction name="FONR:EquityMethodInvestmentOwnershipPercentages" contextRef="AsOf2025-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember" id="Fact001675" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">70.63</ix:nonFraction></span>% and the investors have a <span id="xdx_902_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20250630__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zxHxwmtuVmV2" title="Ownership interest of investors"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2025-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember" id="Fact001677" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">29.37</ix:nonFraction></span>% ownership interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The amount of each class of HDM members&#8217; equity
as of June 30, 2025 and 2024 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001679" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zpwpGT1apE59" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8B6_ztEq0iopB5sf" style="display: none">Schedule of HDM members equity</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Opening Members&#8217; Equity</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">($</td>
<td id="xdx_98A_ecustom--OpeningMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_znAiHf3KbFXi" title="Opening Members Equity" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001681" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,179,608</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zOzt0JgVBvH5" title="Opening Members Equity" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001683" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,817,830</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">($</td>
<td id="xdx_98B_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zy1PfSKSslRl" title="Opening Members Equity" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001685" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,079,293</ix:nonFraction></td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zL92Du8S0pFc" title="Opening Members Equity" style="width: 10%; text-align: right"><ix:nonFraction name="FONR:OpeningMembersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001687" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">54,781,813</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Share of Net Income</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zN67kbqHXNg5" title="Share of Net Income" style="text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001689" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,339,172</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_ecustom--ShareOfNetIncome_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zsL9ATWwlLxl" title="Share of Net Income" style="text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001691" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,727,492</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zp0r4EGY1gOh" title="Share of Net Income" style="text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001693" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,530,021</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf3oB7e51JX" title="Share of Net Income" style="text-align: right"><ix:nonFraction name="FONR:ShareOfNetIncome" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001695" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,705,681</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Buyout of noncontrolling interests</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterests_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZ4IGG0V58N4" title="Buyout of noncontrolling interests" style="text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterests" contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001697" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,425</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zjbgjtgpquH5" title="Buyout of noncontrolling interests" style="text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001699" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8h5a5quHYp9" title="Buyout of noncontrolling interests" style="text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001701" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWRKx4RFYZo3" title="Buyout of noncontrolling interests" style="text-align: right"><ix:nonFraction name="FONR:BuyoutOfNoncontrollingInterestsValue" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001703" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8212;</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Distributions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zmRjD8Qqi74j" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001705" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,682,555</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--Distributions_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zw7Jo6pay2Zh" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001707" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">13,717,445</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVUBnojSS3H5" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001709" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,630,336</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_980_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_ztvFqtzuEfn8" title="Distributions" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="FONR:Distributions" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001711" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">13,669,664</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Ending Members&#8217; Equity</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">($</td>
<td id="xdx_985_ecustom--EndingMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zY4atZ3U5BTe" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001713" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,503,566</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_ecustom--EndingMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zXmeCBvFCRB" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001715" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,827,877</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">($</td>
<td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKfVE2Zz3Olb" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember" id="Fact001717" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,179,608</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZYNXjJopy5k" title="Ending Members Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:EndingMembersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember" id="Fact001719" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,817,830</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>



</ix:nonNumeric><p id="xdx_8A1_zG6j4j8tNkW4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zozmAgJz1t43" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_235_z5jjQdBcY7n2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zM0IJYpVgY5a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zSNNODptJiZf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zL1AarStiY36" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23E_z5Za3DPBba2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_zJLHLYeZC4Q3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zsKmeCb8cwie" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001729" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zwqHCMplvoi9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 - <span id="xdx_82B_zCieNvn11PA9">INCOME TAXES</span> </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income tax expense is computed using an asset and
liability method using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from
temporary differences in the financial reporting basis and the income tax basis of assets and liabilities. The measurement of deferred
tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized.
When it appears more than likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred
tax asset to its realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether or
net deferred tax assets are more likely than not to be realized.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has recorded a deferred tax asset of $<span id="xdx_905_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20250630_z9ALEifb1yPc" title="Deferred tax asset"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2025-06-30" id="Fact001731" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,349,194</ix:nonFraction></span>
and a deferred tax liability of $<span id="xdx_90B_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pp0p0_c20250630_zsXjJYEyfQB4" title="Deferred tax liability"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2025-06-30" id="Fact001733" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">321,159</ix:nonFraction></span> as of June 30, 2025, primarily relating to its allowance for credit losses of $4,366,000, non
deductible accruals of <span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20250630_zclB3ZoWuf54" title="Allowance for doubtful accounts and tax credits">$<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2025-06-30" id="Fact001735" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">759,000</ix:nonFraction></span> and capitalized research and development costs of approximately $<span id="xdx_904_ecustom--CapitalizedResearchAndDevelopmentCosts_c20240701__20250630_zAbzgrodLgzb" title="Capitalized Research and development costs"><ix:nonFraction name="FONR:CapitalizedResearchAndDevelopmentCosts" contextRef="From2024-07-01to2025-06-30" id="Fact001737" format="ixt:numdotdecimal" decimals="0" unitRef="USD">960,000</ix:nonFraction></span>. During fiscal 2025, the Company
utilized all tax credits pertaining to research and development costs. In addition the Company has state operating loss carryforwards
of approximately $<span id="xdx_90C_eus-gaap--OtherOperatingIncome_pp0p0_c20240701__20250630_zb79VO5uq04a" title="City operating loss carryforwards"><ix:nonFraction name="us-gaap:OtherOperatingIncome" contextRef="From2024-07-01to2025-06-30" id="Fact001739" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,694,000</ix:nonFraction></span>. The Company has also fully recorded a valuation allowance against all of the state operating losses since
the Company doesn&#8217;t anticipate being able to utilize them.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company files corporate income tax returns in
the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject to federal,
state and local income tax examinations by tax authorities for years prior to 2021.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Future ownership changes as determined under Section
382 of the Internal Revenue code could further limit the utilization of net operating loss carryforwards. As of June 30, 2025, no such
changes in ownership have occurred.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 4, 2025, the One Big Beautiful Act (&#8220;OBBBA)
was signed into law, which enacts significant changes to the U.S. tax and related laws. Some of the provisions of the new tax law that
affect corporations include but are not limited to expensing of domestic specified research or experimental expenditures, increasing the
limit of the deduction to thirty percent of EBITDA, and one hundred percent bonus depreciation on eligible property acquired after January
19, 2025. The Company is currently evaluating the impact that the new tax law will have on its financial condition and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The valuation allowance for deferred tax assets decreased
during the year ended June 30, 2025, by approximately $<span id="xdx_907_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_c20250630_zJ79D1SD1ugg" title="Valuation allowance for deferred tax assets"><ix:nonFraction name="us-gaap:DeferredTaxAssetInterestCarryforward" contextRef="AsOf2025-06-30" id="Fact001741" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,000</ix:nonFraction></span>. The valuation allowance decreased by approximately $<span id="xdx_902_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_c20240630_zwDMVPpsRLPk" title="Valuation allowance for deferred tax assets"><ix:nonFraction name="us-gaap:DeferredTaxAssetInterestCarryforward" contextRef="AsOf2024-06-30" id="Fact001743" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">171,000</ix:nonFraction></span> during the
year ended June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zyg8wz4tpNs1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zKsgW4oZe8zh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_z0Js5JAm9OUj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zrR6nQ6N0NN8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_234_zovsOdinOPTe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_232_zLkhH0KAAn76" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zoTfWCVi7bad" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_234_zRlgSDBpHIq" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zTwx3n1OhSV" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 - INCOME TAXES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zuMoDr6obTt1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Components of the provision for income taxes are as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001755" name="FONR:ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock_zz2bPnivJCki" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_zVYIGvubxmBc" style="display: none">Schedule of Components of the provision for income taxes</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20240701__20250630_zNWfMiMq1BGj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20230701__20240630_zhGo1SbZ6RSg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center">Components Of The Provision For Income Taxes</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
  <tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_z4sjRIQCIxl6" style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Current:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBKFrCZoWccj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; width: 56%; text-align: left; text-indent: -10pt">Federal</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact001760" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,374,724</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact001761" format="ixt:numdotdecimal" decimals="0" unitRef="USD">429,873</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_z2YvX6RlehAh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact001763" format="ixt:numdotdecimal" decimals="0" unitRef="USD">908,421</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact001764" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,943,588</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_zNJThTghetXh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact001766" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,283,145</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact001767" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,373,461</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z09UcrD66KK7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zqnWvJAgXFb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Federal deferred taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact001772" format="ixt:numdotdecimal" decimals="0" unitRef="USD">838,154</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact001773" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,585,515</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zYOEr0CVljE5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">State deferred taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact001775" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">14,494</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact001776" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,992</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zLSBIH1IY46d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:DeferredIncomeTaxExpensesBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact001778" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">823,660</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="FONR:DeferredIncomeTaxExpensesBenefit" contextRef="From2023-07-012024-06-30" id="Fact001779" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,795,507</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zKt4ZyHUsn0b" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; color: white; text-align: left; text-indent: -10pt">Provision (Benefit) for Income Taxes - Net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact001781" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,106,805</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact001782" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,168,968</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zFHbYG0Uww4j" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A reconciliation of the federal statutory income tax
rate to the Company&#8217;s effective tax rate as reported is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001784" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zSU7EnsUeiKd" summary="xdx: Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zjIR4qgQDwW1" style="display: none">Schedule of
    reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended <br/>June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended <br/>June 30, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percent</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percent</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Taxes at federal statutory rate</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20240701__20250630_z5lBSEif7UZ3" title="Taxes at federal statutory rate" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2024-07-01to2025-06-30" id="Fact001786" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,893,850</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_90B_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20240701__20250630_zBWJGmEN7a92" title="Taxes at federal statutory rate"><ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" contextRef="From2024-07-01to2025-06-30" id="Fact001788" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">21</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20230701__20240630_z7QRiu2Qjzr9" title="Taxes at federal statutory rate" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2023-07-012024-06-30" id="Fact001790" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,169,123</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zestd6NqfEx8" title="Taxes at federal statutory rate"><ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" contextRef="From2023-07-012024-06-30" id="Fact001792" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">21</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">State and local income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20240701__20250630_zSMHn7mBRHuh" title="State and local income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2024-07-01to2025-06-30" id="Fact001794" format="ixt:numdotdecimal" decimals="0" unitRef="USD">978,397</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240701__20250630_zMB8pBpb1hGi" title="State and local income taxes (benefit), net of federal benefit"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2024-07-01to2025-06-30" id="Fact001796" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">7.1</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20230701__20240630_zv2aGkbsy4N1" title="State and local income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-07-012024-06-30" id="Fact001798" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,409,561</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zHEMJnAPkkf8" title="State and local income taxes (benefit), net of federal benefit"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-07-012024-06-30" id="Fact001800" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">7.1</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20240701__20250630_zhFBbtOCAfdb" title="Noncontrolling interests" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" contextRef="From2024-07-01to2025-06-30" id="Fact001802" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657,307</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20240701__20250630_zDBHq1mAvsMg" title="Noncontrolling interest"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2024-07-01to2025-06-30" id="Fact001804" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.6</ix:nonFraction></span></td><td style="text-align: left">%)</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20230701__20240630_zhjJx9fQ2xF5" title="Noncontrolling interests" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" contextRef="From2023-07-012024-06-30" id="Fact001806" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,049,294</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zn4mlqn8ltCe" title="Noncontrolling interest"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" contextRef="From2023-07-012024-06-30" id="Fact001808" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">5.3</ix:nonFraction></span></td><td style="text-align: left">%)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation Allowance</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20240701__20250630_zRsLtTysp0yb" title="Valuation Allowance" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2024-07-01to2025-06-30" id="Fact001810" format="ixt:numdotdecimal" decimals="0" unitRef="USD">218,390</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240701__20250630_zRJrtnPyh7U2" title="Change in the valuation allowance"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2024-07-01to2025-06-30" id="Fact001812" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.6</ix:nonFraction></span></td><td style="text-align: left">%)</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20230701__20240630_zhL2kBthQ037" title="Valuation Allowance" style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-07-012024-06-30" id="Fact001814" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,179</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_zCSZSkVQ8CUi" title="Change in the valuation allowance"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-07-012024-06-30" id="Fact001816" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.2</ix:nonFraction></span></td><td style="text-align: left">%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Permanent items &#8211; Meals and Entertainment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--PermanentItemsMealsEntertainment_c20240701__20250630_zfGovqFcLr36" title="Permanent items Meals and Entertainment" style="text-align: right"><ix:nonFraction name="FONR:PermanentItemsMealsEntertainment" contextRef="From2024-07-01to2025-06-30" id="Fact001818" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,956</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20240701__20250630_zaZ9J9obG4ce" title="Permanent items Meals and Entertainment"><ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" contextRef="From2024-07-01to2025-06-30" id="Fact001820" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--PermanentItemsMealsEntertainment_c20230701__20240630_ziTkJVTQyD16" title="Permanent items Meals and Entertainment" style="text-align: right"><ix:nonFraction name="FONR:PermanentItemsMealsEntertainment" contextRef="From2023-07-012024-06-30" id="Fact001822" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,719</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20230701__20240630_zYtUHBdm1hT3" title="Permanent items Meals and Entertainment"><ix:nonFraction name="FONR:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" contextRef="From2023-07-012024-06-30" id="Fact001824" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.5</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">($</td><td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20240701__20250630_z1pQwvIR8BE1" title="Other" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount" contextRef="From2024-07-01to2025-06-30" id="Fact001826" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,701</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20240701__20250630_zVcX6F8bvXy9" title="Other"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2024-07-01to2025-06-30" id="Fact001828" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.8</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20230701__20240630_zpWQYUB1r5w9" title="Other" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount" contextRef="From2023-07-012024-06-30" id="Fact001830" format="ixt:numdotdecimal" decimals="0" unitRef="USD">561,038</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zZgzn6KXVuy1" title="Other"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2023-07-012024-06-30" id="Fact001832" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.7</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Provision for income taxes </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">($</td><td id="xdx_98C_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20240701__20250630_zZ8BW4ExFSAc" title="Ending Members' Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:IncomeTaxReconciliationIncomeTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact001834" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,106,805</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20240701__20250630_z1bV4CRSHyZi" title="Effective income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2024-07-01to2025-06-30" id="Fact001836" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">22.8</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20230701__20240630_zxXNNNDCHvf1" title="Ending Members' Equity" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="FONR:IncomeTaxReconciliationIncomeTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact001838" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,168,968</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z4QGQjp0IBCj" title="Effective income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-07-012024-06-30" id="Fact001840" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">26.8</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A8_zYaTG4tAiLq7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zCa2YkN5wjk2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zBBd1BpLD3O7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zj6ZOLLdyp0b" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zHS1U7sqkGnc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_z0SbGQjLHVTe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_239_zact0oQCBaVj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zJqssaBjYgme" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_237_z01aPdggXJgf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zsR6ubNvEbE3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 - INCOME TAXES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zPqjx71asf5a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 20pt; text-align: justify">The Company has, for federal income tax
purposes, research and development tax credits and investments tax credits carryforwards aggregating $<span id="xdx_904_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_c20250630_zBIwLx86w5Bf" title="Tax credits carryforwards"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="AsOf2025-06-30" id="Fact001852" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,323,000</ix:nonFraction></span>
as of June 30, 2024. The Company will utilize the full amount for the tax return for the year ended June 30, 2025. These credits can
only be applied after all net operating losses have been used.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Significant components of the Company&#8217;s
deferred tax assets and liabilities at June 30, 2025 and 2024 are as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001854" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zJ4GhaoisuD3" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_ziw2zpP5IrBd" style="display: none">Schedule of deferred tax assets and liabilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49F_20250630_zkbs7EP954tl" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_497_20240630_zhsAJliltjI8" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred tax assets:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zECLwk7a3q6l" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Allowance for credit losses</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2025-06-30" id="Fact001859" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,366,361</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2024-06-30" id="Fact001860" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,969,819</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zlrJbuynPcNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Non-deductible accruals</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2025-06-30" id="Fact001862" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">758,700</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2024-06-30" id="Fact001863" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">758,700</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_z1aIgKDE1uT7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net operating carryforwards</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2025-06-30" id="Fact001865" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">259,319</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2024-06-30" id="Fact001866" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">396,092</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_z31GL3XssfB2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Tax credits</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1868">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" contextRef="AsOf2024-06-30" id="Fact001869" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,323,018</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z8wqoW8RyNjk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Capitalized research and development</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2025-06-30" id="Fact001871" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">960,343</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" contextRef="AsOf2024-06-30" id="Fact001872" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">747,407</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zztmHsOrxxO4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Right of use assets and lease liabilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities" contextRef="AsOf2025-06-30" id="Fact001874" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">146,934</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities" contextRef="AsOf2024-06-30" id="Fact001875" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">114,116</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zlVY0ZqpyoKa" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Inventories</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2025-06-30" id="Fact001877" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,856</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsInventory" contextRef="AsOf2024-06-30" id="Fact001878" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">106,879</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zL69hTFpyRm6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred Tax Assets - gross</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2025-06-30" id="Fact001880" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,608,513</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2024-06-30" id="Fact001881" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,416,031</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zs6ELT8t4z21" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation allowance</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2025-06-30" id="Fact001883" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">259,319</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-06-30" id="Fact001884" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">192,776</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z11MhnyXQ4k7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total deferred tax assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2025-06-30" id="Fact001886" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,349,194</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-06-30" id="Fact001887" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,223,255</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--PropertyAndEquipmentAndDepreciation_iI_pp0p0_maDTLzImD_zEt0WogS8q44" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Property and equipment and depreciation</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:PropertyAndEquipmentAndDepreciation" contextRef="AsOf2025-06-30" id="Fact001889" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">165,532</ix:nonFraction></td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(<ix:nonFraction name="FONR:PropertyAndEquipmentAndDepreciation" contextRef="AsOf2024-06-30" id="Fact001890" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">267,124</ix:nonFraction></td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMIiPtnHGBl3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Intangibles</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2025-06-30" id="Fact001892" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">155,627</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" contextRef="AsOf2024-06-30" id="Fact001893" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">104,436</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zck8AR0paWhk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total deferred tax liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2025-06-30" id="Fact001895" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">321,159</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilities" contextRef="AsOf2024-06-30" id="Fact001896" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">371,560</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zH5nvVJq1Efe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net deferred tax asset</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2025-06-30" id="Fact001898" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,028,035</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2024-06-30" id="Fact001899" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,851,695</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AA_zVA0c9R7Qi75" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zDJx4zJDTqri" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z9YLnUebsYP8" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zDF9F1AQKC68" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_238_z2I45Bqyn4N5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_231_z0PSC7AQhxe8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_z4fMCbiRcMIa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_230_zq5Bkc2slb3i" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_235_zAwhNLwRw0Tj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zGeokjJrdayk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001910" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_802_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zeuRWROSzhC" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 - <span id="xdx_82F_zT4ApAs6BGcd">OTHER CURRENT LIABILITIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b>&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Included in other current liabilities are the following:&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001912" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWWlPqZcNpp" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BA_zGEj3ZqNPTxg" style="display: none">Schedule of other current liabilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49E_20250630_z5jtbRZpGBdi" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49E_20240630_zPWgxgtRm6T7" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_z8pDZ1muGs38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Accrued salaries, commissions and payroll taxes</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2025-06-30" id="Fact001914" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,993,773</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2024-06-30" id="Fact001915" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,677,690</ix:nonFraction></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_z9Vcq33nWbVa" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Sales tax payable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2025-06-30" id="Fact001917" format="ixt:numdotdecimal" decimals="0" unitRef="USD">248,845</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2024-06-30" id="Fact001918" format="ixt:numdotdecimal" decimals="0" unitRef="USD">197,317</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zSu9B9oNstlj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">State income taxes payable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1920">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:TaxesPayableCurrentAndNoncurrent" contextRef="AsOf2024-06-30" id="Fact001921" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,461,336</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zG7EzpUfDLB2" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Legal and other professional fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2025-06-30" id="Fact001923" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,207</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2024-06-30" id="Fact001924" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,207</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AdvancePaymentsByBorrowersForTaxesAndInsurance_iI_zpxETB378hJ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Property taxes</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AdvancePaymentsByBorrowersForTaxesAndInsurance" contextRef="AsOf2025-06-30" id="Fact001926" format="ixt:numdotdecimal" decimals="0" unitRef="USD">391,479</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1927">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccruedUtilitiesCurrent_iI_zxI5oRWs3gS4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Utilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedUtilitiesCurrent" contextRef="AsOf2025-06-30" id="Fact001929" format="ixt:numdotdecimal" decimals="0" unitRef="USD">449,277</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1930">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zGxvk96mbxUd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accounting fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2025-06-30" id="Fact001932" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,000</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2024-06-30" id="Fact001933" format="ixt:numdotdecimal" decimals="0" unitRef="USD">119,800</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--SoftwareLicenses_iI_zgDBCJWlR6pi" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Software Licenses</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:SoftwareLicenses" contextRef="AsOf2025-06-30" id="Fact001935" format="ixt:numdotdecimal" decimals="0" unitRef="USD">442,305</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1936">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--RecruitingFees_iI_zeGdfjc7F6Ci" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Recruiting fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="FONR:RecruitingFees" contextRef="AsOf2025-06-30" id="Fact001938" format="ixt:numdotdecimal" decimals="0" unitRef="USD">135,952</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1939">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zieqIiUKM8Dl" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Self-funded health insurance reserve</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2025-06-30" id="Fact001941" format="ixt:numdotdecimal" decimals="0" unitRef="USD">259,661</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2024-06-30" id="Fact001942" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,445</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zS6RVFuQ13Lf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accrued interest and penalty</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2025-06-30" id="Fact001944" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,534</ix:nonFraction></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact001945" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,534</ix:nonFraction></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_z2eXdxbOnwS5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other general and administrative expenses</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2025-06-30" id="Fact001947" format="ixt:numdotdecimal" decimals="0" unitRef="USD">918,964</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact001948" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,348,710</ix:nonFraction></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zaXyqfygtqoi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other Current Liabilities</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2025-06-30" id="Fact001950" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,974,997</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact001951" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,941,039</ix:nonFraction></td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001953" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zz27K1F2cWGl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 12 - <span id="xdx_82B_zgGpc4uB5I3a">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b>&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Employee Benefit Plans</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a non-contributory 401(k) Plan (the
&#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum service requirements.
There were <span id="xdx_906_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_do_c20240701__20250630_zqiCTbWbQpz5" title="Employer contributions"><span id="xdx_901_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_do_c20230701__20240630_zVsCFrZlSNWl" title="Employer contributions"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2024-07-01to2025-06-30" id="Fact001955" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" contextRef="From2023-07-012024-06-30" id="Fact001957" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> employer contributions to the Plan for the years ended June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zbP1EmJ18J3h" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_234_zmcMuuZC3Ilj" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zKyn64NZydGb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zkLZZajaJ8wl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_z6xmkYWE1s0e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_236_zioZ5QR3hSFc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_zBv0OMIAzshb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_234_zdbz01NwSDuf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zXzQUOl89O29" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 12 - COMMITMENTS AND CONTINGENCIES (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z8CODiAtyrOc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stockholders of the Company approved the 2000
Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217; meeting in April 2000. The ESPP provides
for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect
as of June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other Matters</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is subject to other legal
proceedings and claims arising from the ordinary course of its business, including personal injury, customer contract and employment
claims besides the claim above. The Company is also subject to Cyber security threats that could lead to future litigation. In the
opinion of management, and with consultation with legal counsel, the aggregate liability, if any, with respect to such actions, will
not have a material adverse effect on the consolidated financial position or results of operations of the Company. The company
continuosly evaluates these actions to ensure they are not material, however, it is possible that management estimate may change in
the near term and the effect could have a material impact on the consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third-party insurer to limit the maximum potential liability for individual claims to
$<span id="xdx_902_eus-gaap--ReinsurancePayable_iI_c20250630_zwY9mmGaTWk8" title="Liability for individual claims"><ix:nonFraction name="us-gaap:ReinsurancePayable" contextRef="AsOf2025-06-30" id="Fact001969" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></span> per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company
considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.
As of June 30, 2025 and 2024, the Company had approximately $<span id="xdx_906_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20250630_zOYOBo9erkL7" title="Reserve for self-funded"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" contextRef="AsOf2025-06-30" id="Fact001971" format="ixt:numdotdecimal" decimals="0" unitRef="USD">260,000</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20240630_zwH1hfHE0w75" title="Reserve for self-funded"><ix:nonFraction name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" contextRef="AsOf2024-06-30" id="Fact001973" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,000</ix:nonFraction></span>, respectively, in reserve for its self-funded health
insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the consolidated balance sheets.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company regularly analyzes its reserves for incurred
but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance programs. The Company
believes its reserves are adequate. However, significant judgment is involved in assessing these reserves such as assessing historical
paid claims, average lags between the claims&#8217; incurred date, reported dates and paid dates, and the frequency and severity of claims.
There may be differences between actual settlement amounts and recorded reserves and any resulting adjustments are included in expense
once a probable amount is known. There were no significant adjustments recorded in the years covered by this report.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001975" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_80B_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_z2k3hl3utHY1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 13 - <span id="xdx_822_zC2qoydl63ea">SUPPLEMENTAL CASH FLOW INFORMATION</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2025 and 2024 the
Company paid $<span id="xdx_903_eus-gaap--InterestPaidNet_c20240701__20250630_z42SXLb4y4Yb" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-07-01to2025-06-30" id="Fact001977" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,611</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--InterestPaidNet_c20230701__20240630_zPx1cOrYYzfj" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-07-012024-06-30" id="Fact001979" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,997</ix:nonFraction></span> for interest, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2025 and 2024 the
Company paid $<span id="xdx_909_eus-gaap--IncomeTaxesPaid_c20240701__20250630_z0GJFXPYJKr7" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2024-07-01to2025-06-30" id="Fact001981" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,664,984</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--IncomeTaxesPaid_c20230701__20240630_zKjeeh7NVvE1" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2023-07-012024-06-30" id="Fact001983" format="ixt:numdotdecimal" decimals="0" unitRef="USD">507,139</ix:nonFraction></span> for income taxes, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2025 and June 30,
2024, the Company obtained right-of-use and equipment assets in exchange for lease obligations of $<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentOwnedNet_iI_c20250630_zxyltGJu7v4g" title="Right-of-use and equipment assets"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOwnedNet" contextRef="AsOf2025-06-30" id="Fact001985" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,319,913</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentOwnedNet_iI_c20240630_zKZXhsTgmJO7" title="Right-of-use and equipment assets"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOwnedNet" contextRef="AsOf2024-06-30" id="Fact001987" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,471,883</ix:nonFraction></span> respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended June 30, 2025, the Company sold
a <span id="xdx_90B_eus-gaap--InvestmentInterestRate_iI_dp_c20250630_zv2zlDVfkmb9" title="Interest rate"><ix:nonFraction name="us-gaap:InvestmentInterestRate" contextRef="AsOf2025-06-30" id="Fact001989" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.197</ix:nonFraction></span>% interest in HDM to an employee. The interest was sold for $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240701__20250630_zJrVBaayfhW5" title="Noncash transaction amount"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-07-01to2025-06-30" id="Fact001991" format="ixt:numdotdecimal" decimals="0" unitRef="USD">132,000</ix:nonFraction></span> in a noncash transaction.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zi3AV8Z0gJE7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_233_z6uJDh6mkWWk" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zAGnfbxLqEh6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_231_zzfUXrlXc3d4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_236_zEvPFFoKFfO" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zBe3hbHhwqpb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_233_zFav3EB1hw8l" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23A_ziazyWGncRu2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact002001" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zpUG0KnsThM" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 14 &#8211; <span id="xdx_82D_zFpmYKESBr7j">RELATED PARTY TRANSACTIONS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 31, 2023, the Company entered into an
agreement with Magnetic Resonance Management, LLC (&#8220;MRM&#8221;) for the sale of a MRI scanner. MRM is owned by the CEO and President
of the Company. The sales price of the equipment was $<span id="xdx_90C_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zkrMirZO7Meg" title="Sale of price of the equipment"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember" id="Fact002003" format="ixt:numdotdecimal" decimals="0" unitRef="USD">576,857</ix:nonFraction></span> which is payable based upon a promissory note dated December 1, 2023. The
note bears interest at a rate of <span id="xdx_90A_eus-gaap--DerivativeFixedInterestRate_iI_dp_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zbQ9QMeVfTU4" title="Bears interest rate"><ix:nonFraction name="us-gaap:DerivativeFixedInterestRate" contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember" id="Fact002005" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">9</ix:nonFraction></span>% and is payable in full at the maturity of the note in December 2028. The MRI scanner had zero basis,
which resulted in a gain of $<span id="xdx_90E_eus-gaap--DeferredGainOnSaleOfProperty_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zNIj57nY94ya" title="Gain on sale of equipments"><ix:nonFraction name="us-gaap:DeferredGainOnSaleOfProperty" contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember" id="Fact002007" format="ixt:numdotdecimal" decimals="0" unitRef="USD">576,857</ix:nonFraction></span>. The Company has the option but not the obligation to re-take possession of the scanner in lieu of
payment upon maturity of the note. During fiscal year ended June 30, 2025, MRM paid $<span id="xdx_908_ecustom--PrincipalAmount_c20240701__20250630_z6nufPoWChv7" title="Principal amount"><ix:nonFraction name="FONR:PrincipalAmount" contextRef="From2024-07-01to2025-06-30" id="Fact002009" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,000</ix:nonFraction></span> towards the principal balance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_904_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20240701__20250630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember_zenXvxMENrQg" title="Related party transaction, description"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_BensonhurstMRILimitedPartnershipMember" id="Fact002011" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">Bensonhurst MRI Limited Partnership (&#8220;Bensonhurst&#8221;),
in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum. On February 1, 2024, Bensonhurst entered into a second contract with the
Company for the service and maintenance of a High-Field MRI Scanner for a price of $70,000 per annum. Also during fiscal year ended June
30, 2025 and 2024, the Company charged Bensonhurst MRI Limited Partnership $344,068 and $190,362, respectively, for reimbursable salaries
and marketing expenses</ix:nonNumeric></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Integrity Healthcare Management, LLC, which is owned
by the CEO and President of the Company owns a 7.1% interest in HMCA&#8217;s Class A membership and receives distributions from the Company.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_905_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20240701__20250630__dei--LegalEntityAxis__custom--RadianHealthcareManagementLLCMember_zdAylJW2iSYa" title="Related party transaction, description"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_RadianHealthcareManagementLLCMember" id="Fact002013" name="us-gaap:RelatedPartyTransactionDescriptionOfTransaction">Radian Healthcare Management, LLC (&#8220;Radian&#8221;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of new employees
at a fee of approximately $165,000 and $200,000 during the fiscal year ended June 30, 2025 and 2024, respectively</ix:nonNumeric></span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are two board of directors that own .04% and
.02% interest in HMCA&#8217;s Class A membership, respectively. Each board member receives distributions from the Company with regards
to these interests.&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact002015" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_80F_eus-gaap--SegmentReportingDisclosureTextBlock_zlPtMRktvl17" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 15 - <span id="xdx_825_zegfbXbc3Gmi">SEGMENT AND RELATED INFORMATION</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company provides segment data in accordance with
the provisions of ASC 280, &#8220;Disclosures about Segments of an Enterprise and Related Information&#8221; which was adopted during
our fiscal ending June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our chief operating decision maker (&#8220;CODM&#8221;),
who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit
and loss statements prepared on a basis not consistent with GAAP. The CODM considers actual to budget and current year actual to prior
year actual for revenue and other profit and loss measures on a monthly basis for evaluating performance of each segment and making decisions
about allocating capital and other resources to each segment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company operates in two industry segments - manufacturing
and the servicing of medical equipment and management of diagnostic imaging centers.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounting policies of the segments are the same
as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance
based on income or loss from operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zEgFGcexv1zf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zQpeyOueBo1d" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zjxYWTxkfUL6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_236_zJWkiEPL6374" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_230_zReLHE7257U7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zW8keMGAMkId" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_232_zAhF0xwJKV9d" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_234_zqLQVCAcY311" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_z9pIdszJGuX3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>NOTE 15 - SEGMENT AND RELATED INFORMATION
(CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zDRpIELXZLL3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Summarized financial information concerning the Company&#8217;s
reportable segments is shown in the following table:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Summarized Segment Financial Information&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact002027" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zYhbXlhCHZZ1" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zh3MCVY7AYy5" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Segment Financial Information</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_492_20240701__20250630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_z75PQFVNZ2ha" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_494_20240701__20250630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_z68KcaR412ok" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_495_20240701__20250630__srt--ProductOrServiceAxis__custom--TotalMember_zTtua83YJq46" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Manufacturing and Servicing of Medical</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Management of Diagnostic Imaging</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Fiscal
2025:</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Equipment</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Centers</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Totals</span></td></tr>
<tr id="xdx_40A_eus-gaap--Revenues_zfW3Cp1P8sp2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
revenues from external customers</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,977,349</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">95,373,969</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">104,351,318</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Cost
of Sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToEmployees_zjT3WxjA7fPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:PaymentsToEmployees" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002033" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,905,311</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:PaymentsToEmployees" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002034" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,384,410</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:PaymentsToEmployees" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,289,721</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--RentExpenses_z1Yr3uTf96Dj" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2037">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentExpenses" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002038" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,822,044</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentExpenses" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002039" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,822,044</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zgGNgBinrmV1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
Cost of sales expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherCostOfSalesExpenses" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002041" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,944,740</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherCostOfSalesExpenses" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,385,807</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherCostOfSalesExpenses" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002043" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,330,547</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_ecustom--CostOfSales_zfWFzJDf6m2b" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Total
Cost of sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:CostOfSales" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002045" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,850,051</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:CostOfSales" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002046" format="ixt:numdotdecimal" decimals="0" unitRef="USD">55,592,261</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:CostOfSales" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002047" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,442,312</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Research
and development</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SalariesAndWages_zMQtQgFIE45" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002049" format="ixt:numdotdecimal" decimals="0" unitRef="USD">766,963</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2050">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">766,963</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9uybozGKOml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
research and development costs**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">809,123</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2054">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">809,123</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zynPxaQwa9B8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Total
                                            Research and development costs</span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,576,086</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2058">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,576,086</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zgrFMbaYDFfb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Selling,
general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--SalariesAndWage_i01_zYO9T4bJaXi2" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:SalariesAndWage" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,934,716</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:SalariesAndWage" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,983,643</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:SalariesAndWage" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,918,359</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--RentsExpense_i01I_z5BxBWbdH3I" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentsExpense" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002069" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,251,924</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentsExpense" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,528</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentsExpense" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,288,452</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zLKPgau1ciRb" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
selling, general and administrative expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherSellingGeneralAndAdministrativeExpenses" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002073" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,970,693</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherSellingGeneralAndAdministrativeExpenses" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,556,659</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherSellingGeneralAndAdministrativeExpenses" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,527,352</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zPEfSE3mQkx2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
Selling, general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BenefitsLossesAndExpenses" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,157,333</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BenefitsLossesAndExpenses" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,576,830</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BenefitsLossesAndExpenses" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,734,163</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_z8XhFpbBeyRc" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
costs and expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalCostsAndExpenses" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,619,740</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalCostsAndExpenses" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76,133,091</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalCostsAndExpenses" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,752,561</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_z2k4vhdxzObf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income from operations</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002085" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,606,121</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002086" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,204,878</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,598,757</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zHcmnnUVeGk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Investment
income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002089" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,777</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002090" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,011,203</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,118,980</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherIncome_i01_zxmENsXyrvUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Other
income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,508</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002094" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,993</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,501</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_z3uPmdmQWykb" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income before provision for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002097" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,445,836</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,226,074</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,780,238</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_z4OGAFthe3i7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Provision
for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002101" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,885,852</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002102" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">220,953</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002103" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,106,805</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zhqb4FFRlRbe" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
(Loss) income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002105" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,331,688</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002106" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,005,121</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,673,433</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zWPAILzhwOs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Intersegment
net revenues *</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002109" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,189,130</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2110">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002111" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,189,130</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zYYOKMJdD3A7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation
and amortization</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">209,325</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002114" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,488,996</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,698,321</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_z0lqDLXnYJ25" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
identifiable assets</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalIdentifiableAssets" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,401,915</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalIdentifiableAssets" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">182,646,336</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalIdentifiableAssets" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,048,251</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zFUPHbu0jJ2g" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Capital
expenditures</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CapitalExpenditures" contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">375,599</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CapitalExpenditures" contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002122" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,441,307</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CapitalExpenditures" contextRef="From2024-07-012025-06-30_custom_TotalMember" id="Fact002123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,816,906</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0; display: none">&#160;</p>

<table cellpadding="0" cellspacing="0" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt; width: 46%"><span style="font-family: Times New Roman, Times, Serif">Fiscal
2024:</span></td>
<td style="padding-bottom: 1pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_49B_20230701__20240630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_zzq02cpMvnK2" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_495_20230701__20240630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_zMRIQhRT3iZ1" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_496_20230701__20240630__srt--ProductOrServiceAxis__custom--TotalMember_zM7IjUX6DS01" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--Revenues_zb86Ch12H8fc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
revenues from external customers</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,329,106</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002126" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94,554,983</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002127" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,884,089</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Cost
of Sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToEmployees_zH4UUXMvvoxh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:PaymentsToEmployees" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002129" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,684,218</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:PaymentsToEmployees" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002130" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,913,412</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:PaymentsToEmployees" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,597,630</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--RentExpenses_z54u34xz7Zk8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2133">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentExpenses" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002134" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,532,535</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentExpenses" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002135" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,532,535</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zq88IQEDH58h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
Cost of sales expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherCostOfSalesExpenses" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002137" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,089,924</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherCostOfSalesExpenses" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002138" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,523,955</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherCostOfSalesExpenses" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002139" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,613,879</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_ecustom--CostOfSales_zj38kTaMAc1a" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
Cost of sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostOfSales" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002141" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,774,142</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostOfSales" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002142" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,969,902</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CostOfSales" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002143" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,744,044</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Research
and development</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SalariesAndWages_zy65EV3XrRCg" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002145" format="ixt:numdotdecimal" decimals="0" unitRef="USD">781,012</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2146">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:SalariesAndWages" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002147" format="ixt:numdotdecimal" decimals="0" unitRef="USD">781,012</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9a9ZMeM3JM7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
research and development costs**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002149" format="ixt:numdotdecimal" decimals="0" unitRef="USD">954,937</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2150">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002151" format="ixt:numdotdecimal" decimals="0" unitRef="USD">954,937</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zir0Tax1ENmh" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
Research and development costs</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002153" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,735,949</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2154">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002155" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,735,949</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zw2LaAHeJZlh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Selling,
general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--SalariesAndWage_i01_zB1kSzzPOhN3" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:SalariesAndWage" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002161" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,794,512</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:SalariesAndWage" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002162" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,156,520</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:SalariesAndWage" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002163" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,951,032</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--RentsExpense_i01I_zAqT0Vq6o0Lk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentsExpense" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002165" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,076,069</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentsExpense" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002166" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,676</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:RentsExpense" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002167" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,149,745</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zd85oqp6Si21" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
selling, general and administrative expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherSellingGeneralAndAdministrativeExpenses" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002169" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,906,446</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherSellingGeneralAndAdministrativeExpenses" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002170" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,861,509</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<ix:nonFraction name="FONR:OtherSellingGeneralAndAdministrativeExpenses" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,767,955</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zJGIWhp93SIc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Selling,
general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BenefitsLossesAndExpenses" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002173" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,777,027</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BenefitsLossesAndExpenses" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002174" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,091,705</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:BenefitsLossesAndExpenses" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002175" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,868,732</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_zvgoRlZDs9i" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
costs and expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalCostsAndExpenses" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,287,118</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalCostsAndExpenses" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002178" format="ixt:numdotdecimal" decimals="0" unitRef="USD">71,061,607</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalCostsAndExpenses" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002179" format="ixt:numdotdecimal" decimals="0" unitRef="USD">86,348,725</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_zNyJ92lXc85a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income from operations</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002181" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,958,012</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002182" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,493,376</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002183" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,535,364</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zhAQNu6NDD22" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Investment
income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002185" format="ixt:numdotdecimal" decimals="0" unitRef="USD">120,387</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002186" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,006,052</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002187" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,126,439</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherIncome_i01_zxanVwLepIFa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Other
income (expenses)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002189" format="ixt:numdotdecimal" decimals="0" unitRef="USD">640,952</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002190" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">36,370</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002191" format="ixt:numdotdecimal" decimals="0" unitRef="USD">604,582</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_ztVcI96nKx56" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income before provision for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002193" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,196,673</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002194" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,463,058</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002195" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,266,385</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_zhTaKpsZkPN3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Provision
for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002197" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,788,028</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002198" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">380,940</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002199" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,168,968</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zk90qy0PsyY7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
(Loss) income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002201" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,984,701</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002202" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,082,118</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002203" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,097,417</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zg9dIGI9lyrh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Intersegment
net revenues *</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002205" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,073,333</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2206">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002207" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,073,333</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zKwyCPqTjJTd" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation
and amortization</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002209" format="ixt:numdotdecimal" decimals="0" unitRef="USD">238,802</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002210" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,357,619</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002211" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,596,421</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_ztOyj3w6ikrl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
identifiable assets</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalIdentifiableAssets" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002213" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,360,188</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalIdentifiableAssets" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002214" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,885,781</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:TotalIdentifiableAssets" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002215" format="ixt:numdotdecimal" decimals="0" unitRef="USD">214,245,969</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zVZmutmiwEsj" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Capital
expenditures</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CapitalExpenditures" contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember" id="Fact002217" format="ixt:numdotdecimal" decimals="0" unitRef="USD">32,885</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CapitalExpenditures" contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember" id="Fact002218" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,961</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"/>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="FONR:CapitalExpenditures" contextRef="From2023-07-012024-06-30_custom_TotalMember" id="Fact002219" format="ixt:numdotdecimal" decimals="0" unitRef="USD">822,846</ix:nonFraction></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 2%; vertical-align: top">&#160;*</td>
<td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 98%; vertical-align: top">Amounts eliminated in consolidation</td></tr>
<tr style="vertical-align: bottom">
<td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top">**</td>
<td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top">Other segment costs include supplies, professional fees, marketing expenses, repairs and maintenance and other operational costs.</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AC_zXX8JpLPlUn9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_z4Ag9JIADRM3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_235_zIHcGekENv3j" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zR21FuScO1Ma" style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></ix:exclude>

<ix:exclude><p id="xdx_237_z7PzZonRucOh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p></ix:exclude>

<ix:exclude><p id="xdx_23C_z5iRogZMCIj9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zxeLHpCiWZJa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</p></ix:exclude>

<ix:exclude><p id="xdx_233_zrAVRbXY3Bba" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_235_zPldtEcFyTMj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_238_zGoN8AGqDrji" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zIWIQRUVYuA3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 15 - SEGMENT AND RELATED INFORMATION (CONTINUED)</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zAwCqrBjOhxk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Export Product Sales</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s areas of operations are principally
in the United States. The Company had export sales of medical equipment amounting to <span id="xdx_90B_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20240701__20250630_zASkbpQfzBm7" title="Export sales of medical equipment percentage"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2024-07-01to2025-06-30" id="Fact002232" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.4</ix:nonFraction></span>% and <span id="xdx_90E_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20230701__20240630_zzYS8b3O6ZXa" title="Export sales of medical equipment percentage"><ix:nonFraction name="FONR:ExportSalesOfMedicalEquipmentPercentage" contextRef="From2023-07-012024-06-30" id="Fact002234" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.2</ix:nonFraction></span>% of product sales revenues to third
parties for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foreign product sales, as a percentage of product
sales to unrelated parties, were made to customers in the following countries:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact002236" name="FONR:ScheduleOfExportProductSalesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfExportProductSalesTableTextBlock_zktkVbGR99Kf" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B2_zDos5Oooi5Oj" style="display: none">Schedule of export product sales</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-indent: -10pt">Canada</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--ForeignProductSales_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zAFjhC2VJzWj" title="Foreign product sales"><span style="-sec-ix-hidden: xdx2ixbrl2238">&#8212;</span></span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_906_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zE8ravCbTAe" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2023-07-012024-06-30_country_CA" id="Fact002240" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.2</ix:nonFraction></span></td>
<td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Puerto Rico</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zZOazIXJ73h2" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2024-07-012025-06-30_custom_TwoMember" id="Fact002242" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.4</ix:nonFraction></span></td>
<td style="padding-bottom: 1pt; text-align: left">%</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zbrlHoQ089Pe" title="Foreign product sales"><span style="-sec-ix-hidden: xdx2ixbrl2244">&#8212;</span></span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_ecustom--ForeignProductSales_dp_c20240701__20250630_znq8yXaYTZj1" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2024-07-01to2025-06-30" id="Fact002246" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.4</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_ziHDOYYJSywg" title="Foreign product sales"><ix:nonFraction name="FONR:ForeignProductSales" contextRef="From2023-07-012024-06-30" id="Fact002248" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.2</ix:nonFraction></span></td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A8_zrv5UTh21Oml" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Foreign Service and Repair Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s areas of service and repair are
principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to <span id="xdx_90A_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20240701__20250630_zfoHy8WBXIdf" title="Percentage of service and repair of medical equipment"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2024-07-01to2025-06-30" id="Fact002250" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">7.7</ix:nonFraction></span>% and <span id="xdx_905_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20230701__20240630_zm3J2HR3bxOg" title="Percentage of service and repair of medical equipment"><ix:nonFraction name="FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" contextRef="From2023-07-012024-06-30" id="Fact002252" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">7.4</ix:nonFraction></span>%
of consolidated net service and repair fees for the years ended June 30, 2025 and 2024, respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Foreign Service and Repair Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact002254" name="FONR:ScheduleOfExportServiceRevenuesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_zVvcKbfNzhj" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zkoqgXrUWfsj" style="display: none">Schedule of Foreign Service and Repair Fees</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Puerto Rico</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--PR_zahWiMhoB0Pb" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-012025-06-30_country_PR" id="Fact002256" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.3</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_zGBsn9gzUh3h" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_PR" id="Fact002258" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.9</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CH_zZ3RJee8l0m2" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-012025-06-30_country_CH" id="Fact002260" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5vTlo7PZQI9" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_CH" id="Fact002262" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DE_z460oljBXZ4g" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-012025-06-30_country_DE" id="Fact002264" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.0</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_z3cQptNL8l3a" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_DE" id="Fact002266" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.0</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">England</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zaYtPudlI672" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-012025-06-30_country_GB" id="Fact002268" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_zh4W6et8D85f" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_GB" id="Fact002270" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.7</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">United Arab Emirates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AE_z03a2vakMff6" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-012025-06-30_country_AE" id="Fact002272" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.1</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zvFwShrcAT7" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_AE" id="Fact002274" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Dominican Republic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DO_zLsvieGw6MK7" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-012025-06-30_country_DO" id="Fact002276" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.2</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zSOqJjt6AuMg" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_DO" id="Fact002278" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.2</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Canada</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp0_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zgbYa5DcdHh6" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-012025-06-30_country_CA" id="Fact002280" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.1</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zbyunX35CtWf" title="Foreign service and repair fees"><span style="-sec-ix-hidden: xdx2ixbrl2282">&#8212;</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Greece</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GR_zXFceWHYfoz4" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-012025-06-30_country_GR" id="Fact002284" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.4</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_zwczRDuYtm6a" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_GR" id="Fact002286" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.3</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Australia</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AU_zY43EsoddYge" title="Foreign service and repair fees"><span style="-sec-ix-hidden: xdx2ixbrl2288">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zpKiWFhumPT4" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30_country_AU" id="Fact002290" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.7</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630_zBTPo9XoCkGe" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2024-07-01to2025-06-30" id="Fact002292" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">7.7</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zis670RjOva8" title="Foreign service and repair fees"><ix:nonFraction name="FONR:ForeignServiceAndRepairFees" contextRef="From2023-07-012024-06-30" id="Fact002294" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">7.4</ix:nonFraction></span>.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td>
    </tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

</ix:nonNumeric><p id="xdx_8A4_zj1Vf1KrNOdg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Company does not have any material assets
outside of the United States.&#160;<br/>
</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zNqXGnWKt4b2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_237_zumxSHzl47m" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zvajrWsLr4Z" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zNu9Ykq3Iyx7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_ziw9ikeSJzI7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">JUNE 30, 2025 and 2024</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zsTvByVfXPP1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact002302" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zZcabyD1Cvdc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 16 &#8211; <span id="xdx_824_zHpqgxAyOEL1">SUBSEQUENT EVENTS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates events that have occurred after
the balance sheet date, but before the consolidated financial statements are issued.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On <span style="font-family: Times New Roman, Times, Serif">July
7, 2025, the board of directors received a non-binding proposal from a group led by Timothy Damadian, the Company&#8217;s Chief
Executive Officer, and Luciano Bonanni, the Company&#8217;s Chief Operating Officer, pursuant to which proposal the group would
acquire all of the outstanding common stock and other securities of the Company not currently owned by the members of the group.
Members of the group have voting control of the Company&#8217;s equity securities and the group advised the Company that it was
unwilling to support any alternative transaction. &#160;As proposed, the transaction, if completed, would result in the Company no
longer being a publicly held company, and its Common Stock would be de-listed from the NASDAQ Stock Market. &#160;The Board of
Directors has established a Special Committee of independent and disinterested directors to consider the proposal and negotiate on
behalf of the Company and its stockholders. The Special Committee has retained its own independent financial and legal advisors to
assist it in this process. The group and the Special Committee are engaged in negotiations related to the proposed going private
transaction. &#160;No definitive agreements or terms have been executed by the parties and there is no assurance that the
transaction will be completed. &#160;Any definitive agreement and transaction will require approval by the Company&#8217;s common
stock holders and will require the filing of definitive proxy materials in accordance with the SEC&#8217;s proxy rules to obtain
such approval. </span><span style="font-family: Times New Roman, Times, Serif">In July 2025, the Company entered into a new 10 year
lease for a property in New York where a new MRI is to be built</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_813_z3kbEoo1dfy6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_013"></span>ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
ON ACCOUNTING AND FINANCIAL DISCLOSURE.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There have been no disagreements with our independent
registered public accounting firm or other matters requiring disclosure under Regulation S-K, Item 304(b).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_014"></span>ITEM 9A. CONTROLS AND PROCEDURES</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Evaluation of Disclosure Controls and Procedures</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain disclosure controls and procedures to
ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934,
as amended (the &#8220;Exchange Act&#8221;), is recorded, processed, summarized and reported within the time periods specified in the
SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive
officer and chief financial officer, to allow timely decisions regarding required disclosure.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Chief Executive Officer and our Chief
Operating Officer, Executive Vice President and acting Finance Officer after evaluating the effectiveness of our disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), have concluded that, due to the existence of material
weaknesses in our internal controls in the Company&#8217;s internal control over financial reporting described below, that the
Company&#8217;s disclosure controls and procedures were not effective as of June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management&#8217;s Annual Report on Internal
Control over Financial Reporting</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management of the Company is responsible for establishing
and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f).
The Company&#8217;s internal control over financial reporting is a process designed by, or under the supervision of, our Chief Executive
Officer and Chief Financial Officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted accounting principles.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Because of its inherent limitations, internal control
over financial reporting may not prevent or detect all misstatements. Also, projections of any evaluation of effectiveness to future periods
are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the
policies or procedures may deteriorate.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management, including our Chief Executive
Officer and our Chief Operating Officer, Executive Vice President and acting Finance Officer assessed the effectiveness of the
Company&#8217;s internal control over financial reporting as of June 30, 2025. In making this assessment, management used the
criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the
Treadway Commission (COSO). </p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A material weakness is a deficiency, or a combination
of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement
of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on its assessment, management has concluded
that the Company did not maintain effective internal control over financial reporting as of June 30, 2025, due to the following material
weakness identified by management during the current period:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#8226;Management did not maintain effective information
technology general controls in the areas of user access management within its systems supporting the Company&#8217;s accounting and reporting
processes.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although this material weaknesses did not result in
any material misstatement of our consolidated financial statements for the periods presented, there is a possibility they could lead to
a material misstatement of account balances or disclosures. Accordingly, management has concluded that these control deficiencies constitute
material weaknesses.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management&#8217;s Plan for Remediation</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In response to the material weaknesses, management,
with oversight of the Audit Committee of the Board of Directors, has identified and begun to implement steps to remediate the material
weaknesses. While the Company has made progress during the fiscal year 2025, the remediation efforts are ongoing, as additional time is
needed to complete the remediation and allow for the internal controls to be tested by management. Our continued internal control remediation
efforts include the following:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#8226;Enhancing risk  assessment processes,
user authentication and monitoring controls to enforce appropriate system access.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We are committed to ensuring that our internal controls
over financial reporting are designed and operating effectively. Management believes the efforts taken to date and the planned remediation
will improve the effectiveness of our internal control over financial reporting. While these remediation efforts are ongoing, the controls
must be operating effectively for a sufficient period of time and be tested by management in order to consider them remediated and conclude
that the design is effective to address the risks of material misstatement.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Attestation Report of Independent Registered Public
Accounting Firm</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our independent registered public accounting
firm, CohnReznick LLP, has  independently assessed our internal control over financial reporting and its report is included in Part
II, Item 8 of the Annual Report on Form 10-K.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Changes in Internal Control Over Financial Reporting</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other than the material weakness and the remediation
plan described above, there were no changes in the Company&#8217;s internal controls over financial reporting that have materially affected,
or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting during the fourth quarter
of fiscal year 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_015"></span>Item 9B. OTHER INFORMATION</b></p>

<div id="xdx_981_eecd--MtrlTermsOfTrdArrTextBlock_c20240701__20250630_zf5RuHiJ5Vld"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact002303" name="ecd:MtrlTermsOfTrdArrTextBlock">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Rule 10b5-1 Trading Plan</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">During the fiscal quarter ended June 30, 2025, none of our directors or
executive officers <span id="xdx_902_eecd--Rule10b51ArrAdoptedFlag_dbT_c20240701__20250630_zAMPxrI1zmp6"><span id="xdx_902_eecd--NonRule10b51ArrAdoptedFlag_dbT_c20240701__20250630_zvFnK9E6c852"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact002304" name="ecd:Rule10b51ArrAdoptedFlag"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact002305" name="ecd:NonRule10b51ArrAdoptedFlag">adopted</ix:nonNumeric></ix:nonNumeric></span></span> or <span id="xdx_904_eecd--Rule10b51ArrTrmntdFlag_dbT_c20240701__20250630_zBHCJ2qOTrg9"><span id="xdx_90A_eecd--NonRule10b51ArrTrmntdFlag_dbT_c20240701__20250630_zUYWMo65kmAj"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact002306" name="ecd:Rule10b51ArrTrmntdFlag"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact002307" name="ecd:NonRule10b51ArrTrmntdFlag">terminated</ix:nonNumeric></ix:nonNumeric> </span></span>any contract, instruction or written plan for the purchase or sale of Company securities that
was intend to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement&#8221;.</p>

</ix:nonNumeric></div>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_016"></span>Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">None.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>PART III</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_017"></span>ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Directors serve from the date of their election until
the next annual meeting of stockholders and until their successors are elected and qualify. During fiscal 2025, each director received
a base fee of $20,000 per annum for his or her service as a director, with greater amounts for additional services on the Board of Directors.
Officers serve at the discretion of the Board of Directors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A majority of our board of directors is composed of
independent directors: consisting of, Ronald G. Lehman, Richard E. Turk and Jessica Maher. The outside directors also serve as the members
of the audit committee, which is a standing committee of the board of directors having a charter describing its responsibilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Claudette J.V. Chan retired from her role on the Board
of Directors on June 23, 2025. Ms. Chan has been an instrumental figure in the Company for the majority of its existence, and we are grateful
for her innumerable contributions to our success during her thirty seven years of service.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 2, 2025, the board seat vacated by Ms. Chan
was filled by Robert M. Carrino. Mr. Carrino is an independent director pursuant to NASDAQ standards.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have adopted a code of ethics applicable to, among
other personnel, our principal executive officer, principal financial officer, controllers and persons performing similar functions. The
code is designed to deter wrongdoing and to promote: 1. honest and ethical conduct, including the ethical handling of actual or apparent
conflicts of interest between personal and professional relationships; 2. full, fair, accurate, timely and understandable disclosure in
reports and documents that we file or submit to the Securities and Exchange Commission and in other public communications we make; 3.
compliance with applicable governmental laws, rules and regulations; 4. the prompt internal reporting of violations of the code to an
appropriate person or persons identified in the code and 5. accountability for adherence to the code. We will provide a copy of the code
to any person who requests a copy. A person may request a copy by writing to FONAR Corporation, 110 Marcus Drive, Melville, New York 11747,
to the attention of the Legal Department or Investor Relations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The officers and directors of the Company are set
forth below:&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy R. Damadian</span></td>
    <td style="width: 15%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">60</span></td>
    <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chairman of the Board, President, Chief Executive Officer and Treasurer</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Luciano B. Bonanni</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">70</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Executive Vice President, Chief Operating Officer and acting Principal Financial Officer</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Claudette J.V. Chan</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">87</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Ronald J. Lehman</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">49</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Richard E. Turk</span></td>
    <td style="text-align: justify">41</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Jessica Maher</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">28</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Robert M. Carrino</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">38</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td></tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Timothy Damadian has been the Chairman of the Board
and Treasurer of FONAR since September 7, 2022 and the President and Chief Executive Officer of FONAR since February 11, 2016. From 2010
to 2016 he served as an independent consultant, with a focus on the Company&#8217;s MRI facility management business. Timothy Damadian
began his career at FONAR in 1985, installing MRI scanners and components for FONAR customers. Over the course of the following 16 years,
he held positions of increasing authority, eventually becoming Vice President of Operations. In 1997, Timothy Damadian was appointed President
of the newly formed Health Management Corporation of America (HMCA), a wholly-owned subsidiary of FONAR that was formed to manage medical
and diagnostic imaging offices. In 2001, Timothy Damadian left FONAR to form Integrity Healthcare Management, Inc., a diagnostic imaging
management company that would eventually manage MRI scanning centers in New York and Florida. The company was a success and was sold to
Health Diagnostics, LLC in 2007. Mr. Damadian returned to FONAR as a consultant in 2010. He also serves as a Manager of Health Diagnostics
Management, LLC, which are subsidiaries of HMCA.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Luciano B. Bonanni has served as Chief Operating Officer
(COO) and Executive Vice President (EVP) for FONAR Corporation since June 27, 2016. In September 2022, he was appointed to fill the position
of acting Principal Financial Officer. Prior to his appointment as COO, Mr. Bonanni had served the Company as Vice President since 1989,
during which time he oversaw general operations, research and development, manufacturing, service, sales, finance, accounting and regulatory
compliance. Prior to 1989, Mr. Bonanni held the title of Vice President of Production and Engineering from the time of FONAR&#8217;s initial
public offering in 1981. Mr. Bonanni joined the Company as an electrical engineer in 1978. He holds a Bachelor of Electrical Engineering
degree from Manhattan College.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Claudette J.V. Chan has been a Director of FONAR since
October 1987 and Secretary of FONAR since January 2008. Mrs. Chan was employed from 1992 through 1997 by Raymond V. Damadian, M.D. MR
Scanning Centers Management Company and since 1997 by HMCA, as &#8220;site inspector,&#8221; in which capacity she is responsible for
supervising and implementing standard procedures and policies for MRI scanning centers. From 1989 to 1994 Mrs. Chan was employed by St.
Matthew&#8217;s and St. Timothy&#8217;s Neighborhood Center, Inc., as the director of volunteers in the &#8220;Meals on Wheels&#8221;
program, a program which cares for the elderly. From approximately 1983 to 1989, Mrs. Chan was President of the Claudette Penot Collection,
a retail mail-order business specializing in women&#8217;s apparel and gifts. Mrs. Chan practiced and taught in the field of nursing until
1973, when her son was born. She received a Bachelor of Science degree in nursing from Cornell University in 1960.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ronald G. Lehman has been a Director of FONAR since
April, 2012, and chair of the audit committee since 2021. Mr. Lehman is Managing Director and Head of Investment Banking at Bruderman
Advisory Group, LLC where he is responsible for the firm&#8217;s sell-side advisory and capital raising processes. Mr. Lehman is also
a Partner at Sandy Hill Investors, LLC, participating in and overseeing many of the firm&#8217;s investments. He is Chairman of portfolio
company Persante Acquisition Corp., and was a board member at Seviroli Foods, LLC during the firm&#8217;s investment period. From 2000-2008,
Mr. Lehman worked for various Bruderman entities as a buy and sell-side advisor, and as a principal in several private equity transactions.
In 2008, Mr. Lehman joined Health Diagnostics, LLC, one of the country&#8217;s fastest growing diagnostic imaging providers, as Senior
Vice President of Acquisitions, where he managed the company&#8217;s acquisition and corporate finance activities. Mr. Lehman returned
to Bruderman in 2010 to lead the firm&#8217;s investment banking efforts. Lehman is a graduate of Columbia University and worked at Deutsche
Bank from 1998-2000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Richard E. Turk has been a Director of FONAR since
June, 2020. Mr. Turk is the Chief Financial Officer of PRISM Vision Group, a subsidiary of McKesson Corporation (MCK). PRISM Vision Group
is a multi-location, outpatient comprehensive eye care practice headquartered in New Providence, New Jersey. Mr. Turk joined PRISM in
November, 2018 as the Chief Development Officer and became CFO in March 2021. Mr. Turk has helped PRISM expand from a single-specialty
(retina) provider with 17 locations and 21 physicians to a comprehensive, vertically-integrated, multi-specialty, eye care organization
with approximately 190 physicians and more than 90 locations across New Jersey, Pennsylvania, Delaware, Virginia, Washington, DC, and
Maryland. Mr. Turk helped lead the sale of PRISM Vision Group to McKesson Corporation in 2025. Prior to his tenure at PRISM, Mr. Turk
was employed by Professional Physical Therapy, a private equity-backed outpatient physical and occupational therapy company headquartered
in Uniondale, New York with more than 180 locations across New York, New Jersey, Connecticut, Massachusetts and New Hampshire. During
his four years at Professional Physical Therapy, Mr. Turk sourced, analyzed, and completed 32 acquisitions comprised of 116 clinics, expanding
the company&#8217;s services and adding three states to its geographic footprint. From 2007 to 2014, Mr. Turk was employed by Bruderman
Brothers, a broker dealer involved in investment banking, merchant banking, investment advisory, and consulting for lower middle market
companies ($10M-$250M of enterprise value) in a variety of industries, including healthcare. Mr. Turk was Vice President of Bruderman
Brothers from 2011 to 2014. Mr. Turk graduated from Columbia University in 2007.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Jessica Maher has been a Director of FONAR since March
2023. Mrs. Maher is a staff accountant at Ives &amp; Sultan, LLP in Woodbury, New York, where she is responsible for preparing audited
financial statements for various clients, overseeing audit testing areas, audits of 401(k) plans, and personal and company tax returns.
Mrs. Maher holds a Bachelor of Science in Accounting with a minor in Accounting Information Systems, and a Master of Science in Accounting
from Fairfield University in Fairfield, Connecticut. During her early undergraduate years, Mrs. Maher worked for Tritech Healthcare Management
in Melville, New York, where she reviewed patient files, insurance, charts and documents to ensure that the services provided by clients
were being properly billed. In her senior year, Mrs. Maher interned at Northwell Health in Westbury, New York, where she supported the
financial reporting team for two hospitals, reported into accounts receivable software, and analyzed patient billing records to identify
overpayments. Mrs. Maher&#8217;s first position out of college was with PriceWaterhouseCoopers in Melville, New York, where she was assigned
to two private equity clients, was responsible for a variety of the audit areas, and assisted managers in reviewing financial statements,
footnote disclosures, and audit opinions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Robert M. Carrino has been a Director of FONAR since
July 2025. Mr. Carrino is a Partner at CFGI, LLC, the leading global independent accounting and business advisory firm, backed by The
Carlyle Group and CVC Capital Partners. At CFGI, Mr. Carrino provides complex accounting and consulting services to both public and private
companies of all sizes across various industries. Additionally, Mr. Carrino leads the firms SPAC practice. Mr. Carrino joined CFGI in
2016 as a Manager and became Partner in January 2023. Prior to joining CFGI, Mr. Carrino was an audit manager at KPMG, LLP&#8217;s Metro
New York Long Island Office servicing clients mainly in the media and entertainment industry. Mr. Carrino, a Certified Public Accountant,
earned the degree of Bachelor of Science in Business Administration with a concentration in accounting from Western New England University.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_018"></span>ITEM 11. EXECUTIVE COMPENSATION.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With the exception of the Chief Executive Officer
and the Chairman of the Board of Directors, the compensation of the Company&#8217;s executive officers consist of salary and bonuses based
on performance. The Chief Executive Officer and the Chairman of the Board has no understanding with the Company with respect to bonuses,
options or other incentives, and is not subject to our general policy later discussed.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Board of Directors does not have a compensation
Committee. The Chief Executive Officer and the Chief Operating Officer participate in the determination of compensation for the Company&#8217;s
management and other employees.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board of Directors has established an audit committee.
The members of the committee are Ronald G. Lehman, Richard E. Turk and Jessica Maher.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our compensation policy includes a combination of
salary, commissions, bonuses, stock bonuses and stock options, designed to incentivize our employees. There is no universal plan applicable
to all of our employees. The fixed and variable components of our employees&#8217; compensation tend to be individualized, based on a
combination of the employees&#8217; performance, responsibilities and position, our assessment of how best to motivate a person in such
a position and the needs and preferences of the particular employees, as negotiated between employees and their supervisors or management.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;There is set forth in the following Summary
Compensation Table the compensation provided by us during fiscal 2025, 2024 and 2022 to our Principal Executive Officer, and our acting
Principal Financial Officer. There is set forth in the following Outstanding Equity Awards Table and Director Compensation Table the required
information.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="background-color: yellow">I.</span></td><td><span style="background-color: yellow">SUMMARY COMPENSATION TABLE</span></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">(Reflects information up to end of Fiscal 2024)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center">Name and All Other Principal Position</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Salary<br/> ($)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Cash Bonuses<br/> ($)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Stock Awards<br/> ($)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total Compensation ($)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">(a)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(b)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(c)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(d)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(e)</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">(f)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; text-align: left; text-indent: -10pt; padding-left: 10pt">Timothy R. Damadian</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">295,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">295,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">President, Principal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">372,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">372,885</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Executive Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">152,900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">152,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Luciano Bonanni</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">148,241</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">350,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">498,241</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Chief Operating Officer,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">148,241</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">350,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">498,241</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Executive Vice President and</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">143,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">305,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">449,216</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">acting Principal Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Raymond V. Damadian</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Chairman of the Board,</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Treasurer and</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">23,553</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">305,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">329,353</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Principal Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">John P. Collins<sup>[1]</sup> &#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">294,988</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">142,167</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">437,155</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">General Counsel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">249,990</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">172,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">421,990</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#151;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td></tr>
  </table>





<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p>

<p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt; line-height: 115%"><sup>[1]</sup></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">John Collins was promoted to General Counsel on September 17,
2023.</span></p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"></p>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">II.</td><td>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END</td></tr></table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"></p>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Name</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Number Of Securities Underlying Unexercised Options (#) Exercisable</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Option Exercise Price ($)</td>
<td>&#160;</td>
<td style="text-align: center">Option Exercise Expiration Date</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">(a)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">(b)</td>
<td>&#160;</td>
<td style="text-align: center">(c)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 39%; text-align: left; text-indent: -10pt">Timothy R. Damadian, President and Principal Executive Officer</td>
<td style="width: 4%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 15%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 4%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 15%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 4%">&#160;</td>
<td style="text-align: center; width: 15%">N/A</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Luciano Bonanni, Chief Operating Officer, Executive Vice President and acting Principal Financial Officer</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: center">N/A</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Raymond V. Damadian Chairman of the Board, Treasurer and Principal Financial Officer</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: center">N/A</td></tr>
</table>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">III</td><td>DIRECTOR COMPENSATION</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The following table shows the compensation paid to the Directors for fiscal
2025:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Name</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Fees earned in paid <br/>in cash ($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Stock awards ($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Option awards ($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Non-equity incentive plan compen- <br/>sation</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Nonqualified deferred compen- <br/>sation earnings <br/>($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">All other compen- <br/>sation ($)</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Total <br/>($)</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">(a)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(b)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(c)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(d)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(e)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(f)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(g)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(h)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 37%; text-align: left; text-indent: -10pt">A. Claudette J.V. Chan</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right">20,000</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right">0</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 5%; text-align: right"><p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0">39,486</p></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 2%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 5%; text-align: right"><p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0">59,486</p></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">B. Ronald G. Lehman</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">20,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">65,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">85,000</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">C. Richard E. Turk</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">20,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">15,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">35,000</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">D. Jessica Maher</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">20,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">15,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">35,000</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>EMPLOYEE COMPENSATION PLANS</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR adopted its 2010 Stock Bonus Plan, on June 28,
2010. This Plan permits FONAR to issue an aggregate of 2,000,000 shares of common stock of FONAR as bonus or compensation. As of June
30, 2025, 450,177 shares were available for issuance.<br/>
</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span id="a_019"></span>ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the number and percentage of shares of FONAR&#8217;s
securities held by each director, by each person known by us to own in excess of five percent of FONAR&#8217;s voting securities and by
all officers and directors as a group as of August 8, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p><table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom"><td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Name
                                          and Address of Beneficial Owner (1)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Shares
    Beneficially Owned</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Percent
    of Class</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy R. Damadian, as Trustee
    of the FONAR Class C Trust</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">c/o FONAR Corporation, Melville,
    New York</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Class C Stock</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">382,447</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">99.98</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Kayne Anderson Rudnick</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Investment Management LLC</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">1800 Avenue of the Stars,
    2nd Floor</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Los Angeles, CA 90067</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Common Stock</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">544,036</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">8.77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Money Concepts Capital Corp..</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">11440 North Jog Road</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Palm Beach Gardens, FL 33418-3764</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Common Stock</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">462,760</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">7.46</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The Vanguard Group, Inc.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">100 Vanguard Boulevard</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Malvern, PA 19355-2331</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Common Stock</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">390,345</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">6.29</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Dimensional Fund Advisors
    LP</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Building One</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">6300 Bee Cave Road</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Austin, Texas 78746</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Common Stock</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">372,563</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">6.01</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Renaissance Technologies,
    LLC</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">800 Third Avenue</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">New York, NY 10022</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Common Stock</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">315,516</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">5.09</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy R. Damadian,</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 12pt Times New Roman, Times, Serif; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chairman
    of the Board, President, Chief Executive Officer and Treasurer</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Common Stock</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">79,059</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Class A Preferred</span></td><td style="font: 12pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">800</span></td><td style="font: 12pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td><td style="text-align: right"/><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">*</span></td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Continued:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Name and Address of Beneficial Owner (1)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Shares Beneficially Owned</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percent of Class</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Luciano B. Bonanni,</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Executive Vice President,</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Chief Operating Officer and acting Principal Financial Officer</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Common Stock</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">54,253</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">&#160;</td>
<td style="width: 1%; text-align: left">*</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class A Preferred</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">1,285</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">*</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Claudette Chan</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Director and Secretary</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Common Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">106</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">*</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class A Preferred</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">32</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">*</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Ronald G. Lehman</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Director</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Common Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">4,330</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">*</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Richard E. Turk</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Director</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Common Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">*</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Jessica Maher Director Common Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">*</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Robert M. Carrino Director Common Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">0</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">*</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">All Officers and Directors as a Group (6 persons)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Common Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">137,721</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">2.18</td>
<td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class C Stock</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">382,447</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">99.98</td>
<td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class A Preferred</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">2,117</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">*</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">* Less than one percent</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>





















































<hr style="border-width: 0; background-color: black; height: 1px; width: 25%; color: black"/>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">1. Address provided for each beneficial owner owning more than five percent
of the voting securities of FONAR.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_020"></span>ITEM 13.&#160;CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS AND DIRECTOR INDEPENDENCE.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to HMCA&#8217;s management agreements with
its clients, HMCA provides comprehensive non-medical management and administrative services, including billing and collection of accounts,
payroll and accounts payable processing, office facilities, supplies and utilities. Under the management agreements, HMCA also provides
service for the Fonar Upright&#174; MRI scanners through Fonar. In total, as of September 5, 2025, 22 of our clients had management agreements
with HMCA. Six sites in Florida are owned and operated directly by HMCA subsidiaries.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fees charged under the management agreements are
flat fees charged on a monthly basis. These fees ranged from $70,358 to $459,544 per month in fiscal 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Timothy Damadian, Chairman of the Board, President,
Chief Executive Officer and Treasurer owned three of the imaging facilities in Florida managed by HMCA. (See note below) The facilities
owned by Timothy Damadian in Florida pay HMCA flat rate monthly fees ranging from $271,517 to $411,589 per month. These fees are renegotiable
on an annual basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the fiscal years ended June 30, 2025, June
30, 2024 and June 30, 2023, the net revenues received by HMCA from the imaging facilities owned by Timothy Damadian were approximately
$11.9 million, $11.9 million and $11.9 million respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Magnetic Resonance Management, LLC, in which Timothy
Damadian, the CEO and President of the Company owns, entered into an agreement to purchase equipment from the Company. The selling price
of such equipment was $567,857 which is payable based upon a promissory note dated December 1, 2023. The note bears interest at a rate
of 9% and is payable in full at the maturity of the note in December 2028. The equipment had a zero basis which resulted in a gain of
$576,857. The Company has the option but not the obligation to re-take possession in lieu of payment upon maturity of the note. The balance
of the note as of June 30, 2025 was $554,857.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Bensonhurst MRI Limited Partnership, in which Timothy
Damadian, the CEO and President of the Company holds an interest, is party to two agreements with the Company for the service and maintenance
of its Upright MRI and High-Field Scanners for a price of $110,000 per annum and $70,000 per annum, respectively. Also during fiscal year
ended June 30, 2025 and fiscal year ended June 30, 2024, the Company charged Bensonhurst MRI Limited Partnership $301,480 and $190,362,
respectively for reimbursable salaries and marketing expenses.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Radian Healthcare Management, LLC which Matt Pluta,
the son-in-law of Timothy Damadian, the CEO and President of the Company owns, provided the Company with personnel recruitment of employees
at a fee $165,000 and $200,347 during the fiscal years ended June 30, 2025 and June 30, 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ronald Lehman, a Director of Fonar, holds a .0378%
interest in Health Management Company of America&#8217;s Class A membership interests.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Jessica Maher, a Director of Fonar, holds a .015%
interest in Health Management Company of America&#8217;s Class A membership interests.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Claudette J.V. Chan, a Director Fonar until June 23,
2025, owns a .0378% interest in Health Management Company of America&#8217;s Class A Membership interests.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><br/></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_021"></span>ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Audit Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate fees billed by Cohn Reznick LLP for
the audit of our annual consolidated financial statements for the fiscal year ended June 30, 2025 and the reviews of the financial statements
included in our Forms 10-Q for the second and third quarter of the fiscal year ended June 30, 2025 were $478,000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate fees billed by Marcum LLP for the reviews
of the financial statements included in our Form 10-Q for the first quarter and audit of annual consolidated financial statements for
the fiscal year ended June 30, 2025 were $67,600</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate fees billed by Marcum LLP for the audit
of our annual financial statements for the fiscal year ended June 30, 2024 and the reviews of the financial statements included in our
Forms 10-Q for the fiscal year ended June 30, 2024 were $379,000.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Audit Related Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by CohnReznick LLP for the fiscal
year ended June 30, 2025 for services related to the Audit or review of our financial statements that are not included under the caption
&#8220;Audit Fees&#8221;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for the fiscal years
ended June 30, 2025 or June 30, 2024 for services related to the Audit or review of our financial statements that are not included under
the caption &#8220;Audit Fees&#8221;.&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by CohnReznick LLP for the fiscal
year ended June 30, 2025 for designing, operating, supervising or implementing any of our financial information systems or any hardware
or software systems for our financial information.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for the fiscal years
ended June 30, 2025 or June 30, 2024 for designing, operating, supervising or implementing any of our financial information systems or
any hardware or software systems for our financial information.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tax Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by CohnReznick LLP for tax compliance,
tax advice and tax planning in the fiscal year ended June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for tax compliance,
tax advice and tax planning in the fiscal year ended June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees billed by Marcum LLP for tax compliance, tax
advice and tax planning in the fiscal year ended June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All Other Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by CohnReznick LLP for any other
services during the fiscal year ended June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">No fees were billed by Marcum LLP for any other services
during the fiscal years ended June 30, 2025 and June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since January 1, 2003, the audit committee has adopted
policies and procedures for pre-approving all non-audit work performed by the auditors. Specifically, the committee must pre-approve the
use of the auditors for all such services. The audit committee has pre-approved all non-audit work since that time and in making its determination
has considered whether the provision of such services was compatible with the independence of the auditors.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our audit committee believes that the provision by
Marcum LLP of services in addition to audit services in previous years were compatible with maintaining their independence.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>PART IV</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="a_022"></span>ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES,
AND REPORTS ON FORM 8-K.</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">a)</td><td style="text-align: justify">FINANCIAL STATEMENTS AND SCHEDULES</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following consolidated financial statements are
included in Part II, Item 8.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Report of Independent Registered Public Accounting
Firm (PCAOB ID 596)</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consolidated Balance Sheets as at June 30, 2025 and
2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: red">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consolidated Statements of Income for the Years Ended
June 30, 2025 and 2024<span style="color: red">.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consolidated Statements of Stockholders&#8217; Equity
for the Years Ended June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Consolidated Statements of Cash Flows for the Years
Ended June 30, 2025 and 2024 .</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes to Consolidated Financial Statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Information required by schedules called for under
Regulation S-X is either not applicable or is included in the consolidated financial statements or notes to the consolidated financial
statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">b)</td><td style="text-align: justify">REPORTS ON FORM 8-K</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="text-align: justify; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">1.</span></td>
<td style="text-align: justify; width: 92%"> <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0000355019/000035501922000050/fonar_8-k.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Registrant&#8217;s Report on Form 8-K: Item 2.02, Results of Operations and Financial Condition for the Fiscal Year ended June 30, 2022, reported September 28, 2022. Commission File No. 0- 10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2.</span></td>
<td style="text-align: justify"> <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0000355019/000035501923000014/fonar_8k.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Registrant&#8217;s Report on Form 8-K: Item 5.02, Departure of Directors or Certain Officers, reported March 20, 2023. Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3. </span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0000355019/000035501923000034/fonar_8-k.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Registrant&#8217;s Report on Form 8-K: Item 5.07, Submission of Matters to a Vote of Security Holders, at the annual meeting of stockholders, reported on May 22, 2023. Commission File No. 0-10248.</span></a></td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in">c)</td><td style="text-align: justify">EXHIBITS</td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="text-align: justify; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.1</span></td>
<td style="text-align: justify; width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 3.1 to</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">the Registrant&#8217;s registration statement on Form S-1,Commission File No. 33-13365.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.2</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-95-000015.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">reference to Exhibit 4.1 to the Registrant&#8217;s registration statement on Form S-8, Commission File No. 33-</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">62099.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.3</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501901500018/ex0403.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s registration statement on Form S-3,</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Commission File No. 333-63782.</span></a></td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"></p>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>



<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.4 </span></td>
<td style="width: 92%"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501903000019/x033.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Section A of Article Fourth of the Certificate of Incorporation, as amended, of the Registrant incorporated by reference to Exhibit 3.3 of the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2003, Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.5</span></td>
<td style="text-align: justify"> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">By-Laws, as amended, of the Registrant incorporated by reference
to Exhibit 3.2 to the Registrant&#8217;s registration statement on Form S-1, Commission File No. 33-13365.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">4.1 </span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Specimen Common Stock Certificate incorporated by reference
to Exhibit 4.1 to the Registrant&#8217;s registration statement on Form S-1, Commission File No. 33-13365.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">4.2 </span></td>
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Specimen Class B Common Stock Certificate incorporated by reference
to Exhibit 4.2 to the Registrant&#8217;s registration statement on Form S-1, Commission File No. 33-13365.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.1</span></td>
<td style="text-align: justify"> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">License Agreement between the Registrant and Raymond V. Damadian
incorporated by reference to Exhibit 10 (e) to Form 10-K for the fiscal year ended June 30, 1983, Commission File No. 0-10248.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.2</span></td>
<td style="text-align: justify"> <a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000036.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Stock Purchase Agreement, dated July 31, 1997, by and between U.S. Health Management Corporation, Raymond V. Damadian, M.D. MR Scanning Centers Management Company and Raymond V. Damadian, incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s Form 8-K, July 31, 1997, commission File No: 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.3 </span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-97-000029.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Merger Agreement and Supplemental Agreement dated June 17, 1997 and Letter of Amendment dated June 27, 1997 by and among U.S. Health Management Corporation and Affordable Diagnostics Inc. et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K, June 30, 1997, Commission File No: 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.4</span></td>
<td style="text-align: justify"> <a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000004.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Stock Purchase Agreement dated March 20, 1998 by and among Health Management Corporation of America, FONAR Corporation, Giovanni Marciano, Glenn Muraca et al., incorporated by reference to Exhibit 2.1 to the Registrant&#8217;s 8-K, March 20, 1998, Commission File No: 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.5</span></td>
<td style="text-align: justify"> <a href="http://www.sec.gov/Archives/edgar/data/355019/0000355019-98-000013.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Stock Purchase Agreement dated August 20, 1998 by and among Health Management Corporation of America, FONAR Corporation, Stuart Blumberg and Steven Jonas, incorporated by reference to Exhibit 2 to the Registrant&#8217;s 8-K, September 3, 1998, Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.6 </span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501902000016/x99.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2002 Incentive Stock Option Plan incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s registration statement on Form S-8, Commission File No.: 333-96557.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.7</span></td>
<td style="text-align: justify"> <a href="http://www.sec.gov/Archives/edgar/data/355019/000035501905000018/x2-50801.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Asset Purchase Agreement dated July 28, 2005 among Health Plus Management Services, L.L.C., Health Management Corporation of America, Dynamic Healthcare Management, Inc. and FONAR Corporation, incorporated by reference to Exhibit 2 to the Registrant&#8217;s Form 8-K, August 2, 2005, Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.8 </span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501908000021/x10.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Partnership Interest Purchase Agreement dated September 29, 2008 by and between Diagnostic Management, LLC and Raymond V. Damadian, M.D. MR Scanning Centers Management Company, incorporated by reference to Exhibit 10.35 to Form 10-K for the fiscal year ended June 30, 2008. Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.9</span></td>
<td style="text-align: justify"> <a href="http://www.sec.gov/Archives/edgar/data/355019/000035501910000014/x99.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2010 Stock Bonus Plan, incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s registration statement on Form S-8, Commission File No. 333-168771.</span></a></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="text-align: justify; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.10 </span></td>
<td style="text-align: justify; width: 92%"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501911000020/fonar10x.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Operating Agreement for Imperial Management Services, LLC, incorporated by reference to Exhibit 10.37 to Form 10-K for the fiscal year ended June 30, 2011. Commission File No. 0-10248.</span></a></td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.11</span></td>
<td style="text-align: justify; width: 92%"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Operating Agreement for Health Diagnostics Management, LLC, incorporated by reference to</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibit 10.38 to Form 10-K for the fiscal year ended June 30, 2013. Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.12</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000029/fonar_exhibit10-38.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Modification to Operating Agreement for Health Diagnostics Management, LLC., See Exhibits.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">incorporated by reference to Exhibit 10.38 to Form 10-K for the fiscal year ended June 30, 2013.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.13</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501913000007/fonar_exhibit-10.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Purchase Agreement dated March 5, 2013 among Health Diagnostics Management, LLC, Health</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Diagnostics, LLC and others. Incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Form 8-K filed</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">March 11, 2013. Commission File No. 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">14.1</span></td>
<td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/355019/000035501904000028/x141.txt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Code of Ethics, incorporated by reference to Exhibit 14.1 of Registrant&#8217;s Form 10-K for the fiscal</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">year ended June 30, 2004, Commission File No.: 0-10248.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">21.1</span></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><a href="fonar_exhibit-21.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Subsidiaries of the Registrant.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">23.1&#160;</td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><a href="fonar_exhibit-231.htm">Consent of Cohn Reznick LLP
Independent Registered Public Accounting Firm.</a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">23.2 </span></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><a href="fonar_exhibit-232.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Consent
of Marcum LLP Independent Registered Public Accounting Firm.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">31.1 </span></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><a href="fonar_exhibit-31.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Section
302 Certification.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">32.1 </span></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><a href="fonar_exhibit-32.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Section
906 Certification.</span></a></td></tr>
<tr style="vertical-align: top">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">97.1</span></td>
<td style="text-align: justify"><a href="fonar_exhibit-97.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Policy for the Recovery of Erroneously Awarded Compensation Pursuant to SEC Exchange Act</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Rule 10D-1</span></a></td></tr>
</table>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">SIGNATURES.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of Section 13 or 15 (d)
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="padding: 0pt; white-space: nowrap; text-indent: 0pt">
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">FONAR CORPORATION</p>
    <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p></td></tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; width: 50%; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Dated: September 15, 2025</span></td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; width: 5%; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">By:</span></td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; width: 45%; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Timothy Damadian</span></td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy Damadian, </span></td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chairman of the Board of Directors </span></td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chief Executive Officer</span></td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">President and Treasurer </span></td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">By</span></td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Luciano B. Bonanni</span></td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Luciano B. Bonanni</span></td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;Executive Vice President, </span></td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chief Operating Officer and </span></td>
    </tr>
  <tr>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
    <td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Acting Principal Financial Officer </span></td>
    </tr>
  </table>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
<td style="border-bottom: Black 1pt solid; padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Signature</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Title</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td colspan="2" style="border-bottom: Black 1pt solid; padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Date</span></td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/ Timothy R. Damadian </span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt; width: 2%">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: top; text-indent: 0pt; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chairman of the Board of Directors </span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt; width: 2%">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September 22, 2025</span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt; width: 1%">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy R. Damadian</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: top; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Chief Executive Officer</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">President and Treasurer </span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Claudette J.V. Chan</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September 22, 2025</span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Claudette J.V. Chan</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Ronald G. Lehman</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September 22, 2025</span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Ronald G. Lehman</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Richard E. Turk</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September 22, 2025 </span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Richard E. Turk</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&#160;</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/Jessica Maher</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Director</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">September 22, 2025</span></td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
<tr>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Jessica Maher</span></td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; vertical-align: top; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; white-space: nowrap; vertical-align: bottom; text-indent: 0pt">&#160;</td>
<td style="padding: 0pt; line-height: 115%; text-indent: 0pt">&#160;</td></tr>
</table>

<p style="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0">Page 97</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>





<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>fonar_exhibit-21.htm
<DESCRIPTION>SUBSIDIARIES OF THE REGISTRANT
<TEXT>

<!-- saved from url=(0114)file:///C:/Users/cnaglieri/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/9YPQN7Z5/fonar_exhibit-21.htm -->
<html><head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Exhibit
21.1</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Subsidiaries
of the Registrant</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: -0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: center"><font style="font: normal 11pt Times New Roman, Times, Serif">Subsidiary</font></td>
<td style="font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: center"><font style="font: normal 11pt Times New Roman, Times, Serif">State of Incorporation</font></td>
<td style="font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td colspan="2" style="border-bottom: Black 1pt solid; font: 11pt Times New Roman, Times, Serif; text-align: center"><font style="font: normal 11pt Times New Roman, Times, Serif">Ownership</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 58%; font: 11pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><font style="font: normal 11pt Times New Roman, Times, Serif">Imperial Management Services LLC</font></td>
<td style="width: 5%; font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td style="width: 21%; font: 11pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><font style="font: normal 11pt Times New Roman, Times, Serif">New York</font></td>
<td style="width: 5%; font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td style="width: 10%; font: 11pt Times New Roman, Times, Serif; text-align: right"><font style="font: normal 11pt Times New Roman, Times, Serif">100</font></td>
<td style="width: 1%; font: 11pt Times New Roman, Times, Serif; text-align: left"><font style="font: normal 11pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><font style="font: normal 11pt Times New Roman, Times, Serif">Health Diagnostics Management, LLC d/b/a Health Management Company of America</font></td>
<td style="font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><font style="font: normal 11pt Times New Roman, Times, Serif">New York</font></td>
<td style="font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: right"><font style="font: normal 11pt Times New Roman, Times, Serif">70.6</font></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: left"><font style="font: normal 11pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><font style="font: normal 11pt Times New Roman, Times, Serif">Health Management Corporation of America</font></td>
<td style="font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><font style="font: normal 11pt Times New Roman, Times, Serif">Delaware</font></td>
<td style="font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: right"><font style="font: normal 11pt Times New Roman, Times, Serif">100</font></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: left"><font style="font: normal 11pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font: 11pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><font style="font: normal 11pt Times New Roman, Times, Serif">FCP Services, Inc.</font></td>
<td style="font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><font style="font: normal 11pt Times New Roman, Times, Serif">New York</font></td>
<td style="font: 11pt Times New Roman, Times, Serif"><font style="font: normal 11pt Times New Roman, Times, Serif">&nbsp;</font></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: right"><font style="font: normal 11pt Times New Roman, Times, Serif">100</font></td>
<td style="font: 11pt Times New Roman, Times, Serif; text-align: left"><font style="font: normal 11pt Times New Roman, Times, Serif">%</font></td></tr>
</table>




</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>fonar_exhibit-231.htm
<DESCRIPTION>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibit
23.1</FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="color: Black"><B>Consent of Independent
Registered Public Accounting Firm</B></FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">We consent
to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-138763) of FONAR Corporation and Subsidiaries of
our report dated September 19, 2025, with respect to the consolidated balance sheets of FONAR Corporation and Subsidiaries as of June
30, 2025, the related consolidated statements of income, stockholders' equity, and cash flows for the year ended June 30, 2025, and the
effectiveness of FONAR Corporation and Subsidiaries&rsquo; internal control over financial reporting as of June 30, 2025, included in
this Annual Report (Form 10-K) of FONAR Corporation and Subsidiaries for the year ended June 30, 2025.</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; color: fuchsia"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">Melville,
New York</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">September
22, 2025</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: fuchsia">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>fonar_exhibit-232.htm
<DESCRIPTION>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibit
23.2</FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</U></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We consent to the incorporation by reference in the
Registration Statement on Form S-8 File No. 333-168771 of our report dated September 27, 2024, with respect to the consolidated financial
statements of Fonar Corporation and Subsidiaries included in this Annual Report on Form 10-K for the year ended June 30, 2025.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">/s/ Marcum LLP</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">New York, NY</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">September 22, 2025</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>5
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>

<!-- saved from url=(0114)file:///C:/Users/cnaglieri/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/9YPQN7Z5/fonar_exhibit-31.htm -->
<html><head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Exhibit
31.1</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">CERTIFICATION</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">I,
Timothy R. Damadian certify that:</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">and</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">I,
Luciano Bonanni, certify that:</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">1.
I have reviewed this annual report on Form 10-K of Fonar Corporation;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">2.
Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements made, not misleading with respect to the period
covered by this annual report; and</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">3.
Based on my knowledge, the financial statements, and other financial information, included in this annual report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this annual report.</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(f) for the registrant and
I have:</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others
within those entities, particularly during the period in which this report is being prepared;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
my supervision, to provide reasonable assurance regarding the reliability of financial statements for external purposes in accordance
with generally accepted accounting principles;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions
about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation;
and</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">5.
I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">a)
all significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial data; and</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Date:
September 22, 2025</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
Timothy R. Damadian</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Timothy
R. Damadian,</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">President
and Principal Executive Officer</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">/s/
Luciano Bonanni</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Luciano
Bonanni,</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Executive
Vice President, COO and</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">Acting
Principal Financial Officer</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; font-style: normal; font-weight: normal">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>

<!-- saved from url=(0114)file:///C:/Users/cnaglieri/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/9YPQN7Z5/fonar_exhibit-32.htm -->
<html><head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibit
32.1</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">In
connection with the Annual Report of Fonar Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10-K for the fiscal year
ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Timothy Damadian,
President and Chief Executive Officer of the Company, and I, Luciano Bonanni, Executive Vice President, certify, pursuant to 18 U.S.C.
ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/
Timothy R. Damadian</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Timothy
R. Damadian,</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">President
and Principal Executive Officer</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">/s/
Luciano Bonanni</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Luciano
Bonanni,</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Executive
Vice President, COO and</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Acting
Principal Financial Officer</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Date:
September 22, 2025</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">A
signed original of this written statement required by Section 906 has been provided to Fonar Corporation and will be retained by Fonar
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.</font></p>



</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97
<SEQUENCE>7
<FILENAME>fonar_exhibit-97.htm
<DESCRIPTION>POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION PURSUANT TO SEC EXCH
<TEXT>

<!-- saved from url=(0114)file:///C:/Users/cnaglieri/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/9YPQN7Z5/fonar_exhibit-97.htm -->
<html><head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Exhibit
97&nbsp;</font></p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 4.7pt 83.35pt 0 83.2pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">FONAR
Corporation</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>&nbsp;</b></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 83.25pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>POLICY
FOR <font style="letter-spacing: -0.25pt">THE</font></b></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 83.25pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>RECOVERY
OF ERRONEOUSLY AWARDED <font style="letter-spacing: -0.1pt">COMPENSATION PURSUANT TO SEC EXCHANGE ACT RULE 10D-1</font></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0.05pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
<td style="width: 48pt">&nbsp;</td>
<td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">A.</font></td>
<td style="text-align: left; padding-right: 83.35pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">OVERVIEW</font></td></tr>
</table>


<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 24pt; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">In
accordance with the applicable rules of The Nasdaq Stock Market (the <b><i>&ldquo;Nasdaq Rules&rdquo;</i></b>), Section 10D and Rule
10D-1 of the Securities Exchange Act of 1934, as amended (the &ldquo;<b><i>Exchange Act</i></b>&rdquo;) (&ldquo;<b><i>Rule 10D-1</i></b>&rdquo;),
the Board of Directors (the &ldquo;<b><i>Board</i></b>&rdquo;) of FONAR Corporation (the &ldquo;<b><i>Company</i></b>&rdquo;) has adopted
this Policy (the &ldquo;<b><i>Policy</i></b>&rdquo;) to provide for the recovery of erroneously awarded Incentive-based Compensation
from Executive Officers. All capitalized terms used and not otherwise defined herein shall have the meanings set forth in Section H,
<font style="letter-spacing: -0.1pt">below.</font></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 24pt; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 24pt; text-align: justify; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 48pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">B..</font></td><td style="text-align: left; padding-right: 21pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">RECOVERY
                                            OF ERRONEOUSLY AWARDED <font style="letter-spacing: -0.4pt">C</font><font style="letter-spacing: -0.1pt">OMPENSATION</font></font></td></tr></table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 24pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;&nbsp;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 24pt; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">In the event of an Accounting Restatement, the Company
will reasonably promptly recover the Erroneously Awarded Compensation Received in accordance with Nasdaq Rules and Rule 10D-1 as follows:</font></p>

<p style="font: 10.5pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(i)</font></td><td style="text-align: justify; padding-right: 23.85pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">After
                                            an Accounting Restatement, a majority of independent directors serving on the Board (the
                                            &ldquo;<b><i>Committee</i></b>&rdquo;) shall determine the amount of any Erroneously Awarded
                                            Compensation Received by each Executive Officer and shall promptly notify each Executive
                                            Officer with a written notice containing the amount of any Erroneously Awarded Compensation
                                            and a demand for repayment or return of such compensation, as applicable.</font></td></tr></table>

<p style="font: 9.5pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 3.95pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 96pt"></td><td style="width: 27pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(a)</font></td><td style="text-align: justify; padding-right: 23.9pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">For
                                            Incentive-based Compensation based on (or derived from) the Company&rsquo;s stock price or
                                            total shareholder return, where the amount of Erroneously Awarded Compensation is not subject
                                            to mathematical recalculation directly from the information in the applicable Accounting
                                            Restatement:</font></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 3.95pt 23.9pt 0 123pt; text-align: justify; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 126.95pt"></td><td style="width: 23.05pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">i.</font></td><td style="text-align: justify; padding-right: 23.85pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
                                            amount to be repaid or returned shall be determined by the Committee based on a reasonable
                                            estimate of the effect of the Accounting Restatement on the Company&rsquo;s stock price or
                                            total shareholder return upon which the Incentive-based Compensation was Received; and</font></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 124.8pt"></td><td style="width: 25.2pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">ii.</font></td><td style="text-align: justify; padding-right: 23.9pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
                                            Company shall maintain documentation of the determination of such reasonable estimate and
                                            provide the relevant documentation as required to Nasdaq.</font></td></tr></table>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 150pt; text-align: right; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(ii)</font></td><td style="text-align: justify; padding-right: 23.6pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
                                            Committee shall have discretion to determine the appropriate means of recovering Erroneously
                                            Awarded Compensation based on the particular facts and circumstances. Notwithstanding the
                                            foregoing, except as set forth in Section B(2) below, in no event may the Company accept
                                            an amount that is less than the amount of Erroneously Awarded Compensation in satisfaction
                                            of an Executive Officer&rsquo;s obligations hereunder.</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(iii)</font></td><td style="text-align: justify; padding-right: 23.6pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">To
                                            the extent that the Executive Officer has already reimbursed the Company for any Erroneously
                                            Awarded Compensation Received under any duplicative recovery obligations established by the
                                            Company or applicable law, it shall be appropriate for any such reimbursed amount to be credited
                                            to the amount of Erroneously Awarded Compensation that is subject to recovery under this
                                            Policy. </font></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(iv)</font></td><td style="text-align: justify; padding-right: 23.9pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">To
                                            the extent that an Executive Officer fails to repay all Erroneously Awarded Compensation
                                            to the Company when due, the Company shall take all actions reasonable and appropriate to
                                            recover such Erroneously Awarded Compensation from the applicable Executive Officer. The
                                            applicable Executive Officer shall be required to reimburse the Company for any and all expenses
                                            reasonably incurred (including legal fees) by the Company in recovering such Erroneously
                                            Awarded Compensation in accordance with the immediately preceding sentence.</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 24pt; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Notwithstanding anything herein to the contrary, the
Company shall not be required to take the actions contemplated by Section B(1) above if the Committee determines that recovery would
be impracticable <i>and </i>either of the following conditions are met:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt/98% Times New Roman, Times, Serif; margin-top: 3.95pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(i)</font></td><td style="text-align: justify; padding-right: 25.8pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
                                            Committee has determined that the direct expenses paid to a third party to assist in enforcing
                                            the Policy would exceed the amount to be recovered. Before making this determination, the
                                            Company must make a reasonable attempt to recover the Erroneously Awarded Compensation, documented
                                            such attempt(s) and provided such documentation to <font style="letter-spacing: -0.1pt">Nasdaq;</font></font></td></tr></table>

<p style="font: 10.5pt Times New Roman, Times, Serif; margin: 0.15pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt/98% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.05pt">(ii)</font></td><td style="text-align: justify; padding-right: 23.9pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Recovery
                                            would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly
                                            available to employees of the Company, to fail to meet the requirements of Section 401(a)(13)
                                            or Section 411(a) of the Internal Revenue Code of 1986, as amended, and regulations thereunder.</font></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 48pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">C.</font></td><td style="text-align: left; padding-right: 83.35pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">DISCLOSURE
                                            REQUIREMENTS</font></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
Company shall file all disclosures with respect to this Policy required by applicable U.S. Securities and Exchange Commission (&ldquo;<b><i>SEC</i></b>&rdquo;)
filings and rules.</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 48pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">D.</font></td><td style="text-align: left; padding-right: 83.35pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.2pt">PROHIBITION
                                            OF INDEMNIFICATION</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.65pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">The
Company shall not be permitted to insure or indemnify any Executive Officer against (i) the loss of </font><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">any
Erroneously Awarded Compensation that is repaid, returned or recovered pursuant to the terms of this Policy, or (ii) any claims relating
to the Company&rsquo;s enforcement of its rights under this Policy. Further, the <font style="letter-spacing: -0.2pt">Company shall not
enter into any agreement that exempts any Incentive-based Compensation that is granted, </font><font style="letter-spacing: -0.1pt">paid
or awarded to an Executive Officer from the application of this Policy or that waives the Company&rsquo;s right to recovery of any Erroneously
Awarded Compensation, and this Policy shall supersede any such agreement </font>(whether entered into before, on or after the Effective
Date of this Policy).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 48pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">E.</font></td><td style="text-align: left; padding-right: 83.35pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">ADMINISTRATION
                                            AND <font style="letter-spacing: -0.1pt">INTERPRETATION</font></font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 24.15pt 0 24pt; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">This
Policy shall be administered by the Committee, and any determinations made by the Committee shall be final and binding on all affected
individuals.</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
Committee is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for
the administration of this Policy and for the Company&rsquo;s compliance with Nasdaq Rules, Section 10D, Rule 10D-1 and any other applicable
law, regulation, rule or interpretation of the SEC or Nasdaq promulgated or issued in connection therewith.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 48pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">F.</font></td><td style="text-align: left; padding-right: 83.35pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">AMENDMENT;
                                            <font style="letter-spacing: -0.1pt">TERMINATION</font></font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.75pt 0 27.55pt; text-align: justify; text-indent: 28.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">The
Committee may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary. Notwithstanding
anything in this Section F to the contrary, no amendment or termination of this Policy shall be effective if such amendment or termination
would (after taking <font style="letter-spacing: -0.2pt">into </font>account any actions taken by the Company contemporaneously with
such amendment or termination) cause the Company to violate any federal securities laws, SEC rule or Nasdaq rule.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.55pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 48pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">G.</font></td><td style="text-align: left; padding-right: 83.35pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">OTHER
                                            RECOVERY RIGHTS</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 23.9pt 0 27.55pt; text-align: justify; text-indent: 0.45in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">This
Policy shall be binding and enforceable against all Executive Officers and, to the extent required by applicable law or guidance from
the SEC or Nasdaq, their beneficiaries, heirs, executors, administrators or other legal representatives. The Committee intends that this
Policy will be applied to the fullest extent required by applicable law. Any employment agreement, equity award agreement, compensatory
plan or any other agreement or arrangement with an Executive Officer shall be deemed to include, as a condition to the grant of any benefit
thereunder, an agreement by the Executive Officer to abide by the terms of this Policy. Any right of recovery under this Policy is in
addition to, and not in lieu of, any other remedies or rights of recovery that may be available to the Company under applicable law,
regulation or rule or pursuant to the terms of any policy of the Company or any provision in any employment agreement, equity award agreement,
compensatory plan, agreement or other <font style="letter-spacing: -0.1pt">arrangement.</font></font></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10.5pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 10.5pt Times New Roman, Times, Serif; margin: 0.05pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: bold 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 48pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.65pt">H.</font></td><td style="text-align: left; padding-right: 83.35pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">DEFINITIONS</font></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 60pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">For
purposes of this Policy, the following capitalized terms shall have the meanings set forth <font style="letter-spacing: -0.1pt">below.</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">1.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&ldquo;<b><i>Accounting
                                            Restatement</i></b>&rdquo; means an accounting restatement due to the material noncompliance
                                            of the Company with any financial reporting requirement under the securities laws, including
                                            any required accounting restatement to correct an error in previously issued financial statements
                                            that is material to the previously issued financial statements (a &ldquo;Big R&rdquo; restatement),
                                            or that would result in a material misstatement if the error were corrected in the current
                                            period or left uncorrected in the current period (a &ldquo;little r&rdquo; restatement).</font></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 23.75pt 0 60pt; text-align: justify; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">2.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><i>&ldquo;Clawback
                                            Eligible Incentive Compensation&rdquo;</i></b> means all Incentive-based Compensation Received
                                            by an Executive Officer (i) on or after the effective date of the applicable Nasdaq rules,(ii)
                                            after beginning service as an Executive Officer, (iii) who served as an Executive Officer
                                            at any time during the applicable performance period relating to any Incentive-based Compensation
                                            (whether or not such Executive Officer is serving at the time the Erroneously Awarded Compensation
                                            is required to be repaid to the Company), (iv) while the Company has a class of securities
                                            listed on a national securities exchange or a national securities association, and (v) during
                                            the applicable Clawback Period (as defined below).</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><i>&ldquo;Clawback
                                            Period&rdquo; </i></b>means, with respect to any Accounting Restatement, the three completed
                                            fiscal years of the Company immediately preceding the Restatement Date (as defined below),and
                                            if the Company changes its fiscal year, any transition period of less than nine months within
                                            or immediately following those three completed fiscal years.</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">4.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><i>&ldquo;Erroneously
                                            Awarded Compensation&rdquo;</i></b> means, with respect to each Executive Officer in connection
                                            with an Accounting Restatement, the amount of Clawback Eligible Incentive Compensation that
                                            exceeds the amount of Incentive-based Compensation that otherwise would have been Received
                                            had it been determined based on the restated amounts, computed without regard to any taxes
                                            paid. </font></td></tr></table>

<p style="font: 10.5pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">5.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><i>&ldquo;Executive
                                            Officer&rdquo;</i></b> means each individual who is currently or was previously designated
                                            as an &ldquo;officer&rdquo; of the Company as defined in Rule 16a-1(f) under the Exchange
                                            Act. For the avoidance of doubt, the identification of an executive officer for purposes
                                            of this Policy shall include each executive officer who meets the definition of executive
                                            officer set forth in Rule 10D-1 and the Listing Standards. </font></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 24pt; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 23.75pt 0 96pt; text-align: justify; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">6.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><i>&ldquo;Financial
                                            Reporting Measures&rdquo; </i></b>means measures that are determined and presented in accordance
                                            with the accounting principles used in preparing the Company&rsquo;s financial statements,
                                            and all other measures that are derived wholly or in part from such measures. Stock price
                                            and total shareholder return (and any measures that are derived wholly or in part from stock
                                            price or total shareholder return) shall, for purposes of this Policy, be considered Financial
                                            Reporting Measures. For the avoidance of doubt, a Financial Reporting Measure need not be
                                            presented in the Company&rsquo;s financial statements or included in a filing with the SEC.</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">7.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><i>&ldquo;Incentive-based
                                            Compensation&rdquo; </i></b>means any compensation that is granted, earned or vested based
                                            wholly or in part upon the attainment of a Financial Reporting Measure.</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">8.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><i>&ldquo;Nasdaq&rdquo;
                                            </i></b>means The Nasdaq Stock Market.</font></td></tr></table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0.05pt 23.75pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">9.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><i>&ldquo;Received&rdquo;
                                            </i></b>means, with respect to any Incentive-based Compensation, actual or deemed receipt,
                                            and Incentive-based Compensation shall be deemed received in the Company&rsquo;s fiscal period
                                            during which the Financial Reporting Measure specified in the Incentive-based Compensation
                                            award is attained, even if the payment or grant of the Incentive-based Compensation to the
                                            Executive Officer occurs after the end of that period.</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Times New Roman, Times, Serif; margin-top: 0.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 60pt"></td><td style="width: 36pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">10.</font></td><td style="text-align: justify; padding-right: 23.75pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b><i>&ldquo;Restatement
                                            Date&rdquo;</i></b> means the earlier to occur of (i) the date the Board, a committee of
                                            the Board or the officers of the Company authorized to take such action if Board action is
                                            not required, concludes, or reasonably should have concluded, that the Company is required
                                            to prepare an Accounting Restatement, or (ii) the date a court, regulator or other legally
                                            authorized body directs the Company to prepare an Accounting Restatement.</font></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 24pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Effective
as of <font style="letter-spacing: -0.2pt">December 1, 2023. </font></font></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.2pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 24pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 3.8pt 83.05pt 0 83.25pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>Exhibit
<font style="letter-spacing: -0.5pt">A</font></b></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>&nbsp;</b></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 25.45pt 0 25.65pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>ATTESTATION
AND ACKNOWLEDGEMENT OF POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION</b></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>&nbsp;</b></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>&nbsp;</b></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.45pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>&nbsp;</b></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.05pt 0 0 5.85pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">By
my signature below, I acknowledge and agree <font style="letter-spacing: -0.2pt">that:</font></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.6pt"></td><td style="width: 18pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&middot;</font></td><td style="text-align: justify; padding-right: 5.85pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">I
                                            have received and read the attached Policy for the Recovery of Erroneously Awarded Compensation
                                            (this <font style="letter-spacing: -0.1pt">&ldquo;<b><i>Policy</i></b>&rdquo;).</font></font></td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.6pt"></td><td style="width: 18pt"><p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&middot;</font></p>
                                                       <p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p></td><td style="text-align: justify; padding-right: 5.65pt"><p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"></font></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">I hereby agree to abide by all of the terms of this Policy both during and after my employment with the Company, including, without limitation, by promptly repaying or returning any Erroneously Awarded Compensation to the Company as determined in accordance with this Policy.</font></p></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 221.85pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">Signature:</font><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><u>	</u></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.35pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 4.65pt 0 0 221.85pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Printed
<font style="letter-spacing: -0.1pt">Name:</font><u>	</u></font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0.5pt 0 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 4.65pt 0 0 221.85pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt; letter-spacing: -0.1pt">Date:</font><font style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><u>	</u></font></p>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>fonar_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_logo.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !# ;H# 2(  A$! Q$!_\0
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M1?R76I:O?2WE]<2MEI)9'+LQ/N2:SJ_%L=Q%FF)Q<ZL*LHQ;T2>RZ?\ !/\
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MA^$LYI9EEM)0PN(TY8JRA4BE=);)27O+S4NQW5% (/0T5]B?@!Q/[0GBW5_
M7P/\9>.?#LJ)J.C^&;Z]L7DCW*LL4#NA([C('%?C"O\ P7#_ ."@( SXXT(\
M?] !/\:_8K]KC_DV+XC?]B5JF/\ P$DK^;A<XY'TK\^XUQ^-P5>C&A4<4TV[
M.W4_JKZ.?"O#?$.6YA/,\)3KN$Z:BYQ4K)J3:5^Y]>M_P7$_X* GIXYT,?\
M< 3_ !I#_P %PO\ @H&>GCO1!_W (_\ &OD2C-?$?VYG'_01+[S^DO\ B&?A
M]_T*J'_@M'UW_P /P_\ @H(1@^/-$_\ !!'_ (T?\/PO^"@?_0^:)_X((_\
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M#_HH6N_^$O=?_$U];]=X<_GI?^2GX5_JQXO_ /0+C?\ P&L>N_\ #OS]C/\
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M]#%?DT/B1_==?^#+T?Y'],OP_P#E\)Z0H_Z!<'_HM:W:PO !SX5TG_L%P?\
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MOV.[_P#8C_:,O?A&=4>_TNYLH]2T"]D #RVDC.H#X_B5XW4_[H/>O#:^O/\
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M,D[;K]6>!Q+XB<'<'XR&%S?%>RG./,ERS=U=J]XQ:W3/S8HK]*/^(<#XE_\
M1U&A?^$Q-_\ 'Z/^(<#XE_\ 1U&A?^$Q-_\ 'Z[?]5,]?_+G\8_YGSO_ !'+
MPN_Z&*_\ J__ "!^:]%?I1_Q#@?$O_HZC0O_  F)O_C]'_$.!\2_^CJ-"_\
M"8F_^/T?ZJY[_P ^?QC_ )A_Q''PN_Z&*_\  *O_ ,@:'_!%+XCI\'_V*OCA
M\49?#\>JKH-S]M;397VI<>7:;MC'!P#TZ&L@?\%]O"X_YL@\.'T_XF*?_(]?
M4_[&'_!,&_\ V7/V<OB/\"?'?Q4M-<MO'2.)+ZPTUK?[+&;?RCE7=MQ_BZCI
M7S __!#W]EZ-VB?]O^P5E.&#6MH"#Z?Z^OJJF&XCP>78:EA[1:B^9-QWOYOL
M^A^&83.O!_/N+<XQN<\]55*D'2E!5]8<B3TII6U7VDF5_P#A_OX8/3]B#PY^
M.HI_\CUZ-^R)_P %D?#_ .T'^T=X4^#L7[)VA:"^NZB+=-6MKQ7DMR5)W*!"
MOIZBN!'_  1 _9=_Z2 :?^-M9_\ Q^NX_9K_ ."4O[.O[/GQZ\+?&+P[^W'I
MFJ7FA:HES#I\D5JHN".-F5G)!.<=*C"_ZV?6(>U<7&ZO\&U]>IU9Y_Q 2>2X
MF.!I557=.?)=8JW/ROEO=-6O:]].Y^ED)RGXT^H[5U>,E&R,\'\ :DK]%/Y*
M6P4444#&RG$9/M7P%_P4)_X*KZ+^R-^T5-\([[]FG1O%4D>CVUW_ &K>WBH^
M)-_R8,3<#;Z]Z^_+@D0L1Z5^??[=/_!-_P" G[6W[1.H_%CQA^V+IOAJ]^QP
M6$FC;+9VM_)4C#%IE.XDDX(&.E>+GW]H?4E]2:Y[K>VW7?0_1/#%<)?ZRM\1
MQE+#*G+X54;YKKE_A>\NN^AXL?\ @OOX;[_L0>&Q]-13_P",4A_X+Z^&SU_8
MD\. >VH)_P#&*M#_ ((?_LN9_P"4@6G?C;V?_P D4A_X(A_LM\X_;_L!@<'[
M-9X_]**^-_XS-?:C]]/^OQ/Z$YOH[2T5*K]V+/T-_8V^-L'[1O[,?ASXS6WA
M"#08];M)9$TFU?=';A99$P#M7/W,]!UK^=_QY_R/&L_]A:X_]&M7]%_[+'P7
MT+]GC]G'PS\&O#/B4ZQ8:'I9BMM5,:K]J5V:3S,*2 #O/0FOYT/'G_(\:S_V
M%KC_ -&M5<:*JL%A?:.\K._K:-S+Z.<L!/B7/98%6H<T.1.]^3GJ\OQ:[6WU
M[F57U?\ \$3+I;;_ (**^#HGDVBXL-3BSZYLI3C_ ,=KY0KZ9_X(\7#6_P#P
M49^'!5R-]W>H>>N;&XKX_)I..;X=K^='] >(=-5> LTB_P#H'J_A!G[D?&SX
M,^!OCK\+M9^%/Q%TQ;W2-:LV@NHG ^7/W74]F5@&![$"OY]OVS?V3O'/['/Q
MOU+X3^+XGEMD<S:)J>WY+ZT8_)(#ZXX8=B#7]&[HKKM8<&OFW_@IA^PGX<_;
M3^ UQHVG00VWB_15:Z\+ZDX_Y:@9:W<_\\Y -I]#@]N?U/BC)%FV$YZ:_>PV
M\UU7^7F?Q'X,>)4^!,\^KXN7^QUVE/\ N2Z5$O+:7>.NZ1^ 5.BFEMY5N()&
M1XV#(Z'!4@Y!&*N^*O"_B#P3XDOO"'BK2IK'4M-NGM[VTG3:\4BG#*1]15"O
MQMIIV:LS_0J,Z=>FI0:<6ODS]K?^".'_  4.3]ICX7?\*3^)&J@^-_"EHH5Y
MG&[5+(?*LR^KIPKCW4]Z^,O^"_6DBQ_;>M=3"$?VAX.LI6)'=7EC_DHKY)^"
M7QC\<? #XI:/\7/AUJK6>JZ/=+-"ZGB1?XHV'=6&01Z&O<_^"G_[8WPY_;8^
M(/@_XH>!K&]M+NT\)1V6O6=W;[!#="5W(1LG>OSG!]J^NQ&=PS'AIX:M+]["
M4;?WE?3YK9GX#E7AI7X0\8(9MEM-_4\13J<R2TI3:3Y?*,FKQ[.ZZ(^8JN^%
MR3XCT\D?\OT7_H8JE5[PP"?$NG ?\_T7_H8KY*'QH_?:_P#!EZ,_IF^'R[O!
MVD2D\G2X./\ MFM:U[+'!"9Y9%14RS.QP% '))[5D> &V^"-'/\ U#8/_18K
MY7_X+(?MG)^S+^S;-X*\,:F$\5>-%DL=-6-OG@M\8FG]L [1[M7[]B\92P&#
MGB*FT5?_ "1_E9D>18WB?B&EE>$5ZE6?*O+763\DM7Z'YM?\%;?VPW_:M_:?
MO;/PUJ32>%/"+/IF@JK?),ZG$UQ_P-Q@?[*KZFOED#%*S,[%W8EB<DGJ325^
M$XW%U<?BIUZN\G?_ "7R1_I[PYD6!X8R/#Y7@U:G2BHKS[R?G)ZOS9I^#/"&
MO^/_ !;IO@CPM8FYU+5KV.ULH%_CD=@JCV&3UK^B3]D3X"^$_P!EK]GCPQ\%
M?#]S%G2M.3^T;E, W5V_S32G_><MCT&!VK^<_3-4U+1;^+5-(OYK6YA;=#<6
M\I1T/J&'(-='_P +T^-?_17?$W_@]N/_ (NO9X>SK#Y+.=2=)SE+1.]K+[NI
M^=>*WAOFWB/1P^&I8R-"C3;DXN#DY2>B>DEI%7LN[9_2X=5LBI7[2G3KO%>;
M?M6? ;P7^U'\"/$7P9\374*+JUBZV=TV#]FN1\T4H_W7 SZC([U_/9_PO3XU
M_P#17?$W_@]N/_BZ/^%Y_&KO\7/$Q^NN7'_Q=?25>.L+6IN$\.VFK/WEL_D?
MC^#^C+G& Q=/$X?-8QJ0:E%JF]&G=/XS,\>^!O$GPR\;:K\//&%@;75-%OY;
M.^@)^[)&Q4X/<<9![@@UD58U35M5UW4)=5UK4KB\NICF:YNIFDDD.,99F))/
MUJO7YU+EYGR[=+G]=457]A%5VG.RYFE9-VU:71-WT/N3_@A]^V2OP/\ C[_P
MH;QGJK1^'O'4RPV3228CMM2'^K/)X$GW/]XK7[4P?ZOK^-?R[Z?J%WI.HV^J
M:?<O#<VLZ36\T;8:-U(*L#V((!_"OZ!/^":G[7]E^U_^S)I'C"]O4/B'2XUL
M/$D'&X7**!YF/1QAOJ37Z5P1FWM*3P%1ZQUCZ=5\C^-_I(\"_4\PI\2X6/NU
M;0JVZ32]V?\ V\M'YKS.]_:WY_9B^(X_ZDG5/_222OYN1P,5_2+^UF=W[,OQ
M&)_Z$G5/_262OYNNIXZ8KCX^_P!YH?X7^:/HOHM?\BK,_P#'3_\ 29"*21R*
MU_!OCSQM\.]7.O\ @'Q9J&C7S0M$UWIEV\$AC)!*[D(."0./85D@@]*LZ5HV
MKZ[=&QT32KF\F"%S#:P-(VT=\*"<<BO@8.<9IQ>O2Q_4N(AAZE"4:Z3@]U*U
MFO.^G7J=O_PU=^TUV^/WC#_PH;C_ .+I?^&K_P!IDCGX^^,/_"AN/_BZY=OA
MW\05^]X$UD?72Y?_ (FF_P#" >//^A(U@?73)?\ XFNKV^/_ )I_?(\599PK
MTHT/_ :?^1U/_#5W[3/;X^^+_P#PH;C_ .+JIK7[27[0GB/3Y-(U[XW>*KNU
MF4K+;SZ[.R.#U!!?FL ^ _'(&3X,U;_P72__ !-07GA3Q3IUNUWJ'AK4((E^
M]+-92(J_4D8%3*MC6O>E*WJRZ>5\-1FI0H4KK9J,/\B@QW<G/N<U;T70=<\2
M7\>E^'='NKZYE8+';VD#2.Q] %!-5/:M3PAXU\7^ -:B\1>"?$M[I5_ VZ&[
ML+AHW0^Q4US0Y.97V\O^#H>QB'B?8R]A9SMIS72OTO9-V^1^G/\ P2"_X)2>
M.?!7C&R_:B_:4\/?V7/9Y?PMX:NA^_1R.+J9?X, _(A^;N0. ?T_%OM 42-@
M"ORO_P""6/\ P6$\>Z]\0]+_ &=OVHM:&IQ:O*+?0O%$H FBG/W(9SP'5CP&
MZ@D Y'3]3Q/D9W#\Q7[3PM/+7E:6!V6][<U_,_SH\9H<9QXSG/B3EYVE[/DO
M[/V?10OJDNJ?O7OS'\WO[9?R_M<_$X#_ **#K'_I=+7FO5,?2O1_VQR1^US\
M3QC./B#J_/\ V^RUYS_!^(K\<QEOKE3_ !2_]*9_H)P]KD&$?_3JG_Z1$]X_
MX)C'/[?WPL_[&F+_ - >OZ$H(T)8%1VK^>[_ ()@\_M_?"PD=/$Z?^BI*_H2
MMNA'L*_3. W_ ,)M3_&_RB?QM])U?\9EA/\ KPO_ $Y,?Y47]P?E1Y47]P?E
M3J*^Y/YKLAOE1?W!^5'DQ?W!^5.HH'9$%];P364L,T09'C*LI'!!&#7X(?MZ
M_L&?&KX)?M/>)?#WA/X<:UJNA7]\^H:)?Z;I\DT;V\K%@I* @,I)4CV]Z_?8
M@'@BN8^+ND_$?5/ 6HP?"/Q#IVF>(O)SIESJU@;BV\P=%D165MIZ9!!'7GI7
MB9YDU'.,,H2;3CJFDK^FO<_2/#/Q#S+P]S>I7P\(SA52C*,VXQT=U*Z3:Y=>
MCT;/YS/^&<?VA/\ HBWBK_P23_\ Q-/@_9X_:+M+B.ZM?@YXLCEC<-'(FBS@
MJP.00=O!S7W7^T-_P50_X*J_LK>+)/"'QE^$_A/3&1RMM?'P_.]K=+GAHY1/
MM8'ZY]J\[/\ P7^_;A/31O W_@BE_P#C]?F-7 Y%0FX3K5(M='"S7XH_L[!<
M3>)^:82.(PN782I3FKJ2Q+E%I_\ <-IG=? '_@JW_P %)_A'X3M?!OCO]F>\
M\9V]E"(H+Z^T:[MKPJHP \B*5?CN4R>YKT;_ (?8?MC#C_AWK?GZW-Y_\CU\
M_G_@O]^V^!SHG@8_]P.;_P"/T'_@O[^W"RX&B>!A_P!P*;_X_7M4L[HT8**Q
MU2R[TX_F]3\\Q?AEF&.Q$J]7AK!\TG=\N*K17_@,4DODDCZ!_P"'V/[8_P#T
MCSU#_P ";S_Y'H_X?8_MC'@?\$];_P#\";S_ .1Z^?3_ ,%_/VX,8&C>!0>_
M_$BE_P#C]*/^"_O[</?1? W_ ((IO_C]7_;]+_H.G_X+B<W_ !"?%_\ 1-87
M_P *\1_D>I?%7_@K_P#\%&O&6@SZ'\//V2+CPM+<1%#J(TJ\O)XLCJFY%13[
ME6KX.\0_!#]I[Q5KUYXF\1_"KQA>ZAJ%T]S>W=QHUPSS2NQ9G8E>222:^H#_
M ,%__P!M_I_8O@;_ ,$<W_Q^@?\ !?[]N G_ ) O@8_]P.7_ ./UYV-Q>6Y@
MT\1C*DK;>XDON32^]'U_#>1<9\(PE'*,APE+GM=K$3<G;9.4J;=M=DT?*G_#
M./[0A_YHMXJ_\$<__P 370?"G]C#]H_XK_$?1OAU8?"G7[.35]0CMVO+W2Y8
MXK=&/S2NS* %5<D_2OJ'P3_P6^_X**?$WQ';^$/ /P[\*ZQJ=TX2WLM.\-3R
MR.2<=!/T]SQ7ZA?LC#]J+4/A;!K_ .UJ^@P^);YA*-)T&R,<>GQ$<1NQ=]\G
MK@@#ISUK?*L@RK-*W[FK4:6K?*DO2YY?'7BOQQP5@;9A@\-"I.ZC&->4YWM\
M7)R+2+U;;2V2=V=SX-\+Z9X(\%:=X,T5-MGI.FQ6=L/^F<481?T45_-%X\_Y
M'C6?^PM<?^C6K^G.\"K$YP  A_D:_F-\=@GQQK) _P"8K<?^C6KTN/4HTL.E
M_>_0^+^BW*<\PS6<G=M4F_6]0R:^B?\ @DW<-:_\%#OAA(O\6MR(3_O6TP_K
M7SL>.O%?0/\ P2M./^"A/PKQ_P!#'_[0EKX7*I6S.C_BC^9_37'$5+@S,K_]
M ];_ -(9_0?3+A0R8]^*?00#U%?OQ_EH?F5_P6^_X)WGQ+HLW[87P?TC=J5@
M@'C'3+:+FXMQP+M0.K)P'ZY4Y_A.?RDK^H/7-.LM5L)=,U&R2XMKB)HIX9$!
M5U88((/8C-?AG_P5E_X)_P![^QY\7CXS\%Z=(? OBFY>72I%4E;&X.6>U8]N
MY7U7Z&OS3C'(?9S^OT%H_B2_,_L;Z/?B;];HQX7S.?OP7[B3>\5_R[N^L=X=
MU=;I'R111@^E&#Z&OSVZ/ZNT85?\*D#Q/IQ/_/\ 0_\ H8JA@^AJ_P"&$)\2
MZ<,?\OT/_H8JX-<Z,JW\&7HS^EKP]K6E^'/A=9>(-;O$M[.RT6*>ZGE;"QQK
M$"S$^@ K\"?^"B7[6&I_M@?M/:W\1UN'&B6;G3_#5J6.(K.-B V/[SG+D^K8
M["OT(_X+-?MD'X._LT:!^SEX-U,)X@\::- VI/$_S6VFJ@#'CH9&&T>P;TK\
MA*^[XTS;VDXX&F]%K+UZ+Y'\O?1SX%^J8>MQ-BH>_4;A2OTA=\\E_BDE%/LI
M=PJ[X<\.:]XOUZT\,>%](N+_ %&_G6&SL[6,O)-(QP%4#J:I$C'TK]&_^""G
M[&Q\9^,[S]K;QKI1;3=#D:R\,"6/Y9KLC$LPSU"*=H/]YCZ&ODLJR^KFN.AA
MX==WV75G[QQSQ9@^"N&:^;5]>16C'^:;TC'[VK]E<^34_P""='[<<BAU_9A\
M78/_ %"VI?\ AW-^W)_T;!XN_P#!6U?T1P@>4./S%/P/05^@K@/ ?\_9?A_D
M?RC_ ,3/\6?] 5'_ ,G_ /DC^=G_ (=R_MR_]&P>+O\ P5M1_P .YOVY,X_X
M9@\7?^"MJ_HFP/048'H*?^H> _Y^R_#_ "#_ (F?XL_Z Z/_ )/_ /)'\Z\O
M_!.C]N1%W']F'Q=_X*VKQ_5](U3P]J]UH&N6$MK>V-P\%W;3H5>*5&*LC \@
M@@@BOZA+A<QX &<\<5^*?_!<S]E<?!G]I:/XR^'=-,6B^.T,\Q1,)%?I@2CZ
ML-K?4FO$S_A2GE6!^L49N5GK>VB?4_2O"SQSQG&W$CRG-*-.DYQ;IN'-K*.K
MB[MK6-VO1GP_@'J*^L/^"0?[8S?LM?M.V>@>*-1\KPIXSD33=8:1\+;3,<07
M/T5SM;_9<GM7R?0'>-A)&Q5E(*L.H/K7R6!QE3 8N&(IO6+_ .'/W?B3(<#Q
M/D>(RO&+]W5BXONGTDO.+M)>A_2/^U;M;]ECXAR @Y\$:I\P[_Z+)7\VZ]!]
M*_93]C7]L<?M3?\ !,KQQH/B34!)XI\'^!M0T[6-[9>:(6<GDS>I+*,$^JFO
MQL ( ^E?6<98NCC5A:]-^[*+?XK3Y'X1]'K(\=PU5SK*\9&U2E5A%^=HRLUY
M-6:\FAHY.5X%?<7_  ;_ %I;7G[=%_'>6Z2I_P *_P!0PLB @'[19\\_C7P\
M"<9Q7W)_P;Z'/[==^>/^2>ZA_P"E-G7@\.V>>4%_>1^H>+#:\-\S?_3J7Z'[
M1?V#H??1K7\;=?\ "D/A[0#UT.S_ / 9/\*N45^Y\L>Q_FC[6JOM/[RD?#?A
MT]=!LO\ P%3_  K*\4?#7P%XLTJYT#Q'X-TN\LKN,QW%M<6,;*ZD<@@BNBI"
M%/4"DX0:LT.->O&2E&337FS^>3_@I%^SEI'[+7[8'BKX5^&8&CT<2QW^CQL<
M[+:X02*GT4ED_P" UX77VG_P7L8']OJY (X\(Z:/_1M?%E?@^<TJ>'S6O3AH
ME)V/]/O#S,,5FO V78K$RYJDZ,')]6^5*[_K<M:'KM]X8UNS\2Z7(4N=.NX[
MFV<'&V2-@RG\P*_ID\(ZFNI>%-+U&>,E[C3H)')/4M&I/\Z_F.F9?);G^$U_
M31\/44^ =#)8?\@>V_\ 12U]GP#+6NG_ '?U/YW^E/"E%95.4;O]\O\ TW_7
MS/F+QY_P3*_8=\<>.M7\8^*?@5#=:EJ^JW%YJ-R=>U!/.FDD9W?:MP%7+,3@
M  9X%9R_\$G?^"?9.#^SU!_X46I__)-%%>[7P6#=9OV<=WT7=^1^!X?C#BZG
MAX1AF%=))))5:EDET7O;'2_!W_@G#^Q;\)?BKH?Q%^'OP3BT[6=)OO/T^]77
M+^0PR!&PVV2=E;KT((KZNMB223117L972I4:$E3BEKT5CYO/LTS/-<5"KC:\
MZLDK)SE*32N]+R;=O(FHHHKTCQ HHHH *1_NFBB@:W.?\=^!?!?Q!TAO#GCK
MPII^KV$^5EM-1M$F1@1Z,#7YS?\ !1C]@+]D'X<Z0_BGP'\%;/2+R5F+G3]0
MNHHNO:)9?+7\%%%%>!Q)0H3RZ4I13?=I7W/TCPLS?-L#Q+0I8;$3A&3=U&<H
MIZ/=)I/YGY@:SI&G6>IW%M;V^U$E8*N\G S[FJOV&UV9\K]3117XH]C_ $>P
MTYRH1<G=V0HL;7 _=_\ CQI$L;4YS'GZL:**DTC)]QT%A:,X!B[_ -XU]O?\
M$^/V./V;_C1JUNGQ,^&ZZHIA#E6U6[B!.?2.5?RZ445[.04Z=7,$II->>O4_
M+/%?,<PP'#52>&K2INSUC)Q?7JFC]7O@O^SA\!_@5H\=E\(/A-H?A]-F&?3K
M!5D;KRSG+,?<DUZ#;CY,T45^W4X0I0C&"25NFA_G=B,3B<97G5KS<Y-ZN3;;
M^;U$N(TE/E2+E67!%?&=_P#\$LOV"-3O[C4;[]GRU>:>X>25_P"W-0&YBQ).
M!<8'-%%>?F="C6Y?:13WW2?8]C),XS;*'.6 Q$Z+E:[A.4+VO:_*U?YD0_X)
M2_\ !/\ '3]G>U_\'NH__)%=5\$_^"=G[&?PD^*VB_$7X>?!*VT[6=)O!-I]
M\NKWLAA<J5W;9)F4\,1R#UHHKSZ."P<:L6J<;W71?Y'K8GC#BVOA)TZF85Y1
MDFFG5J---.Z:<M4^Q]64445]*?%!7"?M%?!GX8?'GX97WP]^+G@^VUO1[@QR
M26=RSK\ZME65D965@>ZD&BBL<3&,\/-25U8Z<'6K8;%TZM*3C*+333::?=-:
MIGS*_P#P2C_X)_*<#]G>UZ?]!W4?_DBD_P"'4G_!/[_HW>T_\'NH_P#R1117
MS?U'!?\ /J/_ ("O\C[5\:<8\_\ R,L1_P"#JG_R0?\ #J3_ ()_?]&[VG_@
M]U'_ .2*EL?^"5?[ EK?0W,'[/5JKQRJR,-=U#@@@@_\?%%%'U'!?\^H_P#@
M*_R)_P!=.,7&SS*O_P"#JG_R1Z#\8OV"OV1_C/XXE\9?%#X,6>LZG]EAMA=W
M5_=96*- J( LH  '8#U]37(S_P#!+3]@,#C]F[2NO_00O/\ X]11777P>#G4
ME*5.+;;Z+N<N!XKXIPN A2HX^M&,59)59I)=DE*R(W_X):?L"-'N/[.&EY![
M:C>?_'J^EO@A\+_ 'P;^&6E_#OX8^&+?1]%TZ$K9V%MN*Q[CN8Y8DDDDDDDD
MDT45T9?AL/1K-TX).W1)=3SLWX@S[-L-&ECL75JQ3NE.I.:3MNE)M7.LHHHK
MUSYX**** "O,?VH_V?O@Y^T3X)MO"/QH\"VVO:?;7@N;>"XED0QR@$;E:-E8
M<'UP:**PQ4(5,/*,E=6ZG7@<5B<%C:=?#S<)QDFI1;33ONFK-?(\)'_!*G_@
MG\.G[.&G_P#@VOO_ (_2C_@E1_P3^VEO^&<-/S_V%K[_ ./T45\XL#@K+]U'
M_P !7^1]Q_KEQ?;_ )&-?_P=4_\ DCL/@_\ L+?LI?!U]>A^&OPC@TJ/7]$E
MT[6(X=3NW6ZMG&&C8/*1ZX(P1DX(S7"M_P $J_V 5 "_LZ6/_@XO_P#X_117
M35P>$=&"=.-E?HO(\J'%G%-'&UJL,?64I<O,U5FF[*RN^:[LM%?8;_PZM_8#
M_P"C=+#_ ,&]_P#_ !^O2/V7_P!B#]EC]GCXFR^/?@U\([70]7?39;1KV'4+
MJ4F%V1F3$LK+@E%/3/%%%3A<)A*>(A*-.*=^B1>+XKXHQN J4<1CJTX25G&5
M6;35UHTY-->I]#T445]&?'!0>GXT44 ?-G[2W["G[*/[0'Q/E^(?Q?\ A#;Z
MSK+V,=NU[)J=W$3&F[:NV*55XR>V>:\_'_!*O]@(\?\ #/%G_P"#O4/_ )(H
MHKYK$83"U,1.4J<6[O=(^SP7%G%.#R^E1P^/K0A%62C5FDEV24K)#+S_ ()4
M?L K;.R_L[V><?\ 0;U#_P"2*^Q-*TRPTW3+;3K*W$<-O D<* D[550 .?84
H45WY3AZ%+FY();;)(\GB+.LXS>E2>/Q-2MRMVYYRG:]KVYF[7\C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
M  $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!
M40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y
M.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4
ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/D
MY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAF6BG[\N2.]TOG*_*O6334>[32NT$_=7-+LW\EN_E=7[)IO1GV=17RY\2_\
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M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M( _%+P?X)ABM_"/AGP):Z9HJ).;A5M(GMTAQ(23)E IWDDMG.3G->K?LI?\
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MPK^-GA9_BYX+A2(*D&MV\"+K.F0\@--.1#<(@&"7"_>;YO9O '_!$S0?@O\
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M+*5)4YOWO9Q3?1R4IRE%_P!V2E;;1J]N56ED?\%#_B%K'B#XD_#+X::!\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/-%WZ2OSO7I:,N52O9<DFI+1LZJW,Y\T/BY9JW:RC9QZ\TES-;WDDXO4[?\
M9U\?ZM^SY_P4>\4?L\W'B#Q!XD\':EX#MO'_ (4D\0:Q/JVJ:25O7LKZR:[N
M'>YN8=QMYD:>1W0R2+O*;%C^MZ^2/V<OASJ7Q_\ ^"CWBS]HJX\/>)?#?A6R
M\!V?P_\ "<?B#39])U#5 ;Z:]O[QK&Y1+BVCW_9HD$\<<C^5(VS9Y;-];U?O
M>RA[3X_>O_X'+E^?)R^??6YG+E]K/V?P^[:VWP1YK?\ ;_-\]M+'P!_Q%&_L
M)_\ 1<O_ "S/$'_R#1_Q%&_L)_\ 1<O_ "S/$'_R#7QA_P $#/V(O@O\8_\
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M\LSQ!_\ (->__P##IW]EG_HVG]G_ /\ #>:1_P#(]'_#IW]EG_HVG]G_ /\
M#>:1_P#(] '@'_$4;^PG_P!%R_\ +,\0?_(-'_$4;^PG_P!%R_\ +,\0?_(-
M>_\ _#IW]EG_ *-I_9__ /#>:1_\CT?\.G?V6?\ HVG]G_\ \-YI'_R/0!X!
M_P 11O["?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#7O_\ PZ=_99_Z
M-I_9_P#_  WFD?\ R/1_PZ=_99_Z-I_9_P#_  WFD?\ R/0!X!_Q%&_L)_\
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M_P#PWFD?_(] '@'_ !%&_L)_]%R_\LSQ!_\ (-'_ !%&_L)_]%R_\LSQ!_\
M(->__P##IW]EG_HVG]G_ /\ #>:1_P#(]'_#IW]EG_HVG]G_ /\ #>:1_P#(
M] '@'_$4;^PG_P!%R_\ +,\0?_(-'_$4;^PG_P!%R_\ +,\0?_(->_\ _#IW
M]EG_ *-I_9__ /#>:1_\CT?\.G?V6?\ HVG]G_\ \-YI'_R/0!X!_P 11O["
M?_1<O_+,\0?_ "#1_P 11O["?_1<O_+,\0?_ "#7O_\ PZ=_99_Z-I_9_P#_
M  WFD?\ R/1_PZ=_99_Z-I_9_P#_  WFD?\ R/0!X!_Q%&_L)_\ 1<O_ "S/
M$'_R#1_Q%&_L)_\ 1<O_ "S/$'_R#7O_ /PZ=_99_P"C:?V?_P#PWFD?_(]'
M_#IW]EG_ *-I_9__ /#>:1_\CT > ?\ $4;^PG_T7+_RS/$'_P @T?\ $4;^
MPG_T7+_RS/$'_P @UH?\%-?^"97[-O@+_@FW^T'KNA?L]_ _1=;T7X:^([_3
M]0L/ NEVUU87$6EW+Q312I 'CD1U5E=2"I (((KV_P#X=._LL_\ 1M/[/_\
MX;S2/_D>@#P#_B*-_83_ .BY?^69X@_^0:/^(HW]A/\ Z+E_Y9GB#_Y!KW__
M (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>@#P#_B
M*-_83_Z+E_Y9GB#_ .0:/^(HW]A/_HN7_EF>(/\ Y!KW_P#X=._LL_\ 1M/[
M/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z / /^(HW]A/\ Z+E_Y9GB
M#_Y!H_XBC?V$_P#HN7_EF>(/_D&O?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\
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M?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z /
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M3_Z+E_Y9GB#_ .0:/^(HW]A/_HN7_EF>(/\ Y!KW_P#X=._LL_\ 1M/[/_\
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MO-(_^1Z / /^(HW]A/\ Z+E_Y9GB#_Y!H_XBC?V$_P#HN7_EF>(/_D&O?_\
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ME_Y9GB#_ .0:]_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\
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M&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z / /^(HW]A/_HN7_EF>(/\
MY!H_XBC?V$_^BY?^69X@_P#D&O?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O
M[+/_ $;3^S__ .&\TC_Y'H \ _XBC?V$_P#HN7_EF>(/_D&C_B*-_83_ .BY
M?^69X@_^0:]__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;
MS2/_ )'H \ _XBC?V$_^BY?^69X@_P#D&C_B*-_83_Z+E_Y9GB#_ .0:]_\
M^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>@#P#_B*-
M_83_ .BY?^69X@_^0:/^(HW]A/\ Z+E_Y9GB#_Y!KW__ (=._LL_]&T_L_\
M_AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>@ _88_X*C_  )_X*4?\)1_
MPI3QU_PFG_"%_9/[9_XDNH:=]C^U>?Y'_'W!%OW?9YON;L;.<97/T!7XX_\
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M444 %%%% !1110!\_P#_  33_P"3=?$?_95?B/\ ^IOKM?0%?/\ _P $T_\
MDW7Q'_V57XC_ /J;Z[7T!0 4444 %%%% !1110 4444 %%%% !1110 4444
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M444 %%%% !1110!\_P#_  33_P"3=?$?_95?B/\ ^IOKM?0%?/\ _P $T_\
MDW7Q'_V57XC_ /J;Z[7T!0 4444 %%%% !1110 4444 %%%% !1110 4444
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MXO>(IO''[0FJ:7\.;J_E?3= \/V[P?Z&7/EPRJ&2/<J$ NXF)(SWX[SX"_\
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M_P#_  33_P"3=?$?_95?B/\ ^IOKM?0% !1110 4444 %%%% !1110 4444
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M_DW7Q'_V57XC_P#J;Z[7T!7S_P#\$T_^3=?$?_95?B/_ .IOKM?0% !1110
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M**7JW\VSS'Q9^Q?\*?'OQ=D\>:[\/_#&M^+)HHX7U#4+);IF$8VH=CY3<H
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MUW2;359?#.H#5=,^TKO2TNQ&\:SJI^4NJR.%8@E2V1@X-?-/PG_9ET?XC?\
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MG7R:GI\%S&LBQW$:RJ'4JP##(R#R#STKP72?V6OB7XYTK5?#/Q:^*GA[XA^
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MCO#_ /T#_'G_ (0^M?\ R)7>44 <'_PT=X?_ .@?X\_\(?6O_D2C_AH[P_\
M] _QY_X0^M?_ ")7>44 <'_PT=X?_P"@?X\_\(?6O_D2C_AH[P__ - _QY_X
M0^M?_(E=Y10!P?\ PT=X?_Z!_CS_ ,(?6O\ Y$H_X:.\/_\ 0/\ 'G_A#ZU_
M\B5WE% '!_\ #1WA_P#Z!_CS_P (?6O_ )$H_P"&CO#_ /T#_'G_ (0^M?\
MR)7>44 <'_PT=X?_ .@?X\_\(?6O_D2C_AH[P_\ ] _QY_X0^M?_ ")7>44
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MEM=[:;JZ3U.U_P"&CO#_ /T#_'G_ (0^M?\ R)1_PT=X?_Z!_CS_ ,(?6O\
MY$KO**V/I#@_^&CO#_\ T#_'G_A#ZU_\B4?\-'>'_P#H'^//_"'UK_Y$KO**
M .#_ .&CO#__ $#_ !Y_X0^M?_(E'_#1WA__ *!_CS_PA]:_^1*[RB@#@_\
MAH[P_P#] _QY_P"$/K7_ ,B4?\-'>'_^@?X\_P#"'UK_ .1*[RB@#@_^&CO#
M_P#T#_'G_A#ZU_\ (E'_  T=X?\ ^@?X\_\ "'UK_P"1*[RB@#@_^&CO#_\
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M]C^Q9\'(_%%UI$^NW%[?QZ;9V<<WD+)*R/)EY-K;5"QL>%))P,<DCYP^,?\
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M (/M_#]EI]K;:+:6BV,-DB8AC@"[!&!_=V\8KQ+_ (*Q?\HLOVEO^R5>*/\
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MU*U6X2&4 C< W!!!(*G(/<&NHTK2K70M-@L[&UM[.SM4$4,$$8CCA0<!548
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M%% !1110 4444 %%%% 'Y _\&5/_ "BR\??]E5U'_P!-&CU^OU?D#_P94_\
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MH **** "BBB@#\@?^#<3_E*;_P %./\ LJJ?^G?Q)7Z_5^0/_!N)_P I3?\
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M (*Q?\HLOVEO^R5>*/\ TT75?0% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'S__ ,$T_P#DW7Q'_P!E5^(__J;Z
M[7T!7S__ ,$T_P#DW7Q'_P!E5^(__J;Z[7T!0 4444 %%%% !1110 451\2>
M)M-\':'<ZIK&H6.E:;9(9+B[O)U@@@4=6=V(51[DU\5_'O\ X+E> O#WB/\
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MJ=&')!:%9#POEN3X1X'+Z?+3E)R:;<KMVO\ $WV2^04445N?0!1110 4444
M%%%% !1110 4444 %%%% !1110!\_P#_  5B_P"467[2W_9*O%'_ *:+JOH"
MOG__ (*Q?\HLOVEO^R5>*/\ TT75?0% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% 'S__ ,$T_P#DW7Q'_P!E5^(_
M_J;Z[7T!7S__ ,$T_P#DW7Q'_P!E5^(__J;Z[7T!0 4444 %%>*_M2?\%"_A
M'^QY9R#QKXNL8-65=T>C61^UZE+QD?N4R4![-)L7_:KY+?\ ;W_:<_X*"NUG
M^S_\./\ A7G@^Y)4>,?$H7<\9XWQEE,8Z\K$EPPX(85[.#R'%XB'MFE"G_/-
M\L?DWO\ ),[:. JU(\_PQ[O1?\'Y7/T>KYW_ &_?CW\:/A'IGA[2?@M\,6\<
MZ[XE>:*34KAQ]AT3;LVF5=R<MN8AG=$&SG=G%:W["/[+WC#]E_X<ZI9^.?B;
MK_Q-\0Z]??VA<W6H2.T%BQ0*8H/,9GVY&220#@81.<^Y5S1E1PN*NN6M&/=-
M1>G;1V3^^W8R3A2JW5II>MG^3/SM\-_\$AOB9^UEK=MXB_:B^+.K:\%?SHO"
MV@S"*RM3V!?:(D..&$463_SU/6OM3X!_LM_#W]EWPU_9/@'PGH_AJU90LKVT
M.;BYQT,LS9DE/N[$UWU%;8[.L7BX^SJ2M!;1BN6*_P"W5I]]V7B,=6JKED_=
M[+1?<@HHHKR3D"BBB@ HHHH **** "BBB@ HHHH **** "OG_P"(W_*4WX-_
M]DJ\>?\ IW\&5] 5\_\ Q&_Y2F_!O_LE7CS_ -._@R@#Z HHHH **** "BBB
M@ HHHH **** "BBB@ KR?]J/]B[P'^U_I^EP^,;&[DFT61GM+JSN#!/&K;=\
M><$%&VKD$'&,@@UU_B'XY>"?"*LVK>,/"VEJJAB;O58(< G&?F<<9X^M6/A[
M\7/"?Q<M+JX\*>)_#WB>WL9?(N9-)U&&]2WD_N.8V8*W!X/-82E1J?NI-._3
M3\AYEPY+&8*4<=AG.@[)\T&X;Z7;5M[6\]CA_COXJ7]C;]D/6-2\&^'X;J'P
M3I2)INF_.T:(K)&&?!W,J EW.<D*V6!.:\S_ ."7?[;'BS]LSP5XHN/%>CZ?
M9W'AVZ@AAOK")XK>\$JNQ3:S-\\>U2<'&)4X'4_4<L2S1LCJKHX*LK#(8'L:
M\._::_;B^$/[ $?AS3?&.H1^'5\22R"RM=/TYI B*5\R9TB7Y4!=<G&22<!L
M'&&)G&@U7JU%"G%6=[)=EK]QY>6\&YYFO$.&ADDYSA&$H_5J=/FYVDW=6U7*
MM;):*/1-GN=%? ?[.?PO_:*7_@HA=>)-8U/6+KP#>75U<37K:B)=)O\ 3G5S
M;+!%O(_BC*JJ@IR3CYL_8GQJ_:1\$_L]:=%/XN\1Z7HTETDCVMO/<*L]YL&2
M(T)R>PSP,L 2,BM*.*4X.I-<J3Z_F>9D/$3Q]"K6Q="6&Y*CIVJVC>S235[:
M-NWKHFSN**_'?QE_P<Y>+KB\N!X?^%GAVQ@W$0_VCJ<UTX&>"P18QG'8=^]<
M9/\ \'#_ .T3X^N6M_#_ (2\!PMNV*MAHMY=3#=P@.ZX8%O3"C)['I7R]3CS
M*$[1DY>D7^MC^NL+]$WQ#J1YZ]"G27]^K#3UY7(_;NBOF/\ X)1_M'_%;]I[
M]G"Z\0?%KPT- UB'59+6QF^PR6)U.V"(PE\E^1AV=-PPK;>!D$GZ<KZC!XJ&
M)H1Q%--*2NKJS^:/P?B3(,1D>:5\IQ<HRJ49.,G"2E%M=I+?\&MFDTT%%?%?
M[5?[.'[2OCK_ (*,_#_Q=X%\;3:5\*=,^Q_VE9IJS6]O#''*6NXYK3.+AI4X
M5L'^$$IL#5]J5&%Q4ZLZD)4W'E=DWM+S7D=6?9!A\OPN#Q%#%TZ[KT^>48-N
M5)W:Y*EUI+K_ ,"S91117:?,GY _\&5/_*++Q]_V574?_31H]?K]7Y _\&5/
M_*++Q]_V574?_31H]?K]0 4444 %%%% !1110 4444 %%%% 'YD_MG?LF^.O
MV7OVM_#/QO\ V8]8TWQ5-XZ\>7>H>(_A=JUXB:-K^MV^B:I'<75I>*"]E?-;
MPW4#(V8FG:,R@"/ ^O/V9?VF_"?[8W[ EK\2/!.ESZ%H?BC1M0G.F3VZ6\^G
M72M/'=P2JGR^8ERLP9APS MSFN/^+W_!+2#QW\0K75O"_P 9/B[\.-)D\2W?
MBG4M#T6]LKBVFN[JUN[>YEM);NVFN+&27[7(S&"4(-\A2-)"DL?J&C?L=^'?
MAO\ LGV?P=^'.IZW\+?#>F6"Z=8W6@+:7%]:1;MTF&OX+F*1Y<OYDDL;NQD=
MLAR&'/6IN>!G06[BE%/IHTU?^5:<N[25DHI*)TTZL8XN%;L[M]US-IM?S-:N
MUE=N[DWS+XW_ &%?^$@_XA==&_X13SO^$E_X4WJO]F>3GS?M'V:Z\O9CG?NQ
MM]\5D_MJV=G:_P#!LIX/M_"L,=U<2>#? R>'5MU +WSW>E?960+CGSBI^49/
M/!Z'[,_81_8@TW]@;]GW3_ACHOC;QQXU\(Z)$+;2(/%)TZ632K?+$P1O:6=N
M9$+,3^^\QAT#!0%KF? /_!+OP)X U;0;./7_ !QJ7P]\'ZN-?\,?#Z]O;9O#
M?AR_64S1S0*D"W4BQ2LSQ0W-S-! Q4QQIY<6ST:U2,\75JKX9SIROU2A*<FO
M\34].BDM[.Z\_"PE3P]&,E[U-25NC<E!?=>&O7ED]+JS\^_8@M=1/_!6_P#;
M(G\0%3J@M?!4>F K]W3/[,N"-A(SL-T+K(!QO#\5)_P1D6\.E?M,2?9_L_A^
M3X^>+#HHP=KQ":%9V7D@J;I;G&WCJ.""![3\<_V*=)^+_P 5[/Q]HOB[QK\,
M_'D&EMH-UK_A26R6YU33#)YOV.XCO+:Y@=%D)=)!&)HBS^7(@=PW<? KX&>&
M/V;?A9I?@WP?IO\ 9>@Z0)##$TTEQ++))(TLTTLLA:26:65WD>1V+.[LQ)))
MKGHOE]Y[\G);_MZ$N;YJ"O\ WI2Z).6LX^[R+7WHRN]](2C9^=Y:?W4NK:7X
M\_\ !!/XE^(/!W_!0_\ X*<:EH_@7Q%X@U27XBM<K8P362M9S+J?B-DBGW7
MW$L=O[CS?N-C/R[M#X5_\''?Q1^'OCC5H?'W@_1_%.GM.ZI9PL=)NM.8,1L#
MA'# ="KH6X'S#G/3?\&XG_*4W_@IQ_V55/\ T[^)*_4+XO?LO?#CX^V;P^-/
M WA7Q-O&!+?Z;%-/'VRDI7>A]U8&O"SC X^OR3P%?V;C?1JZEZ^GHS]"\.LX
MX4RW'5:G%N72QE*<5&*C5G3=-IMN247%3<DTO>?N\JY6KRO^0'[3W[>7[/\
M^W!\7-%\8ZU>?$KP+?\ V2*SU>Q71K74895C+$&";[4A4D-MRT>.^,@AOTM^
M"7_!1+P+\7?#EC#X-TG4M9MUA6""!-<T$7!50% ,3ZB),X&.5S7A?Q^_X-T/
M@O\ $E)[CP7J/B+X=:@X CCAG.IZ>A[EHIV\TD^@G4#TKY*UK_@AQ\?O@#XQ
MMK'P_;>'_'GAS4KR..6\L;Q+:2U1B%,DD4Y0K@<G89!@=?3JX/RW,*V8.AFO
MLX0DFW44K:K9<LGK?RY>_KZ7&'!?A)0P6)S_ ,/JE:ECZ\HN="NM)K6]JBO&
M%KM_'+F?36Z_7>T^*FN6%NL,'PF\<0Q)]U([G1%5>_ &H5)_PM_Q!_T2OQY_
MX%Z+_P#+"OB#_AVI^T9\ %W?#GXI"]LX/N6<>IW%B7]/W#[H/S>O''_X+*?'
M_P#9W_:"_P"%9^*-+T?Q;K5K/':3QRVT4TOF.H951[)@CD @$@L00P(R#7U&
M9X'!82G"JL7!QE)05^9-RELK6=KVW=DNK/S/A7*<ZSZM6PV78&<I4:4ZT[.-
MHTZ=N:5W**=KJT5>3V2;/U"_X6_X@_Z)7X\_\"]%_P#EA1_PM_Q!_P!$K\>?
M^!>B_P#RPKY#\!?\%UM%\_[+XS^'^M:3/&VR633;I+K![YCE$17Z;B?Y5[K\
M.?\ @J1\$/B/L2/QG!HMRW6'5[>2SV_61AY7Y/6N*X;S.AK4HRMW7O+\+GAX
M?/,!6^"JOGI^=CT?_A;_ (@_Z)7X\_\  O1?_EA1_P +?\0?]$K\>?\ @7HO
M_P L*ZCPIXWT7QYIWVS0]8TO6K3C]_8W27$?/3YD)%:E>-*+B[2W/5C)-71P
M?_"W_$'_ $2OQY_X%Z+_ /+"C_A;_B#_ *)7X\_\"]%_^6%=Y14C.#_X6_X@
M_P"B5^//_ O1?_EA1_PM_P 0?]$K\>?^!>B__+"N\HH X/\ X6_X@_Z)7X\_
M\"]%_P#EA1_PM_Q!_P!$K\>?^!>B_P#RPKO** .#_P"%O^(/^B5^//\ P+T7
M_P"6%'_"W_$'_1*_'G_@7HO_ ,L*[RB@#@_^%O\ B#_HE?CS_P "]%_^6%'_
M  M_Q!_T2OQY_P"!>B__ "PKO** .#_X6_X@_P"B5^//_ O1?_EA1_PM_P 0
M?]$K\>?^!>B__+"N\HH X/\ X6_X@_Z)7X\_\"]%_P#EA1_PM_Q!_P!$K\>?
M^!>B_P#RPKO** .#_P"%O^(/^B5^//\ P+T7_P"6%'_"W_$'_1*_'G_@7HO_
M ,L*[RB@#Y+_ ."IOQ3US4/^"8W[1MO-\-?&MC#/\+_$T;W,]UI#16ZG2;D%
MW"7S.57J=JLV!P">*]X_X6_X@_Z)7X\_\"]%_P#EA7G?_!6+_E%E^TM_V2KQ
M1_Z:+JOH"@#@_P#A;_B#_HE?CS_P+T7_ .6%'_"W_$'_ $2OQY_X%Z+_ /+"
MN\HH X/_ (6_X@_Z)7X\_P# O1?_ )84?\+?\0?]$K\>?^!>B_\ RPKO** .
M#_X6_P"(/^B5^//_  +T7_Y84?\ "W_$'_1*_'G_ (%Z+_\ +"N\HH X/_A;
M_B#_ *)7X\_\"]%_^6%'_"W_ !!_T2OQY_X%Z+_\L*[RB@#@_P#A;_B#_HE?
MCS_P+T7_ .6%'_"W_$'_ $2OQY_X%Z+_ /+"N\HH X/_ (6_X@_Z)7X\_P#
MO1?_ )84?\+?\0?]$K\>?^!>B_\ RPKO** .#_X6_P"(/^B5^//_  +T7_Y8
M4?\ "W_$'_1*_'G_ (%Z+_\ +"N\HH X/_A;_B#_ *)7X\_\"]%_^6%'_"W_
M !!_T2OQY_X%Z+_\L*[RB@#@_P#A;_B#_HE?CS_P+T7_ .6%'_"W_$'_ $2O
MQY_X%Z+_ /+"N\HH X/_ (6_X@_Z)7X\_P# O1?_ )84?\+?\0?]$K\>?^!>
MB_\ RPKO** .#_X6_P"(/^B5^//_  +T7_Y84?\ "W_$'_1*_'G_ (%Z+_\
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M-73:>NJ=CSZR^*>MZ=9PV]O\)O'$-O;H(XXX[G1%6-0,!0!J&  .,5\H?\%
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MIO\ P4X_[*JG_IW\25^OU?D#_P &XG_*4W_@IQ_V55/_ $[^)*_7Z@ HHHH
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MLSG_ +]BO2OV:?\ @H9\#?VH]*M=+\'>,-!^TO$L$>@WRBPNT4 #REMY N\
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M**** "BBB@ HHHH ^?\ _@K%_P HLOVEO^R5>*/_ $T75?0%?/\ _P %8O\
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MS<FU\Y'W917R/H/_  6J^#.L;?M"^+M*W=?M6F*VWG'/E2/]>,\>_%=IH/\
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M'K]?J_('_@RI_P"467C[_LJNH_\ IHT>OU^K0]0**** "BBB@ HHHH ****
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MI%-L?_QVD^)7[%_PD^)T$TFO^ ?#$S,"TMS#9BTN".Y,L.Q__'J_)77?C?\
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M6%UF->O^E:5<;A]X\W #>W'/IQ0/VE/VUO P_P")A\/UUC8<'_B2+<;OXO\
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M7S__ ,$T_P#DW7Q'_P!E5^(__J;Z[7T!0 4444 %%%% !1110 4444 %%%%
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M[*,R1*HSRV 2/TN^"/QI\._M$_"O1_&GA.]?4?#VO1-+9W#P/"SA7:-LHX#
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M110 4444 %%%% !1110 4444 ?/_ /P33_Y-U\1_]E5^(_\ ZF^NU] 5\_\
M_!-/_DW7Q'_V57XC_P#J;Z[7T!0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7S_\ $;_E*;\&_P#LE7CS_P!._@ROH"OG
M_P"(W_*4WX-_]DJ\>?\ IW\&4 ?0%%%% !1110 4444 %%%% !1110 4444
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MP'_X5]W_ /*RN\HH X/_ (2'XG_]"?X#_P#"ON__ )64?\)#\3_^A/\  ?\
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M?B?_ -"?X#_\*^[_ /E91_PD/Q/_ .A/\!_^%?=__*RN\HH X/\ X2'XG_\
M0G^ _P#PK[O_ .5E'_"0_$__ *$_P'_X5]W_ /*RN\HH X/_ (2'XG_]"?X#
M_P#"ON__ )64?\)#\3_^A/\  ?\ X5]W_P#*RN\HH X/_A(?B?\ ]"?X#_\
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MG^ __"ON_P#Y65WE% '!_P#"0_$__H3_  '_ .%?=_\ RLH_X2'XG_\ 0G^
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M_P#0G^ __"ON_P#Y65WE% '!_P#"0_$__H3_  '_ .%?=_\ RLH_X2'XG_\
M0G^ _P#PK[O_ .5E=Y10!P?_  D/Q/\ ^A/\!_\ A7W?_P K*/\ A(?B?_T)
M_@/_ ,*^[_\ E97>44 <'_PD/Q/_ .A/\!_^%?=__*RC_A(?B?\ ]"?X#_\
M"ON__E97>44 <'_PD/Q/_P"A/\!_^%?=_P#RLH_X2'XG_P#0G^ __"ON_P#Y
M65WE% '!_P#"0_$__H3_  '_ .%?=_\ RLH_X2'XG_\ 0G^ _P#PK[O_ .5E
M=Y10!P?_  D/Q/\ ^A/\!_\ A7W?_P K*\'^(6N_$4_\%.?A"S>%?!2WJ_"_
MQP(HAXIN3$\9U;P?O9G_ +/!5@1& H4A@S$LNT!OK2OG_P"(W_*4WX-_]DJ\
M>?\ IW\&4 >B?\)#\3_^A/\  ?\ X5]W_P#*RC_A(?B?_P!"?X#_ /"ON_\
MY65WE% '!_\ "0_$_P#Z$_P'_P"%?=__ "LH_P"$A^)__0G^ _\ PK[O_P"5
ME=Y10!P?_"0_$_\ Z$_P'_X5]W_\K*/^$A^)_P#T)_@/_P *^[_^5E=Y10!P
M?_"0_$__ *$_P'_X5]W_ /*RC_A(?B?_ -"?X#_\*^[_ /E97>44 <'_ ,)#
M\3_^A/\  ?\ X5]W_P#*RC_A(?B?_P!"?X#_ /"ON_\ Y65WE% '!_\ "0_$
M_P#Z$_P'_P"%?=__ "LH_P"$A^)__0G^ _\ PK[O_P"5E=Y10!P?_"0_$_\
MZ$_P'_X5]W_\K*/^$A^)_P#T)_@/_P *^[_^5E=Y10!P?_"0_$__ *$_P'_X
M5]W_ /*RC_A(?B?_ -"?X#_\*^[_ /E97>44 <'_ ,)#\3_^A/\  ?\ X5]W
M_P#*RC_A(?B?_P!"?X#_ /"ON_\ Y65WE% '!_\ "0_$_P#Z$_P'_P"%?=__
M "LH_P"$A^)__0G^ _\ PK[O_P"5E=Y10!P?_"0_$_\ Z$_P'_X5]W_\K*/^
M$A^)_P#T)_@/_P *^[_^5E=Y10!P?_"0_$__ *$_P'_X5]W_ /*RC_A(?B?_
M -"?X#_\*^[_ /E97>44 <'_ ,)#\3_^A/\  ?\ X5]W_P#*RC_A(?B?_P!"
M?X#_ /"ON_\ Y65WE% 'Y _\&5/_ "BR\??]E5U'_P!-&CU^OU?D#_P94_\
M*++Q]_V574?_ $T:/7Z_4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!^0/_!N)_P I3?\ @IQ_V55/_3OXDK]?J_('_@W$_P"4IO\ P4X_[*JG
M_IW\25^OU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'S_P#\%8O^467[2W_9*O%'_IHNJ^@*^?\ _@K%_P HLOVE
MO^R5>*/_ $T75?0% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]?K]7Y _\&5/_*++Q]_V574?_31H]?K]0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'Y _\&XG_*4W_@IQ_P!E53_T[^)*_7ZOR!_X-Q/^4IO_
M  4X_P"RJI_Z=_$E?K]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!\__ /!6+_E%E^TM_P!DJ\4?^FBZKZ KY_\
M^"L7_*++]I;_ +)5XH_]-%U7T!0 4444 %%%% !1110 4444 %%%% !1110
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MV574?_31H]?K]7Y _P#!E3_RBR\??]E5U'_TT:/7Z_4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!^0/\ P;B?\I3?^"G'_954_P#3OXDK]?J_
M('_@W$_Y2F_\%./^RJI_Z=_$E?K]0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!\__P#!6+_E%E^TM_V2KQ1_Z:+J
MOH"OG_\ X*Q?\HLOVEO^R5>*/_31=5] 4 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 ?/_P#P33_Y-U\1_P#95?B/
M_P"IOKM?0%?/_P#P33_Y-U\1_P#95?B/_P"IOKM?0% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?/_Q&_P"4IOP;_P"R
M5>//_3OX,KZ KY_^(W_*4WX-_P#9*O'G_IW\&4 ?0%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y _\ !E3_
M ,HLO'W_ &574?\ TT:/7Z_5^0/_  94_P#*++Q]_P!E5U'_ --&CU^OU !1
M110 4444 %%%% !1110 445A_$_Q+J/@SX:>(M8T?29M?U;2=,N;RRTR%MLF
MHSQQ,\<"GLSL H/JU9U:BIP=26R3?W%4X.<E!;O0W**_+/\ X)W_ +2_QI_;
M<M-;^)'@SX]S^*O&EAX4T'4=<^'MWI&G0^&]%U2:^U5+[1'MA''?6DT$<"K'
M+)=B5R8Y)3-$8HT_4RNBI3<'RRW^_P":>S3Z-/7?:U\XS4MO+^O)]UTZZW2*
M*_/7]O/_ (*J^-=#_;DTO]GG]G_QW^S#H_Q&L;2&;6[7XMW>K6ZWMQ=8-I96
M#62A&N @WO&[[F%S $4D/CWSX]?M1^.O@+X)^#_@F6V\'Z]\>?BU>Q:'!':P
MW,/A^TN(K8W.IZ@8V=K@V=O''(5C+B21GA0NF]G3*#YX*I'J[+S=[:=+7W;:
M2W=EJ7)<L_9RW2YGY*U]?EJDKM[+70^CJ*^??V</VH?%%[^TQXN^!_Q-7P[-
MX_\ "^AV?BJPUCP_9SV.F^)-)N998/.2UFFGDM98;B%HGC:>8$-&ZO\ ,R1_
M056UHFM4]G\[/[FFGV::W1-W=Q>C5KKU2:^]-->31^0/_!N)_P I3?\ @IQ_
MV55/_3OXDK]?J_('_@W$_P"4IO\ P4X_[*JG_IW\25^OU2,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^?_\ @K%_
MRBR_:6_[)5XH_P#31=5] 5\__P#!6+_E%E^TM_V2KQ1_Z:+JOH"@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y__
M .":?_)NOB/_ +*K\1__ %-]=KZ KY__ .":?_)NOB/_ +*K\1__ %-]=KZ
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M KY_^(W_ "E-^#?_ &2KQY_Z=_!E?0%?/_Q&_P"4IOP;_P"R5>//_3OX,H ^
M@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/^&R/^"R7_1IW[/_ /X-[;_YH:_7ZB@#\@?^&R/^"R7_ $:=^S__ .#>V_\
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M (&5(X/8?\-D?\%DO^C3OV?_ /P;VW_S0U^OU% 'Y _\-D?\%DO^C3OV?_\
MP;VW_P T-'_#9'_!9+_HT[]G_P#\&]M_\T-?K]10!^0/_#9'_!9+_HT[]G__
M ,&]M_\ -#1_PV1_P62_Z-._9_\ _!O;?_-#7Z_44 ?D#_PV1_P62_Z-._9_
M_P#!O;?_ #0T?\-D?\%DO^C3OV?_ /P;VW_S0U^OU% 'Y _\-D?\%DO^C3OV
M?_\ P;VW_P T-'_#9'_!9+_HT[]G_P#\&]M_\T-?K]10!^0/_#9'_!9+_HT[
M]G__ ,&]M_\ -#1_PV1_P62_Z-._9_\ _!O;?_-#7Z_44 ?D#_PV1_P62_Z-
M._9__P#!O;?_ #0T?\-D?\%DO^C3OV?_ /P;VW_S0U^OU% 'Y _\-D?\%DO^
MC3OV?_\ P;VW_P T-'_#9'_!9+_HT[]G_P#\&]M_\T-?K]10!^0/_#9'_!9+
M_HT[]G__ ,&]M_\ -#1_PV1_P62_Z-._9_\ _!O;?_-#7Z_44 ?D#_PV1_P6
M2_Z-._9__P#!O;?_ #0T?\-D?\%DO^C3OV?_ /P;VW_S0U^OU% 'Y _\-D?\
M%DO^C3OV?_\ P;VW_P T-'_#9'_!9+_HT[]G_P#\&]M_\T-?K]10!^0/_#9'
M_!9+_HT[]G__ ,&]M_\ -#1_PV1_P62_Z-._9_\ _!O;?_-#7Z_44 ?D#_PV
M1_P62_Z-._9__P#!O;?_ #0T?\-D?\%DO^C3OV?_ /P;VW_S0U^OU% 'XH_
M_P"+O_!7[X ^"[W0M'_96^!]S9WWB#6_$DCWFMV;R"XU75;O5+A 5U]1Y:SW
MDJH""1&J!F9@6/8?\-D?\%DO^C3OV?\ _P &]M_\T-?K]10!^0/_  V1_P %
MDO\ HT[]G_\ \&]M_P#-#1_PV1_P62_Z-._9_P#_  ;VW_S0U^OU% 'Y _\
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MDO\ HT[]G_\ \&]M_P#-#1_PV1_P62_Z-._9_P#_  ;VW_S0U^OU% 'Y _\
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M /!O;?\ S0U^OU% 'Y _\-D?\%DO^C3OV?\ _P &]M_\T-'_  V1_P %DO\
MHT[]G_\ \&]M_P#-#7Z_44 ?D#_PV1_P62_Z-._9_P#_  ;VW_S0T?\ #9'_
M  62_P"C3OV?_P#P;VW_ ,T-?K]10!^0/_#9'_!9+_HT[]G_ /\ !O;?_-#1
M_P -D?\ !9+_ *-._9__ /!O;?\ S0U^OU% 'Y _\-D?\%DO^C3OV?\ _P &
M]M_\T-'_  V1_P %DO\ HT[]G_\ \&]M_P#-#7Z_44 ?D#_PV1_P62_Z-._9
M_P#_  ;VW_S0T?\ #9'_  62_P"C3OV?_P#P;VW_ ,T-?K]10!^0/_#9'_!9
M+_HT[]G_ /\ !O;?_-#1_P -D?\ !9+_ *-._9__ /!O;?\ S0U^OU% 'Y _
M\-D?\%DO^C3OV?\ _P &]M_\T-'_  V1_P %DO\ HT[]G_\ \&]M_P#-#7Z_
M5RGQC^/'@?\ 9U\(KX@^(/C/PIX%T%IUM1J7B'5[?2[,S,"5C\V=U3>P5B%S
MD[3Z4G)+5C2;V/RL_P"&R/\ @LE_T:=^S_\ ^#>V_P#FAH_X;(_X+)?]&G?L
M_P#_ (-[;_YH:_5#X,_'[P)^T=X4DU[X>>-O"/CS0X;AK1]1\.ZQ;ZI:),H5
MFB,L#N@<!E)7.0&!QR*ZZJ::W)33V/R!_P"&R/\ @LE_T:=^S_\ ^#>V_P#F
MAH_X;(_X+)?]&G?L_P#_ (-[;_YH:_7ZBD,_('_ALC_@LE_T:=^S_P#^#>V_
M^:&C_ALC_@LE_P!&G?L__P#@WMO_ )H:_7ZN!\$?M5?"_P")OQ.U;P3X;^)'
M@'Q!XST'?_:>@:;X@M+O5-.V,%?SK:.0RQ[6(!W*,$@&A:OE6_\ EN#T5WM_
MF?#W_!K_ /L%?%C_ ()V_L"^+O!/QB\*?\(?XFU3X@7FMVMG_:=GJ'FV<FG:
M;"DOF6LLL8S);S+M+!ALR1@@G]'ZY+XO_'WP+^SYH=OJ?C[QKX2\#Z;>3BUM
M[OQ!K%OIL$\QZ1J\SJK.>R@Y-=3;74=[;1S0R1S0S*'1T8,KJ1D$$<$$=Z-U
M=!L[,DHHKS_P7^UC\+/B1\4=2\#^'?B5\/\ 7O&NBEUU#P_IWB&TNM4L"APX
MEMHY#+'M/!W*,'K0M7RK?_+<'HKO;_,] HKDOB_\?? O[/FAV^I^/O&OA+P/
MIMY.+6WN_$&L6^FP3S'I&KS.JLY[*#DUN:YXPTGPQX5NM=U+5-.T_0[*V:\N
M-0N;E(;6"!5W-*\K$(J!>2Q. .<TN9).71;^77\@ZJ/5_P##&C17&_!;]HOX
M??M)>'[C5OAWXZ\&^/M+M9?(GO/#FM6VJ6\,F,[&D@=U5L<X)S6'\:OVV/@S
M^S9XFMM%^(OQ<^&/@'6;RV%Y;V'B/Q38Z5=3P%F02I'/*C,A9'4,!C*L,Y!I
MO1I/=A'WE=?UT_,].HJ.VNH[VVCFADCFAF4.CHP974C(((X(([U)1MHP3NKH
M**** /D'_@JQ^U'\9OV3(_A9J7PSU7X8QZ?X^\=:+X"N;/Q/X6OM2FMIM1G>
M,7J36^I6R[(P%_<F(ECD^:O2O=/ _P"T_P" M0GUWP]>?%'X:ZUXQ^'U@)_&
M<&F:K;P-HA1/WT]Q:FXEELH<ACB9SL'!=L;C\?\ _!4?XY>$?VIO&7PF^'/@
M37K77_&WPV_:)\'0>)-)BCE6?3&19;]LAD&]1;1R2%X]R#RW!8%'"[W@_6=-
M\#_\'"WQ2;5;JQTO^UO@5HVH0O<2+"+B&VU6\6>7)(&V/<@8GH,=A1A[NGRO
M[4ZEF_Y50A5BUWBWS>JEO:*16(7++F7V8PNO-UI4Y?-67HT]+MGU=X<_:N^%
MOC#X:V7C/2?B5X!U3P?J5Z--M-=L_$-I/IMU=%_+$$=PLAC:4O\ +L#%MW&,
M\5J?#KX[>!_C!JNN6/A'QEX5\4WWAFY%GK%OI&K6]]+I,Y!(BN%B=C"^ ?E<
M \=*_#&TU[X7_$W_ ()%6MFMUX%U[7O!?[42?NBUK<W6B07OBQF4@<M#'<6R
MM@C"R1HW4*<?9'[0M[KWA?\ X*O?M&:3\-8_(\63?LK"?1K#2U6.XFU&"]OH
M[+RU3#;U+JJ8((W*!CBL'6:HJLUNF[>F'C7W^;CMV?2S:IWJRI76CBK^M=T?
MT4OO76Z^]_"?[3WPU\??%75_ >A?$/P-K7CCP^&.J>';#7K6YU730I 8SVJ.
M98\%E!WJ,%AZUK?$^^\3VWAZ.#PC9Z?-K5],+=+K4/FLM*4JQ:YFC5TDF5=N
M!%&RM([(I>)2TJ?E5^P/??L\?M1:9^RAXLM_VHO&GB[XE> Y+4>&_AW;3>$M
M/U71+N6V\G4K2:TM=+MK\V:1K.9RTA5XH2X:1BA;]3?B[X^\'^#M M]/\8^*
M-+\+6WBRX&A6+W6MC2)[ZYG5@MO:S"2.3[0P#%!"PD!7*X(R.O$4'!<M[N[C
MV3M:UFK[WMHWY,QHU.9WM9<JEJM5O>Z?:U[M)7NFM'?QO]E7]H;XF:O^U+\3
M/A%\2_\ A"_$-]X'TK2M=M/%'A+2[K2[&:*^-POV*ZM+BYNC;W2&V,@ N7$D
M4R-M3'/F&J?\%%?B;XF^!7Q _:"\&Z+X-U#X&_#N_P!31-(N;6Z_X2'Q=IFF
M2-%?:G:W@F6WM@&AN6@@>WE\](4+30&3Y,/]C?\ 9:N_V.?^"H/Q,\!_#?Q9
MXHUCX-^+?!__  E7B/2=8U:YUF;PIXFFNDBA:.]N&>8-=VRS2LDTCR$PAR=I
M2O,?V;O'&G?LW_\ !O!\3/A[J<\%OXW^%^F^*?AUJ&E.A^U7&N37%W'90+%P
M\CWGVJUDB5<F1;E"N<URSJS6'=>FN::@VHVW:FXNZ79J,%TDIJ5E)JW31I1E
MB%1JZ1<XIN[V<%*R;U5TW)_RN+C=QW_33P/XSTWXC^"M'\1:/<+>:/KUE#J-
MC< %1/!-&LD;@'D95@>>>:X?]JOX@_$/P+\-HX?A3X1T[Q=X]URZ73]+CU>Z
MDL]%TQBCNUY?S1JTBV\:H?EC4R2.4C7!8NO-_L;/H?[-_P !_@[\$/$'B[P_
M_P +(T'P)IMNVB3:K#_:EZEI:QP37$<!82R1+(C R!=N1R17>_M ?M"^"_V6
M?A/JWCCX@>(M+\*^%M%0/=7]_,(HU+':J#/WG9B%51DDD 5U8^G3A4G&$O<3
M=GW2E;?SM;37M9G+@95)TX2DO>:5U;JU?;YWUT[W1\K?L/\ [<'[07_#:NL?
ML^_M->!_AUI?C"3PNWC+P[XE^'MS=2Z#JUA'<1VT\;QW;-<12I)*F"^T-\WR
M@;2[=4_X**_$WQ-\"OB!^T%X-T7P;J'P-^'=_J:)I%S:W7_"0^+M,TR1HK[4
M[6\$RV]L T-RT$#V\OGI"A:: R?)N_LK_M*? WX[?M#ZEXEL?BW\+_&'Q@^(
MFF#1K'1_"WB6SUR[\-:/;++<+:9M)90A#O)+//E8WF:) S".'/SQ^S=XXT[]
MF_\ X-X/B9\/=3G@M_&_POTWQ3\.M0TIT/VJXUR:XNX[*!8N'D>\^U6LD2KD
MR+<H5SFN>M4J0HN<5>I&#:723YG9V6_*N2F[:2E)M:V9U4*=.==4Y.T)3BKW
MU2Y=5?I=J4T]U&*3LFXGU-^TY\=_VAOB3I'AZ/\ 97\+_"_4XM5T>W\13>*_
MB/<W]OH<EM< F"UM8;-?/FN'0>8S,R1Q*8P=S2823_@F!^V_XT_;/^"WC%?B
M#X&M? OQ4^%_B>[\&>*-*MKOSM+DU"WCBE$EM,"Y\ETGC."7923RPPS85C^T
MEX-_X)=?L4_!+X;_ ! \?>!?#OCQ?">F^'M-3Q3K]OIMK/<VMG%%/<333.@%
MO$5+,V0SX"(&D=%/<_\ !/GQK\&]3\ ZUH?PE^(7A7XG75IJ$FM^+->T"^AU
M"'4=5U"22::>6>!GB\UV5L0B1FAB6%,!!'GJJ4X0K5H4Y<T%S)/=WYE9IK2R
MC=/2S;B]6FSCI5)2H4:E16D[-K96Y7=6WNY6:ZI*2NE9/G?^"??[8GQ%_:-^
M.'[0'@KXC:%X*T/4/@_XCL-%MD\-W-S=PS)<6$=V2\\ZQF0CS57(AB'!^4]:
M^I*^'_\ @F7<1M_P48_;NB$B&5/'FA.R _,JG0;4 D>AVG!]CZ5]P5C'6E2E
MWA3;]7"+?WMLN.DJD;WM.:7HIR2_!!11106%%%% !1110 4444 %8?Q*LO$F
MH^!M1A\(ZKH>B>)'C'V&^UC2I=4L;=]P),EM%<6SR KD86=,$@Y.,'<KS_XW
M?M0^ ?V=]=\%Z3XU\2V?A^^^(NL#P_X=2XCD*ZC?&)Y!"'52L9*HV&D*J6VK
MG<R@YUKN#2W>B[W>UO-O8J+L[]M?DM7?R2W/E_\ X)G_ /!2_5/B_P#LE^'O
MB=^T1\1/@?X)F\?ZW?Z)X9TVUB?PX)9K*_N+-XQ)?:C/]KEE:)'5(E0H&P=^
M01]7VW[1'P_O/C)<?#F'QUX.E^(5I:_;I_#":U;-K,-OA6\YK0/YRQX93N*8
MPP.>17Y">(O!]U\/_P#@U^\$WVM0+:6MC\0;#Q.\\HPMO83>-OM$=SDCA&@E
M5@PX*N",@Y/TU^U/\4?AY:?\%^O@-IGB+7_!ZQ^(/A?XB\/R6M_>6^V_FN[F
MR-O9NKG#M.A?9&V?,#$*#GG>7-.HH16KE.%O\-%37S<O=?\ F352INI)?"M4
M_)UG#\(6E\U?1GV>O[7?PG?5M%L%^)_P\:^\2WTNF:1;#Q'9^=JMW$Q62WMU
M\S,LJ,"&1 64C! -7?C1^TO\./V;[739_B)\0/!/@*'69C;:?)XCURUTM;Z4
M $QQ&=T$C $':N3R*_%^UTSPW\._^#=OXB:CH%GX?T=M)^.LC64UG;PPK:FW
M\9Q"WV%1A1'$<(!PJ' PIKWS]H3XF^"[[_@J;^T=\._CA^T%K7P#T/Q5X6T.
M/PT+X>&K?1_%F@263Q7D*W6LZ== !+QKD&*.6(,9'8(S*[#"$G.C"I'>5GKI
M_P NJ=2W77WWM?W8N5G9E**52<9Z*-[]=JDJ=^E]D^FKM=;GZKP7$=U;I+$R
MRQR*'1D.Y7!Y!!Z$&OE#]IS]I/XY?LUS>#_&]U9_#J^\%>(O%>D^'+GP*FEW
M9\50)?W26JR0:C'=O;7-Q'Y@G>W6S";(YE6=@@E;T?\ X)X>#/"7PL_8?^'6
M@^!]>\2^(O F@Z0+3P_K'B&Y@GO-1TV-W6VN#)"J1M"\(1HF"K^Y,60#D#Y0
M_P""K7P;\,_&/X5:'^T[\"?BAJEQ\8_">JVL7@&]T+Q?<:UH/B.[DF2UDTE+
M!9I+1EN$WI(+9$<E"TC%5>MJD5#$Q4=8J<4[_P O,D].[6G=7]V\DD9T^:I1
M>RDXNVNE[7W[)Z]G;6R;9]-?M*_M/^*-,_:.\%_!/X8IX=7X@>+-*O/$FH:K
MKMG/?:;X8TBV9(OM,MM#+!)<2S7$L<4<0GB!"S,9!Y85[W[&_P"U5J?QQ\0_
M$CP+XPL--TWXD?!_6HM%\0)IAD_L_4([BVCNK._MA(2\<4\,@/E.SM$Z2)OD
M"K(_C_BC21\)O^"ZW@_Q;X@D6WL?BI\(I_!VC7$F?)&K6&I"_ELT8C DEMI7
ME5,Y86LIYVUE?L?^--!\/?MM?MG?'C7O%6A:'\+;G6/#_A6UUW4=0CL]),FD
MZ>(KR7[1(PBVK=79MRX;'F0LGWD(J:%N1.6[C-OR<:O)%KM[K6G7FYG]FU5-
M9-16SAR]Y<T%)I]+IN7G^[Y5]J_W+/,((7D8,RHI8A5+,<>@')/L*_.']K7_
M (*&_ME?LD:#=?'#7/@W\(Y/V<]+N89M3\/1ZO>'XAZ7I;R"/[7.6V6*RX97
M-O'YC(7"%CM:0?HSI>J6NN:9;WME<07EG>1+/!/!()(IXV 975AD,I!!!'!!
MKXJ_:4_;V_9H_:$\=7GPY\8?'3X+Z/X+\%:Q!/XIL-7\8:=:W&NW]I*L\>G"
M&297-O%-'$\[%2LI40#=^_"3\-:*;UOL]K)KF;6[26FZU=D^9IK2*3@VU=>6
M_DD^[WV>UVN5._JW[0G[5OB3_A?W@3X._"V/04\>>--&N_%-]JGB"QGO-/\
M"^C6YCC^T36L,L$D\TUQ-'%'")X1\LS,X\L*^'\,/VY_&7B?P7\7/#<W@>W\
M1?&[X-ZS;>'KS0M&N'M]-UV6\AAFT^_CEE#M:VDT4P>7S#(UN(9QF;:C2<"=
M6TO0_P#@ME\/_B5+>,WA?XW?!E_#GA:_N(GACFOK74%U+[,N]04DFM)VF6-M
MK,+:7C*XJ/\ 8W\4:3I7[;/[:GQXU3Q!ING_  O;4=#\/0:S<7 BTX_V+I9&
MH3^:QV%8[BY>%G4XWV[I]Y#5*R@W/W?=J.5]X\E;D3UVM&R=]'S<S6D3-7<K
M1]ZS@HM?;YH*379ZN35M;0Y4[N5\KX,?MQ_M4?!+]N;X?_"7]IKP%\'Y-#^,
MBW\/A/Q+\,[R_E@L+RTMWNGM;V.]/FMF%"?,1$4''WANV6OVUOVJ?VUOAL?%
MGQ ^%'PE^#E]\)? ?VF2ZTGQ7JE_!XP\36UJ3]HN[18]MK:Q,J2&)9FDD=$#
M[<NL=;'PA_;E_9S_ &F/VF?"_P 0)OC+\*==\2*DGA[X=^%M-\26>HZO:K?2
M1K-=O:0RO*MU<+'$""@-M;JPDV%YU79_;:_;G^!OB7Q'X@^ WBCXW?"_P&;J
MT%MXWDUGQ;9:5=VEA.N&L8!+-&_VFXC+*77/D1EG;:[0A\ZL9\D.5VGJE=:7
MO=.2Z\JM==G9ISLWI3Y/:-2UCHW9ZVUOROIS/1?WE=-1=E]"?LQ?'C3_ -J/
M]G+P)\2-*LK[3=-\>:#9:_;6EX +BVCN8$F5'QP64/C(X.,C@BNZKC_@%X]\
M%_$KX/Z#JWPYO-)U#P.UO]ET6XTI-M@]O Q@7[/@!6A'EX1DRC* 5)4@GL*Z
ML1R^UER*RN[)]%?1?(YJ'-[./.[NRNUU?4****Q-0HHHH **** "BBB@ KY9
M_P""PW[4'Q._8E_8E\4_%SX:7G@/[1X'A2ZO],\3:!=ZDFJI)/#"JQ26]];&
MW*F1F+,LH; &%ZU]35^?O_!>7X]>#_BC^Q!\<O@+HFO6MY\6VT#1K]?#BQ2B
MYD@O=8MK:V9#MV2%YL)LC9G!9,J-ZYF47*48QW;6W76[_!._E<WP_+[1.I\-
MU?T;2^6]EYVZGU9\'OV@](BUK2?ASXT^)WPOUKXT_P!G?VCJ&AZ)*FEW4D+9
M<2QZ9+=W-TD0C*Y=G<'!;*@A1I>$OVO?A-X_\$:]XFT'XH?#O6O#?A68V^MZ
MK8>)+.YL='E&"8[F9)"D+ $9#D'D5\K_ +3GV?PE_P %QOV0[C4&M[/^T_!'
MC+2+>61@OVFY2*PE\E3W8(KL!]?6OA_]H?QK\+_B3^S7_P %5/#\NI^!=>U:
MV\1-XITNP>>UNIDV:790IJ$"$DY6X8IYR#*R/C(9@#GB*\E3E6BE\%2?_@%7
MDM\XWETV[:K#"4Y/DIU+W<J<;O\ OT^9OY37+]_70_9SPC^T+X!^('CZ_P#"
MF@^./!^M^*-+M8[Z]T>PUFVN=0L[>3&R:2!',B1MD89E .1@U6O/VGOAKIWQ
MHA^&]Q\0_ T'Q$N(A-%X6DUZU76I8RA<.MF7\XJ5!;(3& 3TKX<\0OIG@W_@
MI]^P3:Z&FEZ;'JGPU\56QBM4CB%Q#_9]A.J *!E?-7>,<9R>YKY;_94U+X/_
M +4O[*'AWPW\:_VG?B%X;^+W@;X@2ZEJ'PNCG\*:;XAB\7V^JRF+[")],&I7
M$TTK)B3[5(6\YD>7 <+VRHVKJETO)/O:-65.Z76RC=^;4;KF3,:=7FH.L^T;
M>LJ?.D_*]U?MK9VL_P!JO'6J:MH_A6ZGT'2X]:U@!4M;22Y6VB=V8+NDD.=L
M:9WN55GVJVU';:I^>OAU^T!\7/ ?[=>F?"'XB7'P^\::7XL\*WWB;3M8\)Z%
M>Z-<:!]DN8(3#?V\]Y>*T<WV@"*=98\O!(OE=U]^^)/Q0\,_!SP?=>(/&'B+
M0_"N@6;(EQJ>L7\5C9P&1Q&@:65E12SLJC)Y9@!R17PUIO[*1_9+_P""O?PY
MU[X/>,/%U_I'QATO4YOBAX<UGQ#>^(H6LK6U9K#5UFNY99H&%T\=NI:0HRR;
M(U 5Q7-3_CQO\+YD_7D;2^^SNKO37W6VMJB?LFUNK/Y75_5VT2>C;[V3]5U'
M]K#XL?'GXJ_%6Q^"=CX"?P[\%;Y=$OY/$EI=S2^,=92W6XN=.M)89HUL4A66
M&(W3QW7[UY!Y&V/<_L_[(W[3&A_MD?LS^"OBAX;CN;?1_&FEQZC%;W 'G6;G
M*RP28XWQ2*\;$9!*$@D8-?+/_!.CQ=H'['UY^V!X<\;ZO9Z'>^$?B;K/Q U&
MXU"40^9HNJ0Q7=K?%FP&B.R:'>"1YEM(O!&*V_\ @C:]E^RI_P $W/@/X/\
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M#\+_ ,$Z/%V@?L?7G[8'ASQOJ]GH=[X1^)NL_$#4;C4)1#YFBZI#%=VM\6;
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M_#_B"VOM/TJUMHX[>));A)&2VM+:$(D8F="^)Y=NYI<>._M;_LZZ?X0_;+^
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M]@<@EHA=03P;B 5^>)\!B1@X(_-SX(_!WXM?#O\ 9^_;H_9IN/$/_"P;K0=
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MK[)M7LKM=.#J1I5H59[1:;ZZ)J]EULM;;NUE=V3^<?V>/VJOB!^R_P#LF?\
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M()(W7HZD9!'U%24V&);>)8T7:B *H'8"G4I6OH3#FY5S;];!1112*.3T_P"
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MGQ$D3PKJN@^$M/TV]6-_OH)H8E?:W<9P>]>K4447>P=;A1110 4444 %%%%
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M4448"(B@ !5   X%:=%%.4FW=@DDK(****0!1110 4444 %%%% !7)Z]\ _
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M!%<+#$HF0!W&U\C#MZFK?P0_9+^%?[,SWS?#?X9_#[X?-J0 O#X:\.V>DFZ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHKQGQ5_P4"^$_@3]JO1?@IKWB+4-!^(OB7=_8
MMEJ?A_4K.RULK"LS+::A+;K97+!74%8IV8/F,C>"H<4V^5;L4FDKO8]FHKRW
M]IC]LCP+^R+:Z//XX;QA#;Z]<K9V<NC>#-9\01M.SI''"[:?:SB*21Y$6-)"
MK2,2$#$''HGAKQ!!XL\.V&J6L=]%:ZE;QW,27EE-97"(ZA@)()E26)P#RDBJ
MZG(8 @BE'WDY+9.WS[>HY:-)[M7^7?T+U%%0ZC?II>GSW4BS-';QM*XAA>:0
MA1D[40%F;CA5!)/ !-)R25V"3;LB:BO(_P!C#]M#PG^W7\*]2\8>#+/Q)8Z3
MIFNWWAZ6/7=-;3KS[39R>5-F!SYD8#Y&V54D!!#(I&*]<IV=DWU2?R:NOO3%
M=.Z71M?-.S_%!115?6-8M/#VDW6H:A=6]C8V,37%S<W$@BAMXU!9G=F("JH!
M)). !FDVDKLI)MV18HKY[L_^"J/P+O;*74AXPU"'PK"K.?&%QX8U:W\'LJ\;
MEUU[8:8RD_*K+<D,V I).*]P\$>,],^(_@O1_$6BW2WVC:]90ZC87*HR"XMY
MHUDC<!@&&Y&4X(!&>0*>]VNEOQO;[[.WH^PI:.S_ *_JZ^\U**** "BBB@ H
MHHH **XGXE?&O_A6_P 1O OAW_A$?&VO?\)S?7%C_:>C:7]JTWP_Y4#3>=J,
MVX?9XGV^6C8;=(RK@9S760:U9W6JW%C%=VLE]9I'+/;K*K2P))NV,RYRH;8^
M"1SL;'0T[.UPV=OG^:_1EJBBO.OVA?VJ?!O[+UMX??Q;-XB,WBJ_;3-)L]#\
M,:GXAOKZX2"2X9$MM/MYYL+%#(Y8IM 0Y-)M+<#T6BOEWPK_ ,%D/@+XT^V/
MI^J?$B2UTO7%\-:C>R_"KQ7;V.DZF9HX/LEW<2::L-M*)98T99G0J77=C-?4
M5%G:_3^G^33^87UMU7_#!1575-:L]#BBDO;NULXYYH[:-IY5C$DLC!(XP21E
MF8A0HY)( YJU0 45XG\:?V]?!OP(_:O^%WP;UC3?&$WBKXMO<KHMU:Z,YTF+
MR(99I!+>.5BWA8C^ZC,DJ[XRR*KJQ[3]H7]HCPO^RW\,;SQCXQ;7X?#VFY:\
MN-)\.ZCKDEI&$9VEDAL8)I4A548M*R!$ ^9AD9F4XJ'M&[1NU?I=;E<LN;DM
MK9.WD[V?X,[BBOF'0/\ @L;^SWK=OX3NKGQ=XD\-:/X\>&/P[K?BCP-K_AS1
M=9:9-\(@U#4+*"T?S$.Y,2_,.1D5]/5I*,ENO+YHFZ>WK\@HJKK.M6?AS2KB
M^U"[M;&QM$,L]Q<2K%%"@ZLS,0% ]2:M5(!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 445Y1^UQ^VS\._V%_A\OBSXG:AX@T7PS
MDB?5+'POJNLVMB 47=<R6-M,+=2SJJM-L#,<*2<BIE)1UDRHQ;=D>KT5XO\
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M+-J-2,=4D]7I*ZZ)KWKPT]^4KO7XI5;<RZI<U.36K:32LUK9TWXG?%[]G?\
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MP;\2M4^&?CN-9_&]EXD'@FTT+1;.ZMUD@O=%?3]0EU,K%(5)BNS<-)$YY1P
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M/<;UFB:)HKAB79?2HO\ @DA\0O%?Q0_:/U;QE\9_"NJ>'_VGM%CT3Q-INC>
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M)Q?^%/FY[7:5GM<_2;1?B+HGB+QIK?AVQU&WNM:\-I;OJ=K'DM9"X5FA#G&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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C "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>fonr-20250630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +KIpo7xRiXgen8uAZHZcOaWO+bPtxZ97WekhsmRxbcmqry8sCmP9fSTMCqRmUVcI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:FONR="http://fonar.com/20250630" elementFormDefault="qualified" targetNamespace="http://fonar.com/20250630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
          <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
          <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity" id="ConsolidatedStatementsOfChangesInEquity">
          <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
          <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" id="DescriptionOfBusinessAndLiquidityAndCapitalResources">
          <link:definition>999014 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
          <link:definition>999016 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories" id="Inventories">
          <link:definition>999017 - Disclosure - INVENTORIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>999018 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingAndFinanceLeases" id="OperatingAndFinanceLeases">
          <link:definition>999019 - Disclosure - OPERATING AND FINANCE LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets" id="OtherIntangibleAssets">
          <link:definition>999020 - Disclosure - OTHER INTANGIBLE ASSETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CapitalStock" id="CapitalStock">
          <link:definition>999021 - Disclosure - CAPITAL STOCK</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" id="ControllingAndNoncontrollingInterests">
          <link:definition>999022 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>999023 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
          <link:definition>999024 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>999025 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
          <link:definition>999026 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>999027 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation" id="SegmentAndRelatedInformation">
          <link:definition>999028 - Disclosure - SEGMENT AND RELATED INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>999029 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>999030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
          <link:definition>999032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/InventoriesTables" id="InventoriesTables">
          <link:definition>999033 - Disclosure - INVENTORIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>999034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingAndFinanceLeasesTables" id="OperatingAndFinanceLeasesTables">
          <link:definition>999035 - Disclosure - OPERATING AND FINANCE LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" id="OtherIntangibleAssetsTables">
          <link:definition>999036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" id="ControllingAndNoncontrollingInterestsTables">
          <link:definition>999037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>999038 - Disclosure - INCOME TAXES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
          <link:definition>999039 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" id="SegmentAndRelatedInformationTables">
          <link:definition>999040 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" id="DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative">
          <link:definition>999041 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" id="SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details">
          <link:definition>999042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" id="SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1">
          <link:definition>999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" id="SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details">
          <link:definition>999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>999045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails">
          <link:definition>999046 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1">
          <link:definition>999047 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails">
          <link:definition>999048 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
          <link:definition>999049 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/Inventories-InventoriesDetails" id="Inventories-InventoriesDetails">
          <link:definition>999050 - Disclosure - INVENTORIES - Inventories (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" id="PropertyAndEquipment-PropertyAndEquipmentDetails">
          <link:definition>999051 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>999052 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" id="OperatingFinancingLeases-LeasePaymentsDetails">
          <link:definition>999053 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" id="OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1">
          <link:definition>999054 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" id="OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2">
          <link:definition>999055 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3" id="OperatingFinancingLeases-RelatedToLeasesDetails3">
          <link:definition>999056 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative" id="OperatingAndFinanceLeasesDetailsNarrative">
          <link:definition>999057 - Disclosure - OPERATING AND FINANCE LEASES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" id="OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails">
          <link:definition>999058 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" id="OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1">
          <link:definition>999059 - Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2" id="OtherIntangibleAssets-IntangleAssets-Details2">
          <link:definition>999060 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" id="OtherIntangibleAssetsDetailsNarrative">
          <link:definition>999061 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" id="CapitalStockDetailsNarrative">
          <link:definition>999062 - Disclosure - CAPITAL STOCK (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" id="ControllingAndNoncontrollingInterests-HdmMembersEquityDetails">
          <link:definition>999063 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" id="ControllingAndNoncontrollingInterestsDetailsNarrative">
          <link:definition>999064 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" id="IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails">
          <link:definition>999065 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" id="IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails">
          <link:definition>999066 - Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" id="IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2">
          <link:definition>999067 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>999068 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
          <link:definition>999069 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>999070 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" id="SupplementalCashFlowInformationDetailsNarrative">
          <link:definition>999071 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>999072 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" id="SegmentAndRelatedInformation-SummarizedSegments-Details">
          <link:definition>999073 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" id="SegmentAndRelatedInformation-ForeignProductSales-Details">
          <link:definition>999074 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" id="SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details">
          <link:definition>999075 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" id="SegmentAndRelatedInformationDetailsNarrative">
          <link:definition>999076 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20250630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20250630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20250630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="fonr-20250630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/cyd/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommonStockholdersMember" name="CommonStockholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredStockholdersMember" name="ClassANonVotingPreferredStockholdersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassAPreferredStockMember" name="ClassAPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassCCommonStockMember" name="ClassCCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticImagingFacilityMember" name="DiagnosticImagingFacilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartiesMember" name="RelatedPartiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartiesMedicalPracticesMember" name="RelatedPartiesMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TwoVendorsMember" name="TwoVendorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticEquipmentMember" name="DiagnosticEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" name="ResearchDeveopmentAndDemonstrationEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableMember" name="ManagementAndOtherFeesReceivableMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" name="ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" name="ResearchDevelopmentAndDemonstrationEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingLeasePaymentsMember" name="OperatingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingLeasePaymentsMember" name="FinancingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SoftwareLicenseMember" name="SoftwareLicenseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatentsAndCopyrightsMember" name="PatentsAndCopyrightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostomerRelationshipsMember" name="CostomerRelationshipsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SoftwareLicensesMember" name="SoftwareLicensesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_N2010StockBonusPlanMember" name="N2010StockBonusPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMMember" name="HDMMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassAControllingInterestsMember" name="ClassAControllingInterestsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassBControllingInterestsMember" name="ClassBControllingInterestsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HDMEquityMember" name="HDMEquityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MagneticResonanceManagementMember" name="MagneticResonanceManagementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BensonhurstMRILimitedPartnershipMember" name="BensonhurstMRILimitedPartnershipMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RadianHealthcareManagementLLCMember" name="RadianHealthcareManagementLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManufacturingandServicingofMedicalEquipmentMember" name="ManufacturingandServicingofMedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementofDiagnosticImagingCentersMember" name="ManagementofDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalMember" name="TotalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TwoMember" name="TwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty" name="PrepaidExpensesAndOtherCurrentAssetsRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NoteReceivableRelatedParty" name="NoteReceivableRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsPayableRelatedPartyNoncurrent" name="AccountsPayableRelatedPartyNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" name="ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" name="RelatedPartyReceivableAllowancesForDoubtfulAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InvestmentIncomeRelatedParty" name="InvestmentIncomeRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherIncomeRelatedParty" name="OtherIncomeRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsolidatedNetIncome" name="ConsolidatedNetIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SaleNonControllingInterest" name="SaleNonControllingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsolidatedNetIncomeLoss" name="ConsolidatedNetIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" name="NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainOnSaleOfEquipmentRelatedParty" name="GainOnSaleOfEquipmentRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainlossOnDispositionOfFixedAssets" name="GainlossOnDispositionOfFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AbandonedPatents" name="AbandonedPatents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInNotesReceivable" name="IncreaseDecreaseInNotesReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerAdvance" name="IncreaseDecreaseInCustomerAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SaleOfNoncontrollingInterest" name="SaleOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureOperatingAndFinanceLeasesAbstract" name="DisclosureOperatingAndFinanceLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureCapitalStockAbstract" name="DisclosureCapitalStockAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CapitalStockDisclosureTextblock" name="CapitalStockDisclosureTextblock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivablePolicyTextBlock" name="MedicalReceivablePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerAdvancesPolicyTextBlock" name="CustomerAdvancesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" name="EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" name="TotalFacilitiesOwnedOrManagedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" name="ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" name="SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock" name="ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfExportProductSalesTableTextBlock" name="ScheduleOfExportProductSalesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfExportServiceRevenuesTableTextBlock" name="ScheduleOfExportServiceRevenuesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetPatientFeeRevenue" name="NetPatientFeeRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncomeLossAvailableToCommonStockholderBasic" name="NetIncomeLossAvailableToCommonStockholderBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageSharesOutstandingBasic" name="WeightedAverageSharesOutstandingBasic" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" name="IncrementalCommonSharesAttributableToConversionOfCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" name="WeightedAverageNumberOfDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" name="ManagementAgreementsWithCompanyTotalMedicalPractices" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" name="ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" name="ScannersWithManagementWithCompanyLocatedInNewYorkState" nillable="true" xbrli:periodType="instant" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMinimum" name="ContractualFeesForServicesRenderedMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ContractualFeesForServicesRenderedMaximum" name="ContractualFeesForServicesRenderedMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalFeeReceivable" name="MedicalFeeReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RevenuePercentage" name="RevenuePercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementFeeReceivableForUnrelatedParties" name="ManagementFeeReceivableForUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementFeeReceivableForRelatedParties" name="ManagementFeeReceivableForRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceContractsNet" name="AccountsReceivableServiceContractsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Penalties" name="Penalties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" name="NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsAdditions" name="AllowanceForDoubtfulAccountsAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AllowanceForDoubtfulAccountsDeductions" name="AllowanceForDoubtfulAccountsDeductions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" name="TotalFacilitiesOwnedOrManagedAtBeginningOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesAddedByInternalDevelopment" name="ManagedFacilitiesAddedByInternalDevelopment" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagedFacilitiesClosedDuringYear" name="ManagedFacilitiesClosedDuringYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" name="TotalFacilitiesOwnedOrManagedAtEndOfYear" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCostsAbstract" name="FinanceLeaseCostsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DepreciationOfLeasedEquipment" name="DepreciationOfLeasedEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinanceLeaseCost" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingCashFlowsFromOperatingLeases" name="OperatingCashFlowsFromOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingCashFlowsFromFinancingLeases" name="FinancingCashFlowsFromFinancingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" name="RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AmountsCapitalized" name="AmountsCapitalized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SoftwareOrPatentsWrittenOff" name="SoftwareOrPatentsWrittenOff" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CorrectionOfError" name="CorrectionOfError" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SharesRegistered" name="SharesRegistered" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfTreasuryShares" name="CancellationOfTreasuryShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfTreasuryStock" name="CancellationOfTreasuryStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OpeningMembersEquity" name="OpeningMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ShareOfNetIncome" name="ShareOfNetIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BuyoutOfNoncontrollingInterests" name="BuyoutOfNoncontrollingInterests" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BuyoutOfNoncontrollingInterestsValue" name="BuyoutOfNoncontrollingInterestsValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Distributions" name="Distributions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EndingMembersEquity" name="EndingMembersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EquityMethodInvestmentOwnershipPercentages" name="EquityMethodInvestmentOwnershipPercentages" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProceedsFromContributionsFromCompany" name="ProceedsFromContributionsFromCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfStandupMriCenters" name="PurchaseOfStandupMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfOtherMriCenters" name="PurchaseOfOtherMriCenters" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationToOutsideInvestors" name="ConsiderationToOutsideInvestors" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalPurchasePrice" name="TotalPurchasePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" name="ConsiderationForNoncompetitionAndConsultingAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EquityMethodInvestmentsOwnershipPercentage" name="EquityMethodInvestmentsOwnershipPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DirectPurchaseOfNoncontrollingInterests" name="DirectPurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DeferredIncomeTaxExpensesBenefit" name="DeferredIncomeTaxExpensesBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" name="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PermanentItemsMealsEntertainment" name="PermanentItemsMealsEntertainment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" name="EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit" name="IncomeTaxReconciliationIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" name="DeferredTaxAssetsInRightUseAssetsAndLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PropertyAndEquipmentAndDepreciation" name="PropertyAndEquipmentAndDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CapitalizedResearchAndDevelopmentCosts" name="CapitalizedResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SoftwareLicenses" name="SoftwareLicenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RecruitingFees" name="RecruitingFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PrincipalAmount" name="PrincipalAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RentExpenses" name="RentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherCostOfSalesExpenses" name="OtherCostOfSalesExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostOfSales" name="CostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SalariesAndWage" name="SalariesAndWage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_RentsExpense" name="RentsExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherSellingGeneralAndAdministrativeExpenses" name="OtherSellingGeneralAndAdministrativeExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalCostsAndExpenses" name="TotalCostsAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalIdentifiableAssets" name="TotalIdentifiableAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CapitalExpenditures" name="CapitalExpenditures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignProductSales" name="ForeignProductSales" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignServiceAndRepairFees" name="ForeignServiceAndRepairFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExportSalesOfMedicalEquipmentPercentage" name="ExportSalesOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" name="ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>fonr-20250630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#Cover" roleURI="http://fonar.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedBalanceSheets" roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedStatementsOfOperations" roleURI="http://fonar.com/role/ConsolidatedStatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedStatementsOfChangesInEquity" roleURI="http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#Inventories" roleURI="http://fonar.com/role/Inventories" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipment" roleURI="http://fonar.com/role/PropertyAndEquipment" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingAndFinanceLeases" roleURI="http://fonar.com/role/OperatingAndFinanceLeases" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets" roleURI="http://fonar.com/role/OtherIntangibleAssets" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CapitalStock" roleURI="http://fonar.com/role/CapitalStock" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterests" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes" roleURI="http://fonar.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherCurrentLiabilities" roleURI="http://fonar.com/role/OtherCurrentLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CommitmentsAndContingencies" roleURI="http://fonar.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SupplementalCashFlowInformation" roleURI="http://fonar.com/role/SupplementalCashFlowInformation" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#RelatedPartyTransactions" roleURI="http://fonar.com/role/RelatedPartyTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation" roleURI="http://fonar.com/role/SegmentAndRelatedInformation" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SubsequentEvents" roleURI="http://fonar.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#InventoriesTables" roleURI="http://fonar.com/role/InventoriesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipmentTables" roleURI="http://fonar.com/role/PropertyAndEquipmentTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingAndFinanceLeasesTables" roleURI="http://fonar.com/role/OperatingAndFinanceLeasesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssetsTables" roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterestsTables" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxesTables" roleURI="http://fonar.com/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherCurrentLiabilitiesTables" roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformationTables" roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#Inventories-InventoriesDetails" roleURI="http://fonar.com/role/Inventories-InventoriesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipmentDetailsNarrative" roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-RelatedToLeasesDetails3" roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingAndFinanceLeasesDetailsNarrative" roleURI="http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets-IntangleAssets-Details2" roleURI="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssetsDetailsNarrative" roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CapitalStockDetailsNarrative" roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" roleURI="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxesDetailsNarrative" roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SupplementalCashFlowInformationDetailsNarrative" roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#RelatedPartyTransactionsDetailsNarrative" roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation-SummarizedSegments-Details" roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformationDetailsNarrative" roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty" xlink:label="loc_FONRPrepaidExpensesAndOtherCurrentAssetsRelatedParty" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRPrepaidExpensesAndOtherCurrentAssetsRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NoteReceivableRelatedParty" xlink:label="loc_FONRNoteReceivableRelatedParty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRNoteReceivableRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="loc_FONRInvestmentIncomeRelatedParty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_FONRInvestmentIncomeRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherIncomeRelatedParty" xlink:label="loc_FONROtherIncomeRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_FONROtherIncomeRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsolidatedNetIncome" xlink:label="loc_FONRConsolidatedNetIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRConsolidatedNetIncome" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRConsolidatedNetIncome" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_FONRConsolidatedNetIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsolidatedNetIncomeLoss" xlink:label="loc_FONRConsolidatedNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRConsolidatedNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_FONRNetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRNetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_GainOnSaleOfEquipmentRelatedParty" xlink:label="loc_FONRGainOnSaleOfEquipmentRelatedParty" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainOnSaleOfEquipmentRelatedParty" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_GainlossOnDispositionOfFixedAssets" xlink:label="loc_FONRGainlossOnDispositionOfFixedAssets" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainlossOnDispositionOfFixedAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AbandonedPatents" xlink:label="loc_FONRAbandonedPatents" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRAbandonedPatents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInNotesReceivableRelatedParties" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInNotesReceivableRelatedParties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInTradingLiabilities" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInTradingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SaleOfNoncontrollingInterest" xlink:label="loc_FONRSaleOfNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_FONRSaleOfNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000012 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000013 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="999014 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="999016 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="999017 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="999018 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinanceLeases" xlink:title="999019 - Disclosure - OPERATING AND FINANCE LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="999020 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="999021 - Disclosure - CAPITAL STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="999022 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="999023 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="999024 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="999025 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="999026 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="999027 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="999028 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="999029 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="999032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="999033 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="999034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinanceLeasesTables" xlink:title="999035 - Disclosure - OPERATING AND FINANCE LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="999036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="999037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="999038 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="999039 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="999040 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="999041 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="999042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="999046 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" xlink:title="999047 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="999048 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="999049 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="999050 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="999051 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999052 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="999053 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" xlink:title="999054 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" xlink:title="999055 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3" xlink:title="999056 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative" xlink:title="999057 - Disclosure - OPERATING AND FINANCE LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:title="999058 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" xlink:title="999059 - Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2" xlink:title="999060 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="999061 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="999062 - Disclosure - CAPITAL STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="999063 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="999064 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="999065 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DeferredIncomeTaxExpensesBenefit" xlink:label="loc_FONRDeferredIncomeTaxExpensesBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="999066 - Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" xlink:title="999067 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:label="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PropertyAndEquipmentAndDepreciation" xlink:label="loc_FONRPropertyAndEquipmentAndDepreciation" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_FONRPropertyAndEquipmentAndDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="999068 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="999069 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999070 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="999071 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999072 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:title="999073 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="999074 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="999075 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="999076 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>fonr-20250630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#Cover" roleURI="http://fonar.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedBalanceSheets" roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedStatementsOfOperations" roleURI="http://fonar.com/role/ConsolidatedStatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedStatementsOfChangesInEquity" roleURI="http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#Inventories" roleURI="http://fonar.com/role/Inventories" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipment" roleURI="http://fonar.com/role/PropertyAndEquipment" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingAndFinanceLeases" roleURI="http://fonar.com/role/OperatingAndFinanceLeases" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets" roleURI="http://fonar.com/role/OtherIntangibleAssets" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CapitalStock" roleURI="http://fonar.com/role/CapitalStock" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterests" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes" roleURI="http://fonar.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherCurrentLiabilities" roleURI="http://fonar.com/role/OtherCurrentLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CommitmentsAndContingencies" roleURI="http://fonar.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SupplementalCashFlowInformation" roleURI="http://fonar.com/role/SupplementalCashFlowInformation" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#RelatedPartyTransactions" roleURI="http://fonar.com/role/RelatedPartyTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation" roleURI="http://fonar.com/role/SegmentAndRelatedInformation" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SubsequentEvents" roleURI="http://fonar.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#InventoriesTables" roleURI="http://fonar.com/role/InventoriesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipmentTables" roleURI="http://fonar.com/role/PropertyAndEquipmentTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingAndFinanceLeasesTables" roleURI="http://fonar.com/role/OperatingAndFinanceLeasesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssetsTables" roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterestsTables" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxesTables" roleURI="http://fonar.com/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherCurrentLiabilitiesTables" roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformationTables" roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#Inventories-InventoriesDetails" roleURI="http://fonar.com/role/Inventories-InventoriesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipmentDetailsNarrative" roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-RelatedToLeasesDetails3" roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingAndFinanceLeasesDetailsNarrative" roleURI="http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets-IntangleAssets-Details2" roleURI="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssetsDetailsNarrative" roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CapitalStockDetailsNarrative" roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" roleURI="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxesDetailsNarrative" roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SupplementalCashFlowInformationDetailsNarrative" roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#RelatedPartyTransactionsDetailsNarrative" roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation-SummarizedSegments-Details" roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformationDetailsNarrative" roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosureWithAdditionalMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpTable" roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsToCompensation" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListsByExecutiveCategory" roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListMeasures" roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpExecutiveCategoriesOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTypeOnly" roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TradingArrangmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ForgoneRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#OutstandingRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardsCloseToMnpiDisc" roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangemenstByInd" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#Defaults" roleURI="http://xbrl.sec.gov/ecd/role/Defaults" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_80" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_80" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_80" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_80" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_80" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_80" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_80" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_80" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_80" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_80" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_80" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_80" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_80" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_80" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_80" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_80" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_80" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_80" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_80" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_80" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_80" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_80" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_80" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_80" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_80" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_80" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_80" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_80" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_80" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_80" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_80" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_80" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_80" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_80" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_80" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_80" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_80" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_80" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_80" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag_80" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag_80" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName_80" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation_80" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId_80" xlink:type="arc" order="62" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRMedicalReceivable_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="loc_us-gaapAccruedFeesAndOtherRevenueReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAccruedFeesAndOtherRevenueReceivable_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryNet_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty" xlink:label="loc_FONRPrepaidExpensesAndOtherCurrentAssetsRelatedParty_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRPrepaidExpensesAndOtherCurrentAssetsRelatedParty_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableNetLongTerm_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NoteReceivableRelatedParty" xlink:label="loc_FONRNoteReceivableRelatedParty_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRNoteReceivableRelatedParty_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapGoodwill_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOtherAssets_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtCurrent_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableCurrent_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueCurrent_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRCustomerDeposits_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtNoncurrent_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesNoncurrent_130" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilities_130" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapAdditionalPaidInCapital_130" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapTreasuryStockValue_130" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapMinorityInterest_130" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_130" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_130" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="49" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares_130" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CommonStockholdersMember" xlink:label="loc_FONRCommonStockholdersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStockholdersMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="loc_FONRClassANonVotingPreferredStockholdersMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockholdersMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRProductSalesNet_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesNet_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesNet_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToProductSales_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapCostsAndExpenses_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseNonoperating_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="loc_FONRInvestmentIncomeRelatedParty_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestmentIncomeRelatedParty_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherIncomeRelatedParty" xlink:label="loc_FONROtherIncomeRelatedParty_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROtherIncomeRelatedParty_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsolidatedNetIncome" xlink:label="loc_FONRConsolidatedNetIncome_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConsolidatedNetIncome_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" xlink:type="arc" order="34" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAPreferredStockMember" xlink:label="loc_FONRClassAPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassAPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRClassCCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SaleNonControllingInterest" xlink:label="loc_FONRSaleNonControllingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSaleNonControllingInterest_90" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000012 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000013 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="999014 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="999016 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="999017 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="999018 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinanceLeases" xlink:title="999019 - Disclosure - OPERATING AND FINANCE LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="999020 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="999021 - Disclosure - CAPITAL STOCK" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="999022 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="999023 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="999024 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="999025 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="999026 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="999027 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="999028 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="999029 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="999032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="999033 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="999034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinanceLeasesTables" xlink:title="999035 - Disclosure - OPERATING AND FINANCE LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="999036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="999037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="999038 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="999039 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="999040 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="999041 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherInvesteesMember" xlink:label="loc_us-gaapOtherInvesteesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_us-gaapOtherInvesteesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="loc_us-gaapInvestmentOwnedPercentOfNetAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedPercentOfNetAssets_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="loc_us-gaapProceedsFromPaymentsToMinorityShareholders_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromPaymentsToMinorityShareholders_80" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="999042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_120" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassCCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAPreferredStockMember" xlink:label="loc_FONRClassAPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassAPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="loc_FONRWeightedAverageSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageSharesOutstandingBasic_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_90" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RelatedPartiesMember" xlink:label="loc_FONRRelatedPartiesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RelatedPartiesMedicalPracticesMember" xlink:label="loc_FONRRelatedPartiesMedicalPracticesMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMedicalPracticesMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TwoVendorsMember" xlink:label="loc_FONRTwoVendorsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRTwoVendorsMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicalFeeReceivable" xlink:label="loc_FONRMedicalFeeReceivable_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRMedicalFeeReceivable_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RevenuePercentage" xlink:label="loc_FONRRevenuePercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRRevenuePercentage_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementFeeReceivableForUnrelatedParties" xlink:label="loc_FONRManagementFeeReceivableForUnrelatedParties_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementFeeReceivableForUnrelatedParties_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementFeeReceivableForRelatedParties" xlink:label="loc_FONRManagementFeeReceivableForRelatedParties_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementFeeReceivableForRelatedParties_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsReceivableServiceContractsNet" xlink:label="loc_FONRAccountsReceivableServiceContractsNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRAccountsReceivableServiceContractsNet_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_150" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_Penalties" xlink:label="loc_FONRPenalties_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRPenalties_150" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_150" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash_150" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_150" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_150" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="999046 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" xlink:title="999047 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions_210" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="999048 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="999049 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="999050 - Disclosure - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="999051 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDevelopmentAndDemonstrationEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDevelopmentAndDemonstrationEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_150" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999052 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherDepreciationAndAmortization_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="999053 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability_30" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" xlink:title="999054 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" xlink:title="999055 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3" xlink:title="999056 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative" xlink:title="999057 - Disclosure - OPERATING AND FINANCE LEASES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:title="999058 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicenseMember" xlink:label="loc_FONRSoftwareLicenseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRSoftwareLicenseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostomerRelationshipsMember" xlink:label="loc_FONRCostomerRelationshipsMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRCostomerRelationshipsMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_210" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" xlink:title="999059 - Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicenseMember" xlink:label="loc_FONRSoftwareLicenseMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRSoftwareLicenseMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_50" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2" xlink:title="999060 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="999061 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicensesMember" xlink:label="loc_FONRSoftwareLicensesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRSoftwareLicensesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_80" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="999062 - Disclosure - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_140" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_140" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CancellationOfTreasuryShares" xlink:label="loc_FONRCancellationOfTreasuryShares_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryShares_140" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CancellationOfTreasuryStock" xlink:label="loc_FONRCancellationOfTreasuryStock_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStock_140" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="999063 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_us-gaapMinorityInterestTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="loc_FONRBuyoutOfNoncontrollingInterests_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterests_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="loc_FONRBuyoutOfNoncontrollingInterestsValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterestsValue_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="999064 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRClassAControllingInterestsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="loc_FONRClassBControllingInterestsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBControllingInterestsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassAControllingInterestsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EquityMethodInvestmentOwnershipPercentages" xlink:label="loc_FONREquityMethodInvestmentOwnershipPercentages_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentOwnershipPercentages_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProceedsFromContributionsFromCompany" xlink:label="loc_FONRProceedsFromContributionsFromCompany_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRProceedsFromContributionsFromCompany_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:label="loc_FONREquityMethodInvestmentsOwnershipPercentage_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentsOwnershipPercentage_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests_110" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="999065 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="999066 - Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" xlink:title="999067 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="999068 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="999069 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999070 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="999071 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999072 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MagneticResonanceManagementMember" xlink:label="loc_FONRMagneticResonanceManagementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_FONRMagneticResonanceManagementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RadianHealthcareManagementLLCMember" xlink:label="loc_FONRRadianHealthcareManagementLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRRadianHealthcareManagementLLCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="loc_us-gaapDerivativeFixedInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDerivativeFixedInterestRate_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredGainOnSaleOfProperty" xlink:label="loc_us-gaapDeferredGainOnSaleOfProperty_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredGainOnSaleOfProperty_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PrincipalAmount" xlink:label="loc_FONRPrincipalAmount_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONRPrincipalAmount_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:title="999073 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManufacturingandServicingofMedicalEquipmentMember" xlink:label="loc_FONRManufacturingandServicingofMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FONRManufacturingandServicingofMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementofDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementofDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FONRManagementofDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalMember" xlink:label="loc_FONRTotalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FONRTotalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapRevenues_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToEmployees" xlink:label="loc_us-gaapPaymentsToEmployees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapPaymentsToEmployees_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RentExpenses" xlink:label="loc_FONRRentExpenses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRRentExpenses_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherCostOfSalesExpenses" xlink:label="loc_FONROtherCostOfSalesExpenses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONROtherCostOfSalesExpenses_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostOfSales" xlink:label="loc_FONRCostOfSales_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRCostOfSales_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapSalariesAndWages_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SalariesAndWage" xlink:label="loc_FONRSalariesAndWage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRSalariesAndWage_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RentsExpense" xlink:label="loc_FONRRentsExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRRentsExpense_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherSellingGeneralAndAdministrativeExpenses" xlink:label="loc_FONROtherSellingGeneralAndAdministrativeExpenses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONROtherSellingGeneralAndAdministrativeExpenses_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BenefitsLossesAndExpenses" xlink:label="loc_us-gaapBenefitsLossesAndExpenses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapBenefitsLossesAndExpenses_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalCostsAndExpenses" xlink:label="loc_FONRTotalCostsAndExpenses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRTotalCostsAndExpenses_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapImpairmentOfInvestments_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapOtherIncome_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalIdentifiableAssets" xlink:label="loc_FONRTotalIdentifiableAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRTotalIdentifiableAssets_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CapitalExpenditures" xlink:label="loc_FONRCapitalExpenditures_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRCapitalExpenditures_70" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="999074 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="loc_countryCA_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TwoMember" xlink:label="loc_FONRTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_FONRTwoMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="999075 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_PR" xlink:label="loc_countryPR_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH" xlink:label="loc_countryCH_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_DE" xlink:label="loc_countryDE_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="loc_countryGB_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AE" xlink:label="loc_countryAE_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_DO" xlink:label="loc_countryDO_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="loc_countryCA_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GR" xlink:label="loc_countryGR_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU" xlink:label="loc_countryAU_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees_210" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="999076 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>fonr-20250630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CommonStockholdersMember" xlink:label="FONR_CommonStockholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommonStockholdersMember" xlink:to="FONR_CommonStockholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommonStockholdersMember_lbl" xml:lang="en-US">Common Stockholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="FONR_ClassANonVotingPreferredStockholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockholdersMember" xlink:to="FONR_ClassANonVotingPreferredStockholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockholdersMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stockholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAPreferredStockMember" xlink:label="FONR_ClassAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassAPreferredStockMember" xlink:to="FONR_ClassAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassAPreferredStockMember_lbl" xml:lang="en-US">Class A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassCCommonStockMember" xlink:label="FONR_ClassCCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassCCommonStockMember" xlink:to="FONR_ClassCCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassCCommonStockMember_lbl" xml:lang="en-US">Class C Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherInvesteesMember" xlink:label="us-gaap_OtherInvesteesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvesteesMember" xlink:to="us-gaap_OtherInvesteesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvesteesMember_lbl" xml:lang="en-US">Nonconsolidated Investees, Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntellectualPropertyMember" xlink:label="us-gaap_IntellectualPropertyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntellectualPropertyMember" xlink:to="us-gaap_IntellectualPropertyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xml:lang="en-US">Intellectual Property [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="FONR_DiagnosticImagingFacilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticImagingFacilityMember" xlink:to="FONR_DiagnosticImagingFacilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticImagingFacilityMember_lbl" xml:lang="en-US">Diagnostic Imaging Facility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RelatedPartiesMember" xlink:label="FONR_RelatedPartiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartiesMember" xlink:to="FONR_RelatedPartiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartiesMember_lbl" xml:lang="en-US">Related Parties [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RelatedPartiesMedicalPracticesMember" xlink:label="FONR_RelatedPartiesMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartiesMedicalPracticesMember" xlink:to="FONR_RelatedPartiesMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartiesMedicalPracticesMember_lbl" xml:lang="en-US">Related Parties Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TwoVendorsMember" xlink:label="FONR_TwoVendorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TwoVendorsMember" xlink:to="FONR_TwoVendorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TwoVendorsMember_lbl" xml:lang="en-US">Two Vendors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="FONR_DiagnosticEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipmentMember" xlink:to="FONR_DiagnosticEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticEquipmentMember_lbl" xml:lang="en-US">Diagnostic Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ResearchDeveopmentAndDemonstrationEquipmentMember_lbl" xml:lang="en-US">Research Deveopment And Demonstration Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember" xlink:label="srt_WeightedAverageMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US">Weighted Average [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance/ Managed Care [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare/Medicaid [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers? Compensation/Personal Injury [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="FONR_ManagementAndOtherFeesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableMember" xlink:to="FONR_ManagementAndOtherFeesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableMember_lbl" xml:lang="en-US">Management And Other Fees Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:to="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_lbl" xml:lang="en-US">Management And Other Fees Receivable Related Medical Practices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesReceivableMember" xlink:label="us-gaap_NotesReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableMember" xlink:to="us-gaap_NotesReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableMember_lbl" xml:lang="en-US">Notes Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" xlink:label="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" xlink:to="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ResearchDevelopmentAndDemonstrationEquipmentMember_lbl" xml:lang="en-US">Research, development and demonstration equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="FONR_OperatingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingLeasePaymentsMember" xlink:to="FONR_OperatingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingLeasePaymentsMember_lbl" xml:lang="en-US">Operating Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="FONR_FinancingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingLeasePaymentsMember" xlink:to="FONR_FinancingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingLeasePaymentsMember_lbl" xml:lang="en-US">Financing Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicenseMember" xlink:label="FONR_SoftwareLicenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareLicenseMember" xlink:to="FONR_SoftwareLicenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SoftwareLicenseMember_lbl" xml:lang="en-US">Software License [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="FONR_PatentsAndCopyrightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatentsAndCopyrightsMember_lbl" xml:lang="en-US">Patents and copyrights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostomerRelationshipsMember" xlink:label="FONR_CostomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostomerRelationshipsMember" xlink:to="FONR_CostomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostomerRelationshipsMember_lbl" xml:lang="en-US">Costomer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicensesMember" xlink:label="FONR_SoftwareLicensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareLicensesMember" xlink:to="FONR_SoftwareLicensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SoftwareLicensesMember_lbl" xml:lang="en-US">Software Licenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="FONR_N2010StockBonusPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_N2010StockBonusPlanMember" xlink:to="FONR_N2010StockBonusPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_N2010StockBonusPlanMember_lbl" xml:lang="en-US">N 2010 Stock Bonus Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="srt_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Combination [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_HDMMember" xlink:label="FONR_HDMMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMMember" xlink:to="FONR_HDMMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMMember_lbl" xml:lang="en-US">HDM [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="FONR_ClassAControllingInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassAControllingInterestsMember" xlink:to="FONR_ClassAControllingInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassAControllingInterestsMember_lbl" xml:lang="en-US">Class A Controlling Interests [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsByNameAxis" xlink:to="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOwnershipInterestsByNameAxis_lbl" xml:lang="en-US">Other Ownership Interests Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="FONR_ClassBControllingInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassBControllingInterestsMember" xlink:to="FONR_ClassBControllingInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassBControllingInterestsMember_lbl" xml:lang="en-US">Class B Controlling Interests [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_HDMEquityMember" xlink:label="FONR_HDMEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HDMEquityMember" xlink:to="FONR_HDMEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HDMEquityMember_lbl" xml:lang="en-US">HDM Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MagneticResonanceManagementMember" xlink:label="FONR_MagneticResonanceManagementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MagneticResonanceManagementMember" xlink:to="FONR_MagneticResonanceManagementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MagneticResonanceManagementMember_lbl" xml:lang="en-US">Magnetic Resonance Management [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BensonhurstMRILimitedPartnershipMember" xlink:to="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BensonhurstMRILimitedPartnershipMember_lbl" xml:lang="en-US">Bensonhurst MRI Limited Partnership [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RadianHealthcareManagementLLCMember" xlink:label="FONR_RadianHealthcareManagementLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RadianHealthcareManagementLLCMember" xlink:to="FONR_RadianHealthcareManagementLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RadianHealthcareManagementLLCMember_lbl" xml:lang="en-US">Radian Healthcare Management LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManufacturingandServicingofMedicalEquipmentMember" xlink:label="FONR_ManufacturingandServicingofMedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManufacturingandServicingofMedicalEquipmentMember" xlink:to="FONR_ManufacturingandServicingofMedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManufacturingandServicingofMedicalEquipmentMember_lbl" xml:lang="en-US">Manufacturingand Servicingof Medical Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementofDiagnosticImagingCentersMember" xlink:label="FONR_ManagementofDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementofDiagnosticImagingCentersMember" xlink:to="FONR_ManagementofDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementofDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Managementof Diagnostic Imaging Centers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalMember" xlink:label="FONR_TotalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalMember" xlink:to="FONR_TotalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalMember_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="country_CA" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl" xml:lang="en-US">CANADA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TwoMember" xlink:label="FONR_TwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TwoMember" xlink:to="FONR_TwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TwoMember_lbl" xml:lang="en-US">Puerto Rico</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_PR" xlink:label="country_PR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_PR" xlink:to="country_PR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_PR_lbl" xml:lang="en-US">PUERTO RICO</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH" xlink:label="country_CH" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CH" xlink:to="country_CH_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CH_lbl" xml:lang="en-US">SWITZERLAND</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_DE" xlink:label="country_DE" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DE" xlink:to="country_DE_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DE_lbl" xml:lang="en-US">GERMANY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="country_GB" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GB_lbl" xml:lang="en-US">UNITED KINGDOM</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AE" xlink:label="country_AE" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AE" xlink:to="country_AE_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AE_lbl" xml:lang="en-US">UNITED ARAB EMIRATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_DO" xlink:label="country_DO" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_DO" xlink:to="country_DO_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_DO_lbl" xml:lang="en-US">DOMINICAN REPUBLIC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GR" xlink:label="country_GR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GR" xlink:to="country_GR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GR_lbl" xml:lang="en-US">GREECE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU" xlink:label="country_AU" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AU" xlink:to="country_AU_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AU_lbl" xml:lang="en-US">AUSTRALIA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable &#8211; net of allowances for credit losses of $264,212 and $166,049 at June 30, 2025 and 2024, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">Medical receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="us-gaap_AccruedFeesAndOtherRevenueReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:to="us-gaap_AccruedFeesAndOtherRevenueReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedFeesAndOtherRevenueReceivable_lbl" xml:lang="en-US">Management and other fees receivable &#8211; net of allowances for credit losses of $14,295,988 and $12,369,921 at June 30, 2025 and 2024, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for credit losses of $7,136,836 and $6,110,399 at June 30, 2025 and 2024, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty" xlink:label="FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty" xlink:to="FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty_lbl" xml:lang="en-US">Prepaid expenses and other current assets &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">Accounts receivable &#8211; long term</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NoteReceivableRelatedParty" xlink:label="FONR_NoteReceivableRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NoteReceivableRelatedParty" xlink:to="FONR_NoteReceivableRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NoteReceivableRelatedParty_lbl" xml:lang="en-US">Note receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use-asset &#8211; finance lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Other intangible assets &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">Finance lease liability &#8211; current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsPayableRelatedPartyNoncurrent" xlink:to="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xml:lang="en-US">Due to related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Finance lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long-term debt, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost &#8211; 34,840 and 45,081 shares of common stock at June 30, 2025 and 2024, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:to="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_lbl" xml:lang="en-US">Accounts receivable - net of allowances for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">Management and other fees receivable - net of allowances for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:to="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts_lbl" xml:lang="en-US">Management and other fees receivable - related party medical practices - net of allowances for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue &#8211; net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees &#8211; related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees &#8211; related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income from Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Income and (Expenses):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="FONR_InvestmentIncomeRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestmentIncomeRelatedParty" xlink:to="FONR_InvestmentIncomeRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InvestmentIncomeRelatedParty_lbl" xml:lang="en-US">Interest income &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherIncomeRelatedParty" xlink:label="FONR_OtherIncomeRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherIncomeRelatedParty" xlink:to="FONR_OtherIncomeRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherIncomeRelatedParty_lbl" xml:lang="en-US">Other income &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income before Provision for Income Taxes and Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsolidatedNetIncome" xlink:label="FONR_ConsolidatedNetIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsolidatedNetIncome" xlink:to="FONR_ConsolidatedNetIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_ConsolidatedNetIncome_lbl" xml:lang="en-US">Consolidated Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income &#8211; Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income &#8211; Attributable to FONAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Income Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Basic Shares Outstanding - Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Diluted Shares Outstanding - Common Stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Balance &#8211; June 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Purchase of Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Purchase of Treasury Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xml:lang="en-US">Cancellation of Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xml:lang="en-US">Cancellation of Treasury Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions &#8211; Non controlling interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income &#8211; Non controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SaleNonControllingInterest" xlink:label="FONR_SaleNonControllingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SaleNonControllingInterest" xlink:to="FONR_SaleNonControllingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SaleNonControllingInterest_lbl" xml:lang="en-US">Sale &#8211; Non controlling interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Balance &#8211; June 30, 2025</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsolidatedNetIncomeLoss" xlink:label="FONR_ConsolidatedNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsolidatedNetIncomeLoss" xlink:to="FONR_ConsolidatedNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsolidatedNetIncomeLoss_lbl" xml:lang="en-US">Consolidated Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile consolidated net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" xlink:label="FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" xlink:to="FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities_lbl" xml:lang="en-US">Net change in operating right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_GainOnSaleOfEquipmentRelatedParty" xlink:label="FONR_GainOnSaleOfEquipmentRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnSaleOfEquipmentRelatedParty" xlink:to="FONR_GainOnSaleOfEquipmentRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainOnSaleOfEquipmentRelatedParty_lbl" xml:lang="en-US">Gain on sale of equipment &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_GainlossOnDispositionOfFixedAssets" xlink:label="FONR_GainlossOnDispositionOfFixedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainlossOnDispositionOfFixedAssets" xlink:to="FONR_GainlossOnDispositionOfFixedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainlossOnDispositionOfFixedAssets_lbl" xml:lang="en-US">Gain on disposition of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AbandonedPatents" xlink:label="FONR_AbandonedPatents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AbandonedPatents" xlink:to="FONR_AbandonedPatents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AbandonedPatents_lbl" xml:lang="en-US">Abandoned patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">&#160;Changes in operating assets and liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivable(s)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="FONR_IncreaseDecreaseInNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInNotesReceivable" xlink:to="FONR_IncreaseDecreaseInNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInNotesReceivable_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties_lbl" xml:lang="en-US">Notes receivable &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInTradingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInTradingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInTradingLiabilities_lbl" xml:lang="en-US">Finance lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_lbl" xml:lang="en-US">Proceeds (Purchase) from short-term investment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US">Proceeds from sale of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">&#160;&#160;CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and finance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SaleOfNoncontrollingInterest" xlink:label="FONR_SaleOfNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SaleOfNoncontrollingInterest" xlink:to="FONR_SaleOfNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SaleOfNoncontrollingInterest_lbl" xml:lang="en-US">Sale of noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xml:lang="en-US">Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH USED IN FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">&#160;&#160;NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS - END OF YEAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xml:lang="en-US">Aggregate Available</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="cyd_MaterialCybersecurityIncidentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentAbstract" xlink:to="cyd_MaterialCybersecurityIncidentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentAbstract_lbl" xml:lang="en-US">Material Cybersecurity Incident [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Nature [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Scope [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Timing [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:label="FONR_DisclosureOperatingAndFinanceLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:to="FONR_DisclosureOperatingAndFinanceLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureOperatingAndFinanceLeasesAbstract_lbl" xml:lang="en-US">Operating And Finance Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">OPERATING AND FINANCE LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="FONR_DisclosureCapitalStockAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureCapitalStockAbstract" xlink:to="FONR_DisclosureCapitalStockAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureCapitalStockAbstract_lbl" xml:lang="en-US">Capital Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CapitalStockDisclosureTextblock" xlink:label="FONR_CapitalStockDisclosureTextblock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CapitalStockDisclosureTextblock" xlink:to="FONR_CapitalStockDisclosureTextblock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CapitalStockDisclosureTextblock_lbl" xml:lang="en-US">CAPITAL STOCK</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xml:lang="en-US">CONTROLLING AND NONCONTROLLING INTERESTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="us-gaap_InventoryWorkInProcessPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessPolicy" xlink:to="us-gaap_InventoryWorkInProcessPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcessPolicy_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicalReceivablePolicyTextBlock" xlink:label="FONR_MedicalReceivablePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivablePolicyTextBlock" xlink:to="FONR_MedicalReceivablePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivablePolicyTextBlock_lbl" xml:lang="en-US">Medical Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="FONR_CustomerAdvancesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesPolicyTextBlock" xlink:to="FONR_CustomerAdvancesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerAdvancesPolicyTextBlock_lbl" xml:lang="en-US">Customer Advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Short-Term Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Adopted Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:to="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Useful Life in Years for Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of patient fee revenue - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Long Term Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_lbl" xml:lang="en-US">Schedule of Summary of Allowance For Credit Losses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xml:lang="en-US">Schedule of facilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Operating Lease and Finance Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:to="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of supplemental cash flow information related to leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of supplemental cash flow information related to leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets, net of accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated amortization of other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestTableTextBlock_lbl" xml:lang="en-US">Schedule of HDM members equity</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock" xlink:label="FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock" xlink:to="FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of the provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred tax assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of Segment Financial Information</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScheduleOfExportProductSalesTableTextBlock" xlink:label="FONR_ScheduleOfExportProductSalesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfExportProductSalesTableTextBlock" xlink:to="FONR_ScheduleOfExportProductSalesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfExportProductSalesTableTextBlock_lbl" xml:lang="en-US">Schedule of export product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScheduleOfExportServiceRevenuesTableTextBlock" xlink:label="FONR_ScheduleOfExportServiceRevenuesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfExportServiceRevenuesTableTextBlock" xlink:to="FONR_ScheduleOfExportServiceRevenuesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfExportServiceRevenuesTableTextBlock_lbl" xml:lang="en-US">Schedule of Foreign Service and Repair Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="us-gaap_InvestmentOwnedPercentOfNetAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:to="us-gaap_InvestmentOwnedPercentOfNetAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedPercentOfNetAssets_lbl" xml:lang="en-US">Investment Owned, Net Assets, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:to="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xml:lang="en-US">Proceeds from (Payments to) Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NetPatientFeeRevenue" xlink:label="FONR_NetPatientFeeRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetPatientFeeRevenue" xlink:to="FONR_NetPatientFeeRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetPatientFeeRevenue_lbl" xml:lang="en-US">Net Patient Fee Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:to="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xml:lang="en-US">Net income available to common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="FONR_WeightedAverageSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageSharesOutstandingBasic" xlink:to="FONR_WeightedAverageSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average shares outstanding basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Basic income per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xml:lang="en-US">Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:to="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock_lbl" xml:lang="en-US">Class C Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Class C Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:to="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xml:lang="en-US">Total Denominator for diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted income per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:to="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfPropertyRepairsAndMaintenance_lbl" xml:lang="en-US">Maintenance and repair expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:to="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAgreementsWithCompanyTotalMedicalPractices_lbl" xml:lang="en-US">Management agreements with company total medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:to="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_lbl" xml:lang="en-US">Scanners with management agreements with company owned by related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:to="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState_lbl" xml:lang="en-US">Scanners with management with company located in new york state</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMinimum" xlink:to="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMinimum_lbl" xml:lang="en-US">Contractual fees for services rendered minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ContractualFeesForServicesRenderedMaximum" xlink:to="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ContractualFeesForServicesRenderedMaximum_lbl" xml:lang="en-US">Contractual fees for services rendered Maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicalFeeReceivable" xlink:label="FONR_MedicalFeeReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalFeeReceivable" xlink:to="FONR_MedicalFeeReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalFeeReceivable_lbl" xml:lang="en-US">Medical fee receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RevenuePercentage" xlink:label="FONR_RevenuePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RevenuePercentage" xlink:to="FONR_RevenuePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RevenuePercentage_lbl" xml:lang="en-US">revenue percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementFeeReceivableForUnrelatedParties" xlink:label="FONR_ManagementFeeReceivableForUnrelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementFeeReceivableForUnrelatedParties" xlink:to="FONR_ManagementFeeReceivableForUnrelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementFeeReceivableForUnrelatedParties_lbl" xml:lang="en-US">Management fee receivable for unrelated parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementFeeReceivableForRelatedParties" xlink:label="FONR_ManagementFeeReceivableForRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementFeeReceivableForRelatedParties" xlink:to="FONR_ManagementFeeReceivableForRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementFeeReceivableForRelatedParties_lbl" xml:lang="en-US">Management Fee Receivable For Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsReceivableServiceContractsNet" xlink:label="FONR_AccountsReceivableServiceContractsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceContractsNet" xlink:to="FONR_AccountsReceivableServiceContractsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceContractsNet_lbl" xml:lang="en-US">Account receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_Penalties" xlink:label="FONR_Penalties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Penalties" xlink:to="FONR_Penalties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Penalties_lbl" xml:lang="en-US">Penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:to="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_lbl" xml:lang="en-US">Conversion of Class C Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Federally insured limits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueThreeToFourYears" xlink:to="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueFourToFiveYears" xlink:to="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueFourToFiveYears_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractReceivableDueFiveYearsOrMore" xlink:label="us-gaap_ContractReceivableDueFiveYearsOrMore" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueFiveYearsOrMore" xlink:to="us-gaap_ContractReceivableDueFiveYearsOrMore_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueFiveYearsOrMore_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsAdditions" xlink:to="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsAdditions_lbl" xml:lang="en-US">Additions (Included in provision for bad debts)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AllowanceForDoubtfulAccountsDeductions" xlink:to="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AllowanceForDoubtfulAccountsDeductions_lbl" xml:lang="en-US">Deductions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xml:lang="en-US">Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at Beginning of Year)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:to="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesAddedByInternalDevelopment_lbl" xml:lang="en-US">Internal development</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="FONR_ManagedFacilitiesClosedDuringYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagedFacilitiesClosedDuringYear" xlink:to="FONR_ManagedFacilitiesClosedDuringYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagedFacilitiesClosedDuringYear_lbl" xml:lang="en-US">Managed Facilities Closed</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:to="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear_lbl" xml:lang="en-US">Total Facilities Owned or Managed (at End of Year)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_AccountsReceivableNetLongTerm_2_lbl" xml:lang="en-US">Long term accounts receivable balances</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">Percentage of consolidated net revenue from management fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts and components</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property plant and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property plant and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:to="FONR_DisclosureOperatingAndFinanceLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_DisclosureOperatingAndFinanceLeasesAbstract_2_lbl" xml:lang="en-US">Operating Financing Leases - Weighted Average Remaining Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Operating leases - years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Finance lease - years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate, operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate, finance leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:to="FONR_DisclosureOperatingAndFinanceLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="FONR_DisclosureOperatingAndFinanceLeasesAbstract_3_lbl" xml:lang="en-US">Operating Financing Leases - Components Of Lease Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="FONR_FinanceLeaseCostsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCostsAbstract" xlink:to="FONR_FinanceLeaseCostsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCostsAbstract_lbl" xml:lang="en-US">Finance lease cost:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="FONR_DepreciationOfLeasedEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DepreciationOfLeasedEquipment" xlink:to="FONR_DepreciationOfLeasedEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DepreciationOfLeasedEquipment_lbl" xml:lang="en-US">Depreciation of leased equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xml:lang="en-US">Interest on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_FinanceLeaseCost" xlink:label="FONR_FinanceLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinanceLeaseCost" xlink:to="FONR_FinanceLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinanceLeaseCost_lbl" xml:lang="en-US">Total finance lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingCashFlowsFromOperatingLeases" xlink:to="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingCashFlowsFromOperatingLeases_lbl" xml:lang="en-US">Operating cash flows from operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingCashFlowsFromFinancingLeases" xlink:to="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingCashFlowsFromFinancingLeases_lbl" xml:lang="en-US">Financing cash flows from finance leases</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_lbl" xml:lang="en-US">Right-of-use and equipment assets obtained in exchange for lease obligations:</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:to="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_lbl" xml:lang="en-US">Operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseIncome" xlink:label="us-gaap_LeaseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseIncome" xlink:to="us-gaap_LeaseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseIncome_lbl" xml:lang="en-US">financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">Weighted average useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Other intangible assets gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">intangible assets net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2029</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Balance - Beginning of Year</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AmountsCapitalized" xlink:label="FONR_AmountsCapitalized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AmountsCapitalized" xlink:to="FONR_AmountsCapitalized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AmountsCapitalized_lbl" xml:lang="en-US">Amounts capitalized</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="FONR_SoftwareOrPatentsWrittenOff" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareOrPatentsWrittenOff" xlink:to="FONR_SoftwareOrPatentsWrittenOff_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SoftwareOrPatentsWrittenOff_lbl" xml:lang="en-US">Patents written off</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CorrectionOfError" xlink:label="FONR_CorrectionOfError" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CorrectionOfError" xlink:to="FONR_CorrectionOfError_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CorrectionOfError_lbl" xml:lang="en-US">Correction of an error</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OtherIntangibleAssetsNet_2_lbl" xml:lang="en-US">Balance - End of Year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2_lbl" xml:lang="en-US">Weighted average amortization period for other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsPayableNature" xlink:label="us-gaap_DividendsPayableNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableNature" xlink:to="us-gaap_DividendsPayableNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableNature_lbl" xml:lang="en-US">Dividends payable, nature</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:to="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_lbl" xml:lang="en-US">Conversuion of shares into one-for-one basis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockVotingRights_lbl" xml:lang="en-US">Common stock, voting rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock, capital shares reserved for future issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SharesRegistered" xlink:label="FONR_SharesRegistered" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesRegistered" xlink:to="FONR_SharesRegistered_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SharesRegistered_lbl" xml:lang="en-US">Shares registered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of shares available for future grant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Number of shares were issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity_2_lbl" xml:lang="en-US">Payments for repurchase of equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xml:lang="en-US">Purchase of treasury shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CancellationOfTreasuryShares" xlink:label="FONR_CancellationOfTreasuryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryShares" xlink:to="FONR_CancellationOfTreasuryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfTreasuryShares_lbl" xml:lang="en-US">Cancellation of treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CancellationOfTreasuryStock" xlink:label="FONR_CancellationOfTreasuryStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfTreasuryStock" xlink:to="FONR_CancellationOfTreasuryStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfTreasuryStock_lbl" xml:lang="en-US">Cancellation of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestTable" xlink:label="us-gaap_MinorityInterestTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestTable" xlink:to="us-gaap_MinorityInterestTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestTable_lbl" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestLineItems" xlink:label="us-gaap_MinorityInterestLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestLineItems" xlink:to="us-gaap_MinorityInterestLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestLineItems_lbl" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OpeningMembersEquity" xlink:label="FONR_OpeningMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OpeningMembersEquity" xlink:to="FONR_OpeningMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OpeningMembersEquity_lbl" xml:lang="en-US">Opening Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ShareOfNetIncome" xlink:label="FONR_ShareOfNetIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ShareOfNetIncome" xlink:to="FONR_ShareOfNetIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ShareOfNetIncome_lbl" xml:lang="en-US">Share of Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="FONR_BuyoutOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterests" xlink:to="FONR_BuyoutOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BuyoutOfNoncontrollingInterests_lbl" xml:lang="en-US">Buyout of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterestsValue" xlink:to="FONR_BuyoutOfNoncontrollingInterestsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue_lbl" xml:lang="en-US">Buyout of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_Distributions" xlink:label="FONR_Distributions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Distributions" xlink:to="FONR_Distributions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Distributions_lbl" xml:lang="en-US">Distributions</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EndingMembersEquity" xlink:label="FONR_EndingMembersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EndingMembersEquity" xlink:to="FONR_EndingMembersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EndingMembersEquity_lbl" xml:lang="en-US">Ending Members Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xml:lang="en-US">Ownership interest of investors</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EquityMethodInvestmentOwnershipPercentages" xlink:label="FONR_EquityMethodInvestmentOwnershipPercentages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EquityMethodInvestmentOwnershipPercentages" xlink:to="FONR_EquityMethodInvestmentOwnershipPercentages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EquityMethodInvestmentOwnershipPercentages_lbl" xml:lang="en-US">Ownership interest of company</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProceedsFromContributionsFromCompany" xlink:label="FONR_ProceedsFromContributionsFromCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProceedsFromContributionsFromCompany" xlink:to="FONR_ProceedsFromContributionsFromCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProceedsFromContributionsFromCompany_lbl" xml:lang="en-US">Company contribution</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromContributionsFromAffiliates_lbl" xml:lang="en-US">Investors contribution</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="FONR_PurchaseOfStandupMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfStandupMriCenters" xlink:to="FONR_PurchaseOfStandupMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfStandupMriCenters_lbl" xml:lang="en-US">Purchase of stand up MRI centers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="FONR_PurchaseOfOtherMriCenters" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfOtherMriCenters" xlink:to="FONR_PurchaseOfOtherMriCenters_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfOtherMriCenters_lbl" xml:lang="en-US">Purchase of other MRI centers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="FONR_ConsiderationToOutsideInvestors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationToOutsideInvestors" xlink:to="FONR_ConsiderationToOutsideInvestors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationToOutsideInvestors_lbl" xml:lang="en-US">HDM purchase price includes consideration to outside investors</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalPurchasePrice" xlink:label="FONR_TotalPurchasePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalPurchasePrice" xlink:to="FONR_TotalPurchasePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalPurchasePrice_lbl" xml:lang="en-US">HDM purchase from Health Diagnostics (HD) ($)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:to="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsiderationForNoncompetitionAndConsultingAgreements_lbl" xml:lang="en-US">HDM entered agreement for consulting and non-competition agreement ($)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:label="FONR_EquityMethodInvestmentsOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:to="FONR_EquityMethodInvestmentsOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EquityMethodInvestmentsOwnershipPercentage_lbl" xml:lang="en-US">Purchase of interests from Class A, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DirectPurchaseOfNoncontrollingInterests" xlink:to="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">Purchase of interests from Class A</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Current:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Deferred:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DeferredIncomeTaxExpensesBenefit" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredIncomeTaxExpensesBenefit" xlink:to="FONR_DeferredIncomeTaxExpensesBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Provision (Benefit) for Income Taxes - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Taxes at federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" xlink:to="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_lbl" xml:lang="en-US">Taxes at federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and local income taxes (benefit), net of federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_lbl" xml:lang="en-US">Noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation Allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in the valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PermanentItemsMealsEntertainment" xlink:label="FONR_PermanentItemsMealsEntertainment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PermanentItemsMealsEntertainment" xlink:to="FONR_PermanentItemsMealsEntertainment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PermanentItemsMealsEntertainment_lbl" xml:lang="en-US">Permanent items Meals and Entertainment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" xlink:to="FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_lbl" xml:lang="en-US">Permanent items Meals and Entertainment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit" xlink:label="FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit" xlink:to="FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Ending Members' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for credit losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Non-deductible accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xml:lang="en-US">Tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Capitalized research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:label="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:to="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities_lbl" xml:lang="en-US">Right of use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="us-gaap_DeferredTaxAssetsInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsInventory_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred Tax Assets - gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PropertyAndEquipmentAndDepreciation" xlink:label="FONR_PropertyAndEquipmentAndDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PropertyAndEquipmentAndDepreciation" xlink:to="FONR_PropertyAndEquipmentAndDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PropertyAndEquipmentAndDepreciation_lbl" xml:lang="en-US">Property and equipment and depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Allowance for doubtful accounts and tax credits</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CapitalizedResearchAndDevelopmentCosts" xlink:label="FONR_CapitalizedResearchAndDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CapitalizedResearchAndDevelopmentCosts" xlink:to="FONR_CapitalizedResearchAndDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CapitalizedResearchAndDevelopmentCosts_lbl" xml:lang="en-US">Capitalized Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOperatingIncome" xlink:label="us-gaap_OtherOperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncome" xlink:to="us-gaap_OtherOperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncome_lbl" xml:lang="en-US">City operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="us-gaap_DeferredTaxAssetInterestCarryforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetInterestCarryforward_lbl" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xml:lang="en-US">Tax credits carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance" xlink:label="us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance" xlink:to="us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance_lbl" xml:lang="en-US">Property taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedUtilitiesCurrent" xlink:label="us-gaap_AccruedUtilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedUtilitiesCurrent" xlink:to="us-gaap_AccruedUtilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedUtilitiesCurrent_lbl" xml:lang="en-US">Utilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicenses" xlink:label="FONR_SoftwareLicenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SoftwareLicenses" xlink:to="FONR_SoftwareLicenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SoftwareLicenses_lbl" xml:lang="en-US">Software Licenses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RecruitingFees" xlink:label="FONR_RecruitingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RecruitingFees" xlink:to="FONR_RecruitingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RecruitingFees_lbl" xml:lang="en-US">Recruiting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Accrued interest and penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other general and administrative expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_lbl" xml:lang="en-US">Employer contributions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReinsurancePayable" xlink:label="us-gaap_ReinsurancePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReinsurancePayable" xlink:to="us-gaap_ReinsurancePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReinsurancePayable_lbl" xml:lang="en-US">Liability for individual claims</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xml:lang="en-US">Reserve for self-funded</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentOwnedNet" xlink:label="us-gaap_PropertyPlantAndEquipmentOwnedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOwnedNet" xlink:to="us-gaap_PropertyPlantAndEquipmentOwnedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentOwnedNet_lbl" xml:lang="en-US">Right-of-use and equipment assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate" xlink:label="us-gaap_InvestmentInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Noncash transaction amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Sale of price of the equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="us-gaap_DerivativeFixedInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFixedInterestRate" xlink:to="us-gaap_DerivativeFixedInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFixedInterestRate_lbl" xml:lang="en-US">Bears interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredGainOnSaleOfProperty" xlink:label="us-gaap_DeferredGainOnSaleOfProperty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredGainOnSaleOfProperty" xlink:to="us-gaap_DeferredGainOnSaleOfProperty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredGainOnSaleOfProperty_lbl" xml:lang="en-US">Gain on sale of equipments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PrincipalAmount" xlink:label="FONR_PrincipalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PrincipalAmount" xlink:to="FONR_PrincipalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PrincipalAmount_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDescriptionOfTransaction_lbl" xml:lang="en-US">Related party transaction, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_lbl" xml:lang="en-US">Segment Reporting, Revenue from External Customer, Product and Service [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Net revenues from external customers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToEmployees" xlink:label="us-gaap_PaymentsToEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToEmployees" xlink:to="us-gaap_PaymentsToEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToEmployees_lbl" xml:lang="en-US">&#160;Salaries and wages</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RentExpenses" xlink:label="FONR_RentExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RentExpenses" xlink:to="FONR_RentExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RentExpenses_lbl" xml:lang="en-US">&#160;Rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherCostOfSalesExpenses" xlink:label="FONR_OtherCostOfSalesExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherCostOfSalesExpenses" xlink:to="FONR_OtherCostOfSalesExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherCostOfSalesExpenses_lbl" xml:lang="en-US">&#160;Other Cost of sales expenses**</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostOfSales" xlink:label="FONR_CostOfSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostOfSales" xlink:to="FONR_CostOfSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostOfSales_lbl" xml:lang="en-US">Total Cost of sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalariesAndWages" xlink:label="us-gaap_SalariesAndWages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesAndWages" xlink:to="us-gaap_SalariesAndWages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SalariesAndWages_lbl" xml:lang="en-US">&#160;Salaries and wages</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xml:lang="en-US">&#160;Other research and development costs**</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Total Research and development costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">&#160;Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SalariesAndWage" xlink:label="FONR_SalariesAndWage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SalariesAndWage" xlink:to="FONR_SalariesAndWage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_SalariesAndWage_lbl" xml:lang="en-US">&#160;Salaries and wages</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RentsExpense" xlink:label="FONR_RentsExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RentsExpense" xlink:to="FONR_RentsExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_RentsExpense_lbl" xml:lang="en-US">&#160;Rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherSellingGeneralAndAdministrativeExpenses" xlink:label="FONR_OtherSellingGeneralAndAdministrativeExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherSellingGeneralAndAdministrativeExpenses" xlink:to="FONR_OtherSellingGeneralAndAdministrativeExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherSellingGeneralAndAdministrativeExpenses_lbl" xml:lang="en-US">&#160;Other selling, general and administrative expenses**</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BenefitsLossesAndExpenses" xlink:label="us-gaap_BenefitsLossesAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BenefitsLossesAndExpenses" xlink:to="us-gaap_BenefitsLossesAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BenefitsLossesAndExpenses_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalCostsAndExpenses" xlink:label="FONR_TotalCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalCostsAndExpenses" xlink:to="FONR_TotalCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalCostsAndExpenses_lbl" xml:lang="en-US">Total costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="us-gaap_ImpairmentOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOfInvestments_lbl" xml:lang="en-US">Investment income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other income (expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xml:lang="en-US">(Loss) Income before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net (Loss) income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Intersegment net revenues *</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalIdentifiableAssets" xlink:label="FONR_TotalIdentifiableAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalIdentifiableAssets" xlink:to="FONR_TotalIdentifiableAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalIdentifiableAssets_lbl" xml:lang="en-US">Total identifiable assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CapitalExpenditures" xlink:label="FONR_CapitalExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CapitalExpenditures" xlink:to="FONR_CapitalExpenditures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CapitalExpenditures_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ForeignProductSales" xlink:label="FONR_ForeignProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignProductSales" xlink:to="FONR_ForeignProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignProductSales_lbl" xml:lang="en-US">Foreign product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="FONR_ForeignServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignServiceAndRepairFees" xlink:to="FONR_ForeignServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignServiceAndRepairFees_lbl" xml:lang="en-US">Foreign service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:to="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExportSalesOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">Export sales of medical equipment percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:to="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_lbl" xml:lang="en-US">Percentage of service and repair of medical equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatentsAndCopyrightsMember_doc" xml:lang="en-US">Patents and copyrights - Member - Custom elements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IntersegmentNetRevenues_doc" xml:lang="en-US">This represents the amount of intersegment net revenues during period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseNonoperating_2_lbl" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConsolidatedNetIncome" xlink:to="FONR_ConsolidatedNetIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConsolidatedNetIncome_2_lbl" xml:lang="en-US">ConsolidatedNetIncome</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_2_lbl" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" xlink:to="FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities_2_lbl" xml:lang="en-US">NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnSaleOfEquipmentRelatedParty" xlink:to="FONR_GainOnSaleOfEquipmentRelatedParty_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainOnSaleOfEquipmentRelatedParty_2_lbl" xml:lang="en-US">GainOnSaleOfEquipmentRelatedParty</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainlossOnDispositionOfFixedAssets" xlink:to="FONR_GainlossOnDispositionOfFixedAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainlossOnDispositionOfFixedAssets_2_lbl" xml:lang="en-US">GainlossOnDispositionOfFixedAssets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties_2_lbl" xml:lang="en-US">Increase (Decrease) in Notes Receivable, Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:to="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromShortTermInvestments_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Short-Term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:to="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_2_lbl" xml:lang="en-US">SupplementalCashFlowInformationRelatedToLeasesTableTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_2_lbl" xml:lang="en-US">Construction Contractor, Receivable, Excluding Contract Retainage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_3_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_2_lbl" xml:lang="en-US">PresentValueDiscountFinancingLease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiability_2_lbl" xml:lang="en-US">Finance Lease, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_2_lbl" xml:lang="en-US">Operating Lease, Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_3_lbl" xml:lang="en-US">Other Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BuyoutOfNoncontrollingInterestsValue" xlink:to="FONR_BuyoutOfNoncontrollingInterestsValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BuyoutOfNoncontrollingInterestsValue_2_lbl" xml:lang="en-US">BuyoutOfNoncontrollingInterestsValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DeferredIncomeTaxExpensesBenefit" xlink:to="FONR_DeferredIncomeTaxExpensesBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DeferredIncomeTaxExpensesBenefit_2_lbl" xml:lang="en-US">DeferredIncomeTaxExpensesBenefit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" xlink:to="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_2_lbl" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:to="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" xlink:to="FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_2_lbl" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInventory" xlink:to="us-gaap_DeferredTaxAssetsInventory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInventory_2_lbl" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesAndWages" xlink:to="us-gaap_SalariesAndWages_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesAndWages_2_lbl" xml:lang="en-US">Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SalariesAndWage" xlink:to="FONR_SalariesAndWage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SalariesAndWage_2_lbl" xml:lang="en-US">SalariesAndWage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_RentsExpense" xlink:to="FONR_RentsExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_RentsExpense_2_lbl" xml:lang="en-US">RentsExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BenefitsLossesAndExpenses" xlink:to="us-gaap_BenefitsLossesAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BenefitsLossesAndExpenses_2_lbl" xml:lang="en-US">Benefits, Losses and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfInvestments_2_lbl" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>fonr-20250630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#Cover" roleURI="http://fonar.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedBalanceSheets" roleURI="http://fonar.com/role/ConsolidatedBalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedBalanceSheetsParenthetical" roleURI="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedStatementsOfOperations" roleURI="http://fonar.com/role/ConsolidatedStatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedStatementsOfChangesInEquity" roleURI="http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResources" roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#Inventories" roleURI="http://fonar.com/role/Inventories" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipment" roleURI="http://fonar.com/role/PropertyAndEquipment" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingAndFinanceLeases" roleURI="http://fonar.com/role/OperatingAndFinanceLeases" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets" roleURI="http://fonar.com/role/OtherIntangibleAssets" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CapitalStock" roleURI="http://fonar.com/role/CapitalStock" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterests" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes" roleURI="http://fonar.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherCurrentLiabilities" roleURI="http://fonar.com/role/OtherCurrentLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CommitmentsAndContingencies" roleURI="http://fonar.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SupplementalCashFlowInformation" roleURI="http://fonar.com/role/SupplementalCashFlowInformation" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#RelatedPartyTransactions" roleURI="http://fonar.com/role/RelatedPartyTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation" roleURI="http://fonar.com/role/SegmentAndRelatedInformation" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SubsequentEvents" roleURI="http://fonar.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#InventoriesTables" roleURI="http://fonar.com/role/InventoriesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipmentTables" roleURI="http://fonar.com/role/PropertyAndEquipmentTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingAndFinanceLeasesTables" roleURI="http://fonar.com/role/OperatingAndFinanceLeasesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssetsTables" roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterestsTables" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxesTables" roleURI="http://fonar.com/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherCurrentLiabilitiesTables" roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformationTables" roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" roleURI="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#Inventories-InventoriesDetails" roleURI="http://fonar.com/role/Inventories-InventoriesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipment-PropertyAndEquipmentDetails" roleURI="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#PropertyAndEquipmentDetailsNarrative" roleURI="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-LeasePaymentsDetails" roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" roleURI="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" roleURI="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingFinancingLeases-RelatedToLeasesDetails3" roleURI="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OperatingAndFinanceLeasesDetailsNarrative" roleURI="http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" roleURI="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssets-IntangleAssets-Details2" roleURI="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherIntangibleAssetsDetailsNarrative" roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CapitalStockDetailsNarrative" roleURI="http://fonar.com/role/CapitalStockDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#ControllingAndNoncontrollingInterestsDetailsNarrative" roleURI="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" roleURI="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" roleURI="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" roleURI="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#IncomeTaxesDetailsNarrative" roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SupplementalCashFlowInformationDetailsNarrative" roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#RelatedPartyTransactionsDetailsNarrative" roleURI="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation-SummarizedSegments-Details" roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation-ForeignProductSales-Details" roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" roleURI="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" />
    <link:roleRef xlink:type="simple" xlink:href="fonr-20250630.xsd#SegmentAndRelatedInformationDetailsNarrative" roleURI="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedFeesAndOtherRevenueReceivable" xlink:label="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccruedFeesAndOtherRevenueReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty" xlink:label="loc_FONRPrepaidExpensesAndOtherCurrentAssetsRelatedParty" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRPrepaidExpensesAndOtherCurrentAssetsRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NoteReceivableRelatedParty" xlink:label="loc_FONRNoteReceivableRelatedParty" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRNoteReceivableRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsPremiumsAndOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:label="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRRelatedPartyReceivableAllowancesForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CommonStockholdersMember" xlink:label="loc_FONRCommonStockholdersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRCommonStockholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassANonVotingPreferredStockholdersMember" xlink:label="loc_FONRClassANonVotingPreferredStockholdersMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_InvestmentIncomeRelatedParty" xlink:label="loc_FONRInvestmentIncomeRelatedParty" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestmentIncomeRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherIncomeRelatedParty" xlink:label="loc_FONROtherIncomeRelatedParty" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROtherIncomeRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsolidatedNetIncome" xlink:label="loc_FONRConsolidatedNetIncome" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConsolidatedNetIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAPreferredStockMember" xlink:label="loc_FONRClassAPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRClassCCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockCommonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SaleNonControllingInterest" xlink:label="loc_FONRSaleNonControllingInterest" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSaleNonControllingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsolidatedNetIncomeLoss" xlink:label="loc_FONRConsolidatedNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_FONRConsolidatedNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" xlink:label="loc_FONRNetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRNetChangeInOperatingRightofuseAssetsAndLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_GainOnSaleOfEquipmentRelatedParty" xlink:label="loc_FONRGainOnSaleOfEquipmentRelatedParty" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRGainOnSaleOfEquipmentRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_GainlossOnDispositionOfFixedAssets" xlink:label="loc_FONRGainlossOnDispositionOfFixedAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_FONRGainlossOnDispositionOfFixedAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AbandonedPatents" xlink:label="loc_FONRAbandonedPatents" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_FONRAbandonedPatents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncreaseDecreaseInNotesReceivable" xlink:label="loc_FONRIncreaseDecreaseInNotesReceivable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInNotesReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInNotesReceivableRelatedParties" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInNotesReceivableRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInTradingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInTradingLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInTradingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SaleOfNoncontrollingInterest" xlink:label="loc_FONRSaleOfNoncontrollingInterest" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_FONRSaleOfNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000012 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="loc_cydCybersecurityRiskRoleOfManagementTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskRoleOfManagementTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000013 - Disclosure - Material Cybersecurity Incident Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="loc_cydMaterialCybersecurityIncidentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentNatureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentNatureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentScopeTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentScopeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentTimingTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentTimingTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources" xlink:title="999014 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="999016 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="999017 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment" xlink:title="999018 - Disclosure - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinanceLeases" xlink:title="999019 - Disclosure - OPERATING AND FINANCE LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="999020 - Disclosure - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStock" xlink:title="999021 - Disclosure - CAPITAL STOCK">
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="loc_FONRDisclosureCapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CapitalStockDisclosureTextblock" xlink:label="loc_FONRCapitalStockDisclosureTextblock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureCapitalStockAbstract" xlink:to="loc_FONRCapitalStockDisclosureTextblock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests" xlink:title="999022 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="loc_us-gaapMinorityInterestDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="999023 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="999024 - Disclosure - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="999025 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="999026 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactions" xlink:title="999027 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="999028 - Disclosure - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="999029 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryWorkInProcessPolicy" xlink:label="loc_us-gaapInventoryWorkInProcessPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryWorkInProcessPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicalReceivablePolicyTextBlock" xlink:label="loc_FONRMedicalReceivablePolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRMedicalReceivablePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReceivablesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CustomerAdvancesPolicyTextBlock" xlink:label="loc_FONRCustomerAdvancesPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONRCustomerAdvancesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:label="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_FONREstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="999032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:label="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="999033 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentTables" xlink:title="999034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinanceLeasesTables" xlink:title="999035 - Disclosure - OPERATING AND FINANCE LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:label="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_FONRScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:label="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_FONRSupplementalCashFlowInformationRelatedToLeasesTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="999036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsTables" xlink:title="999037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesTables" xlink:title="999038 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock" xlink:label="loc_FONRScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="999039 - Disclosure - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="999040 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScheduleOfExportProductSalesTableTextBlock" xlink:label="loc_FONRScheduleOfExportProductSalesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRScheduleOfExportProductSalesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScheduleOfExportServiceRevenuesTableTextBlock" xlink:label="loc_FONRScheduleOfExportServiceRevenuesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRScheduleOfExportServiceRevenuesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative" xlink:title="999041 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherInvesteesMember" xlink:label="loc_us-gaapOtherInvesteesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_us-gaapOtherInvesteesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentOwnedPercentOfNetAssets" xlink:label="loc_us-gaapInvestmentOwnedPercentOfNetAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentOwnedPercentOfNetAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="loc_us-gaapProceedsFromPaymentsToMinorityShareholders" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromPaymentsToMinorityShareholders" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details" xlink:title="999042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember" xlink:label="loc_srtWeightedAverageMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtWeightedAverageMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ResearchDeveopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDeveopmentAndDemonstrationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1" xlink:title="999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NetPatientFeeRevenue" xlink:label="loc_FONRNetPatientFeeRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRNetPatientFeeRevenue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassCCommonStockMember" xlink:label="loc_FONRClassCCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassCCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAPreferredStockMember" xlink:label="loc_FONRClassAPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_WeightedAverageSharesOutstandingBasic" xlink:label="loc_FONRWeightedAverageSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:label="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIncrementalCommonSharesAttributableToConversionOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DiagnosticImagingFacilityMember" xlink:label="loc_FONRDiagnosticImagingFacilityMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_FONRDiagnosticImagingFacilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RelatedPartiesMember" xlink:label="loc_FONRRelatedPartiesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RelatedPartiesMedicalPracticesMember" xlink:label="loc_FONRRelatedPartiesMedicalPracticesMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRRelatedPartiesMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TwoVendorsMember" xlink:label="loc_FONRTwoVendorsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_FONRTwoVendorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfPropertyRepairsAndMaintenance" xlink:label="loc_us-gaapCostOfPropertyRepairsAndMaintenance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCostOfPropertyRepairsAndMaintenance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAgreementsWithCompanyTotalMedicalPractices" xlink:label="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementAgreementsWithCompanyTotalMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:label="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:label="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRScannersWithManagementWithCompanyLocatedInNewYorkState" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ContractualFeesForServicesRenderedMinimum" xlink:label="loc_FONRContractualFeesForServicesRenderedMinimum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ContractualFeesForServicesRenderedMaximum" xlink:label="loc_FONRContractualFeesForServicesRenderedMaximum" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRContractualFeesForServicesRenderedMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MedicalFeeReceivable" xlink:label="loc_FONRMedicalFeeReceivable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRMedicalFeeReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RevenuePercentage" xlink:label="loc_FONRRevenuePercentage" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRRevenuePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementFeeReceivableForUnrelatedParties" xlink:label="loc_FONRManagementFeeReceivableForUnrelatedParties" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementFeeReceivableForUnrelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementFeeReceivableForRelatedParties" xlink:label="loc_FONRManagementFeeReceivableForRelatedParties" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRManagementFeeReceivableForRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsReceivableServiceContractsNet" xlink:label="loc_FONRAccountsReceivableServiceContractsNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRAccountsReceivableServiceContractsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_Penalties" xlink:label="loc_FONRPenalties" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRPenalties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:label="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_FONRNumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="999046 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractReceivableDueFourToFiveYears" xlink:label="loc_us-gaapContractReceivableDueFourToFiveYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueFourToFiveYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractReceivableDueFiveYearsOrMore" xlink:label="loc_us-gaapContractReceivableDueFiveYearsOrMore" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueFiveYearsOrMore" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1" xlink:title="999047 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesReceivableMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:label="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_FONRManagementAndOtherFeesReceivableRelatedMedicalPracticesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesReceivableMember" xlink:label="loc_us-gaapNotesReceivableMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapNotesReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AllowanceForDoubtfulAccountsAdditions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsAdditions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AllowanceForDoubtfulAccountsDeductions" xlink:label="loc_FONRAllowanceForDoubtfulAccountsDeductions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAllowanceForDoubtfulAccountsDeductions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails" xlink:title="999048 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtBeginningOfYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagedFacilitiesAddedByInternalDevelopment" xlink:label="loc_FONRManagedFacilitiesAddedByInternalDevelopment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesAddedByInternalDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagedFacilitiesClosedDuringYear" xlink:label="loc_FONRManagedFacilitiesClosedDuringYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRManagedFacilitiesClosedDuringYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedAtEndOfYear" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="999049 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="999050 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails" xlink:title="999051 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DiagnosticEquipmentMember" xlink:label="loc_FONRDiagnosticEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRDiagnosticEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ResearchDevelopmentAndDemonstrationEquipmentMember" xlink:label="loc_FONRResearchDevelopmentAndDemonstrationEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_FONRResearchDevelopmentAndDemonstrationEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999052 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="999053 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1" xlink:title="999054 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)">
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapFinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2" xlink:title="999055 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2)">
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_FinanceLeaseCostsAbstract" xlink:label="loc_FONRFinanceLeaseCostsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_FONRFinanceLeaseCostsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DepreciationOfLeasedEquipment" xlink:label="loc_FONRDepreciationOfLeasedEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRDepreciationOfLeasedEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="loc_us-gaapFinanceLeaseInterestExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_us-gaapFinanceLeaseInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_FinanceLeaseCost" xlink:label="loc_FONRFinanceLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRFinanceLeaseCostsAbstract" xlink:to="loc_FONRFinanceLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3" xlink:title="999056 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)">
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OperatingCashFlowsFromOperatingLeases" xlink:label="loc_FONROperatingCashFlowsFromOperatingLeases" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_FONROperatingCashFlowsFromOperatingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_FinancingCashFlowsFromFinancingLeases" xlink:label="loc_FONRFinancingCashFlowsFromFinancingLeases" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_FONRFinancingCashFlowsFromFinancingLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:label="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_FONRRightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative" xlink:title="999057 - Disclosure - OPERATING AND FINANCE LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureOperatingAndFinanceLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseIncome" xlink:label="loc_us-gaapLeaseIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingAndFinanceLeasesAbstract" xlink:to="loc_us-gaapLeaseIncome" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails" xlink:title="999058 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicenseMember" xlink:label="loc_FONRSoftwareLicenseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRSoftwareLicenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostomerRelationshipsMember" xlink:label="loc_FONRCostomerRelationshipsMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRCostomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1" xlink:title="999059 - Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicenseMember" xlink:label="loc_FONRSoftwareLicenseMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRSoftwareLicenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2" xlink:title="999060 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_AmountsCapitalized" xlink:label="loc_FONRAmountsCapitalized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRAmountsCapitalized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareOrPatentsWrittenOff" xlink:label="loc_FONRSoftwareOrPatentsWrittenOff" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRSoftwareOrPatentsWrittenOff" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CorrectionOfError" xlink:label="loc_FONRCorrectionOfError" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_FONRCorrectionOfError" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="999061 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicensesMember" xlink:label="loc_FONRSoftwareLicensesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRSoftwareLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CapitalStockDetailsNarrative" xlink:title="999062 - Disclosure - CAPITAL STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DisclosureCapitalStockAbstract" xlink:label="loc_FONRDisclosureCapitalStockAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureCapitalStockAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_N2010StockBonusPlanMember" xlink:label="loc_FONRN2010StockBonusPlanMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_FONRN2010StockBonusPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_BoardOfDirectorsChairmanMember" xlink:label="loc_srtBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DividendsPayableNature" xlink:label="loc_us-gaapDividendsPayableNature" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPayableNature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:label="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockVotingRights" xlink:label="loc_us-gaapCommonStockVotingRights" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockVotingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SharesRegistered" xlink:label="loc_FONRSharesRegistered" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRSharesRegistered" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CancellationOfTreasuryShares" xlink:label="loc_FONRCancellationOfTreasuryShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CancellationOfTreasuryStock" xlink:label="loc_FONRCancellationOfTreasuryStock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfTreasuryStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails" xlink:title="999063 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestTable" xlink:label="loc_us-gaapMinorityInterestTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapMinorityInterestTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestLineItems" xlink:label="loc_us-gaapMinorityInterestLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapMinorityInterestLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_HDMEquityMember" xlink:label="loc_FONRHDMEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRHDMEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OpeningMembersEquity" xlink:label="loc_FONROpeningMembersEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONROpeningMembersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ShareOfNetIncome" xlink:label="loc_FONRShareOfNetIncome" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRShareOfNetIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_BuyoutOfNoncontrollingInterests" xlink:label="loc_FONRBuyoutOfNoncontrollingInterests" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_BuyoutOfNoncontrollingInterestsValue" xlink:label="loc_FONRBuyoutOfNoncontrollingInterestsValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRBuyoutOfNoncontrollingInterestsValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_Distributions" xlink:label="loc_FONRDistributions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONRDistributions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EndingMembersEquity" xlink:label="loc_FONREndingMembersEquity" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMinorityInterestLineItems" xlink:to="loc_FONREndingMembersEquity" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative" xlink:title="999064 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="loc_us-gaapNoncontrollingInterestAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncontrollingInterestAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_HDMMember" xlink:label="loc_FONRHDMMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRHDMMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_FONRClassAControllingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOwnershipInterestsByNameAxis" xlink:label="loc_us-gaapOtherOwnershipInterestsByNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapOtherOwnershipInterestsByNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOwnershipInterestsNameDomain" xlink:label="loc_us-gaapOtherOwnershipInterestsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsByNameAxis" xlink:to="loc_us-gaapOtherOwnershipInterestsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassBControllingInterestsMember" xlink:label="loc_FONRClassBControllingInterestsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassBControllingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ClassAControllingInterestsMember" xlink:label="loc_FONRClassAControllingInterestsMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherOwnershipInterestsNameDomain" xlink:to="loc_FONRClassAControllingInterestsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EquityMethodInvestmentOwnershipPercentages" xlink:label="loc_FONREquityMethodInvestmentOwnershipPercentages" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentOwnershipPercentages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ProceedsFromContributionsFromCompany" xlink:label="loc_FONRProceedsFromContributionsFromCompany" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRProceedsFromContributionsFromCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaapProceedsFromContributionsFromAffiliates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapProceedsFromContributionsFromAffiliates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PurchaseOfStandupMriCenters" xlink:label="loc_FONRPurchaseOfStandupMriCenters" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfStandupMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PurchaseOfOtherMriCenters" xlink:label="loc_FONRPurchaseOfOtherMriCenters" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRPurchaseOfOtherMriCenters" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsiderationToOutsideInvestors" xlink:label="loc_FONRConsiderationToOutsideInvestors" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationToOutsideInvestors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalPurchasePrice" xlink:label="loc_FONRTotalPurchasePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRTotalPurchasePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ConsiderationForNoncompetitionAndConsultingAgreements" xlink:label="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRConsiderationForNoncompetitionAndConsultingAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EquityMethodInvestmentsOwnershipPercentage" xlink:label="loc_FONREquityMethodInvestmentsOwnershipPercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONREquityMethodInvestmentsOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails" xlink:title="999065 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DeferredIncomeTaxExpensesBenefit" xlink:label="loc_FONRDeferredIncomeTaxExpensesBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRDeferredIncomeTaxExpensesBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="999066 - Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" xlink:label="loc_FONREffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONREffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationMinorityInterestIncomeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PermanentItemsMealsEntertainment" xlink:label="loc_FONRPermanentItemsMealsEntertainment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRPermanentItemsMealsEntertainment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" xlink:label="loc_FONREffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONREffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit" xlink:label="loc_FONRIncomeTaxReconciliationIncomeTaxExpenseBenefit" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRIncomeTaxReconciliationIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2" xlink:title="999067 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:label="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_FONRDeferredTaxAssetsInRightUseAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PropertyAndEquipmentAndDepreciation" xlink:label="loc_FONRPropertyAndEquipmentAndDepreciation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRPropertyAndEquipmentAndDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="999068 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CapitalizedResearchAndDevelopmentCosts" xlink:label="loc_FONRCapitalizedResearchAndDevelopmentCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRCapitalizedResearchAndDevelopmentCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherOperatingIncome" xlink:label="loc_us-gaapOtherOperatingIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOtherOperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetInterestCarryforward" xlink:label="loc_us-gaapDeferredTaxAssetInterestCarryforward" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetInterestCarryforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="999069 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapTaxesPayableCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapTaxesPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance" xlink:label="loc_us-gaapAdvancePaymentsByBorrowersForTaxesAndInsurance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAdvancePaymentsByBorrowersForTaxesAndInsurance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedUtilitiesCurrent" xlink:label="loc_us-gaapAccruedUtilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedUtilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SoftwareLicenses" xlink:label="loc_FONRSoftwareLicenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_FONRSoftwareLicenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RecruitingFees" xlink:label="loc_FONRRecruitingFees" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_FONRRecruitingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999070 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:label="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ReinsurancePayable" xlink:label="loc_us-gaapReinsurancePayable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapReinsurancePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="999071 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentOwnedNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOwnedNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOwnedNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentInterestRate" xlink:label="loc_us-gaapInvestmentInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInvestmentInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999072 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_MagneticResonanceManagementMember" xlink:label="loc_FONRMagneticResonanceManagementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_FONRMagneticResonanceManagementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_BensonhurstMRILimitedPartnershipMember" xlink:label="loc_FONRBensonhurstMRILimitedPartnershipMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRBensonhurstMRILimitedPartnershipMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RadianHealthcareManagementLLCMember" xlink:label="loc_FONRRadianHealthcareManagementLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_FONRRadianHealthcareManagementLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativeFixedInterestRate" xlink:label="loc_us-gaapDerivativeFixedInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDerivativeFixedInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredGainOnSaleOfProperty" xlink:label="loc_us-gaapDeferredGainOnSaleOfProperty" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapDeferredGainOnSaleOfProperty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_PrincipalAmount" xlink:label="loc_FONRPrincipalAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_FONRPrincipalAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDescriptionOfTransaction" xlink:label="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionDescriptionOfTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details" xlink:title="999073 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:label="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:label="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManufacturingandServicingofMedicalEquipmentMember" xlink:label="loc_FONRManufacturingandServicingofMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FONRManufacturingandServicingofMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ManagementofDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementofDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FONRManagementofDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalMember" xlink:label="loc_FONRTotalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_FONRTotalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToEmployees" xlink:label="loc_us-gaapPaymentsToEmployees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapPaymentsToEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RentExpenses" xlink:label="loc_FONRRentExpenses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRRentExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherCostOfSalesExpenses" xlink:label="loc_FONROtherCostOfSalesExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONROtherCostOfSalesExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CostOfSales" xlink:label="loc_FONRCostOfSales" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRCostOfSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalariesAndWages" xlink:label="loc_us-gaapSalariesAndWages" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapSalariesAndWages" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_SalariesAndWage" xlink:label="loc_FONRSalariesAndWage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRSalariesAndWage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_RentsExpense" xlink:label="loc_FONRRentsExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRRentsExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_OtherSellingGeneralAndAdministrativeExpenses" xlink:label="loc_FONROtherSellingGeneralAndAdministrativeExpenses" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONROtherSellingGeneralAndAdministrativeExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BenefitsLossesAndExpenses" xlink:label="loc_us-gaapBenefitsLossesAndExpenses" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapBenefitsLossesAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalCostsAndExpenses" xlink:label="loc_FONRTotalCostsAndExpenses" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRTotalCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TotalIdentifiableAssets" xlink:label="loc_FONRTotalIdentifiableAssets" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRTotalIdentifiableAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_CapitalExpenditures" xlink:label="loc_FONRCapitalExpenditures" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="loc_FONRCapitalExpenditures" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details" xlink:title="999074 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_TwoMember" xlink:label="loc_FONRTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_FONRTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ForeignProductSales" xlink:label="loc_FONRForeignProductSales" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignProductSales" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details" xlink:title="999075 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_PR" xlink:label="loc_countryPR" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH" xlink:label="loc_countryCH" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCH" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_DE" xlink:label="loc_countryDE" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="loc_countryGB" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AE" xlink:label="loc_countryAE" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAE" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_DO" xlink:label="loc_countryDO" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryDO" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GR" xlink:label="loc_countryGR" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AU" xlink:label="loc_countryAU" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryAU" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ForeignServiceAndRepairFees" xlink:label="loc_FONRForeignServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_FONRForeignServiceAndRepairFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative" xlink:title="999076 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ExportSalesOfMedicalEquipmentPercentage" xlink:label="loc_FONRExportSalesOfMedicalEquipmentPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRExportSalesOfMedicalEquipmentPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20250630.xsd#FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:label="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_FONRForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 08, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FONR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">CohnReznick LLP<span></span>
</td>
<td class="text">Marcum LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Melville, NY<span></span>
</td>
<td class="text">New York, NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">596<span></span>
</td>
<td class="text">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,203,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 56,333,636<span></span>
</td>
<td class="nump">$ 56,341,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">120,494<span></span>
</td>
<td class="nump">136,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable &#8211; net of allowances for credit losses of $264,212 and $166,049 at June 30, 2025 and 2024, respectively</a></td>
<td class="nump">5,304,698<span></span>
</td>
<td class="nump">4,035,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical receivables</a></td>
<td class="nump">24,489,808<span></span>
</td>
<td class="nump">23,991,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedFeesAndOtherRevenueReceivable', window );">Management and other fees receivable &#8211; net of allowances for credit losses of $14,295,988 and $12,369,921 at June 30, 2025 and 2024, respectively</a></td>
<td class="nump">43,401,252<span></span>
</td>
<td class="nump">41,953,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable &#8211; related party medical practices &#8211; net of allowances for credit losses of $7,136,836 and $6,110,399 at June 30, 2025 and 2024, respectively</a></td>
<td class="nump">9,748,521<span></span>
</td>
<td class="nump">9,865,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories - net</a></td>
<td class="nump">2,812,682<span></span>
</td>
<td class="nump">2,715,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty', window );">Prepaid expenses and other current assets &#8211; related party</a></td>
<td class="nump">410,659<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,050,060<span></span>
</td>
<td class="nump">1,285,962<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">144,671,810<span></span>
</td>
<td class="nump">140,324,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable &#8211; long term</a></td>
<td class="nump">3,549,956<span></span>
</td>
<td class="nump">829,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NoteReceivableRelatedParty', window );">Note receivable &#8211; related party</a></td>
<td class="nump">554,857<span></span>
</td>
<td class="nump">581,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">6,349,194<span></span>
</td>
<td class="nump">7,223,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment &#8211; net</a></td>
<td class="nump">18,531,919<span></span>
</td>
<td class="nump">18,708,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; operating leases</a></td>
<td class="nump">35,136,412<span></span>
</td>
<td class="nump">38,427,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use-asset &#8211; finance lease</a></td>
<td class="nump">376,569<span></span>
</td>
<td class="nump">530,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,269,277<span></span>
</td>
<td class="nump">4,269,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets &#8211; net</a></td>
<td class="nump">2,992,203<span></span>
</td>
<td class="nump">2,870,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">475,680<span></span>
</td>
<td class="nump">481,147<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">216,907,877<span></span>
</td>
<td class="nump">214,245,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">47,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,302,317<span></span>
</td>
<td class="nump">1,855,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">6,974,997<span></span>
</td>
<td class="nump">7,941,039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities &#8211; current portion</a></td>
<td class="nump">3,382,675<span></span>
</td>
<td class="nump">3,473,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liability &#8211; current portion</a></td>
<td class="nump">244,237<span></span>
</td>
<td class="nump">225,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">4,865,936<span></span>
</td>
<td class="nump">3,870,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">354,244<span></span>
</td>
<td class="nump">443,471<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">17,124,406<span></span>
</td>
<td class="nump">17,857,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">3,800,746<span></span>
</td>
<td class="nump">1,174,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">321,159<span></span>
</td>
<td class="nump">371,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsPayableRelatedPartyNoncurrent', window );">Due to related party medical practices</a></td>
<td class="nump">92,663<span></span>
</td>
<td class="nump">92,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities &#8211; net of current portion</a></td>
<td class="nump">35,148,907<span></span>
</td>
<td class="nump">37,467,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liability &#8211; net of current portion</a></td>
<td class="nump">142,523<span></span>
</td>
<td class="nump">394,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">66,938<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">172,853<span></span>
</td>
<td class="nump">32,026<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">39,678,851<span></span>
</td>
<td class="nump">39,600,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">56,803,257<span></span>
</td>
<td class="nump">57,457,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">178,756,712<span></span>
</td>
<td class="nump">180,607,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(5,289,324)<span></span>
</td>
<td class="num">(13,623,585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 34,840 and 45,081 shares of common stock at June 30, 2025 and 2024, respectively</a></td>
<td class="num">(859,893)<span></span>
</td>
<td class="num">(1,016,632)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">172,608,186<span></span>
</td>
<td class="nump">165,967,997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="num">(12,503,566)<span></span>
</td>
<td class="num">(9,179,608)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Equity</a></td>
<td class="nump">160,104,620<span></span>
</td>
<td class="nump">156,788,389<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">216,907,877<span></span>
</td>
<td class="nump">214,245,969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">622<span></span>
</td>
<td class="nump">635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsPayableRelatedPartyNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsPayableRelatedPartyNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NoteReceivableRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NoteReceivableRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedFeesAndOtherRevenueReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, the amount of fees and other revenue, excluding investment income receivable, earned but not yet received, which were recognized in conformity with revenue recognition criteria based on estimates or specific contractual terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedFeesAndOtherRevenueReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-41<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478064/805-740-55-13<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-39<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 42: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 47: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 51: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 52: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 54: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 55: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables', window );">Accounts receivable - net of allowances for credit losses</a></td>
<td class="nump">$ 264,212<span></span>
</td>
<td class="nump">$ 166,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts', window );">Management and other fees receivable - net of allowances for credit losses</a></td>
<td class="nump">14,295,988<span></span>
</td>
<td class="nump">12,369,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts', window );">Management and other fees receivable - related party medical practices - net of allowances for credit losses</a></td>
<td class="nump">$ 7,136,836<span></span>
</td>
<td class="nump">$ 6,110,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">34,840<span></span>
</td>
<td class="nump">45,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">453,000<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">8,500,000<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">6,203,465<span></span>
</td>
<td class="nump">6,328,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">6,168,625<span></span>
</td>
<td class="nump">6,283,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">227,000<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue &#8211; net of contractual allowances and discounts</a></td>
<td class="nump">$ 33,179,446<span></span>
</td>
<td class="nump">$ 33,815,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales</a></td>
<td class="nump">563,296<span></span>
</td>
<td class="nump">737,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees</a></td>
<td class="nump">8,234,053<span></span>
</td>
<td class="nump">7,452,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees &#8211; related parties</a></td>
<td class="nump">180,000<span></span>
</td>
<td class="nump">139,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees</a></td>
<td class="nump">49,900,555<span></span>
</td>
<td class="nump">48,789,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees &#8211; related medical practices</a></td>
<td class="nump">12,293,968<span></span>
</td>
<td class="nump">11,949,900<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">104,351,318<span></span>
</td>
<td class="nump">102,884,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">1,018,029<span></span>
</td>
<td class="nump">1,052,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">4,508,518<span></span>
</td>
<td class="nump">3,577,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees &#8211; related parties</a></td>
<td class="nump">323,504<span></span>
</td>
<td class="nump">144,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">19,130,935<span></span>
</td>
<td class="nump">18,199,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">30,073,045<span></span>
</td>
<td class="nump">28,626,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related medical practices</a></td>
<td class="nump">6,388,281<span></span>
</td>
<td class="nump">6,143,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,576,086<span></span>
</td>
<td class="nump">1,735,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">29,734,163<span></span>
</td>
<td class="nump">26,868,732<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">92,752,561<span></span>
</td>
<td class="nump">86,348,725<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income from Operations</a></td>
<td class="nump">11,598,757<span></span>
</td>
<td class="nump">16,535,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(25,611)<span></span>
</td>
<td class="num">(76,997)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InvestmentIncomeRelatedParty', window );">Interest income &#8211; related party</a></td>
<td class="nump">51,917<span></span>
</td>
<td class="nump">25,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">2,118,980<span></span>
</td>
<td class="nump">2,126,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OtherIncomeRelatedParty', window );">Other income &#8211; related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">576,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">36,195<span></span>
</td>
<td class="nump">78,763<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before Provision for Income Taxes and Noncontrolling Interests</a></td>
<td class="nump">13,780,238<span></span>
</td>
<td class="nump">19,266,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="num">(3,106,805)<span></span>
</td>
<td class="num">(5,168,968)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsolidatedNetIncome', window );">Consolidated Net Income</a></td>
<td class="nump">10,673,433<span></span>
</td>
<td class="nump">14,097,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income &#8211; Noncontrolling Interests</a></td>
<td class="num">(2,339,172)<span></span>
</td>
<td class="num">(3,530,021)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">8,334,261<span></span>
</td>
<td class="nump">10,567,396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember', window );">Common Stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 7,802,351<span></span>
</td>
<td class="nump">$ 9,908,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 1.26<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 1.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding - Common Stockholders</a></td>
<td class="nump">6,210,852<span></span>
</td>
<td class="nump">6,351,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">6,338,356<span></span>
</td>
<td class="nump">6,478,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember', window );">Class A Non Voting Preferred Stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 396,443<span></span>
</td>
<td class="nump">$ 490,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Income and (Expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 135,467<span></span>
</td>
<td class="nump">$ 167,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding - Common Stockholders</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsolidatedNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsolidatedNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InvestmentIncomeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InvestmentIncomeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OtherIncomeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OtherIncomeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_CommonStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Class A Preferred Stock [Member]</div></th>
<th class="th"><div>Class C Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Treasury Stock, Common [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; June 30, 2024 at Jun. 30, 2023</a></td>
<td class="nump">$ 647<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 182,612,518<span></span>
</td>
<td class="num">$ (515,820)<span></span>
</td>
<td class="num">$ (24,190,981)<span></span>
</td>
<td class="num">$ (7,079,293)<span></span>
</td>
<td class="nump">$ 150,827,140<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2023</a></td>
<td class="nump">6,450,882<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,567,396<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,567,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of Treasury Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (2,505,832)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (2,505,832)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of Treasury Stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Cancellation of Treasury Stock</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,005,008)<span></span>
</td>
<td class="nump">$ 2,005,020<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Cancellation of Treasury Stock, shares</a></td>
<td class="num">(122,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions &#8211; Non controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,630,336)<span></span>
</td>
<td class="num">(5,630,336)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income &#8211; Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,530,021<span></span>
</td>
<td class="nump">3,530,021<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; June 30, 2025 at Jun. 30, 2024</a></td>
<td class="nump">$ 635<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">180,607,510<span></span>
</td>
<td class="num">$ (1,016,632)<span></span>
</td>
<td class="num">(13,623,585)<span></span>
</td>
<td class="num">(9,179,608)<span></span>
</td>
<td class="nump">156,788,389<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2024</a></td>
<td class="nump">6,328,294<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,334,261<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,334,261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of Treasury Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1,806,646)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1,806,646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of Treasury Stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Cancellation of Treasury Stock</a></td>
<td class="num">$ (13)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,963,373)<span></span>
</td>
<td class="nump">$ 1,963,385<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Cancellation of Treasury Stock, shares</a></td>
<td class="num">(124,829)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(124,829)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions &#8211; Non controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,682,555)<span></span>
</td>
<td class="num">(5,682,555)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income &#8211; Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,339,172<span></span>
</td>
<td class="nump">2,339,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SaleNonControllingInterest', window );">Sale &#8211; Non controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">112,575<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">19,425<span></span>
</td>
<td class="nump">132,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; June 30, 2025 at Jun. 30, 2025</a></td>
<td class="nump">$ 622<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 178,756,712<span></span>
</td>
<td class="num">$ (859,893)<span></span>
</td>
<td class="num">$ (5,289,324)<span></span>
</td>
<td class="num">$ (12,503,566)<span></span>
</td>
<td class="nump">$ 160,104,620<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Jun. 30, 2025</a></td>
<td class="nump">6,203,465<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SaleNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SaleNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 42: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 47: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 51: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 52: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 54: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 55: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsolidatedNetIncomeLoss', window );">Consolidated Net Income</a></td>
<td class="nump">$ 10,673,433<span></span>
</td>
<td class="nump">$ 14,097,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile consolidated net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,698,321<span></span>
</td>
<td class="nump">4,596,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for credit losses</a></td>
<td class="nump">3,206,756<span></span>
</td>
<td class="nump">1,882,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax - net</a></td>
<td class="nump">823,660<span></span>
</td>
<td class="nump">2,795,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities', window );">Net change in operating right-of-use assets and lease liabilities</a></td>
<td class="num">(493)<span></span>
</td>
<td class="num">(229,590)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_GainOnSaleOfEquipmentRelatedParty', window );">Gain on sale of equipment &#8211; related party</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(581,183)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_GainlossOnDispositionOfFixedAssets', window );">Gain on disposition of fixed assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(75,411)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AbandonedPatents', window );">Abandoned patents</a></td>
<td class="nump">55,707<span></span>
</td>
<td class="nump">225,419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>&#160;Changes in operating assets and liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivable(s)</a></td>
<td class="num">(9,005,766)<span></span>
</td>
<td class="num">(11,676,139)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInNotesReceivable', window );">Notes receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">55,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties', window );">Notes receivable &#8211; related party</a></td>
<td class="nump">26,326<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(97,241)<span></span>
</td>
<td class="num">(145,775)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(1,194,922)<span></span>
</td>
<td class="nump">266,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">5,467<span></span>
</td>
<td class="nump">42,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(553,562)<span></span>
</td>
<td class="nump">276,669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">2,655,567<span></span>
</td>
<td class="nump">2,949,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerAdvance', window );">Customer advances</a></td>
<td class="num">(89,227)<span></span>
</td>
<td class="num">(158,906)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTradingLiabilities', window );">Finance lease liabilities</a></td>
<td class="num">(79,970)<span></span>
</td>
<td class="num">(217,569)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Other liabilities</a></td>
<td class="nump">140,826<span></span>
</td>
<td class="num">(9,724)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="nump">11,264,882<span></span>
</td>
<td class="nump">14,093,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,791,581)<span></span>
</td>
<td class="num">(789,961)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromShortTermInvestments', window );">Proceeds (Purchase) from short-term investment</a></td>
<td class="nump">15,608<span></span>
</td>
<td class="num">(103,303)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(25,325)<span></span>
</td>
<td class="num">(32,885)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="num">(3,801,298)<span></span>
</td>
<td class="num">(850,738)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>&#160;&#160;CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and finance obligations</a></td>
<td class="num">(113,940)<span></span>
</td>
<td class="num">(44,902)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SaleOfNoncontrollingInterest', window );">Sale of noncontrolling interest</a></td>
<td class="nump">132,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Purchase of treasury stock</a></td>
<td class="num">(1,806,646)<span></span>
</td>
<td class="num">(2,505,832)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(5,682,555)<span></span>
</td>
<td class="num">(5,630,336)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED IN FINANCING ACTIVITIES</a></td>
<td class="num">(7,471,141)<span></span>
</td>
<td class="num">(8,181,070)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">&#160;&#160;NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="num">(7,557)<span></span>
</td>
<td class="nump">5,061,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR</a></td>
<td class="nump">56,341,193<span></span>
</td>
<td class="nump">51,279,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS - END OF YEAR</a></td>
<td class="nump">$ 56,333,636<span></span>
</td>
<td class="nump">$ 56,341,193<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AbandonedPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AbandonedPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsolidatedNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsolidatedNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainOnSaleOfEquipmentRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainOnSaleOfEquipmentRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainlossOnDispositionOfFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainlossOnDispositionOfFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SaleOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SaleOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount owed to the reporting entity in the form of loans and obligations (generally evidenced by promissory notes) made to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTradingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of trading liabilities from the reporting entity's trading activities. This include liabilities resulting from sales of assets that the reporting entity does not own and revaluation losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTradingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 8,334,261<span></span>
</td>
<td class="nump">$ 10,567,396<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Rule 10b5-1 Trading Plan</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">During the fiscal quarter ended June 30, 2025, none of our directors or
executive officers <span id="xdx_902_eecd--Rule10b51ArrAdoptedFlag_dbT_c20240701__20250630_zAMPxrI1zmp6"><span id="xdx_902_eecd--NonRule10b51ArrAdoptedFlag_dbT_c20240701__20250630_zvFnK9E6c852">adopted</span></span> or <span id="xdx_904_eecd--Rule10b51ArrTrmntdFlag_dbT_c20240701__20250630_zBHCJ2qOTrg9"><span id="xdx_90A_eecd--NonRule10b51ArrTrmntdFlag_dbT_c20240701__20250630_zUYWMo65kmAj">terminated </span></span>any contract, instruction or written plan for the purchase or sale of Company securities that
was intend to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement&#8221;.</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Risk Management and Strategy</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Cybersecurity Risk Management Strategy includes
a myriad of tools and resources that are designed to ensure the integrity of our information systems. We place particular emphasis on
protecting the privacy of our patient data pursuant to the HIPAA Security Rule. Our cybersecurity risk management process is integrated
with our larger risk <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90C_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240701__20250630_zQUvRfWfjMji">management</span> system and is considered a core function of our overall risk management strategy.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our strategy is based around identification,
mitigation, avoidance and response to material cybersecurity risks. We employ physical and electronic safeguards to control access
to our systems. We employ additional electronic safeguards to control/limit access to the data contained in those systems. We review
and re-assess these processes on a rolling basis with the assistance of both internal staff and outside vendors, including
assessors, consultants, auditors, and other third parties. Some steps we take include the use of standard security protocols such as
password maintenance, multi-factor identification, and penetration testing. We take other steps as may be situationally appropriate
for the specific risk presented.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the fiscal year ended June 30, 2025, management has identified
a material weakness in our internal controls over our information technology systems, as described in greater detail in Item 9A. In response,
we have taken several steps to enhance our cybersecurity efforts. Those steps include increasing the scope of our Multi-Factor Authentication
requirement to include additional tertiary information systems, improving password security, upgrading our anti-virus software, upgrading
our threat detection tools, implementing additional threat detection tools, and replacing and/or decommissioning hardware that has known
vulnerabilities.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We require all of our employees to receive cybersecurity
training as part of their initial onboarding process, and employees are required to complete additional training throughout the year.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate all of our vendors and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240701__20250630_z7T4jZ4Td6Yh">third-party </span>partners
for material cybersecurity risks and take steps to mitigate risk through insurance and contractual risk transfer provisions when appropriate.
Our Information Technology department works collaboratively with our third-party vendors to coordinate a mutually beneficial approach
to cybersecurity in the specific context in which risk is presented. These collaborations sometimes take place on a rolling basis, and
sometimes take place on a semi-annual or annual basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240701__20250630_zhCcuDSrPii7">Cybersecurity threats, including previous cybersecurity incidents, have
not materially affected our results of operations or financial condition. However, cybersecurity threats have the potential to significantly
impair our operations and the operations of the various third parties upon whom we rely.</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<div class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_98B_ecyd--CybersecurityRiskBoardOfDirectorsOversightTextBlock_c20240701__20250630_zMgqBzIaTeUj">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Governance</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240701__20250630_zcKQXoyHGSSl">The audit committee of our Board of Directors provides
oversight of cybersecurity risks.</span> It receives regular reports from management, including our General Counsel, on various cybersecurity
matters during each board meeting. Such reports include information on current cybersecurity risks facing the organization, cybersecurity
incidents involving our partners and/or other participants in our industry, and routine updates on the status of our internal cybersecurity
risk management plan.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our General Counsel oversees and manages our cybersecurity
program. Our General Counsel acts as the coordinator of our cybersecurity team, which includes representatives from our Information Technology
department and Compliance department. In addition, he regularly interacts with various department heads from both our New York and Florida
regions regarding the prevention, detection, mitigation and remediation of cybersecurity risks. Our General Counsel has an educational
background in computer science and has relevant work experience in cybersecurity insurance and risk management.</p>

</div>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">Cybersecurity threats, including previous cybersecurity incidents, have
not materially affected our results of operations or financial condition. However, cybersecurity threats have the potential to significantly
impair our operations and the operations of the various third parties upon whom we rely.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Governance</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240701__20250630_zcKQXoyHGSSl">The audit committee of our Board of Directors provides
oversight of cybersecurity risks.</span> It receives regular reports from management, including our General Counsel, on various cybersecurity
matters during each board meeting. Such reports include information on current cybersecurity risks facing the organization, cybersecurity
incidents involving our partners and/or other participants in our industry, and routine updates on the status of our internal cybersecurity
risk management plan.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our General Counsel oversees and manages our cybersecurity
program. Our General Counsel acts as the coordinator of our cybersecurity team, which includes representatives from our Information Technology
department and Compliance department. In addition, he regularly interacts with various department heads from both our New York and Florida
regions regarding the prevention, detection, mitigation and remediation of cybersecurity risks. Our General Counsel has an educational
background in computer science and has relevant work experience in cybersecurity insurance and risk management.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The audit committee of our Board of Directors provides
oversight of cybersecurity risks.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zm6bDqPEpSSl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 1 - <span id="xdx_82F_zAAccN59coej">DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Description of Business</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR is a Delaware corporation, which was incorporated
on July 17, 1978. FONAR is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles
of MRI for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue
is also generated from our installed-base of customers through our service and upgrade programs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FONAR, through its wholly-owned subsidiary Health
Management Company of America (&#8220;HMCA&#8221;) provides comprehensive management services to diagnostic imaging facilities. The services
provided by the Company include development, administration, leasing of office space, facilities and medical equipment, provision of supplies,
staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and the development and implementation
of practice growth and marketing strategies.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 1, 2015, the Company restructured the corporate
organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely
integrate the operations of Health Management Corporation of America and Health Diagnostics Management (&#8220;HDM&#8221;). Imperial contributed
all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a <span id="xdx_900_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zf3RUtwHRPbg">24.2</span>% interest
in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zpWk0QeY0j8c">45.8</span>% in HDM, and the original investors in HDM
retained a <span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zV44CmBINwsg">30.0</span>% ownership interest in the newly expanded HDM. As of June 30, 2024 the Company had direct ownership interest of <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zDxMTYcBgfW7">70.8</span>%
and the investors&#8217; a <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zSeUsG2lI1e2">29.2</span>% ownership interest. During the year ended June 30, 2025, the Company sold non-controlling interests to
a minority shareholder for $<span id="xdx_902_eus-gaap--ProceedsFromPaymentsToMinorityShareholders_c20240701__20250630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zxD6sSrLwat">132,000</span>. Currently, the Company has a direct ownership interest of <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20250630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zzboe7iRzJn7">70.63</span>% and the investors have a <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zRwGl26FSXrd">29.37</span>%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under
the name &#8220;Health Management Company of America&#8221;.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zyqDtpRlFKlk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 2 - <span id="xdx_829_zR0YgLo1capg">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_z5xPkgHj8hYa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_zx6kXp4uZd52">Principles of Consolidation</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





















<p id="xdx_84F_eus-gaap--UseOfEstimates_zYc49DEOlEDc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zYgLacFU6f57">Use of Estimates</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, and revenue recognition. In addition,
healthcare industry reforms and reimbursement practices will continue to impact the Company&#8217;s operations and the determination of
contractual and other allowance estimates. Actual results could differ from those estimates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_841_eus-gaap--InventoryWorkInProcessPolicy_zOx1Y181YsB9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_zFZ9ThetLNwd">Inventories</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zFYfUM6zwBbf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zRC1ApUdAOxc">Property and Equipment</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment is stated at cost less accumulated
depreciation. Property and equipment purchased in connection with an acquisition is stated at its estimated fair value, generally based
on an appraisal. Property and equipment is being depreciated for financial accounting purposes using the straight-line method over their
estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon
retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts
and the resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to operations.
Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $<span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20240701__20250630_zPvUEDSVTEd3" title="Maintenance and repair expenses">2,751,000</span> and $<span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zSW98m5gQHsi" title="Maintenance and repair expenses">2,948,000</span> for the years
ended June 30, 2025 and 2024 respectively. The estimated useful lives in years are generally as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zzRfNYFNcoyh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_z6ny7nwymeeb" style="display: none">Schedule of Estimated Useful Life in Years for Property and Equipment</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Estimated Useful Life in Years for Property and Equipment</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Diagnostic equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLUOWqTLUb0a">5</span>&#8211;<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z25tJH8zhlvh">13</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6nTPQReSsH2">3</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zNHPd6S4KXHa">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zXdHeCgwiGP9">2</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z6qnagveRi84">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zksgPFS2gqC">3</span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zCr1cYtEgT25">9</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgT9VqsgYLc4">5</span>&#8211;<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaYdZEw4QjCi">10</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt">Building</td>
<td style="width: 10%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 18%; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zD9A92kl2CT6">28</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A6_zUTC8Bz6IHGl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>























<p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z9eSjjxYZdtf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_zxgC1avudAai">Other Intangible Assets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1) Patents and Copyrights</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Patent and copyrights are professional costs
incurred to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zJmhvKVVPtM" title="Finite-lived intangible asset, useful life">15 </span>years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2) Non-Competition Agreements</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (<span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPBsjlpky802" title="Finite-lived intangible asset, useful life">7</span> years).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3) Customer Relationships</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zcjurrsJnO4" title="Finite-lived intangible asset, useful life">20</span> years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4) Software License</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Software license represents a license to improve the
image quality and efficiency of the MRI scanners. Amortization is calculated on the straight-line basis over 3 years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_z0gpOauwkL85" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zbHeehKjQ3k9">Goodwill</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.<br/></p>



























<p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zw2Kb9FZsoO2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_863_zxgdpit5utq1">Revenue Recognition</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included
in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type
and Production-Type Contracts&#8221;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2024, the Company had unearned revenue
on service contracts of $3,870,229 of which all was recognized as revenue in the fiscal year ending June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales (upgrades and supplies)
is recognized upon shipment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized based
upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various
medical providers (the &#8220;PCs&#8221;). As of June 30, 2025, the Company has <span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20250630_ztnifEM7T7Y8" title="Management agreements with company total medical practices">22</span> management agreements of which <span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20250630_z0JA4I1I8wD2" title="Scanners with management agreements with company owned by related party">3</span> were with PC&#8217;s
owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned by Raymond V. Damadian,
M.D., Chairman of the Board of FONAR until his unexpected death in August 2022) (&#8220;the Related medical practices&#8221;) and <span id="xdx_907_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20250630_zzPqbePjCJfh" title="Scanners with management with company located in new york state">19</span> are
with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by four unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$<span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMinimum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zFaBwBpE3p8g" title="Contractual fees for services rendered minimum">70,000</span> to $<span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zOAiTymX0tk2" title="Contractual fees for services rendered Maximum">460,000</span>. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit
loss expense for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the FASB and codified in the ASC 606. The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#8217;s revenue recognition policies and significant judgments employed in the determination of revenue.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2025 and 2024 are summarized in the following table.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zapBwZWhb56k" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_zmol8u26VQ13" style="display: none">Schedule of patient fee
    revenue - net</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patient Fee Revenue - Net</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Commercial Insurance/ Managed Care</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zZud5cYCZia5" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,957,159</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z6IYnDScgTRf" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,952,712</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Medicare/Medicaid</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_z30m7YEAmVl1" style="text-align: right" title="Net Patient Fee Revenue">1,160,839</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zszHemWRubW7" style="text-align: right" title="Net Patient Fee Revenue">1,138,176</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Workers&#8217; Compensation/Personal Injury</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zcAZ74TLZso3" style="text-align: right" title="Net Patient Fee Revenue">19,876,923</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zSnjmVbFtc7" style="text-align: right" title="Net Patient Fee Revenue">20,673,483</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zUbUYJK57Pkk" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">7,184,525</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVrbYwT44pae" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">7,051,425</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Patient Fee Revenue</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630_zNAPiF0XqZ47" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">33,179,446</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zjGCwrRjABoc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">33,815,796</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p id="xdx_8AE_z5b9wb4amYcc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_848_ecustom--MedicalReceivablePolicyTextBlock_zPIMLd4tJ5lb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86F_zazxmUxsiWZ2">Medical Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Medical receivables are due under fee-for-service
contracts from third-party payors, such as hospitals, government sponsored healthcare programs, patient&#8217;s legal counsel and directly
from patients. Substantially all the revenue relates to patients residing in Florida. Medical receivables are recorded at net realizable
value based on the estimated amounts the Company expects to receive from patients and third-party payers. The medical receivable is reduced
by an allowance for contractual adjustments based on the historical experience with each payor class at each location. The medical fee
receivable as of July 1, 2023 was $<span id="xdx_908_ecustom--MedicalFeeReceivable_iI_c20230702_zaZAh3y9yVR8" title="Medical fee receivable">21,259,262</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For LLCs owned by the Company, approximately <span id="xdx_90D_ecustom--RevenuePercentage_iI_dp_c20250630_zh33LI9cxjEf" title="revenue percentage">57</span>%
and <span id="xdx_90F_ecustom--RevenuePercentage_iI_dp_c20240630_z4l7dDmxJqp" title="revenue percentage">67%</span> of net revenues were derived from no-fault and personal injury protection for the years end June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>





















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management and Other Fees Receivable</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#8220;CECL&#8221;) reserve to address the risk that a portion of the contractually obligated management fees receivable from the
PCs may not be collectible. The PC&#8217;s may be limited in their ability to pay the full management fee receivable if they do not collect
sufficient expected fees from third-party payors and patients. The Company&#8217;s management fees are collateralized, individually and
collectively, by the assets of the PCs. The CECL reserve is determined based on the difference between the management fee receivable and
the current amount of outstanding fees estimated to be collected by the PCs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s considerations into the estimate
of the PC&#8217;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#8217;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. Specifically, insurance carriers covering automobile
no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other disallowed
claims.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company combines an objective
and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves objectively
using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and then subjectively
adjusting for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for credit losses for the year ended June 30, 2025 was
$3,079,261. The provision for credit losses is attributable to scan volume at all the PC&#8217;s and the nature of the payor classes,
where there can be longer expected payment terms. Also, during the year ended June 30, 2025, the Company recorded an additional reserve
of approximately $2,300,000 for a specific receivable that is attributable to a American Transit Insurance Company (ATIC). This reserve
for credit losses relates specifically to ATIC, which owes no-fault insurance claims by the PCs to the PCs, which are collateral for the
Company&#8217;s management and other fees receivable. ATIC is a New York based motor vehicle insurer primarily focused on for-hire automobile
insurance. During Fiscal 2025, ATIC posted over $750 million in net losses and has indicated that they are approaching insolvency. ATIC
continues to operate and is working with the New York Department of Financial Services (DFS) to resolve its issues. We continue to monitor
the situation for new developments. However, at the time of this filing, DFS has not publicly announced approval of any plans for ATIC
to resolve its financial situation. In addition, Uber has filed a lawsuit against ATIC alleging they are not properly paying claims. Additional
legislation in New York City to reduce coverage minimums and increase premiums may help to resolve the crisis, but there is no certainty
these efforts will be successful. If ATIC enters receivership or suffers additional adverse consequences, we may need to take additional
reserves in the future. The management fee receivable
for unrelated and related parties as of July 1, 2023 was $<span id="xdx_908_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20230702_z3epp298HNv7" title="Management fee receivable for unrelated parties">35,888,253</span> and $<span id="xdx_902_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20230702_zcVLCbWvau8k" title="Management Fee Receivable For Related Parties">9,161,870</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





















<p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_z2dAUxER9VI6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_864_z9QMwu03zeo5">Accounts Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Credit risk with respect to the Company&#8217;s accounts
receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the commencement
of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed on a monthly
or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The Company controls
credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process, credit limits, monitoring
procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before a product sales contract is
entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service contracts as of July 1,
2023 was $<span id="xdx_90B_ecustom--AccountsReceivableServiceContractsNet_iI_c20230702_zP1nChfqcFzc" title="Account receivable">4,571,597</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zHtlUHAE0r19" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_z41yjjbXl4fj">Research and Development Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_846_eus-gaap--AdvertisingCostsPolicyTextBlock_zx0hhJU3GzG5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86E_z8yGLCjM6W79">Advertising Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred. Advertising
expense approximated $ <span id="xdx_900_eus-gaap--AdvertisingExpense_c20240701__20250630_zy07m58XFKWj">773,000</span> and $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20230701__20240630_zm5LK0BUGRx6">731,000</span> and for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zJjWVKExln06" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86C_zOGPd9JGMpb9">Income Taxes</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>





























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 740, &#8220;Accounting for Income Taxes&#8221;,
prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#8217;s tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#8220;Interest expense, net. Penalties
if incurred would be recognized as a component of &#8220;Selling, general and administrative&#8221; expenses. Penalties for the years
ended June 30, 2025 and June 30, 2024 were $<span id="xdx_90A_ecustom--Penalties_c20240701__20250630_zz9AvmFTMGk6" title="Penalties">0</span> and $<span id="xdx_907_ecustom--Penalties_c20230701__20240630_z7nnh1DiSjA" title="Penalties">20,444</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84B_ecustom--CustomerAdvancesPolicyTextBlock_zt4hi9zatzA2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_z7gmUlKx0OXc">Customer Advances</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zQGycvRWLJ9e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_znvzMFwkxOI2">Earnings Per Share</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic earnings per share (&#8220;EPS&#8221;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class Method&#8221;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2025 and 2024, diluted EPS for common shareholders includes <span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20240701__20250630_zjNb4UsWTUV3" title="Conversion of Class C Common Stock"><span id="xdx_90A_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_z1OhV6G8wArg" title="Conversion of Class C Common Stock">127,504</span></span> shares upon conversion of
Class C Common.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

























<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXgrVghbjdB7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zrMYGGMVn0hh" style="display: none">Schedule of earnings per share</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Preferred <br/>&#160; <br/>Stock</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="text-decoration: underline">Numerator:</span></td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Net income available to common stockholders</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630_zwXbEOpHQRm" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">8,334,261</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHQ0bwZGoRul" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">7,802,352</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zTbMk0MKQADd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">135,467</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zOWRlysqdos5" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">396,443</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Denominator:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted average shares outstanding</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630_z4c3GDKwWT9b" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,906,803</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7R8N2jl43U3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,210,852</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCw1jHBpm25h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zO7lozDT1tS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">313,438</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic income per common share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630_zYJDkImOYcv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.21</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zK59KB7k5em4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.26</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zYUM1NLAtzjh" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.35</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zo7FZ3bjowV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.26</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt">Diluted</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt">Denominator:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted average shares outstanding</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zI5vTOBCSz0j" style="text-align: right" title="Weighted average shares outstanding">6,210,852</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zF2JaGEfpWe5" style="text-align: right" title="Weighted average shares outstanding">382,513</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class C Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcPDQCeFugrf" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_z2aZ6uU4BtZ6" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Denominator for diluted earnings per share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zj5GfCXGL8Hl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,338,356</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zgEFnhclg7m7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Diluted income per common share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5Dc9qQOYSRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.23</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zX4OulzKmGXi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.35</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Preferred <br/>&#160; <br/>Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="text-decoration: underline">Numerator:</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Net income available to common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630_zxqVKlA1jCY9" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">10,567,396</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlznrJUeKC27" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">9,908,920</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCg0idGNEmU1" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">167,700</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zxCM8hZqgwFa" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">490,776</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zI0FmbgqMxUg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">7,046,959</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuHuh97pIZ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,351,008</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztvCZaYHkyU8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zjgiMv3bpst2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">313,438</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_z0Bwby6RQfU2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVrQ7Azo2Gs7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztoADeqDrIP4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zCN37m1AK22f" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.57</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zruxKYiA6jC1" style="text-align: right" title="Weighted average shares outstanding">6,351,008</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zXVyct5TGptj" style="text-align: right" title="Weighted average shares outstanding">382,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsbWP3Ab8yRg" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zhcHa2K3gRM1" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQsK8CJDkgC7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,478,512</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zK9uAEAPE7O1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYlkrMwYg6H" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zUZzwVpni9qh" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><br/>
</span></p>

<p id="xdx_8AF_zWzuXeV2zvI8" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>























<p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zksvfpjlvW22" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_864_zIURIV2GEw48">Cash and Cash Equivalents</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zJBdbK2KByyl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_861_z3MGEx6a1zh4">Short-Term Investments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z64eE4JWji8a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86F_zXte6nDBFVG1">Concentration of Credit Risk</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2025, the Company had cash
on deposit of approximately $<span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20250630_zQ3URKgZSaad" title="Cash deposit">53,676,000</span> in excess of federally insured limits of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20250630_zzM4L0gibjxe" title="Federally insured limits">250,000</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties
accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zb90mruYegCi" title="Concentration risk, percentage"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zkRDkTkOHw8" title="Concentration risk, percentage">12</span></span>% of the consolidated net revenues for the years ended June 30, 2025 and 2024. Net management fee receivables
from the related party medical practices accounted for approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zTYTSQcAQ5" title="Concentration risk, percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zlOJ8OY6S8Le" title="Concentration risk, percentage">12</span></span>% of the consolidated accounts receivable as of June 30, 2025 and
2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the years ended June 30, 2025 and June 30, 2024,
the Company made purchases from two vendors that accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zRVL8LyNfHm" title="Concentration risk, percentage">36%</span> and<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zoQXcPBtgjJ3" title="Concentration risk, percentage"> 0%</span> of total purchases, respectively.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations
in the healthcare industry.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z06zC8G5lp3l" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86F_zRdQdhudXtik">Fair Value of Financial Instruments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures fair value in accordance with
ASC 820-10, &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>



























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the Company&#8217;s financial instruments are
held for purposes other than trading.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>





<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





















<p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zkiejRFiZPTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_z6k5RBXXeNh3">Recently Adopted Accounting Standards</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, The Financial Accounting Standards Board (&#8220;FASB&#8221;)
issued ASU 2023-09, &#8220;Income Taxes (740) &#8220;Improvements to Income Tax Disclosures&#8221;, which requires the annual financial
statements to include consistent categories and great disaggregation of information in the rate reconciliation and income taxes paid disaggregated
by jurisdiction. ASU 2023-09 is effective for the Company&#8217;s annual reporting beginning after December 15, 2024, with early adoption
permitted, and should be applied on a prospective basis, with a retrospective option. The Company recently adopted this ASU retrospectively
for the year ended June 30, 2025 and 2024 and it impacts only our disclosures with no impacts to our financial condition and results of
operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, FASB issued ASU 2023-07, &#8220;Segment
Reporting (Topic 280)&#8221;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company adopted ASU for the year ended June 30,
2025 and it impacts only our disclosures with no impacts to our financial condition and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2024, the FASB issued ASU 2024-03, &#8220;Income
Statement &#8211; Reporting Comprehensive Income &#8211; Expense Disaggregation Disclosures&#8221; (Subtopic 220-40): Disaggregation of
Income Statement Expenses&#8221;. This ASU requires disaggregation of certain income statement expense captions into specified categories
to be disclosed within the notes to the financial statements, but does not change the expense captions on the income statement. The amendments
in this ASU are to be applied prospectively, although retrospective application is permitted, and is effective for annual financial statements
starting in fiscal 2028 and interim periods starting in fiscal 2029, with early adoption permitted. The Company is currently evaluating
the effect that the adoption of ASU 2024-03 will have on our disclosures.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2025 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#8217;s financial accounting
measures or disclosures had they been in effect during 2025 or 2024, and it does not believe that any of those standards will have a significant
impact on the Company&#8217;s consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_808_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zvM69ABmY3yf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;NOTE 3 &#8211; <span id="xdx_823_zGxO2fuc3EH9">ACCOUNTS RECEIVABLE, MEDICAL
RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long Term Accounts Receivable</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long term accounts receivable balances at June 30,
2025 and June 30, 2024 amounted to $<span id="xdx_900_ecustom--AccountsReceivableNetLongTerm_iI_c20250630_zJAsWv7AnoK3" title="Long term accounts receivable balances">3,549,956</span> and $<span id="xdx_90A_ecustom--AccountsReceivableNetLongTerm_iI_c20240630_zGx0BKwHm0e1" title="Long term accounts receivable balances">829,473</span>, respectively. The Company will generate revenue from long-term, non-cancellable
contracts to provide service and repair services. Future revenue to be recognized over the following four years at June 30, 2025 is as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zXijzGO5ESQb" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B5_z0cZf7ccVUwa" style="display: none">Schedule of Long Term Accounts Receivable</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Receivables - Non Current - net</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: left; text-indent: -10pt">2027</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20250630_zY1nO0he1iA7" style="width: 43%; text-align: right" title="2026">1,592,426</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20250630_zl2ff3MRTrt8" style="text-align: right" title="2027">1,031,910</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20250630_zk37cIAqVCyj" style="text-align: right" title="2028">831,660</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2030</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20250630_z5ycbIwXvoMk" style="border-bottom: Black 1pt solid; text-align: right" title="2029">344,750</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20250630_zSm0CQJJejm6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">3,800,746</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zF7jlcHtEv2a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following represents a summary of allowance for
credit losses for the years ended June 30, 2025 and 2024, respectively:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zEJmGmLG4PJe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zUYzCKeQzSsh" style="display: none">Schedule of Summary of Allowance For Credit Losses</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="17" style="text-align: center">Summary of Allowance For Credit Losses</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Description</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance<br/> June 30, 2024</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions (1)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance <br/> June 30, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Accounts receivable</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0ij1s42VJQd" style="width: 10%; text-align: right" title="Beginning Balance">166,049</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z4bTZ0RWGBEd" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)">107,330</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zR9jL8mRuUBc" style="width: 10%; text-align: right" title="Deductions">9,167</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znv4xfD8zong" style="width: 10%; text-align: right" title="Ending Balance">264,212</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zUTSyg7wxChi" style="text-align: right">12,369,921</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z1DWoU1Je85" style="text-align: right">2,052,824</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBPQGFy8jqg3" style="text-align: right">126,757</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zvqySRTABHDh" style="text-align: right">14,295,988</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable - related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztVQkHz0Nx7i" style="text-align: right">6,110,399</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z4UevtFf3qFg" style="text-align: right">1,026,437</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzYUj6zpTFf2" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zdaOks82DPNf" style="text-align: right">7,136,836</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zG80mJzulSue" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zhXdF15EnE15" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zrQhCXjOSeF" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zBgaNioATN1k" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1152">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Description</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions(Recovery)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Accounts receivable</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_za0anvkO7yyi" style="width: 10%; text-align: right">198,593</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zTw9SA4YlWd6" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1154">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqc1aNYDTOK" style="width: 10%; text-align: right">32,544</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqIYwzzax14" style="width: 10%; text-align: right">166,049</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zgO2HKHEL1H2" style="text-align: right">12,608,567</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zLFpcnnnG5Rj" style="text-align: right">(238,646</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNp2SFKHPxX1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1159">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEUUIksXct8j" style="text-align: right">12,369,921</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable - related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zq8rRjBmtWvk" style="text-align: right">3,989,692</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z99NIK7R5Al9" style="text-align: right">2,120,707</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zKWIlhQq0Uvg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1163">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzPXJe4kndel" style="text-align: right">6,110,399</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zNhNbhaSE1ma" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zA3FJdF8vJwb" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zXwWgWj5i4Gl" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zsonrgb7xAri" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(1)</span></td>
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Included in provision for credit losses.</span></td></tr>
  </table>
<p id="xdx_8AF_zYF2UHqoInNe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net revenues from management and other fees
charged to the related party medical practices accounted for approximately <span id="xdx_90A_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20240701__20250630_zBmZE50fBRM5" title="Percentage of consolidated net revenue from management fees"><span id="xdx_902_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20230701__20240630_zU9jx2CA3wy6" title="Percentage of consolidated net revenue from management fees">11</span></span>%
and <span id="xdx_903_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20220701__20230630_zdo5oDpHkHf8" title="Percentage of consolidated net revenue from management fees">12</span>% of the consolidated net revenues for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Tallahassee Magnetic Resonance Imaging, Inc., Stand
Up MRI of Boca Raton, Inc. and Stand Up MRI &amp; Diagnostic Center, Inc. (all related party medical practices) entered into a guaranty
agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under each
individual management agreement.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the number of our facilities
for the years ended June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">Total Facilities</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zOv85HqtP6ba" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B1_zQpHJjCYPWUi" style="display: none">Schedule of facilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_498_20240701__20250630_z126F3J4Yx3f" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_493_20230701__20240630_zIawC8tkkTwh" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zD376GVhfX8h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Total Facilities Owned or Managed (at Beginning of Year)</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">28</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">27</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Facilities Added by:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z99TkL8sA8S7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Internal development</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1191">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">1</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zrsS1XQIBhVa" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Managed Facilities Closed</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_zjB1j5c3yxQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Facilities Owned or Managed (at End of Year)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">28</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">28</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A7_zVniYBQd1lb4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/310-10/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--InventoryDisclosureTextBlock_zlxtrqpo5x8g" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 &#8211; <span id="xdx_822_z0qw8X0GKEMi">INVENTORIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories included in the accompanying consolidated
balance sheets consist of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zXfuasFLh8Y3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zLeNHzBUWhj6" style="display: none">Schedule of inventories</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20250630_zpqQ2Y1skoLc" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_493_20240630_zkiufqQwbpMa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_z4C251s1UJ5f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Purchased parts and components</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">2,630,439</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">2,524,201</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zczgmYK1Nqy8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Work-in-process</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">182,243</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">191,240</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_z5v0Y3GQUwd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Inventories</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">2,812,682</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">2,715,441</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_803_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNfR68MlYpfj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 - <span id="xdx_823_z8QBK0CLcYCg">PROPERTY AND EQUIPMENT</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment, at cost, less accumulated
depreciation and amortization, at June 30, 2025 and 2024, is comprised of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zhQrThtXHej6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B2_zf0Yg3aSYLDj" style="display: none">Schedule of Property and equipment</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Diagnostic equipment</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zK9QK5pEKOR3" style="width: 12%; text-align: right" title="Property plant and equipment, gross">35,276,823</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zYuokfAvcAS" style="width: 12%; text-align: right" title="Property plant and equipment, gross">33,243,694</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zJSildhDTxqc" style="text-align: right" title="Property plant and equipment, gross">6,490,872</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_z1qEXteKY4G" style="text-align: right" title="Property plant and equipment, gross">6,199,941</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zMc7k7RwnCz9" style="text-align: right" title="Property plant and equipment, gross">2,128,398</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zfqYNyooTeNd" style="text-align: right" title="Property plant and equipment, gross">2,069,055</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzCw7Tco2Gtj" style="text-align: right" title="Property plant and equipment, gross">3,756,017</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ziy0RbjYTIaj" style="text-align: right" title="Property plant and equipment, gross">3,742,169</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zlZRvCL1gT26" style="text-align: right" title="Property plant and equipment, gross">17,707,234</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zDg71aaJXVU" style="text-align: right" title="Property plant and equipment, gross">16,312,904</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Building</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zXYkJLFbbe3c" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross">939,614</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zethhpJzCrk5" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross">939,614</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630_zT6kwXaazpdf" style="text-align: right" title="Property plant and equipment, gross">66,298,958</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zUfqB06j7V33" style="text-align: right" title="Property plant and equipment, gross">62,507,377</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less: Accumulated depreciation and amortization</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20250630_zhRXJINJqTW7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization">47,767,039</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zCHOg3CwHw34" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization">43,798,457</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20250630_zYiilL7oZRu2" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net">18,531,919</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zP8Phe8iKCX1" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net">18,708,920</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation of property and equipment for the years
ended June 30, 2025 and 2024 was $<span id="xdx_909_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zYuCYFwKcBVf" title="Depreciation and amortization of property and equipment">3,968,582</span> and $<span id="xdx_907_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20230701__20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_z1F5RNfQ9Cle" title="Depreciation and amortization of property and equipment">4,227,414</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING AND FINANCE LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract', window );"><strong>Operating And Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING AND FINANCE LEASES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zhRhpwUelLVl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 &#8211; <span id="xdx_825_zvvZQ22xs477">OPERATING AND FINANCE LEASES</span> </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for its various operating leases
in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211; Lease, as updated by ASU 2016-02. At the inception
of a lease, the Company recognizes right-of-use lease assets and related lease liabilities measured at present value of future lease payments
on its balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease. Our most common initial term varies
in length from 2 to 19 years. Including renewal options negotiated with the landlord, we have a total span of 2 to 16 years at the facilities
we lease. The Company reviewed its contracts with vendors and customers, determining that its right-to-use lease assets consisted of only
office space operating leases. In determining the right-to-use lease assets and liabilities, the Company did recognize lease extension
options which the Company feels would be reasonably exercised. Our incremental borrowing rate (&#8220;IBR&#8221;) used to discount the
stream of operating lease payments is closely related to the interest rates available to the Company. A reconciliation of operating and
finance lease payments undiscounted cash flows to lease liabilities recognized as of June 30, 2025 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDxsI4Y1txYj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span id="xdx_8B1_zyWAFiHIlaTj" style="display: none">Schedule of Operating Lease and Finance Lease Payments</span></td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Year Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Operating Lease Payments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Finance Lease Payments</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: center; text-indent: -10pt">2026</td><td style="width: 1%; text-align: center">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zWDafO3P5Mpc" style="width: 26%; text-align: right" title="2025">5,753,674</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zdM46sjVWWO8" style="width: 26%; text-align: right" title="2025">244,343</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2027</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpHOsA8i0Oxf" style="text-align: right" title="2026">5,718,999</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zz6FVYs7zQk9" style="text-align: right" title="2026">142,534</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2028</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z2pSmtSplgo4" style="text-align: right" title="2027">5,629,193</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zapwCpj5pNOh" style="text-align: right" title="2027"><span style="-sec-ix-hidden: xdx2ixbrl1288">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2029</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zvxWe8aR5wXa" style="text-align: right" title="2028">5,240,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zgi9a6oLwg2d" style="text-align: right" title="2028">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2030</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zyOQhJ3L78I2" style="text-align: right" title="2029">5,120,717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z4fS9Ud9lM6" style="text-align: right" title="2029">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziPkLtEvicAc" style="text-align: right" title="Thereafter">25,496,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpJoeYoMem4k" style="text-align: right" title="Thereafter">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Present value discount</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--PresentValueDiscount_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zwtqB5IIYRWk" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount">(14,427,905</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBCRri7I40T7" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount">(117</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zkj0dvleg71l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability">38,531,582</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--FinanceLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zEn4RLK9fS0l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability">386,760</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zS6AbEg0VIfd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Weighted Average Remaining Lease Term</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_z3eDopoWTWJj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_zTgX3n0ZahDd" style="display: none">Schedule of Weighted Average Remaining Lease Term</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating leases - years</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zHlomr5OInP6" title="Operating leases - years">10.2</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zSLNi8IY6hMl" title="Operating leases - years">11.0</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Finance lease - years</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zi92dpfFY5si" title="Finance lease - years">1.6</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zOCJPz0V9nag" title="Finance lease - years">2.6</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted Average Discount Rate</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Operating leases</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_zyFv1teZ9Irk" title="Weighted average discount rate, operating leases">6.5</span></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zzJorkakxBe6" title="Weighted average discount rate, operating leases">6.4</span></td>
<td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Finance lease</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_904_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_z4fe2RW4uQRb" title="Weighted average discount rate, finance leases">3.6</span></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90F_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zhSBSeTbvqc8" title="Weighted average discount rate, finance leases">3.6</span></td>
<td style="text-align: left">%</td></tr>
</table>


<p id="xdx_8A1_zrVdHwgD7SWf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">The components of lease expense were as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zljEX1DG6Aqe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt; width: 56%"><span id="xdx_8BE_zAgY4K5dylD1" style="display: none">Schedule of components of lease expense</span> </td>
<td style="width: 8%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td>
<td id="xdx_498_20240701__20250630_zwJTsmfnQdb" style="text-align: right; width: 12%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td>
<td id="xdx_498_20230701__20240630_zFFQzwnCo355" style="text-align: right; width: 12%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Components of lease expense</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating lease cost</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">6,110,496</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">5,685,008</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zNsu6kYYDVx5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Finance lease cost:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zC2enzvr4oii" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Depreciation of leased equipment</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">198,881</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">198,881</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Interest on lease liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">16,812</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">26,534</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_zS5IjtXWMVfi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total finance lease cost</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">215,693</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">225,415</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Supplemental cash flow information related to leases
was as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z2nLlQ5RQM4d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BA_zYxWJuZ5EVlj" style="display: none">Schedule
    of supplemental cash flow information related to leases</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20240701__20250630_zFX1nnOT7YRi" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_495_20230701__20240630_zY41PWDBBtBa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Supplemental cash flow information related to leases</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Cash paid for amounts included in the measurement of lease liabilities:</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zo6hVNilhBz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating cash flows from operating leases</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">5,729,571</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">6,363,561</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zUp3F5j14cah" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Financing cash flows from finance leases</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">264,705</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">244,344</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zdnfXNxVLRrk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Right-of-use and equipment assets obtained in exchange for lease obligations:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zFx4RM1MNeek" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Operating leases</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">2,319,913</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">3,715,138</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for operating leases approximated $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240701__20250630_zpkqqDqSdoMc" title="Operating leases">6,110,000</span>
and $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zXAIAMTZgLl3" title="Operating leases">5,685,000</span>, for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for the finance lease approximated
$<span id="xdx_901_eus-gaap--LeaseIncome_c20240701__20250630_z0t45OaNfeZ" title="financing lease">216,000</span> and $<span id="xdx_906_eus-gaap--LeaseIncome_c20230701__20240630_zWb0iyuHy9V6" title="financing lease">225,000</span> for the years ended June 30, 2025 and 2024, respectively.&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinanceLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zD38rXrHOOs9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 - <span id="xdx_827_zXWJqVwtJ1O9">OTHER INTANGIBLE ASSETS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other intangible assets, net of accumulated amortization,
at June 30, 2025 and 2024, are comprised of:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_ze6jecy5jy7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zjdKFLW30TPa" style="display: none">Schedule of other intangible assets, net of accumulated amortization</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted average useful lives</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Gross carrying amount &#8211; June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Accumulated amortization &#8211; June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Net carrying amount &#8211; June 30, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Capitalized software development costs</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 10%; text-align: right">&#160;&#160;<span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zcxLjNHjo9sb" title="Weighted average useful lives">5</span> years</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zccub73dIco1" style="width: 10%; text-align: right" title="Gross other intangible assets">7,004,847</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zenFCJDbiTWe" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets">(7,004,847</td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zNf0GA3B27F1" style="width: 10%; text-align: right" title=" intangible assets net"><span style="-sec-ix-hidden: xdx2ixbrl1388">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Software License</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zIdQ5TNLS9t7" title="Weighted average useful lives">3</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zs2WTzhFVN68" style="text-align: right" title="Gross other intangible assets">1,260,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z7gmBJxtnlga" style="text-align: right" title="Accumulated amortization intangible assets">(756,000</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z9S58DXrYEbc" style="text-align: right" title=" intangible assets net">504,000</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patents and copy rights</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zXsn4jzgsvt8" title="Weighted average useful lives">15</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmqbV8MRz8t3" style="text-align: right" title="Gross other intangible assets">5,229,429</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zoVolr2puTpb" style="text-align: right" title="Accumulated amortization intangible assets">(4,255,393</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zDMJRimb7izl" style="text-align: right" title=" intangible assets net">974,036</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Non-compete</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_904_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zUlA3pNL0DF8" title="Weighted average useful lives">7</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfwnnbDZAip7" style="text-align: right" title="Gross other intangible assets">4,150,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zulGgrVw5Zol" style="text-align: right" title="Accumulated amortization intangible assets">(4,150,000</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zepyzPDKoKfd" style="text-align: right" title=" intangible assets net"><span style="-sec-ix-hidden: xdx2ixbrl1412">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Customer relationships</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zh8vu5XvfQ22" title="Weighted average useful lives">20</span> years</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmU99ITjAMi3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets">3,900,000</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsNkcMF7qdAk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets">(2,385,833</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKxPB3QSMXV6" style="border-bottom: Black 1pt solid; text-align: right" title=" intangible assets net">1,514,167</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630_zFfyRNB2Xypi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets gross">21,544,276</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630_zaHDM4krr7wd" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets">(18,552,073</td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630_zUDro6zeOWLi" style="border-bottom: Black 2.5pt double; text-align: right" title=" intangible assets net">2,992,203</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted average useful lives</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Gross carrying amount &#8211; June 30, 2024</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Accumulated amortization &#8211; June 30, 2024</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Net carrying amount &#8211; June 30, 2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Capitalized software development costs</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 10%; text-align: right">&#160;&#160;<span id="xdx_909_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuHnLpF844F6" title="Weighted average useful lives">5</span> years</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zkdToiDAbXdi" style="width: 10%; text-align: right" title="Gross other intangible assets">7,004,847</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zwOYD4f6kkBl" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets">(7,004,847</td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhwffGuiU8hg" style="width: 10%; text-align: right" title=" intangible assets net"><span style="-sec-ix-hidden: xdx2ixbrl1434">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patents and copy rights</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zyn1e9LBAJt6" title="Weighted average useful lives">15</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zPaBw6qvJiz8" style="text-align: right" title="Gross other intangible assets">5,259,811</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zwKxMwYWS5C9" style="text-align: right" title="Accumulated amortization intangible assets">(4,103,654</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpryeG6JUIO9" style="text-align: right" title=" intangible assets net">1,156,157</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Non-compete</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_907_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z23R4E4QgYL1" title="Weighted average useful lives">7</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zS0aXBWjl8th" style="text-align: right" title="Gross other intangible assets">4,150,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPx3nknpgai8" style="text-align: right" title="Accumulated amortization intangible assets">(4,150,000</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWacoQ7pjq9b" style="text-align: right" title=" intangible assets net"><span style="-sec-ix-hidden: xdx2ixbrl1450">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Customer relationships</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CostomerRelationshipsMember_zIr2O851xmgb" title="Weighted average useful lives">20</span> years</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5jpHyQUy8o5" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets">3,900,000</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXMVF3Q2PLof" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets">(2,185,833</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDUXS7F6ngUk" style="border-bottom: Black 1pt solid; text-align: right" title=" intangible assets net">1,714,167</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zEeNu0QefyF7" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets gross">20,314,658</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_ztndbXvjdv91" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets">(17,444,334</td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zR5LdadD7Pbg" style="border-bottom: Black 2.5pt double; text-align: right" title=" intangible assets net">2,870,324</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AA_ziCJEZp9ikx" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated amortization of other intangible assets
for the five years ending June 30, 2030 and thereafter is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zL4CB7bn6WA6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span id="xdx_8B8_zXfFJHBEFVI" style="display: none">Schedule of estimated amortization of other intangible assets</span></td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Schedule Of Other Intangible Assets For the Years Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Software License</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Patents and Copyrights</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Customer Relationships</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 23%; text-align: center; text-indent: -10pt">2026</td><td style="width: 1%; text-align: center">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630_zCCOdsJlVbll" style="width: 14%; text-align: right" title="2025">756,880</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zdwFGC3NAu84" style="width: 14%; text-align: right" title="2025">420,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zr0THmwWgClg" style="width: 14%; text-align: right" title="2025">136,880</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5ZEtCVj8JJd" style="width: 14%; text-align: right" title="2025">200,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2027</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630_zgLcCYoSisD3" style="text-align: right" title="2026">402,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zsXJcdAqVhZc" style="text-align: right" title="2026">84,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zCcqbtaWH4" style="text-align: right" title="2026">118,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zJDzhMS8sD2i" style="text-align: right" title="2026">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2028</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630_zp71AsATWC58" style="text-align: right" title="2027">306,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zqM2uyzgpzca" style="text-align: right" title="2027"><span style="-sec-ix-hidden: xdx2ixbrl1496">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zJQ67hcmp083" style="text-align: right" title="2027">106,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z46a9Lcsf8Rf" style="text-align: right" title="2027">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2029</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630_zYTCc38ldubk" style="text-align: right" title="2028">295,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zUHrCSjwdsOd" style="text-align: right" title="2028"><span style="-sec-ix-hidden: xdx2ixbrl1504">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zExzTjdojVo4" style="text-align: right" title="2028">95,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvA4gKxrJVQ7" style="text-align: right" title="2028">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2030</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630_znyGkY0Rl8T7" style="text-align: right" title="2029">291,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zU31l1ljdJgg" style="text-align: right" title="2029"><span style="-sec-ix-hidden: xdx2ixbrl1512">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zDgEwO9Sn4pb" style="text-align: right" title="2029">91,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvSZI8HnqoM5" style="text-align: right" title="2029">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630_zDTUNpSSRAhd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">939,432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zduRQIijkgnb" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"><span style="-sec-ix-hidden: xdx2ixbrl1520">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zeibptIFYaTd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">425,265</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zePM4ZpuYHK4" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">514,167</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Other intangible assets - net</span></td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630_zEj0yRJlnV37" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">2,992,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zylRkfbEs2ua" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">504,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zTIbmCIdVqvf" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">974,036</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyxLZ2YzBNZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">1,514,167</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p id="xdx_8A0_zzFGz7Mz7Dr6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average amortization period for other
intangible assets is <span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630_z1fIAEwKl9N7" title="Weighted average amortization period for other intangible assets">9.0</span> years and they have no expected residual value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Information related to the above intangible assets
for the years ended June 30, 2025 and 2024 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zrN1IKH3zeIj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zRoyqIjQvYx1" style="display: none">Schedule of other
    intangible assets</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other Intangible Assets</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year-ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Balance &#8211; Beginning of Year</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20240701__20250630_zPr8UzMW4XF6" style="width: 12%; text-align: right" title="Balance - Beginning of Year">2,870,324</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zThxwgeLT55b" style="width: 12%; text-align: right" title="Balance - Beginning of Year">3,431,865</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Amounts capitalized</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AmountsCapitalized_pp0p0_c20240701__20250630_zj02muTNgbPk" style="text-align: right" title="Amounts capitalized">25,325</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zo9yVbNL1SA5" style="text-align: right" title="Amounts capitalized">32,885</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patents written off</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20240701__20250630_zKST22nSdIVi" style="text-align: right" title="Patents written off">(55,707</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20230701__20240630_zEDW1XF8MExa" style="text-align: right" title="Patents written off">(225,419</td>
<td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Correction of an error (Note 2)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--CorrectionOfError_pp0p0_c20240701__20250630_zJx9QIn2tu66" style="text-align: right" title="Correction of an error">882,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_ecustom--CorrectionOfError_pp0p0_c20230701__20240630_zUbBj2Bx5eC9" style="text-align: right" title="Correction of an error"><span style="-sec-ix-hidden: xdx2ixbrl1552">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Amortization</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AdjustmentForAmortization_pp0p0_c20240701__20250630_zJWS5jv7WHnc" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization">(729,739</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zySzxFdKmeq9" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization">(369,007</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Balance &#8211; End of Year</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_981_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20240701__20250630_zCpYmqM2OMs" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year">2,992,203</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zZh2Rb5CEhta" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year">2,870,324</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AF_zhoq1KTUX1i7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of patents and copyrights for the years
ended June 30, 2025 and 2024 amounted to $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zAFME4lTP5rc" title="Amortization">151,739</span> and $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zalYfKXEXdqd" title="Amortization of patents and copyrights">169,007</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization of customer relationships for the years
ended June 30, 2025 and 2024 amounted to $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zpzQG8QCvw84" title="Amortization">200,000</span> and $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyjCG4uFWuPk" title="Amortization of customer relationships">200,000</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Amortization of software licenses for the years
ended June 30, 2025 and 2024 amounted to $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_ztuveKsPBA4i" title="Amortization">378,000</span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_zpqZDJfGWJk8" title="Amortization">0</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureCapitalStockAbstract', window );"><strong>Capital Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CapitalStockDisclosureTextblock', window );">CAPITAL STOCK</a></td>
<td class="text"><p id="xdx_80C_ecustom--CapitalStockDisclosureTextblock_zHHv1W1A8TZ6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 - <span id="xdx_827_z4QSNReuWRng">CAPITAL STOCK</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90A_eus-gaap--DividendsPayableNature_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXSswjGHQ8Ie" title="Dividends payable, nature">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class B Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_905_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKQyhbPpBhL" title="Conversuion of shares into one-for-one basis">Class B common stock is convertible into shares of
common stock on a one-for-one basis</span>. <span id="xdx_903_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zJol8IZHUJS4" title="Common stock, voting rights">Class B common stock has 10 votes per share</span>. There were <span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zdo5EDKZUmwi" title="Common stock, shares outstanding">146</span> of such shares outstanding at June 30,
2025and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class C Common Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_901_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3pQJwiLOxbd" title="Common stock, voting rights">The Class C common stock has 25 votes per share</span>, as
compared to 10 votes per share for the Class B common stock and <span id="xdx_903_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zS7ACJoeO16b" title="Common stock, voting rights">one vote per share for the common stock</span>. <span id="xdx_900_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zM2dDRgKwQia">The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock</span>. Although having greater voting power, each share of Class
C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock
is convertible into shares of common stock on a three-for-one basis.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Class A Non-Voting Preferred Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 1995, the stockholders ratified a proposal
consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a
stock dividend on the Company&#8217;s common stock consisting of <span id="xdx_90B_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zJy7J9MEIbbg">one share of Class A non-voting preferred stock for every five shares
of common stock</span>. <span id="xdx_903_eus-gaap--DividendsPayableNature_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zIo256cYieN1">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock is entitled
to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next $20 million and 5-1/2% on amounts in excess of $30
million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company&#8217;s
patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company&#8217;s
patents.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Class A non-voting preferred stock participates
on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights,
liquidation rights and other rights and preferences (other than the voting rights).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock Bonus Plans</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 23, 2010, the Board approved the 2010 Stock
Bonus Plan. The plan entitles the Company to reserve <span id="xdx_901_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zgOy0mSFNc3f" title="Common stock, capital shares reserved for future issuance">2,000,000</span> shares of common stock. On August 10, 2010, the Company filed Form S-8
to register the <span id="xdx_90E_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zfjS1k6B8Ydk" title="Shares registered">2,000,000</span> shares. As of June 30, 2025, <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20250630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_z03zCl9loHLh" title="Number of shares available for future grant">450,177</span> shares of common stock of FONAR were available for future grant under this
plan. For the years ended June 30, 2025 and 2024, <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230701__20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zCU20jmQtUH8" title="Number of shares were issued"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20240701__20250630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zXE6TBaGNNp" title="Number of shares were issued">no</span></span> shares were issued.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Treasury Stock</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 13, 2022, the Company adopted a stock
repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On September 26,
2022, the Board of Directors has approved up to $<span id="xdx_90F_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20230925__20230926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zBELBrIsbBj" title="Payments for repurchase of equity">9</span> million to be repurchased under the plan which will be purchased on the publicly traded
open market at prevailing prices.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes the cost method of accounting
to value the treasury stock when repurchasing stock. Under this method, the shares are valued at the price paid and recorded to treasury
stock. When the treasury stock is cancelled, the par value of the stock is reduced and the additional paid in capital is reduced for the
remaining value based upon the original stock sale. For the year ended June 30, 2025, the Company purchased <span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20240701__20250630_ziC7ZUk2DtMa" title="Purchase of treasury shares">114,588</span> shares at a cost of
$<span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20240701__20250630_zjNDndiUXsIe" title="Purchase of treasury stock">1,806,646</span> and cancelled <span id="xdx_906_ecustom--CancellationOfTreasuryShares_c20240701__20250630_zV3dOSUXvfC5" title="Cancellation of treasury shares">124,829</span> shares valued at $<span id="xdx_904_ecustom--CancellationOfTreasuryStock_c20240701__20250630_zd77AnbpJYRb" title="Cancellation of treasury stock">1,963,385</span>. For the year ended June 30, 2024, the Company purchased <span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_c20230701__20240630_z8tHhEUgsEV" title="Purchase of treasury shares">156,206</span> shares at
a cost of $<span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20230701__20240630_zSFoSXgGTX1d" title="Purchase of treasury stock">2,505,832</span> and cancelled <span id="xdx_904_ecustom--CancellationOfTreasuryShares_c20230701__20240630_z80tr1Ky5Noc" title="Cancellation of treasury shares">122,588</span> shares valued at $<span id="xdx_90B_ecustom--CancellationOfTreasuryStock_c20230701__20240630_z17TtO9LLUwl" title="Cancellation of treasury stock">2,005,020</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CapitalStockDisclosureTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CapitalStockDisclosureTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureCapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureCapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">CONTROLLING AND NONCONTROLLING INTERESTS</a></td>
<td class="text"><p id="xdx_808_eus-gaap--MinorityInterestDisclosureTextBlock_zOQRYD6kMSd8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>NOTE 9 &#8211; <span id="xdx_829_zvV9abneTIy6">CONTROLLING AND NONCONTROLLING
INTERESTS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 13, 2013, the Company entered into an
agreement with outside investors to acquire a 50.5% controlling interest in a newly formed limited liability company, Health Diagnostics
Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM there are two classes of members; Class A members
and one Class B member. The Class A members have an ownership interest of <span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zJnzlOamuYy" title="Ownership interest">49.5</span>% of HDM. The Class B member (HMCA) has an ownership of
<span id="xdx_90B_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zCG94vL5D1oi" title="Ownership percenatge">50.5</span>% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage
of ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be
allocated among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be allocated
solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions of
the operating agreement. The Company contributed $<span id="xdx_903_ecustom--ProceedsFromContributionsFromCompany_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zHaHjctPjc09" title="Company contribution">20,200,000</span> to HDM and the group of outside investors contributed $<span id="xdx_90C_eus-gaap--ProceedsFromContributionsFromAffiliates_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zg0zi1EU0xe6" title="Investors contribution">19,800,000</span> for its
non-controlling membership interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 5, 2013, HDM purchased from Health Diagnostics,
LLC (&#8220;HD&#8221;) and certain of its subsidiaries, a business managing twelve (<span id="xdx_909_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zhJIGAIvrwqa" title="Purchase of stand up MRI centers">12</span>) Stand-Up MRI Centers and two (<span id="xdx_906_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zkSu6U7LrsVg" title="Purchase of other MRI centers">2</span>) other scanning
centers located in the States of New York and Florida for a total purchase price (including consideration of $<span id="xdx_906_ecustom--ConsiderationToOutsideInvestors_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zRErML6KEiIj" title="HDM purchase price includes consideration to outside investors">1.5</span> million to outside investors)
aggregating $<span id="xdx_909_ecustom--TotalPurchasePrice_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zwN76PEMC0H7" title="HDM purchase from Health Diagnostics (HD) ($)">35.9</span> million. Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a
consideration of $<span id="xdx_901_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zCjOqaWpT1ni" title="HDM entered agreement for consulting and non-competition agreement ($)">4.1</span> million. The acquisition was accounted for using the purchase method in accordance with ASC 805, &#8220;Business
Combinations&#8221;. The Company recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration
paid over the fair value of the identified net assets acquired.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 8, 2015, the Company purchased <span id="xdx_904_ecustom--EquityMethodInvestmentsOwnershipPercentage_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zddzxwihBdvg" title="Purchase of interests from Class A,  percentage">20</span>% of the
Class A members ownership interest at a cost of $<span id="xdx_902_ecustom--DirectPurchaseOfNoncontrollingInterests_c20150107__20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zVSQSNLcO1bf" title="Purchase of interests from Class A">4,971,094</span>. The Company has a <span id="xdx_902_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zEVBzxUQyT4e" title="Ownership interest in HDM">60.4</span>% ownership interest in HDM after this transaction.
During the year ended June 30, 2025, the Company sold non-controlling interests to a minority shareholder for $<span id="xdx_90E_ecustom--DirectPurchaseOfNoncontrollingInterests_c20240701__20250630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zWlzXP9AS6nk" title="Purchase of interests from Class A">132,000</span>. Currently, the
Company has a direct ownership interest of <span id="xdx_905_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20250630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z8XBiCfXtdI8" title="Ownership interest of company">70.63</span>% and the investors have a <span id="xdx_902_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20250630__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zxHxwmtuVmV2" title="Ownership interest of investors">29.37</span>% ownership interest.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The amount of each class of HDM members&#8217; equity
as of June 30, 2025 and 2024 is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zpwpGT1apE59" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8B6_ztEq0iopB5sf" style="display: none">Schedule of HDM members equity</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Opening Members&#8217; Equity</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">($</td>
<td id="xdx_98A_ecustom--OpeningMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_znAiHf3KbFXi" style="width: 10%; text-align: right" title="Opening Members Equity">9,179,608</td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zOzt0JgVBvH5" style="width: 10%; text-align: right" title="Opening Members Equity">61,817,830</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">($</td>
<td id="xdx_98B_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zy1PfSKSslRl" style="width: 10%; text-align: right" title="Opening Members Equity">7,079,293</td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zL92Du8S0pFc" style="width: 10%; text-align: right" title="Opening Members Equity">54,781,813</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Share of Net Income</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zN67kbqHXNg5" style="text-align: right" title="Share of Net Income">2,339,172</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_ecustom--ShareOfNetIncome_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zsL9ATWwlLxl" style="text-align: right" title="Share of Net Income">16,727,492</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zp0r4EGY1gOh" style="text-align: right" title="Share of Net Income">3,530,021</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf3oB7e51JX" style="text-align: right" title="Share of Net Income">20,705,681</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Buyout of noncontrolling interests</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterests_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZ4IGG0V58N4" style="text-align: right" title="Buyout of noncontrolling interests">19,425</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zjbgjtgpquH5" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8h5a5quHYp9" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWRKx4RFYZo3" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Distributions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zmRjD8Qqi74j" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(5,682,555</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--Distributions_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zw7Jo6pay2Zh" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(13,717,445</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVUBnojSS3H5" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(5,630,336</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_980_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_ztvFqtzuEfn8" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(13,669,664</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Ending Members&#8217; Equity</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">($</td>
<td id="xdx_985_ecustom--EndingMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zY4atZ3U5BTe" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">12,503,566</td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_ecustom--EndingMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zXmeCBvFCRB" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">64,827,877</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">($</td>
<td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKfVE2Zz3Olb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">9,179,608</td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZYNXjJopy5k" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">61,817,830</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>



<p id="xdx_8A1_zG6j4j8tNkW4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zwqHCMplvoi9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 - <span id="xdx_82B_zCieNvn11PA9">INCOME TAXES</span> </b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income tax expense is computed using an asset and
liability method using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from
temporary differences in the financial reporting basis and the income tax basis of assets and liabilities. The measurement of deferred
tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized.
When it appears more than likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred
tax asset to its realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether or
net deferred tax assets are more likely than not to be realized.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has recorded a deferred tax asset of $<span id="xdx_905_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20250630_z9ALEifb1yPc" title="Deferred tax asset">6,349,194</span>
and a deferred tax liability of $<span id="xdx_90B_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pp0p0_c20250630_zsXjJYEyfQB4" title="Deferred tax liability">321,159</span> as of June 30, 2025, primarily relating to its allowance for credit losses of $4,366,000, non
deductible accruals of <span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20250630_zclB3ZoWuf54" title="Allowance for doubtful accounts and tax credits">$759,000</span> and capitalized research and development costs of approximately $<span id="xdx_904_ecustom--CapitalizedResearchAndDevelopmentCosts_c20240701__20250630_zAbzgrodLgzb" title="Capitalized Research and development costs">960,000</span>. During fiscal 2025, the Company
utilized all tax credits pertaining to research and development costs. In addition the Company has state operating loss carryforwards
of approximately $<span id="xdx_90C_eus-gaap--OtherOperatingIncome_pp0p0_c20240701__20250630_zb79VO5uq04a" title="City operating loss carryforwards">3,694,000</span>. The Company has also fully recorded a valuation allowance against all of the state operating losses since
the Company doesn&#8217;t anticipate being able to utilize them.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company files corporate income tax returns in
the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject to federal,
state and local income tax examinations by tax authorities for years prior to 2021.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Future ownership changes as determined under Section
382 of the Internal Revenue code could further limit the utilization of net operating loss carryforwards. As of June 30, 2025, no such
changes in ownership have occurred.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 4, 2025, the One Big Beautiful Act (&#8220;OBBBA)
was signed into law, which enacts significant changes to the U.S. tax and related laws. Some of the provisions of the new tax law that
affect corporations include but are not limited to expensing of domestic specified research or experimental expenditures, increasing the
limit of the deduction to thirty percent of EBITDA, and one hundred percent bonus depreciation on eligible property acquired after January
19, 2025. The Company is currently evaluating the impact that the new tax law will have on its financial condition and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The valuation allowance for deferred tax assets decreased
during the year ended June 30, 2025, by approximately $<span id="xdx_907_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_c20250630_zJ79D1SD1ugg" title="Valuation allowance for deferred tax assets">67,000</span>. The valuation allowance decreased by approximately $<span id="xdx_902_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_c20240630_zwDMVPpsRLPk" title="Valuation allowance for deferred tax assets">171,000</span> during the
year ended June 30, 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Components of the provision for income taxes are as
follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock_zz2bPnivJCki" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_zVYIGvubxmBc" style="display: none">Schedule of Components of the provision for income taxes</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20240701__20250630_zNWfMiMq1BGj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20230701__20240630_zhGo1SbZ6RSg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center">Components Of The Provision For Income Taxes</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
  <tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_z4sjRIQCIxl6" style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Current:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBKFrCZoWccj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; width: 56%; text-align: left; text-indent: -10pt">Federal</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,374,724</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">429,873</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_z2YvX6RlehAh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">908,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,943,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_zNJThTghetXh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,283,145</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,373,461</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z09UcrD66KK7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zqnWvJAgXFb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Federal deferred taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">838,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,515</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zYOEr0CVljE5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">State deferred taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,494</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">209,992</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zLSBIH1IY46d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">823,660</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,795,507</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zKt4ZyHUsn0b" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; color: white; text-align: left; text-indent: -10pt">Provision (Benefit) for Income Taxes - Net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,106,805</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,168,968</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zFHbYG0Uww4j" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A reconciliation of the federal statutory income tax
rate to the Company&#8217;s effective tax rate as reported is as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zSU7EnsUeiKd" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zjIR4qgQDwW1" style="display: none">Schedule of
    reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended <br/>June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended <br/>June 30, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percent</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percent</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Taxes at federal statutory rate</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20240701__20250630_z5lBSEif7UZ3" style="width: 10%; text-align: right" title="Taxes at federal statutory rate">2,893,850</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_90B_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20240701__20250630_zBWJGmEN7a92" title="Taxes at federal statutory rate">21</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20230701__20240630_z7QRiu2Qjzr9" style="width: 10%; text-align: right" title="Taxes at federal statutory rate">4,169,123</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zestd6NqfEx8" title="Taxes at federal statutory rate">21</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">State and local income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20240701__20250630_zSMHn7mBRHuh" style="text-align: right" title="State and local income taxes">978,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240701__20250630_zMB8pBpb1hGi" title="State and local income taxes (benefit), net of federal benefit">7.1</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20230701__20240630_zv2aGkbsy4N1" style="text-align: right" title="State and local income taxes">1,409,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zHEMJnAPkkf8" title="State and local income taxes (benefit), net of federal benefit">7.1</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20240701__20250630_zhFBbtOCAfdb" style="text-align: right" title="Noncontrolling interests">657,307</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20240701__20250630_zDBHq1mAvsMg" title="Noncontrolling interest">4.6</span></td><td style="text-align: left">%)</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20230701__20240630_zhjJx9fQ2xF5" style="text-align: right" title="Noncontrolling interests">1,049,294</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zn4mlqn8ltCe" title="Noncontrolling interest">5.3</span></td><td style="text-align: left">%)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation Allowance</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20240701__20250630_zRsLtTysp0yb" style="text-align: right" title="Valuation Allowance">218,390</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240701__20250630_zRJrtnPyh7U2" title="Change in the valuation allowance">1.6</span></td><td style="text-align: left">%)</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20230701__20240630_zhL2kBthQ037" style="text-align: right" title="Valuation Allowance">48,179</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_zCSZSkVQ8CUi" title="Change in the valuation allowance">0.2</span></td><td style="text-align: left">%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Permanent items &#8211; Meals and Entertainment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--PermanentItemsMealsEntertainment_c20240701__20250630_zfGovqFcLr36" style="text-align: right" title="Permanent items Meals and Entertainment">131,956</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20240701__20250630_zaZ9J9obG4ce" title="Permanent items Meals and Entertainment">1.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--PermanentItemsMealsEntertainment_c20230701__20240630_ziTkJVTQyD16" style="text-align: right" title="Permanent items Meals and Entertainment">126,719</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20230701__20240630_zYtUHBdm1hT3" title="Permanent items Meals and Entertainment">1.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">($</td><td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20240701__20250630_z1pQwvIR8BE1" style="border-bottom: Black 1pt solid; text-align: right" title="Other">21,701</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20240701__20250630_zVcX6F8bvXy9" title="Other">0.8</span></td><td style="padding-bottom: 1pt; text-align: left">%)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20230701__20240630_zpWQYUB1r5w9" style="border-bottom: Black 1pt solid; text-align: right" title="Other">561,038</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zZgzn6KXVuy1" title="Other">2.7</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Provision for income taxes </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">($</td><td id="xdx_98C_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20240701__20250630_zZ8BW4ExFSAc" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members' Equity">3,106,805</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20240701__20250630_z1bV4CRSHyZi" title="Effective income tax rate">22.8</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20230701__20240630_zxXNNNDCHvf1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members' Equity">5,168,968</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z4QGQjp0IBCj" title="Effective income tax rate">26.8</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p id="xdx_8A8_zYaTG4tAiLq7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 20pt; text-align: justify">The Company has, for federal income tax
purposes, research and development tax credits and investments tax credits carryforwards aggregating $<span id="xdx_904_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_c20250630_zBIwLx86w5Bf" title="Tax credits carryforwards">1,323,000</span>
as of June 30, 2024. The Company will utilize the full amount for the tax return for the year ended June 30, 2025. These credits can
only be applied after all net operating losses have been used.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Significant components of the Company&#8217;s
deferred tax assets and liabilities at June 30, 2025 and 2024 are as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zJ4GhaoisuD3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_ziw2zpP5IrBd" style="display: none">Schedule of deferred tax assets and liabilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49F_20250630_zkbs7EP954tl" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_497_20240630_zhsAJliltjI8" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred tax assets:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zECLwk7a3q6l" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Allowance for credit losses</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">4,366,361</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">3,969,819</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zlrJbuynPcNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Non-deductible accruals</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">758,700</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">758,700</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_z1aIgKDE1uT7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net operating carryforwards</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">259,319</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">396,092</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_z31GL3XssfB2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Tax credits</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1868">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">1,323,018</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z8wqoW8RyNjk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Capitalized research and development</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">960,343</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">747,407</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zztmHsOrxxO4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Right of use assets and lease liabilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">146,934</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">114,116</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zlVY0ZqpyoKa" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Inventories</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">116,856</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">106,879</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zL69hTFpyRm6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred Tax Assets - gross</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">6,608,513</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">7,416,031</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zs6ELT8t4z21" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation allowance</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(259,319</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(192,776</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z11MhnyXQ4k7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total deferred tax assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">6,349,194</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">7,223,255</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--PropertyAndEquipmentAndDepreciation_iI_pp0p0_maDTLzImD_zEt0WogS8q44" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Property and equipment and depreciation</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">165,532</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(267,124</td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMIiPtnHGBl3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Intangibles</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(155,627</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(104,436</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zck8AR0paWhk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total deferred tax liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(321,159</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(371,560</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zH5nvVJq1Efe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net deferred tax asset</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">6,028,035</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">6,851,695</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AA_zVA0c9R7Qi75" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zeuRWROSzhC" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 - <span id="xdx_82F_zT4ApAs6BGcd">OTHER CURRENT LIABILITIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b>&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Included in other current liabilities are the following:&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWWlPqZcNpp" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BA_zGEj3ZqNPTxg" style="display: none">Schedule of other current liabilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49E_20250630_z5jtbRZpGBdi" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49E_20240630_zPWgxgtRm6T7" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_z8pDZ1muGs38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Accrued salaries, commissions and payroll taxes</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">3,993,773</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">4,677,690</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_z9Vcq33nWbVa" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Sales tax payable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">248,845</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">197,317</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zSu9B9oNstlj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">State income taxes payable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1920">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">1,461,336</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zG7EzpUfDLB2" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Legal and other professional fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">93,207</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">11,207</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AdvancePaymentsByBorrowersForTaxesAndInsurance_iI_zpxETB378hJ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Property taxes</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">391,479</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1927">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccruedUtilitiesCurrent_iI_zxI5oRWs3gS4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Utilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">449,277</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1930">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zGxvk96mbxUd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accounting fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">38,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">119,800</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--SoftwareLicenses_iI_zgDBCJWlR6pi" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Software Licenses</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">442,305</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1936">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--RecruitingFees_iI_zeGdfjc7F6Ci" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Recruiting fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">135,952</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1939">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zieqIiUKM8Dl" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Self-funded health insurance reserve</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">259,661</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">121,445</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zS6RVFuQ13Lf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accrued interest and penalty</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">3,534</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">3,534</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_z2eXdxbOnwS5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other general and administrative expenses</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">918,964</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">1,348,710</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zaXyqfygtqoi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other Current Liabilities</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">6,974,997</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">7,941,039</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zz27K1F2cWGl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 12 - <span id="xdx_82B_zgGpc4uB5I3a">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b>&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Employee Benefit Plans</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a non-contributory 401(k) Plan (the
&#8220;401(k) Plan&#8221;). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum service requirements.
There were <span id="xdx_906_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_do_c20240701__20250630_zqiCTbWbQpz5" title="Employer contributions"><span id="xdx_901_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_do_c20230701__20240630_zVsCFrZlSNWl" title="Employer contributions">no</span></span> employer contributions to the Plan for the years ended June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stockholders of the Company approved the 2000
Employee Stock Purchase Plan (&#8220;ESPP&#8221;) at the Company&#8217;s annual stockholders&#8217; meeting in April 2000. The ESPP provides
for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect
as of June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other Matters</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is subject to other legal
proceedings and claims arising from the ordinary course of its business, including personal injury, customer contract and employment
claims besides the claim above. The Company is also subject to Cyber security threats that could lead to future litigation. In the
opinion of management, and with consultation with legal counsel, the aggregate liability, if any, with respect to such actions, will
not have a material adverse effect on the consolidated financial position or results of operations of the Company. The company
continuosly evaluates these actions to ensure they are not material, however, it is possible that management estimate may change in
the near term and the effect could have a material impact on the consolidated financial statements.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third-party insurer to limit the maximum potential liability for individual claims to
$<span id="xdx_902_eus-gaap--ReinsurancePayable_iI_c20250630_zwY9mmGaTWk8" title="Liability for individual claims">150,000</span> per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company
considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.
As of June 30, 2025 and 2024, the Company had approximately $<span id="xdx_906_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20250630_zOYOBo9erkL7" title="Reserve for self-funded">260,000</span> and $<span id="xdx_909_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20240630_zwH1hfHE0w75" title="Reserve for self-funded">121,000</span>, respectively, in reserve for its self-funded health
insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the consolidated balance sheets.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company regularly analyzes its reserves for incurred
but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance programs. The Company
believes its reserves are adequate. However, significant judgment is involved in assessing these reserves such as assessing historical
paid claims, average lags between the claims&#8217; incurred date, reported dates and paid dates, and the frequency and severity of claims.
There may be differences between actual settlement amounts and recorded reserves and any resulting adjustments are included in expense
once a probable amount is known. There were no significant adjustments recorded in the years covered by this report.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_z2k3hl3utHY1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 13 - <span id="xdx_822_zC2qoydl63ea">SUPPLEMENTAL CASH FLOW INFORMATION</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2025 and 2024 the
Company paid $<span id="xdx_903_eus-gaap--InterestPaidNet_c20240701__20250630_z42SXLb4y4Yb" title="Interest paid">25,611</span> and $<span id="xdx_90F_eus-gaap--InterestPaidNet_c20230701__20240630_zPx1cOrYYzfj" title="Interest paid">76,997</span> for interest, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2025 and 2024 the
Company paid $<span id="xdx_909_eus-gaap--IncomeTaxesPaid_c20240701__20250630_z0GJFXPYJKr7" title="Income taxes paid">4,664,984</span> and $<span id="xdx_900_eus-gaap--IncomeTaxesPaid_c20230701__20240630_zKjeeh7NVvE1" title="Income taxes paid">507,139</span> for income taxes, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended June 30, 2025 and June 30,
2024, the Company obtained right-of-use and equipment assets in exchange for lease obligations of $<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentOwnedNet_iI_c20250630_zxyltGJu7v4g" title="Right-of-use and equipment assets">2,319,913</span> and $<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentOwnedNet_iI_c20240630_zKZXhsTgmJO7" title="Right-of-use and equipment assets">9,471,883</span> respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended June 30, 2025, the Company sold
a <span id="xdx_90B_eus-gaap--InvestmentInterestRate_iI_dp_c20250630_zv2zlDVfkmb9" title="Interest rate">0.197</span>% interest in HDM to an employee. The interest was sold for $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240701__20250630_zJrVBaayfhW5" title="Noncash transaction amount">132,000</span> in a noncash transaction.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/230/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zpUG0KnsThM" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 14 &#8211; <span id="xdx_82D_zFpmYKESBr7j">RELATED PARTY TRANSACTIONS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 31, 2023, the Company entered into an
agreement with Magnetic Resonance Management, LLC (&#8220;MRM&#8221;) for the sale of a MRI scanner. MRM is owned by the CEO and President
of the Company. The sales price of the equipment was $<span id="xdx_90C_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zkrMirZO7Meg" title="Sale of price of the equipment">576,857</span> which is payable based upon a promissory note dated December 1, 2023. The
note bears interest at a rate of <span id="xdx_90A_eus-gaap--DerivativeFixedInterestRate_iI_dp_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zbQ9QMeVfTU4" title="Bears interest rate">9</span>% and is payable in full at the maturity of the note in December 2028. The MRI scanner had zero basis,
which resulted in a gain of $<span id="xdx_90E_eus-gaap--DeferredGainOnSaleOfProperty_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zNIj57nY94ya" title="Gain on sale of equipments">576,857</span>. The Company has the option but not the obligation to re-take possession of the scanner in lieu of
payment upon maturity of the note. During fiscal year ended June 30, 2025, MRM paid $<span id="xdx_908_ecustom--PrincipalAmount_c20240701__20250630_z6nufPoWChv7" title="Principal amount">22,000</span> towards the principal balance.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_904_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20240701__20250630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember_zenXvxMENrQg" title="Related party transaction, description">Bensonhurst MRI Limited Partnership (&#8220;Bensonhurst&#8221;),
in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum. On February 1, 2024, Bensonhurst entered into a second contract with the
Company for the service and maintenance of a High-Field MRI Scanner for a price of $70,000 per annum. Also during fiscal year ended June
30, 2025 and 2024, the Company charged Bensonhurst MRI Limited Partnership $344,068 and $190,362, respectively, for reimbursable salaries
and marketing expenses</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Integrity Healthcare Management, LLC, which is owned
by the CEO and President of the Company owns a 7.1% interest in HMCA&#8217;s Class A membership and receives distributions from the Company.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_905_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20240701__20250630__dei--LegalEntityAxis__custom--RadianHealthcareManagementLLCMember_zdAylJW2iSYa" title="Related party transaction, description">Radian Healthcare Management, LLC (&#8220;Radian&#8221;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of new employees
at a fee of approximately $165,000 and $200,000 during the fiscal year ended June 30, 2025 and 2024, respectively</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There are two board of directors that own .04% and
.02% interest in HMCA&#8217;s Class A membership, respectively. Each board member receives distributions from the Company with regards
to these interests.&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--SegmentReportingDisclosureTextBlock_zlPtMRktvl17" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 15 - <span id="xdx_825_zegfbXbc3Gmi">SEGMENT AND RELATED INFORMATION</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company provides segment data in accordance with
the provisions of ASC 280, &#8220;Disclosures about Segments of an Enterprise and Related Information&#8221; which was adopted during
our fiscal ending June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our chief operating decision maker (&#8220;CODM&#8221;),
who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit
and loss statements prepared on a basis not consistent with GAAP. The CODM considers actual to budget and current year actual to prior
year actual for revenue and other profit and loss measures on a monthly basis for evaluating performance of each segment and making decisions
about allocating capital and other resources to each segment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company operates in two industry segments - manufacturing
and the servicing of medical equipment and management of diagnostic imaging centers.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounting policies of the segments are the same
as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance
based on income or loss from operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Summarized financial information concerning the Company&#8217;s
reportable segments is shown in the following table:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Summarized Segment Financial Information&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zYhbXlhCHZZ1" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zh3MCVY7AYy5" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Segment Financial Information</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_492_20240701__20250630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_z75PQFVNZ2ha" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_494_20240701__20250630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_z68KcaR412ok" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_495_20240701__20250630__srt--ProductOrServiceAxis__custom--TotalMember_zTtua83YJq46" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Manufacturing and Servicing of Medical</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Management of Diagnostic Imaging</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Fiscal
2025:</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Equipment</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Centers</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Totals</span></td></tr>
<tr id="xdx_40A_eus-gaap--Revenues_zfW3Cp1P8sp2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
revenues from external customers</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,977,349</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">95,373,969</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">104,351,318</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Cost
of Sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToEmployees_zjT3WxjA7fPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,905,311</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;19,384,410</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;22,289,721</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--RentExpenses_z1Yr3uTf96Dj" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2037">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,822,044</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,822,044</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zgGNgBinrmV1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
Cost of sales expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,944,740</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;31,385,807</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;34,330,547</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_ecustom--CostOfSales_zfWFzJDf6m2b" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Total
Cost of sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;5,850,051</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;55,592,261</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;61,442,312</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Research
and development</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SalariesAndWages_zMQtQgFIE45" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;766,963</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2050">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;766,963</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9uybozGKOml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
research and development costs**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;809,123</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2054">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;809,123</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zynPxaQwa9B8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Total
                                            Research and development costs</span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,576,086</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2058">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,576,086</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zgrFMbaYDFfb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Selling,
general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--SalariesAndWage_i01_zYO9T4bJaXi2" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,934,716</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;10,983,643</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;15,918,359</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--RentsExpense_i01I_z5BxBWbdH3I" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;1,251,924</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;36,528</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;1,288,452</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zLKPgau1ciRb" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
selling, general and administrative expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,970,693</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;9,556,659</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;12,527,352</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zPEfSE3mQkx2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
Selling, general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,157,333</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,576,830</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,734,163</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_z8XhFpbBeyRc" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
costs and expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,619,740</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">76,133,091</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">92,752,561</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_z2k4vhdxzObf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income from operations</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,606,121</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,204,878</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,598,757</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zHcmnnUVeGk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Investment
income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,777</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,011,203</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,118,980</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherIncome_i01_zxmENsXyrvUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Other
income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,508</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,993</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,501</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_z3uPmdmQWykb" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income before provision for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,445,836</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,226,074</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,780,238</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_z4OGAFthe3i7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Provision
for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,885,852</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(220,953</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,106,805</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zhqb4FFRlRbe" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
(Loss) income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,331,688</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,005,121</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,673,433</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zWPAILzhwOs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Intersegment
net revenues *</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,189,130</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2110">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,189,130</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zYYOKMJdD3A7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation
and amortization</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">209,325</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,488,996</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,698,321</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_z0lqDLXnYJ25" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
identifiable assets</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,401,915</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">182,646,336</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">217,048,251</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zFUPHbu0jJ2g" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Capital
expenditures</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">375,599</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,441,307</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,816,906</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0; display: none">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt; width: 46%"><span style="font-family: Times New Roman, Times, Serif">Fiscal
2024:</span></td>
<td style="padding-bottom: 1pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_49B_20230701__20240630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_zzq02cpMvnK2" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_495_20230701__20240630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_zMRIQhRT3iZ1" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_496_20230701__20240630__srt--ProductOrServiceAxis__custom--TotalMember_zM7IjUX6DS01" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--Revenues_zb86Ch12H8fc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
revenues from external customers</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,329,106</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">94,554,983</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,884,089</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Cost
of Sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToEmployees_zH4UUXMvvoxh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,684,218</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;18,913,412</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;21,597,630</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--RentExpenses_z54u34xz7Zk8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2133">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,532,535</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,532,535</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zq88IQEDH58h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
Cost of sales expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,089,924</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;29,523,955</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;31,613,879</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_ecustom--CostOfSales_zj38kTaMAc1a" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
Cost of sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,774,142</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,969,902</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,744,044</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Research
and development</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SalariesAndWages_zy65EV3XrRCg" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;781,012</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2146">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;781,012</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9a9ZMeM3JM7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
research and development costs**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;954,937</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2150">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;954,937</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zir0Tax1ENmh" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
Research and development costs</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,735,949</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2154">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,735,949</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zw2LaAHeJZlh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Selling,
general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--SalariesAndWage_i01_zB1kSzzPOhN3" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,794,512</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;10,156,520</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;14,951,032</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--RentsExpense_i01I_zAqT0Vq6o0Lk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;1,076,069</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;73,676</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;1,149,745</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zd85oqp6Si21" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
selling, general and administrative expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,906,446</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;7,861,509</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;10,767,955</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zJGIWhp93SIc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Selling,
general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,777,027</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,091,705</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,868,732</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_zvgoRlZDs9i" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
costs and expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,287,118</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,061,607</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,348,725</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_zNyJ92lXc85a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income from operations</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,958,012</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,493,376</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,535,364</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zhAQNu6NDD22" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Investment
income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">120,387</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,006,052</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,126,439</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherIncome_i01_zxanVwLepIFa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Other
income (expenses)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">640,952</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(36,370</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">604,582</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_ztVcI96nKx56" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income before provision for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,196,673</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,463,058</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,266,385</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_zhTaKpsZkPN3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Provision
for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,788,028</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(380,940</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,168,968</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zk90qy0PsyY7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
(Loss) income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,984,701</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,082,118</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,097,417</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zg9dIGI9lyrh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Intersegment
net revenues *</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,073,333</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2206">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,073,333</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zKwyCPqTjJTd" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation
and amortization</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">238,802</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,357,619</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,596,421</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_ztOyj3w6ikrl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
identifiable assets</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,360,188</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">183,885,781</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">214,245,969</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zVZmutmiwEsj" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Capital
expenditures</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,885</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">789,961</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">822,846</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 2%; vertical-align: top">&#160;*</td>
<td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 98%; vertical-align: top">Amounts eliminated in consolidation</td></tr>
<tr style="vertical-align: bottom">
<td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top">**</td>
<td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top">Other segment costs include supplies, professional fees, marketing expenses, repairs and maintenance and other operational costs.</td></tr>
</table>


<p id="xdx_8AC_zXX8JpLPlUn9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Export Product Sales</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s areas of operations are principally
in the United States. The Company had export sales of medical equipment amounting to <span id="xdx_90B_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20240701__20250630_zASkbpQfzBm7" title="Export sales of medical equipment percentage">1.4</span>% and <span id="xdx_90E_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20230701__20240630_zzYS8b3O6ZXa" title="Export sales of medical equipment percentage">0.2</span>% of product sales revenues to third
parties for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foreign product sales, as a percentage of product
sales to unrelated parties, were made to customers in the following countries:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfExportProductSalesTableTextBlock_zktkVbGR99Kf" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B2_zDos5Oooi5Oj" style="display: none">Schedule of export product sales</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-indent: -10pt">Canada</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--ForeignProductSales_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zAFjhC2VJzWj" title="Foreign product sales"><span style="-sec-ix-hidden: xdx2ixbrl2238">&#8212;</span></span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_906_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zE8ravCbTAe" title="Foreign product sales">0.2</span></td>
<td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Puerto Rico</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zZOazIXJ73h2" title="Foreign product sales">1.4</span></td>
<td style="padding-bottom: 1pt; text-align: left">%</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zbrlHoQ089Pe" title="Foreign product sales"><span style="-sec-ix-hidden: xdx2ixbrl2244">&#8212;</span></span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_ecustom--ForeignProductSales_dp_c20240701__20250630_znq8yXaYTZj1" title="Foreign product sales">1.4</span></td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_ziHDOYYJSywg" title="Foreign product sales">0.2</span></td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p id="xdx_8A8_zrv5UTh21Oml" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Foreign Service and Repair Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s areas of service and repair are
principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to <span id="xdx_90A_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20240701__20250630_zfoHy8WBXIdf" title="Percentage of service and repair of medical equipment">7.7</span>% and <span id="xdx_905_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20230701__20240630_zm3J2HR3bxOg" title="Percentage of service and repair of medical equipment">7.4</span>%
of consolidated net service and repair fees for the years ended June 30, 2025 and 2024, respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Foreign Service and Repair Fees</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_zVvcKbfNzhj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zkoqgXrUWfsj" style="display: none">Schedule of Foreign Service and Repair Fees</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Puerto Rico</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--PR_zahWiMhoB0Pb" title="Foreign service and repair fees">1.3</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_zGBsn9gzUh3h" title="Foreign service and repair fees">1.9</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CH_zZ3RJee8l0m2" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5vTlo7PZQI9" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DE_z460oljBXZ4g" title="Foreign service and repair fees">3.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_z3cQptNL8l3a" title="Foreign service and repair fees">2.0</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">England</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zaYtPudlI672" title="Foreign service and repair fees">1.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_zh4W6et8D85f" title="Foreign service and repair fees">0.7</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">United Arab Emirates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AE_z03a2vakMff6" title="Foreign service and repair fees">0.1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zvFwShrcAT7" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Dominican Republic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DO_zLsvieGw6MK7" title="Foreign service and repair fees">1.2</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zSOqJjt6AuMg" title="Foreign service and repair fees">1.2</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Canada</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp0_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zgbYa5DcdHh6" title="Foreign service and repair fees">0.1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zbyunX35CtWf" title="Foreign service and repair fees"><span style="-sec-ix-hidden: xdx2ixbrl2282">&#8212;</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Greece</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GR_zXFceWHYfoz4" title="Foreign service and repair fees">0.4</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_zwczRDuYtm6a" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Australia</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AU_zY43EsoddYge" title="Foreign service and repair fees"><span style="-sec-ix-hidden: xdx2ixbrl2288">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zpKiWFhumPT4" title="Foreign service and repair fees">0.7</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630_zBTPo9XoCkGe" title="Foreign service and repair fees">7.7</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zis670RjOva8" title="Foreign service and repair fees">7.4</span>.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td>
    </tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p id="xdx_8A4_zj1Vf1KrNOdg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;The Company does not have any material assets
outside of the United States.&#160;<br/>
</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zZcabyD1Cvdc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 16 &#8211; <span id="xdx_824_zHpqgxAyOEL1">SUBSEQUENT EVENTS</span></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates events that have occurred after
the balance sheet date, but before the consolidated financial statements are issued.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On <span style="font-family: Times New Roman, Times, Serif">July
7, 2025, the board of directors received a non-binding proposal from a group led by Timothy Damadian, the Company&#8217;s Chief
Executive Officer, and Luciano Bonanni, the Company&#8217;s Chief Operating Officer, pursuant to which proposal the group would
acquire all of the outstanding common stock and other securities of the Company not currently owned by the members of the group.
Members of the group have voting control of the Company&#8217;s equity securities and the group advised the Company that it was
unwilling to support any alternative transaction. &#160;As proposed, the transaction, if completed, would result in the Company no
longer being a publicly held company, and its Common Stock would be de-listed from the NASDAQ Stock Market. &#160;The Board of
Directors has established a Special Committee of independent and disinterested directors to consider the proposal and negotiate on
behalf of the Company and its stockholders. The Special Committee has retained its own independent financial and legal advisors to
assist it in this process. The group and the Special Committee are engaged in negotiations related to the proposed going private
transaction. &#160;No definitive agreements or terms have been executed by the parties and there is no assurance that the
transaction will be completed. &#160;Any definitive agreement and transaction will require approval by the Company&#8217;s common
stock holders and will require the filing of definitive proxy materials in accordance with the SEC&#8217;s proxy rules to obtain
such approval. </span><span style="font-family: Times New Roman, Times, Serif">In July 2025, the Company entered into a new 10 year
lease for a property in New York where a new MRI is to be built</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_z5xPkgHj8hYa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_zx6kXp4uZd52">Principles of Consolidation</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





















<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--UseOfEstimates_zYc49DEOlEDc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_863_zYgLacFU6f57">Use of Estimates</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, and revenue recognition. In addition,
healthcare industry reforms and reimbursement practices will continue to impact the Company&#8217;s operations and the determination of
contractual and other allowance estimates. Actual results could differ from those estimates.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessPolicy', window );">Inventories</a></td>
<td class="text"><p id="xdx_841_eus-gaap--InventoryWorkInProcessPolicy_zOx1Y181YsB9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_zFZ9ThetLNwd">Inventories</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_847_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zFYfUM6zwBbf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zRC1ApUdAOxc">Property and Equipment</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment is stated at cost less accumulated
depreciation. Property and equipment purchased in connection with an acquisition is stated at its estimated fair value, generally based
on an appraisal. Property and equipment is being depreciated for financial accounting purposes using the straight-line method over their
estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon
retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts
and the resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to operations.
Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $<span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20240701__20250630_zPvUEDSVTEd3" title="Maintenance and repair expenses">2,751,000</span> and $<span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zSW98m5gQHsi" title="Maintenance and repair expenses">2,948,000</span> for the years
ended June 30, 2025 and 2024 respectively. The estimated useful lives in years are generally as follows:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zzRfNYFNcoyh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_z6ny7nwymeeb" style="display: none">Schedule of Estimated Useful Life in Years for Property and Equipment</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Estimated Useful Life in Years for Property and Equipment</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Diagnostic equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLUOWqTLUb0a">5</span>&#8211;<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z25tJH8zhlvh">13</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6nTPQReSsH2">3</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zNHPd6S4KXHa">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zXdHeCgwiGP9">2</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z6qnagveRi84">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zksgPFS2gqC">3</span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zCr1cYtEgT25">9</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgT9VqsgYLc4">5</span>&#8211;<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaYdZEw4QjCi">10</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt">Building</td>
<td style="width: 10%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 18%; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zD9A92kl2CT6">28</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A6_zUTC8Bz6IHGl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>























<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Other Intangible Assets</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z9eSjjxYZdtf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_869_zxgC1avudAai">Other Intangible Assets</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1) Patents and Copyrights</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Patent and copyrights are professional costs
incurred to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zJmhvKVVPtM" title="Finite-lived intangible asset, useful life">15 </span>years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2) Non-Competition Agreements</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (<span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPBsjlpky802" title="Finite-lived intangible asset, useful life">7</span> years).</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3) Customer Relationships</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zcjurrsJnO4" title="Finite-lived intangible asset, useful life">20</span> years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4) Software License</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Software license represents a license to improve the
image quality and efficiency of the MRI scanners. Amortization is calculated on the straight-line basis over 3 years.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_z0gpOauwkL85" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_865_zbHeehKjQ3k9">Goodwill</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.<br/></p>



























<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zw2Kb9FZsoO2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_863_zxgdpit5utq1">Revenue Recognition</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on sales contracts for scanners, included
in &#8220;product sales&#8221; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 606, &#8220;Revenue Recognition &#8211; Construction-Type
and Production-Type Contracts&#8221;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2024, the Company had unearned revenue
on service contracts of $3,870,229 of which all was recognized as revenue in the fiscal year ending June 30, 2025.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales (upgrades and supplies)
is recognized upon shipment.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue under management contracts is recognized based
upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various
medical providers (the &#8220;PCs&#8221;). As of June 30, 2025, the Company has <span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20250630_ztnifEM7T7Y8" title="Management agreements with company total medical practices">22</span> management agreements of which <span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20250630_z0JA4I1I8wD2" title="Scanners with management agreements with company owned by related party">3</span> were with PC&#8217;s
owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned by Raymond V. Damadian,
M.D., Chairman of the Board of FONAR until his unexpected death in August 2022) (&#8220;the Related medical practices&#8221;) and <span id="xdx_907_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20250630_zzPqbePjCJfh" title="Scanners with management with company located in new york state">19</span> are
with PC&#8217;s, which are all located in the state of New York (&#8220;the New York PC&#8217;s&#8221;), owned by four unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$<span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMinimum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zFaBwBpE3p8g" title="Contractual fees for services rendered minimum">70,000</span> to $<span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zOAiTymX0tk2" title="Contractual fees for services rendered Maximum">460,000</span>. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit
loss expense for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the FASB and codified in the ASC 606. The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#8217;s revenue recognition policies and significant judgments employed in the determination of revenue.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2025 and 2024 are summarized in the following table.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zapBwZWhb56k" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_zmol8u26VQ13" style="display: none">Schedule of patient fee
    revenue - net</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patient Fee Revenue - Net</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Commercial Insurance/ Managed Care</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zZud5cYCZia5" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,957,159</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z6IYnDScgTRf" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,952,712</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Medicare/Medicaid</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_z30m7YEAmVl1" style="text-align: right" title="Net Patient Fee Revenue">1,160,839</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zszHemWRubW7" style="text-align: right" title="Net Patient Fee Revenue">1,138,176</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Workers&#8217; Compensation/Personal Injury</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zcAZ74TLZso3" style="text-align: right" title="Net Patient Fee Revenue">19,876,923</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zSnjmVbFtc7" style="text-align: right" title="Net Patient Fee Revenue">20,673,483</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zUbUYJK57Pkk" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">7,184,525</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVrbYwT44pae" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">7,051,425</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Patient Fee Revenue</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630_zNAPiF0XqZ47" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">33,179,446</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zjGCwrRjABoc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">33,815,796</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p id="xdx_8AE_z5b9wb4amYcc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivablePolicyTextBlock', window );">Medical Receivable</a></td>
<td class="text"><p id="xdx_848_ecustom--MedicalReceivablePolicyTextBlock_zPIMLd4tJ5lb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86F_zazxmUxsiWZ2">Medical Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Medical receivables are due under fee-for-service
contracts from third-party payors, such as hospitals, government sponsored healthcare programs, patient&#8217;s legal counsel and directly
from patients. Substantially all the revenue relates to patients residing in Florida. Medical receivables are recorded at net realizable
value based on the estimated amounts the Company expects to receive from patients and third-party payers. The medical receivable is reduced
by an allowance for contractual adjustments based on the historical experience with each payor class at each location. The medical fee
receivable as of July 1, 2023 was $<span id="xdx_908_ecustom--MedicalFeeReceivable_iI_c20230702_zaZAh3y9yVR8" title="Medical fee receivable">21,259,262</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For LLCs owned by the Company, approximately <span id="xdx_90D_ecustom--RevenuePercentage_iI_dp_c20250630_zh33LI9cxjEf" title="revenue percentage">57</span>%
and <span id="xdx_90F_ecustom--RevenuePercentage_iI_dp_c20240630_z4l7dDmxJqp" title="revenue percentage">67%</span> of net revenues were derived from no-fault and personal injury protection for the years end June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>





















<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management and Other Fees Receivable</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#8220;CECL&#8221;) reserve to address the risk that a portion of the contractually obligated management fees receivable from the
PCs may not be collectible. The PC&#8217;s may be limited in their ability to pay the full management fee receivable if they do not collect
sufficient expected fees from third-party payors and patients. The Company&#8217;s management fees are collateralized, individually and
collectively, by the assets of the PCs. The CECL reserve is determined based on the difference between the management fee receivable and
the current amount of outstanding fees estimated to be collected by the PCs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s considerations into the estimate
of the PC&#8217;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#8217;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. Specifically, insurance carriers covering automobile
no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other disallowed
claims.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company combines an objective
and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves objectively
using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and then subjectively
adjusting for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for credit losses for the year ended June 30, 2025 was
$3,079,261. The provision for credit losses is attributable to scan volume at all the PC&#8217;s and the nature of the payor classes,
where there can be longer expected payment terms. Also, during the year ended June 30, 2025, the Company recorded an additional reserve
of approximately $2,300,000 for a specific receivable that is attributable to a American Transit Insurance Company (ATIC). This reserve
for credit losses relates specifically to ATIC, which owes no-fault insurance claims by the PCs to the PCs, which are collateral for the
Company&#8217;s management and other fees receivable. ATIC is a New York based motor vehicle insurer primarily focused on for-hire automobile
insurance. During Fiscal 2025, ATIC posted over $750 million in net losses and has indicated that they are approaching insolvency. ATIC
continues to operate and is working with the New York Department of Financial Services (DFS) to resolve its issues. We continue to monitor
the situation for new developments. However, at the time of this filing, DFS has not publicly announced approval of any plans for ATIC
to resolve its financial situation. In addition, Uber has filed a lawsuit against ATIC alleging they are not properly paying claims. Additional
legislation in New York City to reduce coverage minimums and increase premiums may help to resolve the crisis, but there is no certainty
these efforts will be successful. If ATIC enters receivership or suffers additional adverse consequences, we may need to take additional
reserves in the future. The management fee receivable
for unrelated and related parties as of July 1, 2023 was $<span id="xdx_908_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20230702_z3epp298HNv7" title="Management fee receivable for unrelated parties">35,888,253</span> and $<span id="xdx_902_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20230702_zcVLCbWvau8k" title="Management Fee Receivable For Related Parties">9,161,870</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_z2dAUxER9VI6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_864_z9QMwu03zeo5">Accounts Receivable</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Credit risk with respect to the Company&#8217;s accounts
receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the commencement
of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed on a monthly
or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The Company controls
credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process, credit limits, monitoring
procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before a product sales contract is
entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service contracts as of July 1,
2023 was $<span id="xdx_90B_ecustom--AccountsReceivableServiceContractsNet_iI_c20230702_zP1nChfqcFzc" title="Account receivable">4,571,597</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zHtlUHAE0r19" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_866_z41yjjbXl4fj">Research and Development Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><p id="xdx_846_eus-gaap--AdvertisingCostsPolicyTextBlock_zx0hhJU3GzG5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86E_z8yGLCjM6W79">Advertising Costs</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advertising costs are expensed as incurred. Advertising
expense approximated $ <span id="xdx_900_eus-gaap--AdvertisingExpense_c20240701__20250630_zy07m58XFKWj">773,000</span> and $<span id="xdx_907_eus-gaap--AdvertisingExpense_c20230701__20240630_zm5LK0BUGRx6">731,000</span> and for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zJjWVKExln06" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86C_zOGPd9JGMpb9">Income Taxes</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>





























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 740, &#8220;Accounting for Income Taxes&#8221;,
prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#8217;s tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#8220;Interest expense, net. Penalties
if incurred would be recognized as a component of &#8220;Selling, general and administrative&#8221; expenses. Penalties for the years
ended June 30, 2025 and June 30, 2024 were $<span id="xdx_90A_ecustom--Penalties_c20240701__20250630_zz9AvmFTMGk6" title="Penalties">0</span> and $<span id="xdx_907_ecustom--Penalties_c20230701__20240630_z7nnh1DiSjA" title="Penalties">20,444</span>, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerAdvancesPolicyTextBlock', window );">Customer Advances</a></td>
<td class="text"><p id="xdx_84B_ecustom--CustomerAdvancesPolicyTextBlock_zt4hi9zatzA2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_z7gmUlKx0OXc">Customer Advances</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zQGycvRWLJ9e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_znvzMFwkxOI2">Earnings Per Share</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic earnings per share (&#8220;EPS&#8221;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class Method&#8221;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2025 and 2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2025 and 2024, diluted EPS for common shareholders includes <span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20240701__20250630_zjNb4UsWTUV3" title="Conversion of Class C Common Stock"><span id="xdx_90A_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_z1OhV6G8wArg" title="Conversion of Class C Common Stock">127,504</span></span> shares upon conversion of
Class C Common.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

























<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXgrVghbjdB7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zrMYGGMVn0hh" style="display: none">Schedule of earnings per share</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Preferred <br/>&#160; <br/>Stock</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="text-decoration: underline">Numerator:</span></td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Net income available to common stockholders</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630_zwXbEOpHQRm" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">8,334,261</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHQ0bwZGoRul" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">7,802,352</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zTbMk0MKQADd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">135,467</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zOWRlysqdos5" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">396,443</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Denominator:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted average shares outstanding</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630_z4c3GDKwWT9b" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,906,803</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7R8N2jl43U3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,210,852</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCw1jHBpm25h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zO7lozDT1tS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">313,438</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic income per common share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630_zYJDkImOYcv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.21</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zK59KB7k5em4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.26</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zYUM1NLAtzjh" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.35</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zo7FZ3bjowV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.26</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt">Diluted</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt">Denominator:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted average shares outstanding</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zI5vTOBCSz0j" style="text-align: right" title="Weighted average shares outstanding">6,210,852</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zF2JaGEfpWe5" style="text-align: right" title="Weighted average shares outstanding">382,513</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class C Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcPDQCeFugrf" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_z2aZ6uU4BtZ6" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Denominator for diluted earnings per share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zj5GfCXGL8Hl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,338,356</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zgEFnhclg7m7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Diluted income per common share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5Dc9qQOYSRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.23</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zX4OulzKmGXi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.35</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Preferred <br/>&#160; <br/>Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="text-decoration: underline">Numerator:</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Net income available to common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630_zxqVKlA1jCY9" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">10,567,396</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlznrJUeKC27" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">9,908,920</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCg0idGNEmU1" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">167,700</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zxCM8hZqgwFa" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">490,776</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zI0FmbgqMxUg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">7,046,959</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuHuh97pIZ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,351,008</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztvCZaYHkyU8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zjgiMv3bpst2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">313,438</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_z0Bwby6RQfU2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVrQ7Azo2Gs7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztoADeqDrIP4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zCN37m1AK22f" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.57</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zruxKYiA6jC1" style="text-align: right" title="Weighted average shares outstanding">6,351,008</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zXVyct5TGptj" style="text-align: right" title="Weighted average shares outstanding">382,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsbWP3Ab8yRg" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zhcHa2K3gRM1" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQsK8CJDkgC7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,478,512</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zK9uAEAPE7O1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYlkrMwYg6H" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zUZzwVpni9qh" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><br/>
</span></p>

<p id="xdx_8AF_zWzuXeV2zvI8" style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>























<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zksvfpjlvW22" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_864_zIURIV2GEw48">Cash and Cash Equivalents</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zJBdbK2KByyl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_861_z3MGEx6a1zh4">Short-Term Investments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z64eE4JWji8a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86F_zXte6nDBFVG1">Concentration of Credit Risk</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2025, the Company had cash
on deposit of approximately $<span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20250630_zQ3URKgZSaad" title="Cash deposit">53,676,000</span> in excess of federally insured limits of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20250630_zzM4L0gibjxe" title="Federally insured limits">250,000</span>.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Related Parties: Net revenues from related parties
accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zb90mruYegCi" title="Concentration risk, percentage"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zkRDkTkOHw8" title="Concentration risk, percentage">12</span></span>% of the consolidated net revenues for the years ended June 30, 2025 and 2024. Net management fee receivables
from the related party medical practices accounted for approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zTYTSQcAQ5" title="Concentration risk, percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zlOJ8OY6S8Le" title="Concentration risk, percentage">12</span></span>% of the consolidated accounts receivable as of June 30, 2025 and
2024.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the years ended June 30, 2025 and June 30, 2024,
the Company made purchases from two vendors that accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zRVL8LyNfHm" title="Concentration risk, percentage">36%</span> and<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zoQXcPBtgjJ3" title="Concentration risk, percentage"> 0%</span> of total purchases, respectively.</p>
<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See Note 3 regarding the Company&#8217;s concentrations
in the healthcare industry.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z06zC8G5lp3l" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_86F_zRdQdhudXtik">Fair Value of Financial Instruments</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures fair value in accordance with
ASC 820-10, &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>



























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of the Company&#8217;s financial instruments are
held for purposes other than trading.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>





<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>





















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards</a></td>
<td class="text"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zkiejRFiZPTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_868_z6k5RBXXeNh3">Recently Adopted Accounting Standards</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, The Financial Accounting Standards Board (&#8220;FASB&#8221;)
issued ASU 2023-09, &#8220;Income Taxes (740) &#8220;Improvements to Income Tax Disclosures&#8221;, which requires the annual financial
statements to include consistent categories and great disaggregation of information in the rate reconciliation and income taxes paid disaggregated
by jurisdiction. ASU 2023-09 is effective for the Company&#8217;s annual reporting beginning after December 15, 2024, with early adoption
permitted, and should be applied on a prospective basis, with a retrospective option. The Company recently adopted this ASU retrospectively
for the year ended June 30, 2025 and 2024 and it impacts only our disclosures with no impacts to our financial condition and results of
operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, FASB issued ASU 2023-07, &#8220;Segment
Reporting (Topic 280)&#8221;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company adopted ASU for the year ended June 30,
2025 and it impacts only our disclosures with no impacts to our financial condition and results of operations.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2024, the FASB issued ASU 2024-03, &#8220;Income
Statement &#8211; Reporting Comprehensive Income &#8211; Expense Disaggregation Disclosures&#8221; (Subtopic 220-40): Disaggregation of
Income Statement Expenses&#8221;. This ASU requires disaggregation of certain income statement expense captions into specified categories
to be disclosed within the notes to the financial statements, but does not change the expense captions on the income statement. The amendments
in this ASU are to be applied prospectively, although retrospective application is permitted, and is effective for annual financial statements
starting in fiscal 2028 and interim periods starting in fiscal 2029, with early adoption permitted. The Company is currently evaluating
the effect that the adoption of ASU 2024-03 will have on our disclosures.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2025 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#8217;s financial accounting
measures or disclosures had they been in effect during 2025 or 2024, and it does not believe that any of those standards will have a significant
impact on the Company&#8217;s consolidated financial statements at the time they become effective.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerAdvancesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerAdvancesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock', window );">Schedule of Estimated Useful Life in Years for Property and Equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zzRfNYFNcoyh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_z6ny7nwymeeb" style="display: none">Schedule of Estimated Useful Life in Years for Property and Equipment</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Estimated Useful Life in Years for Property and Equipment</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Diagnostic equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLUOWqTLUb0a">5</span>&#8211;<span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z25tJH8zhlvh">13</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6nTPQReSsH2">3</span>-<span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zNHPd6S4KXHa">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zXdHeCgwiGP9">2</span>-<span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z6qnagveRi84">7</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zksgPFS2gqC">3</span>-<span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zCr1cYtEgT25">9</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgT9VqsgYLc4">5</span>&#8211;<span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaYdZEw4QjCi">10</span></span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt">Building</td>
<td style="width: 10%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 18%; text-align: right"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zD9A92kl2CT6">28</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of patient fee revenue - net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zapBwZWhb56k" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_zmol8u26VQ13" style="display: none">Schedule of patient fee
    revenue - net</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patient Fee Revenue - Net</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Commercial Insurance/ Managed Care</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zZud5cYCZia5" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,957,159</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z6IYnDScgTRf" style="width: 12%; text-align: right" title="Net Patient Fee Revenue">4,952,712</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Medicare/Medicaid</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_z30m7YEAmVl1" style="text-align: right" title="Net Patient Fee Revenue">1,160,839</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zszHemWRubW7" style="text-align: right" title="Net Patient Fee Revenue">1,138,176</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Workers&#8217; Compensation/Personal Injury</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zcAZ74TLZso3" style="text-align: right" title="Net Patient Fee Revenue">19,876,923</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zSnjmVbFtc7" style="text-align: right" title="Net Patient Fee Revenue">20,673,483</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zUbUYJK57Pkk" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">7,184,525</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVrbYwT44pae" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue">7,051,425</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net Patient Fee Revenue</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630_zNAPiF0XqZ47" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">33,179,446</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zjGCwrRjABoc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue">33,815,796</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXgrVghbjdB7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zrMYGGMVn0hh" style="display: none">Schedule of earnings per share</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Preferred <br/>&#160; <br/>Stock</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="text-decoration: underline">Numerator:</span></td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Net income available to common stockholders</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630_zwXbEOpHQRm" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">8,334,261</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHQ0bwZGoRul" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">7,802,352</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zTbMk0MKQADd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">135,467</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td>
<td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zOWRlysqdos5" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">396,443</td>
<td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Denominator:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted average shares outstanding</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630_z4c3GDKwWT9b" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,906,803</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7R8N2jl43U3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,210,852</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCw1jHBpm25h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zO7lozDT1tS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">313,438</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Basic income per common share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630_zYJDkImOYcv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.21</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zK59KB7k5em4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.26</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zYUM1NLAtzjh" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.35</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zo7FZ3bjowV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.26</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt">Diluted</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt">Denominator:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted average shares outstanding</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zI5vTOBCSz0j" style="text-align: right" title="Weighted average shares outstanding">6,210,852</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zF2JaGEfpWe5" style="text-align: right" title="Weighted average shares outstanding">382,513</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class C Common Stock</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcPDQCeFugrf" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_z2aZ6uU4BtZ6" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Denominator for diluted earnings per share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zj5GfCXGL8Hl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,338,356</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zgEFnhclg7m7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Diluted income per common share</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5Dc9qQOYSRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.23</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zX4OulzKmGXi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.35</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">Basic</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Preferred <br/>&#160; <br/>Stock</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="text-decoration: underline">Numerator:</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Net income available to common stockholders</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630_zxqVKlA1jCY9" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">10,567,396</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlznrJUeKC27" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">9,908,920</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCg0idGNEmU1" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">167,700</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 3%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zxCM8hZqgwFa" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders">490,776</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zI0FmbgqMxUg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">7,046,959</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuHuh97pIZ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">6,351,008</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztvCZaYHkyU8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zjgiMv3bpst2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic">313,438</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Basic income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_z0Bwby6RQfU2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVrQ7Azo2Gs7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztoADeqDrIP4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zCN37m1AK22f" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share">1.57</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Weighted average shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zruxKYiA6jC1" style="text-align: right" title="Weighted average shares outstanding">6,351,008</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zXVyct5TGptj" style="text-align: right" title="Weighted average shares outstanding">382,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Class C Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsbWP3Ab8yRg" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">127,504</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zhcHa2K3gRM1" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Denominator for diluted earnings per share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQsK8CJDkgC7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">6,478,512</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zK9uAEAPE7O1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share">382,513</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Diluted income per common share</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYlkrMwYg6H" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">1.53</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zUZzwVpni9qh" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share">0.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><br/>
</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">Schedule of Long Term Accounts Receivable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zXijzGO5ESQb" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B5_z0cZf7ccVUwa" style="display: none">Schedule of Long Term Accounts Receivable</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Receivables - Non Current - net</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: left; text-indent: -10pt">2027</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20250630_zY1nO0he1iA7" style="width: 43%; text-align: right" title="2026">1,592,426</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20250630_zl2ff3MRTrt8" style="text-align: right" title="2027">1,031,910</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20250630_zk37cIAqVCyj" style="text-align: right" title="2028">831,660</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">2030</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20250630_z5ycbIwXvoMk" style="border-bottom: Black 1pt solid; text-align: right" title="2029">344,750</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20250630_zSm0CQJJejm6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">3,800,746</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Schedule of Summary of Allowance For Credit Losses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zEJmGmLG4PJe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zUYzCKeQzSsh" style="display: none">Schedule of Summary of Allowance For Credit Losses</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td colspan="17" style="text-align: center">Summary of Allowance For Credit Losses</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Description</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance<br/> June 30, 2024</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions (1)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Balance <br/> June 30, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Accounts receivable</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0ij1s42VJQd" style="width: 10%; text-align: right" title="Beginning Balance">166,049</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z4bTZ0RWGBEd" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)">107,330</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zR9jL8mRuUBc" style="width: 10%; text-align: right" title="Deductions">9,167</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znv4xfD8zong" style="width: 10%; text-align: right" title="Ending Balance">264,212</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zUTSyg7wxChi" style="text-align: right">12,369,921</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z1DWoU1Je85" style="text-align: right">2,052,824</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBPQGFy8jqg3" style="text-align: right">126,757</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zvqySRTABHDh" style="text-align: right">14,295,988</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable - related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztVQkHz0Nx7i" style="text-align: right">6,110,399</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z4UevtFf3qFg" style="text-align: right">1,026,437</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzYUj6zpTFf2" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zdaOks82DPNf" style="text-align: right">7,136,836</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zG80mJzulSue" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zhXdF15EnE15" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zrQhCXjOSeF" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zBgaNioATN1k" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1152">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">Balance</td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Description</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2023</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Additions(Recovery)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Deductions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Accounts receivable</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_za0anvkO7yyi" style="width: 10%; text-align: right">198,593</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zTw9SA4YlWd6" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1154">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqc1aNYDTOK" style="width: 10%; text-align: right">32,544</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqIYwzzax14" style="width: 10%; text-align: right">166,049</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zgO2HKHEL1H2" style="text-align: right">12,608,567</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zLFpcnnnG5Rj" style="text-align: right">(238,646</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNp2SFKHPxX1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1159">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEUUIksXct8j" style="text-align: right">12,369,921</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Management and other fees receivable - related medical practices</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zq8rRjBmtWvk" style="text-align: right">3,989,692</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z99NIK7R5Al9" style="text-align: right">2,120,707</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zKWIlhQq0Uvg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1163">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzPXJe4kndel" style="text-align: right">6,110,399</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes receivable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zNhNbhaSE1ma" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zA3FJdF8vJwb" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zXwWgWj5i4Gl" style="text-align: right">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zsonrgb7xAri" style="text-align: right">777,354</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4px; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">(1)</span></td>
    <td style="padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Included in provision for credit losses.</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock', window );">Schedule of facilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zOv85HqtP6ba" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B1_zQpHJjCYPWUi" style="display: none">Schedule of facilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_498_20240701__20250630_z126F3J4Yx3f" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_493_20230701__20240630_zIawC8tkkTwh" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zD376GVhfX8h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Total Facilities Owned or Managed (at Beginning of Year)</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">28</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right">27</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Facilities Added by:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z99TkL8sA8S7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Internal development</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1191">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">1</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zrsS1XQIBhVa" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Managed Facilities Closed</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_zjB1j5c3yxQ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total Facilities Owned or Managed (at End of Year)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">28</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">28</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zXfuasFLh8Y3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BF_zLeNHzBUWhj6" style="display: none">Schedule of inventories</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20250630_zpqQ2Y1skoLc" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_493_20240630_zkiufqQwbpMa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_z4C251s1UJ5f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Purchased parts and components</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">2,630,439</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">2,524,201</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zczgmYK1Nqy8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Work-in-process</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">182,243</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">191,240</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_z5v0Y3GQUwd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Inventories</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">2,812,682</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">2,715,441</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zhQrThtXHej6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B2_zf0Yg3aSYLDj" style="display: none">Schedule of Property and equipment</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Diagnostic equipment</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zK9QK5pEKOR3" style="width: 12%; text-align: right" title="Property plant and equipment, gross">35,276,823</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zYuokfAvcAS" style="width: 12%; text-align: right" title="Property plant and equipment, gross">33,243,694</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Research, development and demonstration equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zJSildhDTxqc" style="text-align: right" title="Property plant and equipment, gross">6,490,872</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_z1qEXteKY4G" style="text-align: right" title="Property plant and equipment, gross">6,199,941</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Machinery and equipment</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zMc7k7RwnCz9" style="text-align: right" title="Property plant and equipment, gross">2,128,398</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zfqYNyooTeNd" style="text-align: right" title="Property plant and equipment, gross">2,069,055</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Furniture and fixtures</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzCw7Tco2Gtj" style="text-align: right" title="Property plant and equipment, gross">3,756,017</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ziy0RbjYTIaj" style="text-align: right" title="Property plant and equipment, gross">3,742,169</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Leasehold improvements</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zlZRvCL1gT26" style="text-align: right" title="Property plant and equipment, gross">17,707,234</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zDg71aaJXVU" style="text-align: right" title="Property plant and equipment, gross">16,312,904</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Building</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zXYkJLFbbe3c" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross">939,614</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zethhpJzCrk5" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross">939,614</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630_zT6kwXaazpdf" style="text-align: right" title="Property plant and equipment, gross">66,298,958</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zUfqB06j7V33" style="text-align: right" title="Property plant and equipment, gross">62,507,377</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less: Accumulated depreciation and amortization</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20250630_zhRXJINJqTW7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization">47,767,039</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zCHOg3CwHw34" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization">43,798,457</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20250630_zYiilL7oZRu2" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net">18,531,919</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zP8Phe8iKCX1" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net">18,708,920</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING AND FINANCE LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract', window );"><strong>Operating And Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease and Finance Lease Payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDxsI4Y1txYj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span id="xdx_8B1_zyWAFiHIlaTj" style="display: none">Schedule of Operating Lease and Finance Lease Payments</span></td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Year Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Operating Lease Payments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Finance Lease Payments</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: center; text-indent: -10pt">2026</td><td style="width: 1%; text-align: center">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zWDafO3P5Mpc" style="width: 26%; text-align: right" title="2025">5,753,674</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zdM46sjVWWO8" style="width: 26%; text-align: right" title="2025">244,343</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2027</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpHOsA8i0Oxf" style="text-align: right" title="2026">5,718,999</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zz6FVYs7zQk9" style="text-align: right" title="2026">142,534</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2028</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z2pSmtSplgo4" style="text-align: right" title="2027">5,629,193</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zapwCpj5pNOh" style="text-align: right" title="2027"><span style="-sec-ix-hidden: xdx2ixbrl1288">&#8212;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2029</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zvxWe8aR5wXa" style="text-align: right" title="2028">5,240,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zgi9a6oLwg2d" style="text-align: right" title="2028">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2030</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zyOQhJ3L78I2" style="text-align: right" title="2029">5,120,717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z4fS9Ud9lM6" style="text-align: right" title="2029">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziPkLtEvicAc" style="text-align: right" title="Thereafter">25,496,885</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpJoeYoMem4k" style="text-align: right" title="Thereafter">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Present value discount</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--PresentValueDiscount_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zwtqB5IIYRWk" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount">(14,427,905</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBCRri7I40T7" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount">(117</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Total lease liability</span></td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zkj0dvleg71l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability">38,531,582</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--FinanceLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zEn4RLK9fS0l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability">386,760</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock', window );">Schedule of Weighted Average Remaining Lease Term</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_z3eDopoWTWJj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_zTgX3n0ZahDd" style="display: none">Schedule of Weighted Average Remaining Lease Term</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">As of June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating leases - years</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zHlomr5OInP6" title="Operating leases - years">10.2</span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zSLNi8IY6hMl" title="Operating leases - years">11.0</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Finance lease - years</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zi92dpfFY5si" title="Finance lease - years">1.6</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zOCJPz0V9nag" title="Finance lease - years">2.6</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Weighted Average Discount Rate</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Operating leases</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_zyFv1teZ9Irk" title="Weighted average discount rate, operating leases">6.5</span></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zzJorkakxBe6" title="Weighted average discount rate, operating leases">6.4</span></td>
<td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Finance lease</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_904_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_z4fe2RW4uQRb" title="Weighted average discount rate, finance leases">3.6</span></td>
<td style="text-align: left">%</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span id="xdx_90F_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zhSBSeTbvqc8" title="Weighted average discount rate, finance leases">3.6</span></td>
<td style="text-align: left">%</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of supplemental cash flow information related to leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zljEX1DG6Aqe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt; width: 56%"><span id="xdx_8BE_zAgY4K5dylD1" style="display: none">Schedule of components of lease expense</span> </td>
<td style="width: 8%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td>
<td id="xdx_498_20240701__20250630_zwJTsmfnQdb" style="text-align: right; width: 12%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td>
<td id="xdx_498_20230701__20240630_zFFQzwnCo355" style="text-align: right; width: 12%">&#160;</td>
<td style="text-align: left; width: 1%">&#160;</td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Components of lease expense</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating lease cost</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">6,110,496</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">5,685,008</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zNsu6kYYDVx5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Finance lease cost:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zC2enzvr4oii" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Depreciation of leased equipment</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">198,881</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">198,881</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Interest on lease liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">16,812</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">26,534</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_zS5IjtXWMVfi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total finance lease cost</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">215,693</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">225,415</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0"></p>

























<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Supplemental cash flow information related to leases
was as follows:</span></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z2nLlQ5RQM4d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BA_zYxWJuZ5EVlj" style="display: none">Schedule
    of supplemental cash flow information related to leases</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20240701__20250630_zFX1nnOT7YRi" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_495_20230701__20240630_zY41PWDBBtBa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Supplemental cash flow information related to leases</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Cash paid for amounts included in the measurement of lease liabilities:</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zo6hVNilhBz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating cash flows from operating leases</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">5,729,571</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">6,363,561</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zUp3F5j14cah" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Financing cash flows from finance leases</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">264,705</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">244,344</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zdnfXNxVLRrk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Right-of-use and equipment assets obtained in exchange for lease obligations:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zFx4RM1MNeek" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Operating leases</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">2,319,913</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">3,715,138</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for operating leases approximated $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240701__20250630_zpkqqDqSdoMc" title="Operating leases">6,110,000</span>
and $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zXAIAMTZgLl3" title="Operating leases">5,685,000</span>, for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for the finance lease approximated
$<span id="xdx_901_eus-gaap--LeaseIncome_c20240701__20250630_z0t45OaNfeZ" title="financing lease">216,000</span> and $<span id="xdx_906_eus-gaap--LeaseIncome_c20230701__20240630_zWb0iyuHy9V6" title="financing lease">225,000</span> for the years ended June 30, 2025 and 2024, respectively.&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock', window );">Schedule of supplemental cash flow information related to leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z2nLlQ5RQM4d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BA_zYxWJuZ5EVlj" style="display: none">Schedule
    of supplemental cash flow information related to leases</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_499_20240701__20250630_zFX1nnOT7YRi" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_495_20230701__20240630_zY41PWDBBtBa" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Supplemental cash flow information related to leases</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For Year Ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Cash paid for amounts included in the measurement of lease liabilities:</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zo6hVNilhBz3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating cash flows from operating leases</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">5,729,571</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">6,363,561</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zUp3F5j14cah" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Financing cash flows from finance leases</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">264,705</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">244,344</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zdnfXNxVLRrk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Right-of-use and equipment assets obtained in exchange for lease obligations:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zFx4RM1MNeek" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Operating leases</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">2,319,913</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">$</td>
<td style="text-align: right">3,715,138</td>
<td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for operating leases approximated $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240701__20250630_zpkqqDqSdoMc" title="Operating leases">6,110,000</span>
and $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zXAIAMTZgLl3" title="Operating leases">5,685,000</span>, for the years ended June 30, 2025 and 2024, respectively.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Rent expense for the finance lease approximated
$<span id="xdx_901_eus-gaap--LeaseIncome_c20240701__20250630_z0t45OaNfeZ" title="financing lease">216,000</span> and $<span id="xdx_906_eus-gaap--LeaseIncome_c20230701__20240630_zWb0iyuHy9V6" title="financing lease">225,000</span> for the years ended June 30, 2025 and 2024, respectively.&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinanceLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of other intangible assets, net of accumulated amortization</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_ze6jecy5jy7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zjdKFLW30TPa" style="display: none">Schedule of other intangible assets, net of accumulated amortization</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted average useful lives</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Gross carrying amount &#8211; June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Accumulated amortization &#8211; June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Net carrying amount &#8211; June 30, 2025</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Capitalized software development costs</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 10%; text-align: right">&#160;&#160;<span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zcxLjNHjo9sb" title="Weighted average useful lives">5</span> years</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zccub73dIco1" style="width: 10%; text-align: right" title="Gross other intangible assets">7,004,847</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zenFCJDbiTWe" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets">(7,004,847</td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zNf0GA3B27F1" style="width: 10%; text-align: right" title=" intangible assets net"><span style="-sec-ix-hidden: xdx2ixbrl1388">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Software License</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zIdQ5TNLS9t7" title="Weighted average useful lives">3</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zs2WTzhFVN68" style="text-align: right" title="Gross other intangible assets">1,260,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z7gmBJxtnlga" style="text-align: right" title="Accumulated amortization intangible assets">(756,000</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z9S58DXrYEbc" style="text-align: right" title=" intangible assets net">504,000</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patents and copy rights</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zXsn4jzgsvt8" title="Weighted average useful lives">15</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmqbV8MRz8t3" style="text-align: right" title="Gross other intangible assets">5,229,429</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zoVolr2puTpb" style="text-align: right" title="Accumulated amortization intangible assets">(4,255,393</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zDMJRimb7izl" style="text-align: right" title=" intangible assets net">974,036</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Non-compete</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_904_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zUlA3pNL0DF8" title="Weighted average useful lives">7</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfwnnbDZAip7" style="text-align: right" title="Gross other intangible assets">4,150,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zulGgrVw5Zol" style="text-align: right" title="Accumulated amortization intangible assets">(4,150,000</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zepyzPDKoKfd" style="text-align: right" title=" intangible assets net"><span style="-sec-ix-hidden: xdx2ixbrl1412">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Customer relationships</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_908_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zh8vu5XvfQ22" title="Weighted average useful lives">20</span> years</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmU99ITjAMi3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets">3,900,000</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsNkcMF7qdAk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets">(2,385,833</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKxPB3QSMXV6" style="border-bottom: Black 1pt solid; text-align: right" title=" intangible assets net">1,514,167</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630_zFfyRNB2Xypi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets gross">21,544,276</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630_zaHDM4krr7wd" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets">(18,552,073</td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630_zUDro6zeOWLi" style="border-bottom: Black 2.5pt double; text-align: right" title=" intangible assets net">2,992,203</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Weighted average useful lives</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Gross carrying amount &#8211; June 30, 2024</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Accumulated amortization &#8211; June 30, 2024</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Net carrying amount &#8211; June 30, 2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Capitalized software development costs</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 10%; text-align: right">&#160;&#160;<span id="xdx_909_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuHnLpF844F6" title="Weighted average useful lives">5</span> years</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zkdToiDAbXdi" style="width: 10%; text-align: right" title="Gross other intangible assets">7,004,847</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zwOYD4f6kkBl" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets">(7,004,847</td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhwffGuiU8hg" style="width: 10%; text-align: right" title=" intangible assets net"><span style="-sec-ix-hidden: xdx2ixbrl1434">&#8212;</span></td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patents and copy rights</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zyn1e9LBAJt6" title="Weighted average useful lives">15</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zPaBw6qvJiz8" style="text-align: right" title="Gross other intangible assets">5,259,811</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zwKxMwYWS5C9" style="text-align: right" title="Accumulated amortization intangible assets">(4,103,654</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpryeG6JUIO9" style="text-align: right" title=" intangible assets net">1,156,157</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Non-compete</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_907_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z23R4E4QgYL1" title="Weighted average useful lives">7</span> years</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zS0aXBWjl8th" style="text-align: right" title="Gross other intangible assets">4,150,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPx3nknpgai8" style="text-align: right" title="Accumulated amortization intangible assets">(4,150,000</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWacoQ7pjq9b" style="text-align: right" title=" intangible assets net"><span style="-sec-ix-hidden: xdx2ixbrl1450">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Customer relationships</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CostomerRelationshipsMember_zIr2O851xmgb" title="Weighted average useful lives">20</span> years</span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5jpHyQUy8o5" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets">3,900,000</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXMVF3Q2PLof" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets">(2,185,833</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDUXS7F6ngUk" style="border-bottom: Black 1pt solid; text-align: right" title=" intangible assets net">1,714,167</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zEeNu0QefyF7" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets gross">20,314,658</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_ztndbXvjdv91" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets">(17,444,334</td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zR5LdadD7Pbg" style="border-bottom: Black 2.5pt double; text-align: right" title=" intangible assets net">2,870,324</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of estimated amortization of other intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zL4CB7bn6WA6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span id="xdx_8B8_zXfFJHBEFVI" style="display: none">Schedule of estimated amortization of other intangible assets</span></td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Schedule Of Other Intangible Assets For the Years Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Software License</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Patents and Copyrights</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Customer Relationships</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 23%; text-align: center; text-indent: -10pt">2026</td><td style="width: 1%; text-align: center">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630_zCCOdsJlVbll" style="width: 14%; text-align: right" title="2025">756,880</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zdwFGC3NAu84" style="width: 14%; text-align: right" title="2025">420,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zr0THmwWgClg" style="width: 14%; text-align: right" title="2025">136,880</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5ZEtCVj8JJd" style="width: 14%; text-align: right" title="2025">200,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2027</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630_zgLcCYoSisD3" style="text-align: right" title="2026">402,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zsXJcdAqVhZc" style="text-align: right" title="2026">84,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zCcqbtaWH4" style="text-align: right" title="2026">118,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zJDzhMS8sD2i" style="text-align: right" title="2026">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2028</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630_zp71AsATWC58" style="text-align: right" title="2027">306,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zqM2uyzgpzca" style="text-align: right" title="2027"><span style="-sec-ix-hidden: xdx2ixbrl1496">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zJQ67hcmp083" style="text-align: right" title="2027">106,103</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z46a9Lcsf8Rf" style="text-align: right" title="2027">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2029</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630_zYTCc38ldubk" style="text-align: right" title="2028">295,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zUHrCSjwdsOd" style="text-align: right" title="2028"><span style="-sec-ix-hidden: xdx2ixbrl1504">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zExzTjdojVo4" style="text-align: right" title="2028">95,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvA4gKxrJVQ7" style="text-align: right" title="2028">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">2030</td><td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630_znyGkY0Rl8T7" style="text-align: right" title="2029">291,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zU31l1ljdJgg" style="text-align: right" title="2029"><span style="-sec-ix-hidden: xdx2ixbrl1512">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zDgEwO9Sn4pb" style="text-align: right" title="2029">91,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvSZI8HnqoM5" style="text-align: right" title="2029">200,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Thereafter</span></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630_zDTUNpSSRAhd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">939,432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zduRQIijkgnb" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"><span style="-sec-ix-hidden: xdx2ixbrl1520">&#8212;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zeibptIFYaTd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">425,265</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zePM4ZpuYHK4" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter">514,167</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Other intangible assets - net</span></td><td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630_zEj0yRJlnV37" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">2,992,203</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zylRkfbEs2ua" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">504,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zTIbmCIdVqvf" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">974,036</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyxLZ2YzBNZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net">1,514,167</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of other intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zrN1IKH3zeIj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zRoyqIjQvYx1" style="display: none">Schedule of other
    intangible assets</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other Intangible Assets</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td>
<td>&#160;</td>
<td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year-ended June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Balance &#8211; Beginning of Year</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20240701__20250630_zPr8UzMW4XF6" style="width: 12%; text-align: right" title="Balance - Beginning of Year">2,870,324</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zThxwgeLT55b" style="width: 12%; text-align: right" title="Balance - Beginning of Year">3,431,865</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Amounts capitalized</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--AmountsCapitalized_pp0p0_c20240701__20250630_zj02muTNgbPk" style="text-align: right" title="Amounts capitalized">25,325</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zo9yVbNL1SA5" style="text-align: right" title="Amounts capitalized">32,885</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Patents written off</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20240701__20250630_zKST22nSdIVi" style="text-align: right" title="Patents written off">(55,707</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20230701__20240630_zEDW1XF8MExa" style="text-align: right" title="Patents written off">(225,419</td>
<td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Correction of an error (Note 2)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--CorrectionOfError_pp0p0_c20240701__20250630_zJx9QIn2tu66" style="text-align: right" title="Correction of an error">882,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_987_ecustom--CorrectionOfError_pp0p0_c20230701__20240630_zUbBj2Bx5eC9" style="text-align: right" title="Correction of an error"><span style="-sec-ix-hidden: xdx2ixbrl1552">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Amortization</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_980_eus-gaap--AdjustmentForAmortization_pp0p0_c20240701__20250630_zJWS5jv7WHnc" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization">(729,739</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_987_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zySzxFdKmeq9" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization">(369,007</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Balance &#8211; End of Year</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_981_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20240701__20250630_zCpYmqM2OMs" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year">2,992,203</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zZh2Rb5CEhta" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year">2,870,324</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Schedule of HDM members equity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zpwpGT1apE59" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><span id="xdx_8B6_ztEq0iopB5sf" style="display: none">Schedule of HDM members equity</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class A Members</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Class B Member</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Opening Members&#8217; Equity</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">($</td>
<td id="xdx_98A_ecustom--OpeningMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_znAiHf3KbFXi" style="width: 10%; text-align: right" title="Opening Members Equity">9,179,608</td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zOzt0JgVBvH5" style="width: 10%; text-align: right" title="Opening Members Equity">61,817,830</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">($</td>
<td id="xdx_98B_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zy1PfSKSslRl" style="width: 10%; text-align: right" title="Opening Members Equity">7,079,293</td>
<td style="width: 1%; text-align: left">)</td>
<td style="width: 3%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td id="xdx_989_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zL92Du8S0pFc" style="width: 10%; text-align: right" title="Opening Members Equity">54,781,813</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Share of Net Income</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zN67kbqHXNg5" style="text-align: right" title="Share of Net Income">2,339,172</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_983_ecustom--ShareOfNetIncome_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zsL9ATWwlLxl" style="text-align: right" title="Share of Net Income">16,727,492</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_986_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zp0r4EGY1gOh" style="text-align: right" title="Share of Net Income">3,530,021</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf3oB7e51JX" style="text-align: right" title="Share of Net Income">20,705,681</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Buyout of noncontrolling interests</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterests_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZ4IGG0V58N4" style="text-align: right" title="Buyout of noncontrolling interests">19,425</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zjbgjtgpquH5" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_985_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8h5a5quHYp9" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_98B_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWRKx4RFYZo3" style="text-align: right" title="Buyout of noncontrolling interests">&#8212;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Distributions</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zmRjD8Qqi74j" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(5,682,555</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_98D_ecustom--Distributions_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zw7Jo6pay2Zh" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(13,717,445</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_986_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVUBnojSS3H5" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(5,630,336</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td id="xdx_980_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_ztvFqtzuEfn8" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions">(13,669,664</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Ending Members&#8217; Equity</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">($</td>
<td id="xdx_985_ecustom--EndingMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zY4atZ3U5BTe" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">12,503,566</td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_983_ecustom--EndingMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zXmeCBvFCRB" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">64,827,877</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">($</td>
<td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKfVE2Zz3Olb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">9,179,608</td>
<td style="padding-bottom: 2.5pt; text-align: left">)</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td id="xdx_98D_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZYNXjJopy5k" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity">61,817,830</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock', window );">Schedule of Components of the provision for income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock_zz2bPnivJCki" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B4_zVYIGvubxmBc" style="display: none">Schedule of Components of the provision for income taxes</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20240701__20250630_zNWfMiMq1BGj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20230701__20240630_zhGo1SbZ6RSg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center">Components Of The Provision For Income Taxes</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Years Ended June 30,</td></tr>
  <tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_z4sjRIQCIxl6" style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Current:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBKFrCZoWccj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; width: 56%; text-align: left; text-indent: -10pt">Federal</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,374,724</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">429,873</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_z2YvX6RlehAh" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">908,421</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,943,588</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_zNJThTghetXh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,283,145</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,373,461</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z09UcrD66KK7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zqnWvJAgXFb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">Federal deferred taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">838,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,515</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zYOEr0CVljE5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt">State deferred taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,494</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">209,992</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zLSBIH1IY46d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">823,660</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,795,507</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zKt4ZyHUsn0b" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; color: white; text-align: left; text-indent: -10pt">Provision (Benefit) for Income Taxes - Net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,106,805</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,168,968</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zSU7EnsUeiKd" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BC_zjIR4qgQDwW1" style="display: none">Schedule of
    reconciliation of federal statutory income tax rate to company&#8217;s effective tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended <br/>June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Year Ended <br/>June 30, 2024</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percent</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Percent</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt">Taxes at federal statutory rate</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20240701__20250630_z5lBSEif7UZ3" style="width: 10%; text-align: right" title="Taxes at federal statutory rate">2,893,850</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_90B_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20240701__20250630_zBWJGmEN7a92" title="Taxes at federal statutory rate">21</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20230701__20240630_z7QRiu2Qjzr9" style="width: 10%; text-align: right" title="Taxes at federal statutory rate">4,169,123</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 3%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zestd6NqfEx8" title="Taxes at federal statutory rate">21</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">State and local income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20240701__20250630_zSMHn7mBRHuh" style="text-align: right" title="State and local income taxes">978,397</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240701__20250630_zMB8pBpb1hGi" title="State and local income taxes (benefit), net of federal benefit">7.1</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20230701__20240630_zv2aGkbsy4N1" style="text-align: right" title="State and local income taxes">1,409,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zHEMJnAPkkf8" title="State and local income taxes (benefit), net of federal benefit">7.1</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Noncontrolling interests</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_98F_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20240701__20250630_zhFBbtOCAfdb" style="text-align: right" title="Noncontrolling interests">657,307</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20240701__20250630_zDBHq1mAvsMg" title="Noncontrolling interest">4.6</span></td><td style="text-align: left">%)</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_98B_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20230701__20240630_zhjJx9fQ2xF5" style="text-align: right" title="Noncontrolling interests">1,049,294</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zn4mlqn8ltCe" title="Noncontrolling interest">5.3</span></td><td style="text-align: left">%)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation Allowance</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_985_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20240701__20250630_zRsLtTysp0yb" style="text-align: right" title="Valuation Allowance">218,390</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240701__20250630_zRJrtnPyh7U2" title="Change in the valuation allowance">1.6</span></td><td style="text-align: left">%)</td><td>&#160;</td>
    <td style="text-align: left">($</td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20230701__20240630_zhL2kBthQ037" style="text-align: right" title="Valuation Allowance">48,179</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_zCSZSkVQ8CUi" title="Change in the valuation allowance">0.2</span></td><td style="text-align: left">%)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Permanent items &#8211; Meals and Entertainment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--PermanentItemsMealsEntertainment_c20240701__20250630_zfGovqFcLr36" style="text-align: right" title="Permanent items Meals and Entertainment">131,956</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20240701__20250630_zaZ9J9obG4ce" title="Permanent items Meals and Entertainment">1.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--PermanentItemsMealsEntertainment_c20230701__20240630_ziTkJVTQyD16" style="text-align: right" title="Permanent items Meals and Entertainment">126,719</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20230701__20240630_zYtUHBdm1hT3" title="Permanent items Meals and Entertainment">1.5</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">($</td><td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20240701__20250630_z1pQwvIR8BE1" style="border-bottom: Black 1pt solid; text-align: right" title="Other">21,701</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20240701__20250630_zVcX6F8bvXy9" title="Other">0.8</span></td><td style="padding-bottom: 1pt; text-align: left">%)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20230701__20240630_zpWQYUB1r5w9" style="border-bottom: Black 1pt solid; text-align: right" title="Other">561,038</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zZgzn6KXVuy1" title="Other">2.7</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Provision for income taxes </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">($</td><td id="xdx_98C_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20240701__20250630_zZ8BW4ExFSAc" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members' Equity">3,106,805</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20240701__20250630_z1bV4CRSHyZi" title="Effective income tax rate">22.8</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20230701__20240630_zxXNNNDCHvf1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members' Equity">5,168,968</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z4QGQjp0IBCj" title="Effective income tax rate">26.8</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zJ4GhaoisuD3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B7_ziw2zpP5IrBd" style="display: none">Schedule of deferred tax assets and liabilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49F_20250630_zkbs7EP954tl" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_497_20240630_zhsAJliltjI8" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred tax assets:</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zECLwk7a3q6l" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Allowance for credit losses</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">4,366,361</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">3,969,819</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zlrJbuynPcNd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Non-deductible accruals</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">758,700</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">758,700</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_z1aIgKDE1uT7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net operating carryforwards</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">259,319</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">396,092</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_z31GL3XssfB2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Tax credits</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1868">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">1,323,018</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z8wqoW8RyNjk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Capitalized research and development</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">960,343</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">747,407</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zztmHsOrxxO4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Right of use assets and lease liabilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">146,934</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">114,116</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zlVY0ZqpyoKa" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Inventories</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">116,856</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">106,879</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zL69hTFpyRm6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Deferred Tax Assets - gross</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">6,608,513</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">7,416,031</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zs6ELT8t4z21" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Valuation allowance</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(259,319</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(192,776</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z11MhnyXQ4k7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total deferred tax assets</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">6,349,194</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">7,223,255</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--PropertyAndEquipmentAndDepreciation_iI_pp0p0_maDTLzImD_zEt0WogS8q44" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Property and equipment and depreciation</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">165,532</td>
<td style="text-align: left">)</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">(267,124</td>
<td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMIiPtnHGBl3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Intangibles</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(155,627</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(104,436</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zck8AR0paWhk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total deferred tax liabilities</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(321,159</td>
<td style="padding-bottom: 1pt; text-align: left">)</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">(371,560</td>
<td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zH5nvVJq1Efe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Net deferred tax asset</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">6,028,035</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">6,851,695</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of other current liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWWlPqZcNpp" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8BA_zGEj3ZqNPTxg" style="display: none">Schedule of other current liabilities</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49E_20250630_z5jtbRZpGBdi" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td id="xdx_49E_20240630_zPWgxgtRm6T7" style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_z8pDZ1muGs38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Accrued salaries, commissions and payroll taxes</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">3,993,773</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">$</td>
<td style="width: 12%; text-align: right">4,677,690</td>
<td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_z9Vcq33nWbVa" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Sales tax payable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">248,845</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">197,317</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zSu9B9oNstlj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">State income taxes payable</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1920">&#8212;</span></td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">1,461,336</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zG7EzpUfDLB2" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Legal and other professional fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">93,207</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">11,207</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AdvancePaymentsByBorrowersForTaxesAndInsurance_iI_zpxETB378hJ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Property taxes</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">391,479</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1927">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccruedUtilitiesCurrent_iI_zxI5oRWs3gS4" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Utilities</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">449,277</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1930">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zGxvk96mbxUd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accounting fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">38,000</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">119,800</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--SoftwareLicenses_iI_zgDBCJWlR6pi" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Software Licenses</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">442,305</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1936">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--RecruitingFees_iI_zeGdfjc7F6Ci" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Recruiting fees</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">135,952</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1939">&#8212;</span></td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zieqIiUKM8Dl" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Self-funded health insurance reserve</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">259,661</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">121,445</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zS6RVFuQ13Lf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Accrued interest and penalty</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">3,534</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">3,534</td>
<td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_z2eXdxbOnwS5" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other general and administrative expenses</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">918,964</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right">1,348,710</td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zaXyqfygtqoi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Other Current Liabilities</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">6,974,997</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
<td style="border-bottom: Black 2.5pt double; text-align: right">7,941,039</td>
<td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Financial Information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zYhbXlhCHZZ1" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zh3MCVY7AYy5" style="display: none; font-family: Times New Roman, Times, Serif">Schedule
of Segment Financial Information</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_492_20240701__20250630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_z75PQFVNZ2ha" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_494_20240701__20250630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_z68KcaR412ok" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_495_20240701__20250630__srt--ProductOrServiceAxis__custom--TotalMember_zTtua83YJq46" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Manufacturing and Servicing of Medical</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">Management of Diagnostic Imaging</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Fiscal
2025:</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Equipment</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Centers</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Totals</span></td></tr>
<tr id="xdx_40A_eus-gaap--Revenues_zfW3Cp1P8sp2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
revenues from external customers</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,977,349</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">95,373,969</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">104,351,318</span></td>
<td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Cost
of Sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToEmployees_zjT3WxjA7fPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,905,311</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;19,384,410</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;22,289,721</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--RentExpenses_z1Yr3uTf96Dj" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2037">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,822,044</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,822,044</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zgGNgBinrmV1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
Cost of sales expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,944,740</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;31,385,807</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;34,330,547</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_ecustom--CostOfSales_zfWFzJDf6m2b" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Total
Cost of sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;5,850,051</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;55,592,261</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;61,442,312</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Research
and development</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SalariesAndWages_zMQtQgFIE45" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;766,963</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2050">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;766,963</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9uybozGKOml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
research and development costs**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;809,123</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2054">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;809,123</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zynPxaQwa9B8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">Total
                                            Research and development costs</span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,576,086</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2058">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,576,086</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zgrFMbaYDFfb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Selling,
general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--SalariesAndWage_i01_zYO9T4bJaXi2" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,934,716</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;10,983,643</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;15,918,359</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--RentsExpense_i01I_z5BxBWbdH3I" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;1,251,924</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;36,528</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;1,288,452</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zLKPgau1ciRb" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
selling, general and administrative expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,970,693</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;9,556,659</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;12,527,352</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zPEfSE3mQkx2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
Selling, general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,157,333</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,576,830</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,734,163</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_z8XhFpbBeyRc" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
costs and expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,619,740</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">76,133,091</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">92,752,561</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_z2k4vhdxzObf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income from operations</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,606,121</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,204,878</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,598,757</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zHcmnnUVeGk" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Investment
income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">107,777</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,011,203</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,118,980</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherIncome_i01_zxmENsXyrvUl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Other
income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,508</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,993</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,501</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_z3uPmdmQWykb" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income before provision for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,445,836</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,226,074</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,780,238</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_z4OGAFthe3i7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Provision
for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,885,852</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(220,953</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,106,805</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zhqb4FFRlRbe" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
(Loss) income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,331,688</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21,005,121</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,673,433</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zWPAILzhwOs3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Intersegment
net revenues *</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,189,130</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2110">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,189,130</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zYYOKMJdD3A7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation
and amortization</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">209,325</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,488,996</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,698,321</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_z0lqDLXnYJ25" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
identifiable assets</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">34,401,915</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">182,646,336</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">217,048,251</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zFUPHbu0jJ2g" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Capital
expenditures</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">375,599</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,441,307</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,816,906</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0; display: none">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt; width: 46%"><span style="font-family: Times New Roman, Times, Serif">Fiscal
2024:</span></td>
<td style="padding-bottom: 1pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_49B_20230701__20240630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_zzq02cpMvnK2" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_495_20230701__20240630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_zMRIQhRT3iZ1" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td id="xdx_496_20230701__20240630__srt--ProductOrServiceAxis__custom--TotalMember_zM7IjUX6DS01" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="padding-bottom: 1pt; text-align: left; width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--Revenues_zb86Ch12H8fc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
revenues from external customers</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,329,106</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">94,554,983</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">102,884,089</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Cost
of Sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToEmployees_zH4UUXMvvoxh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,684,218</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;18,913,412</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;21,597,630</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_401_ecustom--RentExpenses_z54u34xz7Zk8" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2133">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,532,535</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,532,535</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zq88IQEDH58h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
Cost of sales expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,089,924</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;29,523,955</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;31,613,879</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_ecustom--CostOfSales_zj38kTaMAc1a" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
Cost of sales</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,774,142</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52,969,902</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,744,044</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Research
and development</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SalariesAndWages_zy65EV3XrRCg" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;781,012</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2146">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;781,012</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9a9ZMeM3JM7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
research and development costs**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;954,937</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;<span style="-sec-ix-hidden: xdx2ixbrl2150">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;954,937</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zir0Tax1ENmh" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
Research and development costs</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,735,949</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2154">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,735,949</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zw2LaAHeJZlh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Selling,
general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--SalariesAndWage_i01_zB1kSzzPOhN3" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Salaries
and wages</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;4,794,512</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;10,156,520</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;14,951,032</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_406_ecustom--RentsExpense_i01I_zAqT0Vq6o0Lk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Rent
expense</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;1,076,069</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;73,676</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;1,149,745</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zd85oqp6Si21" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">&#160;Other
selling, general and administrative expenses**</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;2,906,446</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;7,861,509</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;10,767,955</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zJGIWhp93SIc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Selling,
general and administrative expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,777,027</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,091,705</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,868,732</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_zvgoRlZDs9i" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
costs and expenses</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,287,118</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,061,607</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,348,725</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_zNyJ92lXc85a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income from operations</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,958,012</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,493,376</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16,535,364</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zhAQNu6NDD22" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Investment
income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">120,387</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,006,052</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,126,439</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--OtherIncome_i01_zxanVwLepIFa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Other
income (expenses)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">640,952</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(36,370</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">604,582</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_ztVcI96nKx56" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">(Loss)
Income before provision for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,196,673</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,463,058</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,266,385</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_zhTaKpsZkPN3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Provision
for income taxes</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,788,028</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(380,940</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,168,968</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zk90qy0PsyY7" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Net
(Loss) income</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,984,701</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,082,118</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,097,417</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zg9dIGI9lyrh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Intersegment
net revenues *</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,073,333</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl2206">&#8212;</span></span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,073,333</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zKwyCPqTjJTd" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Depreciation
and amortization</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">238,802</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,357,619</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,596,421</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_ztOyj3w6ikrl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Total
identifiable assets</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,360,188</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">183,885,781</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">214,245,969</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zVZmutmiwEsj" style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif">Capital
expenditures</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,885</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"></span></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">789,961</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
<td style="text-align: left"></td>
<td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">822,846</span></td>
<td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>



<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 2%; vertical-align: top">&#160;*</td>
<td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 98%; vertical-align: top">Amounts eliminated in consolidation</td></tr>
<tr style="vertical-align: bottom">
<td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top">**</td>
<td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top">Other segment costs include supplies, professional fees, marketing expenses, repairs and maintenance and other operational costs.</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfExportProductSalesTableTextBlock', window );">Schedule of export product sales</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfExportProductSalesTableTextBlock_zktkVbGR99Kf" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)">
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B2_zDos5Oooi5Oj" style="display: none">Schedule of export product sales</span></td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td>
<td>&#160;</td>
<td style="text-align: left">&#160;</td>
<td style="text-align: right">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30</td></tr>
<tr style="vertical-align: bottom">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-indent: -10pt">Canada</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_909_ecustom--ForeignProductSales_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zAFjhC2VJzWj" title="Foreign product sales"><span style="-sec-ix-hidden: xdx2ixbrl2238">&#8212;</span></span></td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 8%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td>
<td style="width: 12%; text-align: right"><span id="xdx_906_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zE8ravCbTAe" title="Foreign product sales">0.2</span></td>
<td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Puerto Rico</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_ecustom--ForeignProductSales_dp_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zZOazIXJ73h2" title="Foreign product sales">1.4</span></td>
<td style="padding-bottom: 1pt; text-align: left">%</td>
<td style="padding-bottom: 1pt">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
<td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_ecustom--ForeignProductSales_dp_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zbrlHoQ089Pe" title="Foreign product sales"><span style="-sec-ix-hidden: xdx2ixbrl2244">&#8212;</span></span></td>
<td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">&#160;</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_ecustom--ForeignProductSales_dp_c20240701__20250630_znq8yXaYTZj1" title="Foreign product sales">1.4</span></td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td>
<td style="padding-bottom: 2.5pt">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td>
<td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_ziHDOYYJSywg" title="Foreign product sales">0.2</span></td>
<td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
</table>


<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfExportServiceRevenuesTableTextBlock', window );">Schedule of Foreign Service and Repair Fees</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_zVvcKbfNzhj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B6_zkoqgXrUWfsj" style="display: none">Schedule of Foreign Service and Repair Fees</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">For the Years Ended June 30,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Puerto Rico</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--PR_zahWiMhoB0Pb" title="Foreign service and repair fees">1.3</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 8%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_zGBsn9gzUh3h" title="Foreign service and repair fees">1.9</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Switzerland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CH_zZ3RJee8l0m2" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5vTlo7PZQI9" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Germany</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DE_z460oljBXZ4g" title="Foreign service and repair fees">3.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_z3cQptNL8l3a" title="Foreign service and repair fees">2.0</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">England</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zaYtPudlI672" title="Foreign service and repair fees">1.3</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_zh4W6et8D85f" title="Foreign service and repair fees">0.7</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">United Arab Emirates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AE_z03a2vakMff6" title="Foreign service and repair fees">0.1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zvFwShrcAT7" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Dominican Republic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DO_zLsvieGw6MK7" title="Foreign service and repair fees">1.2</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zSOqJjt6AuMg" title="Foreign service and repair fees">1.2</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Canada</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp0_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zgbYa5DcdHh6" title="Foreign service and repair fees">0.1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zbyunX35CtWf" title="Foreign service and repair fees"><span style="-sec-ix-hidden: xdx2ixbrl2282">&#8212;</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Greece</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GR_zXFceWHYfoz4" title="Foreign service and repair fees">0.4</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_zwczRDuYtm6a" title="Foreign service and repair fees">0.3</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Australia</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AU_zY43EsoddYge" title="Foreign service and repair fees"><span style="-sec-ix-hidden: xdx2ixbrl2288">&#8212;</span></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zpKiWFhumPT4" title="Foreign service and repair fees">0.7</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630_zBTPo9XoCkGe" title="Foreign service and repair fees">7.7</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zis670RjOva8" title="Foreign service and repair fees">7.4</span>.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td>
    </tr>
  </table>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfExportProductSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfExportProductSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfExportServiceRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfExportServiceRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) - Nonconsolidated Investees, Other [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedPercentOfNetAssets', window );">Investment Owned, Net Assets, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">70.63%<span></span>
</td>
<td class="nump">70.80%<span></span>
</td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Proceeds from (Payments to) Noncontrolling Interests</a></td>
<td class="nump">$ 132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">29.37%<span></span>
</td>
<td class="nump">29.20%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedPercentOfNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of investment owned to net assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedPercentOfNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Research Deveopment And Demonstration Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Research Deveopment And Demonstration Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life</a></td>
<td class="text">28 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDeveopmentAndDemonstrationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 33,179,446<span></span>
</td>
<td class="nump">$ 33,815,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance/ Managed Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">4,957,159<span></span>
</td>
<td class="nump">4,952,712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare/Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">1,160,839<span></span>
</td>
<td class="nump">1,138,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers? Compensation/Personal Injury [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">19,876,923<span></span>
</td>
<td class="nump">20,673,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetPatientFeeRevenue', window );">Net Patient Fee Revenue</a></td>
<td class="nump">$ 7,184,525<span></span>
</td>
<td class="nump">$ 7,051,425<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetPatientFeeRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetPatientFeeRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Net income available to common stockholders</a></td>
<td class="nump">$ 8,334,261<span></span>
</td>
<td class="nump">$ 10,567,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Weighted average shares outstanding basic</a></td>
<td class="nump">6,906,803<span></span>
</td>
<td class="nump">7,046,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 1.21<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Net income available to common stockholders</a></td>
<td class="nump">$ 7,802,352<span></span>
</td>
<td class="nump">$ 9,908,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Weighted average shares outstanding basic</a></td>
<td class="nump">6,210,852<span></span>
</td>
<td class="nump">6,351,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 1.26<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">6,210,852<span></span>
</td>
<td class="nump">6,351,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock', window );">Class C Common Stock</a></td>
<td class="nump">127,504<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">6,338,356<span></span>
</td>
<td class="nump">6,478,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted income per common share</a></td>
<td class="nump">$ 1.23<span></span>
</td>
<td class="nump">$ 1.53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassCCommonStockMember', window );">Class C Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Net income available to common stockholders</a></td>
<td class="nump">$ 135,467<span></span>
</td>
<td class="nump">$ 167,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Weighted average shares outstanding basic</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average shares outstanding</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Class C Common Stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted income per common share</a></td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassAPreferredStockMember', window );">Class A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Net income available to common stockholders</a></td>
<td class="nump">$ 396,443<span></span>
</td>
<td class="nump">$ 490,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageSharesOutstandingBasic', window );">Weighted average shares outstanding basic</a></td>
<td class="nump">313,438<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic income per common share</a></td>
<td class="nump">$ 1.26<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetIncomeLossAvailableToCommonStockholderBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageNumberOfDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480520/718-40-45-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480520/718-40-45-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageBasicSharesOutstandingProForma</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassCCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassCCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 02, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfPropertyRepairsAndMaintenance', window );">Maintenance and repair expenses</a></td>
<td class="nump">$ 2,751,000<span></span>
</td>
<td class="nump">$ 2,948,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices', window );">Management agreements with company total medical practices</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty', window );">Scanners with management agreements with company owned by related party</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState', window );">Scanners with management with company located in new york state</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalFeeReceivable', window );">Medical fee receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,259,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RevenuePercentage', window );">revenue percentage</a></td>
<td class="nump">57.00%<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementFeeReceivableForUnrelatedParties', window );">Management fee receivable for unrelated parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,888,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementFeeReceivableForRelatedParties', window );">Management Fee Receivable For Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,161,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceContractsNet', window );">Account receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,571,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising Expense</a></td>
<td class="nump">$ 773,000<span></span>
</td>
<td class="nump">$ 731,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Penalties', window );">Penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders', window );">Conversion of Class C Common Stock | shares</a></td>
<td class="nump">127,504<span></span>
</td>
<td class="nump">127,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash deposit</a></td>
<td class="nump">$ 53,676,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Federally insured limits</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Related Parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Related Parties Medical Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Vendors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember', window );">Diagnostic Imaging Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMinimum', window );">Contractual fees for services rendered minimum</a></td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ContractualFeesForServicesRenderedMaximum', window );">Contractual fees for services rendered Maximum</a></td>
<td class="nump">$ 460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceContractsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceContractsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ContractualFeesForServicesRenderedMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ContractualFeesForServicesRenderedMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAgreementsWithCompanyTotalMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAgreementsWithCompanyTotalMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementFeeReceivableForRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementFeeReceivableForRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementFeeReceivableForUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementFeeReceivableForUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalFeeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalFeeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Penalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Penalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfPropertyRepairsAndMaintenance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfPropertyRepairsAndMaintenance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FONR_RelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FONR_RelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FONR_RelatedPartiesMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FONR_RelatedPartiesMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=FONR_TwoVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=FONR_TwoVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=FONR_DiagnosticImagingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">2026</a></td>
<td class="nump">$ 1,592,426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueThreeToFourYears', window );">2027</a></td>
<td class="nump">1,031,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueFourToFiveYears', window );">2028</a></td>
<td class="nump">831,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueFiveYearsOrMore', window );">2029</a></td>
<td class="nump">344,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Total</a></td>
<td class="nump">$ 3,800,746<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueFiveYearsOrMore">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueFiveYearsOrMore</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueFourToFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueFourToFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueThreeToFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueThreeToFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="nump">$ 166,049<span></span>
</td>
<td class="nump">$ 198,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="nump">107,330<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="nump">9,167<span></span>
</td>
<td class="nump">32,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="nump">264,212<span></span>
</td>
<td class="nump">166,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember', window );">Management And Other Fees Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="nump">12,369,921<span></span>
</td>
<td class="nump">12,608,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="nump">2,052,824<span></span>
</td>
<td class="num">(238,646)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="nump">126,757<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="nump">14,295,988<span></span>
</td>
<td class="nump">12,369,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember', window );">Management And Other Fees Receivable Related Medical Practices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="nump">6,110,399<span></span>
</td>
<td class="nump">3,989,692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="nump">1,026,437<span></span>
</td>
<td class="nump">2,120,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="nump">7,136,836<span></span>
</td>
<td class="nump">6,110,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning Balance</a></td>
<td class="nump">777,354<span></span>
</td>
<td class="nump">777,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsAdditions', window );">Additions (Included in provision for bad debts)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AllowanceForDoubtfulAccountsDeductions', window );">Deductions</a></td>
<td class="nump">777,354<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 777,354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AllowanceForDoubtfulAccountsDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AllowanceForDoubtfulAccountsDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details) - Integer<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear', window );">Total Facilities Owned or Managed (at Beginning of Year)</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagedFacilitiesAddedByInternalDevelopment', window );">Internal development</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagedFacilitiesClosedDuringYear', window );">Managed Facilities Closed</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear', window );">Total Facilities Owned or Managed (at End of Year)</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesAddedByInternalDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesAddedByInternalDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagedFacilitiesClosedDuringYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagedFacilitiesClosedDuringYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Long term accounts receivable balances</a></td>
<td class="nump">$ 3,549,956<span></span>
</td>
<td class="nump">$ 829,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">Percentage of consolidated net revenue from management fees</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Inventories (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts and components</a></td>
<td class="nump">$ 2,630,439<span></span>
</td>
<td class="nump">$ 2,524,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">182,243<span></span>
</td>
<td class="nump">191,240<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 2,812,682<span></span>
</td>
<td class="nump">$ 2,715,441<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT - Property and equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">$ 66,298,958<span></span>
</td>
<td class="nump">$ 62,507,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="nump">47,767,039<span></span>
</td>
<td class="nump">43,798,457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property plant and equipment, net</a></td>
<td class="nump">18,531,919<span></span>
</td>
<td class="nump">18,708,920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember', window );">Diagnostic Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">35,276,823<span></span>
</td>
<td class="nump">33,243,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDevelopmentAndDemonstrationEquipmentMember', window );">Research, development and demonstration equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">6,490,872<span></span>
</td>
<td class="nump">6,199,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">2,128,398<span></span>
</td>
<td class="nump">2,069,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">3,756,017<span></span>
</td>
<td class="nump">3,742,169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">17,707,234<span></span>
</td>
<td class="nump">16,312,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment, gross</a></td>
<td class="nump">$ 939,614<span></span>
</td>
<td class="nump">$ 939,614<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_DiagnosticEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDevelopmentAndDemonstrationEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=FONR_ResearchDevelopmentAndDemonstrationEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization of property and equipment</a></td>
<td class="nump">$ 3,968,582<span></span>
</td>
<td class="nump">$ 4,227,414<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Lease payments (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember', window );">Operating Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 5,753,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">5,718,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">5,629,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">5,240,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">5,120,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">25,496,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">Present value discount</a></td>
<td class="num">(14,427,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">38,531,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember', window );">Financing Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">244,343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">142,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">Present value discount</a></td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">$ 386,760<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract', window );"><strong>Operating And Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases - years</a></td>
<td class="text">10 years 2 months 12 days<span></span>
</td>
<td class="text">11 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance lease - years</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate, operating leases</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate, finance leases</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinanceLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract', window );"><strong>Operating And Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 6,110,496<span></span>
</td>
<td class="nump">$ 5,685,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCostsAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DepreciationOfLeasedEquipment', window );">Depreciation of leased equipment</a></td>
<td class="nump">198,881<span></span>
</td>
<td class="nump">198,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">16,812<span></span>
</td>
<td class="nump">26,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">$ 215,693<span></span>
</td>
<td class="nump">$ 225,415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DepreciationOfLeasedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DepreciationOfLeasedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinanceLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinanceLeaseCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinanceLeaseCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Related to leases (Details 3) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract', window );"><strong>Operating And Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OperatingCashFlowsFromOperatingLeases', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 5,729,571<span></span>
</td>
<td class="nump">$ 6,363,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_FinancingCashFlowsFromFinancingLeases', window );">Financing cash flows from finance leases</a></td>
<td class="nump">264,705<span></span>
</td>
<td class="nump">244,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract', window );"><strong>Right-of-use and equipment assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases', window );">Operating leases</a></td>
<td class="nump">$ 2,319,913<span></span>
</td>
<td class="nump">$ 3,715,138<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinanceLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_FinancingCashFlowsFromFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_FinancingCashFlowsFromFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OperatingCashFlowsFromOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OperatingCashFlowsFromOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING AND FINANCE LEASES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract', window );"><strong>Operating And Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating leases</a></td>
<td class="nump">$ 6,110,000<span></span>
</td>
<td class="nump">$ 5,685,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseIncome', window );">financing lease</a></td>
<td class="nump">$ 216,000<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingAndFinanceLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingAndFinanceLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets gross</a></td>
<td class="nump">$ 21,544,276<span></span>
</td>
<td class="nump">$ 20,314,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(18,552,073)<span></span>
</td>
<td class="num">(17,444,334)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">intangible assets net</a></td>
<td class="nump">$ 2,992,203<span></span>
</td>
<td class="nump">$ 2,870,324<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets gross</a></td>
<td class="nump">$ 7,004,847<span></span>
</td>
<td class="nump">$ 7,004,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(7,004,847)<span></span>
</td>
<td class="num">(7,004,847)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">intangible assets net</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_SoftwareLicenseMember', window );">Software License [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets gross</a></td>
<td class="nump">$ 1,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(756,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">intangible assets net</a></td>
<td class="nump">$ 504,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets gross</a></td>
<td class="nump">$ 5,229,429<span></span>
</td>
<td class="nump">$ 5,259,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(4,255,393)<span></span>
</td>
<td class="num">(4,103,654)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">intangible assets net</a></td>
<td class="nump">$ 974,036<span></span>
</td>
<td class="nump">$ 1,156,157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets gross</a></td>
<td class="nump">$ 4,150,000<span></span>
</td>
<td class="nump">$ 4,150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(4,150,000)<span></span>
</td>
<td class="num">(4,150,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">intangible assets net</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Other intangible assets gross</a></td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization intangible assets</a></td>
<td class="num">(2,385,833)<span></span>
</td>
<td class="num">(2,185,833)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">intangible assets net</a></td>
<td class="nump">$ 1,514,167<span></span>
</td>
<td class="nump">$ 1,714,167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_CostomerRelationshipsMember', window );">Costomer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 24: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_SoftwareLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_SoftwareLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_CostomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_CostomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong> OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 756,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">402,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">306,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">295,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">291,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">939,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">2,992,203<span></span>
</td>
<td class="nump">$ 2,870,324<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_SoftwareLicenseMember', window );">Software License [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">504,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">136,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">118,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">106,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">95,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">91,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">425,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">974,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">514,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">$ 1,514,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 24: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_SoftwareLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_SoftwareLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - Beginning of Year</a></td>
<td class="nump">$ 2,870,324<span></span>
</td>
<td class="nump">$ 3,431,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AmountsCapitalized', window );">Amounts capitalized</a></td>
<td class="nump">25,325<span></span>
</td>
<td class="nump">32,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SoftwareOrPatentsWrittenOff', window );">Patents written off</a></td>
<td class="num">(55,707)<span></span>
</td>
<td class="num">(225,419)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CorrectionOfError', window );">Correction of an error</a></td>
<td class="nump">882,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="num">(729,739)<span></span>
</td>
<td class="num">(369,007)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Balance - End of Year</a></td>
<td class="nump">$ 2,992,203<span></span>
</td>
<td class="nump">$ 2,870,324<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AmountsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AmountsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CorrectionOfError">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CorrectionOfError</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SoftwareOrPatentsWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SoftwareOrPatentsWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period for other intangible assets</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="nump">$ 151,739<span></span>
</td>
<td class="nump">$ 169,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period for other intangible assets</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_SoftwareLicensesMember', window );">Software Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="nump">$ 378,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 24: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_SoftwareLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_SoftwareLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL STOCK (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Aug. 10, 2010</div></th>
<th class="th"><div>Apr. 23, 2010</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Payments for repurchase of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,806,646<span></span>
</td>
<td class="nump">$ 2,505,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,588<span></span>
</td>
<td class="nump">156,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,806,646<span></span>
</td>
<td class="nump">$ 2,505,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfTreasuryShares', window );">Cancellation of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,829<span></span>
</td>
<td class="nump">122,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfTreasuryStock', window );">Cancellation of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,963,385<span></span>
</td>
<td class="nump">$ 2,005,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Payments for repurchase of equity</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember', window );">N 2010 Stock Bonus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SharesRegistered', window );">Shares registered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Number of shares were issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends payable, nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one vote per share for the common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,168,625<span></span>
</td>
<td class="nump">6,283,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Conversuion of shares into one-for-one basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Class B common stock is convertible into shares of
common stock on a one-for-one basis<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Class B common stock has 10 votes per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare', window );">Conversuion of shares into one-for-one basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Class C common stock has 25 votes per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableNature', window );">Dividends payable, nature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common stock, voting rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one share of Class A non-voting preferred stock for every five shares
of common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfTreasuryStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfTreasuryStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SharesRegistered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SharesRegistered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=FONR_N2010StockBonusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details) - HDM Equity [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">$ 9,179,608<span></span>
</td>
<td class="nump">$ 7,079,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">2,339,172<span></span>
</td>
<td class="nump">3,530,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterests', window );">Buyout of noncontrolling interests</a></td>
<td class="nump">19,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterestsValue', window );">Buyout of noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="num">(5,682,555)<span></span>
</td>
<td class="num">(5,630,336)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="nump">12,503,566<span></span>
</td>
<td class="nump">9,179,608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OpeningMembersEquity', window );">Opening Members Equity</a></td>
<td class="nump">61,817,830<span></span>
</td>
<td class="nump">54,781,813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ShareOfNetIncome', window );">Share of Net Income</a></td>
<td class="nump">16,727,492<span></span>
</td>
<td class="nump">20,705,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_BuyoutOfNoncontrollingInterestsValue', window );">Buyout of noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Distributions', window );">Distributions</a></td>
<td class="num">(13,717,445)<span></span>
</td>
<td class="num">(13,669,664)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EndingMembersEquity', window );">Ending Members Equity</a></td>
<td class="nump">$ 64,827,877<span></span>
</td>
<td class="nump">$ 61,817,830<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BuyoutOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BuyoutOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_BuyoutOfNoncontrollingInterestsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_BuyoutOfNoncontrollingInterestsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Distributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Distributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EndingMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EndingMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OpeningMembersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OpeningMembersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ShareOfNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ShareOfNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_HDMEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_HDMEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative) - HDM [Member]<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 08, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 13, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 05, 2013 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfStandupMriCenters', window );">Purchase of stand up MRI centers | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfOtherMriCenters', window );">Purchase of other MRI centers | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsiderationToOutsideInvestors', window );">HDM purchase price includes consideration to outside investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalPurchasePrice', window );">HDM purchase from Health Diagnostics (HD) ($)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements', window );">HDM entered agreement for consulting and non-competition agreement ($)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">Class B Controlling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EquityMethodInvestmentOwnershipPercentages', window );">Ownership interest of company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProceedsFromContributionsFromCompany', window );">Company contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">Class A Controlling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EquityMethodInvestmentOwnershipPercentages', window );">Ownership interest of company</a></td>
<td class="nump">60.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EquityMethodInvestmentsOwnershipPercentage', window );">Purchase of interests from Class A, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DirectPurchaseOfNoncontrollingInterests', window );">Purchase of interests from Class A</a></td>
<td class="nump">$ 4,971,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember', window );">Class A Controlling Interests [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership interest of investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.50%<span></span>
</td>
<td class="nump">29.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Investors contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationForNoncompetitionAndConsultingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationForNoncompetitionAndConsultingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConsiderationToOutsideInvestors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConsiderationToOutsideInvestors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DirectPurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DirectPurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EquityMethodInvestmentOwnershipPercentages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EquityMethodInvestmentOwnershipPercentages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EquityMethodInvestmentsOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EquityMethodInvestmentsOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProceedsFromContributionsFromCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProceedsFromContributionsFromCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfOtherMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfOtherMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfStandupMriCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfStandupMriCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_HDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_HDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBControllingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassBControllingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassAControllingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsByNameAxis=FONR_ClassAControllingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=FONR_ClassAControllingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=FONR_ClassAControllingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Components of provision for income taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 1,374,724<span></span>
</td>
<td class="nump">$ 429,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">908,421<span></span>
</td>
<td class="nump">1,943,588<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Subtotal</a></td>
<td class="nump">2,283,145<span></span>
</td>
<td class="nump">2,373,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal deferred taxes</a></td>
<td class="nump">838,154<span></span>
</td>
<td class="nump">2,585,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State deferred taxes</a></td>
<td class="num">(14,494)<span></span>
</td>
<td class="nump">209,992<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DeferredIncomeTaxExpensesBenefit', window );">Subtotal</a></td>
<td class="nump">823,660<span></span>
</td>
<td class="nump">2,795,507<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (Benefit) for Income Taxes - Net</a></td>
<td class="nump">$ 3,106,805<span></span>
</td>
<td class="nump">$ 5,168,968<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DeferredIncomeTaxExpensesBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DeferredIncomeTaxExpensesBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong> INCOME TAXES - Reconciliation of federal statutory income tax rate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Taxes at federal statutory rate</a></td>
<td class="nump">$ 2,893,850<span></span>
</td>
<td class="nump">$ 4,169,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates', window );">Taxes at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes</a></td>
<td class="nump">$ 978,397<span></span>
</td>
<td class="nump">$ 1,409,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes (benefit), net of federal benefit</a></td>
<td class="nump">7.10%<span></span>
</td>
<td class="nump">7.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interests</a></td>
<td class="nump">$ 657,307<span></span>
</td>
<td class="nump">$ 1,049,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interest</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation Allowance</a></td>
<td class="nump">$ 218,390<span></span>
</td>
<td class="nump">$ 48,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in the valuation allowance</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PermanentItemsMealsEntertainment', window );">Permanent items Meals and Entertainment</a></td>
<td class="nump">$ 131,956<span></span>
</td>
<td class="nump">$ 126,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment', window );">Permanent items Meals and Entertainment</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount', window );">Other</a></td>
<td class="nump">$ 21,701<span></span>
</td>
<td class="nump">$ 561,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit', window );">Ending Members' Equity</a></td>
<td class="nump">$ 3,106,805<span></span>
</td>
<td class="nump">$ 5,168,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">22.80%<span></span>
</td>
<td class="nump">26.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PermanentItemsMealsEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PermanentItemsMealsEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to cross-border tax law classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax benefit (expense) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to other reconciling items. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Deferred tax assets and liabilities - (Details 2) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for credit losses</a></td>
<td class="nump">$ 4,366,361<span></span>
</td>
<td class="nump">$ 3,969,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Non-deductible accruals</a></td>
<td class="nump">758,700<span></span>
</td>
<td class="nump">758,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating carryforwards</a></td>
<td class="nump">259,319<span></span>
</td>
<td class="nump">396,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,323,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized research and development</a></td>
<td class="nump">960,343<span></span>
</td>
<td class="nump">747,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities', window );">Right of use assets and lease liabilities</a></td>
<td class="nump">146,934<span></span>
</td>
<td class="nump">114,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">116,856<span></span>
</td>
<td class="nump">106,879<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred Tax Assets - gross</a></td>
<td class="nump">6,608,513<span></span>
</td>
<td class="nump">7,416,031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(259,319)<span></span>
</td>
<td class="num">(192,776)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">6,349,194<span></span>
</td>
<td class="nump">7,223,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PropertyAndEquipmentAndDepreciation', window );">Property and equipment and depreciation</a></td>
<td class="nump">165,532<span></span>
</td>
<td class="num">(267,124)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(155,627)<span></span>
</td>
<td class="num">(104,436)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(321,159)<span></span>
</td>
<td class="num">(371,560)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 6,028,035<span></span>
</td>
<td class="nump">$ 6,851,695<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PropertyAndEquipmentAndDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PropertyAndEquipmentAndDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">$ 6,349,194<span></span>
</td>
<td class="nump">$ 7,223,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred tax liability</a></td>
<td class="nump">321,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Allowance for doubtful accounts and tax credits</a></td>
<td class="nump">759,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CapitalizedResearchAndDevelopmentCosts', window );">Capitalized Research and development costs</a></td>
<td class="nump">960,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">City operating loss carryforwards</a></td>
<td class="nump">3,694,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">Valuation allowance for deferred tax assets</a></td>
<td class="nump">67,000<span></span>
</td>
<td class="nump">$ 171,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Tax credits carryforwards</a></td>
<td class="nump">$ 1,323,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 3,993,773<span></span>
</td>
<td class="nump">$ 4,677,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">248,845<span></span>
</td>
<td class="nump">197,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">State income taxes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,461,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">93,207<span></span>
</td>
<td class="nump">11,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance', window );">Property taxes</a></td>
<td class="nump">391,479<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedUtilitiesCurrent', window );">Utilities</a></td>
<td class="nump">449,277<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">38,000<span></span>
</td>
<td class="nump">119,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SoftwareLicenses', window );">Software Licenses</a></td>
<td class="nump">442,305<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RecruitingFees', window );">Recruiting fees</a></td>
<td class="nump">135,952<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">259,661<span></span>
</td>
<td class="nump">121,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Accrued interest and penalty</a></td>
<td class="nump">3,534<span></span>
</td>
<td class="nump">3,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other general and administrative expenses</a></td>
<td class="nump">918,964<span></span>
</td>
<td class="nump">1,348,710<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Current Liabilities</a></td>
<td class="nump">$ 6,974,997<span></span>
</td>
<td class="nump">$ 7,941,039<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RecruitingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RecruitingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SoftwareLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SoftwareLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedUtilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedUtilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of accumulated prepayments received by financial institutions from borrowers for taxes (for example, property taxes) and insurance (for example, property and catastrophe) which will periodically be remitted to the appropriate governmental agency or vendor on behalf of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP', window );">Employer contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsurancePayable', window );">Liability for individual claims</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Reserve for self-funded</a></td>
<td class="nump">$ 260,000<span></span>
</td>
<td class="nump">$ 121,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-9E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">$ 25,611<span></span>
</td>
<td class="nump">$ 76,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">4,664,984<span></span>
</td>
<td class="nump">507,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOwnedNet', window );">Right-of-use and equipment assets</a></td>
<td class="nump">$ 2,319,913<span></span>
</td>
<td class="nump">$ 9,471,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Interest rate</a></td>
<td class="nump">0.197%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Noncash transaction amount</a></td>
<td class="nump">$ 132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOwnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation, of long-lived, depreciable flight asset owned. Excludes right-of-use asset from finance lease for flight asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOwnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PrincipalAmount', window );">Principal amount</a></td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember', window );">Bensonhurst MRI Limited Partnership [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related party transaction, description</a></td>
<td class="text">Bensonhurst MRI Limited Partnership (&#8220;Bensonhurst&#8221;),
in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum. On February 1, 2024, Bensonhurst entered into a second contract with the
Company for the service and maintenance of a High-Field MRI Scanner for a price of $70,000 per annum. Also during fiscal year ended June
30, 2025 and 2024, the Company charged Bensonhurst MRI Limited Partnership $344,068 and $190,362, respectively, for reimbursable salaries
and marketing expenses<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=FONR_RadianHealthcareManagementLLCMember', window );">Radian Healthcare Management LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction', window );">Related party transaction, description</a></td>
<td class="text">Radian Healthcare Management, LLC (&#8220;Radian&#8221;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of new employees
at a fee of approximately $165,000 and $200,000 during the fiscal year ended June 30, 2025 and 2024, respectively<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=FONR_MagneticResonanceManagementMember', window );">Magnetic Resonance Management [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Sale of price of the equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 576,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Bears interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredGainOnSaleOfProperty', window );">Gain on sale of equipments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 576,857<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredGainOnSaleOfProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain on the sale of property that does not qualify for gain recognition as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredGainOnSaleOfProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481440/840-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479741/842-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_BensonhurstMRILimitedPartnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=FONR_RadianHealthcareManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=FONR_RadianHealthcareManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=FONR_MagneticResonanceManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=FONR_MagneticResonanceManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Summarized segments - (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">$ 104,351,318<span></span>
</td>
<td class="nump">$ 102,884,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and development costs</a></td>
<td class="nump">1,576,086<span></span>
</td>
<td class="nump">1,735,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">&#160;Selling, general and administrative expenses</a></td>
<td class="nump">29,734,163<span></span>
</td>
<td class="nump">26,868,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,698,321<span></span>
</td>
<td class="nump">4,596,421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=FONR_ManufacturingandServicingofMedicalEquipmentMember', window );">Manufacturingand Servicingof Medical Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">8,977,349<span></span>
</td>
<td class="nump">8,329,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToEmployees', window );">&#160;Salaries and wages</a></td>
<td class="nump">2,905,311<span></span>
</td>
<td class="nump">2,684,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RentExpenses', window );">&#160;Rent expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OtherCostOfSalesExpenses', window );">&#160;Other Cost of sales expenses**</a></td>
<td class="nump">2,944,740<span></span>
</td>
<td class="nump">2,089,924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostOfSales', window );">Total Cost of sales</a></td>
<td class="nump">5,850,051<span></span>
</td>
<td class="nump">4,774,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">&#160;Salaries and wages</a></td>
<td class="nump">766,963<span></span>
</td>
<td class="nump">781,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">&#160;Other research and development costs**</a></td>
<td class="nump">809,123<span></span>
</td>
<td class="nump">954,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and development costs</a></td>
<td class="nump">1,576,086<span></span>
</td>
<td class="nump">1,735,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SalariesAndWage', window );">&#160;Salaries and wages</a></td>
<td class="nump">4,934,716<span></span>
</td>
<td class="nump">4,794,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RentsExpense', window );">&#160;Rent expense</a></td>
<td class="nump">1,251,924<span></span>
</td>
<td class="nump">1,076,069<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OtherSellingGeneralAndAdministrativeExpenses', window );">&#160;Other selling, general and administrative expenses**</a></td>
<td class="nump">2,970,693<span></span>
</td>
<td class="nump">2,906,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Selling, general and administrative expenses</a></td>
<td class="nump">9,157,333<span></span>
</td>
<td class="nump">8,777,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalCostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">16,619,740<span></span>
</td>
<td class="nump">15,287,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="num">(7,606,121)<span></span>
</td>
<td class="num">(6,958,012)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Investment income</a></td>
<td class="nump">107,777<span></span>
</td>
<td class="nump">120,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income (expenses)</a></td>
<td class="nump">52,508<span></span>
</td>
<td class="nump">640,952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax', window );">(Loss) Income before provision for income taxes</a></td>
<td class="num">(7,445,836)<span></span>
</td>
<td class="num">(6,196,673)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Provision for income taxes</a></td>
<td class="num">(2,885,852)<span></span>
</td>
<td class="num">(4,788,028)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (Loss) income</a></td>
<td class="num">(10,331,688)<span></span>
</td>
<td class="num">(10,984,701)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues *</a></td>
<td class="nump">1,189,130<span></span>
</td>
<td class="nump">1,073,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">209,325<span></span>
</td>
<td class="nump">238,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalIdentifiableAssets', window );">Total identifiable assets</a></td>
<td class="nump">34,401,915<span></span>
</td>
<td class="nump">30,360,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">375,599<span></span>
</td>
<td class="nump">32,885<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=FONR_ManagementofDiagnosticImagingCentersMember', window );">Managementof Diagnostic Imaging Centers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">95,373,969<span></span>
</td>
<td class="nump">94,554,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToEmployees', window );">&#160;Salaries and wages</a></td>
<td class="nump">19,384,410<span></span>
</td>
<td class="nump">18,913,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RentExpenses', window );">&#160;Rent expense</a></td>
<td class="nump">4,822,044<span></span>
</td>
<td class="nump">4,532,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OtherCostOfSalesExpenses', window );">&#160;Other Cost of sales expenses**</a></td>
<td class="nump">31,385,807<span></span>
</td>
<td class="nump">29,523,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostOfSales', window );">Total Cost of sales</a></td>
<td class="nump">55,592,261<span></span>
</td>
<td class="nump">52,969,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">&#160;Salaries and wages</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">&#160;Other research and development costs**</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and development costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SalariesAndWage', window );">&#160;Salaries and wages</a></td>
<td class="nump">10,983,643<span></span>
</td>
<td class="nump">10,156,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RentsExpense', window );">&#160;Rent expense</a></td>
<td class="nump">36,528<span></span>
</td>
<td class="nump">73,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OtherSellingGeneralAndAdministrativeExpenses', window );">&#160;Other selling, general and administrative expenses**</a></td>
<td class="nump">9,556,659<span></span>
</td>
<td class="nump">7,861,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Selling, general and administrative expenses</a></td>
<td class="nump">20,576,830<span></span>
</td>
<td class="nump">18,091,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalCostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">76,133,091<span></span>
</td>
<td class="nump">71,061,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">19,204,878<span></span>
</td>
<td class="nump">23,493,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Investment income</a></td>
<td class="nump">2,011,203<span></span>
</td>
<td class="nump">2,006,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income (expenses)</a></td>
<td class="nump">9,993<span></span>
</td>
<td class="num">(36,370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax', window );">(Loss) Income before provision for income taxes</a></td>
<td class="nump">21,226,074<span></span>
</td>
<td class="nump">25,463,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Provision for income taxes</a></td>
<td class="num">(220,953)<span></span>
</td>
<td class="num">(380,940)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (Loss) income</a></td>
<td class="nump">21,005,121<span></span>
</td>
<td class="nump">25,082,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues *</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,488,996<span></span>
</td>
<td class="nump">4,357,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalIdentifiableAssets', window );">Total identifiable assets</a></td>
<td class="nump">182,646,336<span></span>
</td>
<td class="nump">183,885,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">3,441,307<span></span>
</td>
<td class="nump">789,961<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=FONR_TotalMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues from external customers</a></td>
<td class="nump">104,351,318<span></span>
</td>
<td class="nump">102,884,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToEmployees', window );">&#160;Salaries and wages</a></td>
<td class="nump">22,289,721<span></span>
</td>
<td class="nump">21,597,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RentExpenses', window );">&#160;Rent expense</a></td>
<td class="nump">4,822,044<span></span>
</td>
<td class="nump">4,532,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OtherCostOfSalesExpenses', window );">&#160;Other Cost of sales expenses**</a></td>
<td class="nump">34,330,547<span></span>
</td>
<td class="nump">31,613,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostOfSales', window );">Total Cost of sales</a></td>
<td class="nump">61,442,312<span></span>
</td>
<td class="nump">57,744,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalariesAndWages', window );">&#160;Salaries and wages</a></td>
<td class="nump">766,963<span></span>
</td>
<td class="nump">781,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">&#160;Other research and development costs**</a></td>
<td class="nump">809,123<span></span>
</td>
<td class="nump">954,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Total Research and development costs</a></td>
<td class="nump">1,576,086<span></span>
</td>
<td class="nump">1,735,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_SalariesAndWage', window );">&#160;Salaries and wages</a></td>
<td class="nump">15,918,359<span></span>
</td>
<td class="nump">14,951,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_RentsExpense', window );">&#160;Rent expense</a></td>
<td class="nump">1,288,452<span></span>
</td>
<td class="nump">1,149,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OtherSellingGeneralAndAdministrativeExpenses', window );">&#160;Other selling, general and administrative expenses**</a></td>
<td class="nump">12,527,352<span></span>
</td>
<td class="nump">10,767,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Selling, general and administrative expenses</a></td>
<td class="nump">29,734,163<span></span>
</td>
<td class="nump">26,868,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalCostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">92,752,561<span></span>
</td>
<td class="nump">86,348,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">11,598,757<span></span>
</td>
<td class="nump">16,535,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Investment income</a></td>
<td class="nump">2,118,980<span></span>
</td>
<td class="nump">2,126,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income (expenses)</a></td>
<td class="nump">62,501<span></span>
</td>
<td class="nump">604,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax', window );">(Loss) Income before provision for income taxes</a></td>
<td class="nump">13,780,238<span></span>
</td>
<td class="nump">19,266,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Provision for income taxes</a></td>
<td class="num">(3,106,805)<span></span>
</td>
<td class="num">(5,168,968)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net (Loss) income</a></td>
<td class="nump">10,673,433<span></span>
</td>
<td class="nump">14,097,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Intersegment net revenues *</a></td>
<td class="nump">1,189,130<span></span>
</td>
<td class="nump">1,073,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,698,321<span></span>
</td>
<td class="nump">4,596,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalIdentifiableAssets', window );">Total identifiable assets</a></td>
<td class="nump">217,048,251<span></span>
</td>
<td class="nump">214,245,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="nump">$ 3,816,906<span></span>
</td>
<td class="nump">$ 822,846<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CapitalExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CapitalExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of intersegment net revenues during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OtherCostOfSalesExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OtherCostOfSalesExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OtherSellingGeneralAndAdministrativeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OtherSellingGeneralAndAdministrativeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_RentsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_RentsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SalariesAndWage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SalariesAndWage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalIdentifiableAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalIdentifiableAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-8A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of cash to employees, including wages and salaries, during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesAndWages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesAndWages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=FONR_ManufacturingandServicingofMedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=FONR_ManufacturingandServicingofMedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=FONR_ManagementofDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=FONR_ManagementofDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=FONR_TotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=FONR_TotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign product sales</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=FONR_TwoMember', window );">Puerto Rico</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign product sales</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignProductSales', window );">Foreign product sales</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=FONR_TwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=FONR_TwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">PUERTO RICO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CH', window );">SWITZERLAND</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DE', window );">GERMANY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AE', window );">UNITED ARAB EMIRATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_DO', window );">DOMINICAN REPUBLIC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GR', window );">GREECE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_AU', window );">AUSTRALIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignServiceAndRepairFees', window );">Foreign service and repair fees</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_DO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_DO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExportSalesOfMedicalEquipmentPercentage', window );">Export sales of medical equipment percentage</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage', window );">Percentage of service and repair of medical equipment</a></td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExportSalesOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExportSalesOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>213</ContextCount>
  <ElementCount>443</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>78</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>999014 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>999016 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>999017 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>999018 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipment</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>999019 - Disclosure - OPERATING AND FINANCE LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingAndFinanceLeases</Role>
      <ShortName>OPERATING AND FINANCE LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>999020 - Disclosure - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets</Role>
      <ShortName>OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>999021 - Disclosure - CAPITAL STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CapitalStock</Role>
      <ShortName>CAPITAL STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>999022 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterests</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>999023 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>999024 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>999025 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>999026 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>999027 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>999028 - Disclosure - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>999029 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>999030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>999032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>999033 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Inventories</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>999034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/PropertyAndEquipment</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>999035 - Disclosure - OPERATING AND FINANCE LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingAndFinanceLeasesTables</Role>
      <ShortName>OPERATING AND FINANCE LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OperatingAndFinanceLeases</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>999036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsTables</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssets</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>999037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterestsTables</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/ControllingAndNoncontrollingInterests</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>999038 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>999039 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>999040 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationTables</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>999041 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>999042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>999045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>999046 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>999047 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>999048 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>999049 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>999050 - Disclosure - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories-InventoriesDetails</Role>
      <ShortName>INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>999051 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT - Property and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>999052 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>999053 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Lease payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>999054 - Disclosure - OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>999055 - Disclosure - OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Components of lease expense (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>999056 - Disclosure - OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Related to leases (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>999057 - Disclosure - OPERATING AND FINANCE LEASES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative</Role>
      <ShortName>OPERATING AND FINANCE LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OperatingAndFinanceLeasesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>999058 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>999059 - Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1</Role>
      <ShortName> OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>999060 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>999061 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>999062 - Disclosure - CAPITAL STOCK (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CapitalStockDetailsNarrative</Role>
      <ShortName>CAPITAL STOCK (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CapitalStock</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>999063 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>999064 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative</Role>
      <ShortName>CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/ControllingAndNoncontrollingInterestsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>999065 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Components of provision for income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>999066 - Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails</Role>
      <ShortName> INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>999067 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2</Role>
      <ShortName>INCOME TAXES - Deferred tax assets and liabilities - (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>999068 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>999069 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>999070 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>999071 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>999072 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/RelatedPartyTransactions</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>999073 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>999074 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>999075 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="e6836_10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>999076 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformationTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="e6836_10k.htm">e6836_10k.htm</File>
    <File>fonr-20250630.xsd</File>
    <File>fonr-20250630_cal.xml</File>
    <File>fonr-20250630_def.xml</File>
    <File>fonr-20250630_lab.xml</File>
    <File>fonr-20250630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar_logo.jpg</File>
    <File>image_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="808">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="6">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="43">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>93
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "e6836_10k.htm": {
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20250630",
   "dts": {
    "inline": {
     "local": [
      "e6836_10k.htm"
     ]
    },
    "schema": {
     "local": [
      "fonr-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "fonr-20250630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20250630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20250630_pre.xml"
     ]
    }
   },
   "keyStandard": 323,
   "keyCustom": 120,
   "axisStandard": 23,
   "axisCustom": 0,
   "memberStandard": 38,
   "memberCustom": 36,
   "hidden": {
    "total": 109,
    "http://fonar.com/20250630": 25,
    "http://fasb.org/us-gaap/2025": 80,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 213,
   "entityCount": 1,
   "segmentCount": 78,
   "elementCount": 750,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 808,
    "http://xbrl.sec.gov/dei/2025": 43,
    "http://xbrl.sec.gov/cyd/2025": 6,
    "http://xbrl.sec.gov/ecd/2025": 5
   },
   "report": {
    "R1": {
     "role": "http://fonar.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://fonar.com/role/ConsolidatedBalanceSheets",
     "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://fonar.com/role/ConsolidatedStatementsOfOperations",
     "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
     "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ConsolidatedNetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ConsolidatedNetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:MtrlTermsOfTrdArrTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources",
     "longName": "999014 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "shortName": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "999015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "longName": "999016 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://fonar.com/role/Inventories",
     "longName": "999017 - Disclosure - INVENTORIES",
     "shortName": "INVENTORIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://fonar.com/role/PropertyAndEquipment",
     "longName": "999018 - Disclosure - PROPERTY AND EQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://fonar.com/role/OperatingAndFinanceLeases",
     "longName": "999019 - Disclosure - OPERATING AND FINANCE LEASES",
     "shortName": "OPERATING AND FINANCE LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://fonar.com/role/OtherIntangibleAssets",
     "longName": "999020 - Disclosure - OTHER INTANGIBLE ASSETS",
     "shortName": "OTHER INTANGIBLE ASSETS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://fonar.com/role/CapitalStock",
     "longName": "999021 - Disclosure - CAPITAL STOCK",
     "shortName": "CAPITAL STOCK",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:CapitalStockDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:CapitalStockDisclosureTextblock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterests",
     "longName": "999022 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://fonar.com/role/IncomeTaxes",
     "longName": "999023 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities",
     "longName": "999024 - Disclosure - OTHER CURRENT LIABILITIES",
     "shortName": "OTHER CURRENT LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://fonar.com/role/CommitmentsAndContingencies",
     "longName": "999025 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformation",
     "longName": "999026 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://fonar.com/role/RelatedPartyTransactions",
     "longName": "999027 - Disclosure - RELATED PARTY TRANSACTIONS",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation",
     "longName": "999028 - Disclosure - SEGMENT AND RELATED INFORMATION",
     "shortName": "SEGMENT AND RELATED INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://fonar.com/role/SubsequentEvents",
     "longName": "999029 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "999030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "longName": "999032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://fonar.com/role/InventoriesTables",
     "longName": "999033 - Disclosure - INVENTORIES (Tables)",
     "shortName": "INVENTORIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://fonar.com/role/PropertyAndEquipmentTables",
     "longName": "999034 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://fonar.com/role/OperatingAndFinanceLeasesTables",
     "longName": "999035 - Disclosure - OPERATING AND FINANCE LEASES (Tables)",
     "shortName": "OPERATING AND FINANCE LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsTables",
     "longName": "999036 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)",
     "shortName": "OTHER INTANGIBLE ASSETS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterestsTables",
     "longName": "999037 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://fonar.com/role/IncomeTaxesTables",
     "longName": "999038 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://fonar.com/role/OtherCurrentLiabilitiesTables",
     "longName": "999039 - Disclosure - OTHER CURRENT LIABILITIES (Tables)",
     "shortName": "OTHER CURRENT LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformationTables",
     "longName": "999040 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)",
     "shortName": "SEGMENT AND RELATED INFORMATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
     "longName": "999041 - Disclosure - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "shortName": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "AsOf2015-07-01_us-gaap_OtherInvesteesMember",
      "name": "us-gaap:InvestmentOwnedPercentOfNetAssets",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2015-07-01_us-gaap_OtherInvesteesMember",
      "name": "us-gaap:InvestmentOwnedPercentOfNetAssets",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details",
     "longName": "999042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1",
     "longName": "999043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:NetPatientFeeRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:NetPatientFeeRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
     "longName": "999044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "999045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:CostOfPropertyRepairsAndMaintenance",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
     "longName": "999046 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:ContractReceivableDueTwoToThreeYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:ContractReceivableDueTwoToThreeYears",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1",
     "longName": "999047 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_AccountsReceivableMember",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_AccountsReceivableMember",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails",
     "longName": "999048 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "longName": "999049 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "FONR:AccountsReceivableNetLongTerm",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:PercentageOfConsolidatedNetRevenueFromManagementFees",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://fonar.com/role/Inventories-InventoriesDetails",
     "longName": "999050 - Disclosure - INVENTORIES - Inventories (Details)",
     "shortName": "INVENTORIES - Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:OtherInventorySupplies",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
     "longName": "999051 - Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)",
     "shortName": "PROPERTY AND EQUIPMENT - Property and equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "999052 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)",
     "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "From2024-07-012025-06-30_us-gaap_PropertyPlantAndEquipmentMember",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012025-06-30_us-gaap_PropertyPlantAndEquipmentMember",
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
     "longName": "999053 - Disclosure - OPERATING & FINANCING LEASES - Lease payments (Details)",
     "shortName": "OPERATING & FINANCING LEASES - Lease payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30_custom_OperatingLeasePaymentsMember",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1",
     "longName": "999054 - Disclosure - OPERATING & FINANCING LEASES - Weighted average remaining lease term (Details 1)",
     "shortName": "OPERATING & FINANCING LEASES - Weighted average remaining lease term (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2",
     "longName": "999055 - Disclosure - OPERATING & FINANCING LEASES - Components of lease expense (Details 2)",
     "shortName": "OPERATING & FINANCING LEASES - Components of lease expense (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3",
     "longName": "999056 - Disclosure - OPERATING & FINANCING LEASES - Related to leases (Details 3)",
     "shortName": "OPERATING & FINANCING LEASES - Related to leases (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:OperatingCashFlowsFromOperatingLeases",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative",
     "longName": "999057 - Disclosure - OPERATING AND FINANCE LEASES (Details Narrative)",
     "shortName": "OPERATING AND FINANCE LEASES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
     "longName": "999058 - Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)",
     "shortName": "OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1",
     "longName": "999059 - Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)",
     "shortName": " OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2",
     "longName": "999060 - Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)",
     "shortName": "OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OtherIntangibleAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:OtherIntangibleAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
     "longName": "999061 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "shortName": "OTHER INTANGIBLE ASSETS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012025-06-30_us-gaap_PatentsMember",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://fonar.com/role/CapitalStockDetailsNarrative",
     "longName": "999062 - Disclosure - CAPITAL STOCK (Details Narrative)",
     "shortName": "CAPITAL STOCK (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:PaymentsForRepurchaseOfEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:CancellationOfTreasuryShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "FONR:CapitalStockDisclosureTextblock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
     "longName": "999063 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "name": "FONR:OpeningMembersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember",
      "name": "FONR:OpeningMembersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative",
     "longName": "999064 - Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "shortName": "CONTROLLING AND NONCONTROLLING INTERESTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2013-03-05_custom_HDMMember",
      "name": "FONR:PurchaseOfStandupMriCenters",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2013-03-05_custom_HDMMember",
      "name": "FONR:PurchaseOfStandupMriCenters",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:MinorityInterestDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails",
     "longName": "999065 - Disclosure - INCOME TAXES - Components of provision for income taxes (Details)",
     "shortName": "INCOME TAXES - Components of provision for income taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails",
     "longName": "999066 - Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)",
     "shortName": " INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2",
     "longName": "999067 - Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)",
     "shortName": "INCOME TAXES - Deferred tax assets and liabilities - (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://fonar.com/role/IncomeTaxesDetailsNarrative",
     "longName": "999068 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:DeferredTaxAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "longName": "999069 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "shortName": "OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "999070 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative",
     "longName": "999071 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:InterestPaidNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "999072 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:PrincipalAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:PrincipalAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details",
     "longName": "999073 - Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
     "longName": "999074 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ForeignProductSales",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfExportProductSalesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ForeignProductSales",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfExportProductSalesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details",
     "longName": "999075 - Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)",
     "shortName": "SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ForeignServiceAndRepairFees",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfExportServiceRevenuesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ForeignServiceAndRepairFees",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfExportServiceRevenuesTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative",
     "longName": "999076 - Disclosure - SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "shortName": "SEGMENT AND RELATED INFORMATION (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "FONR:ExportSalesOfMedicalEquipmentPercentage",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e6836_10k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "country_AE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "AE",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED ARAB EMIRATES"
       }
      }
     },
     "auth_ref": []
    },
    "country_AU": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "AU",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AUSTRALIA"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AbandonedPatents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "AbandonedPatents",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Abandoned patents"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r1086"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r60"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER CURRENT LIABILITIES",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r834"
     ]
    },
    "FONR_AccountsPayableRelatedPartyNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "AccountsPayableRelatedPartyNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related party medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Construction Contractor, Receivable, Excluding Contract Retainage",
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract."
       }
      }
     },
     "auth_ref": [
      "r1189"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r727",
      "r1073"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 net of allowances for credit losses of $264,212 and $166,049 at June 30, 2025 and 2024, respectively",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "AccountsReceivableNetLongTerm",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 long term",
        "verboseLabel": "Long term accounts receivable balances"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AccountsReceivableServiceContractsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "AccountsReceivableServiceContractsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Account receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedFeesAndOtherRevenueReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedFeesAndOtherRevenueReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 net of allowances for credit losses of $14,295,988 and $12,369,921 at June 30, 2025 and 2024, respectively",
        "documentation": "For an unclassified balance sheet, the amount of fees and other revenue, excluding investment income receivable, earned but not yet received, which were recognized in conformity with revenue recognition criteria based on estimates or specific contractual terms."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal and other professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r1234"
     ]
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued salaries, commissions and payroll taxes",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r748"
     ]
    },
    "us-gaap_AccruedUtilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedUtilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Utilities",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: Accumulated depreciation and amortization",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r135",
      "r571"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average useful lives",
        "verboseLabel": "Weighted average amortization period for other intangible assets",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r741"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid-in capital in excess of par value",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r834",
      "r1236"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r620",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1172",
      "r1238"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile consolidated net income to net cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvancePaymentsByBorrowersForTaxesAndInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdvancePaymentsByBorrowersForTaxesAndInsurance",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property taxes",
        "documentation": "Carrying amount of accumulated prepayments received by financial institutions from borrowers for taxes (for example, property taxes) and insurance (for example, property and catastrophe) which will periodically be remitted to the appropriate governmental agency or vendor on behalf of the borrower."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Costs",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r786"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r905",
      "r919",
      "r946"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r908",
      "r922",
      "r949"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r941"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r898",
      "r909",
      "r923",
      "r941",
      "r950",
      "r954",
      "r962"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r960"
     ]
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Summary of Allowance For Credit Losses",
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable."
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "FONR_AllowanceForDoubtfulAccountsAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "AllowanceForDoubtfulAccountsAdditions",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions (Included in provision for bad debts)"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_AllowanceForDoubtfulAccountsDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "AllowanceForDoubtfulAccountsDeductions",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deductions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable - net of allowances for credit losses",
        "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r242",
      "r250",
      "r251",
      "r252",
      "r1197"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r158",
      "r261",
      "r268",
      "r745",
      "r750",
      "r751",
      "r753",
      "r755"
     ]
    },
    "FONR_AmountsCapitalized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "AmountsCapitalized",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts capitalized"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r112",
      "r139",
      "r167",
      "r168",
      "r169",
      "r203",
      "r217",
      "r226",
      "r229",
      "r247",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r445",
      "r449",
      "r474",
      "r553",
      "r554",
      "r560",
      "r661",
      "r766",
      "r767",
      "r773",
      "r834",
      "r851",
      "r852",
      "r864",
      "r1113",
      "r1114",
      "r1181"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r148",
      "r167",
      "r168",
      "r169",
      "r247",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r445",
      "r449",
      "r474",
      "r834",
      "r1113",
      "r1114",
      "r1181"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r876",
      "r878",
      "r901"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r876",
      "r878",
      "r901"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r876",
      "r878",
      "r901"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_BenefitsLossesAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BenefitsLossesAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Selling, general and administrative expenses",
        "label": "Benefits, Losses and Expenses",
        "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r851",
      "r852"
     ]
    },
    "FONR_BensonhurstMRILimitedPartnershipMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "BensonhurstMRILimitedPartnershipMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bensonhurst MRI Limited Partnership [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]"
       }
      }
     },
     "auth_ref": [
      "r1082"
     ]
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BuildingMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r601",
      "r783",
      "r784",
      "r1162",
      "r1164",
      "r1165"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r601",
      "r783",
      "r784",
      "r1162",
      "r1164",
      "r1165"
     ]
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResources"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES",
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "FONR_BuyoutOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "BuyoutOfNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Buyout of noncontrolling interests"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_BuyoutOfNoncontrollingInterestsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "BuyoutOfNoncontrollingInterestsValue",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Buyout of noncontrolling interests",
        "label": "BuyoutOfNoncontrollingInterestsValue"
       }
      }
     },
     "auth_ref": []
    },
    "country_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "CA",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA"
       }
      }
     },
     "auth_ref": []
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "CH",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CancellationOfTreasuryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CancellationOfTreasuryShares",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of treasury shares"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CancellationOfTreasuryStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CancellationOfTreasuryStock",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of treasury stock"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CapitalExpenditures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CapitalExpenditures",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditures"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CapitalStockDisclosureTextblock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CapitalStockDisclosureTextblock",
     "presentation": [
      "http://fonar.com/role/CapitalStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CAPITAL STOCK"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CapitalizedResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CapitalizedResearchAndDevelopmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Research and development costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash deposit",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r563",
      "r632",
      "r656",
      "r834",
      "r851",
      "r852",
      "r864",
      "r988"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r133",
      "r746"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS - END OF YEAR",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r83",
      "r164"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation",
        "documentation": "Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r83"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federally insured limits",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASH FLOW INFORMATION",
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassAControllingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ClassAControllingInterestsMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Controlling Interests [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ClassANonVotingPreferredStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassANonVotingPreferredStockholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ClassANonVotingPreferredStockholdersMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Non Voting Preferred Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ClassAPreferredStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassBControllingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ClassBControllingInterestsMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Controlling Interests [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ClassCCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ClassCCommonStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class C Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r143",
      "r144",
      "r145",
      "r167",
      "r169",
      "r192",
      "r193",
      "r198",
      "r200",
      "r205",
      "r206",
      "r247",
      "r285",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r296",
      "r297",
      "r299",
      "r300",
      "r302",
      "r305",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r474",
      "r609",
      "r610",
      "r611",
      "r612",
      "r620",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r648",
      "r669",
      "r690",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r982",
      "r1059",
      "r1060",
      "r1069"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CommercialInsuranceManagedCareMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Insurance/ Managed Care [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS AND CONTINGENCIES",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r279",
      "r280",
      "r728",
      "r1108",
      "r1110"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1238"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1238"
     ]
    },
    "us-gaap_CommonClassCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassCMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class C [Member]",
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, capital shares reserved for future issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r854",
      "r855",
      "r856",
      "r858",
      "r859",
      "r860",
      "r861",
      "r1065",
      "r1066",
      "r1068",
      "r1172",
      "r1232",
      "r1238"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r648"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r53",
      "r648",
      "r667",
      "r1238",
      "r1239"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock value",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r297",
      "r304",
      "r565",
      "r834"
     ]
    },
    "us-gaap_CommonStockVotingRights": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockVotingRights",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, voting rights",
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "FONR_CommonStockholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CommonStockholdersMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stockholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r236",
      "r602",
      "r603",
      "r727",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r236",
      "r602",
      "r603",
      "r727",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r236",
      "r602",
      "r603",
      "r727",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r473"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration risk, percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r236",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r236",
      "r602",
      "r603",
      "r727",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076"
     ]
    },
    "FONR_ConsiderationForNoncompetitionAndConsultingAgreements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ConsiderationForNoncompetitionAndConsultingAgreements",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM entered agreement for consulting and non-competition agreement ($)"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ConsiderationToOutsideInvestors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ConsiderationToOutsideInvestors",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM purchase price includes consideration to outside investors"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ConsolidatedNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ConsolidatedNetIncome",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Consolidated Net Income",
        "label": "ConsolidatedNetIncome"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ConsolidatedNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ConsolidatedNetIncomeLoss",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Net Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table]",
        "documentation": "Disclosure of information about effect of change in parent's ownership interest in subsidiary on equity attributable to parent. Excludes change from deconsolidation of subsidiary."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r37"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r757"
     ]
    },
    "us-gaap_ContractReceivableDueFiveYearsOrMore": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractReceivableDueFiveYearsOrMore",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2029",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1190"
     ]
    },
    "us-gaap_ContractReceivableDueFourToFiveYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractReceivableDueFourToFiveYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1190"
     ]
    },
    "us-gaap_ContractReceivableDueThreeToFourYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractReceivableDueThreeToFourYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1190"
     ]
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractReceivableDueTwoToThreeYears",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1190"
     ]
    },
    "FONR_ContractualFeesForServicesRenderedMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ContractualFeesForServicesRenderedMaximum",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual fees for services rendered Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ContractualFeesForServicesRenderedMinimum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ContractualFeesForServicesRenderedMinimum",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual fees for services rendered minimum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of price of the equipment",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r101",
      "r1195"
     ]
    },
    "FONR_CorrectionOfError": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CorrectionOfError",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Correction of an error"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfPropertyRepairsAndMaintenance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfPropertyRepairsAndMaintenance",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maintenance and repair expenses",
        "documentation": "The aggregate costs of keeping the property in good condition but that do not appreciably prolong the life or increase the value of the property."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "FONR_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CostOfSales",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Cost of sales"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CostomerRelationshipsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costomer Relationships [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Costs and Expenses",
        "label": "Costs and Expenses [Default Label]",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CostsRelatedToManagementAndOtherFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees \u2013 related medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToProductSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CostsRelatedToProductSales",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CostsRelatedToServiceAndRepairFees",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees \u2013 related parties"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r987",
      "r1057",
      "r1062",
      "r1156"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r1057",
      "r1062"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r987",
      "r1057",
      "r1062",
      "r1156"
     ]
    },
    "FONR_CustomerAdvancesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CustomerAdvancesPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Advances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r1073"
     ]
    },
    "FONR_CustomerDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "CustomerDeposits",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r801",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1102",
      "r1105",
      "r1106"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r973"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r973"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r888",
      "r975"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r888",
      "r975"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r890",
      "r977"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r888",
      "r975"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r881",
      "r968"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r882",
      "r969"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r882",
      "r969"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r880",
      "r967"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r883",
      "r970"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r885",
      "r972"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r885",
      "r972"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r886",
      "r973"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r889",
      "r976"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r887",
      "r974"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r884",
      "r971"
     ]
    },
    "country_DE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "DE",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GERMANY"
       }
      }
     },
     "auth_ref": []
    },
    "country_DO": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "DO",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DOMINICAN REPUBLIC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "FONR_DeferredIncomeTaxExpensesBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal deferred taxes",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1062",
      "r1155",
      "r1156"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredGainOnSaleOfProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredGainOnSaleOfProperty",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on sale of equipments",
        "documentation": "Amount of gain on the sale of property that does not qualify for gain recognition as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax - net",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r123",
      "r1057",
      "r1062"
     ]
    },
    "FONR_DeferredIncomeTaxExpensesBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "DeferredIncomeTaxExpensesBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "DeferredIncomeTaxExpensesBenefit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax liability",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue on service contracts",
        "label": "Deferred Revenue, Noncurrent",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": "FONR_DeferredIncomeTaxExpensesBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State deferred taxes",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1062",
      "r1155",
      "r1156"
     ]
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetInterestCarryforward",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation allowance for deferred tax assets",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income tax asset",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Tax Assets - gross",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r368"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized research and development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "FONR_DeferredTaxAssetsInRightUseAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "DeferredTaxAssetsInRightUseAssetsAndLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use assets and lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsInventory",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventories",
        "label": "Deferred Tax Assets, Inventory",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax asset",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1151"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2",
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred tax asset",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1151"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-deductible accruals",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax credits",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax credits carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for credit losses",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1151"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Intangibles",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liability",
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus."
       }
      }
     },
     "auth_ref": [
      "r1229"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r23"
     ]
    },
    "FONR_DepreciationOfLeasedEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "DepreciationOfLeasedEquipment",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation of leased equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativeFixedInterestRate",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bears interest rate",
        "documentation": "Fixed interest rate related to the interest rate derivative."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DiagnosticEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "DiagnosticEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diagnostic Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DiagnosticImagingFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "DiagnosticImagingFacilityMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diagnostic Imaging Facility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DirectPurchaseOfNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "DirectPurchaseOfNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of interests from Class A"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r315",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r315",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of patient fee revenue - net",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1119"
     ]
    },
    "FONR_DisclosureCapitalStockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "DisclosureCapitalStockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_DisclosureOperatingAndFinanceLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "DisclosureOperatingAndFinanceLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating And Finance Leases",
        "verboseLabel": "Operating Financing Leases - Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Financing Leases - Components Of Lease Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for income taxes",
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r67",
      "r1198"
     ]
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Loss) Income before provision for income taxes",
        "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r43"
     ]
    },
    "FONR_Distributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "Distributions",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPayableNature": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DividendsPayableNature",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends payable, nature",
        "documentation": "Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r876",
      "r878",
      "r901"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r876",
      "r878",
      "r901",
      "r942"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r865"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r868"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Net Income Per Common Share Available to Common Stockholders",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r156",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r189",
      "r192",
      "r198",
      "r199",
      "r200",
      "r202",
      "r295",
      "r347",
      "r386",
      "r442",
      "r466",
      "r467",
      "r552",
      "r578",
      "r758"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted Net Income Per Common Share Available to Common Stockholders",
        "verboseLabel": "Diluted income per common share",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r156",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r192",
      "r198",
      "r199",
      "r200",
      "r202",
      "r295",
      "r347",
      "r386",
      "r442",
      "r466",
      "r467",
      "r552",
      "r578",
      "r758"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r16",
      "r201"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective income tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r787"
     ]
    },
    "FONR_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Taxes at federal statutory rate",
        "label": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Permanent items Meals and Entertainment",
        "label": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in the valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r787",
      "r1057",
      "r1063",
      "r1148"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount of reported income tax expense (benefit) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to cross-border tax law classified as other."
       }
      }
     },
     "auth_ref": [
      "r787",
      "r1150"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling interest",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1063",
      "r1148",
      "r1149"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent",
        "documentation": "Percentage of reported income tax benefit (expense) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to other reconciling items. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law."
       }
      }
     },
     "auth_ref": [
      "r1149"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and local income taxes (benefit), net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r787",
      "r1057",
      "r1063",
      "r1148"
     ]
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOwnershipPlanESOPCashContributionsToESOP",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employer contributions",
        "documentation": "This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r1146"
     ]
    },
    "FONR_EndingMembersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "EndingMembersEquity",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ending Members Equity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r867"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from External Customer [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r126",
      "r128",
      "r129",
      "r152",
      "r153",
      "r154",
      "r173",
      "r174",
      "r175",
      "r177",
      "r184",
      "r186",
      "r188",
      "r204",
      "r248",
      "r249",
      "r275",
      "r294",
      "r313",
      "r347",
      "r375",
      "r376",
      "r383",
      "r384",
      "r385",
      "r387",
      "r441",
      "r442",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r485",
      "r488",
      "r502",
      "r577",
      "r594",
      "r595",
      "r596",
      "r620",
      "r690"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r382",
      "r474",
      "r983",
      "r984",
      "r985",
      "r1157",
      "r1158",
      "r1159",
      "r1160"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r474"
     ]
    },
    "FONR_EquityMethodInvestmentOwnershipPercentages": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "EquityMethodInvestmentOwnershipPercentages",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership interest of company"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_EquityMethodInvestmentsOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "EquityMethodInvestmentsOwnershipPercentage",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of interests from Class A, percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r905",
      "r919",
      "r946"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r902",
      "r916",
      "r943"
     ]
    },
    "FONR_EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Estimated Useful Life in Years for Property and Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "FONR_ExportSalesOfMedicalEquipmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ExportSalesOfMedicalEquipmentPercentage",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Export sales of medical equipment percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "FONR_FinanceLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "FinanceLeaseCost",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total finance lease cost"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_FinanceLeaseCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "FinanceLeaseCostsAbstract",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease cost:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest on lease liabilities",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r492",
      "r833"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total lease liability",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r496"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease liability \u2013 current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease liability \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2029",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use-asset \u2013 finance lease",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average discount rate, finance leases",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r833"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease - years",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r833"
     ]
    },
    "FONR_FinancingCashFlowsFromFinancingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "FinancingCashFlowsFromFinancingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing cash flows from finance leases"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_FinancingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "FinancingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Lease Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-lived intangible asset, useful life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated amortization intangible assets",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r254",
      "r267",
      "r745"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1103",
      "r1240"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r741",
      "r745"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2029",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r741",
      "r745"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r741",
      "r745"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r741",
      "r745"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r741",
      "r745"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r270",
      "r271",
      "r515",
      "r516",
      "r601",
      "r741",
      "r745",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r267",
      "r516",
      "r745"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r267",
      "r270",
      "r271",
      "r273",
      "r515",
      "r741",
      "r745",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r270",
      "r271",
      "r601",
      "r741",
      "r745",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "intangible assets net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r1102"
     ]
    },
    "FONR_ForeignProductSales": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ForeignProductSales",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign product sales"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of service and repair of medical equipment"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ForeignServiceAndRepairFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ForeignServiceAndRepairFees",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r909",
      "r923",
      "r950"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r909",
      "r923",
      "r950"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r909",
      "r923",
      "r950"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r909",
      "r923",
      "r950"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r909",
      "r923",
      "r950"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "GB",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "country_GR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "GR",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GREECE"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_GainOnSaleOfEquipmentRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "GainOnSaleOfEquipmentRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on sale of equipment \u2013 related party",
        "label": "GainOnSaleOfEquipmentRelatedParty"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_GainlossOnDispositionOfFixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "GainlossOnDispositionOfFixedAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on disposition of fixed assets",
        "label": "GainlossOnDispositionOfFixedAssets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r256",
      "r551",
      "r767",
      "r772",
      "r788",
      "r789",
      "r790",
      "r820",
      "r826",
      "r834",
      "r1093",
      "r1094",
      "r1166"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r257",
      "r772"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Intangible Assets",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1092",
      "r1095"
     ]
    },
    "FONR_HDMEquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "HDMEquityMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM Equity [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_HDMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "HDMMember",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "documentation": "Information by major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r1119"
     ]
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "auth_ref": [
      "r1119"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r876",
      "r878",
      "r901"
     ]
    },
    "us-gaap_ImpairmentOfInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOfInvestments",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment income",
        "label": "Other than Temporary Impairment Losses, Investments",
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Loss) Income from operations",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r66",
      "r86",
      "r129",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r196",
      "r200",
      "r442"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "FONR_ConsolidatedNetIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before Provision for Income Taxes and Noncontrolling Interests",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r106",
      "r111",
      "r553",
      "r555",
      "r573",
      "r752",
      "r754",
      "r756",
      "r762",
      "r766",
      "r1071",
      "r1077",
      "r1078",
      "r1079",
      "r1080"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income from Operations",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic income per common share",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r107",
      "r129",
      "r156",
      "r176",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r192",
      "r198",
      "r199",
      "r295",
      "r386",
      "r442",
      "r467",
      "r552",
      "r1199"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r451",
      "r452",
      "r453",
      "r454",
      "r469",
      "r470",
      "r471",
      "r475",
      "r476",
      "r477",
      "r591",
      "r593",
      "r675",
      "r741",
      "r742",
      "r788",
      "r790",
      "r824",
      "r825",
      "r827",
      "r832",
      "r1161",
      "r1163",
      "r1201"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r451",
      "r452",
      "r453",
      "r454",
      "r469",
      "r470",
      "r471",
      "r475",
      "r476",
      "r477",
      "r591",
      "r593",
      "r675",
      "r741",
      "r742",
      "r788",
      "r790",
      "r824",
      "r825",
      "r827",
      "r832",
      "r1161",
      "r1163",
      "r1201"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r170",
      "r355",
      "r359",
      "r363",
      "r364",
      "r365",
      "r366",
      "r371",
      "r377",
      "r379",
      "r380",
      "r381",
      "r558",
      "r600",
      "r614",
      "r787"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "FONR_ConsolidatedNetIncome",
       "weight": -1.0,
       "order": 2.0
      },
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/IncomeTaxes-ComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for Income Taxes",
        "totalLabel": "Provision (Benefit) for Income Taxes - Net",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r124",
      "r167",
      "r187",
      "r188",
      "r203",
      "r221",
      "r229",
      "r358",
      "r359",
      "r378",
      "r582",
      "r752",
      "r754",
      "r756",
      "r787"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r356",
      "r357",
      "r366",
      "r367",
      "r370",
      "r373",
      "r608"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r787",
      "r1148"
     ]
    },
    "FONR_IncomeTaxReconciliationIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ending Members' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes at federal statutory rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r787"
     ]
    },
    "us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationMinorityInterestIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Noncontrolling interests",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r1148",
      "r1149"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and local income taxes",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r787",
      "r1148"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes paid",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r85",
      "r1055",
      "r1152",
      "r1153"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts, medical and management fee receivable(s)",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "FONR_IncreaseDecreaseInCustomerAdvance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "IncreaseDecreaseInCustomerAdvance",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer advances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "FONR_IncreaseDecreaseInNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "IncreaseDecreaseInNotesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInNotesReceivableRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInNotesReceivableRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Notes receivable \u2013 related party",
        "label": "Increase (Decrease) in Notes Receivable, Related Parties",
        "documentation": "The increase (decrease) during the reporting period in the amount owed to the reporting entity in the form of loans and obligations (generally evidenced by promissory notes) made to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities, net:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other current liabilities",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "documentation": "Amount of increase (decrease) in current liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_IncreaseDecreaseInTradingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInTradingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance lease liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of trading liabilities from the reporting entity's trading activities. This include liabilities resulting from sales of assets that the reporting entity does not own and revaluation losses."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "FONR_IncrementalCommonSharesAttributableToConversionOfCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "IncrementalCommonSharesAttributableToConversionOfCommonStock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class C Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class C Common Stock",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r195",
      "r200",
      "r348",
      "r349"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r909",
      "r923",
      "r941",
      "r950",
      "r954",
      "r962"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r960"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r879",
      "r966"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r879",
      "r966"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r879",
      "r966"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OTHER INTANGIBLE ASSETS",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r272",
      "r274",
      "r740",
      "r741"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets \u2013 net",
        "verboseLabel": "Other intangible assets - net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r1102",
      "r1104"
     ]
    },
    "us-gaap_IntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntellectualPropertyMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intellectual Property [Member]",
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights."
       }
      }
     },
     "auth_ref": [
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1102",
      "r1105",
      "r1106"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r752",
      "r756",
      "r1007"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r162",
      "r163"
     ]
    },
    "FONR_IntersegmentNetRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "IntersegmentNetRevenues",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intersegment net revenues *",
        "documentation": "This represents the amount of intersegment net revenues during period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVENTORIES",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      },
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories - net",
        "totalLabel": "Inventories",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r747",
      "r834"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work-in-process",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "us-gaap_InventoryWorkInProcessPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryWorkInProcessPolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories",
        "documentation": "Disclosure of accounting policy for the basis and manner that goods are added and removed from inventory in the course of production (work in process). If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory and how cost is determined (such as FIFO, LIFO, average)."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_InvestmentIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment income",
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r75"
     ]
    },
    "FONR_InvestmentIncomeRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "InvestmentIncomeRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentInterestRate",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "documentation": "Rate of interest on investment."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r697",
      "r701",
      "r702",
      "r704",
      "r705",
      "r710",
      "r711",
      "r856",
      "r1087",
      "r1088"
     ]
    },
    "us-gaap_InvestmentOwnedPercentOfNetAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentOwnedPercentOfNetAssets",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Owned, Net Assets, Percentage",
        "documentation": "Percentage of investment owned to net assets."
       }
      }
     },
     "auth_ref": [
      "r635",
      "r637",
      "r638",
      "r698",
      "r707",
      "r708",
      "r709",
      "r715",
      "r856",
      "r1233"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Investments",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r579",
      "r604",
      "r605",
      "r606",
      "r607",
      "r699",
      "r700"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinanceLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of supplemental cash flow information related to leases",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1177"
     ]
    },
    "us-gaap_LeaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "financing lease",
        "documentation": "Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor."
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r498"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinanceLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Operating Lease and Finance Lease Payments",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1178"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r1058",
      "r1064",
      "r1192"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinanceLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING AND FINANCE LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r167",
      "r168",
      "r169",
      "r247",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r446",
      "r449",
      "r450",
      "r474",
      "r647",
      "r761",
      "r773",
      "r864",
      "r1113",
      "r1181",
      "r1182"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r103",
      "r568",
      "r834",
      "r851",
      "r852",
      "r1057",
      "r1061",
      "r1090",
      "r1175"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r132",
      "r167",
      "r168",
      "r169",
      "r247",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r446",
      "r449",
      "r450",
      "r474",
      "r834",
      "r1113",
      "r1181",
      "r1182"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Long-Term Liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r48",
      "r49",
      "r50",
      "r51",
      "r167",
      "r168",
      "r169",
      "r247",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r446",
      "r449",
      "r450",
      "r474",
      "r1113",
      "r1181",
      "r1182"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve for self-funded",
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date."
       }
      }
     },
     "auth_ref": [
      "r846",
      "r850",
      "r851",
      "r1193",
      "r1202"
     ]
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
        "documentation": "The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r1081"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of long-term debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term debt, less current portion",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MagneticResonanceManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "MagneticResonanceManagementMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Magnetic Resonance Management [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r236",
      "r775",
      "r778",
      "r844",
      "r849",
      "r1200",
      "r1203",
      "r1204",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1230",
      "r1231"
     ]
    },
    "FONR_ManagedFacilitiesAddedByInternalDevelopment": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagedFacilitiesAddedByInternalDevelopment",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Internal development"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagedFacilitiesClosedDuringYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagedFacilitiesClosedDuringYear",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Managed Facilities Closed"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAgreementsWithCompanyTotalMedicalPractices": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagementAgreementsWithCompanyTotalMedicalPractices",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management agreements with company total medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagementAndOtherFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagementAndOtherFeesReceivableMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management And Other Fees Receivable Related Medical Practices [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 related medical practices"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementAndOtherReceivableAllowancesForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagementAndOtherReceivableAllowancesForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable - net of allowances for credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementFeeReceivableForRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagementFeeReceivableForRelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee Receivable For Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementFeeReceivableForUnrelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagementFeeReceivableForUnrelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management fee receivable for unrelated parties"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagementofDiagnosticImagingCentersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagementofDiagnosticImagingCentersMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Managementof Diagnostic Imaging Centers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 related party medical practices \u2013 net of allowances for credit losses of $7,136,836 and $6,110,399 at June 30, 2025 and 2024, respectively"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ManufacturingandServicingofMedicalEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ManufacturingandServicingofMedicalEquipmentMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturingand Servicingof Medical Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r912",
      "r913"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r912",
      "r914"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r912",
      "r915"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r912",
      "r915"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r912",
      "r915"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r912",
      "r915"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r212",
      "r281",
      "r282",
      "r283",
      "r284",
      "r319",
      "r342",
      "r343",
      "r344",
      "r350",
      "r468",
      "r513",
      "r590",
      "r592",
      "r599",
      "r639",
      "r640",
      "r696",
      "r701",
      "r705",
      "r706",
      "r710",
      "r722",
      "r723",
      "r725",
      "r726",
      "r738",
      "r739",
      "r771",
      "r774",
      "r785",
      "r788",
      "r791",
      "r792",
      "r828",
      "r829",
      "r830",
      "r831",
      "r845",
      "r1115",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "FONR_MedicalFeeReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "MedicalFeeReceivable",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical fee receivable"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MedicalReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "MedicalReceivable",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivables"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MedicalReceivablePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "MedicalReceivablePolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_MedicareMedicaidMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "MedicareMedicaidMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicare/Medicaid [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r212",
      "r281",
      "r282",
      "r283",
      "r284",
      "r319",
      "r342",
      "r343",
      "r344",
      "r350",
      "r468",
      "r513",
      "r590",
      "r592",
      "r599",
      "r639",
      "r640",
      "r696",
      "r701",
      "r705",
      "r706",
      "r710",
      "r722",
      "r723",
      "r725",
      "r726",
      "r738",
      "r739",
      "r771",
      "r774",
      "r785",
      "r788",
      "r791",
      "r792",
      "r828",
      "r829",
      "r830",
      "r845",
      "r1115",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling interests",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r102",
      "r167",
      "r168",
      "r169",
      "r247",
      "r285",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r567",
      "r650",
      "r1175"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions \u2013 Non controlling interest",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONTROLLING AND NONCONTROLLING INTERESTS",
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_MinorityInterestLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestLineItems",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership interest of investors",
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestTable",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Table]",
        "documentation": "Disclosure of information about noncontrolling interest, including, but not limited to, name of subsidiary, ownership percentage held by parent, ownership percentage held by noncontrolling owner, amount of noncontrolling interest and its location in statement of financial position, explanation of increase (decrease) in noncontrolling interest, noncontrolling interest share of net income (loss) of subsidiary and its location in statement of income, amount of noncontrolling interest represented by preferred stock, description and dividend requirement of preferred stock, and nature of noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r34",
      "r58",
      "r68"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "FONR_N2010StockBonusPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "N2010StockBonusPlanMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "N 2010 Stock Bonus Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r236",
      "r775",
      "r778",
      "r844",
      "r849",
      "r1200",
      "r1203",
      "r1204",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1230",
      "r1231"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r84",
      "r86"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net change in operating right-of-use assets and lease liabilities",
        "label": "NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income \u2013 Attributable to FONAR",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r86",
      "r108",
      "r129",
      "r130",
      "r149",
      "r150",
      "r154",
      "r167",
      "r168",
      "r169",
      "r172",
      "r176",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r187",
      "r188",
      "r196",
      "r247",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r298",
      "r301",
      "r306",
      "r347",
      "r386",
      "r442",
      "r467",
      "r474",
      "r576",
      "r668",
      "r688",
      "r689",
      "r752",
      "r754",
      "r756",
      "r862",
      "r1113"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net Income \u2013 Noncontrolling Interests",
        "label": "Net Income \u2013 Non controlling interests",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r95",
      "r149",
      "r150",
      "r184",
      "r187",
      "r188",
      "r575",
      "r1005"
     ]
    },
    "FONR_NetIncomeLossAvailableToCommonStockholderBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "NetIncomeLossAvailableToCommonStockholderBasic",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income available to common stockholders"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income Available to Common Stockholders",
        "verboseLabel": "Net (Loss) income",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r157",
      "r180",
      "r181",
      "r182",
      "r183",
      "r189",
      "r190",
      "r197",
      "r200",
      "r298",
      "r301",
      "r306",
      "r442"
     ]
    },
    "FONR_NetPatientFeeRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "NetPatientFeeRevenue",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Patient Fee Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently Adopted Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncompeteAgreementsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncompete Agreements [Member]",
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party."
       }
      }
     },
     "auth_ref": [
      "r797",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1102",
      "r1105",
      "r1106"
     ]
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncontrollingInterestAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r313",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1238"
     ]
    },
    "FONR_NoteReceivableRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "NoteReceivableRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note receivable \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesReceivableMember",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Receivable [Member]",
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Class C Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OpeningMembersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "OpeningMembersEquity",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Opening Members Equity"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OperatingCashFlowsFromOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "OperatingCashFlowsFromOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating cash flows from operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-ComponentsOfLeaseExpenseDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r833"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinanceLeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating leases",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1176"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities \u2013 current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liabilities \u2013 net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "FONR_OperatingLeasePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "OperatingLeasePaymentsMember",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use-asset \u2013 operating leases",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average discount rate, operating leases",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r833"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-WeightedAverageRemainingLeaseTermDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases - years",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r833"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts and tax credits",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest and penalty",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r138",
      "r559",
      "r767",
      "r851",
      "r852",
      "r864"
     ]
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCostOfOperatingRevenue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to patient fee revenue",
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "FONR_OtherCostOfSalesExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "OtherCostOfSalesExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Cost of sales expenses**"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherDepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization of property and equipment",
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r23",
      "r71"
     ]
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expenses)",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r580",
      "r670",
      "r712",
      "r713",
      "r714",
      "r851",
      "r852"
     ]
    },
    "FONR_OtherIncomeRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "OtherIncomeRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIntangibleAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance - Beginning of Year",
        "periodEndLabel": "Balance - End of Year",
        "label": "Other Intangible Assets, Net",
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInventorySupplies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherInventorySupplies",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchased parts and components",
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "us-gaap_OtherInvesteesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherInvesteesMember",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonconsolidated Investees, Other [Member]",
        "documentation": "Investment in group of nonconsolidated investees classified as other."
       }
      }
     },
     "auth_ref": [
      "r1089",
      "r1175"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r561",
      "r643",
      "r644",
      "r773",
      "r851",
      "r852",
      "r864",
      "r1196",
      "r1235"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "totalLabel": "Other Current Liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r834"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r823"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and (Expenses):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherOperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherOperatingIncome",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City operating loss carryforwards",
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_OtherOwnershipInterestsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherOwnershipInterestsByNameAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Ownership Interests Name [Axis]",
        "documentation": "Information by ownership interests about other units or shares or classes of ownership in a partnership. Excludes limited or general partners' ownership interests."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_OtherOwnershipInterestsNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherOwnershipInterestsNameDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the ownership interest, which details special or unusual rights. Does not include limited or general partners' ownership interests."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "FONR_OtherRevenueSourceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "OtherRevenueSourceMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_OtherSellingGeneralAndAdministrativeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "OtherSellingGeneralAndAdministrativeExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other selling, general and administrative expenses**"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other general and administrative expenses",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r46"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r907",
      "r921",
      "r948"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r899",
      "r910",
      "r924",
      "r951"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r899",
      "r910",
      "r924",
      "r951"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "country_PR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "PR",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PatentsAndCopyrightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PatentsAndCopyrightsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents and copyrights [Member]",
        "documentation": "Patents and copyrights - Member - Custom elements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PatentsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1102",
      "r1105",
      "r1106"
     ]
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue \u2013 net of contractual allowances and discounts"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForProceedsFromShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForProceedsFromShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Proceeds (Purchase) from short-term investment",
        "label": "Payments for (Proceeds from) Short-Term Investments",
        "documentation": "The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r1050",
      "r1051",
      "r1054"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForRepurchaseOfEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of treasury stock",
        "label": "Payments for repurchase of equity",
        "documentation": "The cash outflow to reacquire common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r612"
     ]
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfDividendsMinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distributions to noncontrolling interests",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of patents",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_PaymentsToEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToEmployees",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salaries and wages",
        "documentation": "Payments of cash to employees, including wages and salaries, during the current period."
       }
      }
     },
     "auth_ref": [
      "r1052"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "FONR_Penalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "Penalties",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Penalties"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r934"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of consolidated net revenue from management fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PermanentItemsMealsEntertainment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PermanentItemsMealsEntertainment",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-ReconciliationOfFederalStatutoryIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent items Meals and Entertainment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1129",
      "r1130",
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_PreferredClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredClassAMember",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Class A [Member]",
        "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r854",
      "r855",
      "r858",
      "r859",
      "r860",
      "r861",
      "r1232",
      "r1238"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r307"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r648"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r307"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r648",
      "r667",
      "r1238",
      "r1239"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock value",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r297",
      "r303",
      "r564",
      "r834"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "FONR_PrepaidExpensesAndOtherCurrentAssetsRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets \u2013 related party"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PresentValueDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PresentValueDiscount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value discount"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PresentValueDiscountFinancingLease",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Present value discount",
        "label": "PresentValueDiscountFinancingLease"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromContributionsFromAffiliates",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors contribution",
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "FONR_ProceedsFromContributionsFromCompany": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ProceedsFromContributionsFromCompany",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company contribution"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (Payments to) Noncontrolling Interests",
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sale of equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r232",
      "r514",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r743",
      "r751",
      "r754",
      "r756",
      "r775",
      "r776",
      "r843",
      "r845",
      "r847",
      "r850",
      "r853",
      "r986",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1111",
      "r1112",
      "r1200",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1230",
      "r1231"
     ]
    },
    "FONR_ProductSalesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ProductSalesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "auth_ref": [
      "r232",
      "r514",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r743",
      "r751",
      "r754",
      "r756",
      "r775",
      "r776",
      "r843",
      "r845",
      "r847",
      "r850",
      "r853",
      "r986",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1111",
      "r1112",
      "r1200",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1230",
      "r1231"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r149",
      "r150",
      "r160",
      "r167",
      "r168",
      "r169",
      "r172",
      "r176",
      "r184",
      "r187",
      "r188",
      "r247",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r347",
      "r386",
      "r442",
      "r444",
      "r447",
      "r448",
      "r467",
      "r474",
      "r553",
      "r555",
      "r574",
      "r619",
      "r668",
      "r688",
      "r689",
      "r821",
      "r822",
      "r863",
      "r1005",
      "r1113"
     ]
    },
    "FONR_PropertyAndEquipmentAndDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PropertyAndEquipmentAndDepreciation",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/IncomeTaxes-DeferredTaxAssetsAndLiabilities-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment and depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r498"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PROPERTY AND EQUIPMENT",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r120",
      "r121",
      "r122"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment, gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r134",
      "r572"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Member]",
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment \u2013 net",
        "verboseLabel": "Property plant and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r498",
      "r557",
      "r572",
      "r834"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentOwnedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentOwnedNet",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use and equipment assets",
        "documentation": "Amount, after accumulated depreciation, of long-lived, depreciable flight asset owned. Excludes right-of-use asset from finance lease for flight asset."
       }
      }
     },
     "auth_ref": [
      "r1107"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r120",
      "r121",
      "r570"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r498"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ProvisionForBadDebts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ProvisionForBadDebts",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PurchaseOfOtherMriCenters": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PurchaseOfOtherMriCenters",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of other MRI centers"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_PurchaseOfStandupMriCenters": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "PurchaseOfStandupMriCenters",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of stand up MRI centers"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "FONR_RadianHealthcareManagementLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RadianHealthcareManagementLLCMember",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Radian Healthcare Management LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r212",
      "r281",
      "r282",
      "r283",
      "r284",
      "r316",
      "r319",
      "r342",
      "r343",
      "r344",
      "r346",
      "r350",
      "r468",
      "r511",
      "r512",
      "r513",
      "r590",
      "r592",
      "r599",
      "r639",
      "r640",
      "r696",
      "r701",
      "r705",
      "r706",
      "r710",
      "r722",
      "r723",
      "r725",
      "r726",
      "r738",
      "r739",
      "r771",
      "r774",
      "r785",
      "r788",
      "r791",
      "r792",
      "r828",
      "r829",
      "r830",
      "r831",
      "r845",
      "r856",
      "r1109",
      "r1115",
      "r1173",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "auth_ref": [
      "r212",
      "r281",
      "r282",
      "r283",
      "r284",
      "r316",
      "r319",
      "r342",
      "r343",
      "r344",
      "r346",
      "r350",
      "r468",
      "r511",
      "r512",
      "r513",
      "r590",
      "r592",
      "r599",
      "r639",
      "r640",
      "r696",
      "r701",
      "r705",
      "r706",
      "r710",
      "r722",
      "r723",
      "r725",
      "r726",
      "r738",
      "r739",
      "r771",
      "r774",
      "r785",
      "r788",
      "r791",
      "r792",
      "r828",
      "r829",
      "r830",
      "r831",
      "r845",
      "r856",
      "r1109",
      "r1115",
      "r1173",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188"
     ]
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r60"
     ]
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r243",
      "r1084"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r891",
      "r902",
      "r916",
      "r943"
     ]
    },
    "FONR_RecruitingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RecruitingFees",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recruiting fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of HDM members equity",
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r1116",
      "r1117"
     ]
    },
    "us-gaap_ReinsurancePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ReinsurancePayable",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for individual claims",
        "documentation": "The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RelatedPartiesMedicalPracticesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RelatedPartiesMedicalPracticesMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties Medical Practices [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RelatedPartiesMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r171",
      "r172",
      "r237",
      "r317",
      "r318",
      "r506",
      "r507",
      "r562",
      "r569",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r666",
      "r695",
      "r1237"
     ]
    },
    "FONR_RelatedPartyReceivableAllowancesForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RelatedPartyReceivableAllowancesForDoubtfulAccounts",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable - related party medical practices - net of allowances for credit losses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDescriptionOfTransaction",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party transaction, description",
        "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r142",
      "r497",
      "r499",
      "r501",
      "r505"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r171",
      "r172",
      "r237",
      "r317",
      "r318",
      "r506",
      "r507",
      "r562",
      "r569",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r666",
      "r695",
      "r1180",
      "r1237"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r504",
      "r505",
      "r507",
      "r508",
      "r615",
      "r616",
      "r617",
      "r673",
      "r674",
      "r675",
      "r693",
      "r694"
     ]
    },
    "FONR_RentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RentExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rent expense"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RentsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RentsExpense",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Rent expense",
        "label": "RentsExpense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of borrowings and finance obligations",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "verboseLabel": "Total Research and development costs",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r741",
      "r752",
      "r753",
      "r766",
      "r1191"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other research and development costs**",
        "documentation": "Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r1147"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Costs",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "FONR_ResearchDevelopmentAndDemonstrationEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ResearchDevelopmentAndDemonstrationEquipmentMember",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research, development and demonstration equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ResearchDeveopmentAndDemonstrationEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ResearchDeveopmentAndDemonstrationEquipmentMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research Deveopment And Demonstration Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r892",
      "r903",
      "r917",
      "r944"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r893",
      "r904",
      "r918",
      "r945"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r900",
      "r911",
      "r925",
      "r952"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r91",
      "r566",
      "r597",
      "r598",
      "r613",
      "r649",
      "r834"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r128",
      "r129",
      "r173",
      "r174",
      "r175",
      "r177",
      "r184",
      "r186",
      "r188",
      "r248",
      "r249",
      "r275",
      "r294",
      "r347",
      "r375",
      "r376",
      "r383",
      "r384",
      "r385",
      "r387",
      "r441",
      "r442",
      "r455",
      "r457",
      "r458",
      "r460",
      "r465",
      "r485",
      "r488",
      "r594",
      "r596",
      "r620",
      "r1238"
     ]
    },
    "FONR_RevenuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RevenuePercentage",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "revenue percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Revenues \u2013 Net",
        "label": "Net revenues from external customers",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r110",
      "r155",
      "r167",
      "r168",
      "r169",
      "r203",
      "r218",
      "r219",
      "r225",
      "r229",
      "r232",
      "r234",
      "r236",
      "r247",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r474",
      "r553",
      "r555",
      "r766",
      "r823",
      "r851",
      "r852",
      "r1113"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-RelatedToLeasesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use and equipment assets obtained in exchange for lease obligations:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "FONR_SalariesAndWage": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "SalariesAndWage",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Salaries and wages",
        "label": "SalariesAndWage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalariesAndWages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalariesAndWages",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Salaries and wages",
        "label": "Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold",
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold."
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "FONR_SaleNonControllingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "SaleNonControllingInterest",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale \u2013 Non controlling interest"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SaleOfNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "SaleOfNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of noncontrolling interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash transaction amount",
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalesAndExciseTaxPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales tax payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r1073",
      "r1074"
     ]
    },
    "FONR_ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scanners with management agreements with company owned by related party"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ScannersWithManagementWithCompanyLocatedInNewYorkState": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ScannersWithManagementWithCompanyLocatedInNewYorkState",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scanners with management with company located in new york state"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-AllowanceForDoubtfulAccountsDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r60",
      "r238",
      "r1086"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other current liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "FONR_ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of the provision for income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long Term Accounts Receivable",
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of deferred tax assets and liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1151"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of earnings per share",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of reconciliation of federal statutory income tax rate to company\u2019s effective tax rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r787",
      "r1148"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Revenue from External Customer, Product and Service [Table]",
        "documentation": "Disclosure of information about revenue from external customer by product and service when not provided as part of reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r382",
      "r474",
      "r983",
      "r984",
      "r985",
      "r1157",
      "r1158",
      "r1159",
      "r1160"
     ]
    },
    "FONR_ScheduleOfExportProductSalesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ScheduleOfExportProductSalesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of export product sales"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ScheduleOfExportServiceRevenuesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ScheduleOfExportServiceRevenuesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Foreign Service and Repair Fees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r267",
      "r270",
      "r271",
      "r273",
      "r515",
      "r741",
      "r745",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other intangible assets",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r745",
      "r1101"
     ]
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other intangible assets, net of accumulated amortization",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r1092",
      "r1095"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://fonar.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of inventories",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r61",
      "r62",
      "r63"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "documentation": "Disclosure of information about concentration risk of product within nature of operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://fonar.com/role/PropertyAndEquipment-PropertyAndEquipmentDetails",
      "http://fonar.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r498"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r64"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Financial Information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r19"
     ]
    },
    "FONR_ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinanceLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Remaining Lease Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated amortization of other intangible assets",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r745",
      "r1103"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "auth_ref": [
      "r209",
      "r234",
      "r235",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r553",
      "r554",
      "r555",
      "r556",
      "r634",
      "r636",
      "r638",
      "r698",
      "r703",
      "r708",
      "r715",
      "r722",
      "r724",
      "r725",
      "r726",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r744",
      "r759",
      "r775",
      "r777",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r848",
      "r856",
      "r1200",
      "r1203",
      "r1204",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1230",
      "r1231"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT AND RELATED INFORMATION",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r203",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r222",
      "r223",
      "r224",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r763",
      "r764",
      "r765",
      "r766",
      "r768",
      "r769",
      "r770"
     ]
    },
    "us-gaap_SelfInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SelfInsuranceReserve",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Self-funded health insurance reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expenses",
        "verboseLabel": "Selling, general and administrative expenses",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r751",
      "r752",
      "r753",
      "r756",
      "r1045"
     ]
    },
    "FONR_ServiceAndRepairFeesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ServiceAndRepairFeesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 related parties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares available for future grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares were issued",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345"
     ]
    },
    "FONR_ShareOfNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "ShareOfNetIncome",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of Net Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SharesRegistered": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "SharesRegistered",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares registered"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-term investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r994"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166"
     ]
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software and Software Development Costs [Member]",
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SoftwareLicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "SoftwareLicenseMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntangibleAssetsNetOfAmortizationDetails",
      "http://fonar.com/role/OtherIntangibleAssets-ScheduleOfOtherIntangibleAssets-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software License [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SoftwareLicenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "SoftwareLicenses",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Licenses"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SoftwareLicensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "SoftwareLicensesMember",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Licenses [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SoftwareOrPatentsWrittenOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "SoftwareOrPatentsWrittenOff",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-IntangleAssets-Details2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents written off"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/ControllingAndNoncontrollingInterests-HdmMembersEquityDetails",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r143",
      "r144",
      "r145",
      "r167",
      "r169",
      "r192",
      "r193",
      "r198",
      "r200",
      "r205",
      "r206",
      "r247",
      "r285",
      "r287",
      "r288",
      "r289",
      "r292",
      "r293",
      "r296",
      "r297",
      "r299",
      "r300",
      "r302",
      "r305",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r474",
      "r609",
      "r610",
      "r611",
      "r612",
      "r620",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r633",
      "r648",
      "r669",
      "r690",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r982",
      "r1059",
      "r1060",
      "r1069"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r53",
      "r57",
      "r58",
      "r126",
      "r128",
      "r129",
      "r152",
      "r153",
      "r154",
      "r173",
      "r174",
      "r175",
      "r177",
      "r184",
      "r186",
      "r188",
      "r204",
      "r248",
      "r249",
      "r275",
      "r294",
      "r313",
      "r347",
      "r375",
      "r376",
      "r383",
      "r384",
      "r385",
      "r387",
      "r441",
      "r442",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r485",
      "r488",
      "r502",
      "r577",
      "r594",
      "r595",
      "r596",
      "r620",
      "r690"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details",
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignServiceAndRepairFees-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r209",
      "r234",
      "r235",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r553",
      "r554",
      "r555",
      "r556",
      "r634",
      "r636",
      "r638",
      "r698",
      "r703",
      "r708",
      "r715",
      "r722",
      "r724",
      "r725",
      "r726",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r744",
      "r759",
      "r775",
      "r777",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r848",
      "r856",
      "r1200",
      "r1203",
      "r1204",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1230",
      "r1231"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r204",
      "r296",
      "r297",
      "r299",
      "r302",
      "r488",
      "r514",
      "r604",
      "r621",
      "r633",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r648",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r657",
      "r658",
      "r659",
      "r660",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r671",
      "r672",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r690",
      "r754",
      "r756",
      "r857",
      "r1237"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/ConsolidatedStatementsOfOperations",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndLiquidityAndCapitalResourcesDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r204",
      "r237",
      "r296",
      "r297",
      "r299",
      "r302",
      "r488",
      "r514",
      "r604",
      "r621",
      "r633",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r648",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r657",
      "r658",
      "r659",
      "r660",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r671",
      "r672",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r690",
      "r754",
      "r756",
      "r857",
      "r1237"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r895",
      "r906",
      "r920",
      "r947"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of Treasury Stock, shares",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": [
      "r1118"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancellation of Treasury Stock",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited",
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of Treasury Stock, shares",
        "verboseLabel": "Purchase of treasury shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r52",
      "r53",
      "r91",
      "r612",
      "r690",
      "r719"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative",
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of Treasury Stock",
        "label": "Purchase of treasury stock",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r52",
      "r53",
      "r91",
      "r620",
      "r690",
      "r719",
      "r863"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Fonar Corporation\u2019s Stockholders\u2019 Equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r57",
      "r58",
      "r87",
      "r650",
      "r667",
      "r691",
      "r692",
      "r834",
      "r864",
      "r1057",
      "r1060",
      "r1061",
      "r1090",
      "r1175",
      "r1238"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets",
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Equity",
        "periodStartLabel": "Balance \u2013 June 30, 2024",
        "periodEndLabel": "Balance \u2013 June 30, 2025",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r35",
      "r126",
      "r127",
      "r128",
      "r129",
      "r153",
      "r173",
      "r174",
      "r175",
      "r177",
      "r184",
      "r186",
      "r248",
      "r249",
      "r275",
      "r294",
      "r313",
      "r347",
      "r375",
      "r376",
      "r383",
      "r384",
      "r385",
      "r387",
      "r441",
      "r442",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r465",
      "r478",
      "r479",
      "r483",
      "r486",
      "r502",
      "r595",
      "r596",
      "r618",
      "r650",
      "r667",
      "r691",
      "r692",
      "r721",
      "r851",
      "r852",
      "r863",
      "r1057",
      "r1060",
      "r1061",
      "r1090",
      "r1175",
      "r1238"
     ]
    },
    "us-gaap_StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversuion of shares into one-for-one basis",
        "documentation": "Description of reason for including or excluding share issuable in conversion of contingently convertible security in calculation of diluted earnings per share."
       }
      }
     },
     "auth_ref": [
      "r312"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://fonar.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r510"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowElementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_SupplementalCashFlowInformationRelatedToLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock",
     "presentation": [
      "http://fonar.com/role/OperatingAndFinanceLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of supplemental cash flow information related to leases",
        "label": "SupplementalCashFlowInformationRelatedToLeasesTableTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State income taxes payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r98",
      "r1194"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1082",
      "r1179"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://fonar.com/role/CapitalStockDetailsNarrative"
     ],
     "auth_ref": []
    },
    "FONR_TotalCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "TotalCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total costs and expenses"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtBeginningOfYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "TotalFacilitiesOwnedOrManagedAtBeginningOfYear",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Facilities Owned or Managed (at Beginning of Year)"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalFacilitiesOwnedOrManagedAtEndOfYear": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "TotalFacilitiesOwnedOrManagedAtEndOfYear",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-TotalFacilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Facilities Owned or Managed (at End of Year)"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalFacilitiesOwnedOrManagedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "TotalFacilitiesOwnedOrManagedTableTextBlock",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of facilities"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalIdentifiableAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "TotalIdentifiableAssets",
     "crdr": "debit",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total identifiable assets"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "TotalMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SummarizedSegments-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TotalPurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "TotalPurchasePrice",
     "crdr": "credit",
     "presentation": [
      "http://fonar.com/role/ControllingAndNoncontrollingInterestsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "HDM purchase from Health Diagnostics (HD) ($)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransactionDomain",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r749",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1167",
      "r1169",
      "r1170",
      "r1171"
     ]
    },
    "us-gaap_TransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransactionTypeAxis",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Type [Axis]",
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r749",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1168",
      "r1169",
      "r1170",
      "r1171"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r964"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r965"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury stock, shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://fonar.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://fonar.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost \u2013 34,840 and 45,081 shares of common stock at June 30, 2025 and 2024, respectively",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r53",
      "r57"
     ]
    },
    "FONR_TwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "TwoMember",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-ForeignProductSales-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Puerto Rico"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_TwoVendorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "TwoVendorsMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Vendors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://fonar.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r207",
      "r210",
      "r211",
      "r212",
      "r553",
      "r555",
      "r760"
     ]
    },
    "us-gaap_WeightedAverageBasicSharesOutstandingProForma": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageBasicSharesOutstandingProForma",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding",
        "documentation": "The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering."
       }
      }
     },
     "auth_ref": []
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-UsefulLifeInYears-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]"
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r468",
      "r512",
      "r738",
      "r739",
      "r828",
      "r1183",
      "r1185",
      "r1188"
     ]
    },
    "FONR_WeightedAverageNumberOfDilutedEarningsPerShare": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "WeightedAverageNumberOfDilutedEarningsPerShare",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Denominator for diluted earnings per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Diluted Shares Outstanding - Common Stockholders",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r200"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://fonar.com/role/ConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Basic Shares Outstanding - Common Stockholders",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r200"
     ]
    },
    "FONR_WeightedAverageSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "WeightedAverageSharesOutstandingBasic",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average shares outstanding basic"
       }
      }
     },
     "auth_ref": []
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fonar.com/20250630",
     "localname": "WorkersCompensationPersonalInjuryMember",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-PatientFeeRevenueRecognition-Details1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Workers? Compensation/Personal Injury [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "330",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-10"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4M"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/230/tableOfContent"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-8A"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481440/840-10-50-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-9"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480520/718-40-45-7"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480520/718-40-45-9"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-4"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479741/842-40-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-7"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-9"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/310-10/tableOfContent"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(cc)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>94
<FILENAME>0001731122-25-001281-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001731122-25-001281-xbrl.zip
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MGG:_<^J4^NF-;<XVVN\SS'D6(C:>=0[^S/P!YG9-SG>Z+V7+6.C.;"\,+C0
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MJ YNW2##(IY-%V <(Q,[CR-0+!.4/I]OUS.7-.[<]?/M:V:\11HY<2[1Q;6
M4'X!&PNSYT/.QNRRD:<C&7=92WZ.9#2>("MQ&I(QA?WGP:>R.7/%8]8DXREV
M_<R$\OGV-5LK[$-(QA-L9WUMMO(.2*C"[R+"H9D5?1)34S\NL?N]U1Q;XX9)
MI:GZYC.M<B+ KVZB"?#<W'R:M3(%14O4!99FC,?%R<EKG@S90C#X2ZQV,AXT
MOXZO]G%X@)_IHJ>X]ABU5 &Z4T+?8\7K#PF5,H>1;:I/_J$7XR2=*(SKZ[*B
M\.IMXJW(K[':]#]7$K\_" 264I;3%$;FJ9(HB^5,\!#5C/T@ <'U/">;X&6Q
M9_66H!J?ZD/]L>_A%QU?Q#9M0I16"&\=_5HL!SKZLI[L7=EL<JX!19V,+2%)
MG3C==U+Q*=^)&B?_;O0M 71<OB-WG,_MF6^HC\W9U6<2E!/!JY6LQCI6!5\8
MD'+A^_13OG8]OOQF=L !Z._6U][?42_E1<"6HQ>SQ_QS^8T'*[D=!"!82BG2
M]GQXD%H@&)%3@$EDKL>DBK,.;:MYZR<KG]0C8_O]^*YT>&-A[TI7]I,'+<_A
MN0^: +/WBD[:W/ K/.K6:SOJUNLXZD)IJ-,H_"U"NV-IC:CE/'IVCMR__:5#
MA(D>GX41=PH2Y,8C),C-IY8@%TXH+V*>"9S9DZ"%P[>">/W$P"DMW5?1YWFD
MS\]R2RI$F'-$>#:*H(3S5W3T>0[@W!SWL]W[ZKCGX;B?_797YK17<J^K@WY5
M-[JRF[Z:.UT=]>NZU96)_-7<ZNJHE^16WUM4+Y=6>EQD8:E/7F:*E._Y.0]_
MCH-#[JV)7J',RZ/,?'F#IFO,,\&J^7J0:&HH5)1H.DI4H=5BH-6"4*M*$'X1
M07@1*5"%*B^/*O-%5:12O?$JS-^8J)8.L;)B% HL\S27)O"-I[:@;)3)(TOK
MR"P_=$,&F2-_YHL<?4ES@M=P[N/;7M9#O]>WN=78WMW<VE[?6N*#GS<J_^0N
MD5*MLZ+R<T#E7^3H*RJ_Y(<^*L+?W9YG><\^+[UTQ_Z7E=6/(L'D'D;+CP 3
M][ZLA_^P9KG+CP#S2 &>C?=7%&#^*,"SRP 36BXL_\F7;WQ9"?_HL=_9]V7Y
M#_^N[2\Y"BQDUN:S"T8569P'LOCLHE!%%N>-+#YY!.E]+O#780Z;"]OW'#O!
MIXO8JFSG+V4[GW_4N2\JZW6@S/S1F;F,R[HGX+BB,W-!9^82=>YF496/[Z61
M9BZ9TQW]"BL/P7QX"!89B2H/PPM[&.8?>>Z6>"JV]=)L:RYEG<DZ5<6VYI%M
M+1@256QKGMC67"+/9)FG\B"]F =I_J6=R6A3>:#FP@,U_R@TF6U5E&<^*,]<
M,JS):%-1GOFC//.%0M-6/.5DL9WM*EELB8JJ58ZHN7)$O?315Q:Y5W+HE45M
MSBQJ+XD$E45L?E)%GOWP*[UR'F*BG_W8*[UP+O3"9T2!QA:KG1H%SM*>B(_"
M:]BX$ M\[Y,X_7 )J_"R0)QU^-Q/1-J+/-Y<C@WFIT*<.GU1Q(HRB+P,-JC#
M>CYLN.M&+!W*/">UJ%#XJ7C:J)=E6;!S&;%AOK*^E@YE*H*VT"A\KQMG6?!T
M>?!B\3PZ%0[-&P[-JP%@Z5"F8H_+B,)X,$$@W#1S@O,X@I$17HN.HX=^Z*?B
MV+\6<.P P:[?#D0S242:[ U/G#^BF'V5!328#(K7@@QT9_L#D8IF-Q9TR9>
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MO&HNI9O)?H\[>=7N]I*BS5SRJ@7$G+MXU2M GOGB57.)/^L:?S9XJL6I%E<
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M!2CWAN8W)M=0NZZ(Q70R1(4E%2VY7[(XOUA$_)B2I9Q?5,1B.LFB0H.*&J"
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M';)JX<U$PE9X?$C&,S7+[[#Z@(2I)B$>4QJ?$KYRN-E!!,IQ+,F9 X>(/4H
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M(Q9&,3I\DL*B5X&-AE#* V# <7"^C8LJ-*DEN57JH*5GY%=B=,7AL4=MBLC
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M^93Q&537D*B&XV.T4"? W#2 1@^3(06Y+11&+/C)&QX10G@X6)*;I2O'0 Q
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MRR]NL#IF(-IDD5!?DPDP8<Z,D<L4]\%VI3S AL)..(]:J\H4"DE-IZ0YST3
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M\0@$!#DA!BS%2=%VL:H,*9S=06MB95\>/CRMZ04G7DN[)/9KHD3T_"PLG!Q
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M= R86'#$+R>%($O64!%@$1%+ZJ++PPT<;%L1#7I1VW<M R<G439&3J2MGC\
M#)7(-Q4F4A88RS<2H^[ 2"NGKUUGH&M!<#"24317SN\GLMX W6_$6%US2E]^
MS.0FE%ZU]P25'#9&T(MFIXM<,N5S1E06@23XL1WPO7'T'++^J<)7B891K,DM
M59("G"P0H&L?3CS*-&_!'1?V1[DTZ7! !6XQB I8DHK#S='927''J ER/2^F
M^(4;5*-KAE,1_'VJOTA2/]:["D#=$*I/DA_'B]V4HQR#I2>,W9^*+4C";]U%
M^,,?G',&1^?_B04+J2QWG7!8#01/>50YE^,K&'_[44IIP;I4G$T-8FO<JQ*.
M1#+J.$JY,'A$C0F<L!MH.FBOV6]R9'Q+NL;[3;C.Z(%,[#>A<- ;>(T1+( C
M;]$32531*;*=7'A 6(RLAZ\,KB8*L8]4="TLNDMD($E':+_!.V+!=27'H=VF
M3ENT/;H\01[>G=Y$>OV8YHVNU(@"QM[A9+C#;/".1!'[:P(,L(/DQ N&5A)U
MTANN!!9$-TF!(;'.S:$XN $9N0D?]<G& MJOM =1:+:@>$1 _T2PTX"4<TZ[
M+E*8+.$(.#>+$V1Q1$DP]]-AI0\..*9J>-BB4,]'75 SP5^,L>8$V957DS4]
MJ:Z=:D <R<<8"Y3,B0]?^PXII5E*O0,=KXXQ%*I8"AVE/AJ5@8[!=DB+U%D
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M%AI38J02')290;DE%A?-"H)'@17YX1\9L4AJPD &QQX1$*%[KJ+@AO5;%9O
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M*S1B-]WD"0R3>/S0/@A! :*)++:RTV!/O6"0[3BE;CILHLJ'\ =M$D1-*?:
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MH)@;-[JJN\YE"SZE?65L:'-\N(@SK2@+Y%<T'NFXI%Q9;'HK$0LY=H:U@+C
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M3 ":6I>V$Q;:6BG*04HHXR@-LTE,IYM6,R[O9/T4OS8G/TJ5-0N^B< D%4F
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MQI8?@;1DLXA,;+2@>M45:K =.N"V1,N560F'1UI-D'Y<BN-"YZ=1>@4*CE+
M8@%QD;7:V$*AB-Q3!>Q A/%PK\LHR:830CRX%6UT7F%C7"2F:GO(Q/;HP'HT
M%%38YW%B>C4*)2F-@NB:Y5.3O8$GE=2T2QP+:N>+-9'*40L>0]'Q#A,X$<+
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M0/O.Z2&FA;0?T<,O$TM8:NV< P_.1-!V @A@ZE3#$<WGUSB^6N9"RPV8]=D
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M@"F.,LZ/*:*6T5*X0$D8*7AA>"D\VWFO=-H+7548P2RCR/@I]I'<XZ)@M.@
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M\%A%&FO6S&B3@":98G K**DRRZ$_H.O(,CH&'1$G2=0QQQB7UX#83$P;41I
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M5I_1WQAYU;\_^7&B.PBW.2U@8^B_?O1OXK <PUU65[][]AH&D.O=K[%\ $X
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M0R(^07:%RRD=&#"BG<T?/;S@!9'R@8F5$%$,3/W*Y92_QQN\U,EG#$7M]_2
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M(&QU!LPS1H*D4P7\?@*^@-M)UEE6V@CF5E7!QZ3TF8$CRT2X[G7J+O&42^S
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MRN;1.WKV16E\SBDK'85#1R6QY'+:">4@RQ+ME&/4/*FJ J2'FFM3NVJ:['&
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M41QB]@B7;RG;I,H0";90=]RDR$%6XNEC*/3O9'<2@@U'^=NL)Q?5+.\Z[TF
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M*K*H31+3\BS^HTS[ZN;.4.XYOUD ;9(KQFK2-9^[_K/SGO6';7QQP0!&++I
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MTG4.Q :S#[XUG]5X5;KF7YG'05;C@34/?VBB'=4/HC YO.&BPIZO/7PG@9.
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MJS!)[P[X^7E2K]R6[^][4Q3TR<,'?LX.P&F(S#9'1LAL^\%ST#A' 8E&P^=
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M%M%JH0^B(G$@*O"2^M%P[8"3088+N5_,!(6B<4I,SFAM9BB66-+I89HZ;TT
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MA'41X#>GH^G0O%;1E4%T IRKY>1\GK/4/2LJ4>UF;2LJ4=WIN=5WPCRCXU&
M(Y<4W=(EW!6UP*L)YO4.^* Q\)6*(0U]EP(>;]5Q%@N'#P8JNPRBW&'25!]K
M\.;&U'#:&&!C.+Q/?3I45! JF*4V3'N7S7L<BGZR7.[4D'O3(0A/WJ'_O(;7
M-V!1'OIL'7S!CD-TV5X0"(CTB=D[[#S-&MEI61;XX^*!/=@T:(=3(TDQ;YS
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MTX%HL*Q.0)C[_]G[LN;$E67==WZ%;L=>-[HC<&\0<_>^*X+1QA,VX/&%$$B
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MOCD=&(L./[#INT!P6D! DTK0M,'5[ R4+;ZQN.J98/$K/0-V-,T\?O,Q!%R
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MP,#F9=N2J9N6S'^I^LTS9:1?+0.RSF^)>/X?^W$K\R*?L#,OD*2A(@A)("J
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M"/P982"[SYN+?6%1MA,);8&]B;9)#;,]W7/NMZ\N[#>H;Z9%Y28I8M8^6:\
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M;'6&01=(]P] =\97G,F)RQC1)?4=1]][?N'Z$#43Z$2S9R+-8]#%=>!_BIG
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M!"?'4A9>8-F8'4PWW1/!\H5XQ[()#+_](?-H4>@<S2]CS>HK@X]9HX^EE_:
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MFP(4W,R/P$Q&=<5TXI^@#'<;/%ZY0#CZM=0_EN1VMXU?2G%_=R>\PO#*!,W
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M^O+I3<R'J.HO/0BUCO&L"UFY4JH]GB<!F=XQ-=AO,C4&YG;RQP&NC5],>RA
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M*3MEUAC/>KKZHD51Z[P5=D,YV[B_2(J%IV0$  3A&M:YCE'L3F9BJG[3JT4
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M]BS!_F2*.KZ31?31,0P90Q*)(W.*.SN?H]/84P:R:"#*8&WQ3.F?332!/,I
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M5>W);^XHB9WH8DNR@+R"C#SIBH-Y:+ Z2A(4_6N# 8]H,H&QM\QI6L!3[$[
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M2S4!;E?@F3AJQ>$YH)3S=," [F,$834:"#V'<,%S!A\,EI):+5V7>W+G25K
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M,C+5(QY$B( =#K+P!?B/QH)?P41M"@ 9.:$Y>2C.J@[FK4:1?)[#\49NWYB
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MS@!_8GA5* COL]:KD W]+E/]*<O \.B,)$P"?QYO^D/:(.@NX@R<F!CX%38
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MPC94[F#&3?([:80;\%E?XT:=7[Z_Y%I*OK,":GZOH :?C6[<$&F8X#R!TVQ
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M=#%!VI0_)YG%GUA(?#><]C5]$M696=;JLQMSD@.M&/?N#FSC*BX6]HF#P%4
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M>B8,=<E..$9)I[!B619AL=(GV&T8#8,?ZW],97C5@S&Y"^9O!%-=4U"L0W:
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M"(")RMCYUCOM?JNBW];9FXI<6Z96>S66LPY[&9*QM@K8,&<]S!!^3QZ^KAU
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M>)[R"YG&P4<XIM+5=,7(L%OO<;TG-3<G[@;MF[:AM)0C@AV=DII+H1B-PW-
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M7[;D.B #\ WU^8:_]#P3#HN!;;F=H:JP:Q9J-X[6"9N/VU38:W:FL*YS!7X
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MA@ (<- %@(@S5,9O3X%B!KY+7SKS D#4)$-U<CV@QV/*?7D"O]N3D"\$%3;
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M8V+!$>::=\J)G#J!$[$-WSZ[WRFV$=Y1F,/Y[HN=\8\]K=VCR8)L\SR=:3A
MDPHCJSB<"HM5#3BAP'(3/#+F5$S)(4&_T*(^.;_;%&8YHZ&,L%WF)3N#._1
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M&.4$%EK#OR+E4W$15TR(*^DQ*6F=MJM2(2>FY8ADWBV(8KF5O!5ZV<@=7D8
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MRO""9P_ TEJ2^_C;M'@"/"K#<UKZ:+3M!&O!878300>N]Z4/+ 9@<SH283L
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MZ.HIG5]4N*\ <8**,,+Z3C=;U#7A9_5,Q6&]Z(3G=&(->KEZ"A<9:XU+R)R
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M;Q-G+Q:K(Z3NNX4=GWWK^ ]02P,$%     @ IH4V6S:-%:S] @  HPH  !4
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M_U\N-G^RN/P[K6YM&AVW9%9;IUM.?P)02P,$%     @ IH4V6V*K2-IN @
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M^>]C-6.>H603'CZ%D_Z( +MNI99!(#>$!J%RJ@,'X,1)R"8Y7-ZLN,M:(@
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M?A3$(B=62<SZVB>;*5&B]XHG.B(,*= D$PQ'F(L[0QF2F.EB6BNA!;T?@XF
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M_JM)4F;FM&[ :-R(C[JQQ#L5G(382E("'[ *+%$,+50RDX7Q@0Z*6W1)*-]
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M,&5;*<H5/WSQX1A7*/_:Y*+[7?L006J&:9W>-\GX1<]8KJ@8726GJIJHTB[
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MXP@]W>3]='&?8TE^^1694AR21R]WL&"&MM"+!#_THKY[\O]02P,$%     @
MIH4V6XU=FG#W-0  :#@   X   !F;VYA<E]L;V=O+FIP9YV["3A4[_\W?DK9
M(TFR3B4I1&7+DOFT((20/29)MI 0B3E%*$L3DK)-LE5BE"S9QBZ$[#LS]MT,
M8PPS<^8Y/M_?\SS7<_W^U_5__O_CFF.<<^[W?;_O^_U^O5\O]PQKD$4 #AKH
MZNL">_;L 4;A'X U EP%]N[9/7;/>W>/?6R[Y_W[]K'M8]_/SO[OBX.+$WYQ
ML+-S\G!R<>\>\#M>'F[>W3]VC?RGZ=[];&S[N3G8.;C_/Q^L&D" $[93SK;G
M!+!78 ^;P!Y6 X  @#W[_QW>'N"_CCU[V?;M9^> A\$#/U!\$!X^&QL\Z/WP
MB.&[(?!]8)_ _D/'SU]F%S1UY#CA<_C"\[@,3JDKWVN%S+I()Y7N/@KEXCXB
M?%1$5/J4S.DSLLHJJFH7U36N7M/1U;NN;V!^R\+2RMK&UNF>\WT75S=W7S__
MQP&!3X+"7H1'1+Y\%16?\#;Q7=+[#\F?,K.R<W(_?_GZH^AG<4EIV:_RNOJ&
MQJ;FWRVMW3V]??T#@T/#Q,FIZ9G9N?F%1?+Z!F63ND7;WMGU:P_ MN=_'O^/
M?@G ?NW=70..7;_V[ W8?4!@W_[CY]D/73;E</01/''A.>?A*W$9WVNYI)3,
M2$)W'W5Q'SFI3)0F[[KVKV?_=XZ%_O_R['\Y]K_]&@9XV?; B\<F ""!3<RP
M)L0C1/<-OLC,J/0A;=5!JMU2/<I(X4554;]'\Z[+;^I]3[KR"+8,9R9/@40:
M@G3S; 8&\],!7&1#T 8BH"'>9FHY#;M"YK!F =U#'NT=CQ4N!>+JO]N,>XO;
MZXBN__#.6V5T06_OI8N1]@<G\5@^<>8X8Q[F/=2T4I8STO,XQ)\%\->P@-#G
MX%]F)DB(0)(S(<1S%K!_+PO(H.NR@%I>< IU@JJ^HE]FB1CYT,E@ 4G0/A;P
MA\(")D4"G[* *^4(F@)R.B3@_\Z4U^TIY4-[:I&)_X<UY*0([<G_BRWPO]GR
M1JV?'L=/FS)_I;* SFV08,*HAXYC([$4N0RX]12DMXAD'*J N)WIUE OMG@V
MA90[R0*BE9>J1$-.4">M/7_^#&]K/#*C^;Q#::0*_=%].!V;[5;D'A1+N6E7
M$SZ7[K8WRU5=OH$$2"R1MB!.ZQJP]A_E9W8(LK%[( O "VUQK%3!PW)DOM%B
MFU(\B&X#A;3%EB3/E93>"G,P4G4VO)^PIKPOTE(SD%?#Y03^*G%T(D&*2FLM
M_Z6<BATM<5GWC@[>+V_RRK3MXE,VUZ_G4C-TS]BH&ZR7EA>LYC\N\,67\#.$
M(XE6=6-F<[6((DQ$3Y-&;)&RKX=YJU-/5S/BE+9;X=,8Q9R@@7J\  L@? =+
MUQHTOTB7TMI8 "?C@LN1<O8T7EGA'E\YM4E.G MJ) #B',QD@[B8\'2'8*!+
M!J 7/TW*VYLFLS+'I")IFX%EC,=*8J:E[Z_(_;R=-"-61$&+$#LDB:G*=\L,
M!6T_C?M;B+0PLM4X=W1/;_O!2W$-]#HBG4+]1([0;Y&R<#2$U^X@LPR<GP^^
MBRXOLNK5IWN#M6+3FN80UV:0R1TQ%E!JS@*(Q4@"AB..!>RCX)L+0+K_D_2Z
MTANM2-IA%O";CEBY406V2YCOSBU^6VH&1PL$5YI'J!_)+W?<._486D@JO)"9
M6'(D=,"V.AM9@F,(#((=EW L  F-Z;.  _FP93BZLYY.0%A&$+:P@ 7,.B,8
MW. T8O@7R!3H0Y(LX:'$:]LA23=9P,B+368NPY$%A-TOP-:")$N0=IH_]'Y,
M+?TR:O%FDR_5_GX'SPOO+Z?%6<"$Q1J&[@G6BK]9 6DR?>M87PPSWPA1RL$0
M*,1LZVW^9QYON=T]4^W\01'NDO$J\8&7U<L<HO:!SSTL(-?:&[J^AG3&T2Y*
MVJ49]]0CBU'/3H2*&#0JOF1HQ9;(8_$G>?5'EGXFO&[.1K\/1I*W7FA+!QJW
M-6NSDR5ROF2Y6RY<"F>FUDXEJXKL$V"4AW*J;)\"/==H4K #J> X..'$ C!6
M%>AF/,F*?Q!9#TEW@2YKX2"'/X;-3:/_ZXG2^$D+U3>W#:Y\>?"[D4UUCU1,
M:OIL==&ICKXS3^4=%(04[R57K0W1O\X1M8\'/B;WCFL>_^UCK2?VJ^EV?,YD
MXHB^4>O9QU:Q)?K8#*OG-C;EL;E'-W'U:_#:U7J WFE2#3OO$IVFVB6.E^"3
M3[^=-XT7NOU,"7L957:HO*KB0BHC O]^0A+\3?[& @9MIUB ;K%CT_ME![XT
MX2N9L:,X%Z_F@*[FR(O@2_*3J#^DPH(,46,MLEGQZ)JWG=2B"2V$!3 .\T-1
M[+%PFA]E 4T86L@6X_#!5.Q+6W464+:+#E)@Q&G<<VBT YQC5&]!+IM(QE5%
M?G#>XBH<5)E+"?"Y>A=B!#HQ%&_&P69(A3K!.*0'<:<40+T[Q5NUJ&&.6]]-
MCGZJZHCVW\>S+R@&V$L.[]!J$'G EY<P.#!E[Q$HV"QYAN8V=4EIDB/4_\DW
M%4_)385O"H20?/&7C_A"-!$WC1[/C!I^()!]\FRS<B6_5"QL+)8CU!JK#SQT
M>/K&LNY.X5O29G*E[!59K1]V#L-E55D5?K^8FG6WIK]([->NY(&XEN@>M*O4
M+IJ0VU2*X4O"P/)>6UJ*@?F[TE]L:WL&G)@SR$CWK09_GT1D-KHM$J<GI*OB
MIMED,,\"+FW<QDG$WU=Y>'3PHD6NC(A,%Z[G:XCEIX%I/..P!\2=04=!G<@2
M_FBT8+ B.2+%X]."[Y62-Z-N7'(%\W$I\L8F*CM=J.=XDG59#(ITLU/2A993
M D]N"1=*J>GH-V-!A1?S1HT;9\T]\$Y4,'-5)\&'X^A _>RMX[;<,5EO)[,2
MS"-*0OSO3S"T60#$S34QR?<:7(4+5U^:%,3C1@=1B]02-<1!95_Q@?-9SUQ-
M8T)K)#?)*_:D"4:,)6*3+@Q%R&T8/!E_-(L'%6&4_< ,LZLWX<\T,'+V4P77
M5Q ] 6%K]WN#U7,6U7AY2X\<;#G/1DL^9[)D6QP.@[7. 2FH]C$+V#GK\1CO
M'U%HTH*8M;B6J"_=59CE<HW^AZ.W.Y[#EKPV$DE-^PO>ZQR:<Z!5?#7&NI<6
MGYOO[U;5[@G<%CBV.9>P?$#'O9=$<;;,_'FW8*CG6<W=C1O^\I)'Q/MD]77/
M^"<\-ES3/@]'4CY8:X>617?B)04)F.7._(57VM%>8@U; :J&#[7_+GXK5+@.
M?'UC-_9]<* M#.*)VRUGS8S7Y?R0X (+:+1J=5 DWZ^:ZA1:=% EZS"2;-_A
M0L[.;#;DOXNW$:\XKSV=W(%K_#ZJDWS7QS>/^T>,79?,#[@A7#YU KWK^#A:
MU@V.:EER)P9]CYI-_9CRMC2AHG\@2"'J]PX=0L3]5_$<N<P"ZD*0M*^[6= (
MC_I9>K7J7[@6?-F]N,VK=VIL5G6$N9)[..QCI^W,D_&'I3C%2NI !%H2OYWX
M%\YO5^9+N!G<O-8T&*3?"NRQI:G0+R\.!Z<?/QA2]$]9<;&=?]DKW9/1KC+R
ME6I_L09,]M@^FB6'9 3^ QB&/!*,(LE-YH21?6M*<R3,_^G-K"A1WT:Y;<=%
M^CNWQHV>Q\W74WUI$T3^81G":A@YH5;M\K)*NX9Z@V/8T9--)\-?0B?OW&+*
M4= "';GO';.O_,29B8ZMPK JLX/XC;X4&!!)E)]]Y_RN^V;=I/),U(_PZ]E^
M[UKTG[:U&WX?,_WG&$79:A#[3-QDA6MR#%6#8F,X3V'Y6E]]GH=$JJN^/Y$:
MS9._J9DA5?9;W&J*&_;R(5Q6/Q[CI4U=T0+_[D$VX>_B/3#;JHHO)ZC2[N]9
M0(V^W';9[:DX"JZS;  16VN5*2HD;FY4H>F/_%K].EBN/OCJNUG!/Z2W2V7&
MR=&IM[XE)[BA?FTN@;4^2,)'F=S7?G#P/(17471W2>IV(2D]7;.+@UDC!5_;
M/A0ST !ZN2 H HJ54#P+>.E"W&)R?P8)/_]E2?7P\Z$"85/M@G DP P@%D%B
M*-).(YC\R3(0Y[\6> LEC+5_AK. <AW%E=$1*%1ZZSO8H 2G2+@?DF2K#:=6
M)!'F-2Q@/K@+2;J,H'7!AO\=" OXN_4))(0BR;@W6XI;D7.&;X)N%OV9V+6!
MV65:$_]A6EV;S%*&L!S$O<?[6%RE(W'[''HY'7$;T1+^U&J9R0(X> +[ZZ"1
MZ\PLM-#0A,UW'NU\8K]KMC&:_*K%C..C(RJYU\J(3ZKC\RTSBY3U(%S#AB^2
M4^MB^[GU3'.%7)[-T.EXB@_3JQ*SX$1 -K. %RS@)Z:>CGPUP5'IZ/'-3>T:
M[@-/+.GZ^?(S-QE=9;];"SG>! G85U,@$F.)Q %Q/:<[!V*INLQ,2JZG@RD1
M)>"@XS1II)YUXI25YRMM#?8K0YTY.NCM>O^S#6>T#J[JW?Q=G['OGBC3)'+C
MO4N@\5-;GV[#38<;D"39JGX1$I];XLU:O/DU]4OK\,@W9^]B25S!Z]:YC7"Z
M\R%\<6?#<@ M[!NX\*!X=OGZ-:G^*BEJ<S-#9:"!I M.$A9A2+([^Z2FJ19K
MRW 2@;;-&68P>_\ O2(M>D22DE@ ]A8+H+Q,;X=7E$3"1 0_I3\(OD@"8RB:
MGB:&O5JZWQT&'70ES_S-3/O&;_I&;HL;09-A <MWAU"T^QC.AYH+<JAP;.%6
M(XH]F(^9K\5%]I@46BX9/A5>D-^?J7QD12[+\>B]$^NC<36X@>MX0CF29'+Q
MA]TD7YDO9CMQ%4]+IA?P-\S<>FAN_>6R88JQAT._/>2R(8/YI28^JV4:\27>
M%*?A'F4R=*:XO?/2=M 0+FX9)*UU#C;G,I3TPE@ Z>;;2(AKFR["UKS<2=@M
MU=E/..$H@3VOU>*<F^0K1ZY:E</ZP0TD[F!))OP[IVW7H$-;*(91B/= H._V
M CB=2T0M-D?#\\ #E_@:#\D*%L#'8,; ,3K$0,"VWF9"$G /+*#K9R 2SILS
M#O^ A/()DLE!'Q; PV8/HYS#$@MXE0T'][_]FIB\M)W[3R<(>V+G''PC/G('
M![-(YMXI]&)S1: FU9"9IGW(/7\*"2<+>[!ZAL?!D>MOW%55><1?BCS4)0YN
MX=KQ+R=(5Q##@I-6#6>]FW>P*SQ$=JQ-GTSEV]:$(W_BE>XPE3!UU?V5S/)J
M7G0?\H=)(S\"W0$=Z_7JJ=\Y,*HF:.AX]F?<'\\/ ZX/N:;*</7'I]9BRWZ3
M<=&7U'OAN?^Z#9ULG"9GZRHD_0RK3)+[4=WI7/"':55;(#FU.%C9E"\/]LG5
MUJ7VN;MG#??K/UTW5AT?=Z4_P1/&<:\'MT%7)#LX\>NKO29T8)XVN/-"8!'Q
MD^/%C0,77C%>9BL626F&D+NKQ?_-H"EO)E^U/#PW:0,L0,B!"(?;*!G1B!2
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M'G-S]*1B[WB<YAV8A\6J.57/6S+8J)<%N,'0O>#X<X)WMO.*DH*EW0#JP\#
M741-&2ZTE23XATRJ;\X;:/$:8EYJ%C>/(*P*-\P6/Q@5+L<.IW2?WZYB%.P@
MW!;Q),.)%TG(PD_H-DMMX6[=(O[(1">R2-'EA\-O)!W?MY0^%C4+[.3V045(
M*I)R\ 03(7<';K)EBG1Z;M:$H0OH<;I>1]G+]"V34X6I_2/TA5,Q&J[)M4$L
MX-X1$D>CF.(PID[#6M0EZJC=TJSTI-P,ZMW5URE_G;3S4$^;1,XB/]<+7%&E
MNG=,P! ,0+=WD('1T1A!JU9?C0+#(Z.3T]2\"D.&A_.8PMQ<+/HU;'D?^,"'
ML";A +54*_766=-"=2M(7>]N[*NP^/,FAC*>>2SH"ZY#MIOD'5UYF8 XLI"N
M1LKY1 UZ%P<*S83_,8J(LAZ]4,CX!Q?6ZBLR$SA_5^K'6("]U?83;.]M_[KW
M#BK$8%T+VY9VAPN03?Y=R$1O&IZ_AMH?>OG:E1CJ&69NI3K=!MVIP=]TEN]Z
M8^-,8;3U3_/VXDE> ZS1*.:^T))[;9,.>DVW6(.2:<:WJ*\R#[Y_S^"3DV^V
MJ)V\.V66FGHO?:%Q*+,=](CG6*XG(T9J-6 :W0(KB7)Q7BM*+-T.0VM"OIR#
MLM+,68#^/=SL+%X-!M6M9 01_, ,H=C":6'I FF .S="JW_"=>9\,"?-G'X-
M/:"&WD.K)XQX^NIC:@>2/%S\K$]_.%5JX?TV[(T$7F-;H1J&]C"TG?=*'XC=
M.>C/SSS]$_?NMR/WAT9.?7MU1"DMXU4#@7'I3][-E!=3!D8&9W/2DW.*3?XR
M3R%)!IC!8RR@O6P>O[7N#2E@:/YZR[#FT)V"LW6B!4\KWQ%KEYQ(DW2E,I:H
MB>]F6,#&(I+&C>S ;39'8QE_Y&#H',8RXC8Z&1J95 X6D.G3!:Y-3S#LG6EX
MB(N+OI^&NY:B:_+\79"O0=;9V90 >5^=U:SOB.P0E5F,=T=&9>_*M[/CBXNW
M7BN+N 1P YLG*5_>V;QK/6L0XPD=ME=0GA+U/YSQ?J \"$T%&7$,"APK5_!.
M,'D<Q%!CJFBZ_GKX[M4'F;T_>88 _K-9,8ML4[3$*7_D:MAXI6IU)3R1_>AN
M- \3=NC!C>!+O9^JNQG2'QLSQ>:/*ON.RG>WG;&$I-G_^;#P]J0_[LT267[X
MM1C_A[[<2-IA>!6DF @"KY?/>Y(#AU"R(O55CW& I2?%,\"G"'U7J=+]7FS4
MCY@\OH\[ Y0J4K-Y93G-@[B4JQF3+)%YY.3T[&%UW.Q +5J@+QB<.J!8,RS.
M;CAV%Y+3O&5Q,BD.UO<#*LRS-*5Z?>(:QX(&VY%3S3="1^,UEF.M=JR&'W*G
M+1675NQ@.[ &#W0%].2R9M:@S2%O[S%<Q]Q&$=WI$-(#_XJ&V+CICV&>?5<Y
MROL184#!C!Q%,E0Z&ZALD#O[=Q:0_6,@9>^5N5(ADG7G5BMV,@EZV[EX(PRZ
M=M1D9].$!5Q_F1DE5\I,U>9&H;M "2TE$M)X8+([EZR04^*S*%CC?)W++.#P
MOB/B?ONLQGE@ND$,-I3AH'[^BR>]3V$!F $'#ND_1;)>.9+8"\8CN+YTCD.T
M5[6CB)@(8;7&IV<ZM%H>M8_9YXV?]_#K;(^2HV1"QVMHL"#2,\T B>?56 #B
MOU\IF-@TOP2NSY$QVUA-%B#05K>V<Q3'V(MC <?0'EVH; 29CZ,!OZ,1"P^(
MZQ6>QOSO%Q8+GK( ;1"N->_!!A]2!10!1RJ0QP)^BR)(.HHO%T@@599&).NB
M^)N_%H3Y4OM[G$.^^,P,>PTV<P"4>8]C8&U(I0)R]K?6Q1#DY%TL X,RAYH0
MI!MB+&#(E_J(AB')-(-"9U7:O"6D7BE^4^XOI<O?GVA5MWH\"D9_7D"=0S(.
M;E$=8H=EF/AEH;?$,-OAO?RY.SL[7]][2=7.#+I;/]7Y7'UO- "?LKR#B'!4
MPG%LK)[M./^K\Y*%69;$F<M6_>*O+IW)]K0:UD]D 40(.GH)>9>?#ZT1!:Y?
M"E);?@5KI#BX8*YPT/4"S0G+J!^/PS]65WR.]NO+QPE-ETKKCWZ\4IW^J0S.
MYWW_,)/ A6.BX)0G3,2;E\J8R7#BOL47X9:WR4MU$T<K->D^"\G9L^%?I?]H
M!,?9?BZ3BOU@T[)O3D+V''[)I?_XRNW;7CB29TA0FLT<XQ_]Z;+W!#<+BS'U
M=?N[^9VMV]Y^?3B/">.YA7LR9V@]BYI65C%O'\200,#=@'D8,K#;?]CTGZ96
M'Q'M/I(PX[ ,Q(W[!!?@G[<F.-?P]]/$&LWT,D=@A><^/BZK?7)B_4[#Z('J
MJJ6UMM!K\GK9Z!!H#$DR@JD&MKAT1? SPYH<N1*=0W/?6GYHK9_YH.1QZ?JM
MF/-N;U=/)H2R:UA%8T'7$/T0_8*G^2NE]A3D-5+CPZ2=U@F!)K-ZV4<T"]WM
M@E]@^)I"Q7P@G"*A=)HW?ODR\3NE%T;F&#,$31$7T8D:3*A_]M2=BP4TR?Z%
M'T) ;1]8P-OG;A.Q55B8?L"/G4 LEW8@O>E[GM?25=*1E$_5:I"2"C5SJP?"
M"^X(ILROG!62Q3^69QY@QE:KUM)UH3]H<5J[)Y%3^>AFA?X]HU-]6WI>1VP$
M@97;S#\4"8_M"?(< R/:R0PO0%(\K"@HNGRP\%^\"V:HN1[)7JDT:?[-VC7(
M)FK$XOQ7YA?[9!,E[NO VB4NW-S59NRZE@>2>J0,EL_Y%DU17VL=0S(KOZTM
MN8ZVS<_)[Z,E77JWWS9265VP:EM]<9UAN^*YN>ILU0=+^VMMV26P@U$T#9D$
MU[+"WLG.@@?9%^$H\9CAWG&!.,D/^^&G3+&1^V_';@5\?K*4(A9%8R0;JU=+
MX.;T*!PO_?H<]K:?@'6\)([(CIX.?D!3(GB_QO,48\.1 GZ-5=TJ>:JABS)L
M,YUC_I<^6+-S?-^+QWJ/J%&-R9W+OF2\&<UDDI9N=\]7]=67E6W%_*.,>+:E
MUT<?'QN@>,T75%@_])B=H)V)7)8A=HZ8$%2:8G,O'RB-IEAXX'@6C9$SGT4\
M I ;'?^H8J^&C6![:9DG;4H$TY.9RZH;_Q* !C1O8*+VODYM7'027>+Q6Q;P
M2R'QT/JP_53! N+9K?F<=^,69:&Z>K%A4AFU9GR7C^95RY+P+[4$)PW7. /S
M#)*;S7J\TL>IW7[#Y.NYO%DA.C=Q3<-N0WE*3.Z8A8&<;/94VVTE:BG$">OM
M_7PFPT[$ ,89Y"O1S]IJI.Q/X4]2O?KD(UN+%/-RN:?&3()H;1#/9E8T8B1H
MP)Q3CQH9]BW[KI[_$R?(0&X:&XHZRO AL4V^PY!]B?U?^X,*,'Y%5Q8#X\ H
M58F^B,N2$56=$#=(=PI69Y9H'Z,A)R.??_/V5%C1DI9X5^42X%UXU4\ZX+B8
M3!!CCF.XND(@K?X\,3<B7W&\SK1T*Y&RG?^!QF=!S$8?)(>*E-@9,4T$C',O
M&!J8NVFC3K?D-1>5SV/>?UT+;]&6ZFE!K#.%H0C91 =2C4Q#^4/$QNZ?<M,9
MY,RM8;@,)V4B<[PCVRIJAZ]EK?N5P2%3XF$[\*-YWZDG]V[=:E/Z7G.3XV1Z
M7QR!?800*PZ+2%5^YA&Y&9 F'[F2BBU27!Y1"ZT\_^4%V2KVB*&$BI-W.D_P
M73=F(5_7:A^=JBABN"<L_41.EQ6<;6#B!TF=V$GT\>Q$HM"B!59V?< &>;(8
M'3D[P! JI=:#PZ54;%41J3^K.]"\3G[G?NC7B9,=N8*WP9K1.^"/O$6/F3?G
M#?YT-(Z]NOM(?]%(&BT8V]C7/)GK4+ >P *DU_5VGM9_.,(1<4%+VRK,,M=
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M7<^"BY 96(O$SX^M($E//\-%1>>P53M3;S\+T(:KS#/<NG8?.??H!@OXW2;
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M"(^N?U!ER*L%FWG+#KBU4,!N:_I\&QU=,-A8WZ!5X 5[@7FOK D-/<PY0E]
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M^2+YK.%?6<W7ST6>WH-K,; /$CRK%\?D4[1C_/@'XU_D]YQPM>P:I;^KS(E
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M^=!*OG%/O#L3JWN\1?#S_P!02P,$%     @ IH4V6X MSABP&P  ^EL! !4
M  !F;VYR+3(P,C4P-C,P7V-A;"YX;6S5/6MOX[:6WQ?8_Z#- HLNL)Y,DLZT
M,^WLA>-'QEC']K6<]O93P4BT(XPLI7HD<7_]DI1DRY9('LF2R"EP[\0V>7@>
MY'F1//SU'V];UWC!0>CXWI>+JW?O+PSL6;[M>)LO%P]FKV\.)I,+(XR09R/7
M]_"7"\^_^,?__ON_&>2_7_^CUS/&#G;MS\;0MWH3;^W_8LS0%G\V[K"' Q3Y
MP2_&;\B-Z3?^V'%Q8 S\[;.+(TQ^2 ;^;'Q\=XV,7@\ ]C?LV7[PL)SLP3Y%
MT7/X^?+R]?7UG>>_H%<_^!:^L_PM#* 9H2@.]]#>O[U/_TNZ_^HZWK?/]/\>
M48@-PBXO_/P6.E\NZ+CIL*\W[_Q@<WG]_OW5Y;_NIZ;UA+>HYWB4;1:^R'I1
M*&7]KCY]^G3)?LV:%EJ^/09N-L;-98;.'C+YU1&TSV$2.I]#AM[4MU#$I"X=
MQN"VH)]Z6;,>_:IW==V[N7KW%MH7&?,9!P/?Q4N\-AB9GZ/=,YE)H4,GPD7Z
MW5. UU\NUKX7$$#7']Y_O'E/P?SGP"?S\\*@ (C8]^B2ABB@8KZDOURFK2X;
M&]0+?=>Q483M6^12YIE/&$<A !%NS]:16Z  >]$3CAP+N?4Q/0'3!MITU>$M
M&26<K^?/5%&0J5B-N3P0;:,[>$+>!H<3;_17[$2[VC@7X+2.. J?QJ[_6I_-
M.0CUD,UT-=,B(;;>;?R72VMG7U("Z!^,DH2*W2.Q#MB* \*<I1-^NT<>VC!,
M^A[!BL@;;W9#)[1</XP#7"2J,$A"6V6XK9-Z3X8,'.0>H3;Q+,<F2%6G$ RN
MJ0DWQ*$5.,]T_<W7MW'H>#@,"3.G#IG9-AF<_#U STZ$W"4._3BPL'P.U@/:
M%$EFO-VB8#=?F\[&<]9$$9+I85E^[$7$-5J0Q6$Y "*@8)I".X4=+K&%G1?T
MZ.)[;%,M?OB"L.UHQL^)H@_&&.?Z2,EJ:IBFR)YX+V04/X"(Y*AM4P@L I]8
M(#8GJ39_ID1+,2GOU!1*J4GT-@3\V/&H=9]BXJ7).23HV1AR=#9,/.*4;APZ
M6<(0XEIQ>C5F-Q-M8D:^]4UN(H\:-VBZ(]+;39@_\TDHMO^"$(X#',)<4 B4
MYE8?&1FOT!MH]>7:-CJ;!G% O=:I@QX=UXD@JH#;KSEQ;K=.Q)PG:JU\IO5)
M? U!3MBW.3/W3%K108B[D#IW-#@.MLR;!M@W2?^F$%UBESJC)#*)=JL >2&R
M8!$#OV-C/,2;U,:E8U5BH+!S<V)^#/%?,1EH1(T?Q&\Y[="M8]6P@]6\HP4;
M=T7=G*:(R(#IY2L"26QVL!;\1B =)3W:]"&!6(FZMNY/ G&4]F_5MX0B*>K;
MJ9,'1+@2K!8</O"R*?1HV?FK(G!^[RY\!*B1 (!0F= 9X@@Y;CA# 5WF+_(D
M0C.#=&O0>P\A7L?NU%GCB?<'1D'82U%JR,B+!NB8U 7A,)EPQ (O,3%Z,?G'
M\DD'*K ,J:NFR 8.UC$+1BCPR.=P@0/S"06X:6'SX7=+:.6U6Q>L7KXK5)H-
MCZ87$WI]EP3MU!T;^\'0CQ\CHG\RT.!EWBDNFC%PY1,3-496ZCMT.ZNXH^O%
MI,H:IJUA6P@=>[F_H<*7=6\SJ.R5?0E%O#K -DFI/*U@0!J/F9. E_R1A+P]
M]L\"[5AZ%\KZBM!:)^)W[&R>2"#2?R$--@3Z%CE>]O,*!UNP]6ABB-;)I<?6
M?"\Y",&^&KT]8R_,=,QU?2KED%LG+HTI5W[R.1WYICY-7("MYZ,JZX0*D%K-
M4?5*OYWA:+[N;_T@<OYFP3Y8730Q1KL$TX.2=NSB^;K\=[@".1-\NV0F7YP.
M"U 8U:"U2D3U506#TL;F?65<Q9T[S?OVOMK;>[RE)[>2<X'0Y7XF]$Z)K"Z@
M>E!;2'@?&6OB3;XX] 0["5=S;>!!0#VP;9!%\VT>#2)1DI =8YM819>=CB>Q
MR6[?=DG,>AT"ZPW0!JE#O,9!0'P3])9H)99TWN?^X?JY'M 62*J\GH1]6]Z9
MZ?&^K^38U(';P;&>&IJM JR.COW42 =7A-?VL:#*%, !=;$EV$ORZ\[?V$Z;
M5=AGJ@NW$\*(12,AO4<LG!U;D8G<"NN^/N N23-Q\.)8F+5Y1@Y+2#9*HGB
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M]0K!7]!%(S>_2(EXX9:TUVB*'>\DL,M7V99RQ=E7'9)&,0)8J%7YU-WF<!K
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M&J'AQ5F0[%S/VLD=>+;SY-B1Y1:B-=>M=D*[WRS?GI.1%,D\:5__1N!;M!A
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M\,_#L<1(AB-8FB-043=#3R<,C7TF IN%4R?(GZTM7SDW"NIO,)PE^  -7S-
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M5R"1[$FE=Y&$N4T)*Z:)6D GK&SHK.C#/[=O=G/R67$P0:ESZY23(LP9%W*
M624?E?FYE3KK"4<404,1Q[Q$3 I1U VDD4I7$V#7HZX!Q09N'6OEX2!T%GM*
MA)6/P?::2GH763Q8D8VJ]TQ ]%,4(#+\^A8](;Q-<E)OT09[01@_PZH&2>%Q
M=)6I+HE5.?Y $+6=?/?68NUXR#^ZVB +"0HZZ2J37 )&168@S'[4AME=Y!-I
M1CYB%SN>Z4_2["*XCZ[:O.41D_ " ?9!&V#LV@T-D0PV6Q\_Q65:9(@).NF*
M&)6'3,8,A-G/VC"[B1R7EI25P73<KGG+^FQH> S )K?.F"R?P4/LKH1F?^C\
M<&V: C*4AV75F(+0U%&R2C$@.R$J%.'D#J$I4;"\B/QG@5?Q]]/8[#4O.)N[
M)5H@.'O523[;(=_M)!_N9+Z<"=-VKC4%:@ESUFKEHY457[-*R,Q-EOPBD/?4
ML[(!NB2!67$O8X*QJG"=K&T5F>@)OQ8 ]A.RW'#=LWPT]E>6Y_S%F$E8F<77
M_\2N4O41M/E+E9#");EJ)HY3,:0R-UN1,?2X30L#5!Q?<UVHS4)LLD.UL6G0
MJ'.5EFXBNYMCN0./Z$BT+$1<>L2FI(I?F%/HJLGE6F+-X>*,5;T? Q#%Y6'\
MI$R,8PM!X3?6Y4X]#P<!+^!&6;'LOV#_*_*#;/7U"?DW??ANX/T[\G=",!1[
MZ_*2GH=.$>9 KVG%<+&;AT<,"/&!FNMR@IX'B) ;T U:,0(C%.:L=4#ZO*8/
MUYKN$!6US,0,M-#'DKY%2-8PR^$7Y;SG2EH5<JND7^H0LZH3T&_I3WB_5%^Y
M5%^I$R#VJC%9@K1\K^+E\GR7EEPLAW@UR'&1)5%FO?+::KY.#DH82RDWS\-P
M'A8F>PS.Q\O0J^,J;]"G/.4><M>DX D6 U:@&-S"*M:?&9D]%0$S3P6_M2YS
M7RYC&=%-V?6,ANZ$-$&^3Y_+49(TM\,#;QV:)6R8;G!OJ=XLS+QF]40T_?@I
MJ\PLB"\-WUB!LX -Q@*#F/VP5 E>%(S*2EQ>QW<O<J\JBQ!2ZFLV,.HL&*?5
M'B84O9L?/\,0$9*3TL_8H\8]HY]Q!1_:!0<R%] S^ %/(EWHGDS, [G9V3GQ
M\1VM% QC6V@8XY$MS@UXXE6[BY(IYZ>OB\1;.J/J^"%',A,)W0%S.&8V?F!S
M/6=(<X&LA#,POJ!Q*R[&T;&&)MR:SQG8W'E0(7_0;"C[,+J:HC2*J 3&RUO'
MC<AO3_WI:AJ39!!SX2O)"QB6TE:XZX3*A'AX00(=S$5*@6X(E9^,#5^IO!MP
MQKN;YCP30'09.UJ$F0<A<D!S$][A3@;48CHAKD@1)GY78P)<"G")RBZ)!&-\
M\.N.BAP-R5JQ3]_MN=G=6__&?NR<$H;#"@UB1ID$(6BX/'?&^1L$U!]H%Q:T
MEXN!/Y">^%L9M)3Q%DG,I'"=+M!-#O0U/C$,C0O2<LJNBQ9A9+GI?319@!#N
MHRN*57:1GAJR0KXJ#W154P]\LT4AZJY\I'8K&>ZC*RI6#7@2OBJ/FIT?D8^"
M$&]H^J<;.[37SE:*GJ"3KI3D:N"3,0:Z"[7AEWG$65XRC-NX=;JO@&6#HBX9
M*F4*#:>I'CU5)%D0 W,USG,@,%EK/ ,F3?6W!AMKY7BK.VM!'U,5WWV1]-)U
MQ0*>\=S26S#MH.=:GPY E!8RW^*(]M0)OM[L;I"W6&\L7Y)S+._9NM-%51C5
M!8)KP"\E6)H6*^VIYR!2!D&&'5\0)AU2]8%G\A%6$\"&NC=FEHN"Y)[7"$GK
MXG&;ZXH+*J\IK,@#!,\O)IU_<EM*V.DEG'IRVTI;DDR.6I6RO,).QAQS$H5>
M@7.C#[<S@6K9D58>3$,/LM0_EJ-<U6,(=#3F<).6.51A!#SAJG5&2=_-H&[/
MA%PH6,Y>I\BW:\_Y!3  05 VDZ\4 M3=/%X>D2=ZH5W0O/D7CP1"Q2H4-W06
M-82 D>?.V2@UZ@QD(15D3RP_= 1UIN.BZ/FFC9\02M,;*Q -G@857QPX)8"6
M/G(G/G59+@H*G->U^0(KYR( <P%!<GU=,2;S;_AWY-G8%\O_M%GS182+RII/
M,2C7MQI]HT%X>(-HBK:60S9*S[XGC(7(HR7:1):(M//#]7MM]9X+)H@J<P/!
M:&#JF$K5;I7>+8)1G1UP.59<9I"5.&1OE^QS7KXXX9H6>+.\W1R'EGNZ&P,;
M89FAV@#=>;R!NG2U.,X6ED=?5J=$28BE3[#;-[O,B;L#$#UOT+9@6P6758<5
M"Z&<(7!(!Z-[RPA]^P/[7]G%H$+HR@9K-ZIJW%7M,P>K\%(?%,L5O4,HN,/^
M#/E/=.N8THM2/K*31UT! )7[MP6S@@Q5[2<J#U/\1FQYF.+^+PBF+$,03&5O
M>PH+)KNL*.<".4_ =;)#B>'CIFT1/DP[).>?JG95L+CP!/G4AT[V5= O<=*N
M+1(&"(?$^W-="OD1Q&21??;\(R>)5 V7#= 60(IR!#KMFD)J>AY.TQ>&$H\?
MT+RMV'.=7!H/#@0E9U5ZB 4C% ((*?5M"SP%F($]K+I\2%W["9')$SC>JO],
M"\\+/$;YMFV 2$(\[)RM=KE,D&>Y@DUK__<VR)1#,"C'B@WUM I*7,?F\Q9[
M1X6,,K4P!]["C6QJAZ854[94H\Z4P8DK D*(U/"EMF!;&^O@+-&7-&<%:T&H
M@_RU#:#ER 4%76VJ1T%!W]T.>NP-(&1W-_30%$L^U[QE4 #T@]AHJ]*42]LZ
MF&C7 H@$O=J$E)0-$# =!9SRZF;BN#C\@D4O]^YVSV8OV5"'TJ&)X#62#Z=U
MG9("3K/.M-_K#W[OW@S[_]6Y[Y/)W1UF?M?ICFX[]]U1]V/_OD_K/I%_CN>?
M^M/.7;^?[9QYG.0@/O-$=-5U7?R-QG_)@7:+H\=P&;GIT*)7<G^J78!DR)2V
M#IGG'3NAKF,EY.E_23<5U B'B(;3A]CR,L+-+4J.N:$\@NZ26T>4,C()N7<.
MS1T@YL:!9.5"7 4'-*8\5U'0P5I=I21J? 4O5:YH''3/H?3*S7FC&I#37 YL
M7*$0P/FC:Z8<$RF[&L)OK>?R3B5 8 7V(,ST7>LY'S0C$ZJ;!=;0*SX\E5)\
MMP?JH>D)7^$BXN^E/,JKWBGER7-<W5S\9J]29UT5M52 *,@%N%P:1B4)1Q5*
MLC]K3%U53ZK"4,X<!*V^LBAL_U??!KG-=5UL++ )PG2#07!]03R!HT*8LI-N
M^$K]']YJ>FKN3*NR"'<0ME7'S@4D=6V;B1,*2RGU;1U6!3EK2 T1>P"IG[DD
M4(?.+PZI4]9 .ZVUOO,K=BDAJ6%V>"R!YPK^N0%7,*.F<R"G)>YUE2<F?FDL
M%)%]B*(>J0V\)R(+[-/'X3,_PY/G_9M3[@>CWPDWXVG\[GMFD-HA3Z_'$2C[
M?T;.EL)ZQ?NE@)WK4W8FT_&D/YW_P>#I__/S8,+ (G](!NY8GMU!Z="ZW[1/
MJ9JX%IO3>YYS6R7WQ1!I7]U1#)#&(N^'"$<P)DZA#J7H-1$%:1D?D@#94"GV
MI=39@ "#(E:X.'/&!0Y@5A5<TDJ=]805BJ"AB*/9P82Z@30YU% KV)IJ/>\I
M4:SR?-)>4]2@R.+A%GSFL-&0[3Y% 2+#KV_1$W+Q-C%$;M&&6*9)LI<:)L4'
MTO722DFT2C(([IG:#K][:[$F"IQ_9)'('-2"3KI>[2B!HR(S$&;Z7NJXBWPB
M36(0LFCR,_U)^M *W$=70*@\8A)>S(O_#)$5L*3^P6;KXR>UAXT$G1Y^;AMD
M,F8@S'[6AME-Y+CTY7893,?MB*;4-FAX#,"6N'E6VD<?!V4,;M9/9\Y].7>*
M"C]5A^2J2 6*-A$+W-^BK8\6#E.1R,\N8F+VZ&T//W3^8K\'>12F#E7RA?9-
MB&HY;X]WAG]56B9-S9>D*U[STEO2.B*&@AB'*'+U_JUBL,.DA] OT8U+=.,2
MW;A$-R[1C4MTH^5 7J(;9EV? "F7>20D'=L3%E'GQ[A=ER5O9<VQ$RL,1D_6
M4]<=C-(:DA)#"AZ+QNR7,>&34.:M]C>UF/<RN&+_F5@[YKP49&V].S5DJ!G3
MG0]&'SO_Q]IL_]:Y&XRZHQ[]][#?G;',-#9V9YL,KCMOBY6?5;1D>&TU62XI
M)3+[Y*2=,58(+/93JX/+J?&VQ< CBPP=N*0?H5(6VA3"3OIL"3X"6)UTX\XL
M@%J9:BGIIL<Z4)&\$E;FV@-UP&6R#5 QI(WF-.U5BB,50IA"(^JB28576R)8
MG8>JMT! ^L=ZG)+T15UJ6"3UB%_*!"A_C9D208#0\;P9.M8CO:>SVZO>]"'H
MYW#^#;E/Z)YL(VN!^E!V1%UVEK(.>!9CQD6(X[F**@"\Z$C& UV*(>.T2]7I
M^@>R_/DW?/Z"3@8R'MXR_"B$>\U:OE)4%0<P'LTB?(#:9RO6*/FFP,=2>"CC
MD2W'$82QMN+-2A-4C*WR$,9C6HP3"$MM]:&+3,D[' F3C8N-9#RRI1B" -96
M9%IE?HJ!51W!>$ +,0(!6?;UJ697:B8_[LR52D8R'MA2#$$ EWW_JIF5*@16
M=03C 2W$" 1DV>>Q&ENIW66(_.J6Z]%PQD-<GBM1I-+,E:L(=*%AC >X.#>5
M^Y*A1Z%\%! B?K?<"-$D"^!)%/;<$J>IN9(74@Q*M^HGMS@$'(<1"LCZN&/[
M),^A'\1!F\\&V(0%"6;\#N;"HT W"(M9;I:"IX?QD,!4@X!D?"7Z$_J^(&>U
M#I'=?2(-5FB*J'32/\^1OQ$\6?/^QQ)9?ND'.U;\Q8Z??K+CL@1 <JINCAZB
MJ:<V'2@1^AP]]N@A/UZR7R4//R84O>4)XGT)01R^T\'+A'<4?^K _MO&V4^*
M2\]Q_.^$D'<\KG-//BEPG0S?"7',<N;-H7>U\[I_>@ =,2>\DI=[ENG )+V3
M%[/83QELKC DRRD>>*'EK1Q:.I-8(V%PQ?WM"(7C93;?6)"XFRL]&A? '(SF
MW='' 2N2.9OUYQ1*]JV.L_]8QV)?ZW@HI#/:RGQ0=S+O'94XV9^?Z).3Q\+)
M;?#<DTFAM^ZKB@(JE2\KRL<P)E&X"*3@A455F1F?5BQ@Y&9W;_T;^^SY57&:
M<:%!#+C"J(Q>3F4K*BN#DD@$U!]H'UD;Z7VXP@/I26,N@Y8RWB*)F93HK MT
MDY.A&Y\8AEZ2G.%E^,UBE<#2'S,E^7HXD-?94AY"4]9UV16,RW-9];X/.!M3
M0H;.@AI^PH1L;EM=12//A$3,#[@!5^U()Z8H?27$LWMXN_.I8T*<$P]WT%7T
ML0(<)$Q!8.@K_CC"]!K %H6HN_*16BE!N(^NXH_5;&H2OB#P]!6"[$5!B#?(
M9XX@^M[+VME*T1-TTE4(LAKX9(Q!^)4N"@GLA/3T4T>%=A'T>+C^J968*+$%
M*@8_Z7O(;?%GY/C(%K!_XN;_'*!EY Z=I>AYMS-&U?8\U1E>H?/YA::&B6:C
MI&2HK&<; 5;CJ4T.GTS=2[7**L7'>F% "[D$S0X#H1>6_A3W>V&0[CD"73,Z
MXNW<Z-S!=<W_NRC6GGO43A"92[]#PW 8B-)='<7839O>N?EPB<I=HG*7J-PE
M*G>)REVB<I>HW"4J5W-4KK9PC7FJ]WGA&C-KZ"0A#6F9V&RSED;20%8J#Z*9
MY_K7E!Q>O^M?6!K#1"4GZTQ)\J4+E2LZ8]P'34^9U.2@4F2X3;YF#D\JQ7"*
M#_?BIT*6SS;90! KTB(K90;\/F;!GM,V>:T!9J3U.TJ,]UW,@CVC"KYOXR>!
M[&YYB?&^CTF0,@I- ITW0 OPHEYEH.R@+WXZY+F%YH2V@EV<\%W_>>%&]/W5
MCQC;WQP6?@# 5^G=0I25V8+@_&!,C#/^Q6E(DW=K]L,;];N&Z:B<Z&5]5V1Y
M_"E<&?UPK<J7,<\X7B*QETCL)1)[B<1>(K&72.PE$GN)Q!H4B=43"VQGF!9D
MQ;P([246J#46J);?(+X!Q&]LH/5=,L,ARQ#H1KE<^CE<@C'O)I[,TCF;7>/"
ML%FGX'AYRHP >&&_-D(K9TC!=FG,F=:SMDYHN;,0+[ZJ^)C>GOJ8>MW)8-X=
M=F;S<>\?YGB6+L_H:O'^O/1G=/=DLV-]O&3K1NR]$70Q^PE=*:\&>5^R),IL
M;5Y;/3X4N82QE'+SG"+G86&R:^-\O SU5?3P9H,]1J?4%CYMJJDVDV M8#G!
MYFU@C$K&U(T:!-FVNOQ&!4'(D6R@?^A :*\ #CV]WJ R./3J]/.<[STEPR"?
MF,BQLUCJ1>4UUU4;2QD-F&H($'W%KR:NY5$WEEC9/6YEMG[+X\B@=-:4/)D*
M==I.CRK+%29?WN9JKN5$;K+&6AB61J\UCMZ^N7[#MLD;[$4!I43H^0?;ZW+^
M U,:JY+<D'L_\,/,]"?_.DQ]\H^'.?7O45^E[3PY=F2YP!Y/V@)-#=WH88+!
M&:Y5[E^<<)T-Q<UQWPN=< ?N1SP&98,T?#Y(,1!@I2:/VD\0 V$T\LRI#^HF
MW282M&^PY=OCY:WCHP49,>BM+<??" XNTDG<AS#7\.EUQEK#A9B"O?K:[)A;
MRB_R[&!B[>B9,;+"R!>$6OCM'ZXUV9;* 181W1 L^FK)4P5IC5U"1=#_,R+3
M;H1#--ALK44X7O:P]T3^P *JY&?ZHA(1@+N+?Q_2Z.H,+2*?2!X%8^_6<:,0
MV7W+IZ][!1/DS]:6".(FOF[^A&E."H8Z7YD ?L>4M2DK1J[D!,]V,!]D(>'&
MN4 RU++I$XRC, @MCUY/4@(GUZM5" '4-V.[E(,I32=AE$]1@/PG9-]A_RZB
MI\\@""+Z"IX2=FI#M0K0(BR!'N"*,R\36E9.$"+_D#-TFG-YTLQ@L</D@MX6
M;6H/)?/&"I!-'^4DYI<5R\ZWR.E*F;S9'9HD3X!WOQ&U>Q11(8V7,9_=)\MQ
MJ8Y'IM)'TE=0H;>N+QH\'QKA')I:'UHWM6(VZ5Y$<Q^)XN9@WJ9PKE1YGWG!
MDPAF%YHY/^F[M\+(#L@$GZ)MY"_6A)GQ,C8)!#$143?SD54@'T+J9ZU6\X%:
M^Y:87]XJGESQA)/8O,*^YF.FR@,$W"\F O>[Y48R7X6H:[MAR[  ^PXK?H*(
MZMRNFR3LSWUD!9&_ ]</>ZQ'T,5@^:N1#LJ]ZJ>?^)30R5%,[+1'.Z5^H!P4
M>L;WTMR=$.R%Y <W?KF>O?2V_\7 HP95$ 97G^Q-[.I/O(7PX^X?WN4NC8Q'
M\^EX.$Q?LQ^-1]E?#4;S_K0_8Q58/MW>=V(,@@YB']+]J/N]XV&?T)&*(H=\
M?M<6=-%S IT2)+EO C0WYMJ)%)*3(TC(_N422C.Y&V(0+G=1+G=1=&-A9)9%
M97@9?1=%+>T[W[8=MU%.*39O#[M<1ZG\.DJ %C^L\--K&SDQ!.2'@^3)/QZ&
M:&6Y<=H-<)R35KE&9A_@/(IK#33+Q2S)QB--M&9,"B2& 0KK/7BKEJB1QVIA
MJ3>:*4^LX-C*%N;'G[1J^BR$IB464ECU9@!(<+Q%-!7IR&4!B)'75-<- V7+
M5D@X)..JGZFB;L3Q<H3"@;? &YY#81^=SS1KA6RY1%>MMP%RO8EV. K)Q_FN
M.$#,DEZMD+H*#PUM(!)2H+B- A=QT.,%P'%@!#P7J\7DU@E"WWF,6-(Z(/RC
M-JV0<IYB2)P5)X/U69:ARA'):=D*T4)T0P+.I(:9%7Y1J=7U8^FPBS%EO(@L
M NPZ-HN<#5$0S->6]V5-A+$;?_.0/8L> \=V+'\W(<>S%])?^O3Z2BJH_G*)
M%F$P7O;6-$>'OG"0FR \ET:MG]7ETZF>*4G<J,9/&A-[:F2*YOQ7-4-I? SL
M)@J(C(* 5=(,8MR%$3"P@S;W6?T@8C4)&.=]YE$:5TR5EF90Z*HGOB:3OAPK
MK@1,"K;5"9N1/L-ZH&W:L2AS*6H-K*DO! P0W<SN)KDUOM^[X=(:)TU>_K&4
MY[G6N%!AJ$3E&G*-FJ^JP9<=1[9F5<LH(UXC-__B$#2ZL<<I!CV.ZT"XW\NZ
M-7T,""8R+D9U,YM+ 76)O?.7VSV#FYV\S)Y"UY=_?JC+HFIO=%W0J]2>4^BJ
MQ\!1QT$)/[,K!=8)H)&G7=T@-W\VWI0[&P7==*6]J:^@TR-3Q@QH.U4<6ZU+
M6=$4DBH/B(P9,$ZES5=W&G[;LSTA&@/92JP5(KO#41 K;@+OD*6'?+C6E7BJ
M(09PII2@F53Q5IMF>X5K; ^\)T+G)LO_@58H?*\^P/>!?AF95.T" [">^'B!
MD!W<$0&Q?2S-88A_L=E:'I1/H-+U^\%771K&&;5"TKO+I>,Z5B@J3* XP/<Q
M&<K(I&IC%UKL^QH9,UJ=+-K>^TX/41ZAG5S0X_M 4TD($'P5IWH=Z&#*:@'P
M3MI_C]!Q10"JYA6;2H1MAPS,V)YC6AV0_#/6 C (GZ37]P.BDB @*,M6\P*@
MG./0<M-9-?$=;F%$VC+?\/L!#.(=PJALW2R5Y7:'?690;;8HC,7LV;1!Y-)2
MJMV5CY@;36D1JH[U_2!]AGB@R5"V-%<A8S;@&%Z%C%G> -\/[$5E F%=MIH7
M>+6 UK4_G/G%[MXH]OY^4"XD$-!?D1%68^GX\76ON?6,@BMJ>V./3<\E,<J>
MG"#>JC)M!&60WI_FXP]&O?%]OS/O_JM/2QT=1N_@96>;CM]98K_CL"]T0OJ)
M3 &D@SCJ8GF*"$X+9F&RXE5WB&[1+BT_$9&UM-NWG1(35,#\AU/F3[D__A"5
MP#+^5"=(OY610H<<$ZA10=PF;_61?\5ON9,3:>A8CX1B6O/^*B'E+8_YGR3(
MIV,SSBPV>H=8AQWW,#YIM;^5\;8!?E4NF/PL9(MWB:0>LID]UHM\G]5A.T "
M_5XP37\Y96D\_]2?=GJ?I]/^:-X9#KHW@^%@/F"PL?$[R0<Z0RY8=?%,2U@X
M\5$9JT;QDPP+1PFZG][D[P;=WP_F]X3)&;L;1"\&#48?^Z/>H%$L9]%V&T>C
M+;=G!>L[%W\;>&0+W+!]086WZU/>9I\GDV&?\M8==GK=V:?.W7#\A<S6N_'T
MOCL?C$<-,L@>V:'5@?UP-_<M+[ 6S)>GPMG;4\ZF_6%WWK_M3+K3^1^=^;0[
MFG5[E"&C[G"Y1#O",0V96LE!>KN-_^>L;'*J!>^J495?T538;;%&=D3?9:J
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M23WA@43N4/,7@8&0N:J=T>"]ZOWG 0@R+5Z$U$_Y4?#N-NS+LUS+=Q!5.KX
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M6!<9"GFM#BH%V"L!VI,(_O&UL-05KG_E8N'3:MOZW'&*Y_2?JE5+F6 08@A
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M' 7,/F,&0H"8(D>F8$@CC$KI, >TR^H1S2"+!3QI"1B]N.?CVEK0@U/;4EE
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M60[@M!J!^&8S=-.(0^27Y:"MSRMX(S;!(^UP32D=E%?J@9I"%"Z?M$,T*9>
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M1ZK2X*M?M0ZDD%6EI^854 X1KV_CZ#E.XB+FOO)TK<Z?.C/G R&:PK+G>DB
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M*:PA-3Z4%V<U8L'YT!1M^"4CO\_3ZO:ADN?*U".=2I R&AKPTC(:$GDP/+(
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MI V&>\Z0)6M\E2SBPA>H-'3)+8&Y9%[CW:WA@GD[5<^+R];.#%:9C7I@F.D
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M#G=EM_@&'/LL*X<#WY*6XSR,KBV-,J&Q+E>DVF*&G[/=9U[,L%\?!4<4.Y3
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MY1/0+:F?0.I'K(A\ K][RT>@<6]-?6%COJPSY"T:U'GNL'N!G7.%H9E YXY
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M/^2AIF&<Q('HP?Q((YH'R6L9E%6904YKAUAMMG )H5BT?=&Q* VJ+R#<=Z?
M/MIA_1U!9OE8,4<. MNX"'RC.707<UZ%HR_=6)VHYA.]*%=P::D6+]7H/&WJ
MQD#UNLB(Q(EP0_-#D+)-+89VG%]HD!0/,$)(R1E6[KS^TQ!8VX*#G+-$S7ZJ
MI[7+94S\;MG\B9U^801L/*&A<NRY,A%8V<6',G]]$S?[CGS"'\!+&(7^#$<Q
M\+KSAS8:PDR-2-D.($WG6*Z^VN72L&%1S<\YVP.=U,(I,:ND#]!)'9P%BRK
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MB',!+7GRO<V#'SK*_?U%,2C0-IQO:^1#P?G."7ZGR2'>''FN>4*X7R<ZC3_
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MKF*I!@)TJ@IG>/.U"E09VYP!ILP "IMH@R]1RDK8#X$TH<G:Q:G21]W*)*V
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M(NY]0OFT(31!O.^CF6?55:TY,("F4 @,-QWVI))2]YP(I*XUYXYKZ-:^+X+
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MA<)33@))G,?'2IP'6P(?)VMN?T^#L/CVDFTMQS.\T Z%2";KI&$S.*,?U$G
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M2G>;MKZT';2VH? E;NO%Q;Y@6[?M4]^LE=>PQWBBO4JK$[O[2PBUVV?UJ\C
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M':XTD87*FK=JBX!B@AVO.V?BL5:"W2D/D;!!1N_$?Q;.49@@%3%2WY6/'/S
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M;F-"VYL@2LVA/SS1^C11BY?U=D<@RX;-H%_$:FWHZUBU)O%ABO OCI\0'O?
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M>MO1OX5NOH5NOH5NOH5NOH5NFA+\%KKY%KJ)G\VDTP!"6^,ZWP((;?&?VA5
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M]RDKILKY\>?O*G%2XT\\2$H$)^>>KV*0%"MQ^L @RKZ G_,CDW5)#B'E47*
M,"EI#6R'5[J)_]5S28'7)7DA04(>V"@9,U6A@>./DB@.]^S@='=D:X>;;,30
M6!'ZXFT(W.?5ZN<L,<)HM$'J[FH5"WR/EZDXE?FR)KR]>9.6Z$:7XZP<$=\<
MK(Y\5Q&-"XK#_G56&O:/WS+YYC233F)^947K2_Z!*)9BT(V?"D9<L==2\^RY
MYW7%D2F4PBI#OTZ&KIQ)0;)EJTC"C@H[)_\J^SG</A+7VSC^*3A1XUPR;@?-
MVJ'&N<ZEU!"CCDZ[9P-GN+WWG%T01K&WF>R='>O3B'"3BMQ=FPD$;@#-<-&
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M22_IGO2M(*M4D=MBCM$W69FX8.7;B36)R,6P5I-!1^3'A3HW7F+JQM+XVEB
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M[:C$'%YX? Y;Y/F3KR"!^/-KZJZ:ST9,;JFR/+N?SK:?N42$ N!M7,K %S0
M.\QSEA, \R<=S,*CPE5SCI;Q 9$S+T,^K-R=2=\I\PZ?*G PA9R0>,2K=D-
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M>4M(V<.QTIJ@D64@Z8+T2^GO-("7T@^^&R2#XF PNJ20E&)3A=^8IF9?;2C
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M\IVBG^4YV.@\_LH?"6(GJ5 ,@;G8*IRVKA"LI"+MFGZL3.W(/9 TTU8<&V$
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MZ7_.?QU];'9?EW=?"5;9R4F2Q>[V &FLUL-N_#B TJWCNS8K#[9,&J,,?1H
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MY)%E8,S)=+JJ>^T3N;GBUN[=MZL,S"<>0L?FK:3?W16*0ZX14FKX<7DW)4;
M,>9-:7#/:2TN\Y7#:K'H?96;DT5B_K84= D("-G_PVJIO#,HS$^-FWR#PN"
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M6M>J4-#H1=[)>DY%HJOUQ,%(;OX=0XDFS(P(H]RC7XU'U"U'L.RNI31@@_8
M'!'3359H(0PM'6$GUD]>W]Y0E"H>_<@^V@-2EQ+52%_)2/0X WQ\?5TW9Z,B
MN=20D58\?2W'W?EC[L*!JEO7:US MVSF@HD\9G'9U_9YX[E@SFP!Q33#8+?J
MP[JF'\!_PGY"KIX!+D82#(GF(3J_+SXT7U(OA76C@-O[5TDWN5INI/IF=[JF
M"]3*U4@G#JY&]3[3[?1J=O01=_O\UM]2;M6HPIG9S[U;558[5M8ET"'$05S
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M65W**B 2A1F ^M"J\(^X,[AFJ7M"WS9+W$1S5K.>;_ELX:WV[O>'7V[NL//
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M?(-#9+]^_904UYLQJO+!XOSCQ*H]DT?Z%HIIWR@E-%#89SJ<_H(<S$?TTT"
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MTY'/ J4-03\4ZQ(,[;FI]LASR]FC-% ;GZ+E6:(M.0H(V=<+0,Q9 /YSZ&/
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M/P,FALJSU"P!^!:X&883+/GFL3P^XU?+'VYH_)@H=7IE*:I==[VN]U%?R9@
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M0E7JX4\$$J5IFCGY4(*=74^*@-V=F4SKXV%[Z5&VP\=&T X/*K_5X!7=OQV
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MQ33GA8*X3HEQAKRZO^S4T0E9)&Y/BO@[C48X_FAQB<]A"#'C<*=87UP4LUR
M"$H$"?9\=\:/,+8KP07<[S%KA]O5J!O:7322,ZU2>,U;FL8&6RUNS.V9#USB
M3._5W3H"J&X/[+M+>#12U?=EFO+[RK0?+0^$W/N<&/^HV8[[O_W\]=_5/\/U
M9\/"([>V.+RG(QD'H!JI(98JLIMX'.6-$0 GZ$LR1 ';)728W_A77Y<+E,*X
M*OB%FWUNVUZ)Q,<YCP6TV=*KT >@:$BC5P]F9J!'(%^VAP@"%#Z&*Y=>;6U_
M3]F,]RLGS)L^N)!IO'C;YG%US8>HIV^"^ AC9N[DEHAXQR(K2A:-&Q"C'.NO
M(;L>80@!5HO%/-(6IU?;N&.:F)J[;BA<E/=C6\)\_].(Z1I+ X$(=L?8_V>A
M> !> 'D"+DM[09G4 :?K29!<1;QI>R81?''XLJXJ1P,==^EAT4]#TLXC<<>D
M9-GS5RM+IN?.%)\'.&Y1!Z*V]+30WFUWZTGSIM]JZW;:U[0W%>O0,R'_N<=V
M&:9@V(PETU2<D-%T,884I2[=K6(%Q:$ONM*&S'T46&[OZ #X#@GZ*6X&T@J\
MQ]R.7,B5_9QZW79PC@LZ5OFV;)-XJ#@2VZ@(KJ1K_,3XO^#6$+W;J"ZU Y G
ME<1/.0 QU/:Z)-;Y.X1?3*!(;..L?O^;@KTLVXS&SR=-M_HWRE+(;1@QY"?4
M*9;<;Z3(.,.<@B<1$YJ()ZIEXS<T()PS"S?>'C]=J73?>.@CG^7U/]V+<L?>
M8&Z7).,'F01PJW>T7\?TX-;>[EDY:P)H-L6-[R>1 ^7V[VO*,00LC P[SI #
MH(?*PNLKPOI6_;M(L&%BJRXTTQ7QM;=N-E'ZQ^O,0)=L Q%==$]Y6B 9VT4\
MR8!3K ?B&,](KESPX1YL2KI^=MW*RU5-JX8K[DIGAC[UV1T])<J3/T@]]"QT
M$DH8<:: 1 #<NOQ(5Y4>UZ??FD1 V&C)8AU/RA_33\WR&)S6Q,S?/[_X(GIN
MS$JN0D"@D?C9UUQ#INW[3Z0@0NHKBX=QX2N"H\R^'R="V<P^D>P#E?:V6A^[
M??&!Q^ES(N>/'HU=!XG:9G$#TH=_V% A1?,!CAR XK:-#T _PO?V%4Q,6J]V
M$BT-[ /0:5YD6)?%"0:4<J;H/#4W!J%&)G*,+/_-UV\N[T)5#"Z_=/O,6V,8
M\O+D$.5ZGR4U=)U(V2*S=QLCCF#^#9(A/M\HC9-#:*%*')U6>*2E!:W]G,_<
M<),OO^YT^9A@7\BK!UL1NZ'(&DRE'S3H.Y48AZ?<_7?E?W$@=1UA?KC++U#L
M"%FRN5+>>K.S2%>X7^INJ>HK-]&QFW4Q-:J99>XJ8IR>0#3K5 1=#6ATP7T+
M=ITA+KI45/N&\CHON#@#'*;YY$T?P<9!J2:VPIG$QY]-I#/#,$$EJ7O'U+J*
M.,98HG +\Z\(W;*5?*[8TMGR\KC""H=R='F*G&:9I8'@R80W(+[K("XVGS&#
MJR;8D%/2M5%)<F7_M[8%3D6=%.Z/N,M 51FP]N!0K';!(MY71)S5>K4<##H(
M=86GYNX\G6L0<KOIW%#]4>R0,.T-Q*Q67]347$N#+$FL[RU*$!0,&R>0DH!$
M%TMG8F<V(\('2A83)CZ(FWIZDK<_JU3^TQ')*Z#%(JA /[Z^N.L E*BC7U,!
M)),L>IQ1%M.8QY/-"GYF/?RV]U:U+"\8;UXRN7C1Q/*4=0C;*]XC1SOEDXJL
MF0C\8.3P>^=VUPK&O^.U&29>3#^"8!]'6)$V J87B[MU_6#=*CW\L94&B\QK
MRDT/8I.[6\830F]*/;:_[7$ST[A+8WS@GU E+UT%7N*Y.\[B>83/^2/NJ2M8
MH@63UB_31HI"YO'*6DNB074+2>WX$<;" 0CE0AI?2/[1XJH<I]4+CM<7!["+
M([=ZD I?@V#G@%";]$'<^"Y4;NL)YISD>HX07\:TI.@5*4D;2%?ZS!+I$)\D
MTDI3>CR2C1+Z?*<@$;'RI$.W9-8GY,\@DY9VW$!ITQ!:7Y(Y3EME%Z(*T *
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MVQQ7WT#]V.V@7-6%$==!PMK8C'-P WMUXQ:J&.7LN@"O2(,L%A+9<5((;ZI
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M;?/P$A@ZZG_NU?ZQF&6G+0%0.AM#+[T/?W[7.;"')>CU9_F;DIY:M2\MQRA
MCGX[QV9;Z8-GL+7:>:Z!TR:?,,84VY0=?,("USCBQENBXVJ^<JL7_]M'8<?\
MDU87'G"+)D74*!R]ELJSEP5U7V<4S$"NY.3@'?^%<GP_/\@V%2Y+8P&V5%E:
M&56KJYA[+;\?2V7O@HF&,\MSXYI-UH.,,L_I00,KE>H;8@OY6N)?\WO(J2ZB
M(Y1$^DR>?)O8;,=(AIOT;6*=.V_^+WV_Y&N%OQ5.U3QSXYNOS9WR$6V<K:T>
M_YCI__USZU#<=T ZL+[^ZU>V:H58X !$-P5D::Z4PJ+F)3_OE1!"X8Z#9R$,
MYO6LTG5U.M/+H[F\O,'D6: :VV.I.*W(Z@'!^X:HCQC"'HFX(8N!.AA%,ZY/
M$[;BWK04.XQM[M#16@_&V ;R?J#GRR>?C?I));Q.6#:(?*,Y7UN6L8<9GD I
MX4<B?\N\P^RW-S""=K_N5/^/6M?)=A^ A ] )%E@C8PYANJ66O*#L'@<112V
M &-P$%[VYC?6Q$_DSR^_GFV7QP\S5S=$M"IDU<=AM\7 3!ALY/!P6!K_?^V\
M]G]=JY9GOD$M5KKRXW@8'E3VN":)&0@Y-*6ID'\#C=ZM<0MZ[VN*_S,%D1]R
M_SY_@_=<VMN[#R)K#$(?/CLO-S+,8_+ 9J95(8R.%B&M6D5W&@<B"(STT6(
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M'N$H!M\Q6@O01P<?GM3Y#LIH?Z0IF4Z"13UI'N4&O+IQ(A/-CL,Y:9<BV@]
M_&;/'C]LC+.YTYN31="KK^V7FY^4VS]&1C%X:XRR%B$?(2<8:E1I)%LQ+9C*
MEYN T JM\O%RB**2XN">9A]L(D)>?E&6"0G*/ADR=T*[#D(>8/#L.0.)-<CQ
ML_8,S]8)A"[='(Z<M:"*=;#XH]8L&R>5UO5[L39[+@&2V R0JJ/Z<>:6O#>'
M/UI%8+FV<B7LB^4Z\Y/<5L2E26QGIEE32:4A5ZV,%6DYQGG/C&#>'-SQRLG_
M6U9'?FB'QRCRN[[6!R"/[OH_Y6(FP6<T]UPDIX/-3;U+1G//C9!:W3V<MI_;
MO2AZYOH 22S^\[A8&+)N,'4 VHD*IW"+'[YU!:< 'R!+K(]BC*C#W>_!ZTM<
MO]$50- V.,'?96+=RGB]+5_037/IE/"FW.;ZJ!PA<<=K(Y$"[7-M@JQOD6''
M +,^'?;H+3W[1\_*7'P=L/'+4TMIXV2A"Z^,SH2&E)G'LSF7>=R_FMK8;]^L
M8<N=4!%/#RB6__,LY?'N2@4::_M5E9!9X1#K< #R//L3Z6N5Y=*&4>@<_50@
M(0(,TSJ9J2@/\/<)<DL>"1\-.8/4@!_KP0IKI3_!E%'/X!3Y>1R<."_R97)X
M[XP86J=I?L9[I\!FA/+^.[:O1$<@)W"RP+DEBQC7DTCQWRP5W#12YMT[WJ5N
MXO=Q: Z_@T>3Q84FX<^4[V%E(_P.@7(/[%7.Q,3=M?W7+^^Z&=6+=2JY!/D%
MSZL75K[6EOX<K?B& DY5Y^8T?TL$'D=PP,GO._\0]A<' T6D!+R78]V-Y/BX
MOT 9WH>O6R/N,<N09P!.A!?]EB)$%,FSZF5Y2.P2G/#+006S8-4C;)]#6\PC
MU 5\GKX)2XH[_K"Z/62+>SZU1CA;/F#A2VD6U$A&J:C=5.>RD?$'3/"VJ<T
M)[N@U?T5=I%KI=(=V)1\F_!!7>*\I=&0*Y962K\'/0!1[J($'!FNWY#2\!-B
M[.3<^%J&6I4)..["-SV/DH75EF?5JU]7XE9GO)H#@#_"@IZ?/<A/A136G+W(
MW'W<S_]G2L@+%$?=82K>WK_ 3IV.0MQ"U=BMM=U-%&UTL1.!75HT]WCT9+77
M26RH[,+W#Y9?_!&'AR[*"BA8REU_1(8<8=P"ENK@2V14(GBGT,95P@7P[1]7
ML-\9_K!9^S;Y3O,?-\<'&:+_I93/U%UR W\^NHL7QS\\  DS[( ^BAOY73KU
MEM%7I#SBDOG]J8@US,F"#0&7IDFWVZTM4.F...\,86T"KW)AEM<73]E@-X[+
M,@J.>0OS5B5OBJL+E\'7K-=K395#H49#:&2J=2#T+K5):L^D/ 2!)N-G!6A1
M%('U9GKX@@^>/^L!E7M]FVQR "()36ELG5Z9/M=3T5?>%3Z%<ZYVZ/90NF"I
M7O_I?( ;,CJ"A@-FZ7>07X@-V)X#4+*.Q0"G^"J1+-ZX".4HY*)_G+(2NX#Y
MD<0QYA<LTM=V.3\HX%*<D:M2E-ZC_B\U \44@W01Z,)Y9OE.IRPM#H>-I^7_
M=Y@S.JXN<#3A&B=*(QZTY!AG"J&7M0RUO]E8:#QZ(!O$JS\CT,2L_#<2@'@.
MXI/^'4O*[0[3OP)7NS&I=ZQZ);_\)Y:]9RVQY)NC6?[5)[RZGM\:0>+WP\J&
MP?_=4/@1W?*^9R#G[*\#4&7$+G*+BJ,K[.;6>$QWE.N[X!;F]67#74.J0F;=
MK!;! Q82<%O6:325?3$]D>$5MI3.A>V9UQK(?X!M<\Y^W:8^[FKA]0PJXF@@
M%!'8H'5#*^\BX^/0M]T^!';1];L9F2OZ4#94)B'>YH[D^-A@!3&KKI? I:4>
M_J)3^6.QM?<+LK/!(O=?U>)]/!_?4<39GVJZL@U=-27H6$:A!#I1#"XG_%]9
M\%IE>:B#'T)_ T\Y687ZP?@L5Y*4&?7_-C[A%>H1/A72Q-X+2<=I3NA?AMOX
M"7335(QI:B;O"NQ(K^_R78QRXFXR',N5^4-\=I?4SD84TE='(+]"8)@S *P'
MR9>_30J>S$D.A;<]RIQYBP+^YCC6(E>6_M+>D0H3_[2L2]3(U1G$Y5Z,UUW8
M6UOYC4!HN_*)LNF=&_@6D'HW5+<N3 '[:1XGY@=3)DAH'?*G$4L!X0Y8+[IR
MS2$DOOHW)]>T3Z=;94Z8Z63WM;&=N'+Q",Y&=T]_(K5:52MP#F%!'>A-E:7I
MM$[O.)\XI2^K',TV-EYZ2[4'_BDNZ/;H%RM5/J?"/M#?QM%:2]MU5_7RS[LV
M6)AZ^+E!A>%SB;V*UK=K;A@8KDX2S -OF4OO[2[L.QZB<K$8SZ,OAS 'V)GE
M5#?#8D/JQ56U6T?G[ I$DI,?GJW-O'[]>VC>^:>JE5Q7!ZD80/M-QF'Z\PA8
MP>:PAIH^RK)*^)MI:,0A8MAN,),8MO^,'S-' Q.SSYV.@"R*"?1E)&BT#V]Q
MF-4YF_":G1]+]LN=JN%@3_^IW!!G\_&TH1DM($6*HV7"87<>BME=C1"%Q.8<
MS3ZM43U46@']XC!DL\H@,G17X:Z,\Q4#Q4W!OQCG1):<='YU%T<Y(&-E>^:M
MP3!%I/QJ;FX(141(:U"L'0B1SKS>>D'8NT><H_('Q)E9B["G9-$\F!E( 4#
MB!KWEFR1M, >YQ9(LBS5;';SJ?#ASS2=2JZUX(S/=X#C?#Z_M73O5>45NC9
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MWLNO,Q#',#@ G71/=HMD0W>TU/B%/F*^;9UYFQUM(O89=>7,^0"NT7C4OY%
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M*5=FKZC&=LM<R*M!^X6/9F/9E:N:NT\1SCT+VUZMZODQ0\&5)G+C;TZM*50
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MM<8$\RS'H1D8.U-N+,]8H=9+1>! %7>_F,5*E"GUX#37!O$EJ&6J==KIR%*
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M="TR,2YH=&U02P$"% ,4    " "FA39;-HT5K/T"  "C"@  %0
M    @ $/E@( 9F]N87)?97AH:6)I="TR,S$N:'1M4$L! A0#%     @ IH4V
M6V*K2-IN @  L0<  !4              ( !/YD" &9O;F%R7V5X:&EB:70M
M,C,R+FAT;5!+ 0(4 Q0    ( *:%-EM_2CQ:]@8  'XT   4
M  "  >"; @!F;VYA<E]E>&AI8FET+3,Q+FAT;5!+ 0(4 Q0    ( *:%-EOK
M!Q+@200  /(6   4              "  0BC @!F;VYA<E]E>&AI8FET+3,R
M+FAT;5!+ 0(4 Q0    ( *:%-EMW8(;P4!D  (W$   4              "
M 8.G @!F;VYA<E]E>&AI8FET+3DW+FAT;5!+ 0(4 Q0    ( *:%-EN-79IP
M]S4  &@X   .              "  07! @!F;VYA<E]L;V=O+FIP9U!+ 0(4
M Q0    ( *:%-EO+2/IKMA@  ($8 0 1              "  2CW @!F;VYR
M+3(P,C4P-C,P+GAS9%!+ 0(4 Q0    ( *:%-EN +<X8L!L  /I; 0 5
M          "  0T0 P!F;VYR+3(P,C4P-C,P7V-A;"YX;6Q02P$"% ,4
M" "FA39;>Q=AQ(%#  #)(00 %0              @ 'P*P, 9F]N<BTR,#(U
M,#8S,%]D968N>&UL4$L! A0#%     @ IH4V6XVVXWUAB   1ZH' !4
M         ( !I&\# &9O;G(M,C R-3 V,S!?;&%B+GAM;%!+ 0(4 Q0    (
M *:%-EL2!B8EMF0  &9>!@ 5              "  3CX P!F;VYR+3(P,C4P
M-C,P7W!R92YX;6Q02P$"% ,4    " "FA39;M/)WNUDW 0#O?0$ #0
M        @ $A700 :6UA9V5?,# R+FIP9U!+!08     #@ . (L#  "EE 4
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>e6836_10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20250630"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20250630.xsd" xlink:type="simple"/>
    <context id="From2024-07-01to2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-09-08_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-08</instant>
        </period>
    </context>
    <context id="AsOf2025-09-08_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-08</instant>
        </period>
    </context>
    <context id="AsOf2025-09-08_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-08</instant>
        </period>
    </context>
    <context id="AsOf2025-09-08_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-08</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_CommonStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:CommonStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ClassANonVotingPreferredStockholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember516945625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ClassAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ClassAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ClassAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonStockMember516945765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ClassAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ClassCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_DiagnosticImagingFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">FONR:DiagnosticImagingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-07-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-07-02</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:RelatedPartiesMedicalPracticesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoVendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:TwoVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoVendorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">FONR:TwoVendorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDeveopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_BuildingMember_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ClassAPreferredStockMember516949718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ClassAPreferredStockMember516949796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">FONR:ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_NotesReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_DiagnosticEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:DiagnosticEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDevelopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">FONR:ResearchDevelopmentAndDemonstrationEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MachineryAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_OperatingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_FinancingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_SoftwareLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_SoftwareLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_CostomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:CostomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_SoftwareLicensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:SoftwareLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_SoftwareLicensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:SoftwareLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2010-04-23_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-04-23</instant>
        </period>
    </context>
    <context id="AsOf2010-08-10_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-08-10</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_N2010StockBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">FONR:N2010StockBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-09-252023-09-26_srt_BoardOfDirectorsChairmanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-25</startDate>
            <endDate>2023-09-26</endDate>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-02-13</instant>
        </period>
    </context>
    <context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassBControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-12</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-02-12</startDate>
            <endDate>2013-02-13</endDate>
        </period>
    </context>
    <context id="AsOf2013-03-05_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-03-05</instant>
        </period>
    </context>
    <context id="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-01-08</instant>
        </period>
    </context>
    <context id="From2015-01-072015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-07</startDate>
            <endDate>2015-01-08</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherOwnershipInterestsByNameAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">FONR:ClassAControllingInterestsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:HDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:HDMEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_MagneticResonanceManagementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">FONR:MagneticResonanceManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_BensonhurstMRILimitedPartnershipMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:BensonhurstMRILimitedPartnershipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_RadianHealthcareManagementLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">FONR:RadianHealthcareManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingandServicingofMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManagementofDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_TotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManufacturingandServicingofMedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:ManagementofDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_TotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">FONR:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_TwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FONR:TwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_TwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">FONR:TwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_PR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_CH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_DE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_AE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_AE">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_DO">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:DO</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_GR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_AU">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>FONR:Integer</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-07-01to2025-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2024-07-01to2025-06-30" id="Fact000004">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-07-01to2025-06-30" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2024-07-01to2025-06-30" id="Fact000006">0000355019</dei:EntityCentralIndexKey>
    <FONR:PrepaidExpensesAndOtherCurrentAssetsRelatedParty
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0104"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0145"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0187"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0470"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0471"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0474"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0484"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0485"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0497"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0507"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterest
      contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0532"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0533"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0536"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0541"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0548"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0549"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0551"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0552"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0553"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0561"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0563"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0566"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0571"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterest
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0577"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0579"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0581"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0582"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0586"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0587"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0600"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0603"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0604"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0607"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0608"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0609"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0611"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0624"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0627"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0628"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0631"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0632"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleNonControllingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0635"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0639"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0643"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:GainOnSaleOfEquipmentRelatedParty
      contextRef="From2024-07-01to2025-06-30"
      id="xdx2ixbrl0672"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:GainlossOnDispositionOfFixedAssets
      contextRef="From2024-07-01to2025-06-30"
      id="xdx2ixbrl0675"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IncreaseDecreaseInNotesReceivable
      contextRef="From2024-07-01to2025-06-30"
      id="xdx2ixbrl0687"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInNotesReceivableRelatedParties
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0691"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SaleOfNoncontrollingInterest
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0745"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2025-06-30_us-gaap_NotesReceivableMember"
      id="xdx2ixbrl1152"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember"
      id="xdx2ixbrl1154"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember"
      id="xdx2ixbrl1159"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      id="xdx2ixbrl1163"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2024-07-01to2025-06-30"
      id="xdx2ixbrl1191"
      unitRef="Integer"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember"
      id="xdx2ixbrl1288"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="xdx2ixbrl1388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl1412"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="xdx2ixbrl1434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl1450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      id="xdx2ixbrl1496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      id="xdx2ixbrl1504"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      id="xdx2ixbrl1512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      id="xdx2ixbrl1520"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CorrectionOfError
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl1552"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl1868"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl1920"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdvancePaymentsByBorrowersForTaxesAndInsurance
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1927"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedUtilitiesCurrent
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1930"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:SoftwareLicenses
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1936"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:RecruitingFees
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1939"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:RentExpenses
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      id="xdx2ixbrl2037"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      id="xdx2ixbrl2050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      id="xdx2ixbrl2054"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      id="xdx2ixbrl2058"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      id="xdx2ixbrl2110"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:RentExpenses
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      id="xdx2ixbrl2133"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SalariesAndWages
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      id="xdx2ixbrl2146"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      id="xdx2ixbrl2150"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      id="xdx2ixbrl2154"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      id="xdx2ixbrl2206"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:ForeignProductSales
      contextRef="From2024-07-012025-06-30_country_CA"
      id="xdx2ixbrl2238"
      unitRef="Ratio"
      xsi:nil="true"/>
    <FONR:ForeignProductSales
      contextRef="From2023-07-012024-06-30_custom_TwoMember"
      id="xdx2ixbrl2244"
      unitRef="Ratio"
      xsi:nil="true"/>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_CA"
      id="xdx2ixbrl2282"
      unitRef="Ratio"
      xsi:nil="true"/>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-012025-06-30_country_AU"
      id="xdx2ixbrl2288"
      unitRef="Ratio"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-07-01to2025-06-30" id="Fact000013">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2024-07-01to2025-06-30" id="Fact000014">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-07-01to2025-06-30" id="Fact000015">2025-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-07-01to2025-06-30" id="Fact000016">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="From2024-07-01to2025-06-30" id="Fact000017">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-07-01to2025-06-30" id="Fact000018">0-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-07-01to2025-06-30" id="Fact000019">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-07-01to2025-06-30" id="Fact000020">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-07-01to2025-06-30" id="Fact000021">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-07-01to2025-06-30" id="Fact000022">110 Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2024-07-01to2025-06-30" id="Fact000023">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-07-01to2025-06-30" id="Fact000024">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-07-01to2025-06-30" id="Fact000025">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-07-01to2025-06-30" id="Fact000027">631</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-07-01to2025-06-30" id="Fact000028">694-2929</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2024-07-01to2025-06-30" id="Fact000029">Common     Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-07-01to2025-06-30" id="Fact000030">FONR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-07-01to2025-06-30" id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2024-07-01to2025-06-30" id="Fact000033">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2024-07-01to2025-06-30" id="Fact000035">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2024-07-01to2025-06-30" id="Fact000036">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-07-01to2025-06-30" id="Fact000037">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-07-01to2025-06-30" id="Fact000038">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-07-01to2025-06-30" id="Fact000039">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-07-01to2025-06-30" id="Fact000040">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2024-07-01to2025-06-30" id="Fact000041">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:IcfrAuditorAttestationFlag contextRef="From2024-07-01to2025-06-30" id="Fact000042">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="From2024-07-01to2025-06-30" id="Fact000043">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2024-12-31"
      decimals="-5"
      id="Fact000045"
      unitRef="USD">91800000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-09-08_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000047"
      unitRef="Shares">6203465</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-09-08_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000049"
      unitRef="Shares">146</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-09-08_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000051"
      unitRef="Shares">382513</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-09-08_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000053"
      unitRef="Shares">313438</dei:EntityCommonStockSharesOutstanding>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000054">

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Risk Management and Strategy&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our Cybersecurity Risk Management Strategy includes
a myriad of tools and resources that are designed to ensure the integrity of our information systems. We place particular emphasis on
protecting the privacy of our patient data pursuant to the HIPAA Security Rule. Our cybersecurity risk management process is integrated
with our larger risk &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90C_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20240701__20250630_zQUvRfWfjMji"&gt;management&lt;/span&gt; system and is considered a core function of our overall risk management strategy.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our strategy is based around identification,
mitigation, avoidance and response to material cybersecurity risks. We employ physical and electronic safeguards to control access
to our systems. We employ additional electronic safeguards to control/limit access to the data contained in those systems. We review
and re-assess these processes on a rolling basis with the assistance of both internal staff and outside vendors, including
assessors, consultants, auditors, and other third parties. Some steps we take include the use of standard security protocols such as
password maintenance, multi-factor identification, and penetration testing. We take other steps as may be situationally appropriate
for the specific risk presented.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the fiscal year ended June 30, 2025, management has identified
a material weakness in our internal controls over our information technology systems, as described in greater detail in Item 9A. In response,
we have taken several steps to enhance our cybersecurity efforts. Those steps include increasing the scope of our Multi-Factor Authentication
requirement to include additional tertiary information systems, improving password security, upgrading our anti-virus software, upgrading
our threat detection tools, implementing additional threat detection tools, and replacing and/or decommissioning hardware that has known
vulnerabilities.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We require all of our employees to receive cybersecurity
training as part of their initial onboarding process, and employees are required to complete additional training throughout the year.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We evaluate all of our vendors and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240701__20250630_z7T4jZ4Td6Yh"&gt;third-party &lt;/span&gt;partners
for material cybersecurity risks and take steps to mitigate risk through insurance and contractual risk transfer provisions when appropriate.
Our Information Technology department works collaboratively with our third-party vendors to coordinate a mutually beneficial approach
to cybersecurity in the specific context in which risk is presented. These collaborations sometimes take place on a rolling basis, and
sometimes take place on a semi-annual or annual basis.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240701__20250630_zhCcuDSrPii7"&gt;Cybersecurity threats, including previous cybersecurity incidents, have
not materially affected our results of operations or financial condition. However, cybersecurity threats have the potential to significantly
impair our operations and the operations of the various third parties upon whom we rely.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;div class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_98B_ecyd--CybersecurityRiskBoardOfDirectorsOversightTextBlock_c20240701__20250630_zMgqBzIaTeUj"&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Governance&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240701__20250630_zcKQXoyHGSSl"&gt;The audit committee of our Board of Directors provides
oversight of cybersecurity risks.&lt;/span&gt; It receives regular reports from management, including our General Counsel, on various cybersecurity
matters during each board meeting. Such reports include information on current cybersecurity risks facing the organization, cybersecurity
incidents involving our partners and/or other participants in our industry, and routine updates on the status of our internal cybersecurity
risk management plan.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our General Counsel oversees and manages our cybersecurity
program. Our General Counsel acts as the coordinator of our cybersecurity team, which includes representatives from our Information Technology
department and Compliance department. In addition, he regularly interacts with various department heads from both our New York and Florida
regions regarding the prevention, detection, mitigation and remediation of cybersecurity risks. Our General Counsel has an educational
background in computer science and has relevant work experience in cybersecurity insurance and risk management.&lt;/p&gt;

&lt;/div&gt;

</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="From2024-07-01to2025-06-30" id="Fact000055">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="From2024-07-01to2025-06-30" id="Fact000056">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000057">Cybersecurity threats, including previous cybersecurity incidents, have
not materially affected our results of operations or financial condition. However, cybersecurity threats have the potential to significantly
impair our operations and the operations of the various third parties upon whom we rely.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000058">

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Governance&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240701__20250630_zcKQXoyHGSSl"&gt;The audit committee of our Board of Directors provides
oversight of cybersecurity risks.&lt;/span&gt; It receives regular reports from management, including our General Counsel, on various cybersecurity
matters during each board meeting. Such reports include information on current cybersecurity risks facing the organization, cybersecurity
incidents involving our partners and/or other participants in our industry, and routine updates on the status of our internal cybersecurity
risk management plan.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our General Counsel oversees and manages our cybersecurity
program. Our General Counsel acts as the coordinator of our cybersecurity team, which includes representatives from our Information Technology
department and Compliance department. In addition, he regularly interacts with various department heads from both our New York and Florida
regions regarding the prevention, detection, mitigation and remediation of cybersecurity risks. Our General Counsel has an educational
background in computer science and has relevant work experience in cybersecurity insurance and risk management.&lt;/p&gt;

</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000059">The audit committee of our Board of Directors provides
oversight of cybersecurity risks.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <dei:AuditorName contextRef="From2024-07-01to2025-06-30" id="Fact000060">CohnReznick LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2024-07-01to2025-06-30" id="Fact000061">Melville, NY</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2024-07-01to2025-06-30" id="Fact000062">596</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2023-07-012024-06-30" id="Fact000063">Marcum LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2023-07-012024-06-30" id="Fact000064">New York, NY</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2023-07-012024-06-30" id="Fact000065">688</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000070"
      unitRef="USD">56333636</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000071"
      unitRef="USD">56341193</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000073"
      unitRef="USD">120494</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000074"
      unitRef="USD">136102</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000079"
      unitRef="USD">264212</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000081"
      unitRef="USD">166049</us-gaap:AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000076"
      unitRef="USD">5304698</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000077"
      unitRef="USD">4035336</us-gaap:AccountsReceivableNetCurrent>
    <FONR:MedicalReceivable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000083"
      unitRef="USD">24489808</FONR:MedicalReceivable>
    <FONR:MedicalReceivable
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000084"
      unitRef="USD">23991533</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000089"
      unitRef="USD">14295988</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000091"
      unitRef="USD">12369921</FONR:ManagementAndOtherReceivableAllowancesForDoubtfulAccounts>
    <us-gaap:AccruedFeesAndOtherRevenueReceivable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000086"
      unitRef="USD">43401252</us-gaap:AccruedFeesAndOtherRevenueReceivable>
    <us-gaap:AccruedFeesAndOtherRevenueReceivable
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000087"
      unitRef="USD">41953657</us-gaap:AccruedFeesAndOtherRevenueReceivable>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000096"
      unitRef="USD">7136836</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000098"
      unitRef="USD">6110399</FONR:RelatedPartyReceivableAllowancesForDoubtfulAccounts>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000093"
      unitRef="USD">9748521</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000094"
      unitRef="USD">9865061</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:InventoryNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000100"
      unitRef="USD">2812682</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000101"
      unitRef="USD">2715441</us-gaap:InventoryNet>
    <FONR:PrepaidExpensesAndOtherCurrentAssetsRelatedParty
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000103"
      unitRef="USD">410659</FONR:PrepaidExpensesAndOtherCurrentAssetsRelatedParty>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000106"
      unitRef="USD">2050060</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000107"
      unitRef="USD">1285962</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000109"
      unitRef="USD">144671810</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000110"
      unitRef="USD">140324285</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000112"
      unitRef="USD">3549956</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000113"
      unitRef="USD">829473</FONR:AccountsReceivableNetLongTerm>
    <FONR:NoteReceivableRelatedParty
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000115"
      unitRef="USD">554857</FONR:NoteReceivableRelatedParty>
    <FONR:NoteReceivableRelatedParty
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000116"
      unitRef="USD">581183</FONR:NoteReceivableRelatedParty>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000118"
      unitRef="USD">6349194</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000119"
      unitRef="USD">7223255</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000121"
      unitRef="USD">18531919</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000122"
      unitRef="USD">18708920</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000124"
      unitRef="USD">35136412</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000125"
      unitRef="USD">38427757</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000127"
      unitRef="USD">376569</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000128"
      unitRef="USD">530348</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000130"
      unitRef="USD">4269277</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000131"
      unitRef="USD">4269277</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000133"
      unitRef="USD">2992203</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000134"
      unitRef="USD">2870324</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000136"
      unitRef="USD">475680</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000137"
      unitRef="USD">481147</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000139"
      unitRef="USD">216907877</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000140"
      unitRef="USD">214245969</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000146"
      unitRef="USD">47002</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000148"
      unitRef="USD">1302317</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000149"
      unitRef="USD">1855879</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000151"
      unitRef="USD">6974997</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000152"
      unitRef="USD">7941039</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000154"
      unitRef="USD">3382675</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000155"
      unitRef="USD">3473674</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000157"
      unitRef="USD">244237</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000158"
      unitRef="USD">225786</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000160"
      unitRef="USD">4865936</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000161"
      unitRef="USD">3870229</us-gaap:DeferredRevenueCurrent>
    <FONR:CustomerDeposits
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000163"
      unitRef="USD">354244</FONR:CustomerDeposits>
    <FONR:CustomerDeposits
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000164"
      unitRef="USD">443471</FONR:CustomerDeposits>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000166"
      unitRef="USD">17124406</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000167"
      unitRef="USD">17857080</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000172"
      unitRef="USD">3800746</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000173"
      unitRef="USD">1174844</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000175"
      unitRef="USD">321159</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000176"
      unitRef="USD">371560</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000178"
      unitRef="USD">92663</FONR:AccountsPayableRelatedPartyNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000179"
      unitRef="USD">92663</FONR:AccountsPayableRelatedPartyNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000181"
      unitRef="USD">35148907</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000182"
      unitRef="USD">37467746</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000184"
      unitRef="USD">142523</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000185"
      unitRef="USD">394723</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000188"
      unitRef="USD">66938</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000190"
      unitRef="USD">172853</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000191"
      unitRef="USD">32026</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000193"
      unitRef="USD">39678851</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000194"
      unitRef="USD">39600500</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000196"
      unitRef="USD">56803257</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000197"
      unitRef="USD">57457580</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000202"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000204"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000206"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000208"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000210"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000212"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000214"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      id="Fact000216"
      unitRef="Shares">313438</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      id="Fact000218"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="0"
      id="Fact000220"
      unitRef="USD">31</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000222"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000224"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000226"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000228"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000230"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000232"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000234"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000236"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000238"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000240"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000242"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000244"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000246"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000248"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000250"
      unitRef="Shares">6203465</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000252"
      unitRef="Shares">6328494</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000254"
      unitRef="Shares">6168625</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000256"
      unitRef="Shares">6283213</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000258"
      unitRef="USD">622</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000260"
      unitRef="USD">635</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000262"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000264"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000266"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000268"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000270"
      unitRef="Shares">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000272"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000274"
      unitRef="Shares">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000276"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember"
      decimals="0"
      id="Fact000278"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="0"
      id="Fact000280"
      unitRef="USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000282"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000284"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000286"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000288"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000290"
      unitRef="Shares">382513</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000292"
      unitRef="Shares">382513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000294"
      unitRef="Shares">382513</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000296"
      unitRef="Shares">382513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000298"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000300"
      unitRef="USD">38</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000302"
      unitRef="USD">178756712</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000303"
      unitRef="USD">180607510</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000305"
      unitRef="USD">-5289324</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000306"
      unitRef="USD">-13623585</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000311"
      unitRef="Shares">34840</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000313"
      unitRef="Shares">45081</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000308"
      unitRef="USD">859893</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000309"
      unitRef="USD">1016632</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000315"
      unitRef="USD">172608186</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000316"
      unitRef="USD">165967997</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000318"
      unitRef="USD">-12503566</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000319"
      unitRef="USD">-9179608</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000321"
      unitRef="USD">160104620</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000322"
      unitRef="USD">156788389</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000324"
      unitRef="USD">216907877</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000325"
      unitRef="USD">214245969</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000330"
      unitRef="USD">33179446</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000331"
      unitRef="USD">33815796</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000333"
      unitRef="USD">563296</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000334"
      unitRef="USD">737727</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000336"
      unitRef="USD">8234053</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000337"
      unitRef="USD">7452212</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000339"
      unitRef="USD">180000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000340"
      unitRef="USD">139167</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000342"
      unitRef="USD">49900555</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000343"
      unitRef="USD">48789287</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000345"
      unitRef="USD">12293968</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000346"
      unitRef="USD">11949900</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000348"
      unitRef="USD">104351318</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000349"
      unitRef="USD">102884089</us-gaap:Revenues>
    <FONR:CostsRelatedToProductSales
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000354"
      unitRef="USD">1018029</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000355"
      unitRef="USD">1052159</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000357"
      unitRef="USD">4508518</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000358"
      unitRef="USD">3577570</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000360"
      unitRef="USD">323504</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000361"
      unitRef="USD">144413</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000363"
      unitRef="USD">19130935</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000364"
      unitRef="USD">18199579</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000366"
      unitRef="USD">30073045</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000367"
      unitRef="USD">28626595</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000369"
      unitRef="USD">6388281</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000370"
      unitRef="USD">6143728</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000372"
      unitRef="USD">1576086</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000373"
      unitRef="USD">1735949</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000375"
      unitRef="USD">29734163</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000376"
      unitRef="USD">26868732</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000378"
      unitRef="USD">92752561</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000379"
      unitRef="USD">86348725</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000381"
      unitRef="USD">11598757</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000382"
      unitRef="USD">16535364</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000387"
      unitRef="USD">25611</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000388"
      unitRef="USD">76997</us-gaap:InterestExpenseNonoperating>
    <FONR:InvestmentIncomeRelatedParty
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000390"
      unitRef="USD">51917</FONR:InvestmentIncomeRelatedParty>
    <FONR:InvestmentIncomeRelatedParty
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000391"
      unitRef="USD">25959</FONR:InvestmentIncomeRelatedParty>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000393"
      unitRef="USD">2118980</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000394"
      unitRef="USD">2126439</us-gaap:InvestmentIncomeNet>
    <FONR:OtherIncomeRelatedParty
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000396"
      unitRef="USD">0</FONR:OtherIncomeRelatedParty>
    <FONR:OtherIncomeRelatedParty
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000397"
      unitRef="USD">576857</FONR:OtherIncomeRelatedParty>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000399"
      unitRef="USD">36195</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000400"
      unitRef="USD">78763</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000402"
      unitRef="USD">13780238</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000403"
      unitRef="USD">19266385</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000405"
      unitRef="USD">3106805</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000406"
      unitRef="USD">5168968</us-gaap:IncomeTaxExpenseBenefit>
    <FONR:ConsolidatedNetIncome
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000408"
      unitRef="USD">10673433</FONR:ConsolidatedNetIncome>
    <FONR:ConsolidatedNetIncome
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000409"
      unitRef="USD">14097417</FONR:ConsolidatedNetIncome>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000411"
      unitRef="USD">2339172</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000412"
      unitRef="USD">3530021</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000414"
      unitRef="USD">8334261</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000415"
      unitRef="USD">10567396</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember"
      decimals="0"
      id="Fact000417"
      unitRef="USD">7802351</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="0"
      id="Fact000419"
      unitRef="USD">9908920</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012025-06-30_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="0"
      id="Fact000421"
      unitRef="USD">396443</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30_custom_ClassANonVotingPreferredStockholdersMember"
      decimals="0"
      id="Fact000423"
      unitRef="USD">490776</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000425"
      unitRef="USD">135467</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="0"
      id="Fact000427"
      unitRef="USD">167700</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000429"
      unitRef="USDPShares">1.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000431"
      unitRef="USDPShares">1.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000433"
      unitRef="USDPShares">1.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000435"
      unitRef="USDPShares">1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000437"
      unitRef="USDPShares">0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000439"
      unitRef="USDPShares">0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000441"
      unitRef="USDPShares">0.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000443"
      unitRef="USDPShares">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000445"
      unitRef="Shares">6210852</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000447"
      unitRef="Shares">6351008</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012025-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000449"
      unitRef="Shares">6338356</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012024-06-30_custom_CommonStockholdersMember"
      decimals="INF"
      id="Fact000451"
      unitRef="Shares">6478512</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000453"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000455"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000457"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012024-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      id="Fact000459"
      unitRef="Shares">382513</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000461"
      unitRef="USD">647</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000464"
      unitRef="Shares">6450882</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_ClassAPreferredStockMember"
      decimals="INF"
      id="Fact000466"
      unitRef="Shares">313438</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_ClassAPreferredStockMember"
      decimals="0"
      id="Fact000462"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_ClassCCommonStockMember"
      decimals="INF"
      id="Fact000468"
      unitRef="Shares">382513</us-gaap:SharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000476"
      unitRef="USD">12</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000479"
      unitRef="Shares">-122588</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember516945625"
      decimals="0"
      id="Fact000487"
      unitRef="USD">635</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember516945625"
      decimals="INF"
      id="Fact000490"
      unitRef="Shares">6328294</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_custom_ClassAPreferredStockMember"
      decimals="INF"
      id="Fact000492"
      unitRef="Shares">313438</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_custom_ClassAPreferredStockMember"
      decimals="0"
      id="Fact000488"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_custom_ClassCCommonStockMember"
      decimals="INF"
      id="Fact000494"
      unitRef="Shares">382513</us-gaap:SharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000502"
      unitRef="USD">13</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000505"
      unitRef="Shares">-124829</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember516945765"
      decimals="0"
      id="Fact000516"
      unitRef="USD">622</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember516945765"
      decimals="INF"
      id="Fact000519"
      unitRef="Shares">6203465</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-06-30_custom_ClassAPreferredStockMember"
      decimals="INF"
      id="Fact000521"
      unitRef="Shares">313438</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_custom_ClassAPreferredStockMember"
      decimals="0"
      id="Fact000517"
      unitRef="USD">31</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-06-30_custom_ClassCCommonStockMember"
      decimals="INF"
      id="Fact000523"
      unitRef="Shares">382513</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      id="Fact000525"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000526"
      unitRef="USD">182612518</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000529"
      unitRef="Shares">11463</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000527"
      unitRef="USD">-515820</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000539"
      unitRef="Shares">156206</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000537"
      unitRef="USD">2505832</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000542"
      unitRef="USD">2005008</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000545"
      unitRef="Shares">-122588</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2023-07-012024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000543"
      unitRef="USD">-2005020</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      id="Fact000555"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000556"
      unitRef="USD">180607510</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000559"
      unitRef="Shares">45081</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000557"
      unitRef="USD">-1016632</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000569"
      unitRef="Shares">114588</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000567"
      unitRef="USD">1806646</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000572"
      unitRef="USD">1963373</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000575"
      unitRef="Shares">-124829</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-07-012025-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000573"
      unitRef="USD">-1963385</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <FONR:SaleNonControllingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000578"
      unitRef="USD">112575</FONR:SaleNonControllingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_custom_ClassCCommonStockMember"
      decimals="0"
      id="Fact000589"
      unitRef="USD">38</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000590"
      unitRef="USD">178756712</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000593"
      unitRef="Shares">34840</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="0"
      id="Fact000591"
      unitRef="USD">-859893</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000595"
      unitRef="USD">-24190981</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000596"
      unitRef="USD">-7079293</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000597"
      unitRef="USD">150827140</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000599"
      unitRef="USD">10567396</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000601"
      unitRef="USD">10567396</us-gaap:ProfitLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000605"
      unitRef="USD">2505832</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000612"
      unitRef="USD">5630336</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000613"
      unitRef="USD">5630336</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000616"
      unitRef="USD">3530021</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000617"
      unitRef="USD">3530021</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000619"
      unitRef="USD">-13623585</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000620"
      unitRef="USD">-9179608</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000621"
      unitRef="USD">156788389</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000623"
      unitRef="USD">8334261</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000625"
      unitRef="USD">8334261</us-gaap:ProfitLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000629"
      unitRef="USD">1806646</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000633"
      unitRef="USD">1</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <FONR:SaleNonControllingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000636"
      unitRef="USD">19425</FONR:SaleNonControllingInterest>
    <FONR:SaleNonControllingInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000637"
      unitRef="USD">132000</FONR:SaleNonControllingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000640"
      unitRef="USD">5682555</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000641"
      unitRef="USD">5682555</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000644"
      unitRef="USD">2339172</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000645"
      unitRef="USD">2339172</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000647"
      unitRef="USD">-5289324</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="0"
      id="Fact000648"
      unitRef="USD">-12503566</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000649"
      unitRef="USD">160104620</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <FONR:ConsolidatedNetIncomeLoss
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000654"
      unitRef="USD">10673433</FONR:ConsolidatedNetIncomeLoss>
    <FONR:ConsolidatedNetIncomeLoss
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000655"
      unitRef="USD">14097417</FONR:ConsolidatedNetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000660"
      unitRef="USD">4698321</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000661"
      unitRef="USD">4596421</us-gaap:DepreciationAndAmortization>
    <FONR:ProvisionForBadDebts
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000663"
      unitRef="USD">3206756</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000664"
      unitRef="USD">1882061</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000666"
      unitRef="USD">823660</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000667"
      unitRef="USD">2795507</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <FONR:NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000669"
      unitRef="USD">493</FONR:NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities>
    <FONR:NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000670"
      unitRef="USD">229590</FONR:NetChangeInOperatingRightofuseAssetsAndLeaseLiabilities>
    <FONR:GainOnSaleOfEquipmentRelatedParty
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000673"
      unitRef="USD">581183</FONR:GainOnSaleOfEquipmentRelatedParty>
    <FONR:GainlossOnDispositionOfFixedAssets
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000676"
      unitRef="USD">75411</FONR:GainlossOnDispositionOfFixedAssets>
    <FONR:AbandonedPatents
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000678"
      unitRef="USD">55707</FONR:AbandonedPatents>
    <FONR:AbandonedPatents
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000679"
      unitRef="USD">225419</FONR:AbandonedPatents>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000684"
      unitRef="USD">9005766</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000685"
      unitRef="USD">11676139</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <FONR:IncreaseDecreaseInNotesReceivable
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000688"
      unitRef="USD">55200</FONR:IncreaseDecreaseInNotesReceivable>
    <us-gaap:IncreaseDecreaseInNotesReceivableRelatedParties
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000690"
      unitRef="USD">-26326</us-gaap:IncreaseDecreaseInNotesReceivableRelatedParties>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000693"
      unitRef="USD">97241</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000694"
      unitRef="USD">145775</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000696"
      unitRef="USD">1194922</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000697"
      unitRef="USD">-266606</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000699"
      unitRef="USD">-5467</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000700"
      unitRef="USD">-42359</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000702"
      unitRef="USD">-553562</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000703"
      unitRef="USD">276669</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000705"
      unitRef="USD">2655567</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000706"
      unitRef="USD">2949962</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000708"
      unitRef="USD">-89227</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000709"
      unitRef="USD">-158906</FONR:IncreaseDecreaseInCustomerAdvance>
    <us-gaap:IncreaseDecreaseInTradingLiabilities
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000711"
      unitRef="USD">-79970</us-gaap:IncreaseDecreaseInTradingLiabilities>
    <us-gaap:IncreaseDecreaseInTradingLiabilities
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000712"
      unitRef="USD">-217569</us-gaap:IncreaseDecreaseInTradingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000714"
      unitRef="USD">140826</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000715"
      unitRef="USD">-9724</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000717"
      unitRef="USD">11264882</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000718"
      unitRef="USD">14093294</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000723"
      unitRef="USD">3791581</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000724"
      unitRef="USD">789961</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000726"
      unitRef="USD">-15608</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:PaymentsForProceedsFromShortTermInvestments
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000727"
      unitRef="USD">103303</us-gaap:PaymentsForProceedsFromShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000729"
      unitRef="USD">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000730"
      unitRef="USD">75411</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000732"
      unitRef="USD">25325</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000733"
      unitRef="USD">32885</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000735"
      unitRef="USD">-3801298</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000736"
      unitRef="USD">-850738</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000741"
      unitRef="USD">113940</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000742"
      unitRef="USD">44902</us-gaap:RepaymentsOfNotesPayable>
    <FONR:SaleOfNoncontrollingInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000744"
      unitRef="USD">132000</FONR:SaleOfNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000747"
      unitRef="USD">1806646</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000748"
      unitRef="USD">2505832</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000750"
      unitRef="USD">5682555</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000751"
      unitRef="USD">5630336</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000753"
      unitRef="USD">-7471141</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000754"
      unitRef="USD">-8181070</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000756"
      unitRef="USD">-7557</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000757"
      unitRef="USD">5061486</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000759"
      unitRef="USD">56341193</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000760"
      unitRef="USD">51279707</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000762"
      unitRef="USD">56333636</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000763"
      unitRef="USD">56341193</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000765">&lt;p id="xdx_806_eus-gaap--BusinessDescriptionAndAccountingPoliciesTextBlock_zm6bDqPEpSSl" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;NOTE 1 - &lt;span id="xdx_82F_zAAccN59coej"&gt;DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Description of Business&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;FONAR is a Delaware corporation, which was incorporated
on July 17, 1978. FONAR is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles
of MRI for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue
is also generated from our installed-base of customers through our service and upgrade programs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;FONAR, through its wholly-owned subsidiary Health
Management Company of America (&#x201c;HMCA&#x201d;) provides comprehensive management services to diagnostic imaging facilities. The services
provided by the Company include development, administration, leasing of office space, facilities and medical equipment, provision of supplies,
staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and the development and implementation
of practice growth and marketing strategies.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 1, 2015, the Company restructured the corporate
organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely
integrate the operations of Health Management Corporation of America and Health Diagnostics Management (&#x201c;HDM&#x201d;). Imperial contributed
all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a &lt;span id="xdx_900_eus-gaap--InvestmentOwnedPercentOfNetAssets_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zf3RUtwHRPbg"&gt;24.2&lt;/span&gt;% interest
in HDM. Health Management Corporation of America retained a direct ownership interest of &lt;span id="xdx_903_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zpWk0QeY0j8c"&gt;45.8&lt;/span&gt;% in HDM, and the original investors in HDM
retained a &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zV44CmBINwsg"&gt;30.0&lt;/span&gt;% ownership interest in the newly expanded HDM. As of June 30, 2024 the Company had direct ownership interest of &lt;span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zDxMTYcBgfW7"&gt;70.8&lt;/span&gt;%
and the investors&#x2019; a &lt;span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zSeUsG2lI1e2"&gt;29.2&lt;/span&gt;% ownership interest. During the year ended June 30, 2025, the Company sold non-controlling interests to
a minority shareholder for $&lt;span id="xdx_902_eus-gaap--ProceedsFromPaymentsToMinorityShareholders_c20240701__20250630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zxD6sSrLwat"&gt;132,000&lt;/span&gt;. Currently, the Company has a direct ownership interest of &lt;span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20250630__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zzboe7iRzJn7"&gt;70.63&lt;/span&gt;% and the investors have a &lt;span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__us-gaap--OtherInvesteesMember_zRwGl26FSXrd"&gt;29.37&lt;/span&gt;%
ownership interest. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under
the name &#x201c;Health Management Company of America&#x201d;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000766"
      unitRef="Ratio">0.242</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2015-07-01_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000767"
      unitRef="Ratio">0.458</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000768"
      unitRef="Ratio">0.300</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-06-30_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000769"
      unitRef="Ratio">0.708</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000770"
      unitRef="Ratio">0.292</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="From2024-07-012025-06-30_us-gaap_OtherInvesteesMember"
      decimals="0"
      id="Fact000771"
      unitRef="USD">132000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2025-06-30_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000772"
      unitRef="Ratio">0.7063</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2025-06-30_us-gaap_NoncontrollingInterestMember_us-gaap_OtherInvesteesMember"
      decimals="INF"
      id="Fact000773"
      unitRef="Ratio">0.2937</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000775">&lt;p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zyqDtpRlFKlk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;NOTE 2 - &lt;span id="xdx_829_zR0YgLo1capg"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_z5xPkgHj8hYa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zx6kXp4uZd52"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





















&lt;p id="xdx_84F_eus-gaap--UseOfEstimates_zYc49DEOlEDc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zYgLacFU6f57"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, and revenue recognition. In addition,
healthcare industry reforms and reimbursement practices will continue to impact the Company&#x2019;s operations and the determination of
contractual and other allowance estimates. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--InventoryWorkInProcessPolicy_zOx1Y181YsB9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zFZ9ThetLNwd"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zFYfUM6zwBbf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zRC1ApUdAOxc"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment is stated at cost less accumulated
depreciation. Property and equipment purchased in connection with an acquisition is stated at its estimated fair value, generally based
on an appraisal. Property and equipment is being depreciated for financial accounting purposes using the straight-line method over their
estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon
retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts
and the resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to operations.
Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $&lt;span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20240701__20250630_zPvUEDSVTEd3" title="Maintenance and repair expenses"&gt;2,751,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zSW98m5gQHsi" title="Maintenance and repair expenses"&gt;2,948,000&lt;/span&gt; for the years
ended June 30, 2025 and 2024 respectively. The estimated useful lives in years are generally as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zzRfNYFNcoyh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B4_z6ny7nwymeeb" style="display: none"&gt;Schedule of Estimated Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"&gt;Estimated Useful Life in Years for Property and Equipment&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLUOWqTLUb0a"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z25tJH8zhlvh"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6nTPQReSsH2"&gt;3&lt;/span&gt;-&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zNHPd6S4KXHa"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Machinery and equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zXdHeCgwiGP9"&gt;2&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z6qnagveRi84"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zksgPFS2gqC"&gt;3&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zCr1cYtEgT25"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Leasehold improvements&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgT9VqsgYLc4"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaYdZEw4QjCi"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt"&gt;Building&lt;/td&gt;
&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zD9A92kl2CT6"&gt;28&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A6_zUTC8Bz6IHGl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;























&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z9eSjjxYZdtf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zxgC1avudAai"&gt;Other Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;1) Patents and Copyrights&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Patent and copyrights are professional costs
incurred to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over &lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zJmhvKVVPtM" title="Finite-lived intangible asset, useful life"&gt;15 &lt;/span&gt;years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;2) Non-Competition Agreements&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPBsjlpky802" title="Finite-lived intangible asset, useful life"&gt;7&lt;/span&gt; years).&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;3) Customer Relationships&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over &lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zcjurrsJnO4" title="Finite-lived intangible asset, useful life"&gt;20&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;4) Software License&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Software license represents a license to improve the
image quality and efficiency of the MRI scanners. Amortization is calculated on the straight-line basis over 3 years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_z0gpOauwkL85" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zbHeehKjQ3k9"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.&lt;br/&gt;&lt;/p&gt;



























&lt;p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zw2Kb9FZsoO2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_863_zxgdpit5utq1"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue on sales contracts for scanners, included
in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type
and Production-Type Contracts&#x201d;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2024, the Company had unearned revenue
on service contracts of $3,870,229 of which all was recognized as revenue in the fiscal year ending June 30, 2025.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue from product sales (upgrades and supplies)
is recognized upon shipment.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue under management contracts is recognized based
upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various
medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2025, the Company has &lt;span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20250630_ztnifEM7T7Y8" title="Management agreements with company total medical practices"&gt;22&lt;/span&gt; management agreements of which &lt;span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20250630_z0JA4I1I8wD2" title="Scanners with management agreements with company owned by related party"&gt;3&lt;/span&gt; were with PC&#x2019;s
owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned by Raymond V. Damadian,
M.D., Chairman of the Board of FONAR until his unexpected death in August 2022) (&#x201c;the Related medical practices&#x201d;) and &lt;span id="xdx_907_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20250630_zzPqbePjCJfh" title="Scanners with management with company located in new york state"&gt;19&lt;/span&gt; are
with PC&#x2019;s, which are all located in the state of New York (&#x201c;the New York PC&#x2019;s&#x201d;), owned by four unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$&lt;span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMinimum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zFaBwBpE3p8g" title="Contractual fees for services rendered minimum"&gt;70,000&lt;/span&gt; to $&lt;span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zOAiTymX0tk2" title="Contractual fees for services rendered Maximum"&gt;460,000&lt;/span&gt;. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit
loss expense for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the FASB and codified in the ASC 606. The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#x2019;s revenue recognition policies and significant judgments employed in the determination of revenue.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2025 and 2024 are summarized in the following table.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zapBwZWhb56k" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B4_zmol8u26VQ13" style="display: none"&gt;Schedule of patient fee
    revenue - net&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Patient Fee Revenue - Net&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zZud5cYCZia5" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,957,159&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z6IYnDScgTRf" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,952,712&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Medicare/Medicaid&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_z30m7YEAmVl1" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,160,839&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zszHemWRubW7" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,138,176&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Workers&#x2019; Compensation/Personal Injury&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zcAZ74TLZso3" style="text-align: right" title="Net Patient Fee Revenue"&gt;19,876,923&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zSnjmVbFtc7" style="text-align: right" title="Net Patient Fee Revenue"&gt;20,673,483&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Other&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zUbUYJK57Pkk" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;7,184,525&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVrbYwT44pae" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;7,051,425&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Net Patient Fee Revenue&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630_zNAPiF0XqZ47" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;33,179,446&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zjGCwrRjABoc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;33,815,796&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8AE_z5b9wb4amYcc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--MedicalReceivablePolicyTextBlock_zPIMLd4tJ5lb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zazxmUxsiWZ2"&gt;Medical Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Medical receivables are due under fee-for-service
contracts from third-party payors, such as hospitals, government sponsored healthcare programs, patient&#x2019;s legal counsel and directly
from patients. Substantially all the revenue relates to patients residing in Florida. Medical receivables are recorded at net realizable
value based on the estimated amounts the Company expects to receive from patients and third-party payers. The medical receivable is reduced
by an allowance for contractual adjustments based on the historical experience with each payor class at each location. The medical fee
receivable as of July 1, 2023 was $&lt;span id="xdx_908_ecustom--MedicalFeeReceivable_iI_c20230702_zaZAh3y9yVR8" title="Medical fee receivable"&gt;21,259,262&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For LLCs owned by the Company, approximately &lt;span id="xdx_90D_ecustom--RevenuePercentage_iI_dp_c20250630_zh33LI9cxjEf" title="revenue percentage"&gt;57&lt;/span&gt;%
and &lt;span id="xdx_90F_ecustom--RevenuePercentage_iI_dp_c20240630_z4l7dDmxJqp" title="revenue percentage"&gt;67%&lt;/span&gt; of net revenues were derived from no-fault and personal injury protection for the years end June 30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;





















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management and Other Fees Receivable&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#x201c;CECL&#x201d;) reserve to address the risk that a portion of the contractually obligated management fees receivable from the
PCs may not be collectible. The PC&#x2019;s may be limited in their ability to pay the full management fee receivable if they do not collect
sufficient expected fees from third-party payors and patients. The Company&#x2019;s management fees are collateralized, individually and
collectively, by the assets of the PCs. The CECL reserve is determined based on the difference between the management fee receivable and
the current amount of outstanding fees estimated to be collected by the PCs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s considerations into the estimate
of the PC&#x2019;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#x2019;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. Specifically, insurance carriers covering automobile
no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other disallowed
claims.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The Company combines an objective
and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves objectively
using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and then subjectively
adjusting for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The provision for credit losses for the year ended June 30, 2025 was
$3,079,261. The provision for credit losses is attributable to scan volume at all the PC&#x2019;s and the nature of the payor classes,
where there can be longer expected payment terms. Also, during the year ended June 30, 2025, the Company recorded an additional reserve
of approximately $2,300,000 for a specific receivable that is attributable to a American Transit Insurance Company (ATIC). This reserve
for credit losses relates specifically to ATIC, which owes no-fault insurance claims by the PCs to the PCs, which are collateral for the
Company&#x2019;s management and other fees receivable. ATIC is a New York based motor vehicle insurer primarily focused on for-hire automobile
insurance. During Fiscal 2025, ATIC posted over $750 million in net losses and has indicated that they are approaching insolvency. ATIC
continues to operate and is working with the New York Department of Financial Services (DFS) to resolve its issues. We continue to monitor
the situation for new developments. However, at the time of this filing, DFS has not publicly announced approval of any plans for ATIC
to resolve its financial situation. In addition, Uber has filed a lawsuit against ATIC alleging they are not properly paying claims. Additional
legislation in New York City to reduce coverage minimums and increase premiums may help to resolve the crisis, but there is no certainty
these efforts will be successful. If ATIC enters receivership or suffers additional adverse consequences, we may need to take additional
reserves in the future. The management fee receivable
for unrelated and related parties as of July 1, 2023 was $&lt;span id="xdx_908_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20230702_z3epp298HNv7" title="Management fee receivable for unrelated parties"&gt;35,888,253&lt;/span&gt; and $&lt;span id="xdx_902_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20230702_zcVLCbWvau8k" title="Management Fee Receivable For Related Parties"&gt;9,161,870&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





















&lt;p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_z2dAUxER9VI6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_864_z9QMwu03zeo5"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Credit risk with respect to the Company&#x2019;s accounts
receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the commencement
of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed on a monthly
or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The Company controls
credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process, credit limits, monitoring
procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before a product sales contract is
entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service contracts as of July 1,
2023 was $&lt;span id="xdx_90B_ecustom--AccountsReceivableServiceContractsNet_iI_c20230702_zP1nChfqcFzc" title="Account receivable"&gt;4,571,597&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zHtlUHAE0r19" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_z41yjjbXl4fj"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--AdvertisingCostsPolicyTextBlock_zx0hhJU3GzG5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86E_z8yGLCjM6W79"&gt;Advertising Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Advertising costs are expensed as incurred. Advertising
expense approximated $ &lt;span id="xdx_900_eus-gaap--AdvertisingExpense_c20240701__20250630_zy07m58XFKWj"&gt;773,000&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--AdvertisingExpense_c20230701__20240630_zm5LK0BUGRx6"&gt;731,000&lt;/span&gt; and for the years ended June 30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zJjWVKExln06" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zOGPd9JGMpb9"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;





























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 740, &#x201c;Accounting for Income Taxes&#x201d;,
prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#x2019;s tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#x201c;Interest expense, net. Penalties
if incurred would be recognized as a component of &#x201c;Selling, general and administrative&#x201d; expenses. Penalties for the years
ended June 30, 2025 and June 30, 2024 were $&lt;span id="xdx_90A_ecustom--Penalties_c20240701__20250630_zz9AvmFTMGk6" title="Penalties"&gt;0&lt;/span&gt; and $&lt;span id="xdx_907_ecustom--Penalties_c20230701__20240630_z7nnh1DiSjA" title="Penalties"&gt;20,444&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--CustomerAdvancesPolicyTextBlock_zt4hi9zatzA2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_z7gmUlKx0OXc"&gt;Customer Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zQGycvRWLJ9e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_znvzMFwkxOI2"&gt;Earnings Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class Method&#x201d;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2025 and 2024, diluted EPS for common shareholders includes &lt;span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20240701__20250630_zjNb4UsWTUV3" title="Conversion of Class C Common Stock"&gt;&lt;span id="xdx_90A_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_z1OhV6G8wArg" title="Conversion of Class C Common Stock"&gt;127,504&lt;/span&gt;&lt;/span&gt; shares upon conversion of
Class C Common.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

























&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXgrVghbjdB7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BF_zrMYGGMVn0hh" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Basic&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Preferred &lt;br/&gt;&#160; &lt;br/&gt;Stock&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="text-decoration: underline"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Net income available to common stockholders&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630_zwXbEOpHQRm" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;8,334,261&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHQ0bwZGoRul" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;7,802,352&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zTbMk0MKQADd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;135,467&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zOWRlysqdos5" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;396,443&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630_z4c3GDKwWT9b" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,906,803&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7R8N2jl43U3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,210,852&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCw1jHBpm25h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zO7lozDT1tS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;313,438&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Basic income per common share&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630_zYJDkImOYcv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.21&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zK59KB7k5em4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.26&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zYUM1NLAtzjh" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.35&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zo7FZ3bjowV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.26&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt"&gt;Diluted&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zI5vTOBCSz0j" style="text-align: right" title="Weighted average shares outstanding"&gt;6,210,852&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zF2JaGEfpWe5" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Class C Common Stock&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcPDQCeFugrf" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_z2aZ6uU4BtZ6" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zj5GfCXGL8Hl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,338,356&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zgEFnhclg7m7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Diluted income per common share&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5Dc9qQOYSRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.23&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zX4OulzKmGXi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.35&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Preferred &lt;br/&gt;&#160; &lt;br/&gt;Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="text-decoration: underline"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630_zxqVKlA1jCY9" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;10,567,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlznrJUeKC27" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;9,908,920&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCg0idGNEmU1" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;167,700&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zxCM8hZqgwFa" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;490,776&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zI0FmbgqMxUg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;7,046,959&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuHuh97pIZ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,351,008&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztvCZaYHkyU8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zjgiMv3bpst2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;313,438&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_z0Bwby6RQfU2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVrQ7Azo2Gs7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztoADeqDrIP4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zCN37m1AK22f" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.57&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zruxKYiA6jC1" style="text-align: right" title="Weighted average shares outstanding"&gt;6,351,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zXVyct5TGptj" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsbWP3Ab8yRg" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zhcHa2K3gRM1" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQsK8CJDkgC7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,478,512&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zK9uAEAPE7O1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYlkrMwYg6H" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zUZzwVpni9qh" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;br/&gt;
&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AF_zWzuXeV2zvI8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;























&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zksvfpjlvW22" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_864_zIURIV2GEw48"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zJBdbK2KByyl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_z3MGEx6a1zh4"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z64eE4JWji8a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zXte6nDBFVG1"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2025, the Company had cash
on deposit of approximately $&lt;span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20250630_zQ3URKgZSaad" title="Cash deposit"&gt;53,676,000&lt;/span&gt; in excess of federally insured limits of $&lt;span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20250630_zzM4L0gibjxe" title="Federally insured limits"&gt;250,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Related Parties: Net revenues from related parties
accounted for approximately &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zb90mruYegCi" title="Concentration risk, percentage"&gt;&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zkRDkTkOHw8" title="Concentration risk, percentage"&gt;12&lt;/span&gt;&lt;/span&gt;% of the consolidated net revenues for the years ended June 30, 2025 and 2024. Net management fee receivables
from the related party medical practices accounted for approximately &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zTYTSQcAQ5" title="Concentration risk, percentage"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zlOJ8OY6S8Le" title="Concentration risk, percentage"&gt;12&lt;/span&gt;&lt;/span&gt;% of the consolidated accounts receivable as of June 30, 2025 and
2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the years ended June 30, 2025 and June 30, 2024,
the Company made purchases from two vendors that accounted for &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zRVL8LyNfHm" title="Concentration risk, percentage"&gt;36%&lt;/span&gt; and&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zoQXcPBtgjJ3" title="Concentration risk, percentage"&gt; 0%&lt;/span&gt; of total purchases, respectively.&lt;/p&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;See Note 3 regarding the Company&#x2019;s concentrations
in the healthcare industry.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z06zC8G5lp3l" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zRdQdhudXtik"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company measures fair value in accordance with
ASC 820-10, &#x201c;Fair Value Measurements and Disclosures&#x201d;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;



























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All of the Company&#x2019;s financial instruments are
held for purposes other than trading.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





















&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zkiejRFiZPTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_z6k5RBXXeNh3"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2023, The Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
issued ASU 2023-09, &#x201c;Income Taxes (740) &#x201c;Improvements to Income Tax Disclosures&#x201d;, which requires the annual financial
statements to include consistent categories and great disaggregation of information in the rate reconciliation and income taxes paid disaggregated
by jurisdiction. ASU 2023-09 is effective for the Company&#x2019;s annual reporting beginning after December 15, 2024, with early adoption
permitted, and should be applied on a prospective basis, with a retrospective option. The Company recently adopted this ASU retrospectively
for the year ended June 30, 2025 and 2024 and it impacts only our disclosures with no impacts to our financial condition and results of
operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2023, FASB issued ASU 2023-07, &#x201c;Segment
Reporting (Topic 280)&#x201d;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company adopted ASU for the year ended June 30,
2025 and it impacts only our disclosures with no impacts to our financial condition and results of operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Income
Statement &#x2013; Reporting Comprehensive Income &#x2013; Expense Disaggregation Disclosures&#x201d; (Subtopic 220-40): Disaggregation of
Income Statement Expenses&#x201d;. This ASU requires disaggregation of certain income statement expense captions into specified categories
to be disclosed within the notes to the financial statements, but does not change the expense captions on the income statement. The amendments
in this ASU are to be applied prospectively, although retrospective application is permitted, and is effective for annual financial statements
starting in fiscal 2028 and interim periods starting in fiscal 2029, with early adoption permitted. The Company is currently evaluating
the effect that the adoption of ASU 2024-03 will have on our disclosures.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2025 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#x2019;s financial accounting
measures or disclosures had they been in effect during 2025 or 2024, and it does not believe that any of those standards will have a significant
impact on the Company&#x2019;s consolidated financial statements at the time they become effective.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

















</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000777">&lt;p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_z5xPkgHj8hYa" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_zx6kXp4uZd52"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements include the
accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are
included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions
have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





















</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2024-07-01to2025-06-30" id="Fact000788">&lt;p id="xdx_84F_eus-gaap--UseOfEstimates_zYc49DEOlEDc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_863_zYgLacFU6f57"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of the consolidated financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial
statements and accompanying notes. The most significant estimates relate to receivable allowances, and revenue recognition. In addition,
healthcare industry reforms and reimbursement practices will continue to impact the Company&#x2019;s operations and the determination of
contractual and other allowance estimates. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:InventoryWorkInProcessPolicy contextRef="From2024-07-01to2025-06-30" id="Fact000790">&lt;p id="xdx_841_eus-gaap--InventoryWorkInProcessPolicy_zOx1Y181YsB9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zFZ9ThetLNwd"&gt;Inventories&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventories consist of purchased parts, components
and supplies, as well as work-in-process, and are stated at the lower of cost or net realizable value.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InventoryWorkInProcessPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000792">&lt;p id="xdx_847_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zFYfUM6zwBbf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zRC1ApUdAOxc"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment is stated at cost less accumulated
depreciation. Property and equipment purchased in connection with an acquisition is stated at its estimated fair value, generally based
on an appraisal. Property and equipment is being depreciated for financial accounting purposes using the straight-line method over their
estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon
retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts
and the resulting gains or losses are reflected in the results of operations. Expenses for maintenance and repairs are charged to operations.
Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $&lt;span id="xdx_904_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20240701__20250630_zPvUEDSVTEd3" title="Maintenance and repair expenses"&gt;2,751,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--CostOfPropertyRepairsAndMaintenance_c20230701__20240630_zSW98m5gQHsi" title="Maintenance and repair expenses"&gt;2,948,000&lt;/span&gt; for the years
ended June 30, 2025 and 2024 respectively. The estimated useful lives in years are generally as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zzRfNYFNcoyh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B4_z6ny7nwymeeb" style="display: none"&gt;Schedule of Estimated Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"&gt;Estimated Useful Life in Years for Property and Equipment&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLUOWqTLUb0a"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z25tJH8zhlvh"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6nTPQReSsH2"&gt;3&lt;/span&gt;-&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zNHPd6S4KXHa"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Machinery and equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zXdHeCgwiGP9"&gt;2&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z6qnagveRi84"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zksgPFS2gqC"&gt;3&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zCr1cYtEgT25"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Leasehold improvements&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgT9VqsgYLc4"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaYdZEw4QjCi"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt"&gt;Building&lt;/td&gt;
&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zD9A92kl2CT6"&gt;28&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A6_zUTC8Bz6IHGl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;























</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000794"
      unitRef="USD">2751000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <us-gaap:CostOfPropertyRepairsAndMaintenance
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000796"
      unitRef="USD">2948000</us-gaap:CostOfPropertyRepairsAndMaintenance>
    <FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000798">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock_zzRfNYFNcoyh" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  - Useful Life in Years - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B4_z6ny7nwymeeb" style="display: none"&gt;Schedule of Estimated Useful Life in Years for Property and Equipment&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"&gt;Estimated Useful Life in Years for Property and Equipment&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zLUOWqTLUb0a"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_z25tJH8zhlvh"&gt;13&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_z6nTPQReSsH2"&gt;3&lt;/span&gt;-&lt;span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDeveopmentAndDemonstrationEquipmentMember_zNHPd6S4KXHa"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Machinery and equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zXdHeCgwiGP9"&gt;2&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z6qnagveRi84"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zksgPFS2gqC"&gt;3&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zCr1cYtEgT25"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Leasehold improvements&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MinimumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgT9VqsgYLc4"&gt;5&lt;/span&gt;&#x2013;&lt;span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__srt--RangeAxis__srt--MaximumMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaYdZEw4QjCi"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 70%; text-align: left; text-indent: -10pt"&gt;Building&lt;/td&gt;
&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember__srt--RangeAxis__srt--WeightedAverageMember_zD9A92kl2CT6"&gt;28&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</FONR:EstimatedUsefulLifeInYearsForPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MinimumMember_custom_DiagnosticEquipmentMember"
      id="Fact000799">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MaximumMember_custom_DiagnosticEquipmentMember"
      id="Fact000800">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MinimumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember"
      id="Fact000801">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MaximumMember_custom_ResearchDeveopmentAndDemonstrationEquipmentMember"
      id="Fact000802">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MinimumMember_us-gaap_MachineryAndEquipmentMember"
      id="Fact000803">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MaximumMember_us-gaap_MachineryAndEquipmentMember"
      id="Fact000804">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MinimumMember_us-gaap_FurnitureAndFixturesMember"
      id="Fact000805">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MaximumMember_us-gaap_FurnitureAndFixturesMember"
      id="Fact000806">P9Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MinimumMember_us-gaap_LeaseholdImprovementsMember"
      id="Fact000807">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_srt_MaximumMember_us-gaap_LeaseholdImprovementsMember"
      id="Fact000808">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-06-30_us-gaap_BuildingMember_srt_WeightedAverageMember"
      id="Fact000809">P28Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000821">&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z9eSjjxYZdtf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_869_zxgC1avudAai"&gt;Other Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;1) Patents and Copyrights&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Patent and copyrights are professional costs
incurred to acquire certain patent and copyrights. Amortization is calculated on the straight-line basis over &lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zJmhvKVVPtM" title="Finite-lived intangible asset, useful life"&gt;15 &lt;/span&gt;years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;2) Non-Competition Agreements&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The non-competition agreements are agreements entered
into with past principal owners of entities that the Company had acquired. The non-competition agreements are being amortized on the straight-line
basis over the length of the agreement (&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPBsjlpky802" title="Finite-lived intangible asset, useful life"&gt;7&lt;/span&gt; years).&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;3) Customer Relationships&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Customer relationships represents customer lists acquired
in acquisition of prior entities. Amortization is calculated on the straight-line basis over &lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zcjurrsJnO4" title="Finite-lived intangible asset, useful life"&gt;20&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;4) Software License&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Software license represents a license to improve the
image quality and efficiency of the MRI scanners. Amortization is calculated on the straight-line basis over 3 years.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2025-06-30_us-gaap_IntellectualPropertyMember"
      id="Fact000823">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember"
      id="Fact000825">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      id="Fact000827">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2024-07-01to2025-06-30" id="Fact000829">&lt;p id="xdx_843_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_z0gpOauwkL85" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_865_zbHeehKjQ3k9"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill represents the cost of a business acquisition
in excess of the fair value of the net assets acquired. Goodwill is not amortized and is reviewed for impairment annually, or more frequently
if facts and circumstances indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying
amount including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the
Company performs a quantitative test to identify and measure the amount of goodwill impairment loss. The Company compares the fair value
of the reporting unit with its carrying amount. If the carrying amount exceeds fair value, goodwill of the reporting unit is considered
impaired, and that excess is recognized as a goodwill impairment loss.&lt;br/&gt;&lt;/p&gt;



























</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000843">&lt;p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_zw2Kb9FZsoO2" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_863_zxgdpit5utq1"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue on sales contracts for scanners, included
in &#x201c;product sales&#x201d; in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion
method in accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 606, &#x201c;Revenue Recognition &#x2013; Construction-Type
and Production-Type Contracts&#x201d;. The Company manufactures its scanners under specific contracts that provide for progress payments.
Production and installation take approximately three to six months.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue on scanner service contracts is recognized
on the straight-line method over the related contract period, usually one year. As of June 30, 2024, the Company had unearned revenue
on service contracts of $3,870,229 of which all was recognized as revenue in the fiscal year ending June 30, 2025.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue from product sales (upgrades and supplies)
is recognized upon shipment.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue under management contracts is recognized based
upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various
medical providers (the &#x201c;PCs&#x201d;). As of June 30, 2025, the Company has &lt;span id="xdx_903_ecustom--ManagementAgreementsWithCompanyTotalMedicalPractices_iI_c20250630_ztnifEM7T7Y8" title="Management agreements with company total medical practices"&gt;22&lt;/span&gt; management agreements of which &lt;span id="xdx_908_ecustom--ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty_iI_c20250630_z0JA4I1I8wD2" title="Scanners with management agreements with company owned by related party"&gt;3&lt;/span&gt; were with PC&#x2019;s
owned by Timothy Damadian, Chairman of the Board, President, Chief Executive Officer and Treasurer (formerly owned by Raymond V. Damadian,
M.D., Chairman of the Board of FONAR until his unexpected death in August 2022) (&#x201c;the Related medical practices&#x201d;) and &lt;span id="xdx_907_ecustom--ScannersWithManagementWithCompanyLocatedInNewYorkState_iI_c20250630_zzPqbePjCJfh" title="Scanners with management with company located in new york state"&gt;19&lt;/span&gt; are
with PC&#x2019;s, which are all located in the state of New York (&#x201c;the New York PC&#x2019;s&#x201d;), owned by four unrelated radiologists.
The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately
$&lt;span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMinimum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zFaBwBpE3p8g" title="Contractual fees for services rendered minimum"&gt;70,000&lt;/span&gt; to $&lt;span id="xdx_90A_ecustom--ContractualFeesForServicesRenderedMaximum_iI_c20250630__us-gaap--TransactionTypeAxis__custom--DiagnosticImagingFacilityMember_zOAiTymX0tk2" title="Contractual fees for services rendered Maximum"&gt;460,000&lt;/span&gt;. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. The Company records a credit
loss expense for estimated uncollectible fees, which is reflected in other operating expenses on the Consolidated Statement of Operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company currently recognizes revenue in accordance
with the recognition accounting standard issued by the FASB and codified in the ASC 606. The revenue recognition standard in ASC 606 outlines
a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services
transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding the
Company&#x2019;s revenue recognition policies and significant judgments employed in the determination of revenue.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s revenues generally relate to net
patient fees&#160;received from various payers and patients themselves under contracts in which our performance obligations are to provide
diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied.
Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships
with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance
companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent
upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the
third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify
payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services
or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates
to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s patient fee revenues, net of contractual
allowances and discounts for the years ended June 30, 2025 and 2024 are summarized in the following table.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zapBwZWhb56k" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B4_zmol8u26VQ13" style="display: none"&gt;Schedule of patient fee
    revenue - net&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Patient Fee Revenue - Net&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zZud5cYCZia5" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,957,159&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z6IYnDScgTRf" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,952,712&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Medicare/Medicaid&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_z30m7YEAmVl1" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,160,839&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zszHemWRubW7" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,138,176&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Workers&#x2019; Compensation/Personal Injury&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zcAZ74TLZso3" style="text-align: right" title="Net Patient Fee Revenue"&gt;19,876,923&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zSnjmVbFtc7" style="text-align: right" title="Net Patient Fee Revenue"&gt;20,673,483&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Other&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zUbUYJK57Pkk" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;7,184,525&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVrbYwT44pae" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;7,051,425&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Net Patient Fee Revenue&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630_zNAPiF0XqZ47" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;33,179,446&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zjGCwrRjABoc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;33,815,796&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8AE_z5b9wb4amYcc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <FONR:ManagementAgreementsWithCompanyTotalMedicalPractices
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000845"
      unitRef="Ratio">22</FONR:ManagementAgreementsWithCompanyTotalMedicalPractices>
    <FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000847"
      unitRef="Ratio">3</FONR:ScannersWithManagementAgreementsWithCompanyOwnedByRelatedParty>
    <FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000849"
      unitRef="Ratio">19</FONR:ScannersWithManagementWithCompanyLocatedInNewYorkState>
    <FONR:ContractualFeesForServicesRenderedMinimum
      contextRef="AsOf2025-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      id="Fact000851"
      unitRef="USD">70000</FONR:ContractualFeesForServicesRenderedMinimum>
    <FONR:ContractualFeesForServicesRenderedMaximum
      contextRef="AsOf2025-06-30_custom_DiagnosticImagingFacilityMember"
      decimals="0"
      id="Fact000853"
      unitRef="USD">460000</FONR:ContractualFeesForServicesRenderedMaximum>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000868">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--DisaggregationOfRevenueTableTextBlock_zapBwZWhb56k" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details 1)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B4_zmol8u26VQ13" style="display: none"&gt;Schedule of patient fee
    revenue - net&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Patient Fee Revenue - Net&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_zZud5cYCZia5" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,957,159&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_z6IYnDScgTRf" style="width: 12%; text-align: right" title="Net Patient Fee Revenue"&gt;4,952,712&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Medicare/Medicaid&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_z30m7YEAmVl1" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,160,839&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_zszHemWRubW7" style="text-align: right" title="Net Patient Fee Revenue"&gt;1,138,176&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Workers&#x2019; Compensation/Personal Injury&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zcAZ74TLZso3" style="text-align: right" title="Net Patient Fee Revenue"&gt;19,876,923&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_zSnjmVbFtc7" style="text-align: right" title="Net Patient Fee Revenue"&gt;20,673,483&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Other&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zUbUYJK57Pkk" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;7,184,525&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_zVrbYwT44pae" style="border-bottom: Black 1pt solid; text-align: right" title="Net Patient Fee Revenue"&gt;7,051,425&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Net Patient Fee Revenue&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--NetPatientFeeRevenue_pp0p0_c20240701__20250630_zNAPiF0XqZ47" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;33,179,446&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_ecustom--NetPatientFeeRevenue_pp0p0_c20230701__20240630_zjGCwrRjABoc" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Patient Fee Revenue"&gt;33,815,796&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-012025-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      id="Fact000870"
      unitRef="USD">4957159</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012024-06-30_custom_CommercialInsuranceManagedCareMember"
      decimals="0"
      id="Fact000872"
      unitRef="USD">4952712</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-012025-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      id="Fact000874"
      unitRef="USD">1160839</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012024-06-30_custom_MedicareMedicaidMember"
      decimals="0"
      id="Fact000876"
      unitRef="USD">1138176</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-012025-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      id="Fact000878"
      unitRef="USD">19876923</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012024-06-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="0"
      id="Fact000880"
      unitRef="USD">20673483</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-012025-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      id="Fact000882"
      unitRef="USD">7184525</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012024-06-30_custom_OtherRevenueSourceMember"
      decimals="0"
      id="Fact000884"
      unitRef="USD">7051425</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000886"
      unitRef="USD">33179446</FONR:NetPatientFeeRevenue>
    <FONR:NetPatientFeeRevenue
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000888"
      unitRef="USD">33815796</FONR:NetPatientFeeRevenue>
    <FONR:MedicalReceivablePolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000890">&lt;p id="xdx_848_ecustom--MedicalReceivablePolicyTextBlock_zPIMLd4tJ5lb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zazxmUxsiWZ2"&gt;Medical Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Medical receivables are due under fee-for-service
contracts from third-party payors, such as hospitals, government sponsored healthcare programs, patient&#x2019;s legal counsel and directly
from patients. Substantially all the revenue relates to patients residing in Florida. Medical receivables are recorded at net realizable
value based on the estimated amounts the Company expects to receive from patients and third-party payers. The medical receivable is reduced
by an allowance for contractual adjustments based on the historical experience with each payor class at each location. The medical fee
receivable as of July 1, 2023 was $&lt;span id="xdx_908_ecustom--MedicalFeeReceivable_iI_c20230702_zaZAh3y9yVR8" title="Medical fee receivable"&gt;21,259,262&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For LLCs owned by the Company, approximately &lt;span id="xdx_90D_ecustom--RevenuePercentage_iI_dp_c20250630_zh33LI9cxjEf" title="revenue percentage"&gt;57&lt;/span&gt;%
and &lt;span id="xdx_90F_ecustom--RevenuePercentage_iI_dp_c20240630_z4l7dDmxJqp" title="revenue percentage"&gt;67%&lt;/span&gt; of net revenues were derived from no-fault and personal injury protection for the years end June 30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;





















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management and Other Fees Receivable&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management fees receivable is related to management
fees outstanding from the related and non related PCs under management agreements. The Company has established a current expected credit
loss (&#x201c;CECL&#x201d;) reserve to address the risk that a portion of the contractually obligated management fees receivable from the
PCs may not be collectible. The PC&#x2019;s may be limited in their ability to pay the full management fee receivable if they do not collect
sufficient expected fees from third-party payors and patients. The Company&#x2019;s management fees are collateralized, individually and
collectively, by the assets of the PCs. The CECL reserve is determined based on the difference between the management fee receivable and
the current amount of outstanding fees estimated to be collected by the PCs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s considerations into the estimate
of the PC&#x2019;s fee collection is based on a combination of factors. As each management agreement specifies the Company&#x2019;s ultimate
collateral for unpaid management fees are the patient fee receivables owned by each PC, the Company considers the historical loss rates
to pools of receivables with similar risks characteristics, aging of the patient fee receivables, and the financial condition of each
PC. In addition, the Company subjectively adjusts its estimated expected credit losses for current and forward-looking economic conditions
which would include trends seen within the industry and newly enacted regulation. Specifically, insurance carriers covering automobile
no-fault and workers compensation claims incur longer payment cycles and rigorous informational requirements and certain other disallowed
claims.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The Company combines an objective
and subjective loss-rate methodology to estimate expected credit losses based on the collateral owned by each PC. This involves objectively
using historical loss rates to pools of receivables with similar risk characteristics (i.e., various insurance payors) and then subjectively
adjusting for current and forward-looking economic conditions which would include trends seen within the industry and newly enacted regulation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The provision for credit losses for the year ended June 30, 2025 was
$3,079,261. The provision for credit losses is attributable to scan volume at all the PC&#x2019;s and the nature of the payor classes,
where there can be longer expected payment terms. Also, during the year ended June 30, 2025, the Company recorded an additional reserve
of approximately $2,300,000 for a specific receivable that is attributable to a American Transit Insurance Company (ATIC). This reserve
for credit losses relates specifically to ATIC, which owes no-fault insurance claims by the PCs to the PCs, which are collateral for the
Company&#x2019;s management and other fees receivable. ATIC is a New York based motor vehicle insurer primarily focused on for-hire automobile
insurance. During Fiscal 2025, ATIC posted over $750 million in net losses and has indicated that they are approaching insolvency. ATIC
continues to operate and is working with the New York Department of Financial Services (DFS) to resolve its issues. We continue to monitor
the situation for new developments. However, at the time of this filing, DFS has not publicly announced approval of any plans for ATIC
to resolve its financial situation. In addition, Uber has filed a lawsuit against ATIC alleging they are not properly paying claims. Additional
legislation in New York City to reduce coverage minimums and increase premiums may help to resolve the crisis, but there is no certainty
these efforts will be successful. If ATIC enters receivership or suffers additional adverse consequences, we may need to take additional
reserves in the future. The management fee receivable
for unrelated and related parties as of July 1, 2023 was $&lt;span id="xdx_908_ecustom--ManagementFeeReceivableForUnrelatedParties_iI_c20230702_z3epp298HNv7" title="Management fee receivable for unrelated parties"&gt;35,888,253&lt;/span&gt; and $&lt;span id="xdx_902_ecustom--ManagementFeeReceivableForRelatedParties_iI_c20230702_zcVLCbWvau8k" title="Management Fee Receivable For Related Parties"&gt;9,161,870&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





















</FONR:MedicalReceivablePolicyTextBlock>
    <FONR:MedicalFeeReceivable
      contextRef="AsOf2023-07-02"
      decimals="0"
      id="Fact000892"
      unitRef="USD">21259262</FONR:MedicalFeeReceivable>
    <FONR:RevenuePercentage
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000894"
      unitRef="Ratio">0.57</FONR:RevenuePercentage>
    <FONR:RevenuePercentage
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000896"
      unitRef="Ratio">0.67</FONR:RevenuePercentage>
    <FONR:ManagementFeeReceivableForUnrelatedParties
      contextRef="AsOf2023-07-02"
      decimals="0"
      id="Fact000907"
      unitRef="USD">35888253</FONR:ManagementFeeReceivableForUnrelatedParties>
    <FONR:ManagementFeeReceivableForRelatedParties
      contextRef="AsOf2023-07-02"
      decimals="0"
      id="Fact000909"
      unitRef="USD">9161870</FONR:ManagementFeeReceivableForRelatedParties>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000920">&lt;p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_z2dAUxER9VI6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_864_z9QMwu03zeo5"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Credit risk with respect to the Company&#x2019;s accounts
receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the commencement
of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed on a monthly
or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The Company controls
credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process, credit limits, monitoring
procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before a product sales contract is
entered into or service and repair fees are provided.&#160;The account receivable balance for scanner service contracts as of July 1,
2023 was $&lt;span id="xdx_90B_ecustom--AccountsReceivableServiceContractsNet_iI_c20230702_zP1nChfqcFzc" title="Account receivable"&gt;4,571,597&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ReceivablesPolicyTextBlock>
    <FONR:AccountsReceivableServiceContractsNet
      contextRef="AsOf2023-07-02"
      decimals="0"
      id="Fact000922"
      unitRef="USD">4571597</FONR:AccountsReceivableServiceContractsNet>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2024-07-01to2025-06-30" id="Fact000924">&lt;p id="xdx_847_eus-gaap--ResearchAndDevelopmentExpensePolicy_zHtlUHAE0r19" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_866_z41yjjbXl4fj"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Research and development costs are charged to expense
as incurred. The costs of equipment that are acquired or constructed for research and development activities, and have alternative future
uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their
estimated useful lives.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000926">&lt;p id="xdx_846_eus-gaap--AdvertisingCostsPolicyTextBlock_zx0hhJU3GzG5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86E_z8yGLCjM6W79"&gt;Advertising Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Advertising costs are expensed as incurred. Advertising
expense approximated $ &lt;span id="xdx_900_eus-gaap--AdvertisingExpense_c20240701__20250630_zy07m58XFKWj"&gt;773,000&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--AdvertisingExpense_c20230701__20240630_zm5LK0BUGRx6"&gt;731,000&lt;/span&gt; and for the years ended June 30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000927"
      unitRef="USD">773000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000928"
      unitRef="USD">731000</us-gaap:AdvertisingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000930">&lt;p id="xdx_841_eus-gaap--IncomeTaxPolicyTextBlock_zJjWVKExln06" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86C_zOGPd9JGMpb9"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Deferred tax assets and liabilities are determined
based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates
in effect in the years in which the differences are expected to reverse.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The ultimate realization of deferred tax assets is
dependent on the generation of future taxable income during the periods in which temporary differences become deductible or when such
net operating losses can be utilized. The Company considers projected future taxable income, the regulatory environment of the industry,
and tax planning strategies in making this assessment. At present, the Company believes that it is more likely than not that the benefits
from certain deferred tax asset carryforwards, will not all be fully realized. In recognition of this inherent risk, a valuation allowance
was established for the partial value of the deferred tax asset, which principally related to certain state net operating losses. A valuation
allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;





























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 740, &#x201c;Accounting for Income Taxes&#x201d;,
prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC 740. The Company believes there are no uncertain tax positions in prior year&#x2019;s tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In accordance with ASC 740, interest costs related
to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as &#x201c;Interest expense, net. Penalties
if incurred would be recognized as a component of &#x201c;Selling, general and administrative&#x201d; expenses. Penalties for the years
ended June 30, 2025 and June 30, 2024 were $&lt;span id="xdx_90A_ecustom--Penalties_c20240701__20250630_zz9AvmFTMGk6" title="Penalties"&gt;0&lt;/span&gt; and $&lt;span id="xdx_907_ecustom--Penalties_c20230701__20240630_z7nnh1DiSjA" title="Penalties"&gt;20,444&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <FONR:Penalties
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000945"
      unitRef="USD">0</FONR:Penalties>
    <FONR:Penalties
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact000947"
      unitRef="USD">20444</FONR:Penalties>
    <FONR:CustomerAdvancesPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000949">&lt;p id="xdx_84B_ecustom--CustomerAdvancesPolicyTextBlock_zt4hi9zatzA2" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_z7gmUlKx0OXc"&gt;Customer Advances&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash advances and progress payments received on sales
orders are reflected as customer advances until such time as revenue recognition occurs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</FONR:CustomerAdvancesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000951">&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zQGycvRWLJ9e" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_862_znvzMFwkxOI2"&gt;Earnings Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) is computed
by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the
period. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class Method&#x201d;, the Company used the Two-Class
method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the
years ended June 30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Diluted EPS reflects the potential dilution from the
exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during
the period. For the years ended June 30, 2025 and 2024, diluted EPS for common shareholders includes &lt;span id="xdx_900_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20240701__20250630_zjNb4UsWTUV3" title="Conversion of Class C Common Stock"&gt;&lt;span id="xdx_90A_ecustom--NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders_c20230701__20240630_z1OhV6G8wArg" title="Conversion of Class C Common Stock"&gt;127,504&lt;/span&gt;&lt;/span&gt; shares upon conversion of
Class C Common.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

























&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXgrVghbjdB7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BF_zrMYGGMVn0hh" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Basic&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Preferred &lt;br/&gt;&#160; &lt;br/&gt;Stock&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="text-decoration: underline"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Net income available to common stockholders&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630_zwXbEOpHQRm" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;8,334,261&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHQ0bwZGoRul" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;7,802,352&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zTbMk0MKQADd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;135,467&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zOWRlysqdos5" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;396,443&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630_z4c3GDKwWT9b" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,906,803&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7R8N2jl43U3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,210,852&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCw1jHBpm25h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zO7lozDT1tS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;313,438&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Basic income per common share&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630_zYJDkImOYcv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.21&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zK59KB7k5em4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.26&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zYUM1NLAtzjh" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.35&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zo7FZ3bjowV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.26&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt"&gt;Diluted&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zI5vTOBCSz0j" style="text-align: right" title="Weighted average shares outstanding"&gt;6,210,852&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zF2JaGEfpWe5" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Class C Common Stock&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcPDQCeFugrf" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_z2aZ6uU4BtZ6" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zj5GfCXGL8Hl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,338,356&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zgEFnhclg7m7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Diluted income per common share&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5Dc9qQOYSRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.23&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zX4OulzKmGXi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.35&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Preferred &lt;br/&gt;&#160; &lt;br/&gt;Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="text-decoration: underline"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630_zxqVKlA1jCY9" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;10,567,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlznrJUeKC27" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;9,908,920&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCg0idGNEmU1" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;167,700&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zxCM8hZqgwFa" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;490,776&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zI0FmbgqMxUg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;7,046,959&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuHuh97pIZ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,351,008&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztvCZaYHkyU8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zjgiMv3bpst2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;313,438&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_z0Bwby6RQfU2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVrQ7Azo2Gs7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztoADeqDrIP4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zCN37m1AK22f" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.57&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zruxKYiA6jC1" style="text-align: right" title="Weighted average shares outstanding"&gt;6,351,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zXVyct5TGptj" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsbWP3Ab8yRg" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zhcHa2K3gRM1" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQsK8CJDkgC7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,478,512&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zK9uAEAPE7O1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYlkrMwYg6H" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zUZzwVpni9qh" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;br/&gt;
&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AF_zWzuXeV2zvI8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;























</us-gaap:EarningsPerSharePolicyTextBlock>
    <FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000953"
      unitRef="Shares">127504</FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders>
    <FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000955"
      unitRef="Shares">127504</FONR:NumberOfSharesUponConversionOfClassCCommonIncludedInDilutedEpsForCommonShareholders>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000968">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXgrVghbjdB7" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings per share - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BF_zrMYGGMVn0hh" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Basic&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Preferred &lt;br/&gt;&#160; &lt;br/&gt;Stock&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="text-decoration: underline"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Net income available to common stockholders&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630_zwXbEOpHQRm" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;8,334,261&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHQ0bwZGoRul" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;7,802,352&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zTbMk0MKQADd" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;135,467&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zOWRlysqdos5" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;396,443&lt;/td&gt;
&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630_z4c3GDKwWT9b" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,906,803&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7R8N2jl43U3" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,210,852&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCw1jHBpm25h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--WeightedAverageSharesOutstandingBasic_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zO7lozDT1tS2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;313,438&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Basic income per common share&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630_zYJDkImOYcv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.21&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zK59KB7k5em4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.26&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zYUM1NLAtzjh" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.35&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zo7FZ3bjowV3" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.26&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt"&gt;Diluted&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-align: left; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zI5vTOBCSz0j" style="text-align: right" title="Weighted average shares outstanding"&gt;6,210,852&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zF2JaGEfpWe5" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Class C Common Stock&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zcPDQCeFugrf" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_z2aZ6uU4BtZ6" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zj5GfCXGL8Hl" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,338,356&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zgEFnhclg7m7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Diluted income per common share&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5Dc9qQOYSRb" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.23&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zX4OulzKmGXi" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.35&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;Basic&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Preferred &lt;br/&gt;&#160; &lt;br/&gt;Stock&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="text-decoration: underline"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630_zxqVKlA1jCY9" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;10,567,396&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zlznrJUeKC27" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;9,908,920&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pp0p0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zCg0idGNEmU1" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;167,700&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zxCM8hZqgwFa" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="Net income available to common stockholders"&gt;490,776&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630_zI0FmbgqMxUg" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;7,046,959&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zZuHuh97pIZ4" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;6,351,008&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztvCZaYHkyU8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageSharesOutstandingBasic_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zjgiMv3bpst2" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average shares outstanding basic"&gt;313,438&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630_z0Bwby6RQfU2" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVrQ7Azo2Gs7" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.56&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_ztoADeqDrIP4" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassAPreferredStockMember_zCN37m1AK22f" style="border-bottom: Black 2.5pt double; text-align: right" title="Basic income per common share"&gt;1.57&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt"&gt;Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-decoration: underline; text-indent: -10pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zruxKYiA6jC1" style="text-align: right" title="Weighted average shares outstanding"&gt;6,351,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageBasicSharesOutstandingProForma_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zXVyct5TGptj" style="text-align: right" title="Weighted average shares outstanding"&gt;382,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IncrementalCommonSharesAttributableToConversionOfCommonStock_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsbWP3Ab8yRg" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;127,504&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_d0_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zhcHa2K3gRM1" style="border-bottom: Black 1pt solid; text-align: right" title="Class C Common Stock"&gt;&#x2014;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total Denominator for diluted earnings per share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQsK8CJDkgC7" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;6,478,512&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zK9uAEAPE7O1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Denominator for diluted earnings per share"&gt;382,513&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYlkrMwYg6H" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;1.53&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_c20230701__20240630__us-gaap--StatementClassOfStockAxis__custom--ClassCCommonStockMember_zUZzwVpni9qh" style="border-bottom: Black 2.5pt double; text-align: right" title="Diluted income per common share"&gt;0.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;br/&gt;
&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact000970"
      unitRef="USD">8334261</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718"
      decimals="0"
      id="Fact000972"
      unitRef="USD">7802352</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718"
      decimals="0"
      id="Fact000974"
      unitRef="USD">135467</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember516949718"
      decimals="0"
      id="Fact000976"
      unitRef="USD">396443</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000978"
      unitRef="Shares">6906803</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718"
      decimals="INF"
      id="Fact000980"
      unitRef="Shares">6210852</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718"
      decimals="INF"
      id="Fact000982"
      unitRef="Shares">382513</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember516949718"
      decimals="INF"
      id="Fact000984"
      unitRef="Shares">313438</FONR:WeightedAverageSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000986"
      unitRef="USDPShares">1.21</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718"
      decimals="INF"
      id="Fact000988"
      unitRef="USDPShares">1.26</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718"
      decimals="INF"
      id="Fact000990"
      unitRef="USDPShares">0.35</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-07-012025-06-30_custom_ClassAPreferredStockMember516949718"
      decimals="INF"
      id="Fact000992"
      unitRef="USDPShares">1.26</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718"
      decimals="INF"
      id="Fact000994"
      unitRef="Shares">6210852</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718"
      decimals="INF"
      id="Fact000996"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718"
      decimals="INF"
      id="Fact000998"
      unitRef="Shares">127504</FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718"
      decimals="INF"
      id="Fact001000"
      unitRef="Shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718"
      decimals="INF"
      id="Fact001002"
      unitRef="Shares">6338356</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718"
      decimals="INF"
      id="Fact001004"
      unitRef="Shares">382513</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718"
      decimals="INF"
      id="Fact001006"
      unitRef="USDPShares">1.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012025-06-30_custom_ClassCCommonStockMember516949718"
      decimals="INF"
      id="Fact001008"
      unitRef="USDPShares">0.35</us-gaap:EarningsPerShareDiluted>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001010"
      unitRef="USD">10567396</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781"
      decimals="0"
      id="Fact001012"
      unitRef="USD">9908920</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796"
      decimals="0"
      id="Fact001014"
      unitRef="USD">167700</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember516949796"
      decimals="0"
      id="Fact001016"
      unitRef="USD">490776</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001018"
      unitRef="Shares">7046959</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781"
      decimals="INF"
      id="Fact001020"
      unitRef="Shares">6351008</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796"
      decimals="INF"
      id="Fact001022"
      unitRef="Shares">382513</FONR:WeightedAverageSharesOutstandingBasic>
    <FONR:WeightedAverageSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember516949796"
      decimals="INF"
      id="Fact001024"
      unitRef="Shares">313438</FONR:WeightedAverageSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001026"
      unitRef="USDPShares">1.50</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781"
      decimals="INF"
      id="Fact001028"
      unitRef="USDPShares">1.56</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796"
      decimals="INF"
      id="Fact001030"
      unitRef="USDPShares">0.44</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-07-012024-06-30_custom_ClassAPreferredStockMember516949796"
      decimals="INF"
      id="Fact001032"
      unitRef="USDPShares">1.57</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781"
      decimals="INF"
      id="Fact001034"
      unitRef="Shares">6351008</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796"
      decimals="INF"
      id="Fact001036"
      unitRef="Shares">382513</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781"
      decimals="INF"
      id="Fact001038"
      unitRef="Shares">127504</FONR:IncrementalCommonSharesAttributableToConversionOfCommonStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796"
      decimals="INF"
      id="Fact001040"
      unitRef="Shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781"
      decimals="INF"
      id="Fact001042"
      unitRef="Shares">6478512</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796"
      decimals="INF"
      id="Fact001044"
      unitRef="Shares">382513</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember516949781"
      decimals="INF"
      id="Fact001046"
      unitRef="USDPShares">1.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30_custom_ClassCCommonStockMember516949796"
      decimals="INF"
      id="Fact001048"
      unitRef="USDPShares">0.44</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001060">&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zksvfpjlvW22" style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span id="xdx_864_zIURIV2GEw48"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents includes cash on hand, cash
in banks, investments in certificates of deposit with original maturities of 90 days or less, and money market funds.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001062">&lt;p id="xdx_84F_eus-gaap--InvestmentPolicyTextBlock_zJBdbK2KByyl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_861_z3MGEx6a1zh4"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Short-term investments include certificates of deposit
with original maturities of greater than 90 days. Interest is recorded as earned.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2024-07-01to2025-06-30" id="Fact001064">&lt;p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z64eE4JWji8a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zXte6nDBFVG1"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash: The Company maintains its cash and cash equivalents
with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2025, the Company had cash
on deposit of approximately $&lt;span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20250630_zQ3URKgZSaad" title="Cash deposit"&gt;53,676,000&lt;/span&gt; in excess of federally insured limits of $&lt;span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20250630_zzM4L0gibjxe" title="Federally insured limits"&gt;250,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Related Parties: Net revenues from related parties
accounted for approximately &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zb90mruYegCi" title="Concentration risk, percentage"&gt;&lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zkRDkTkOHw8" title="Concentration risk, percentage"&gt;12&lt;/span&gt;&lt;/span&gt;% of the consolidated net revenues for the years ended June 30, 2025 and 2024. Net management fee receivables
from the related party medical practices accounted for approximately &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMember_zTYTSQcAQ5" title="Concentration risk, percentage"&gt;&lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--RelatedPartiesMedicalPracticesMember_zlOJ8OY6S8Le" title="Concentration risk, percentage"&gt;12&lt;/span&gt;&lt;/span&gt;% of the consolidated accounts receivable as of June 30, 2025 and
2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the years ended June 30, 2025 and June 30, 2024,
the Company made purchases from two vendors that accounted for &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20250630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zRVL8LyNfHm" title="Concentration risk, percentage"&gt;36%&lt;/span&gt; and&lt;span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20240630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zoQXcPBtgjJ3" title="Concentration risk, percentage"&gt; 0%&lt;/span&gt; of total purchases, respectively.&lt;/p&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;See Note 3 regarding the Company&#x2019;s concentrations
in the healthcare industry.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:Cash
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001066"
      unitRef="USD">53676000</us-gaap:Cash>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001068"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember"
      decimals="INF"
      id="Fact001070"
      unitRef="Ratio">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember"
      decimals="INF"
      id="Fact001072"
      unitRef="Ratio">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMember"
      decimals="INF"
      id="Fact001074"
      unitRef="Ratio">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_RelatedPartiesMedicalPracticesMember"
      decimals="INF"
      id="Fact001076"
      unitRef="Ratio">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-07-012025-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoVendorsMember"
      decimals="INF"
      id="Fact001078"
      unitRef="Ratio">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-07-012024-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoVendorsMember"
      decimals="INF"
      id="Fact001080"
      unitRef="Ratio">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-07-01to2025-06-30" id="Fact001082">&lt;p id="xdx_847_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z06zC8G5lp3l" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zRdQdhudXtik"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company measures fair value in accordance with
ASC 820-10, &#x201c;Fair Value Measurements and Disclosures&#x201d;. ASC 820-10 clarifies that fair value is an exit price, representing
the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants.
As such, fair value is a market-based measurement that should be determined based on assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The standard establishes a three-tier fair value hierarchy,
which prioritizes the inputs used in measuring and revaluing fair value. These tiers include, Level 1, defined as observable inputs such
as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or
indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity
to develop its own assumptions.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following methods and assumptions were used to
estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and cash equivalents: The carrying amount approximates
fair value because of the short-term maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;



























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Short-term investments: The carrying amount approximates
fair value because of the short-term maturity of those instruments. Such amounts include Certificates of Deposits with original maturities
greater than 90 days. These securities are classified as Level 1.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Receivable and accounts payable: The carrying amounts
approximate fair value because of the short maturity of those instruments.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long-term debt and notes payable: The carrying amounts
of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices
and/or due to the interest rates not being significantly different from the current market rates available to the Company.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All of the Company&#x2019;s financial instruments are
held for purposes other than trading.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





















</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001105">&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zkiejRFiZPTk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_868_z6k5RBXXeNh3"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2023, The Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
issued ASU 2023-09, &#x201c;Income Taxes (740) &#x201c;Improvements to Income Tax Disclosures&#x201d;, which requires the annual financial
statements to include consistent categories and great disaggregation of information in the rate reconciliation and income taxes paid disaggregated
by jurisdiction. ASU 2023-09 is effective for the Company&#x2019;s annual reporting beginning after December 15, 2024, with early adoption
permitted, and should be applied on a prospective basis, with a retrospective option. The Company recently adopted this ASU retrospectively
for the year ended June 30, 2025 and 2024 and it impacts only our disclosures with no impacts to our financial condition and results of
operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2023, FASB issued ASU 2023-07, &#x201c;Segment
Reporting (Topic 280)&#x201d;, which is intended to improve reportable segment disclosure requirements through enhanced disclosures about
significant segment expenses. The amendments require disclosure of significant segment expenses regularly provided to the chief operating
decision maker (CODM) as well as other segment items, extended certain annual disclosures to interim periods, clarify the applicability
to single reportable segment entities, permit more than one measure of profit or loss to be reported under certain conditions, and require
disclosure of the title and position of the CODM. The effective date for public entities is for fiscal years beginning after December
15, 2023 and interim periods with fiscal years beginning after December 15, 2024. The Company adopted ASU for the year ended June 30,
2025 and it impacts only our disclosures with no impacts to our financial condition and results of operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Income
Statement &#x2013; Reporting Comprehensive Income &#x2013; Expense Disaggregation Disclosures&#x201d; (Subtopic 220-40): Disaggregation of
Income Statement Expenses&#x201d;. This ASU requires disaggregation of certain income statement expense captions into specified categories
to be disclosed within the notes to the financial statements, but does not change the expense captions on the income statement. The amendments
in this ASU are to be applied prospectively, although retrospective application is permitted, and is effective for annual financial statements
starting in fiscal 2028 and interim periods starting in fiscal 2029, with early adoption permitted. The Company is currently evaluating
the effect that the adoption of ASU 2024-03 will have on our disclosures.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;FASB, the Emerging Issues Task Force and the SEC have
issued certain other accounting standards, updates, and regulations as of June 30, 2025 that will become effective in subsequent periods;
however, management does not believe that any of those updates would have significantly affected the Company&#x2019;s financial accounting
measures or disclosures had they been in effect during 2025 or 2024, and it does not believe that any of those standards will have a significant
impact on the Company&#x2019;s consolidated financial statements at the time they become effective.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

















</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001114">&lt;p id="xdx_808_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zvM69ABmY3yf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;NOTE 3 &#x2013; &lt;span id="xdx_823_zGxO2fuc3EH9"&gt;ACCOUNTS RECEIVABLE, MEDICAL
RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long Term Accounts Receivable&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long term accounts receivable balances at June 30,
2025 and June 30, 2024 amounted to $&lt;span id="xdx_900_ecustom--AccountsReceivableNetLongTerm_iI_c20250630_zJAsWv7AnoK3" title="Long term accounts receivable balances"&gt;3,549,956&lt;/span&gt; and $&lt;span id="xdx_90A_ecustom--AccountsReceivableNetLongTerm_iI_c20240630_zGx0BKwHm0e1" title="Long term accounts receivable balances"&gt;829,473&lt;/span&gt;, respectively. The Company will generate revenue from long-term, non-cancellable
contracts to provide service and repair services. Future revenue to be recognized over the following four years at June 30, 2025 is as
follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zXijzGO5ESQb" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B5_z0cZf7ccVUwa" style="display: none"&gt;Schedule of Long Term Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Receivables - Non Current - net&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: left; text-indent: -10pt"&gt;2027&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20250630_zY1nO0he1iA7" style="width: 43%; text-align: right" title="2026"&gt;1,592,426&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;2028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20250630_zl2ff3MRTrt8" style="text-align: right" title="2027"&gt;1,031,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;2029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20250630_zk37cIAqVCyj" style="text-align: right" title="2028"&gt;831,660&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;2030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20250630_z5ycbIwXvoMk" style="border-bottom: Black 1pt solid; text-align: right" title="2029"&gt;344,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20250630_zSm0CQJJejm6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;3,800,746&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zF7jlcHtEv2a" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following represents a summary of allowance for
credit losses for the years ended June 30, 2025 and 2024, respectively:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zEJmGmLG4PJe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zUYzCKeQzSsh" style="display: none"&gt;Schedule of Summary of Allowance For Credit Losses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="17" style="text-align: center"&gt;Summary of Allowance For Credit Losses&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Description&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Balance&lt;br/&gt; June 30, 2024&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Additions (1)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Balance &lt;br/&gt; June 30, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0ij1s42VJQd" style="width: 10%; text-align: right" title="Beginning Balance"&gt;166,049&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z4bTZ0RWGBEd" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"&gt;107,330&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zR9jL8mRuUBc" style="width: 10%; text-align: right" title="Deductions"&gt;9,167&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znv4xfD8zong" style="width: 10%; text-align: right" title="Ending Balance"&gt;264,212&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zUTSyg7wxChi" style="text-align: right"&gt;12,369,921&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z1DWoU1Je85" style="text-align: right"&gt;2,052,824&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBPQGFy8jqg3" style="text-align: right"&gt;126,757&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zvqySRTABHDh" style="text-align: right"&gt;14,295,988&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztVQkHz0Nx7i" style="text-align: right"&gt;6,110,399&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z4UevtFf3qFg" style="text-align: right"&gt;1,026,437&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzYUj6zpTFf2" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zdaOks82DPNf" style="text-align: right"&gt;7,136,836&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Notes receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zG80mJzulSue" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zhXdF15EnE15" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zrQhCXjOSeF" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zBgaNioATN1k" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1152"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;Balance&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;Balance&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Description&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Additions(Recovery)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_za0anvkO7yyi" style="width: 10%; text-align: right"&gt;198,593&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zTw9SA4YlWd6" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1154"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqc1aNYDTOK" style="width: 10%; text-align: right"&gt;32,544&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqIYwzzax14" style="width: 10%; text-align: right"&gt;166,049&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zgO2HKHEL1H2" style="text-align: right"&gt;12,608,567&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zLFpcnnnG5Rj" style="text-align: right"&gt;(238,646&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNp2SFKHPxX1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1159"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEUUIksXct8j" style="text-align: right"&gt;12,369,921&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zq8rRjBmtWvk" style="text-align: right"&gt;3,989,692&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z99NIK7R5Al9" style="text-align: right"&gt;2,120,707&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zKWIlhQq0Uvg" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1163"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzPXJe4kndel" style="text-align: right"&gt;6,110,399&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Notes receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zNhNbhaSE1ma" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zA3FJdF8vJwb" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zXwWgWj5i4Gl" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zsonrgb7xAri" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4px; padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Included in provision for credit losses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_zYF2UHqoInNe" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Net revenues from management and other fees
charged to the related party medical practices accounted for approximately &lt;span id="xdx_90A_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20240701__20250630_zBmZE50fBRM5" title="Percentage of consolidated net revenue from management fees"&gt;&lt;span id="xdx_902_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20230701__20240630_zU9jx2CA3wy6" title="Percentage of consolidated net revenue from management fees"&gt;11&lt;/span&gt;&lt;/span&gt;%
and &lt;span id="xdx_903_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_dp_c20220701__20230630_zdo5oDpHkHf8" title="Percentage of consolidated net revenue from management fees"&gt;12&lt;/span&gt;% of the consolidated net revenues for the years ended June 30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Tallahassee Magnetic Resonance Imaging, Inc., Stand
Up MRI of Boca Raton, Inc. and Stand Up MRI &amp;amp; Diagnostic Center, Inc. (all related party medical practices) entered into a guaranty
agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under each
individual management agreement.&lt;/p&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table sets forth the number of our facilities
for the years ended June 30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;Total Facilities&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zOv85HqtP6ba" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B1_zQpHJjCYPWUi" style="display: none"&gt;Schedule of facilities&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_498_20240701__20250630_z126F3J4Yx3f" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_493_20230701__20240630_zIawC8tkkTwh" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zD376GVhfX8h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Total Facilities Owned or Managed (at Beginning of Year)&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;28&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;27&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Facilities Added by:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z99TkL8sA8S7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"&gt;Internal development&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1191"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;1&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zrsS1XQIBhVa" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Managed Facilities Closed&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_zjB1j5c3yxQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total Facilities Owned or Managed (at End of Year)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;28&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;28&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A7_zVniYBQd1lb4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001116"
      unitRef="USD">3549956</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001118"
      unitRef="USD">829473</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001120">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_zXijzGO5ESQb" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B5_z0cZf7ccVUwa" style="display: none"&gt;Schedule of Long Term Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Receivables - Non Current - net&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 44%; text-align: left; text-indent: -10pt"&gt;2027&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pp0p0_c20250630_zY1nO0he1iA7" style="width: 43%; text-align: right" title="2026"&gt;1,592,426&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;2028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pp0p0_c20250630_zl2ff3MRTrt8" style="text-align: right" title="2027"&gt;1,031,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;2029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ContractReceivableDueFourToFiveYears_iI_pp0p0_c20250630_zk37cIAqVCyj" style="text-align: right" title="2028"&gt;831,660&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;2030&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ContractReceivableDueFiveYearsOrMore_iI_pp0p0_c20250630_z5ycbIwXvoMk" style="border-bottom: Black 1pt solid; text-align: right" title="2029"&gt;344,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_pp0p0_c20250630_zSm0CQJJejm6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;3,800,746&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <us-gaap:ContractReceivableDueTwoToThreeYears
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001122"
      unitRef="USD">1592426</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:ContractReceivableDueThreeToFourYears
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001124"
      unitRef="USD">1031910</us-gaap:ContractReceivableDueThreeToFourYears>
    <us-gaap:ContractReceivableDueFourToFiveYears
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001126"
      unitRef="USD">831660</us-gaap:ContractReceivableDueFourToFiveYears>
    <us-gaap:ContractReceivableDueFiveYearsOrMore
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001128"
      unitRef="USD">344750</us-gaap:ContractReceivableDueFiveYearsOrMore>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001130"
      unitRef="USD">3800746</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001132">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zEJmGmLG4PJe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Allowance for doubtful accounts (Details 1)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zUYzCKeQzSsh" style="display: none"&gt;Schedule of Summary of Allowance For Credit Losses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td colspan="17" style="text-align: center"&gt;Summary of Allowance For Credit Losses&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Description&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Balance&lt;br/&gt; June 30, 2024&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Additions (1)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Balance &lt;br/&gt; June 30, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z0ij1s42VJQd" style="width: 10%; text-align: right" title="Beginning Balance"&gt;166,049&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_z4bTZ0RWGBEd" style="width: 10%; text-align: right" title="Additions (Included in provision for bad debts)"&gt;107,330&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zR9jL8mRuUBc" style="width: 10%; text-align: right" title="Deductions"&gt;9,167&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_znv4xfD8zong" style="width: 10%; text-align: right" title="Ending Balance"&gt;264,212&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zUTSyg7wxChi" style="text-align: right"&gt;12,369,921&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsAdditions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_z1DWoU1Je85" style="text-align: right"&gt;2,052,824&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsDeductions_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zBPQGFy8jqg3" style="text-align: right"&gt;126,757&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zvqySRTABHDh" style="text-align: right"&gt;14,295,988&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_ztVQkHz0Nx7i" style="text-align: right"&gt;6,110,399&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z4UevtFf3qFg" style="text-align: right"&gt;1,026,437&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzYUj6zpTFf2" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zdaOks82DPNf" style="text-align: right"&gt;7,136,836&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Notes receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zG80mJzulSue" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zhXdF15EnE15" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zrQhCXjOSeF" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20240701__20250630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zBgaNioATN1k" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1152"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;Balance&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;Balance&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Description&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2023&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Additions(Recovery)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Deductions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Accounts receivable&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_za0anvkO7yyi" style="width: 10%; text-align: right"&gt;198,593&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_982_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_fKDEp_zTw9SA4YlWd6" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1154"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqc1aNYDTOK" style="width: 10%; text-align: right"&gt;32,544&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zqIYwzzax14" style="width: 10%; text-align: right"&gt;166,049&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Management and other fees receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zgO2HKHEL1H2" style="text-align: right"&gt;12,608,567&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_fKDEp_zLFpcnnnG5Rj" style="text-align: right"&gt;(238,646&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zNp2SFKHPxX1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1159"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableMember_zEUUIksXct8j" style="text-align: right"&gt;12,369,921&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Management and other fees receivable - related medical practices&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zq8rRjBmtWvk" style="text-align: right"&gt;3,989,692&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_fKDEp_z99NIK7R5Al9" style="text-align: right"&gt;2,120,707&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zKWIlhQq0Uvg" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1163"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__custom--ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember_zzPXJe4kndel" style="text-align: right"&gt;6,110,399&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Notes receivable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zNhNbhaSE1ma" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsAdditions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_fKDEp_zA3FJdF8vJwb" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--AllowanceForDoubtfulAccountsDeductions_pp0p0_d0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zXwWgWj5i4Gl" style="text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230701__20240630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--NotesReceivableMember_zsonrgb7xAri" style="text-align: right"&gt;777,354&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 4px; padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 10pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Included in provision for credit losses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001134"
      unitRef="USD">166049</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001136"
      unitRef="USD">107330</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2024-07-012025-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001138"
      unitRef="USD">9167</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2025-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001140"
      unitRef="USD">264212</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001141"
      unitRef="USD">12369921</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001142"
      unitRef="USD">2052824</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001143"
      unitRef="USD">126757</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2025-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001144"
      unitRef="USD">14295988</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001145"
      unitRef="USD">6110399</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001146"
      unitRef="USD">1026437</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2024-07-012025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001147"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2025-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001148"
      unitRef="USD">7136836</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001149"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2024-07-012025-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001150"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2024-07-012025-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001151"
      unitRef="USD">777354</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001153"
      unitRef="USD">198593</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2023-07-012024-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001155"
      unitRef="USD">32544</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_us-gaap_AccountsReceivableMember"
      decimals="0"
      id="Fact001156"
      unitRef="USD">166049</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001157"
      unitRef="USD">12608567</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001158"
      unitRef="USD">-238646</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableMember"
      decimals="0"
      id="Fact001160"
      unitRef="USD">12369921</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001161"
      unitRef="USD">3989692</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2023-07-012024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001162"
      unitRef="USD">2120707</FONR:AllowanceForDoubtfulAccountsAdditions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_custom_ManagementAndOtherFeesReceivableRelatedMedicalPracticesMember"
      decimals="0"
      id="Fact001164"
      unitRef="USD">6110399</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001165"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:AllowanceForDoubtfulAccountsAdditions
      contextRef="From2023-07-012024-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001166"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsAdditions>
    <FONR:AllowanceForDoubtfulAccountsDeductions
      contextRef="From2023-07-012024-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001167"
      unitRef="USD">0</FONR:AllowanceForDoubtfulAccountsDeductions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-06-30_us-gaap_NotesReceivableMember"
      decimals="0"
      id="Fact001168"
      unitRef="USD">777354</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001180"
      unitRef="Ratio">0.11</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001182"
      unitRef="Ratio">0.11</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2022-07-012023-06-30"
      decimals="INF"
      id="Fact001184"
      unitRef="Ratio">0.12</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:TotalFacilitiesOwnedOrManagedTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001186">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zOv85HqtP6ba" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Total Facilities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B1_zQpHJjCYPWUi" style="display: none"&gt;Schedule of facilities&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_498_20240701__20250630_z126F3J4Yx3f" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_493_20230701__20240630_zIawC8tkkTwh" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--TotalFacilitiesOwnedOrManagedAtBeginningOfYear_zD376GVhfX8h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Total Facilities Owned or Managed (at Beginning of Year)&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;28&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;27&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Facilities Added by:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--ManagedFacilitiesAddedByInternalDevelopment_z99TkL8sA8S7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"&gt;Internal development&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1191"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;1&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--ManagedFacilitiesClosedDuringYear_d0_zrsS1XQIBhVa" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Managed Facilities Closed&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--TotalFacilitiesOwnedOrManagedAtEndOfYear_zjB1j5c3yxQ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total Facilities Owned or Managed (at End of Year)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;28&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;28&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</FONR:TotalFacilitiesOwnedOrManagedTableTextBlock>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001188"
      unitRef="Integer">28</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001189"
      unitRef="Integer">27</FONR:TotalFacilitiesOwnedOrManagedAtBeginningOfYear>
    <FONR:ManagedFacilitiesAddedByInternalDevelopment
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001192"
      unitRef="Integer">1</FONR:ManagedFacilitiesAddedByInternalDevelopment>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001194"
      unitRef="Integer">0</FONR:ManagedFacilitiesClosedDuringYear>
    <FONR:ManagedFacilitiesClosedDuringYear
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001195"
      unitRef="Integer">0</FONR:ManagedFacilitiesClosedDuringYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001197"
      unitRef="Integer">28</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001198"
      unitRef="Integer">28</FONR:TotalFacilitiesOwnedOrManagedAtEndOfYear>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001200">&lt;p id="xdx_808_eus-gaap--InventoryDisclosureTextBlock_zlxtrqpo5x8g" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 4 &#x2013; &lt;span id="xdx_822_z0qw8X0GKEMi"&gt;INVENTORIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventories included in the accompanying consolidated
balance sheets consist of:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zXfuasFLh8Y3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BF_zLeNHzBUWhj6" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_499_20250630_zpqQ2Y1skoLc" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_493_20240630_zkiufqQwbpMa" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_z4C251s1UJ5f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Purchased parts and components&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;2,630,439&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;2,524,201&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zczgmYK1Nqy8" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Work-in-process&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;182,243&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;191,240&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_z5v0Y3GQUwd4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Inventories&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,812,682&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,715,441&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;



















</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001202">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zXfuasFLh8Y3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BF_zLeNHzBUWhj6" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_499_20250630_zpqQ2Y1skoLc" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_493_20240630_zkiufqQwbpMa" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OtherInventorySupplies_iI_maIFGAWzdt0_z4C251s1UJ5f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Purchased parts and components&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;2,630,439&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;2,524,201&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_maIFGAWzdt0_zczgmYK1Nqy8" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Work-in-process&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;182,243&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;191,240&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--InventoryNet_iTI_mtIFGAWzdt0_z5v0Y3GQUwd4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Inventories&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,812,682&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,715,441&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001204"
      unitRef="USD">2630439</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001205"
      unitRef="USD">2524201</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001207"
      unitRef="USD">182243</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001208"
      unitRef="USD">191240</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001210"
      unitRef="USD">2812682</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001211"
      unitRef="USD">2715441</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001221">&lt;p id="xdx_803_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zNfR68MlYpfj" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 - &lt;span id="xdx_823_z8QBK0CLcYCg"&gt;PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment, at cost, less accumulated
depreciation and amortization, at June 30, 2025 and 2024, is comprised of:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zhQrThtXHej6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B2_zf0Yg3aSYLDj" style="display: none"&gt;Schedule of Property and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zK9QK5pEKOR3" style="width: 12%; text-align: right" title="Property plant and equipment, gross"&gt;35,276,823&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zYuokfAvcAS" style="width: 12%; text-align: right" title="Property plant and equipment, gross"&gt;33,243,694&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zJSildhDTxqc" style="text-align: right" title="Property plant and equipment, gross"&gt;6,490,872&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_z1qEXteKY4G" style="text-align: right" title="Property plant and equipment, gross"&gt;6,199,941&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Machinery and equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zMc7k7RwnCz9" style="text-align: right" title="Property plant and equipment, gross"&gt;2,128,398&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zfqYNyooTeNd" style="text-align: right" title="Property plant and equipment, gross"&gt;2,069,055&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzCw7Tco2Gtj" style="text-align: right" title="Property plant and equipment, gross"&gt;3,756,017&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ziy0RbjYTIaj" style="text-align: right" title="Property plant and equipment, gross"&gt;3,742,169&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Leasehold improvements&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zlZRvCL1gT26" style="text-align: right" title="Property plant and equipment, gross"&gt;17,707,234&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zDg71aaJXVU" style="text-align: right" title="Property plant and equipment, gross"&gt;16,312,904&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Building&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zXYkJLFbbe3c" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross"&gt;939,614&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zethhpJzCrk5" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross"&gt;939,614&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630_zT6kwXaazpdf" style="text-align: right" title="Property plant and equipment, gross"&gt;66,298,958&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zUfqB06j7V33" style="text-align: right" title="Property plant and equipment, gross"&gt;62,507,377&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Less: Accumulated depreciation and amortization&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20250630_zhRXJINJqTW7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;47,767,039&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zCHOg3CwHw34" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;43,798,457&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20250630_zYiilL7oZRu2" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net"&gt;18,531,919&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zP8Phe8iKCX1" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net"&gt;18,708,920&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Depreciation of property and equipment for the years
ended June 30, 2025 and 2024 was $&lt;span id="xdx_909_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20240701__20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_zYuCYFwKcBVf" title="Depreciation and amortization of property and equipment"&gt;3,968,582&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--OtherDepreciationAndAmortization_pp0p0_c20230701__20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--PropertyPlantAndEquipmentMember_z1F5RNfQ9Cle" title="Depreciation and amortization of property and equipment"&gt;4,227,414&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001223">&lt;table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_zhQrThtXHej6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT - Property and equipment (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B2_zf0Yg3aSYLDj" style="display: none"&gt;Schedule of Property and equipment&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Diagnostic equipment&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zK9QK5pEKOR3" style="width: 12%; text-align: right" title="Property plant and equipment, gross"&gt;35,276,823&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--DiagnosticEquipmentMember_zYuokfAvcAS" style="width: 12%; text-align: right" title="Property plant and equipment, gross"&gt;33,243,694&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Research, development and demonstration equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_zJSildhDTxqc" style="text-align: right" title="Property plant and equipment, gross"&gt;6,490,872&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ResearchDevelopmentAndDemonstrationEquipmentMember_z1qEXteKY4G" style="text-align: right" title="Property plant and equipment, gross"&gt;6,199,941&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Machinery and equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zMc7k7RwnCz9" style="text-align: right" title="Property plant and equipment, gross"&gt;2,128,398&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zfqYNyooTeNd" style="text-align: right" title="Property plant and equipment, gross"&gt;2,069,055&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Furniture and fixtures&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zzCw7Tco2Gtj" style="text-align: right" title="Property plant and equipment, gross"&gt;3,756,017&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ziy0RbjYTIaj" style="text-align: right" title="Property plant and equipment, gross"&gt;3,742,169&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Leasehold improvements&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zlZRvCL1gT26" style="text-align: right" title="Property plant and equipment, gross"&gt;17,707,234&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zDg71aaJXVU" style="text-align: right" title="Property plant and equipment, gross"&gt;16,312,904&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Building&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20250630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zXYkJLFbbe3c" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross"&gt;939,614&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20240630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--BuildingMember_zethhpJzCrk5" style="border-bottom: Black 1pt solid; text-align: right" title="Property plant and equipment, gross"&gt;939,614&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250630_zT6kwXaazpdf" style="text-align: right" title="Property plant and equipment, gross"&gt;66,298,958&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20240630_zUfqB06j7V33" style="text-align: right" title="Property plant and equipment, gross"&gt;62,507,377&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Less: Accumulated depreciation and amortization&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20250630_zhRXJINJqTW7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;47,767,039&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pp0p0_c20240630_zCHOg3CwHw34" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation and amortization"&gt;43,798,457&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20250630_zYiilL7oZRu2" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net"&gt;18,531,919&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20240630_zP8Phe8iKCX1" style="border-bottom: Black 2.5pt double; text-align: right" title="Property plant and equipment, net"&gt;18,708,920&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      id="Fact001225"
      unitRef="USD">35276823</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_custom_DiagnosticEquipmentMember"
      decimals="0"
      id="Fact001227"
      unitRef="USD">33243694</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember"
      decimals="0"
      id="Fact001229"
      unitRef="USD">6490872</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_custom_ResearchDevelopmentAndDemonstrationEquipmentMember"
      decimals="0"
      id="Fact001231"
      unitRef="USD">6199941</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact001233"
      unitRef="USD">2128398</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_us-gaap_MachineryAndEquipmentMember"
      decimals="0"
      id="Fact001235"
      unitRef="USD">2069055</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact001237"
      unitRef="USD">3756017</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact001239"
      unitRef="USD">3742169</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact001241"
      unitRef="USD">17707234</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact001243"
      unitRef="USD">16312904</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-06-30_us-gaap_BuildingMember"
      decimals="0"
      id="Fact001245"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30_us-gaap_BuildingMember"
      decimals="0"
      id="Fact001247"
      unitRef="USD">939614</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001249"
      unitRef="USD">66298958</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001251"
      unitRef="USD">62507377</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001253"
      unitRef="USD">47767039</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001255"
      unitRef="USD">43798457</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001257"
      unitRef="USD">18531919</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001259"
      unitRef="USD">18708920</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2024-07-012025-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      id="Fact001261"
      unitRef="USD">3968582</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2023-07-012024-06-30_us-gaap_PropertyPlantAndEquipmentMember"
      decimals="0"
      id="Fact001263"
      unitRef="USD">4227414</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001265">&lt;p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zhRhpwUelLVl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 6 &#x2013; &lt;span id="xdx_825_zvvZQ22xs477"&gt;OPERATING AND FINANCE LEASES&lt;/span&gt; &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for its various operating leases
in accordance with Accounting Standards Codification (&#x2018;ASC&#x2019;) 842 &#x2013; Lease, as updated by ASU 2016-02. At the inception
of a lease, the Company recognizes right-of-use lease assets and related lease liabilities measured at present value of future lease payments
on its balance sheet. Lease expense is recognized on a straight-line basis over the term of the lease. Our most common initial term varies
in length from 2 to 19 years. Including renewal options negotiated with the landlord, we have a total span of 2 to 16 years at the facilities
we lease. The Company reviewed its contracts with vendors and customers, determining that its right-to-use lease assets consisted of only
office space operating leases. In determining the right-to-use lease assets and liabilities, the Company did recognize lease extension
options which the Company feels would be reasonably exercised. Our incremental borrowing rate (&#x201c;IBR&#x201d;) used to discount the
stream of operating lease payments is closely related to the interest rates available to the Company. A reconciliation of operating and
finance lease payments undiscounted cash flows to lease liabilities recognized as of June 30, 2025 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





















&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDxsI4Y1txYj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span id="xdx_8B1_zyWAFiHIlaTj" style="display: none"&gt;Schedule of Operating Lease and Finance Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Year Ending June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Operating Lease Payments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Finance Lease Payments&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: center; text-indent: -10pt"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zWDafO3P5Mpc" style="width: 26%; text-align: right" title="2025"&gt;5,753,674&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zdM46sjVWWO8" style="width: 26%; text-align: right" title="2025"&gt;244,343&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2027&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpHOsA8i0Oxf" style="text-align: right" title="2026"&gt;5,718,999&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zz6FVYs7zQk9" style="text-align: right" title="2026"&gt;142,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2028&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z2pSmtSplgo4" style="text-align: right" title="2027"&gt;5,629,193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zapwCpj5pNOh" style="text-align: right" title="2027"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1288"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2029&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zvxWe8aR5wXa" style="text-align: right" title="2028"&gt;5,240,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zgi9a6oLwg2d" style="text-align: right" title="2028"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2030&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zyOQhJ3L78I2" style="text-align: right" title="2029"&gt;5,120,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z4fS9Ud9lM6" style="text-align: right" title="2029"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziPkLtEvicAc" style="text-align: right" title="Thereafter"&gt;25,496,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpJoeYoMem4k" style="text-align: right" title="Thereafter"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Present value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PresentValueDiscount_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zwtqB5IIYRWk" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;(14,427,905&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBCRri7I40T7" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;(117&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zkj0dvleg71l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;38,531,582&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zEn4RLK9fS0l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;386,760&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zS6AbEg0VIfd" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_z3eDopoWTWJj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B7_zTgX3n0ZahDd" style="display: none"&gt;Schedule of Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Operating leases - years&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zHlomr5OInP6" title="Operating leases - years"&gt;10.2&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zSLNi8IY6hMl" title="Operating leases - years"&gt;11.0&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Finance lease - years&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zi92dpfFY5si" title="Finance lease - years"&gt;1.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zOCJPz0V9nag" title="Finance lease - years"&gt;2.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Weighted Average Discount Rate&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Operating leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_zyFv1teZ9Irk" title="Weighted average discount rate, operating leases"&gt;6.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zzJorkakxBe6" title="Weighted average discount rate, operating leases"&gt;6.4&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Finance lease&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_z4fe2RW4uQRb" title="Weighted average discount rate, finance leases"&gt;3.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zhSBSeTbvqc8" title="Weighted average discount rate, finance leases"&gt;3.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A1_zrVdHwgD7SWf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zljEX1DG6Aqe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Components of lease expense (Details 2)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt; width: 56%"&gt;&lt;span id="xdx_8BE_zAgY4K5dylD1" style="display: none"&gt;Schedule of components of lease expense&lt;/span&gt; &lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_498_20240701__20250630_zwJTsmfnQdb" style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_498_20230701__20240630_zFFQzwnCo355" style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Components of lease expense&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Operating lease cost&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;6,110,496&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;5,685,008&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zNsu6kYYDVx5" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Finance lease cost:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zC2enzvr4oii" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Depreciation of leased equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;198,881&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;198,881&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Interest on lease liabilities&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,812&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,534&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_zS5IjtXWMVfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total finance lease cost&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;215,693&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;225,415&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Supplemental cash flow information related to leases
was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z2nLlQ5RQM4d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Related to leases (Details 3)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BA_zYxWJuZ5EVlj" style="display: none"&gt;Schedule
    of supplemental cash flow information related to leases&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_499_20240701__20250630_zFX1nnOT7YRi" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_495_20230701__20240630_zY41PWDBBtBa" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Supplemental cash flow information related to leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zo6hVNilhBz3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Operating cash flows from operating leases&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;5,729,571&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;6,363,561&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zUp3F5j14cah" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Financing cash flows from finance leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;264,705&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;244,344&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zdnfXNxVLRrk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Right-of-use and equipment assets obtained in exchange for lease obligations:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zFx4RM1MNeek" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Operating leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;2,319,913&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;3,715,138&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Rent expense for operating leases approximated $&lt;span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240701__20250630_zpkqqDqSdoMc" title="Operating leases"&gt;6,110,000&lt;/span&gt;
and $&lt;span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zXAIAMTZgLl3" title="Operating leases"&gt;5,685,000&lt;/span&gt;, for the years ended June 30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Rent expense for the finance lease approximated
$&lt;span id="xdx_901_eus-gaap--LeaseIncome_c20240701__20250630_z0t45OaNfeZ" title="financing lease"&gt;216,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--LeaseIncome_c20230701__20240630_zWb0iyuHy9V6" title="financing lease"&gt;225,000&lt;/span&gt; for the years ended June 30, 2025 and 2024, respectively.&#160;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001276">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zDxsI4Y1txYj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span id="xdx_8B1_zyWAFiHIlaTj" style="display: none"&gt;Schedule of Operating Lease and Finance Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Year Ending June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Operating Lease Payments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Finance Lease Payments&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 27%; text-align: center; text-indent: -10pt"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zWDafO3P5Mpc" style="width: 26%; text-align: right" title="2025"&gt;5,753,674&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zdM46sjVWWO8" style="width: 26%; text-align: right" title="2025"&gt;244,343&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2027&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpHOsA8i0Oxf" style="text-align: right" title="2026"&gt;5,718,999&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zz6FVYs7zQk9" style="text-align: right" title="2026"&gt;142,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2028&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z2pSmtSplgo4" style="text-align: right" title="2027"&gt;5,629,193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zapwCpj5pNOh" style="text-align: right" title="2027"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1288"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2029&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zvxWe8aR5wXa" style="text-align: right" title="2028"&gt;5,240,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zgi9a6oLwg2d" style="text-align: right" title="2028"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2030&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zyOQhJ3L78I2" style="text-align: right" title="2029"&gt;5,120,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z4fS9Ud9lM6" style="text-align: right" title="2029"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziPkLtEvicAc" style="text-align: right" title="Thereafter"&gt;25,496,885&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_d0_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zpJoeYoMem4k" style="text-align: right" title="Thereafter"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Present value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PresentValueDiscount_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zwtqB5IIYRWk" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;(14,427,905&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PresentValueDiscountFinancingLease_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zBCRri7I40T7" style="border-bottom: Black 1pt solid; text-align: right" title="Present value discount"&gt;(117&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Total lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zkj0dvleg71l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;38,531,582&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiability_iI_c20250630__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zEn4RLK9fS0l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total lease liability"&gt;386,760&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001278"
      unitRef="USD">5753674</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001280"
      unitRef="USD">244343</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001282"
      unitRef="USD">5718999</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001284"
      unitRef="USD">142534</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001286"
      unitRef="USD">5629193</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001290"
      unitRef="USD">5240019</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001292"
      unitRef="USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001294"
      unitRef="USD">5120717</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001296"
      unitRef="USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001298"
      unitRef="USD">25496885</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001300"
      unitRef="USD">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount
      contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001302"
      unitRef="USD">-14427905</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease
      contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001304"
      unitRef="USD">-117</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2025-06-30_custom_OperatingLeasePaymentsMember"
      decimals="0"
      id="Fact001306"
      unitRef="USD">38531582</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="AsOf2025-06-30_custom_FinancingLeasePaymentsMember"
      decimals="0"
      id="Fact001308"
      unitRef="USD">386760</us-gaap:FinanceLeaseLiability>
    <FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001310">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock_z3eDopoWTWJj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Weighted average remaining lease term (Details 1)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B7_zTgX3n0ZahDd" style="display: none"&gt;Schedule of Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Operating leases - years&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zHlomr5OInP6" title="Operating leases - years"&gt;10.2&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zSLNi8IY6hMl" title="Operating leases - years"&gt;11.0&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Finance lease - years&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20250630_zi92dpfFY5si" title="Finance lease - years"&gt;1.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--FinanceLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20240630_zOCJPz0V9nag" title="Finance lease - years"&gt;2.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Weighted Average Discount Rate&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Operating leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_zyFv1teZ9Irk" title="Weighted average discount rate, operating leases"&gt;6.5&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zzJorkakxBe6" title="Weighted average discount rate, operating leases"&gt;6.4&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Finance lease&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20250630_z4fe2RW4uQRb" title="Weighted average discount rate, finance leases"&gt;3.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--FinanceLeaseWeightedAverageDiscountRatePercent_iI_dp_c20240630_zhSBSeTbvqc8" title="Weighted average discount rate, finance leases"&gt;3.6&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</FONR:ScheduleOfWeightedAverageRemainingLeaseTermTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2025-06-30" id="Fact001312">P10Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-06-30" id="Fact001314">P11Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2025-06-30" id="Fact001316">P1Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-06-30" id="Fact001318">P2Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact001320"
      unitRef="Ratio">0.065</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001322"
      unitRef="Ratio">0.064</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact001324"
      unitRef="Ratio">0.036</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001326"
      unitRef="Ratio">0.036</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001328">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zljEX1DG6Aqe" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Components of lease expense (Details 2)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt; width: 56%"&gt;&lt;span id="xdx_8BE_zAgY4K5dylD1" style="display: none"&gt;Schedule of components of lease expense&lt;/span&gt; &lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_498_20240701__20250630_zwJTsmfnQdb" style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_498_20230701__20240630_zFFQzwnCo355" style="text-align: right; width: 12%"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Components of lease expense&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeaseCost_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Operating lease cost&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;6,110,496&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;5,685,008&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--FinanceLeaseCostsAbstract_iB_zNsu6kYYDVx5" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Finance lease cost:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--DepreciationOfLeasedEquipment_i01_pp0p0_zC2enzvr4oii" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Depreciation of leased equipment&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;198,881&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;198,881&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--FinanceLeaseInterestExpense_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Interest on lease liabilities&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,812&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,534&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--FinanceLeaseCost_i01_pp0p0_zS5IjtXWMVfi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total finance lease cost&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;215,693&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;225,415&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Supplemental cash flow information related to leases
was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z2nLlQ5RQM4d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Related to leases (Details 3)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BA_zYxWJuZ5EVlj" style="display: none"&gt;Schedule
    of supplemental cash flow information related to leases&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_499_20240701__20250630_zFX1nnOT7YRi" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_495_20230701__20240630_zY41PWDBBtBa" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Supplemental cash flow information related to leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zo6hVNilhBz3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Operating cash flows from operating leases&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;5,729,571&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;6,363,561&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zUp3F5j14cah" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Financing cash flows from finance leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;264,705&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;244,344&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zdnfXNxVLRrk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Right-of-use and equipment assets obtained in exchange for lease obligations:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zFx4RM1MNeek" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Operating leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;2,319,913&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;3,715,138&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Rent expense for operating leases approximated $&lt;span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240701__20250630_zpkqqDqSdoMc" title="Operating leases"&gt;6,110,000&lt;/span&gt;
and $&lt;span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zXAIAMTZgLl3" title="Operating leases"&gt;5,685,000&lt;/span&gt;, for the years ended June 30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Rent expense for the finance lease approximated
$&lt;span id="xdx_901_eus-gaap--LeaseIncome_c20240701__20250630_z0t45OaNfeZ" title="financing lease"&gt;216,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--LeaseIncome_c20230701__20240630_zWb0iyuHy9V6" title="financing lease"&gt;225,000&lt;/span&gt; for the years ended June 30, 2025 and 2024, respectively.&#160;&lt;/p&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001330"
      unitRef="USD">6110496</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001331"
      unitRef="USD">5685008</us-gaap:OperatingLeaseCost>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001336"
      unitRef="USD">198881</FONR:DepreciationOfLeasedEquipment>
    <FONR:DepreciationOfLeasedEquipment
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001337"
      unitRef="USD">198881</FONR:DepreciationOfLeasedEquipment>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001339"
      unitRef="USD">16812</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001340"
      unitRef="USD">26534</us-gaap:FinanceLeaseInterestExpense>
    <FONR:FinanceLeaseCost
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001342"
      unitRef="USD">215693</FONR:FinanceLeaseCost>
    <FONR:FinanceLeaseCost
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001343"
      unitRef="USD">225415</FONR:FinanceLeaseCost>
    <FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001356">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SupplementalCashFlowInformationRelatedToLeasesTableTextBlock_z2nLlQ5RQM4d" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Related to leases (Details 3)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BA_zYxWJuZ5EVlj" style="display: none"&gt;Schedule
    of supplemental cash flow information related to leases&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_499_20240701__20250630_zFX1nnOT7YRi" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_495_20230701__20240630_zY41PWDBBtBa" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Supplemental cash flow information related to leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For Year Ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--OperatingCashFlowsFromOperatingLeases_zo6hVNilhBz3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Operating cash flows from operating leases&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;5,729,571&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;6,363,561&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--FinancingCashFlowsFromFinancingLeases_zUp3F5j14cah" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Financing cash flows from finance leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;264,705&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;244,344&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObligationsAbstract_iB_zdnfXNxVLRrk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Right-of-use and equipment assets obtained in exchange for lease obligations:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases_zFx4RM1MNeek" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Operating leases&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;2,319,913&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;$&lt;/td&gt;
&lt;td style="text-align: right"&gt;3,715,138&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company rents its operating facilities and certain
equipment, pursuant to operating lease agreements expiring at various dates through November 2033. The leases for certain facilities contain
escalation clauses relating to increases in real property taxes as well as certain maintenance costs.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Rent expense for operating leases approximated $&lt;span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20240701__20250630_zpkqqDqSdoMc" title="Operating leases"&gt;6,110,000&lt;/span&gt;
and $&lt;span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20230701__20240630_zXAIAMTZgLl3" title="Operating leases"&gt;5,685,000&lt;/span&gt;, for the years ended June 30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Rent expense for the finance lease approximated
$&lt;span id="xdx_901_eus-gaap--LeaseIncome_c20240701__20250630_z0t45OaNfeZ" title="financing lease"&gt;216,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--LeaseIncome_c20230701__20240630_zWb0iyuHy9V6" title="financing lease"&gt;225,000&lt;/span&gt; for the years ended June 30, 2025 and 2024, respectively.&#160;&lt;/p&gt;

</FONR:SupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001358"
      unitRef="USD">5729571</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:OperatingCashFlowsFromOperatingLeases
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001359"
      unitRef="USD">6363561</FONR:OperatingCashFlowsFromOperatingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001361"
      unitRef="USD">264705</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:FinancingCashFlowsFromFinancingLeases
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001362"
      unitRef="USD">244344</FONR:FinancingCashFlowsFromFinancingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001367"
      unitRef="USD">2319913</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001368"
      unitRef="USD">3715138</FONR:RightofuseEquipmentAssetsObtainedInExchangeForLeaseObiligationsOperatingLeases>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001370"
      unitRef="USD">6110000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001372"
      unitRef="USD">5685000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseIncome
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001374"
      unitRef="USD">216000</us-gaap:LeaseIncome>
    <us-gaap:LeaseIncome
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001376"
      unitRef="USD">225000</us-gaap:LeaseIncome>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001378">&lt;p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zD38rXrHOOs9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 7 - &lt;span id="xdx_827_zXWJqVwtJ1O9"&gt;OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Other intangible assets, net of accumulated amortization,
at June 30, 2025 and 2024, are comprised of:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_ze6jecy5jy7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zjdKFLW30TPa" style="display: none"&gt;Schedule of other intangible assets, net of accumulated amortization&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted average useful lives&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Gross carrying amount &#x2013; June 30, 2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated amortization &#x2013; June 30, 2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net carrying amount &#x2013; June 30, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Capitalized software development costs&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right"&gt;&#160;&#160;&lt;span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zcxLjNHjo9sb" title="Weighted average useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zccub73dIco1" style="width: 10%; text-align: right" title="Gross other intangible assets"&gt;7,004,847&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zenFCJDbiTWe" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"&gt;(7,004,847&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zNf0GA3B27F1" style="width: 10%; text-align: right" title=" intangible assets net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1388"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Software License&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zIdQ5TNLS9t7" title="Weighted average useful lives"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zs2WTzhFVN68" style="text-align: right" title="Gross other intangible assets"&gt;1,260,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z7gmBJxtnlga" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(756,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z9S58DXrYEbc" style="text-align: right" title=" intangible assets net"&gt;504,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Patents and copy rights&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zXsn4jzgsvt8" title="Weighted average useful lives"&gt;15&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmqbV8MRz8t3" style="text-align: right" title="Gross other intangible assets"&gt;5,229,429&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zoVolr2puTpb" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(4,255,393&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zDMJRimb7izl" style="text-align: right" title=" intangible assets net"&gt;974,036&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Non-compete&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_904_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zUlA3pNL0DF8" title="Weighted average useful lives"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfwnnbDZAip7" style="text-align: right" title="Gross other intangible assets"&gt;4,150,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zulGgrVw5Zol" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(4,150,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zepyzPDKoKfd" style="text-align: right" title=" intangible assets net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1412"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Customer relationships&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_908_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zh8vu5XvfQ22" title="Weighted average useful lives"&gt;20&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmU99ITjAMi3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;3,900,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsNkcMF7qdAk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"&gt;(2,385,833&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKxPB3QSMXV6" style="border-bottom: Black 1pt solid; text-align: right" title=" intangible assets net"&gt;1,514,167&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Total&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630_zFfyRNB2Xypi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets gross"&gt;21,544,276&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630_zaHDM4krr7wd" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"&gt;(18,552,073&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630_zUDro6zeOWLi" style="border-bottom: Black 2.5pt double; text-align: right" title=" intangible assets net"&gt;2,992,203&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted average useful lives&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Gross carrying amount &#x2013; June 30, 2024&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated amortization &#x2013; June 30, 2024&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net carrying amount &#x2013; June 30, 2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Capitalized software development costs&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right"&gt;&#160;&#160;&lt;span id="xdx_909_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuHnLpF844F6" title="Weighted average useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zkdToiDAbXdi" style="width: 10%; text-align: right" title="Gross other intangible assets"&gt;7,004,847&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zwOYD4f6kkBl" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"&gt;(7,004,847&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhwffGuiU8hg" style="width: 10%; text-align: right" title=" intangible assets net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1434"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Patents and copy rights&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zyn1e9LBAJt6" title="Weighted average useful lives"&gt;15&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zPaBw6qvJiz8" style="text-align: right" title="Gross other intangible assets"&gt;5,259,811&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zwKxMwYWS5C9" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(4,103,654&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpryeG6JUIO9" style="text-align: right" title=" intangible assets net"&gt;1,156,157&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Non-compete&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_907_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z23R4E4QgYL1" title="Weighted average useful lives"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zS0aXBWjl8th" style="text-align: right" title="Gross other intangible assets"&gt;4,150,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPx3nknpgai8" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(4,150,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWacoQ7pjq9b" style="text-align: right" title=" intangible assets net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1450"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Customer relationships&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CostomerRelationshipsMember_zIr2O851xmgb" title="Weighted average useful lives"&gt;20&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5jpHyQUy8o5" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;3,900,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXMVF3Q2PLof" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"&gt;(2,185,833&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDUXS7F6ngUk" style="border-bottom: Black 1pt solid; text-align: right" title=" intangible assets net"&gt;1,714,167&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Total&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zEeNu0QefyF7" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets gross"&gt;20,314,658&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_ztndbXvjdv91" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"&gt;(17,444,334&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zR5LdadD7Pbg" style="border-bottom: Black 2.5pt double; text-align: right" title=" intangible assets net"&gt;2,870,324&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AA_ziCJEZp9ikx" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The estimated amortization of other intangible assets
for the five years ending June 30, 2030 and thereafter is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zL4CB7bn6WA6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span id="xdx_8B8_zXfFJHBEFVI" style="display: none"&gt;Schedule of estimated amortization of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Schedule Of Other Intangible Assets For the Years Ending June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Software License&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Patents and Copyrights&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer Relationships&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 23%; text-align: center; text-indent: -10pt"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630_zCCOdsJlVbll" style="width: 14%; text-align: right" title="2025"&gt;756,880&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zdwFGC3NAu84" style="width: 14%; text-align: right" title="2025"&gt;420,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zr0THmwWgClg" style="width: 14%; text-align: right" title="2025"&gt;136,880&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5ZEtCVj8JJd" style="width: 14%; text-align: right" title="2025"&gt;200,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2027&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630_zgLcCYoSisD3" style="text-align: right" title="2026"&gt;402,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zsXJcdAqVhZc" style="text-align: right" title="2026"&gt;84,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zCcqbtaWH4" style="text-align: right" title="2026"&gt;118,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zJDzhMS8sD2i" style="text-align: right" title="2026"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2028&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630_zp71AsATWC58" style="text-align: right" title="2027"&gt;306,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zqM2uyzgpzca" style="text-align: right" title="2027"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1496"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zJQ67hcmp083" style="text-align: right" title="2027"&gt;106,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z46a9Lcsf8Rf" style="text-align: right" title="2027"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2029&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630_zYTCc38ldubk" style="text-align: right" title="2028"&gt;295,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zUHrCSjwdsOd" style="text-align: right" title="2028"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1504"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zExzTjdojVo4" style="text-align: right" title="2028"&gt;95,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvA4gKxrJVQ7" style="text-align: right" title="2028"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2030&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630_znyGkY0Rl8T7" style="text-align: right" title="2029"&gt;291,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zU31l1ljdJgg" style="text-align: right" title="2029"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zDgEwO9Sn4pb" style="text-align: right" title="2029"&gt;91,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvSZI8HnqoM5" style="text-align: right" title="2029"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630_zDTUNpSSRAhd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;939,432&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zduRQIijkgnb" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zeibptIFYaTd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;425,265&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zePM4ZpuYHK4" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;514,167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Other intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630_zEj0yRJlnV37" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;2,992,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zylRkfbEs2ua" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;504,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zTIbmCIdVqvf" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;974,036&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyxLZ2YzBNZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;1,514,167&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8A0_zzFGz7Mz7Dr6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The weighted average amortization period for other
intangible assets is &lt;span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630_z1fIAEwKl9N7" title="Weighted average amortization period for other intangible assets"&gt;9.0&lt;/span&gt; years and they have no expected residual value.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Information related to the above intangible assets
for the years ended June 30, 2025 and 2024 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zrN1IKH3zeIj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zRoyqIjQvYx1" style="display: none"&gt;Schedule of other
    intangible assets&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Other Intangible Assets&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year-ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Balance &#x2013; Beginning of Year&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20240701__20250630_zPr8UzMW4XF6" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;2,870,324&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zThxwgeLT55b" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;3,431,865&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Amounts capitalized&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AmountsCapitalized_pp0p0_c20240701__20250630_zj02muTNgbPk" style="text-align: right" title="Amounts capitalized"&gt;25,325&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zo9yVbNL1SA5" style="text-align: right" title="Amounts capitalized"&gt;32,885&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Patents written off&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20240701__20250630_zKST22nSdIVi" style="text-align: right" title="Patents written off"&gt;(55,707&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20230701__20240630_zEDW1XF8MExa" style="text-align: right" title="Patents written off"&gt;(225,419&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Correction of an error (Note 2)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--CorrectionOfError_pp0p0_c20240701__20250630_zJx9QIn2tu66" style="text-align: right" title="Correction of an error"&gt;882,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--CorrectionOfError_pp0p0_c20230701__20240630_zUbBj2Bx5eC9" style="text-align: right" title="Correction of an error"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1552"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Amortization&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AdjustmentForAmortization_pp0p0_c20240701__20250630_zJWS5jv7WHnc" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;(729,739&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zySzxFdKmeq9" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;(369,007&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Balance &#x2013; End of Year&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20240701__20250630_zCpYmqM2OMs" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;2,992,203&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zZh2Rb5CEhta" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;2,870,324&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AF_zhoq1KTUX1i7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization of patents and copyrights for the years
ended June 30, 2025 and 2024 amounted to $&lt;span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zAFME4lTP5rc" title="Amortization"&gt;151,739&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zalYfKXEXdqd" title="Amortization of patents and copyrights"&gt;169,007&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization of customer relationships for the years
ended June 30, 2025 and 2024 amounted to $&lt;span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zpzQG8QCvw84" title="Amortization"&gt;200,000&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyjCG4uFWuPk" title="Amortization of customer relationships"&gt;200,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;Amortization of software licenses for the years
ended June 30, 2025 and 2024 amounted to $&lt;span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_ztuveKsPBA4i" title="Amortization"&gt;378,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_zpqZDJfGWJk8" title="Amortization"&gt;0&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001380">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_ze6jecy5jy7l" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other intangible assets net of amortization (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zjdKFLW30TPa" style="display: none"&gt;Schedule of other intangible assets, net of accumulated amortization&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted average useful lives&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Gross carrying amount &#x2013; June 30, 2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated amortization &#x2013; June 30, 2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net carrying amount &#x2013; June 30, 2025&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Capitalized software development costs&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right"&gt;&#160;&#160;&lt;span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zcxLjNHjo9sb" title="Weighted average useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zccub73dIco1" style="width: 10%; text-align: right" title="Gross other intangible assets"&gt;7,004,847&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zenFCJDbiTWe" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"&gt;(7,004,847&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zNf0GA3B27F1" style="width: 10%; text-align: right" title=" intangible assets net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1388"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Software License&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zIdQ5TNLS9t7" title="Weighted average useful lives"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zs2WTzhFVN68" style="text-align: right" title="Gross other intangible assets"&gt;1,260,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z7gmBJxtnlga" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(756,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_z9S58DXrYEbc" style="text-align: right" title=" intangible assets net"&gt;504,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Patents and copy rights&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zXsn4jzgsvt8" title="Weighted average useful lives"&gt;15&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zmqbV8MRz8t3" style="text-align: right" title="Gross other intangible assets"&gt;5,229,429&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zoVolr2puTpb" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(4,255,393&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zDMJRimb7izl" style="text-align: right" title=" intangible assets net"&gt;974,036&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Non-compete&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_904_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zUlA3pNL0DF8" title="Weighted average useful lives"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zfwnnbDZAip7" style="text-align: right" title="Gross other intangible assets"&gt;4,150,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zulGgrVw5Zol" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(4,150,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zepyzPDKoKfd" style="text-align: right" title=" intangible assets net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1412"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Customer relationships&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_908_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20240701__20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zh8vu5XvfQ22" title="Weighted average useful lives"&gt;20&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zmU99ITjAMi3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;3,900,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsNkcMF7qdAk" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"&gt;(2,385,833&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zKxPB3QSMXV6" style="border-bottom: Black 1pt solid; text-align: right" title=" intangible assets net"&gt;1,514,167&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Total&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20250630_zFfyRNB2Xypi" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets gross"&gt;21,544,276&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20250630_zaHDM4krr7wd" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"&gt;(18,552,073&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20250630_zUDro6zeOWLi" style="border-bottom: Black 2.5pt double; text-align: right" title=" intangible assets net"&gt;2,992,203&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted average useful lives&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Gross carrying amount &#x2013; June 30, 2024&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated amortization &#x2013; June 30, 2024&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net carrying amount &#x2013; June 30, 2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Capitalized software development costs&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 10%; text-align: right"&gt;&#160;&#160;&lt;span id="xdx_909_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zuHnLpF844F6" title="Weighted average useful lives"&gt;5&lt;/span&gt; years&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zkdToiDAbXdi" style="width: 10%; text-align: right" title="Gross other intangible assets"&gt;7,004,847&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zwOYD4f6kkBl" style="width: 10%; text-align: right" title="Accumulated amortization intangible assets"&gt;(7,004,847&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_zhwffGuiU8hg" style="width: 10%; text-align: right" title=" intangible assets net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1434"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Patents and copy rights&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_90F_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zyn1e9LBAJt6" title="Weighted average useful lives"&gt;15&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zPaBw6qvJiz8" style="text-align: right" title="Gross other intangible assets"&gt;5,259,811&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zwKxMwYWS5C9" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(4,103,654&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zpryeG6JUIO9" style="text-align: right" title=" intangible assets net"&gt;1,156,157&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Non-compete&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_907_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_z23R4E4QgYL1" title="Weighted average useful lives"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zS0aXBWjl8th" style="text-align: right" title="Gross other intangible assets"&gt;4,150,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zPx3nknpgai8" style="text-align: right" title="Accumulated amortization intangible assets"&gt;(4,150,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zWacoQ7pjq9b" style="text-align: right" title=" intangible assets net"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1450"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Customer relationships&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_900_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230701__20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CostomerRelationshipsMember_zIr2O851xmgb" title="Weighted average useful lives"&gt;20&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5jpHyQUy8o5" style="border-bottom: Black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;3,900,000&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zXMVF3Q2PLof" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization intangible assets"&gt;(2,185,833&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zDUXS7F6ngUk" style="border-bottom: Black 1pt solid; text-align: right" title=" intangible assets net"&gt;1,714,167&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Total&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20240630_zEeNu0QefyF7" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets gross"&gt;20,314,658&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20240630_ztndbXvjdv91" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization intangible assets"&gt;(17,444,334&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20240630_zR5LdadD7Pbg" style="border-bottom: Black 2.5pt double; text-align: right" title=" intangible assets net"&gt;2,870,324&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="Fact001382">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001384"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001386"
      unitRef="USD">-7004847</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012025-06-30_custom_SoftwareLicenseMember"
      id="Fact001390">P3Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact001392"
      unitRef="USD">1260000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact001394"
      unitRef="USD">-756000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact001396"
      unitRef="USD">504000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012025-06-30_custom_PatentsAndCopyrightsMember"
      id="Fact001398">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-06-30_custom_PatentsAndCopyrightsMember"
      decimals="0"
      id="Fact001400"
      unitRef="USD">5229429</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-06-30_custom_PatentsAndCopyrightsMember"
      decimals="0"
      id="Fact001402"
      unitRef="USD">-4255393</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-06-30_custom_PatentsAndCopyrightsMember"
      decimals="0"
      id="Fact001404"
      unitRef="USD">974036</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012025-06-30_us-gaap_NoncompeteAgreementsMember"
      id="Fact001406">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      id="Fact001408"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      id="Fact001410"
      unitRef="USD">-4150000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2024-07-012025-06-30_us-gaap_CustomerRelationshipsMember"
      id="Fact001414">P20Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001416"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001418"
      unitRef="USD">-2385833</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001420"
      unitRef="USD">1514167</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001422"
      unitRef="USD">21544276</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001424"
      unitRef="USD">-18552073</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001426"
      unitRef="USD">2992203</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-07-012024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      id="Fact001428">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001430"
      unitRef="USD">7004847</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="0"
      id="Fact001432"
      unitRef="USD">-7004847</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-07-012024-06-30_custom_PatentsAndCopyrightsMember"
      id="Fact001436">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember"
      decimals="0"
      id="Fact001438"
      unitRef="USD">5259811</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember"
      decimals="0"
      id="Fact001440"
      unitRef="USD">-4103654</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30_custom_PatentsAndCopyrightsMember"
      decimals="0"
      id="Fact001442"
      unitRef="USD">1156157</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-07-012024-06-30_us-gaap_NoncompeteAgreementsMember"
      id="Fact001444">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      id="Fact001446"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="0"
      id="Fact001448"
      unitRef="USD">-4150000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="From2023-07-012024-06-30_custom_CostomerRelationshipsMember"
      id="Fact001452">P20Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001454"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001456"
      unitRef="USD">-2185833</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001458"
      unitRef="USD">1714167</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001460"
      unitRef="USD">20314658</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001462"
      unitRef="USD">-17444334</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001464"
      unitRef="USD">2870324</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001476">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zL4CB7bn6WA6" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  OTHER INTANGIBLE ASSETS - Schedule of other intangible assets - (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span id="xdx_8B8_zXfFJHBEFVI" style="display: none"&gt;Schedule of estimated amortization of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Schedule Of Other Intangible Assets For the Years Ending June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Software License&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Patents and Copyrights&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Customer Relationships&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 23%; text-align: center; text-indent: -10pt"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630_zCCOdsJlVbll" style="width: 14%; text-align: right" title="2025"&gt;756,880&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zdwFGC3NAu84" style="width: 14%; text-align: right" title="2025"&gt;420,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zr0THmwWgClg" style="width: 14%; text-align: right" title="2025"&gt;136,880&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5ZEtCVj8JJd" style="width: 14%; text-align: right" title="2025"&gt;200,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2027&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630_zgLcCYoSisD3" style="text-align: right" title="2026"&gt;402,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zsXJcdAqVhZc" style="text-align: right" title="2026"&gt;84,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zCcqbtaWH4" style="text-align: right" title="2026"&gt;118,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zJDzhMS8sD2i" style="text-align: right" title="2026"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2028&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630_zp71AsATWC58" style="text-align: right" title="2027"&gt;306,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zqM2uyzgpzca" style="text-align: right" title="2027"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1496"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zJQ67hcmp083" style="text-align: right" title="2027"&gt;106,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z46a9Lcsf8Rf" style="text-align: right" title="2027"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2029&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630_zYTCc38ldubk" style="text-align: right" title="2028"&gt;295,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zUHrCSjwdsOd" style="text-align: right" title="2028"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1504"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zExzTjdojVo4" style="text-align: right" title="2028"&gt;95,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvA4gKxrJVQ7" style="text-align: right" title="2028"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;2030&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630_znyGkY0Rl8T7" style="text-align: right" title="2029"&gt;291,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zU31l1ljdJgg" style="text-align: right" title="2029"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zDgEwO9Sn4pb" style="text-align: right" title="2029"&gt;91,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zvSZI8HnqoM5" style="text-align: right" title="2029"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630_zDTUNpSSRAhd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;939,432&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zduRQIijkgnb" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1520"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zeibptIFYaTd" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;425,265&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zePM4ZpuYHK4" style="border-bottom: Black 1pt solid; text-align: right" title="Thereafter"&gt;514,167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;Other intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630_zEj0yRJlnV37" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;2,992,203&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zylRkfbEs2ua" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;504,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zTIbmCIdVqvf" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;974,036&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_pp0p0_c20250630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyxLZ2YzBNZ6" style="border-bottom: Black 2.5pt double; text-align: right" title="Other intangible assets - net"&gt;1,514,167&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001478"
      unitRef="USD">756880</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact001480"
      unitRef="USD">420000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2025-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001482"
      unitRef="USD">136880</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001484"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001486"
      unitRef="USD">402426</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact001488"
      unitRef="USD">84000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2025-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001490"
      unitRef="USD">118426</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001492"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001494"
      unitRef="USD">306103</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2025-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001498"
      unitRef="USD">106103</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001500"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001502"
      unitRef="USD">295898</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2025-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001506"
      unitRef="USD">95898</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001508"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001510"
      unitRef="USD">291464</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2025-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001514"
      unitRef="USD">91464</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001516"
      unitRef="USD">200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001518"
      unitRef="USD">939432</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2025-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001522"
      unitRef="USD">425265</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001524"
      unitRef="USD">514167</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001526"
      unitRef="USD">2992203</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2025-06-30_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact001528"
      unitRef="USD">504000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2025-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001530"
      unitRef="USD">974036</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001532"
      unitRef="USD">1514167</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2024-07-01to2025-06-30" id="Fact001534">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001536">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zrN1IKH3zeIj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Intangle assets - (Details 2)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zRoyqIjQvYx1" style="display: none"&gt;Schedule of other
    intangible assets&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Other Intangible Assets&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year-ended June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Balance &#x2013; Beginning of Year&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_985_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20240701__20250630_zPr8UzMW4XF6" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;2,870,324&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_eus-gaap--OtherIntangibleAssetsNet_iS_pp0p0_c20230701__20240630_zThxwgeLT55b" style="width: 12%; text-align: right" title="Balance - Beginning of Year"&gt;3,431,865&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Amounts capitalized&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--AmountsCapitalized_pp0p0_c20240701__20250630_zj02muTNgbPk" style="text-align: right" title="Amounts capitalized"&gt;25,325&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--AmountsCapitalized_pp0p0_c20230701__20240630_zo9yVbNL1SA5" style="text-align: right" title="Amounts capitalized"&gt;32,885&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Patents written off&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_c20240701__20250630_zKST22nSdIVi" style="text-align: right" title="Patents written off"&gt;(55,707&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--SoftwareOrPatentsWrittenOff_pp0p0_d0_c20230701__20240630_zEDW1XF8MExa" style="text-align: right" title="Patents written off"&gt;(225,419&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Correction of an error (Note 2)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--CorrectionOfError_pp0p0_c20240701__20250630_zJx9QIn2tu66" style="text-align: right" title="Correction of an error"&gt;882,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_ecustom--CorrectionOfError_pp0p0_c20230701__20240630_zUbBj2Bx5eC9" style="text-align: right" title="Correction of an error"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1552"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Amortization&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_eus-gaap--AdjustmentForAmortization_pp0p0_c20240701__20250630_zJWS5jv7WHnc" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;(729,739&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_987_eus-gaap--AdjustmentForAmortization_pp0p0_c20230701__20240630_zySzxFdKmeq9" style="border-bottom: Black 1pt solid; text-align: right" title="Amortization"&gt;(369,007&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Balance &#x2013; End of Year&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_981_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20240701__20250630_zCpYmqM2OMs" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;2,992,203&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_eus-gaap--OtherIntangibleAssetsNet_iE_pp0p0_c20230701__20240630_zZh2Rb5CEhta" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance - End of Year"&gt;2,870,324&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001538"
      unitRef="USD">2870324</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001540"
      unitRef="USD">3431865</us-gaap:OtherIntangibleAssetsNet>
    <FONR:AmountsCapitalized
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001542"
      unitRef="USD">25325</FONR:AmountsCapitalized>
    <FONR:AmountsCapitalized
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001544"
      unitRef="USD">32885</FONR:AmountsCapitalized>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001546"
      unitRef="USD">-55707</FONR:SoftwareOrPatentsWrittenOff>
    <FONR:SoftwareOrPatentsWrittenOff
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001548"
      unitRef="USD">-225419</FONR:SoftwareOrPatentsWrittenOff>
    <FONR:CorrectionOfError
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001550"
      unitRef="USD">882000</FONR:CorrectionOfError>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001554"
      unitRef="USD">-729739</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001556"
      unitRef="USD">-369007</us-gaap:AdjustmentForAmortization>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001558"
      unitRef="USD">2992203</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001560"
      unitRef="USD">2870324</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-07-012025-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001562"
      unitRef="USD">151739</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-07-012024-06-30_us-gaap_PatentsMember"
      decimals="0"
      id="Fact001564"
      unitRef="USD">169007</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-07-012025-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001566"
      unitRef="USD">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-07-012024-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="0"
      id="Fact001568"
      unitRef="USD">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-07-012025-06-30_custom_SoftwareLicensesMember"
      decimals="0"
      id="Fact001570"
      unitRef="USD">378000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-07-012024-06-30_custom_SoftwareLicensesMember"
      decimals="0"
      id="Fact001572"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <FONR:CapitalStockDisclosureTextblock contextRef="From2024-07-01to2025-06-30" id="Fact001582">&lt;p id="xdx_80C_ecustom--CapitalStockDisclosureTextblock_zHHv1W1A8TZ6" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 8 - &lt;span id="xdx_827_z4QSNReuWRng"&gt;CAPITAL STOCK&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Common Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_90A_eus-gaap--DividendsPayableNature_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zXSswjGHQ8Ie" title="Dividends payable, nature"&gt;Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Class B Common Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_905_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKQyhbPpBhL" title="Conversuion of shares into one-for-one basis"&gt;Class B common stock is convertible into shares of
common stock on a one-for-one basis&lt;/span&gt;. &lt;span id="xdx_903_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zJol8IZHUJS4" title="Common stock, voting rights"&gt;Class B common stock has 10 votes per share&lt;/span&gt;. There were &lt;span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zdo5EDKZUmwi" title="Common stock, shares outstanding"&gt;146&lt;/span&gt; of such shares outstanding at June 30,
2025and 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Class C Common Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_901_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3pQJwiLOxbd" title="Common stock, voting rights"&gt;The Class C common stock has 25 votes per share&lt;/span&gt;, as
compared to 10 votes per share for the Class B common stock and &lt;span id="xdx_903_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zS7ACJoeO16b" title="Common stock, voting rights"&gt;one vote per share for the common stock&lt;/span&gt;. &lt;span id="xdx_900_eus-gaap--StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zM2dDRgKwQia"&gt;The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock&lt;/span&gt;. Although having greater voting power, each share of Class
C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock
is convertible into shares of common stock on a three-for-one basis.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Class A Non-Voting Preferred Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 3, 1995, the stockholders ratified a proposal
consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a
stock dividend on the Company&#x2019;s common stock consisting of &lt;span id="xdx_90B_eus-gaap--CommonStockVotingRights_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zJy7J9MEIbbg"&gt;one share of Class A non-voting preferred stock for every five shares
of common stock&lt;/span&gt;. &lt;span id="xdx_903_eus-gaap--DividendsPayableNature_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zIo256cYieN1"&gt;The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Class A non-voting preferred stock is entitled
to a special dividend equal to 3-1/4% of the first $10 million, 4-1/2% of the next $20 million and 5-1/2% on amounts in excess of $30
million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company&#x2019;s
patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company&#x2019;s
patents.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Class A non-voting preferred stock participates
on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights,
liquidation rights and other rights and preferences (other than the voting rights).&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Stock Bonus Plans&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 23, 2010, the Board approved the 2010 Stock
Bonus Plan. The plan entitles the Company to reserve &lt;span id="xdx_901_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20100423__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zgOy0mSFNc3f" title="Common stock, capital shares reserved for future issuance"&gt;2,000,000&lt;/span&gt; shares of common stock. On August 10, 2010, the Company filed Form S-8
to register the &lt;span id="xdx_90E_ecustom--SharesRegistered_iI_c20100810__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zfjS1k6B8Ydk" title="Shares registered"&gt;2,000,000&lt;/span&gt; shares. As of June 30, 2025, &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20250630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_z03zCl9loHLh" title="Number of shares available for future grant"&gt;450,177&lt;/span&gt; shares of common stock of FONAR were available for future grant under this
plan. For the years ended June 30, 2025 and 2024, &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20230701__20240630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zCU20jmQtUH8" title="Number of shares were issued"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_do_c20240701__20250630__us-gaap--PlanNameAxis__custom--N2010StockBonusPlanMember_zXE6TBaGNNp" title="Number of shares were issued"&gt;no&lt;/span&gt;&lt;/span&gt; shares were issued.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Treasury Stock&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On September 13, 2022, the Company adopted a stock
repurchase plan. The plan has no expiration date and cannot determine the number of shares which will be repurchased. On September 26,
2022, the Board of Directors has approved up to $&lt;span id="xdx_90F_eus-gaap--PaymentsForRepurchaseOfEquity_pdn6_c20230925__20230926__srt--TitleOfIndividualAxis__srt--BoardOfDirectorsChairmanMember_zBELBrIsbBj" title="Payments for repurchase of equity"&gt;9&lt;/span&gt; million to be repurchased under the plan which will be purchased on the publicly traded
open market at prevailing prices.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company utilizes the cost method of accounting
to value the treasury stock when repurchasing stock. Under this method, the shares are valued at the price paid and recorded to treasury
stock. When the treasury stock is cancelled, the par value of the stock is reduced and the additional paid in capital is reduced for the
remaining value based upon the original stock sale. For the year ended June 30, 2025, the Company purchased &lt;span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20240701__20250630_ziC7ZUk2DtMa" title="Purchase of treasury shares"&gt;114,588&lt;/span&gt; shares at a cost of
$&lt;span id="xdx_90D_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20240701__20250630_zjNDndiUXsIe" title="Purchase of treasury stock"&gt;1,806,646&lt;/span&gt; and cancelled &lt;span id="xdx_906_ecustom--CancellationOfTreasuryShares_c20240701__20250630_zV3dOSUXvfC5" title="Cancellation of treasury shares"&gt;124,829&lt;/span&gt; shares valued at $&lt;span id="xdx_904_ecustom--CancellationOfTreasuryStock_c20240701__20250630_zd77AnbpJYRb" title="Cancellation of treasury stock"&gt;1,963,385&lt;/span&gt;. For the year ended June 30, 2024, the Company purchased &lt;span id="xdx_904_eus-gaap--StockRepurchasedDuringPeriodShares_c20230701__20240630_z8tHhEUgsEV" title="Purchase of treasury shares"&gt;156,206&lt;/span&gt; shares at
a cost of $&lt;span id="xdx_90A_eus-gaap--StockRepurchasedDuringPeriodValue_pp0p0_c20230701__20240630_zSFoSXgGTX1d" title="Purchase of treasury stock"&gt;2,505,832&lt;/span&gt; and cancelled &lt;span id="xdx_904_ecustom--CancellationOfTreasuryShares_c20230701__20240630_z80tr1Ky5Noc" title="Cancellation of treasury shares"&gt;122,588&lt;/span&gt; shares valued at $&lt;span id="xdx_90B_ecustom--CancellationOfTreasuryStock_c20230701__20240630_z17TtO9LLUwl" title="Cancellation of treasury stock"&gt;2,005,020&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</FONR:CapitalStockDisclosureTextblock>
    <us-gaap:DividendsPayableNature
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718"
      id="Fact001584">Cash dividends payable on the common stock shall,
in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock
and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock</us-gaap:DividendsPayableNature>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassBMember"
      id="Fact001586">Class B common stock is convertible into shares of
common stock on a one-for-one basis</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassBMember"
      id="Fact001588">Class B common stock has 10 votes per share</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact001590"
      unitRef="Shares">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockVotingRights
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember"
      id="Fact001592">The Class C common stock has 25 votes per share</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockVotingRights
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember516949718"
      id="Fact001594">one vote per share for the common stock</us-gaap:CommonStockVotingRights>
    <us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassCMember"
      id="Fact001595">The Class C common stock was
offered on a three-for-one basis to the holders of the Class B common stock</us-gaap:StockholdersEquityNoteImpactOfConversionOfContingentlyConvertibleSecuritiesOnDilutedEarningsPerShare>
    <us-gaap:CommonStockVotingRights
      contextRef="From2024-07-012025-06-30_us-gaap_PreferredClassAMember"
      id="Fact001596">one share of Class A non-voting preferred stock for every five shares
of common stock</us-gaap:CommonStockVotingRights>
    <us-gaap:DividendsPayableNature
      contextRef="From2024-07-012025-06-30_us-gaap_PreferredClassAMember"
      id="Fact001597">The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued
pursuant to such stock dividend approximates 313,000 shares</us-gaap:DividendsPayableNature>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2010-04-23_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001609"
      unitRef="Shares">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <FONR:SharesRegistered
      contextRef="AsOf2010-08-10_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001611"
      unitRef="Shares">2000000</FONR:SharesRegistered>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2025-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001613"
      unitRef="Shares">450177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2023-07-012024-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001615"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2024-07-012025-06-30_custom_N2010StockBonusPlanMember"
      decimals="INF"
      id="Fact001617"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="From2023-09-252023-09-26_srt_BoardOfDirectorsChairmanMember"
      decimals="0"
      id="Fact001619"
      unitRef="USD">9000000</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001621"
      unitRef="Shares">114588</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001623"
      unitRef="USD">1806646</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:CancellationOfTreasuryShares
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001625"
      unitRef="Shares">124829</FONR:CancellationOfTreasuryShares>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001627"
      unitRef="USD">1963385</FONR:CancellationOfTreasuryStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001629"
      unitRef="Shares">156206</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001631"
      unitRef="USD">2505832</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:CancellationOfTreasuryShares
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001633"
      unitRef="Shares">122588</FONR:CancellationOfTreasuryShares>
    <FONR:CancellationOfTreasuryStock
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001635"
      unitRef="USD">2005020</FONR:CancellationOfTreasuryStock>
    <us-gaap:MinorityInterestDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001637">&lt;p id="xdx_808_eus-gaap--MinorityInterestDisclosureTextBlock_zOQRYD6kMSd8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;b&gt;NOTE 9 &#x2013; &lt;span id="xdx_829_zvV9abneTIy6"&gt;CONTROLLING AND NONCONTROLLING
INTERESTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February 13, 2013, the Company entered into an
agreement with outside investors to acquire a 50.5% controlling interest in a newly formed limited liability company, Health Diagnostics
Management LLC (HDM). According to the February 13, 2013, LLC operating agreement of HDM there are two classes of members; Class A members
and one Class B member. The Class A members have an ownership interest of &lt;span id="xdx_903_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zJnzlOamuYy" title="Ownership interest"&gt;49.5&lt;/span&gt;% of HDM. The Class B member (HMCA) has an ownership of
&lt;span id="xdx_90B_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zCG94vL5D1oi" title="Ownership percenatge"&gt;50.5&lt;/span&gt;% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage
of ownership interest. Profits and losses on all items of income, gain or loss, deductions or other allocations of the Company will be
allocated among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership
interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be allocated
solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions of
the operating agreement. The Company contributed $&lt;span id="xdx_903_ecustom--ProceedsFromContributionsFromCompany_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassBControllingInterestsMember_zHaHjctPjc09" title="Company contribution"&gt;20,200,000&lt;/span&gt; to HDM and the group of outside investors contributed $&lt;span id="xdx_90C_eus-gaap--ProceedsFromContributionsFromAffiliates_pp0p0_c20130212__20130213__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zg0zi1EU0xe6" title="Investors contribution"&gt;19,800,000&lt;/span&gt; for its
non-controlling membership interest.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 5, 2013, HDM purchased from Health Diagnostics,
LLC (&#x201c;HD&#x201d;) and certain of its subsidiaries, a business managing twelve (&lt;span id="xdx_909_ecustom--PurchaseOfStandupMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zhJIGAIvrwqa" title="Purchase of stand up MRI centers"&gt;12&lt;/span&gt;) Stand-Up MRI Centers and two (&lt;span id="xdx_906_ecustom--PurchaseOfOtherMriCenters_iI_uInteger_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zkSu6U7LrsVg" title="Purchase of other MRI centers"&gt;2&lt;/span&gt;) other scanning
centers located in the States of New York and Florida for a total purchase price (including consideration of $&lt;span id="xdx_906_ecustom--ConsiderationToOutsideInvestors_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zRErML6KEiIj" title="HDM purchase price includes consideration to outside investors"&gt;1.5&lt;/span&gt; million to outside investors)
aggregating $&lt;span id="xdx_909_ecustom--TotalPurchasePrice_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zwN76PEMC0H7" title="HDM purchase from Health Diagnostics (HD) ($)"&gt;35.9&lt;/span&gt; million. Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a
consideration of $&lt;span id="xdx_901_ecustom--ConsiderationForNoncompetitionAndConsultingAgreements_iI_pn5n6_c20130305__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zCjOqaWpT1ni" title="HDM entered agreement for consulting and non-competition agreement ($)"&gt;4.1&lt;/span&gt; million. The acquisition was accounted for using the purchase method in accordance with ASC 805, &#x201c;Business
Combinations&#x201d;. The Company recognized and measured goodwill as of the acquisition date, as the excess of the fair value of the consideration
paid over the fair value of the identified net assets acquired.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 8, 2015, the Company purchased &lt;span id="xdx_904_ecustom--EquityMethodInvestmentsOwnershipPercentage_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zddzxwihBdvg" title="Purchase of interests from Class A,  percentage"&gt;20&lt;/span&gt;% of the
Class A members ownership interest at a cost of $&lt;span id="xdx_902_ecustom--DirectPurchaseOfNoncontrollingInterests_c20150107__20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zVSQSNLcO1bf" title="Purchase of interests from Class A"&gt;4,971,094&lt;/span&gt;. The Company has a &lt;span id="xdx_902_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20150108__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zEVBzxUQyT4e" title="Ownership interest in HDM"&gt;60.4&lt;/span&gt;% ownership interest in HDM after this transaction.
During the year ended June 30, 2025, the Company sold non-controlling interests to a minority shareholder for $&lt;span id="xdx_90E_ecustom--DirectPurchaseOfNoncontrollingInterests_c20240701__20250630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_zWlzXP9AS6nk" title="Purchase of interests from Class A"&gt;132,000&lt;/span&gt;. Currently, the
Company has a direct ownership interest of &lt;span id="xdx_905_ecustom--EquityMethodInvestmentOwnershipPercentages_iI_dp_c20250630__us-gaap--OtherOwnershipInterestsByNameAxis__custom--ClassAControllingInterestsMember__us-gaap--BusinessAcquisitionAxis__custom--HDMMember_z8XBiCfXtdI8" title="Ownership interest of company"&gt;70.63&lt;/span&gt;% and the investors have a &lt;span id="xdx_902_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20250630__us-gaap--BusinessAcquisitionAxis__custom--HDMMember__srt--OwnershipAxis__custom--ClassAControllingInterestsMember_zxHxwmtuVmV2" title="Ownership interest of investors"&gt;29.37&lt;/span&gt;% ownership interest.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The amount of each class of HDM members&#x2019; equity
as of June 30, 2025 and 2024 is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zpwpGT1apE59" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_ztEq0iopB5sf" style="display: none"&gt;Schedule of HDM members equity&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Members&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class B Member&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Members&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class B Member&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Opening Members&#x2019; Equity&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_znAiHf3KbFXi" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;9,179,608&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zOzt0JgVBvH5" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;61,817,830&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zy1PfSKSslRl" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;7,079,293&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zL92Du8S0pFc" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;54,781,813&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Share of Net Income&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zN67kbqHXNg5" style="text-align: right" title="Share of Net Income"&gt;2,339,172&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--ShareOfNetIncome_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zsL9ATWwlLxl" style="text-align: right" title="Share of Net Income"&gt;16,727,492&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zp0r4EGY1gOh" style="text-align: right" title="Share of Net Income"&gt;3,530,021&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf3oB7e51JX" style="text-align: right" title="Share of Net Income"&gt;20,705,681&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Buyout of noncontrolling interests&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterests_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZ4IGG0V58N4" style="text-align: right" title="Buyout of noncontrolling interests"&gt;19,425&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zjbgjtgpquH5" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8h5a5quHYp9" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWRKx4RFYZo3" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Distributions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zmRjD8Qqi74j" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(5,682,555&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--Distributions_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zw7Jo6pay2Zh" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(13,717,445&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVUBnojSS3H5" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(5,630,336&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_ztvFqtzuEfn8" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(13,669,664&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Ending Members&#x2019; Equity&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_985_ecustom--EndingMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zY4atZ3U5BTe" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;12,503,566&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_ecustom--EndingMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zXmeCBvFCRB" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;64,827,877&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKfVE2Zz3Olb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;9,179,608&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZYNXjJopy5k" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;61,817,830&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8A1_zG6j4j8tNkW4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;



















</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember"
      decimals="INF"
      id="Fact001639"
      unitRef="Ratio">0.495</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <FONR:EquityMethodInvestmentOwnershipPercentages
      contextRef="AsOf2013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember"
      decimals="INF"
      id="Fact001641"
      unitRef="Ratio">0.505</FONR:EquityMethodInvestmentOwnershipPercentages>
    <FONR:ProceedsFromContributionsFromCompany
      contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassBControllingInterestsMember"
      decimals="0"
      id="Fact001643"
      unitRef="USD">20200000</FONR:ProceedsFromContributionsFromCompany>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="From2013-02-122013-02-13_custom_HDMMember_custom_ClassAControllingInterestsMember"
      decimals="0"
      id="Fact001645"
      unitRef="USD">19800000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <FONR:PurchaseOfStandupMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      id="Fact001657"
      unitRef="Integer">12</FONR:PurchaseOfStandupMriCenters>
    <FONR:PurchaseOfOtherMriCenters
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="INF"
      id="Fact001659"
      unitRef="Integer">2</FONR:PurchaseOfOtherMriCenters>
    <FONR:ConsiderationToOutsideInvestors
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-5"
      id="Fact001661"
      unitRef="USD">1500000</FONR:ConsiderationToOutsideInvestors>
    <FONR:TotalPurchasePrice
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-5"
      id="Fact001663"
      unitRef="USD">35900000</FONR:TotalPurchasePrice>
    <FONR:ConsiderationForNoncompetitionAndConsultingAgreements
      contextRef="AsOf2013-03-05_custom_HDMMember"
      decimals="-5"
      id="Fact001665"
      unitRef="USD">4100000</FONR:ConsiderationForNoncompetitionAndConsultingAgreements>
    <FONR:EquityMethodInvestmentsOwnershipPercentage
      contextRef="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="INF"
      id="Fact001667"
      unitRef="Ratio">0.20</FONR:EquityMethodInvestmentsOwnershipPercentage>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2015-01-072015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="0"
      id="Fact001669"
      unitRef="USD">4971094</FONR:DirectPurchaseOfNoncontrollingInterests>
    <FONR:EquityMethodInvestmentOwnershipPercentages
      contextRef="AsOf2015-01-08_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="INF"
      id="Fact001671"
      unitRef="Ratio">0.604</FONR:EquityMethodInvestmentOwnershipPercentages>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2024-07-012025-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="0"
      id="Fact001673"
      unitRef="USD">132000</FONR:DirectPurchaseOfNoncontrollingInterests>
    <FONR:EquityMethodInvestmentOwnershipPercentages
      contextRef="AsOf2025-06-30_custom_ClassAControllingInterestsMember_custom_HDMMember"
      decimals="INF"
      id="Fact001675"
      unitRef="Ratio">0.7063</FONR:EquityMethodInvestmentOwnershipPercentages>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2025-06-30_custom_HDMMember_custom_ClassAControllingInterestsMember"
      decimals="INF"
      id="Fact001677"
      unitRef="Ratio">0.2937</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001679">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--RedeemableNoncontrollingInterestTableTextBlock_zpwpGT1apE59" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTROLLING AND NONCONTROLLING INTERESTS - HDM members equity (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_ztEq0iopB5sf" style="display: none"&gt;Schedule of HDM members equity&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Members&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class B Member&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class A Members&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Class B Member&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Opening Members&#x2019; Equity&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98A_ecustom--OpeningMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_znAiHf3KbFXi" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;9,179,608&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--OpeningMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zOzt0JgVBvH5" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;61,817,830&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zy1PfSKSslRl" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;7,079,293&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_989_ecustom--OpeningMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zL92Du8S0pFc" style="width: 10%; text-align: right" title="Opening Members Equity"&gt;54,781,813&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Share of Net Income&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_981_ecustom--ShareOfNetIncome_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zN67kbqHXNg5" style="text-align: right" title="Share of Net Income"&gt;2,339,172&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_983_ecustom--ShareOfNetIncome_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zsL9ATWwlLxl" style="text-align: right" title="Share of Net Income"&gt;16,727,492&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zp0r4EGY1gOh" style="text-align: right" title="Share of Net Income"&gt;3,530,021&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--ShareOfNetIncome_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zf3oB7e51JX" style="text-align: right" title="Share of Net Income"&gt;20,705,681&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Buyout of noncontrolling interests&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98C_ecustom--BuyoutOfNoncontrollingInterests_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZ4IGG0V58N4" style="text-align: right" title="Buyout of noncontrolling interests"&gt;19,425&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98F_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zjbgjtgpquH5" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_985_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_z8h5a5quHYp9" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98B_ecustom--BuyoutOfNoncontrollingInterestsValue_iI_pp0p0_d0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zWRKx4RFYZo3" style="text-align: right" title="Buyout of noncontrolling interests"&gt;&#x2014;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Distributions&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--Distributions_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zmRjD8Qqi74j" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(5,682,555&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--Distributions_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zw7Jo6pay2Zh" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(13,717,445&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_986_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zVUBnojSS3H5" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(5,630,336&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_980_ecustom--Distributions_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_ztvFqtzuEfn8" style="border-bottom: Black 1pt solid; text-align: right" title="Distributions"&gt;(13,669,664&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Ending Members&#x2019; Equity&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_985_ecustom--EndingMembersEquity_iI_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zY4atZ3U5BTe" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;12,503,566&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_983_ecustom--EndingMembersEquity_pp0p0_c20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zXmeCBvFCRB" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;64,827,877&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;
&lt;td id="xdx_98E_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--HDMEquityMember_zKfVE2Zz3Olb" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;9,179,608&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td id="xdx_98D_ecustom--EndingMembersEquity_pp0p0_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--HDMEquityMember_zZYNXjJopy5k" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members Equity"&gt;61,817,830&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001681"
      unitRef="USD">9179608</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001683"
      unitRef="USD">61817830</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001685"
      unitRef="USD">7079293</FONR:OpeningMembersEquity>
    <FONR:OpeningMembersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001687"
      unitRef="USD">54781813</FONR:OpeningMembersEquity>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001689"
      unitRef="USD">2339172</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001691"
      unitRef="USD">16727492</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001693"
      unitRef="USD">3530021</FONR:ShareOfNetIncome>
    <FONR:ShareOfNetIncome
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001695"
      unitRef="USD">20705681</FONR:ShareOfNetIncome>
    <FONR:BuyoutOfNoncontrollingInterests
      contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001697"
      unitRef="USD">19425</FONR:BuyoutOfNoncontrollingInterests>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001699"
      unitRef="USD">0</FONR:BuyoutOfNoncontrollingInterestsValue>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001701"
      unitRef="USD">0</FONR:BuyoutOfNoncontrollingInterestsValue>
    <FONR:BuyoutOfNoncontrollingInterestsValue
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001703"
      unitRef="USD">0</FONR:BuyoutOfNoncontrollingInterestsValue>
    <FONR:Distributions
      contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001705"
      unitRef="USD">-5682555</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001707"
      unitRef="USD">-13717445</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001709"
      unitRef="USD">-5630336</FONR:Distributions>
    <FONR:Distributions
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001711"
      unitRef="USD">-13669664</FONR:Distributions>
    <FONR:EndingMembersEquity
      contextRef="AsOf2025-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001713"
      unitRef="USD">12503566</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2025-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001715"
      unitRef="USD">64827877</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001717"
      unitRef="USD">9179608</FONR:EndingMembersEquity>
    <FONR:EndingMembersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember_custom_HDMEquityMember"
      decimals="0"
      id="Fact001719"
      unitRef="USD">61817830</FONR:EndingMembersEquity>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001729">&lt;p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_zwqHCMplvoi9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 10 - &lt;span id="xdx_82B_zCieNvn11PA9"&gt;INCOME TAXES&lt;/span&gt; &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Income tax expense is computed using an asset and
liability method using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from
temporary differences in the financial reporting basis and the income tax basis of assets and liabilities. The measurement of deferred
tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized.
When it appears more than likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred
tax asset to its realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether or
net deferred tax assets are more likely than not to be realized.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has recorded a deferred tax asset of $&lt;span id="xdx_905_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_c20250630_z9ALEifb1yPc" title="Deferred tax asset"&gt;6,349,194&lt;/span&gt;
and a deferred tax liability of $&lt;span id="xdx_90B_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_iI_pp0p0_c20250630_zsXjJYEyfQB4" title="Deferred tax liability"&gt;321,159&lt;/span&gt; as of June 30, 2025, primarily relating to its allowance for credit losses of $4,366,000, non
deductible accruals of &lt;span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20250630_zclB3ZoWuf54" title="Allowance for doubtful accounts and tax credits"&gt;$759,000&lt;/span&gt; and capitalized research and development costs of approximately $&lt;span id="xdx_904_ecustom--CapitalizedResearchAndDevelopmentCosts_c20240701__20250630_zAbzgrodLgzb" title="Capitalized Research and development costs"&gt;960,000&lt;/span&gt;. During fiscal 2025, the Company
utilized all tax credits pertaining to research and development costs. In addition the Company has state operating loss carryforwards
of approximately $&lt;span id="xdx_90C_eus-gaap--OtherOperatingIncome_pp0p0_c20240701__20250630_zb79VO5uq04a" title="City operating loss carryforwards"&gt;3,694,000&lt;/span&gt;. The Company has also fully recorded a valuation allowance against all of the state operating losses since
the Company doesn&#x2019;t anticipate being able to utilize them.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company files corporate income tax returns in
the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject to federal,
state and local income tax examinations by tax authorities for years prior to 2021.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Future ownership changes as determined under Section
382 of the Internal Revenue code could further limit the utilization of net operating loss carryforwards. As of June 30, 2025, no such
changes in ownership have occurred.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 4, 2025, the One Big Beautiful Act (&#x201c;OBBBA)
was signed into law, which enacts significant changes to the U.S. tax and related laws. Some of the provisions of the new tax law that
affect corporations include but are not limited to expensing of domestic specified research or experimental expenditures, increasing the
limit of the deduction to thirty percent of EBITDA, and one hundred percent bonus depreciation on eligible property acquired after January
19, 2025. The Company is currently evaluating the impact that the new tax law will have on its financial condition and results of operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The valuation allowance for deferred tax assets decreased
during the year ended June 30, 2025, by approximately $&lt;span id="xdx_907_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_c20250630_zJ79D1SD1ugg" title="Valuation allowance for deferred tax assets"&gt;67,000&lt;/span&gt;. The valuation allowance decreased by approximately $&lt;span id="xdx_902_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_c20240630_zwDMVPpsRLPk" title="Valuation allowance for deferred tax assets"&gt;171,000&lt;/span&gt; during the
year ended June 30, 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Components of the provision for income taxes are as
follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock_zz2bPnivJCki" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B4_zVYIGvubxmBc" style="display: none"&gt;Schedule of Components of the provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240701__20250630_zNWfMiMq1BGj" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20230701__20240630_zhGo1SbZ6RSg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center"&gt;Components Of The Provision For Income Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_z4sjRIQCIxl6" style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Current:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBKFrCZoWccj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 30pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Federal&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,374,724&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;429,873&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_z2YvX6RlehAh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"&gt;State&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;908,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,943,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_zNJThTghetXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,283,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,373,461&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z09UcrD66KK7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zqnWvJAgXFb6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"&gt;Federal deferred taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;838,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zYOEr0CVljE5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"&gt;State deferred taxes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,494&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;209,992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zLSBIH1IY46d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;823,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,795,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zKt4ZyHUsn0b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; color: white; text-align: left; text-indent: -10pt"&gt;Provision (Benefit) for Income Taxes - Net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,106,805&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,168,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zFHbYG0Uww4j" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A reconciliation of the federal statutory income tax
rate to the Company&#x2019;s effective tax rate as reported is as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zSU7EnsUeiKd" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BC_zjIR4qgQDwW1" style="display: none"&gt;Schedule of
    reconciliation of federal statutory income tax rate to company&#x2019;s effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended &lt;br/&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended &lt;br/&gt;June 30, 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Percent&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Percent&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Taxes at federal statutory rate&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20240701__20250630_z5lBSEif7UZ3" style="width: 10%; text-align: right" title="Taxes at federal statutory rate"&gt;2,893,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20240701__20250630_zBWJGmEN7a92" title="Taxes at federal statutory rate"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20230701__20240630_z7QRiu2Qjzr9" style="width: 10%; text-align: right" title="Taxes at federal statutory rate"&gt;4,169,123&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zestd6NqfEx8" title="Taxes at federal statutory rate"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;State and local income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20240701__20250630_zSMHn7mBRHuh" style="text-align: right" title="State and local income taxes"&gt;978,397&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240701__20250630_zMB8pBpb1hGi" title="State and local income taxes (benefit), net of federal benefit"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20230701__20240630_zv2aGkbsy4N1" style="text-align: right" title="State and local income taxes"&gt;1,409,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zHEMJnAPkkf8" title="State and local income taxes (benefit), net of federal benefit"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Noncontrolling interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20240701__20250630_zhFBbtOCAfdb" style="text-align: right" title="Noncontrolling interests"&gt;657,307&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20240701__20250630_zDBHq1mAvsMg" title="Noncontrolling interest"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20230701__20240630_zhjJx9fQ2xF5" style="text-align: right" title="Noncontrolling interests"&gt;1,049,294&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zn4mlqn8ltCe" title="Noncontrolling interest"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Valuation Allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20240701__20250630_zRsLtTysp0yb" style="text-align: right" title="Valuation Allowance"&gt;218,390&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240701__20250630_zRJrtnPyh7U2" title="Change in the valuation allowance"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20230701__20240630_zhL2kBthQ037" style="text-align: right" title="Valuation Allowance"&gt;48,179&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_zCSZSkVQ8CUi" title="Change in the valuation allowance"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Permanent items &#x2013; Meals and Entertainment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--PermanentItemsMealsEntertainment_c20240701__20250630_zfGovqFcLr36" style="text-align: right" title="Permanent items Meals and Entertainment"&gt;131,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20240701__20250630_zaZ9J9obG4ce" title="Permanent items Meals and Entertainment"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PermanentItemsMealsEntertainment_c20230701__20240630_ziTkJVTQyD16" style="text-align: right" title="Permanent items Meals and Entertainment"&gt;126,719&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20230701__20240630_zYtUHBdm1hT3" title="Permanent items Meals and Entertainment"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20240701__20250630_z1pQwvIR8BE1" style="border-bottom: Black 1pt solid; text-align: right" title="Other"&gt;21,701&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20240701__20250630_zVcX6F8bvXy9" title="Other"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20230701__20240630_zpWQYUB1r5w9" style="border-bottom: Black 1pt solid; text-align: right" title="Other"&gt;561,038&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zZgzn6KXVuy1" title="Other"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Provision for income taxes &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20240701__20250630_zZ8BW4ExFSAc" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members' Equity"&gt;3,106,805&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20240701__20250630_z1bV4CRSHyZi" title="Effective income tax rate"&gt;22.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20230701__20240630_zxXNNNDCHvf1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members' Equity"&gt;5,168,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z4QGQjp0IBCj" title="Effective income tax rate"&gt;26.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A8_zYaTG4tAiLq7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-indent: 20pt; text-align: justify"&gt;The Company has, for federal income tax
purposes, research and development tax credits and investments tax credits carryforwards aggregating $&lt;span id="xdx_904_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pp0p0_c20250630_zBIwLx86w5Bf" title="Tax credits carryforwards"&gt;1,323,000&lt;/span&gt;
as of June 30, 2024. The Company will utilize the full amount for the tax return for the year ended June 30, 2025. These credits can
only be applied after all net operating losses have been used.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;Significant components of the Company&#x2019;s
deferred tax assets and liabilities at June 30, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zJ4GhaoisuD3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B7_ziw2zpP5IrBd" style="display: none"&gt;Schedule of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49F_20250630_zkbs7EP954tl" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_497_20240630_zhsAJliltjI8" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Deferred tax assets:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zECLwk7a3q6l" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Allowance for credit losses&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;4,366,361&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;3,969,819&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zlrJbuynPcNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Non-deductible accruals&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;758,700&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;758,700&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_z1aIgKDE1uT7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Net operating carryforwards&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;259,319&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;396,092&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_z31GL3XssfB2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Tax credits&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1868"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;1,323,018&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z8wqoW8RyNjk" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Capitalized research and development&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;960,343&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;747,407&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zztmHsOrxxO4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Right of use assets and lease liabilities&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;146,934&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;114,116&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zlVY0ZqpyoKa" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Inventories&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;116,856&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;106,879&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zL69hTFpyRm6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Deferred Tax Assets - gross&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;6,608,513&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;7,416,031&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zs6ELT8t4z21" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Valuation allowance&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(259,319&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(192,776&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z11MhnyXQ4k7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total deferred tax assets&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;6,349,194&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;7,223,255&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--PropertyAndEquipmentAndDepreciation_iI_pp0p0_maDTLzImD_zEt0WogS8q44" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Property and equipment and depreciation&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;165,532&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(267,124&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMIiPtnHGBl3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Intangibles&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(155,627&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(104,436&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zck8AR0paWhk" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total deferred tax liabilities&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(321,159&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(371,560&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zH5nvVJq1Efe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Net deferred tax asset&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,028,035&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,851,695&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AA_zVA0c9R7Qi75" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;





















</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001731"
      unitRef="USD">6349194</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001733"
      unitRef="USD">321159</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001735"
      unitRef="USD">759000</us-gaap:OperatingLossCarryforwards>
    <FONR:CapitalizedResearchAndDevelopmentCosts
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001737"
      unitRef="USD">960000</FONR:CapitalizedResearchAndDevelopmentCosts>
    <us-gaap:OtherOperatingIncome
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001739"
      unitRef="USD">3694000</us-gaap:OtherOperatingIncome>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001741"
      unitRef="USD">67000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001743"
      unitRef="USD">171000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <FONR:ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001755">&lt;table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock_zz2bPnivJCki" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Components of provision for income taxes (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B4_zVYIGvubxmBc" style="display: none"&gt;Schedule of Components of the provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240701__20250630_zNWfMiMq1BGj" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20230701__20240630_zhGo1SbZ6RSg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center"&gt;Components Of The Provision For Income Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_z4sjRIQCIxl6" style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Current:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_d0_maCITEBzHyE_zBKFrCZoWccj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 30pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Federal&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,374,724&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;429,873&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maCITEBzHyE_z2YvX6RlehAh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"&gt;State&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;908,421&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,943,588&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzXA8_mtCITEBzHyE_zNJThTghetXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,283,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,373,461&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_z09UcrD66KK7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Deferred:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_maDITEBzROz_zqnWvJAgXFb6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"&gt;Federal deferred taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;838,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maDITEBzROz_zYOEr0CVljE5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 30pt; text-align: left; text-indent: -10pt"&gt;State deferred taxes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,494&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;209,992&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredIncomeTaxExpensesBenefit_iT_pp0p0_mtDITEBzROz_maITEBzXA8_zLSBIH1IY46d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;823,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,795,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXA8_zKt4ZyHUsn0b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; color: white; text-align: left; text-indent: -10pt"&gt;Provision (Benefit) for Income Taxes - Net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,106,805&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,168,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FONR:ScheduleOfComponentsOfIncomeTaxExpenseBenefitsTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001760"
      unitRef="USD">1374724</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001761"
      unitRef="USD">429873</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001763"
      unitRef="USD">908421</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001764"
      unitRef="USD">1943588</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001766"
      unitRef="USD">2283145</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001767"
      unitRef="USD">2373461</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001772"
      unitRef="USD">838154</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001773"
      unitRef="USD">2585515</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001775"
      unitRef="USD">-14494</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001776"
      unitRef="USD">209992</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <FONR:DeferredIncomeTaxExpensesBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001778"
      unitRef="USD">823660</FONR:DeferredIncomeTaxExpensesBenefit>
    <FONR:DeferredIncomeTaxExpensesBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001779"
      unitRef="USD">2795507</FONR:DeferredIncomeTaxExpensesBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001781"
      unitRef="USD">3106805</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001782"
      unitRef="USD">5168968</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001784">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zSU7EnsUeiKd" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure -  INCOME TAXES - Reconciliation of federal statutory income tax rate (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BC_zjIR4qgQDwW1" style="display: none"&gt;Schedule of
    reconciliation of federal statutory income tax rate to company&#x2019;s effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended &lt;br/&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Year Ended &lt;br/&gt;June 30, 2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Percent&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;Percent&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 40%; text-align: left; text-indent: -10pt"&gt;Taxes at federal statutory rate&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20240701__20250630_z5lBSEif7UZ3" style="width: 10%; text-align: right" title="Taxes at federal statutory rate"&gt;2,893,850&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20240701__20250630_zBWJGmEN7a92" title="Taxes at federal statutory rate"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20230701__20240630_z7QRiu2Qjzr9" style="width: 10%; text-align: right" title="Taxes at federal statutory rate"&gt;4,169,123&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&lt;span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates_dp_c20230701__20240630_zestd6NqfEx8" title="Taxes at federal statutory rate"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;State and local income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20240701__20250630_zSMHn7mBRHuh" style="text-align: right" title="State and local income taxes"&gt;978,397&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20240701__20250630_zMB8pBpb1hGi" title="State and local income taxes (benefit), net of federal benefit"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20230701__20240630_zv2aGkbsy4N1" style="text-align: right" title="State and local income taxes"&gt;1,409,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20230701__20240630_zHEMJnAPkkf8" title="State and local income taxes (benefit), net of federal benefit"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Noncontrolling interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20240701__20250630_zhFBbtOCAfdb" style="text-align: right" title="Noncontrolling interests"&gt;657,307&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20240701__20250630_zDBHq1mAvsMg" title="Noncontrolling interest"&gt;4.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeTaxReconciliationMinorityInterestIncomeExpense_c20230701__20240630_zhjJx9fQ2xF5" style="text-align: right" title="Noncontrolling interests"&gt;1,049,294&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_dp_c20230701__20240630_zn4mlqn8ltCe" title="Noncontrolling interest"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Valuation Allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20240701__20250630_zRsLtTysp0yb" style="text-align: right" title="Valuation Allowance"&gt;218,390&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20240701__20250630_zRJrtnPyh7U2" title="Change in the valuation allowance"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_c20230701__20240630_zhL2kBthQ037" style="text-align: right" title="Valuation Allowance"&gt;48,179&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20230701__20240630_zCSZSkVQ8CUi" title="Change in the valuation allowance"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Permanent items &#x2013; Meals and Entertainment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--PermanentItemsMealsEntertainment_c20240701__20250630_zfGovqFcLr36" style="text-align: right" title="Permanent items Meals and Entertainment"&gt;131,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20240701__20250630_zaZ9J9obG4ce" title="Permanent items Meals and Entertainment"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PermanentItemsMealsEntertainment_c20230701__20240630_ziTkJVTQyD16" style="text-align: right" title="Permanent items Meals and Entertainment"&gt;126,719&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment_dp_c20230701__20240630_zYtUHBdm1hT3" title="Permanent items Meals and Entertainment"&gt;1.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20240701__20250630_z1pQwvIR8BE1" style="border-bottom: Black 1pt solid; text-align: right" title="Other"&gt;21,701&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20240701__20250630_zVcX6F8bvXy9" title="Other"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount_c20230701__20240630_zpWQYUB1r5w9" style="border-bottom: Black 1pt solid; text-align: right" title="Other"&gt;561,038&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp_c20230701__20240630_zZgzn6KXVuy1" title="Other"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;Provision for income taxes &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;($&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20240701__20250630_zZ8BW4ExFSAc" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members' Equity"&gt;3,106,805&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20240701__20250630_z1bV4CRSHyZi" title="Effective income tax rate"&gt;22.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IncomeTaxReconciliationIncomeTaxExpenseBenefit_c20230701__20240630_zxXNNNDCHvf1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending Members' Equity"&gt;5,168,968&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20230701__20240630_z4QGQjp0IBCj" title="Effective income tax rate"&gt;26.8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001786"
      unitRef="USD">2893850</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001788"
      unitRef="Ratio">0.21</FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001790"
      unitRef="USD">4169123</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001792"
      unitRef="Ratio">0.21</FONR:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRates>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001794"
      unitRef="USD">978397</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001796"
      unitRef="Ratio">0.071</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001798"
      unitRef="USD">1409561</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001800"
      unitRef="Ratio">0.071</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001802"
      unitRef="USD">657307</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001804"
      unitRef="Ratio">0.046</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001806"
      unitRef="USD">1049294</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001808"
      unitRef="Ratio">0.053</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001810"
      unitRef="USD">218390</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001812"
      unitRef="Ratio">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001814"
      unitRef="USD">48179</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001816"
      unitRef="Ratio">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <FONR:PermanentItemsMealsEntertainment
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001818"
      unitRef="USD">131956</FONR:PermanentItemsMealsEntertainment>
    <FONR:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001820"
      unitRef="Ratio">0.010</FONR:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment>
    <FONR:PermanentItemsMealsEntertainment
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001822"
      unitRef="USD">126719</FONR:PermanentItemsMealsEntertainment>
    <FONR:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001824"
      unitRef="Ratio">0.015</FONR:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsPermanentitemsMealsEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001826"
      unitRef="USD">21701</us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001828"
      unitRef="Ratio">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001830"
      unitRef="USD">561038</us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001832"
      unitRef="Ratio">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <FONR:IncomeTaxReconciliationIncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001834"
      unitRef="USD">3106805</FONR:IncomeTaxReconciliationIncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001836"
      unitRef="Ratio">0.228</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <FONR:IncomeTaxReconciliationIncomeTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001838"
      unitRef="USD">5168968</FONR:IncomeTaxReconciliationIncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001840"
      unitRef="Ratio">0.268</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001852"
      unitRef="USD">1323000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001854">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zJ4GhaoisuD3" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES - Deferred tax assets and liabilities - (Details 2)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B7_ziw2zpP5IrBd" style="display: none"&gt;Schedule of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49F_20250630_zkbs7EP954tl" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_497_20240630_zhsAJliltjI8" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNetAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Deferred tax assets:&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_maDTAGzM4n_zECLwk7a3q6l" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Allowance for credit losses&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;4,366,361&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;3,969,819&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0_maDTAGzM4n_zlrJbuynPcNd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Non-deductible accruals&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;758,700&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;758,700&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzM4n_z1aIgKDE1uT7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Net operating carryforwards&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;259,319&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;396,092&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_i01I_pp0p0_maDTAGzM4n_z31GL3XssfB2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Tax credits&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1868"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;1,323,018&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsInProcessResearchAndDevelopment_i01I_pp0p0_maDTAGzM4n_z8wqoW8RyNjk" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Capitalized research and development&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;960,343&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;747,407&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--DeferredTaxAssetsInRightUseAssetsAndLiabilities_i01I_pp0p0_maDTAGzM4n_zztmHsOrxxO4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Right of use assets and lease liabilities&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;146,934&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;114,116&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsInventory_i01I_pp0p0_maDTAGzM4n_zlVY0ZqpyoKa" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Inventories&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;116,856&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;106,879&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzM4n_maDTANzJzu_zL69hTFpyRm6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Deferred Tax Assets - gross&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;6,608,513&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;7,416,031&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzJzu_zs6ELT8t4z21" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Valuation allowance&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(259,319&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(192,776&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzJzu_maDTALNzFAZ_z11MhnyXQ4k7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total deferred tax assets&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;6,349,194&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;7,223,255&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--PropertyAndEquipmentAndDepreciation_iI_pp0p0_maDTLzImD_zEt0WogS8q44" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Property and equipment and depreciation&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;165,532&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;(267,124&lt;/td&gt;
&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_iNI_pp0p0_di_maDTLzImD_zMIiPtnHGBl3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Intangibles&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(155,627&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(104,436&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DeferredTaxLiabilities_iNTI_pp0p0_di_msDTALNzFAZ_mtDTLzImD_zck8AR0paWhk" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Total deferred tax liabilities&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(321,159&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(371,560&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzFAZ_zH5nvVJq1Efe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Net deferred tax asset&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,028,035&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,851,695&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001859"
      unitRef="USD">4366361</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001860"
      unitRef="USD">3969819</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001862"
      unitRef="USD">758700</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001863"
      unitRef="USD">758700</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001865"
      unitRef="USD">259319</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001866"
      unitRef="USD">396092</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001869"
      unitRef="USD">1323018</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001871"
      unitRef="USD">960343</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001872"
      unitRef="USD">747407</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001874"
      unitRef="USD">146934</FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities>
    <FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001875"
      unitRef="USD">114116</FONR:DeferredTaxAssetsInRightUseAssetsAndLiabilities>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001877"
      unitRef="USD">116856</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001878"
      unitRef="USD">106879</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001880"
      unitRef="USD">6608513</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001881"
      unitRef="USD">7416031</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001883"
      unitRef="USD">259319</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001884"
      unitRef="USD">192776</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001886"
      unitRef="USD">6349194</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001887"
      unitRef="USD">7223255</us-gaap:DeferredTaxAssetsNet>
    <FONR:PropertyAndEquipmentAndDepreciation
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001889"
      unitRef="USD">165532</FONR:PropertyAndEquipmentAndDepreciation>
    <FONR:PropertyAndEquipmentAndDepreciation
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001890"
      unitRef="USD">-267124</FONR:PropertyAndEquipmentAndDepreciation>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001892"
      unitRef="USD">155627</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001893"
      unitRef="USD">104436</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001895"
      unitRef="USD">321159</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001896"
      unitRef="USD">371560</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001898"
      unitRef="USD">6028035</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001899"
      unitRef="USD">6851695</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001910">&lt;p id="xdx_802_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zeuRWROSzhC" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 11 - &lt;span id="xdx_82F_zT4ApAs6BGcd"&gt;OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Included in other current liabilities are the following:&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWWlPqZcNpp" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BA_zGEj3ZqNPTxg" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49E_20250630_z5jtbRZpGBdi" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49E_20240630_zPWgxgtRm6T7" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_z8pDZ1muGs38" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;3,993,773&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;4,677,690&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_z9Vcq33nWbVa" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Sales tax payable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;248,845&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;197,317&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zSu9B9oNstlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;State income taxes payable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1920"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;1,461,336&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zG7EzpUfDLB2" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Legal and other professional fees&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;93,207&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;11,207&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AdvancePaymentsByBorrowersForTaxesAndInsurance_iI_zpxETB378hJ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Property taxes&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;391,479&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1927"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AccruedUtilitiesCurrent_iI_zxI5oRWs3gS4" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Utilities&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;449,277&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1930"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zGxvk96mbxUd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Accounting fees&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;38,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;119,800&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--SoftwareLicenses_iI_zgDBCJWlR6pi" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Software Licenses&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;442,305&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1936"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--RecruitingFees_iI_zeGdfjc7F6Ci" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Recruiting fees&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;135,952&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1939"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zieqIiUKM8Dl" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Self-funded health insurance reserve&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;259,661&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;121,445&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zS6RVFuQ13Lf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Accrued interest and penalty&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;3,534&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;3,534&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_z2eXdxbOnwS5" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Other general and administrative expenses&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;918,964&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,348,710&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zaXyqfygtqoi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Other Current Liabilities&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,974,997&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,941,039&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001912">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWWlPqZcNpp" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8BA_zGEj3ZqNPTxg" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49E_20250630_z5jtbRZpGBdi" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td id="xdx_49E_20240630_zPWgxgtRm6T7" style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AccruedSalariesCurrent_iI_maOLCzbf4_z8pDZ1muGs38" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;3,993,773&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;4,677,690&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_maOLCzbf4_z9Vcq33nWbVa" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Sales tax payable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;248,845&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;197,317&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--TaxesPayableCurrentAndNoncurrent_iI_maOLCzbf4_zSu9B9oNstlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;State income taxes payable&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1920"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;1,461,336&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--AccruedProfessionalFeesCurrent_iI_maOLCzbf4_zG7EzpUfDLB2" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Legal and other professional fees&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;93,207&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;11,207&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--AdvancePaymentsByBorrowersForTaxesAndInsurance_iI_zpxETB378hJ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Property taxes&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;391,479&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1927"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--AccruedUtilitiesCurrent_iI_zxI5oRWs3gS4" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Utilities&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;449,277&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1930"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_maOLCzbf4_zGxvk96mbxUd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Accounting fees&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;38,000&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;119,800&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--SoftwareLicenses_iI_zgDBCJWlR6pi" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Software Licenses&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;442,305&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1936"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--RecruitingFees_iI_zeGdfjc7F6Ci" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Recruiting fees&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;135,952&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1939"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_maOLCzbf4_zieqIiUKM8Dl" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Self-funded health insurance reserve&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;259,661&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;121,445&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_maOLCzbf4_zS6RVFuQ13Lf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Accrued interest and penalty&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;3,534&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;3,534&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzbf4_z2eXdxbOnwS5" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Other general and administrative expenses&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;918,964&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,348,710&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzbf4_zaXyqfygtqoi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Other Current Liabilities&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,974,997&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,941,039&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001914"
      unitRef="USD">3993773</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001915"
      unitRef="USD">4677690</us-gaap:AccruedSalariesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001917"
      unitRef="USD">248845</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001918"
      unitRef="USD">197317</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001921"
      unitRef="USD">1461336</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001923"
      unitRef="USD">93207</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001924"
      unitRef="USD">11207</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AdvancePaymentsByBorrowersForTaxesAndInsurance
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001926"
      unitRef="USD">391479</us-gaap:AdvancePaymentsByBorrowersForTaxesAndInsurance>
    <us-gaap:AccruedUtilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001929"
      unitRef="USD">449277</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001932"
      unitRef="USD">38000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001933"
      unitRef="USD">119800</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <FONR:SoftwareLicenses
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001935"
      unitRef="USD">442305</FONR:SoftwareLicenses>
    <FONR:RecruitingFees
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001938"
      unitRef="USD">135952</FONR:RecruitingFees>
    <us-gaap:SelfInsuranceReserve
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001941"
      unitRef="USD">259661</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001942"
      unitRef="USD">121445</us-gaap:SelfInsuranceReserve>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001944"
      unitRef="USD">3534</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001945"
      unitRef="USD">3534</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001947"
      unitRef="USD">918964</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001948"
      unitRef="USD">1348710</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001950"
      unitRef="USD">6974997</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001951"
      unitRef="USD">7941039</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001953">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zz27K1F2cWGl" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 12 - &lt;span id="xdx_82B_zgGpc4uB5I3a"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Employee Benefit Plans&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has a non-contributory 401(k) Plan (the
&#x201c;401(k) Plan&#x201d;). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum service requirements.
There were &lt;span id="xdx_906_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_do_c20240701__20250630_zqiCTbWbQpz5" title="Employer contributions"&gt;&lt;span id="xdx_901_eus-gaap--EmployeeStockOwnershipPlanESOPCashContributionsToESOP_pp0p0_do_c20230701__20240630_zVsCFrZlSNWl" title="Employer contributions"&gt;no&lt;/span&gt;&lt;/span&gt; employer contributions to the Plan for the years ended June 30, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The stockholders of the Company approved the 2000
Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) at the Company&#x2019;s annual stockholders&#x2019; meeting in April 2000. The ESPP provides
for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect
as of June 30, 2025.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Other Matters&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is subject to other legal
proceedings and claims arising from the ordinary course of its business, including personal injury, customer contract and employment
claims besides the claim above. The Company is also subject to Cyber security threats that could lead to future litigation. In the
opinion of management, and with consultation with legal counsel, the aggregate liability, if any, with respect to such actions, will
not have a material adverse effect on the consolidated financial position or results of operations of the Company. The company
continuosly evaluates these actions to ensure they are not material, however, it is possible that management estimate may change in
the near term and the effect could have a material impact on the consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company maintains a self-funded health insurance
program with a stop-loss umbrella policy with a third-party insurer to limit the maximum potential liability for individual claims to
$&lt;span id="xdx_902_eus-gaap--ReinsurancePayable_iI_c20250630_zwY9mmGaTWk8" title="Liability for individual claims"&gt;150,000&lt;/span&gt; per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company
considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.
As of June 30, 2025 and 2024, the Company had approximately $&lt;span id="xdx_906_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20250630_zOYOBo9erkL7" title="Reserve for self-funded"&gt;260,000&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--LiabilityForClaimsAndClaimsAdjustmentExpense_iI_c20240630_zwH1hfHE0w75" title="Reserve for self-funded"&gt;121,000&lt;/span&gt;, respectively, in reserve for its self-funded health
insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d; in the consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company regularly analyzes its reserves for incurred
but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance programs. The Company
believes its reserves are adequate. However, significant judgment is involved in assessing these reserves such as assessing historical
paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid dates, and the frequency and severity of claims.
There may be differences between actual settlement amounts and recorded reserves and any resulting adjustments are included in expense
once a probable amount is known. There were no significant adjustments recorded in the years covered by this report.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001955"
      unitRef="USD">0</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001957"
      unitRef="USD">0</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:ReinsurancePayable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001969"
      unitRef="USD">150000</us-gaap:ReinsurancePayable>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001971"
      unitRef="USD">260000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001973"
      unitRef="USD">121000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001975">&lt;p id="xdx_80B_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_z2k3hl3utHY1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 13 - &lt;span id="xdx_822_zC2qoydl63ea"&gt;SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the years ended June 30, 2025 and 2024 the
Company paid $&lt;span id="xdx_903_eus-gaap--InterestPaidNet_c20240701__20250630_z42SXLb4y4Yb" title="Interest paid"&gt;25,611&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--InterestPaidNet_c20230701__20240630_zPx1cOrYYzfj" title="Interest paid"&gt;76,997&lt;/span&gt; for interest, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the years ended June 30, 2025 and 2024 the
Company paid $&lt;span id="xdx_909_eus-gaap--IncomeTaxesPaid_c20240701__20250630_z0GJFXPYJKr7" title="Income taxes paid"&gt;4,664,984&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--IncomeTaxesPaid_c20230701__20240630_zKjeeh7NVvE1" title="Income taxes paid"&gt;507,139&lt;/span&gt; for income taxes, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the years ended June 30, 2025 and June 30,
2024, the Company obtained right-of-use and equipment assets in exchange for lease obligations of $&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentOwnedNet_iI_c20250630_zxyltGJu7v4g" title="Right-of-use and equipment assets"&gt;2,319,913&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentOwnedNet_iI_c20240630_zKZXhsTgmJO7" title="Right-of-use and equipment assets"&gt;9,471,883&lt;/span&gt; respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended June 30, 2025, the Company sold
a &lt;span id="xdx_90B_eus-gaap--InvestmentInterestRate_iI_dp_c20250630_zv2zlDVfkmb9" title="Interest rate"&gt;0.197&lt;/span&gt;% interest in HDM to an employee. The interest was sold for $&lt;span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240701__20250630_zJrVBaayfhW5" title="Noncash transaction amount"&gt;132,000&lt;/span&gt; in a noncash transaction.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;



















</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaidNet
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001977"
      unitRef="USD">25611</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001979"
      unitRef="USD">76997</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001981"
      unitRef="USD">4664984</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2023-07-012024-06-30"
      decimals="0"
      id="Fact001983"
      unitRef="USD">507139</us-gaap:IncomeTaxesPaid>
    <us-gaap:PropertyPlantAndEquipmentOwnedNet
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001985"
      unitRef="USD">2319913</us-gaap:PropertyPlantAndEquipmentOwnedNet>
    <us-gaap:PropertyPlantAndEquipmentOwnedNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001987"
      unitRef="USD">9471883</us-gaap:PropertyPlantAndEquipmentOwnedNet>
    <us-gaap:InvestmentInterestRate
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact001989"
      unitRef="Ratio">0.00197</us-gaap:InvestmentInterestRate>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact001991"
      unitRef="USD">132000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact002001">&lt;p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zpUG0KnsThM" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 14 &#x2013; &lt;span id="xdx_82D_zFpmYKESBr7j"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 31, 2023, the Company entered into an
agreement with Magnetic Resonance Management, LLC (&#x201c;MRM&#x201d;) for the sale of a MRI scanner. MRM is owned by the CEO and President
of the Company. The sales price of the equipment was $&lt;span id="xdx_90C_eus-gaap--ConvertibleNotesPayable_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zkrMirZO7Meg" title="Sale of price of the equipment"&gt;576,857&lt;/span&gt; which is payable based upon a promissory note dated December 1, 2023. The
note bears interest at a rate of &lt;span id="xdx_90A_eus-gaap--DerivativeFixedInterestRate_iI_dp_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zbQ9QMeVfTU4" title="Bears interest rate"&gt;9&lt;/span&gt;% and is payable in full at the maturity of the note in December 2028. The MRI scanner had zero basis,
which resulted in a gain of $&lt;span id="xdx_90E_eus-gaap--DeferredGainOnSaleOfProperty_iI_c20231231__us-gaap--TypeOfArrangementAxis__custom--MagneticResonanceManagementMember_zNIj57nY94ya" title="Gain on sale of equipments"&gt;576,857&lt;/span&gt;. The Company has the option but not the obligation to re-take possession of the scanner in lieu of
payment upon maturity of the note. During fiscal year ended June 30, 2025, MRM paid $&lt;span id="xdx_908_ecustom--PrincipalAmount_c20240701__20250630_z6nufPoWChv7" title="Principal amount"&gt;22,000&lt;/span&gt; towards the principal balance.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_904_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20240701__20250630__dei--LegalEntityAxis__custom--BensonhurstMRILimitedPartnershipMember_zenXvxMENrQg" title="Related party transaction, description"&gt;Bensonhurst MRI Limited Partnership (&#x201c;Bensonhurst&#x201d;),
in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum. On February 1, 2024, Bensonhurst entered into a second contract with the
Company for the service and maintenance of a High-Field MRI Scanner for a price of $70,000 per annum. Also during fiscal year ended June
30, 2025 and 2024, the Company charged Bensonhurst MRI Limited Partnership $344,068 and $190,362, respectively, for reimbursable salaries
and marketing expenses&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Integrity Healthcare Management, LLC, which is owned
by the CEO and President of the Company owns a 7.1% interest in HMCA&#x2019;s Class A membership and receives distributions from the Company.&lt;/p&gt;
&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_905_eus-gaap--RelatedPartyTransactionDescriptionOfTransaction_c20240701__20250630__dei--LegalEntityAxis__custom--RadianHealthcareManagementLLCMember_zdAylJW2iSYa" title="Related party transaction, description"&gt;Radian Healthcare Management, LLC (&#x201c;Radian&#x201d;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of new employees
at a fee of approximately $165,000 and $200,000 during the fiscal year ended June 30, 2025 and 2024, respectively&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There are two board of directors that own .04% and
.02% interest in HMCA&#x2019;s Class A membership, respectively. Each board member receives distributions from the Company with regards
to these interests.&#160;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember"
      decimals="0"
      id="Fact002003"
      unitRef="USD">576857</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember"
      decimals="INF"
      id="Fact002005"
      unitRef="Ratio">0.09</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DeferredGainOnSaleOfProperty
      contextRef="AsOf2023-12-31_custom_MagneticResonanceManagementMember"
      decimals="0"
      id="Fact002007"
      unitRef="USD">576857</us-gaap:DeferredGainOnSaleOfProperty>
    <FONR:PrincipalAmount
      contextRef="From2024-07-01to2025-06-30"
      decimals="0"
      id="Fact002009"
      unitRef="USD">22000</FONR:PrincipalAmount>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction
      contextRef="From2024-07-012025-06-30_custom_BensonhurstMRILimitedPartnershipMember"
      id="Fact002011">Bensonhurst MRI Limited Partnership (&#x201c;Bensonhurst&#x201d;),
in which the CEO and President of the Company holds an interest, is party to an agreement with the Company for the service and maintenance
of its Upright MRI Scanner for a price of $110,000 per annum. On February 1, 2024, Bensonhurst entered into a second contract with the
Company for the service and maintenance of a High-Field MRI Scanner for a price of $70,000 per annum. Also during fiscal year ended June
30, 2025 and 2024, the Company charged Bensonhurst MRI Limited Partnership $344,068 and $190,362, respectively, for reimbursable salaries
and marketing expenses</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction
      contextRef="From2024-07-012025-06-30_custom_RadianHealthcareManagementLLCMember"
      id="Fact002013">Radian Healthcare Management, LLC (&#x201c;Radian&#x201d;),
which is owned by the son-in-law of the CEO and President of the Company provided the Company with personnel recruitment of new employees
at a fee of approximately $165,000 and $200,000 during the fiscal year ended June 30, 2025 and 2024, respectively</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact002015">&lt;p id="xdx_80F_eus-gaap--SegmentReportingDisclosureTextBlock_zlPtMRktvl17" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 15 - &lt;span id="xdx_825_zegfbXbc3Gmi"&gt;SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company provides segment data in accordance with
the provisions of ASC 280, &#x201c;Disclosures about Segments of an Enterprise and Related Information&#x201d; which was adopted during
our fiscal ending June 30, 2025.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our chief operating decision maker (&#x201c;CODM&#x201d;),
who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit
and loss statements prepared on a basis not consistent with GAAP. The CODM considers actual to budget and current year actual to prior
year actual for revenue and other profit and loss measures on a monthly basis for evaluating performance of each segment and making decisions
about allocating capital and other resources to each segment.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company operates in two industry segments - manufacturing
and the servicing of medical equipment and management of diagnostic imaging centers.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accounting policies of the segments are the same
as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance
based on income or loss from operations.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Summarized financial information concerning the Company&#x2019;s
reportable segments is shown in the following table:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Summarized Segment Financial Information&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zYhbXlhCHZZ1" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zh3MCVY7AYy5" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Segment Financial Information&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_492_20240701__20250630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_z75PQFVNZ2ha" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_494_20240701__20250630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_z68KcaR412ok" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_495_20240701__20250630__srt--ProductOrServiceAxis__custom--TotalMember_zTtua83YJq46" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Manufacturing and Servicing of Medical&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Management of Diagnostic Imaging&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fiscal
2025:&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Centers&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--Revenues_zfW3Cp1P8sp2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
revenues from external customers&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,977,349&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95,373,969&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;104,351,318&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Cost
of Sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--PaymentsToEmployees_zjT3WxjA7fPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,905,311&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;19,384,410&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;22,289,721&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--RentExpenses_z1Yr3uTf96Dj" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Rent
expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2037"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,822,044&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,822,044&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zgGNgBinrmV1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
Cost of sales expenses**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,944,740&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;31,385,807&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;34,330,547&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--CostOfSales_zfWFzJDf6m2b" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Total
Cost of sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;5,850,051&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;55,592,261&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;61,442,312&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Research
and development&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--SalariesAndWages_zMQtQgFIE45" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;766,963&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2050"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;766,963&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9uybozGKOml" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
research and development costs**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;809,123&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2054"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;809,123&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zynPxaQwa9B8" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
                                            Research and development costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,576,086&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2058"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,576,086&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zgrFMbaYDFfb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Selling,
general and administrative expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--SalariesAndWage_i01_zYO9T4bJaXi2" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,934,716&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;10,983,643&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;15,918,359&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--RentsExpense_i01I_z5BxBWbdH3I" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Rent
expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;1,251,924&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;36,528&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;1,288,452&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zLKPgau1ciRb" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
selling, general and administrative expenses**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,970,693&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;9,556,659&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;12,527,352&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zPEfSE3mQkx2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,157,333&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,576,830&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,734,163&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_z8XhFpbBeyRc" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
costs and expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,619,740&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;76,133,091&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;92,752,561&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_z2k4vhdxzObf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)
Income from operations&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,606,121&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,204,878&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,598,757&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zHcmnnUVeGk" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment
income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;107,777&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,011,203&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,118,980&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherIncome_i01_zxmENsXyrvUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,508&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,993&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,501&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_z3uPmdmQWykb" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)
Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,445,836&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,226,074&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,780,238&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_z4OGAFthe3i7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision
for income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,885,852&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(220,953&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,106,805&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zhqb4FFRlRbe" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
(Loss) income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,331,688&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,005,121&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,673,433&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zWPAILzhwOs3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intersegment
net revenues *&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,189,130&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2110"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,189,130&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zYYOKMJdD3A7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
and amortization&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;209,325&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,488,996&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,698,321&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_z0lqDLXnYJ25" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
identifiable assets&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,401,915&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;182,646,336&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;217,048,251&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zFUPHbu0jJ2g" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capital
expenditures&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;375,599&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,441,307&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,816,906&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0; display: none"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt; width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fiscal
2024:&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_49B_20230701__20240630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_zzq02cpMvnK2" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_495_20230701__20240630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_zMRIQhRT3iZ1" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_496_20230701__20240630__srt--ProductOrServiceAxis__custom--TotalMember_zM7IjUX6DS01" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--Revenues_zb86Ch12H8fc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
revenues from external customers&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,329,106&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;94,554,983&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,884,089&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Cost
of Sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--PaymentsToEmployees_zH4UUXMvvoxh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,684,218&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;18,913,412&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;21,597,630&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--RentExpenses_z54u34xz7Zk8" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Rent
expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2133"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,532,535&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,532,535&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zq88IQEDH58h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
Cost of sales expenses**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,089,924&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;29,523,955&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;31,613,879&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--CostOfSales_zj38kTaMAc1a" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
Cost of sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,774,142&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,969,902&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,744,044&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Research
and development&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--SalariesAndWages_zy65EV3XrRCg" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;781,012&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2146"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;781,012&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9a9ZMeM3JM7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
research and development costs**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;954,937&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2150"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;954,937&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zir0Tax1ENmh" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
Research and development costs&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,735,949&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2154"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,735,949&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zw2LaAHeJZlh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Selling,
general and administrative expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--SalariesAndWage_i01_zB1kSzzPOhN3" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,794,512&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;10,156,520&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;14,951,032&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--RentsExpense_i01I_zAqT0Vq6o0Lk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Rent
expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;1,076,069&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;73,676&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;1,149,745&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zd85oqp6Si21" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
selling, general and administrative expenses**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,906,446&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;7,861,509&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;10,767,955&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zJGIWhp93SIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Selling,
general and administrative expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,777,027&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,091,705&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,868,732&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_zvgoRlZDs9i" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
costs and expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,287,118&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,061,607&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;86,348,725&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_zNyJ92lXc85a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)
Income from operations&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,958,012&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,493,376&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,535,364&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zhAQNu6NDD22" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment
income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;120,387&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,006,052&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,126,439&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherIncome_i01_zxanVwLepIFa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
income (expenses)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;640,952&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(36,370&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;604,582&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_ztVcI96nKx56" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)
Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,196,673&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,463,058&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,266,385&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_zhTaKpsZkPN3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision
for income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,788,028&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(380,940&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,168,968&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zk90qy0PsyY7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
(Loss) income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,984,701&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,082,118&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,097,417&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zg9dIGI9lyrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intersegment
net revenues *&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,073,333&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2206"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,073,333&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zKwyCPqTjJTd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
and amortization&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;238,802&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,357,619&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,596,421&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_ztOyj3w6ikrl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
identifiable assets&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;30,360,188&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;183,885,781&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;214,245,969&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zVZmutmiwEsj" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capital
expenditures&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;32,885&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;789,961&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;822,846&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 2%; vertical-align: top"&gt;&#160;*&lt;/td&gt;
&lt;td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 98%; vertical-align: top"&gt;Amounts eliminated in consolidation&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top"&gt;**&lt;/td&gt;
&lt;td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top"&gt;Other segment costs include supplies, professional fees, marketing expenses, repairs and maintenance and other operational costs.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AC_zXX8JpLPlUn9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

























&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Export Product Sales&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s areas of operations are principally
in the United States. The Company had export sales of medical equipment amounting to &lt;span id="xdx_90B_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20240701__20250630_zASkbpQfzBm7" title="Export sales of medical equipment percentage"&gt;1.4&lt;/span&gt;% and &lt;span id="xdx_90E_ecustom--ExportSalesOfMedicalEquipmentPercentage_dp_c20230701__20240630_zzYS8b3O6ZXa" title="Export sales of medical equipment percentage"&gt;0.2&lt;/span&gt;% of product sales revenues to third
parties for the years ended June 30, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The foreign product sales, as a percentage of product
sales to unrelated parties, were made to customers in the following countries:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfExportProductSalesTableTextBlock_zktkVbGR99Kf" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B2_zDos5Oooi5Oj" style="display: none"&gt;Schedule of export product sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-indent: -10pt"&gt;Canada&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignProductSales_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zAFjhC2VJzWj" title="Foreign product sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2238"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zE8ravCbTAe" title="Foreign product sales"&gt;0.2&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Puerto Rico&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zZOazIXJ73h2" title="Foreign product sales"&gt;1.4&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zbrlHoQ089Pe" title="Foreign product sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2244"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignProductSales_dp_c20240701__20250630_znq8yXaYTZj1" title="Foreign product sales"&gt;1.4&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_ziHDOYYJSywg" title="Foreign product sales"&gt;0.2&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8A8_zrv5UTh21Oml" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Foreign Service and Repair Fees&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s areas of service and repair are
principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to &lt;span id="xdx_90A_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20240701__20250630_zfoHy8WBXIdf" title="Percentage of service and repair of medical equipment"&gt;7.7&lt;/span&gt;% and &lt;span id="xdx_905_ecustom--ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage_dp_c20230701__20240630_zm3J2HR3bxOg" title="Percentage of service and repair of medical equipment"&gt;7.4&lt;/span&gt;%
of consolidated net service and repair fees for the years ended June 30, 2025 and 2024, respectively. Foreign service and repair fees,
as a percentage of total service and repair fees, were provided principally to the following countries:&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;Foreign Service and Repair Fees&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_zVvcKbfNzhj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zkoqgXrUWfsj" style="display: none"&gt;Schedule of Foreign Service and Repair Fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Puerto Rico&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--PR_zahWiMhoB0Pb" title="Foreign service and repair fees"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_zGBsn9gzUh3h" title="Foreign service and repair fees"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Switzerland&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CH_zZ3RJee8l0m2" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5vTlo7PZQI9" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Germany&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DE_z460oljBXZ4g" title="Foreign service and repair fees"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_z3cQptNL8l3a" title="Foreign service and repair fees"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;England&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zaYtPudlI672" title="Foreign service and repair fees"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_zh4W6et8D85f" title="Foreign service and repair fees"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;United Arab Emirates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AE_z03a2vakMff6" title="Foreign service and repair fees"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zvFwShrcAT7" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Dominican Republic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DO_zLsvieGw6MK7" title="Foreign service and repair fees"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zSOqJjt6AuMg" title="Foreign service and repair fees"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Canada&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp0_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zgbYa5DcdHh6" title="Foreign service and repair fees"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zbyunX35CtWf" title="Foreign service and repair fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2282"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Greece&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GR_zXFceWHYfoz4" title="Foreign service and repair fees"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_zwczRDuYtm6a" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Australia&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AU_zY43EsoddYge" title="Foreign service and repair fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2288"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zpKiWFhumPT4" title="Foreign service and repair fees"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630_zBTPo9XoCkGe" title="Foreign service and repair fees"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zis670RjOva8" title="Foreign service and repair fees"&gt;7.4&lt;/span&gt;.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8A4_zj1Vf1KrNOdg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;The Company does not have any material assets
outside of the United States.&#160;&lt;br/&gt;
&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;















</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact002027">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zYhbXlhCHZZ1" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zh3MCVY7AYy5" style="display: none; font-family: Times New Roman, Times, Serif"&gt;Schedule
of Segment Financial Information&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_492_20240701__20250630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_z75PQFVNZ2ha" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_494_20240701__20250630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_z68KcaR412ok" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_495_20240701__20250630__srt--ProductOrServiceAxis__custom--TotalMember_zTtua83YJq46" style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Manufacturing and Servicing of Medical&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Management of Diagnostic Imaging&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fiscal
2025:&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Centers&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--Revenues_zfW3Cp1P8sp2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; width: 46%; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
revenues from external customers&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,977,349&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;95,373,969&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;104,351,318&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Cost
of Sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--PaymentsToEmployees_zjT3WxjA7fPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,905,311&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;19,384,410&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;22,289,721&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--RentExpenses_z1Yr3uTf96Dj" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Rent
expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2037"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,822,044&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,822,044&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zgGNgBinrmV1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
Cost of sales expenses**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,944,740&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;31,385,807&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;34,330,547&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--CostOfSales_zfWFzJDf6m2b" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Total
Cost of sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;5,850,051&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;55,592,261&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;61,442,312&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Research
and development&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--SalariesAndWages_zMQtQgFIE45" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;766,963&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2050"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;766,963&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9uybozGKOml" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
research and development costs**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;809,123&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2054"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;809,123&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zynPxaQwa9B8" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
                                            Research and development costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,576,086&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2058"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,576,086&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zgrFMbaYDFfb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Selling,
general and administrative expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--SalariesAndWage_i01_zYO9T4bJaXi2" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,934,716&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;10,983,643&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;15,918,359&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--RentsExpense_i01I_z5BxBWbdH3I" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Rent
expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;1,251,924&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;36,528&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;1,288,452&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zLKPgau1ciRb" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
selling, general and administrative expenses**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,970,693&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;9,556,659&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;12,527,352&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zPEfSE3mQkx2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,157,333&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,576,830&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,734,163&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_z8XhFpbBeyRc" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
costs and expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,619,740&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;76,133,091&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;92,752,561&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_z2k4vhdxzObf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)
Income from operations&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,606,121&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,204,878&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,598,757&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zHcmnnUVeGk" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment
income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;107,777&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,011,203&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,118,980&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherIncome_i01_zxmENsXyrvUl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,508&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,993&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,501&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_z3uPmdmQWykb" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)
Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,445,836&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,226,074&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,780,238&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_z4OGAFthe3i7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision
for income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,885,852&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(220,953&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,106,805&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zhqb4FFRlRbe" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
(Loss) income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,331,688&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;21,005,121&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,673,433&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zWPAILzhwOs3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intersegment
net revenues *&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,189,130&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2110"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,189,130&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zYYOKMJdD3A7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
and amortization&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;209,325&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,488,996&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,698,321&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_z0lqDLXnYJ25" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
identifiable assets&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;34,401,915&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;182,646,336&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;217,048,251&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zFUPHbu0jJ2g" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capital
expenditures&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;375,599&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,441,307&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,816,906&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0; display: none"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Summarized segments - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="border-bottom: Black 1pt solid; padding: 0pt 0pt 1pt 10pt; text-align: left; text-indent: -10pt; width: 46%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fiscal
2024:&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_49B_20230701__20240630__srt--ProductOrServiceAxis__custom--ManufacturingandServicingofMedicalEquipmentMember_zzq02cpMvnK2" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_495_20230701__20240630__srt--ProductOrServiceAxis__custom--ManagementofDiagnosticImagingCentersMember_zMRIQhRT3iZ1" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td id="xdx_496_20230701__20240630__srt--ProductOrServiceAxis__custom--TotalMember_zM7IjUX6DS01" style="border-bottom: Black 1pt solid; text-align: right; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--Revenues_zb86Ch12H8fc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
revenues from external customers&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,329,106&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;94,554,983&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;102,884,089&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Cost
of Sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--PaymentsToEmployees_zH4UUXMvvoxh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,684,218&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;18,913,412&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;21,597,630&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--RentExpenses_z54u34xz7Zk8" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Rent
expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2133"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,532,535&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,532,535&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--OtherCostOfSalesExpenses_zq88IQEDH58h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
Cost of sales expenses**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,089,924&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;29,523,955&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;31,613,879&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--CostOfSales_zj38kTaMAc1a" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
Cost of sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,774,142&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,969,902&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,744,044&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Research
and development&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--SalariesAndWages_zy65EV3XrRCg" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;781,012&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2146"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;781,012&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_z9a9ZMeM3JM7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
research and development costs**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;954,937&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2150"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;954,937&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_zir0Tax1ENmh" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
Research and development costs&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,735,949&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2154"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,735,949&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCAEzSDb_zw2LaAHeJZlh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Selling,
general and administrative expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--SalariesAndWage_i01_zB1kSzzPOhN3" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Salaries
and wages&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;4,794,512&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;10,156,520&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;14,951,032&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--RentsExpense_i01I_zAqT0Vq6o0Lk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Rent
expense&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;1,076,069&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;73,676&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;1,149,745&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--OtherSellingGeneralAndAdministrativeExpenses_i01_zd85oqp6Si21" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;Other
selling, general and administrative expenses**&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;2,906,446&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;7,861,509&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;10,767,955&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--BenefitsLossesAndExpenses_i01_zJGIWhp93SIc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Selling,
general and administrative expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,777,027&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;18,091,705&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,868,732&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--TotalCostsAndExpenses_i01_zvgoRlZDs9i" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
costs and expenses&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,287,118&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,061,607&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;86,348,725&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperations_i01_zNyJ92lXc85a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)
Income from operations&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,958,012&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;23,493,376&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,535,364&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ImpairmentOfInvestments_i01_zhAQNu6NDD22" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investment
income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;120,387&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,006,052&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,126,439&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OtherIncome_i01_zxanVwLepIFa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
income (expenses)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;640,952&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(36,370&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;604,582&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_i01_ztVcI96nKx56" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)
Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(6,196,673&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,463,058&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,266,385&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_i01_zhTaKpsZkPN3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Provision
for income taxes&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,788,028&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(380,940&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(5,168,968&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zk90qy0PsyY7" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
(Loss) income&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,984,701&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,082,118&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,097,417&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--IntersegmentNetRevenues_i01_zg9dIGI9lyrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Intersegment
net revenues *&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,073,333&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2206"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,073,333&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DepreciationAndAmortization_i01_zKwyCPqTjJTd" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Depreciation
and amortization&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;238,802&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,357,619&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,596,421&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--TotalIdentifiableAssets_i01_ztOyj3w6ikrl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
identifiable assets&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;30,360,188&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;183,885,781&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;214,245,969&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--CapitalExpenditures_i01_zVZmutmiwEsj" style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capital
expenditures&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;32,885&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;789,961&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;822,846&lt;/span&gt;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 2%; vertical-align: top"&gt;&#160;*&lt;/td&gt;
&lt;td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; width: 98%; vertical-align: top"&gt;Amounts eliminated in consolidation&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="font: 12pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top"&gt;**&lt;/td&gt;
&lt;td style="font: 11pt/115% Times New Roman, Times, Serif; padding: 0pt; text-align: left; text-indent: 0pt; vertical-align: top"&gt;Other segment costs include supplies, professional fees, marketing expenses, repairs and maintenance and other operational costs.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002029"
      unitRef="USD">8977349</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002030"
      unitRef="USD">95373969</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002031"
      unitRef="USD">104351318</us-gaap:Revenues>
    <us-gaap:PaymentsToEmployees
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002033"
      unitRef="USD">2905311</us-gaap:PaymentsToEmployees>
    <us-gaap:PaymentsToEmployees
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002034"
      unitRef="USD">19384410</us-gaap:PaymentsToEmployees>
    <us-gaap:PaymentsToEmployees
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002035"
      unitRef="USD">22289721</us-gaap:PaymentsToEmployees>
    <FONR:RentExpenses
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002038"
      unitRef="USD">4822044</FONR:RentExpenses>
    <FONR:RentExpenses
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002039"
      unitRef="USD">4822044</FONR:RentExpenses>
    <FONR:OtherCostOfSalesExpenses
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002041"
      unitRef="USD">2944740</FONR:OtherCostOfSalesExpenses>
    <FONR:OtherCostOfSalesExpenses
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002042"
      unitRef="USD">31385807</FONR:OtherCostOfSalesExpenses>
    <FONR:OtherCostOfSalesExpenses
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002043"
      unitRef="USD">34330547</FONR:OtherCostOfSalesExpenses>
    <FONR:CostOfSales
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002045"
      unitRef="USD">5850051</FONR:CostOfSales>
    <FONR:CostOfSales
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002046"
      unitRef="USD">55592261</FONR:CostOfSales>
    <FONR:CostOfSales
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002047"
      unitRef="USD">61442312</FONR:CostOfSales>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002049"
      unitRef="USD">766963</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002051"
      unitRef="USD">766963</us-gaap:SalariesAndWages>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002053"
      unitRef="USD">809123</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002055"
      unitRef="USD">809123</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002057"
      unitRef="USD">1576086</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002059"
      unitRef="USD">1576086</us-gaap:ResearchAndDevelopmentExpense>
    <FONR:SalariesAndWage
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002065"
      unitRef="USD">4934716</FONR:SalariesAndWage>
    <FONR:SalariesAndWage
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002066"
      unitRef="USD">10983643</FONR:SalariesAndWage>
    <FONR:SalariesAndWage
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002067"
      unitRef="USD">15918359</FONR:SalariesAndWage>
    <FONR:RentsExpense
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002069"
      unitRef="USD">1251924</FONR:RentsExpense>
    <FONR:RentsExpense
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002070"
      unitRef="USD">36528</FONR:RentsExpense>
    <FONR:RentsExpense
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002071"
      unitRef="USD">1288452</FONR:RentsExpense>
    <FONR:OtherSellingGeneralAndAdministrativeExpenses
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002073"
      unitRef="USD">2970693</FONR:OtherSellingGeneralAndAdministrativeExpenses>
    <FONR:OtherSellingGeneralAndAdministrativeExpenses
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002074"
      unitRef="USD">9556659</FONR:OtherSellingGeneralAndAdministrativeExpenses>
    <FONR:OtherSellingGeneralAndAdministrativeExpenses
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002075"
      unitRef="USD">12527352</FONR:OtherSellingGeneralAndAdministrativeExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002077"
      unitRef="USD">9157333</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002078"
      unitRef="USD">20576830</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002079"
      unitRef="USD">29734163</us-gaap:BenefitsLossesAndExpenses>
    <FONR:TotalCostsAndExpenses
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002081"
      unitRef="USD">16619740</FONR:TotalCostsAndExpenses>
    <FONR:TotalCostsAndExpenses
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002082"
      unitRef="USD">76133091</FONR:TotalCostsAndExpenses>
    <FONR:TotalCostsAndExpenses
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002083"
      unitRef="USD">92752561</FONR:TotalCostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002085"
      unitRef="USD">-7606121</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002086"
      unitRef="USD">19204878</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002087"
      unitRef="USD">11598757</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002089"
      unitRef="USD">107777</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002090"
      unitRef="USD">2011203</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002091"
      unitRef="USD">2118980</us-gaap:ImpairmentOfInvestments>
    <us-gaap:OtherIncome
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002093"
      unitRef="USD">52508</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002094"
      unitRef="USD">9993</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002095"
      unitRef="USD">62501</us-gaap:OtherIncome>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002097"
      unitRef="USD">-7445836</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002098"
      unitRef="USD">21226074</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002099"
      unitRef="USD">13780238</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002101"
      unitRef="USD">-2885852</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002102"
      unitRef="USD">-220953</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002103"
      unitRef="USD">-3106805</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002105"
      unitRef="USD">-10331688</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002106"
      unitRef="USD">21005121</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002107"
      unitRef="USD">10673433</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <FONR:IntersegmentNetRevenues
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002109"
      unitRef="USD">1189130</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002111"
      unitRef="USD">1189130</FONR:IntersegmentNetRevenues>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002113"
      unitRef="USD">209325</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002114"
      unitRef="USD">4488996</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002115"
      unitRef="USD">4698321</us-gaap:DepreciationAndAmortization>
    <FONR:TotalIdentifiableAssets
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002117"
      unitRef="USD">34401915</FONR:TotalIdentifiableAssets>
    <FONR:TotalIdentifiableAssets
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002118"
      unitRef="USD">182646336</FONR:TotalIdentifiableAssets>
    <FONR:TotalIdentifiableAssets
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002119"
      unitRef="USD">217048251</FONR:TotalIdentifiableAssets>
    <FONR:CapitalExpenditures
      contextRef="From2024-07-012025-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002121"
      unitRef="USD">375599</FONR:CapitalExpenditures>
    <FONR:CapitalExpenditures
      contextRef="From2024-07-012025-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002122"
      unitRef="USD">3441307</FONR:CapitalExpenditures>
    <FONR:CapitalExpenditures
      contextRef="From2024-07-012025-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002123"
      unitRef="USD">3816906</FONR:CapitalExpenditures>
    <us-gaap:Revenues
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002125"
      unitRef="USD">8329106</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002126"
      unitRef="USD">94554983</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002127"
      unitRef="USD">102884089</us-gaap:Revenues>
    <us-gaap:PaymentsToEmployees
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002129"
      unitRef="USD">2684218</us-gaap:PaymentsToEmployees>
    <us-gaap:PaymentsToEmployees
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002130"
      unitRef="USD">18913412</us-gaap:PaymentsToEmployees>
    <us-gaap:PaymentsToEmployees
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002131"
      unitRef="USD">21597630</us-gaap:PaymentsToEmployees>
    <FONR:RentExpenses
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002134"
      unitRef="USD">4532535</FONR:RentExpenses>
    <FONR:RentExpenses
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002135"
      unitRef="USD">4532535</FONR:RentExpenses>
    <FONR:OtherCostOfSalesExpenses
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002137"
      unitRef="USD">2089924</FONR:OtherCostOfSalesExpenses>
    <FONR:OtherCostOfSalesExpenses
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002138"
      unitRef="USD">29523955</FONR:OtherCostOfSalesExpenses>
    <FONR:OtherCostOfSalesExpenses
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002139"
      unitRef="USD">31613879</FONR:OtherCostOfSalesExpenses>
    <FONR:CostOfSales
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002141"
      unitRef="USD">4774142</FONR:CostOfSales>
    <FONR:CostOfSales
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002142"
      unitRef="USD">52969902</FONR:CostOfSales>
    <FONR:CostOfSales
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002143"
      unitRef="USD">57744044</FONR:CostOfSales>
    <us-gaap:SalariesAndWages
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002145"
      unitRef="USD">781012</us-gaap:SalariesAndWages>
    <us-gaap:SalariesAndWages
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002147"
      unitRef="USD">781012</us-gaap:SalariesAndWages>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002149"
      unitRef="USD">954937</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002151"
      unitRef="USD">954937</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002153"
      unitRef="USD">1735949</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002155"
      unitRef="USD">1735949</us-gaap:ResearchAndDevelopmentExpense>
    <FONR:SalariesAndWage
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002161"
      unitRef="USD">4794512</FONR:SalariesAndWage>
    <FONR:SalariesAndWage
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002162"
      unitRef="USD">10156520</FONR:SalariesAndWage>
    <FONR:SalariesAndWage
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002163"
      unitRef="USD">14951032</FONR:SalariesAndWage>
    <FONR:RentsExpense
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002165"
      unitRef="USD">1076069</FONR:RentsExpense>
    <FONR:RentsExpense
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002166"
      unitRef="USD">73676</FONR:RentsExpense>
    <FONR:RentsExpense
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002167"
      unitRef="USD">1149745</FONR:RentsExpense>
    <FONR:OtherSellingGeneralAndAdministrativeExpenses
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002169"
      unitRef="USD">2906446</FONR:OtherSellingGeneralAndAdministrativeExpenses>
    <FONR:OtherSellingGeneralAndAdministrativeExpenses
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002170"
      unitRef="USD">7861509</FONR:OtherSellingGeneralAndAdministrativeExpenses>
    <FONR:OtherSellingGeneralAndAdministrativeExpenses
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002171"
      unitRef="USD">10767955</FONR:OtherSellingGeneralAndAdministrativeExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002173"
      unitRef="USD">8777027</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002174"
      unitRef="USD">18091705</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002175"
      unitRef="USD">26868732</us-gaap:BenefitsLossesAndExpenses>
    <FONR:TotalCostsAndExpenses
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002177"
      unitRef="USD">15287118</FONR:TotalCostsAndExpenses>
    <FONR:TotalCostsAndExpenses
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002178"
      unitRef="USD">71061607</FONR:TotalCostsAndExpenses>
    <FONR:TotalCostsAndExpenses
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002179"
      unitRef="USD">86348725</FONR:TotalCostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002181"
      unitRef="USD">-6958012</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002182"
      unitRef="USD">23493376</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002183"
      unitRef="USD">16535364</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002185"
      unitRef="USD">120387</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002186"
      unitRef="USD">2006052</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002187"
      unitRef="USD">2126439</us-gaap:ImpairmentOfInvestments>
    <us-gaap:OtherIncome
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002189"
      unitRef="USD">640952</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002190"
      unitRef="USD">-36370</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002191"
      unitRef="USD">604582</us-gaap:OtherIncome>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002193"
      unitRef="USD">-6196673</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002194"
      unitRef="USD">25463058</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002195"
      unitRef="USD">19266385</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002197"
      unitRef="USD">-4788028</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002198"
      unitRef="USD">-380940</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002199"
      unitRef="USD">-5168968</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002201"
      unitRef="USD">-10984701</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002202"
      unitRef="USD">25082118</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002203"
      unitRef="USD">14097417</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002205"
      unitRef="USD">1073333</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002207"
      unitRef="USD">1073333</FONR:IntersegmentNetRevenues>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002209"
      unitRef="USD">238802</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002210"
      unitRef="USD">4357619</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002211"
      unitRef="USD">4596421</us-gaap:DepreciationAndAmortization>
    <FONR:TotalIdentifiableAssets
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002213"
      unitRef="USD">30360188</FONR:TotalIdentifiableAssets>
    <FONR:TotalIdentifiableAssets
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002214"
      unitRef="USD">183885781</FONR:TotalIdentifiableAssets>
    <FONR:TotalIdentifiableAssets
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002215"
      unitRef="USD">214245969</FONR:TotalIdentifiableAssets>
    <FONR:CapitalExpenditures
      contextRef="From2023-07-012024-06-30_custom_ManufacturingandServicingofMedicalEquipmentMember"
      decimals="0"
      id="Fact002217"
      unitRef="USD">32885</FONR:CapitalExpenditures>
    <FONR:CapitalExpenditures
      contextRef="From2023-07-012024-06-30_custom_ManagementofDiagnosticImagingCentersMember"
      decimals="0"
      id="Fact002218"
      unitRef="USD">789961</FONR:CapitalExpenditures>
    <FONR:CapitalExpenditures
      contextRef="From2023-07-012024-06-30_custom_TotalMember"
      decimals="0"
      id="Fact002219"
      unitRef="USD">822846</FONR:CapitalExpenditures>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact002232"
      unitRef="Ratio">0.014</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ExportSalesOfMedicalEquipmentPercentage
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact002234"
      unitRef="Ratio">0.002</FONR:ExportSalesOfMedicalEquipmentPercentage>
    <FONR:ScheduleOfExportProductSalesTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact002236">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfExportProductSalesTableTextBlock_zktkVbGR99Kf" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign product sales - (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B2_zDos5Oooi5Oj" style="display: none"&gt;Schedule of export product sales&lt;/span&gt;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-indent: -10pt"&gt;Canada&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ForeignProductSales_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zAFjhC2VJzWj" title="Foreign product sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2238"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignProductSales_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zE8ravCbTAe" title="Foreign product sales"&gt;0.2&lt;/span&gt;&lt;/td&gt;
&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Puerto Rico&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignProductSales_dp_c20240701__20250630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zZOazIXJ73h2" title="Foreign product sales"&gt;1.4&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignProductSales_dp_c20230701__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoMember_zbrlHoQ089Pe" title="Foreign product sales"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2244"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
&lt;td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ForeignProductSales_dp_c20240701__20250630_znq8yXaYTZj1" title="Foreign product sales"&gt;1.4&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--ForeignProductSales_dp_c20230701__20240630_ziHDOYYJSywg" title="Foreign product sales"&gt;0.2&lt;/span&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

</FONR:ScheduleOfExportProductSalesTableTextBlock>
    <FONR:ForeignProductSales
      contextRef="From2023-07-012024-06-30_country_CA"
      decimals="INF"
      id="Fact002240"
      unitRef="Ratio">0.002</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2024-07-012025-06-30_custom_TwoMember"
      decimals="INF"
      id="Fact002242"
      unitRef="Ratio">0.014</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact002246"
      unitRef="Ratio">0.014</FONR:ForeignProductSales>
    <FONR:ForeignProductSales
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact002248"
      unitRef="Ratio">0.002</FONR:ForeignProductSales>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact002250"
      unitRef="Ratio">0.077</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact002252"
      unitRef="Ratio">0.074</FONR:ForeignRevenuesOfServiceAndRepairOfMedicalEquipmentPercentage>
    <FONR:ScheduleOfExportServiceRevenuesTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact002254">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfExportServiceRevenuesTableTextBlock_zVvcKbfNzhj" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Foreign service and repair fees - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&lt;span id="xdx_8B6_zkoqgXrUWfsj" style="display: none"&gt;Schedule of Foreign Service and Repair Fees&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; text-align: center"&gt;For the Years Ended June 30,&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt"&gt;Puerto Rico&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--PR_zahWiMhoB0Pb" title="Foreign service and repair fees"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 8%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--PR_zGBsn9gzUh3h" title="Foreign service and repair fees"&gt;1.9&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Switzerland&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--CH_zZ3RJee8l0m2" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CH_z5vTlo7PZQI9" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Germany&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DE_z460oljBXZ4g" title="Foreign service and repair fees"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DE_z3cQptNL8l3a" title="Foreign service and repair fees"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;England&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zaYtPudlI672" title="Foreign service and repair fees"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_zh4W6et8D85f" title="Foreign service and repair fees"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;United Arab Emirates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AE_z03a2vakMff6" title="Foreign service and repair fees"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AE_zvFwShrcAT7" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Dominican Republic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--DO_zLsvieGw6MK7" title="Foreign service and repair fees"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--DO_zSOqJjt6AuMg" title="Foreign service and repair fees"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Canada&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp0_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zgbYa5DcdHh6" title="Foreign service and repair fees"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zbyunX35CtWf" title="Foreign service and repair fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2282"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Greece&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--GR_zXFceWHYfoz4" title="Foreign service and repair fees"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--GR_zwczRDuYtm6a" title="Foreign service and repair fees"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;Australia&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_900_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630__srt--StatementGeographicalAxis__country--AU_zY43EsoddYge" title="Foreign service and repair fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2288"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630__srt--StatementGeographicalAxis__country--AU_zpKiWFhumPT4" title="Foreign service and repair fees"&gt;0.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--ForeignServiceAndRepairFees_dp_c20240701__20250630_zBTPo9XoCkGe" title="Foreign service and repair fees"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_90A_ecustom--ForeignServiceAndRepairFees_dp_c20230701__20240630_zis670RjOva8" title="Foreign service and repair fees"&gt;7.4&lt;/span&gt;.4&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

</FONR:ScheduleOfExportServiceRevenuesTableTextBlock>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-012025-06-30_country_PR"
      decimals="INF"
      id="Fact002256"
      unitRef="Ratio">0.013</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_PR"
      decimals="INF"
      id="Fact002258"
      unitRef="Ratio">0.019</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-012025-06-30_country_CH"
      decimals="INF"
      id="Fact002260"
      unitRef="Ratio">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_CH"
      decimals="INF"
      id="Fact002262"
      unitRef="Ratio">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-012025-06-30_country_DE"
      decimals="INF"
      id="Fact002264"
      unitRef="Ratio">0.030</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_DE"
      decimals="INF"
      id="Fact002266"
      unitRef="Ratio">0.020</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-012025-06-30_country_GB"
      decimals="INF"
      id="Fact002268"
      unitRef="Ratio">0.013</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_GB"
      decimals="INF"
      id="Fact002270"
      unitRef="Ratio">0.007</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-012025-06-30_country_AE"
      decimals="INF"
      id="Fact002272"
      unitRef="Ratio">0.001</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_AE"
      decimals="INF"
      id="Fact002274"
      unitRef="Ratio">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-012025-06-30_country_DO"
      decimals="INF"
      id="Fact002276"
      unitRef="Ratio">0.012</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_DO"
      decimals="INF"
      id="Fact002278"
      unitRef="Ratio">0.012</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-012025-06-30_country_CA"
      decimals="INF"
      id="Fact002280"
      unitRef="Ratio">0.001</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-012025-06-30_country_GR"
      decimals="INF"
      id="Fact002284"
      unitRef="Ratio">0.004</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_GR"
      decimals="INF"
      id="Fact002286"
      unitRef="Ratio">0.003</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30_country_AU"
      decimals="INF"
      id="Fact002290"
      unitRef="Ratio">0.007</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact002292"
      unitRef="Ratio">0.077</FONR:ForeignServiceAndRepairFees>
    <FONR:ForeignServiceAndRepairFees
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact002294"
      unitRef="Ratio">0.074</FONR:ForeignServiceAndRepairFees>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact002302">&lt;p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zZcabyD1Cvdc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 16 &#x2013; &lt;span id="xdx_824_zHpqgxAyOEL1"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluates events that have occurred after
the balance sheet date, but before the consolidated financial statements are issued.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On &lt;span style="font-family: Times New Roman, Times, Serif"&gt;July
7, 2025, the board of directors received a non-binding proposal from a group led by Timothy Damadian, the Company&#x2019;s Chief
Executive Officer, and Luciano Bonanni, the Company&#x2019;s Chief Operating Officer, pursuant to which proposal the group would
acquire all of the outstanding common stock and other securities of the Company not currently owned by the members of the group.
Members of the group have voting control of the Company&#x2019;s equity securities and the group advised the Company that it was
unwilling to support any alternative transaction. &#160;As proposed, the transaction, if completed, would result in the Company no
longer being a publicly held company, and its Common Stock would be de-listed from the NASDAQ Stock Market. &#160;The Board of
Directors has established a Special Committee of independent and disinterested directors to consider the proposal and negotiate on
behalf of the Company and its stockholders. The Special Committee has retained its own independent financial and legal advisors to
assist it in this process. The group and the Special Committee are engaged in negotiations related to the proposed going private
transaction. &#160;No definitive agreements or terms have been executed by the parties and there is no assurance that the
transaction will be completed. &#160;Any definitive agreement and transaction will require approval by the Company&#x2019;s common
stock holders and will require the filing of definitive proxy materials in accordance with the SEC&#x2019;s proxy rules to obtain
such approval. &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In July 2025, the Company entered into a new 10 year
lease for a property in New York where a new MRI is to be built&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact002303">

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;Rule 10b5-1 Trading Plan&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0"&gt;During the fiscal quarter ended June 30, 2025, none of our directors or
executive officers &lt;span id="xdx_902_eecd--Rule10b51ArrAdoptedFlag_dbT_c20240701__20250630_zAMPxrI1zmp6"&gt;&lt;span id="xdx_902_eecd--NonRule10b51ArrAdoptedFlag_dbT_c20240701__20250630_zvFnK9E6c852"&gt;adopted&lt;/span&gt;&lt;/span&gt; or &lt;span id="xdx_904_eecd--Rule10b51ArrTrmntdFlag_dbT_c20240701__20250630_zBHCJ2qOTrg9"&gt;&lt;span id="xdx_90A_eecd--NonRule10b51ArrTrmntdFlag_dbT_c20240701__20250630_zUYWMo65kmAj"&gt;terminated &lt;/span&gt;&lt;/span&gt;any contract, instruction or written plan for the purchase or sale of Company securities that
was intend to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &#x201c;non-Rule 10b5-1 trading arrangement&#x201d;.&lt;/p&gt;

</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2024-07-01to2025-06-30" id="Fact002304">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2024-07-01to2025-06-30" id="Fact002305">true</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2024-07-01to2025-06-30" id="Fact002306">true</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2024-07-01to2025-06-30" id="Fact002307">true</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
